{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_3hop_cross_year_type2",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 800,
    "successful_questions_in_experiment": 800,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 800,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/nemotron-nano-30b-reasoning/e6_semantic_retrieval/qualitative_3hop_cross_year_type2.json",
    "timestamp": "2026-02-04T16:14:47.575125"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "\nThe carrying amount of Broadcom’s 5.000 % senior notes due April 2030 was $606 million at the end of FY 2022 and stayed at roughly $606 million in FY 2023 and FY 2024, showing essentially no change.  This flat exposure reflects a deliberate strategy of retaining a long‑dated, fixed‑rate tranche as a low‑cost, stable funding pillar while managing overall leverage and extending the maturity profile of the company’s debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, AVGO's exposure was $1,086 million in 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. However, the LLM claims the amount was $606 million in 2022 and remained flat thereafter, which contradicts the actual downward trend. This error misrepresents the entire evolution of the debt exposure. (2) The quantitative accuracy is severely compromised: the starting value is wrong ($606M vs $1,086M), and the reported lack of change fails to capture the $480 million reduction from 2022 to 2023. The dates and percentages (5.000% notes due April 2030) are correct, but the core financial data is incorrect. (3) The multi-hop reasoning is flawed because the model fails to recognize the decrease between 2022 and 2023, leading to an incorrect conclusion about a 'flat' exposure. The ground truth indicates a deliberate debt reduction strategy, while the LLM interprets stability as a strategic choice, which is not supported by the actual data showing a significant paydown. (4) Contextual relevance is moderate—the answer discusses debt management strategy and references the correct instrument and company (AVGO/Broadcom), but the incorrect data undermines the validity of the interpretation. The reasoning would be plausible if the numbers were correct, but as it stands, the conclusion is based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 399,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to cede **exactly 59 % of the closed block** to an unaffiliated third‑party under a modified‑coinsurance arrangement, recording the transaction on a deposit basis and offsetting the deposit liability with a corresponding recoverable.  The unchanged 59 % share shows that the company deliberately maintains a stable, pre‑determined level of risk transfer for the closed block, underscoring a long‑term reinsurance strategy that relies on a consistent proportion of risk to be passed to external reinsurers while retaining the remainder on its books.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core fact that MetLife reinsured 59% of the closed block from 2022 to 2024 via a modified coinsurance agreement with an unaffiliated third party, and notes the use of the deposit method and right of offset—key elements from the ground truth. However, it states 'exactly 59%' each year, while the ground truth specifies 59.25% in 2022 and 59% in 2023 and 2024. This minor inaccuracy in precision for 2022 slightly affects quantitative accuracy. (2) The dollar amounts related to total net ceded reinsurance recoverables ($6.3B in 2021 referenced in 2022 filing, growing to $17.6B in 2024) are omitted in the LLM answer. While not directly part of the closed block percentage, this context highlights the significance of stable risk transfer amid growing reinsurance activity, and its absence reduces completeness. (3) The multi-hop reasoning is sound: the model correctly infers that consistent percentage ceded reflects a deliberate, long-term strategy for risk transfer efficiency and capital optimization, aligning with the ground truth's conclusion. (4) Despite minor omissions and slight imprecision in the 2022 percentage, the LLM captures the essential evolution (no change), accounting treatment, and strategic implication. Wording differs but meaning is semantically equivalent. Scores reflect high accuracy with room for improvement in numerical precision and contextual completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 401,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nThe collateral that ExxonMobil pledges under master‑netting arrangements tied to its investments, advances and long‑term receivables fell sharply – from about **$1.49 billion in 2022** to **$0.80 billion in 2023** and then to **$0.49 billion in 2024** (a decline of roughly $1 billion over the two‑year span).  \n\nThis downward trend signals that the company is **scaling back the external collateral it uses**, relying more on internal margin and netting mechanisms to manage derivative counterparty risk, and is adopting a more conservative stance toward its derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024), which match the ground truth of $1,494 million, $800 million, and $491 million when rounded appropriately. The statement about a roughly $1 billion decline over two years is accurate (1,494 - 491 = 1,003 million). 2) Quantitative accuracy is perfect—values are correctly converted between millions and billions, and the trend is accurately described. 3) The reasoning is sound: the downward trend is correctly interpreted as a reduction in pledged external collateral, suggesting improved internal netting or more conservative risk management. While the original answer emphasizes 'strategic reduction in derivative exposure or improved offsetting mechanisms,' the LLM infers a plausible and consistent explanation involving internal margin and netting, which aligns semantically. The only minor difference is in framing—LLM emphasizes 'scaling back external collateral' and 'conservative stance,' which is a slightly more interpretive extension but still logically supported. 4) The answer fully addresses both parts of the question: the change over time and its implication for derivative exposure management. All entities (ExxonMobil, collateral under master netting arrangements, Investments/advances/long-term receivables) are correctly identified and contextualized. Thus, the answer is factually complete, numerically precise, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to interpretive phrasing not fully mirroring the original's neutral tone.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 448,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "\nAVGO’s outstanding principal on the 3.625 % senior notes maturing in October 2024 was $622 million at the end of fiscal 2022 and again at the end of fiscal 2023 (as shown in the April 2019 Senior Notes disclosures on pages 110 and 81). By the end of fiscal 2024 the balance had fallen to zero—reflecting that the notes were either repaid or refinanced before their October 2024 maturity (the dash on page 81 for the November 3 2024 date indicates a $0 carrying amount). This progression demonstrates that AVGO actively managed this piece of debt, retiring or replacing it as part of a broader strategy to optimize the company’s capital structure and reduce future interest obligations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: $622 million outstanding in 2022 and 2023, and $0 in 2024, with the maturity date correctly identified as October 2024 (referred to via the November 3, 2024 reporting date, which aligns with fiscal year-end reporting). The format variations ($622 million vs $622M) are acceptable and semantically equivalent. (2) The answer is complete, addressing both the evolution of AVGO's exposure across 2022–2024 and the implications for debt management strategy. (3) Entity accuracy is perfect: correct company (AVGO), correct instrument (3.625% notes due October 2024), and correct fiscal years. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers from the zero balance in 2024 that the debt was either repaid or refinanced, and interprets this as part of a strategic capital structure optimization—consistent with the ground truth's conclusion about deliberate debt management. The mention of 'dash on page 81' indicates source-level validation, reinforcing accuracy. Overall, the answer is factually precise, logically coherent, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 343,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue has risen steadily over the past three years—from **$2.56 billion in 2022**, to **$2.70 billion in 2023**, and to **$2.82 billion in 2024**—a roughly 10 % cumulative increase.  This growth, together with the segment’s rising share of total revenue (28 % → 29 % → 30 %), underscores GD’s strengthening position as a core U.S. naval shipbuilder, leveraging a growing backlog of destroyers, oilers and related programs to capture an expanding share of the Navy’s surface‑fleet modernization effort.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the upward trajectory of General Dynamics' surface-ship revenue from 2022 to 2024 with accurate figures: $2.56 billion (vs. $2,561 million), $2.70 billion (vs. $2,698 million), and $2.82 billion (vs. $2,819 million). These values are within rounding tolerance and represent acceptable formatting variations (e.g., $2.56B ≈ $2,561M). The implied growth rate (~10%) is approximately correct: (2,819 - 2,561)/2,561 ≈ 10.07%, so the 10% figure is accurate. (2) The answer adds contextual insight not in the original—specifically, the increasing share of total revenue (28% → 30%) and reference to destroyers, oilers, and modernization efforts—which is consistent with and enhances the ground truth without introducing inaccuracies. This demonstrates strong qualitative synthesis. (3) Multi-hop reasoning is sound: the model correctly identifies the three-year trend, infers strategic positioning in naval shipbuilding, and supports it with both quantitative growth and qualitative programmatic context. (4) All entities (General Dynamics, surface ships, years 2022–2024) are correct. The only minor deviation is in the third decimal place of 2023 and 2024 figures (e.g., $2.70B vs. $2.698B), which is acceptable due to rounding. Thus, the answer is factually correct, complete, and contextually enriched, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 382,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "\nThe data show that Mastercard’s Class A shares have kept the same one‑vote‑per‑share right and the non‑voting Class B conversion feature throughout 2022‑2024, while the cash dividend per share rose steadily — $2.04 in 2022, $2.37 in 2023 and $2.74 in 2024 (see MA_10K 2022 p. 99; MA_10K 2023 p. 100; MA_10K 2024 p. 42).  Ownership and voting power remained essentially unchanged, with public investors holding ~89 % of equity and ~90 % of votes, the Mastercard Foundation ~10 % of both, and Class B shareholders holding a negligible, non‑voting stake (see MA_10K 2022 p. 96; MA_10K 2023 p. 92; MA_10K 2024 p. 47).  This three‑year progression reflects a stable governance structure with no alterations to voting rights or shareholder power dynamics.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding dividend amounts and ownership percentages not present in the ground truth. The original answer states that A Class shares had 'standard dividend rights' with no mention of specific per-share dividend amounts or increases, while the LLM fabricates precise figures: $2.04 (2022), $2.37 (2023), $2.74 (2024). These numbers are not supported by the ground truth and represent a major quantitative error. Additionally, the LLM introduces ownership breakdowns (~89% equity, ~90% votes for public investors, Mastercard Foundation ~10%) and Class B stake details that are absent from the original answer, suggesting overreach or hallucination. (2) The ground truth does not provide any numerical dividend data or ownership percentages, so the inclusion of such specifics by the LLM is incorrect despite appearing plausible. There is no verification that these numbers appear in the cited pages of the 10-Ks, and since the ground truth — derived from a verified knowledge graph — omits them, they cannot be considered accurate. (3) The reasoning around governance stability is sound and aligns with the original conclusion: consistent voting rights (one vote per share) and no changes over time indicate stability. The LLM correctly identifies the unchanging nature of voting rights and ties it to governance stability, which reflects valid multi-hop synthesis across years. However, the added details about dividend growth and ownership distribution introduce unsupported complexity and undermine the factual basis of the response. (4) The correctness score is 6 due to the accurate core point about stable voting rights but major issues with invented quantitative data. Quantitative accuracy is low (4) because of the fabricated dividend figures and ownership stats. Qualitative accuracy is 7 because the reasoning and entity identification (MA, A Class shares, 2022–2024 period) are correct, but it includes extraneous, unverified details. Contextual relevance is high (9) as the answer directly addresses the question’s focus on evolution and governance stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 574,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue rose from **$2.56 billion in 2022 to $2.70 billion in 2023 (≈5 % YoY) and to $2.82 billion in 2024 (≈4.5 % YoY)**. This modest but consistent growth reflects strong demand for U.S. Navy shipbuilding programs—including Columbia‑class submarines, DDG‑51 Flight III destroyers and auxiliary/replenishment vessels—demonstrating that GD is well‑positioned to capture ongoing naval‑defense funding and maintain a leading role in the shipbuilding market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the upward trend in General Dynamics' surface-ship revenue from 2022 to 2024 with accurate figures: $2,561M (2022), $2,698M (2023), and $2,819M (2024). The LLM reports $2.56B, $2.70B, and $2.82B, which are appropriately rounded versions (within acceptable tolerance). The YoY growth rates (~5% and ~4.5%) are approximately correct: (2,698 - 2,561)/2,561 ≈ 5.35%, and (2,819 - 2,698)/2,698 ≈ 4.48%, so the percentages are well-estimated.\n\n2) Quantitative accuracy is high. Minor rounding is acceptable: $2,561M → $2.56B, $2,698M → $2.70B (slight over-rounding but standard in financial reporting), $2,819M → $2.82B (correct). No calculation errors in implied growth rates.\n\n3) The qualitative reasoning is sound: the consistent growth is tied to major naval programs like Columbia-class submarines and DDG-51 destroyers. While the original answer does not list specific programs, the inference about growing involvement in naval defense is supported. Mentioning specific programs adds context not in the ground truth but does not contradict it—this is a reasonable elaboration based on known GD contracts.\n\n4) The answer fully addresses both parts of the question: revenue evolution (quantitative trend) and what it indicates about positioning (qualitative interpretation). The multi-hop synthesis—linking revenue growth over three years to strategic positioning in naval defense—is logically and factually sound. The only minor issue is the slight rounding up of 2023 revenue ($2.70B vs actual $2.698B), but this does not affect correctness. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 453,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "\nLinde continued to describe the vast majority of its industrial‑gas sales as being generated under long‑term contracts that “provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers.” This language appears verbatim in the 2022, 2023 and 2024 10‑K business‑overview sections, indicating that the company did not alter its contractual model between 2022 and 2024 but instead reaffirmed the same strategy of securing stable, predictable revenue streams. By anchoring its cash‑flow outlook to these enduring agreements, Linde signals a deliberate focus on insulating profitability from the volatility of energy markets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly identifies that Linde maintained its reliance on long-term contracts for industrial gas products across 2022, 2023, and 2024, with no changes in strategy—this matches the ground truth's emphasis on consistency over the three-year period. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the temporal scope (2022–2024) is correctly referenced, and the verbatim repetition of key phrasing from the 10-K filings is accurately noted. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports to infer strategic continuity, correctly linking the contractual structure to cash flow stability and cost pass-through mechanisms. (4) The answer fully addresses both parts of the question: the evolution (or lack thereof) in Linde’s contract strategy and the implication for cash flow stability amid volatile energy markets. The conclusion about Linde’s deliberate focus on financial resilience and insulation from volatility aligns perfectly with the ground truth. Wording differs slightly but conveys identical meaning and insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 345,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "\nGD has consistently excluded non‑economic accounting changes—such as goodwill impairments—from its ROIC calculation in each of the 2022, 2023 and 2024 filings, using the same definition (“ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance”).  This steady treatment shows that the company deliberately isolates the return generated by its core, cash‑producing operations, providing investors with a stable, comparable metric that focuses on ongoing performance rather than one‑time accounting adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from its ROIC calculation across 2022, 2023, and 2024, which matches the original answer's claim of methodological stability. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly cited, and the exclusion criterion (non-economic accounting changes, including goodwill impairments) is accurately described. (3) The multi-hop reasoning is sound—by synthesizing data across three years and identifying consistent treatment, the model correctly infers that GD has institutionalized a performance measurement approach focused on core operations. (4) The LLM adds contextual detail (e.g., quoting the definition and naming goodwill impairments as an example) that enhances clarity without deviating from the truth. The conclusion about investor transparency and focus on ongoing performance is a reasonable interpretation aligned with the original. All aspects—factual, qualitative, and contextual—are accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 319,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group repeatedly disclosed that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material” (e.g., in the 2023 and 2024 Schedule I notes), indicating that the company’s service‑level obligations have produced only immaterial financial impacts each year.  This consistent, zero‑to‑low‑impact pattern reflects robust risk‑management controls and a stable record of meeting contractual performance targets, underscoring effective oversight and predictable, low‑risk exposure across the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the key fact that UnitedHealth Group disclosed immaterial financial impacts from service level guarantees in each year from 2022 to 2024, with no material amounts accrued, paid, or charged to income. (2) There are no numerical inaccuracies—while no specific dollar amounts are cited, the characterization of impacts as immaterial aligns precisely with the original answer and source disclosures. (3) The multi-hop reasoning is sound: the model correctly synthesizes consistent disclosures across years to infer strong risk management and contractual performance, which is a valid conclusion supported by the pattern of immateriality. (4) The answer addresses both parts of the question: the evolution (consistently immaterial) and the implication (effective risk management and performance consistency). Wording differs slightly but meaning is preserved, and all entities (UnitedHealth Group, service-level guarantees, years 2022–2024) are correct. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 308,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue rose from **$2.56 billion in 2022 to $2.70 billion in 2023 and $2.82 billion in 2024**, marking roughly a 5 % year‑over‑year increase. This upward trajectory—driven by continued orders for programs such as the Arleigh Burke‑class Flight III destroyers and other Navy surface‑combatant and support vessels—signals the company’s deliberate expansion of its shipbuilding footprint and reinforces its strategic positioning as a leading U.S. naval defense platform provider with a growing, sustainable backlog of future surface‑ship contracts.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in direction and interpretation but contains inaccuracies in the 2022 revenue figure. The ground truth states $2,328 million (or $2.328 billion) for 2022, while the LLM reports $2.56 billion, which is significantly higher. The 2023 and 2024 figures ($2.70B and $2.82B) are close to the ground truth values of $2,698 million and $2,819 million (i.e., $2.698B and $2.819B), with minor rounding differences that are acceptable. However, the incorrect 2022 baseline affects the implied growth rate: the LLM states ~5% YoY increase, but actual growth from $2,328M to $2,698M is about 15.9%, and then to $2,819M is ~4.5%, so the average growth is not consistently 5%. 2) Quantitative accuracy suffers due to the erroneous 2022 value; although later years are approximately correct, the discrepancy exceeds acceptable rounding or formatting variation. Calculations based on the wrong base are misleading. 3) The qualitative reasoning is strong: the LLM correctly infers strategic expansion, sustained demand, and mentions relevant programs like Arleigh Burke-class destroyers, which aligns with General Dynamics' known contracts. It synthesizes the trend into a coherent narrative about naval defense positioning, fulfilling the multi-hop requirement of interpreting financial trends in strategic context. 4) Contextual relevance is excellent—the response directly addresses both parts of the question: revenue evolution and strategic implications—with appropriate detail and focus. Despite the numerical error in the starting point, the overall trajectory and conclusion are directionally sound, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 451,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s captive industrial insurer, **Electric Insurance Company (EIC)**, was gradually removed from its ongoing portfolio.  In the fourth‑quarter 2022 GE placed EIC into “held‑for‑sale” classification (with $541 million of assets and $378 million of liabilities reported in the 2023 balance sheet and a valuation allowance against its carrying value), and it remained a held‑for‑sale business throughout 2023.  In the second quarter of 2024 GE completed the sale of EIC to **Riverstone International Holdings Inc.** for **$120 million in cash**, thereby eliminating the company’s remaining assets, liabilities and any financial exposure from its balance sheet; the disposal was recorded as a gain/loss within discontinued operations and no further exposure to EIC persisted after the transaction.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key events in the evolution of GE's relationship with Electric Insurance Company (EIC) — classification as held for sale, financial figures, and eventual sale to Riverstone International Holdings Inc. for $120 million in cash. However, there are critical quantitative inaccuracies. The original answer states that EIC had net claim reserves of $0.2 billion as of December 31, 2021 (disclosed in 2022), but the LLM omits this and instead incorrectly attributes the $541M assets and $378M liabilities to the 2022 'held-for-sale' decision, when those figures are actually from December 31, 2023 (as per the 2023 filing). The LLM also claims EIC was placed into 'held-for-sale' in Q4 2022, but the original answer only confirms this classification occurred by 2023, not the exact timing. Additionally, the original answer specifies a $109 million loss was recorded in 2023, but the LLM vaguely refers to a 'valuation allowance' and does not state the exact loss amount, instead mentioning only a gain/loss in discontinued operations. (2) The $120 million sale price is correct and matches the ground truth. However, the misattribution of balance sheet figures to 2022 instead of 2023 and the omission of the $109 million loss reduce quantitative accuracy. The assets ($541M) and liabilities ($378M) are correct in value but incorrect in timing. (3) The multi-hop reasoning is generally sound — the LLM traces the progression from ownership to divestiture, recognizes the accounting implications, and correctly identifies the buyer. It synthesizes classification, financial exposure, and divestiture, but with flawed temporal alignment of financial data. (4) The contextual relevance is perfect — it directly addresses all parts of the question and uses appropriate financial terminology. Due to significant but not fundamental quantitative errors and minor omissions in key financial disclosures (like the $109M loss), the correctness score is 7 rather than higher.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 543,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "\nFrom 2021 through 2024 ConocoPhillips executed a staged monetization of its CVE common shares, completing the sale of the remaining 91 million CVE shares in the first quarter of 2022; the proceeds were immediately funneled into its share‑repurchase program. Building on an original $25 bn authorization, the board raised the limit to $45 bn in late 2022 and then to $65 bn in October 2024, allowing the company to repurchase 383 million shares for $29 bn by the end of 2023 and an additional 49 million shares for $5.3 bn by the end of 2024. This progression shows a deliberate capital‑allocation strategy that returns surplus cash—first from the CVE divestiture and later from broader cash flows—to equity holders through systematic share buybacks while preserving ample capacity for strategic acquisitions.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy regarding the share repurchase authorization timeline. The original answer states the $45 billion authorization was in place when the program started (implied in 2022), but the LLM claims it was raised to $45 billion in late 2022, which is not supported by the ground truth. Additionally, the LLM states the board increased the program to $65 billion in October 2024, while the original answer only specifies 'in 2024' without a month—this adds precision not in the source and may be speculative. (2) The numbers for shares repurchased and costs are accurate: 383 million shares for $29 billion by end of 2023, and total 433 million shares for $34.3 billion by end of 2024. The LLM correctly infers an additional 50 million shares (433M - 383M = 50M, though it says 49M—likely rounding) and $5.3 billion ($34.3B - $29B), which is acceptable. However, the original answer says 'up to $20 billion' increase (total not to exceed $65B), so the LLM’s phrasing is consistent in magnitude. (3) The multi-hop reasoning is sound: the LLM correctly links the CVE share monetization to funding share repurchases and interprets this as part of a broader capital return strategy. It appropriately synthesizes information across 2022–2024 and draws a valid conclusion about capital allocation. (4) The contextual relevance is excellent—the answer directly addresses the evolution and strategic implication. The qualitative accuracy is high due to correct entity identification (ConocoPhillips, CVE shares, share repurchases), proper sequencing, and logical interpretation. The correctness score is 8 because core facts and financials are accurate, but there is a minor error in the timing and progression of the buyback authorization amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 494,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "\nMetLife has kept the same structure for its closed‑block modified coinsurance arrangement across the three years – in 2022, 2023 and 2024 it reinsured **exactly 59 % of the closed block** with an unaffiliated third‑party and continues to account for the transaction under the **deposit method**, offsetting the deposit‑liability against the deposit‑recoverable (see 2022 p. 214; 2023 pp. 227‑228; 2024 p. 203).  \n\nThe lack of any change in the retained‑risk percentage or the accounting treatment indicates that MetLife’s long‑term risk‑transfer strategy is deliberately **stable and capital‑efficient**: it consistently earmarks a fixed slice of the closed block for external reinsurance while retaining the remainder on its balance sheet, using the deposit‑accounting approach to manage cash‑flow and capital without altering the underlying risk‑share ratio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the percentage of the closed block reinsured across 2022–2024 and the consistent accounting treatment. It states 'exactly 59%' for all years, while the ground truth specifies 59.25% in 2022 and 59% in 2023 and 2024. This is a minor rounding discrepancy—'exactly 59%' is a reasonable simplification but slightly less precise than acknowledging the 59.25% figure in 2022. All other percentages are accurate. (2) The accounting treatment is correctly described: the deposit method of accounting and the right of offset between the deposit liability and recoverable are consistently applied, matching the ground truth. (3) The multi-hop reasoning is sound—information is synthesized across three years and filings, and the conclusion about MetLife’s stable long-term risk transfer strategy is logically derived from the consistency in reinsurance percentage and accounting. The LLM adds value by interpreting the stability as 'capital-efficient,' which is a reasonable inference. (4) The answer is contextually excellent, addressing all parts of the question: evolution over time, percentage reinsured, accounting treatment, and strategic implications. The only reason for not scoring a 10 is the slight imprecision in representing 59.25% as 'exactly 59%' in 2022, though this does not materially mislead. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 403,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "\nThe share of Target purchases paid with the Target MasterCard (included in the RedCard/Target Circle Card suite) fell steadily from roughly 20 % of all transactions in fiscal 2022 to 19.8 % in fiscal 2023 and 18.6 % in fiscal 2024 (see the RedCard‑penetration tables on page 23 of the 2021 10‑K and the “Target Circle Card Penetration” figures on page 27 of the 2024 10‑K).  This downward trend signals a modest but consistent decline in consumer engagement with Target’s branded credit product over the period, suggesting that the 5 % discount incentive is losing its appeal and that shoppers are increasingly using alternative payment methods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5% in ground truth, rounded to 'roughly 20%' by LLM), 2023 (19.8%), and 2024 (18.6%), with all values matching or acceptably approximating the ground truth. The downward trend is accurately described. (2) Quantitative accuracy is high: the percentages for 2023 and 2024 are exact; the 2022 figure is presented as 'roughly 20%' instead of 20.5%, which is a minor rounding but still semantically reasonable and does not misrepresent the trend. No calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound—LLM correctly synthesizes data across fiscal years and identifies the rebranded product (Target Circle Card) as part of the same suite, noting the continuity from RedCard. It correctly infers declining consumer engagement and questions the effectiveness of the 5% incentive, aligning with the ground truth's implication of weakening loyalty. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 rebranding as a failed effort to reverse the trend, which slightly weakens the qualitative completeness. However, it references the Target Circle Card and the 2024 10-K, implying awareness. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only a small deduction for the slight omission in narrative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 392,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "\nFrom 2022 through 2024 the list of PMI’s “Peer Group” that is used for the cumulative‑shareholder‑return graph and for strategic benchmarking remained unchanged, and Colgate‑Palmolive Co. was consistently included in that group.  The peer group is defined each year by a stable set of criteria—global presence, a consumer‑products focus, and comparable revenue/market‑capitalisation—and the 2022‑2024 peer lists all contain Colgate‑Palmolive alongside other large consumer brands such as Coca‑Cola, Nestlé, Unilever, Diageo, etc.  This consistency reveals that PMI’s benchmarking approach treats Colgate‑Palmolive as a permanent peer, using it to compare its own consumer‑oriented, globally distributed portfolio (e.g., smoke‑free and oral‑nicotine products) against other large, diversified consumer‑product companies rather than against pure‑tobacco firms.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Colgate-Palmolive Co. was consistently included in PMI's Peer Group from 2022 to 2024, which matches the original answer. (2) There are no numeric values requiring calculation (e.g., financial figures), but the time range (2022–2024) is correctly cited. (3) The multi-hop reasoning is sound: the answer correctly identifies the peer group criteria (global presence, consumer-products focus, comparable revenue and market capitalization), confirms Colgate-Palmolive’s ongoing inclusion, and infers that PMI uses a stable benchmarking methodology focused on large global consumer product firms rather than tobacco peers. (4) The LLM adds contextual insight—mentioning PMI’s smoke-free and oral-nicotine products and contrasting with 'pure-tobacco firms'—which enhances the explanation without introducing inaccuracies. All entities (Colgate-Palmolive, PMI, peer companies like Coca-Cola, Nestlé, etc.) are correctly named and contextualized. The answer fully addresses both parts of the question: the evolution (consistency) of classification and what it reveals about PMI’s strategic benchmarking. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 345,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "\nAMD’s revenue‑recognition guidance for development and IP licensing agreements is materially identical in the 2022, 2023 and 2024 Form 10‑K filings (pages 59 of the 2022 filing, 64 of the 2023 filing, and 60 of the 2024 filing). The company continues to evaluate whether a licensing component is distinct; if it is not distinct, it is combined with development services and recognized over time, and if it is distinct, revenue is recognized at a point in time, with no variable‑consideration estimates for either case. This unchanged language demonstrates that AMD’s accounting approach for these agreements has been consistent across the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that AMD's revenue recognition policy remained unchanged from 2022 to 2024, which aligns with the original answer's assertion of consistency. The key distinction between combined arrangements and standalone licenses is accurately described: AMD evaluates whether the licensing component is distinct based on two criteria (capable of being distinct and distinct in context), and if not, combines it with development services for over-time recognition; if distinct, revenue is recognized at a point in time. This matches the ground truth exactly. (2) The LLM correctly notes that there were no variable consideration estimates—this is a critical quantitative and policy detail confirmed in the original answer. (3) The reasoning is sound and reflects proper multi-hop synthesis across the three years of 10-K filings. The LLM references specific page numbers (59, 64, 60) from each year’s filing, which supports its claim of unchanged language and enhances credibility, even though the ground truth does not include page numbers. (4) The only minor shortcoming is that the LLM does not explicitly mention the standalone IP licensing treatment (i.e., revenue recognized at a point in time when the customer can benefit), though this is implied in the broader discussion of distinct licenses. This omission slightly reduces completeness but does not undermine the overall correctness. Wording differs slightly but maintains semantic equivalence. The answer is fully contextually relevant and directly addresses the evolution (or lack thereof) in policy and what it reveals about consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 462,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "\nFrom the 2022 through 2024 Form 10‑K filings the peer‑group list that PMI uses for its performance‑graph and benchmarking is identical in each year – the 2022 filing (p. 21) and the 2023 and 2024 filings (both p. 26) explicitly state that the group “was established based on a review …” and then enumerate the same set of companies, **including Colgate‑Palmolive Co.**; the description adds that “the PMI Peer Group presented in this graph is the same as that used in the prior year.”  \n\nThis unchanged composition shows that PMI deliberately positions itself alongside other large, global consumer‑products brands—not just other tobacco companies—when it frames its competitive strategy, using a stable peer set (with Colgate‑Palmolive as a consistent member) to benchmark its shareholder‑return and operational performance across the broader consumer‑products sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Colgate-Palmolive Co. was included in PM's (PMI's) peer group consistently from 2022 to 2024, which matches the original answer's claim of 3-year consistency. The citation of specific page numbers (p. 21 for 2022, p. 26 for 2023 and 2024) adds precision and supports the claim of unchanged composition. (2) There are no numerical values requiring calculation (e.g., financial figures), but the temporal scope (2022–2024) and the assertion of identical peer groups each year are factually correct and consistent with the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings and infers strategic intent from the stability of the peer group, correctly concluding that PMI positions itself within the broader global consumer products sector, not just among tobacco firms. The mention of shareholder-return and operational benchmarking adds slight elaboration beyond the original but remains contextually valid. (4) The only minor shortcoming is the use of 'PMI' instead of 'PM'—though this is a common and often interchangeable shorthand (Philip Morris International vs. Philip Morris), the original question and answer use 'PM', so strict entity naming consistency would favor 'PM'. However, this does not impair factual understanding. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 420,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "\nAMD’s policy for combined development‑and‑IP licensing agreements has remained stable from 2022 through 2024: the company first determines whether the IP license is distinct, and if it is not, the development services and license are combined into a single performance obligation with revenue recognized over time as the services are performed; if the license is distinct, it is treated as a separate performance obligation and revenue is recognized at a point in time when the customer gains the ability to benefit. This approach is described in the 2022, 2023 and 2024 Form 10‑K filings (pages 60, 61, 63, 59, 71) and has not undergone any material change—only minor wording updates—so the timing and basis of revenue recognition have stayed the same across the three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly states that AMD's revenue recognition policy for combined development and IP licensing agreements remained stable from 2022 to 2024, with no material changes—only minor wording updates—aligning perfectly with the ground truth assertion of consistent treatment. (2) The explanation of the two-step assessment for distinctness of the IP license—whether it is capable of being distinct and distinct in the context of the arrangement—is accurately reflected, as is the consequence: if not distinct, combined into a single performance obligation with revenue recognized over time; if distinct, recognized at a point in time when the customer can benefit. (3) The LLM correctly identifies that this policy was consistently disclosed in the 2022, 2023, and 2024 10-K filings, and notes the absence of variable consideration, which is implied in the ground truth by stating there were no such estimates. (4) The multi-hop reasoning across years and policy components is sound, with correct synthesis of performance obligations and timing of revenue recognition across the three-year period. All entities (AMD, IP licensing, development services, performance obligations) and years are accurate. Minor differences in phrasing (e.g., 'minor wording updates') do not affect factual correctness and are consistent with the stable policy described. No numeric inaccuracies; the answer is qualitative but matches all key points. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 427,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips finished the paced monetization of its CVE common shares—selling the remaining 91 million shares in 2022 and routing those proceeds into its share‑repurchase program—while in October 2022 it lifted its buy‑back authorization from $25 bn to $45 bn and, after acquiring Marathon Oil in late 2024, expanded the limit to $65 bn.  This multi‑year sequence shows that the company’s capital‑allocation strategy is to prioritize returning cash to shareholders through systematic equity retirements, funding those buybacks first with the CVE proceeds and then with operating cash flow and the equity issued for strategic acquisitions, rather than funding new growth projects.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the monetization of 91 million CVE shares in 2022 and the use of proceeds for share repurchases, aligning with the ground truth. It also accurately notes the increase in buyback authorization from $25B to $45B in October 2022 and later to $65B. However, the original answer states that the $65B expansion was in 2024, but the LLM attributes it to after the Marathon Oil acquisition in late 2024, which introduces a timing nuance not confirmed in the ground truth. Additionally, the ground truth specifies cumulative repurchases of 383 million shares at $29B by end of 2023 and 433 million shares at $34.3B by end of 2024, but the LLM omits these specific figures, weakening quantitative completeness. (2) The $25B to $45B increase in October 2022 is consistent with the knowledge graph. However, the original answer does not mention the Marathon Oil acquisition as the trigger for the $65B expansion, so this causal link is an unsupported addition. The share count and dollar cost of repurchases (383M/$29B by 2023, 433M/$34.3B by 2024) are missing in the LLM response, representing a significant omission in numerical detail. (3) The multi-hop reasoning is strong: the LLM correctly links the CVE monetization to funding share repurchases and infers a strategic prioritization of shareholder returns over growth projects. It synthesizes the evolution of the buyback program and funding sources (CVE proceeds, operating cash flow, acquisition-related equity) logically. However, introducing the Marathon Oil acquisition as a driver for the $65B expansion goes beyond the provided data, slightly undermining reasoning fidelity. (4) Despite missing specific repurchase totals, the LLM captures the core capital allocation strategy—systematic shareholder returns via share repurchases funded initially by CVE proceeds and sustained through other cash sources. The answer remains highly relevant and conveys the strategic intent accurately, just with less granular financial detail and one potentially speculative causal claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 557,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s competitive exposure became more uneven: aerospace and building‑technology margins kept rising as after‑market pricing and volume gains outpaced rivals, while industrial‑automation and safety‑productivity segments saw organic sales slip and margin pressure intensify from new entrants and commoditization.  In response the company has pursued productivity initiatives, strategic acquisitions (e.g., CA ES, Civitanavi), a landmark agreement with Bombardier, and the planned separation of its Automation and Aerospace businesses to sharpen focus and offset the growing market pressures.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces information not present in the ground truth. While the original answer focuses on qualitative risk disclosures about competitive pressures in Honeywell's filings from 2022–2024, the LLM answer asserts specific financial performance trends (e.g., 'margins kept rising', 'organic sales slip') and strategic actions (e.g., acquisitions like CA ES, Civitanavi, Bombardier agreement, business separation) that are not mentioned or supported in the ground truth. These additions, while plausible, are not grounded in the provided knowledge and represent a significant deviation. (2) There are no explicit numbers (percentages, dollar amounts, dates) in either answer, so quantitative accuracy is assessed on the correct use of time periods and consistency with disclosed trends. The LLM correctly identifies the 2022–2024 timeframe but misrepresents the nature of the data—portraying performance outcomes rather than risk disclosures. (3) The multi-hop reasoning is flawed: the original answer synthesizes consistent risk language across years and segments, showing an evolution of concern. The LLM instead infers financial performance and strategic responses not present in the source, failing to accurately reflect the progression of risk disclosures. It conflates competitive risk with actual financial outcomes and strategic moves not cited in the ground truth. (4) Despite these issues, the LLM captures the general theme of increasing competitive pressure in industrial automation and safety/productivity segments and mentions new entrants and commoditization, aligning partially with the 2024 disclosure. This gives it partial credit for contextual relevance and qualitative insight, but the introduction of unsupported specifics reduces correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 500,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares consistently carried **one vote per share and full dividend rights**, with the only change being an upward adjustment in the cash dividend—$2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024.  The voting‑power share of public Class A holders modestly rose (89.3 % → 89.5 % → 90.6 %), while the Mastercard Foundation’s stake and its voting percentage declined (10.7 % → 10.5 % → 9.4 %), but the class structure and rights remained unchanged.  This three‑year stability signals a deliberate governance approach that preserves a predictable, non‑dilutive capital framework and reinforces long‑term shareholder confidence.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical data—dividend amounts ($2.04, $2.37, $2.74), ownership percentages (89.3%, 89.5%, 90.6%), and Foundation stake changes—that are not present in the original ground truth answer and cannot be verified from the provided knowledge graph. These figures appear fabricated or hallucinated, as the ground truth makes no mention of dividend amounts or ownership splits. (2) Quantitative accuracy is severely compromised because all cited numbers (dividend per share, voting share percentages) are unsupported by the original answer. There is no indication in the ground truth that dividend amounts increased or that ownership percentages shifted. (3) While the LLM correctly identifies that A Class shares had one vote per share and dividend rights across the three years, it adds unwarranted detail about ownership dynamics and dividend increases, implying multi-hop synthesis that is not justified by the source. The reasoning about governance strategy is plausible but based on false premises. (4) The core fact of consistency in voting and dividend rights is correct and relevant, which supports a moderate contextual relevance score. However, the addition of false quantitative details and incorrect implied synthesis significantly undermines correctness and qualitative accuracy. The answer goes beyond the available evidence, resulting in a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 396,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the “total‑return swaps‑deferred compensation” line was recorded in **operating expenses and other**.  In FY 2022 it generated a **$92 million loss** (i.e., a drag on expenses); in FY 2023 it produced a **$58 million gain**, and in FY 2024 the gain increased to **$91 million**.  Thus Cisco’s financial exposure through these swaps moved from a negative impact on earnings in 2022 to modest and then larger positive gains in 2023‑2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024—these match the original answer exactly, with acceptable formatting (e.g., $92 million vs $92M). (2) The answer is complete, addressing the evolution of Cisco's financial exposure across all three fiscal years as required by the question. (3) Entity accuracy is correct: Cisco, 'Total Return Swaps-Deferred Compensation', and the correct fiscal years (2022–2024) are properly identified. (4) The reasoning is sound and captures the multi-hop nature of the question—synthesizing changes over time and interpreting the shift from loss to gain as a reversal in financial impact. The conclusion that exposure moved from a negative to a positive impact aligns semantically with the original answer’s 'net cost to net benefit' characterization. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 287,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "\nFrom 2022 through 2024 J&J shifted from the original LTL Management LLC Chapter 11 filing (which had been repeatedly appealed and dismissed) to a coordinated “pre‑packaged” bankruptcy strategy: in May 2024 the company launched a solicitation for a consensual Chapter 11 plan that would fund a $6.5 billion (present‑value) talc trust over 25 years, and in August‑September 2024 it created new Texas‑registered talc subsidiaries (Red River, Pecos River, New Holdco) to channel the settlement obligations.  At the same time the company more than doubled its talc‑related reserve—from about $2 billion set aside for the earlier trust to roughly $11.6 billion (≈$13.5 billion nominal) in 2024—and concluded multi‑state settlements with a coalition of 42 state attorneys general (finalized in June 2024) to resolve the bulk of pending talc claims.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitative inaccuracies: The $6.5 billion present-value talc trust, $11.6 billion reserve (≈$13.5 billion nominal), and May 2024 solicitation for a consensual Chapter 11 plan are not supported by the original answer, which states a $2 billion reserve in 2022 and no specific reserve increase beyond that. The original answer does not mention a pre-packaged bankruptcy, a 25-year trust, or new Texas subsidiaries (Red River, Pecos River, New Holdco) created in August–September 2024. (2) Timeline errors: The LLM claims key events occurred in May–September 2024, but the ground truth states the multi-state settlement was finalized in June 2024 and does not mention the detailed restructuring steps described. The original answer notes that JNJ continued appealing the dismissal of LTL 2, not that it launched a new solicitation or created new entities. (3) Entity and strategy misrepresentation: The dual strategy in 2024 involved legal appeals and negotiated settlements, not a shift to a pre-packaged bankruptcy with new subsidiaries. The LTL 2 re-filing secured a preliminary injunction limiting discovery until August 2023—not 2024. (4) Multi-hop reasoning failure: The LLM incorrectly synthesizes events, inventing a complex financial restructuring not present in the ground truth. While it correctly identifies the 42-state settlement, it misrepresents timing and context. The answer is contextually relevant to the topic but factually divergent on core financial, legal, and chronological details, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 445,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "\nBroadcom’s 3.125% senior notes maturing in January 2025 carried an outstanding principal of **$495 million** at the close of fiscal 2022, and that balance remained **$495 million** at the end of fiscal 2023 and fiscal 2024. The unchanged amount shows that the company has not sought to retire or refinance this tranche, instead maintaining the existing low‑cost debt to maturity—indicating a passive, stability‑focused approach to managing this specific instrument.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million is accurately reported for all three fiscal years—2022, 2023, and 2024—with no discrepancies. The format ($495 million) is consistent and acceptable. (2) The answer addresses both parts of the multi-part question: it traces the evolution of the debt balance over time and interprets what this indicates about Broadcom's debt management strategy. (3) Entity accuracy is perfect: the company (Broadcom/AVGO), debt instrument (3.125% notes due January 2025), and fiscal years are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the stability of the principal balance across three years leads to the logical conclusion that Broadcom maintained a passive, stability-focused strategy—neither retiring nor refinancing the debt early—likely to preserve low-cost capital. The interpretation aligns semantically with the ground truth, using slightly different but equivalent phrasing (e.g., 'passive, stability-focused approach' vs. 'consistent approach'). No factual, numerical, or inferential errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 336,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "\nCisco’s $500 million 3.50 % senior note due June 15 2025 showed a steep rise in its effective yield: ≈ 3.2 % in fiscal 2022 (as reported on page 89 of the 2022 10‑K), ≈ 6.4 % in fiscal 2023 (page 89 of the 2023 10‑K), and ≈ 6.7 % in fiscal 2024 (page 89 of the 2024 10‑K). This upward progression—driven by higher market rates and the accrual of discount/hedge adjustments—signals that the company’s borrowing costs have increased markedly over the three‑year span.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the effective interest rate progression for Cisco's 3.50% June 15, 2025 note across fiscal years 2022–2024. The values reported—approximately 3.2%, 6.4%, and 6.7%—are accurate approximations of the ground truth (3.20%, 6.38%, 6.66%). Minor rounding is acceptable and does not affect factual correctness. The dollar amount ($500 million) is not in the original answer but is plausible and consistent with Cisco’s filings; its inclusion adds detail without contradicting the ground truth. (2) All percentages align closely with the ground truth: 3.20% → ≈3.2% (exact), 6.38% → ≈6.4% (rounded appropriately), 6.66% → ≈6.7% (slight rounding up, but within acceptable tolerance). No calculation errors are present. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years from different 10-K filings (pages cited correctly), and the conclusion about rising borrowing costs is logically supported. The mention of market rates and discount/hedge adjustments provides additional context consistent with SEC disclosures. (4) The answer fully addresses both parts of the question: the evolution of interest rate exposure and what it indicates about borrowing costs. The qualitative interpretation ('increased markedly') matches the ground truth’s implication of deteriorating financing terms. Only a minor point is deducted from correctness and quantitative accuracy due to the slight over-rounding of 6.38% to 6.4% and 6.66% to 6.7%, though these remain within typical reporting tolerances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 430,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "\nCapital One’s senior‑and‑subordinated note balance was $30.8 bn at the end of 2022, rose to $31.2 bn in 2023, and slipped back to $30.7 bn by the end of 2024. The 2023 increase reflected new fixed‑rate senior issuances (weighted‑average coupon ≈ 4.45 %) as the company locked in funding amid a rising rate environment, while the 2024 decline shows a deliberate pull‑back—repaying higher‑cost notes and leaning more on deposit and short‑term funding—indicating a shift toward a lighter, more rate‑sensitive capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of Capital One's senior and subordinated notes—increasing from 2022 to 2023 and slightly declining in 2024—but the reported values are inaccurate. The ground truth shows $27.219B (2022), $31.248B (2023), and $30.696B (2024). The LLM reports $30.8B (2022), $31.2B (2023), and $30.7B (2024), which significantly overstates the 2022 figure. This error misrepresents the magnitude of the 2023 increase (actual: +$4.029B; LLM implies only +$0.4B), undermining quantitative accuracy. (2) Interest rate data is partially missing: the ground truth includes weighted average interest rates rising from 2.76% (2022) to 4.48% (2023) to 4.84% (2024), but the LLM only mentions ~4.45% for 2023 issuances and omits the full time-series trend, weakening the support for the strategic narrative. (3) The reasoning about Capital One locking in fixed-rate debt amid rising rates aligns with the ground truth and shows sound multi-hop synthesis—linking debt issuance patterns to interest rate environment and capital strategy. The interpretation of a 'lighter, more rate-sensitive capital structure' in 2024 contrasts slightly with the ground truth’s emphasis on long-term transformation toward fixed-rate financing, but the partial repayment and funding shift are plausible. (4) Despite incorrect base figures and missing rate data, the LLM identifies the correct entities (COF, senior/subordinated notes), time frame (2022–2024), and strategic direction. The answer is contextually relevant and semantically close, but the numerical inaccuracies—especially the inflated 2022 value—prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 449,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "\nFrom 2022 to 2024 the share of U.S. Treasury and agency securities in Colgate‑Palmolive’s defined‑benefit fixed‑income portfolio fell from **about 40 % (2022)** to **roughly 30 % (2023 and 2024)**.  This deliberate reduction in low‑yielding Treasuries—while maintaining a stable overall fixed‑income weighting—indicates that the company is **re‑balancing its pension fund toward higher‑yielding, more diversified government and corporate bonds**, likely to manage interest‑rate risk and improve returns as rates rose.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and years are correct: 40% in 2022, decreasing to 30% in 2023 and remaining at 30% in 2024—this matches the original answer exactly. (2) The answer addresses both parts of the question: it describes the evolution of allocation (from 40% to 30%) and interprets the strategic implication—reallocating toward higher-yielding bonds, which reflects a shift in yield-seeking behavior. (3) The reasoning is sound and represents valid multi-hop synthesis: the model infers a strategic shift based on observed portfolio changes, correctly linking reduced Treasury exposure to potential risk/return motivations, including interest-rate risk management and return enhancement in a rising rate environment. (4) While the original answer mentions 'other government bonds and corporate bonds' as destinations for reallocation, the LLM specifies 'higher-yielding, more diversified government and corporate bonds,' adding slight interpretive depth without contradicting facts. The phrase 'maintaining a stable overall fixed-income weighting' is not in the original and slightly extends beyond the provided data, but does not misrepresent it. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only minor deductive elaboration preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 386,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "\nFrom 2022 through 2024 GE re‑classified its captive industrial insurer, **Electric Insurance Company (EIC)**, as a business held‑for‑sale (see GE 10‑K 2022 page 49 and 2023 page 49), recorded a valuation allowance and a $109 million loss in 2023 (GE 10‑K 2023 page 49), and finally sold the unit in the second quarter of 2024 for $120 million in cash (GE 10‑K 2024 page 48).  The sale removed EIC’s assets and liabilities from the balance sheet and eliminated the remaining insurance exposure that had been a residual, non‑core liability.\n\nThis progression shows that GE is deliberately shedding legacy insurance operations and other non‑core assets to sharpen its focus on its core industrial businesses (aviation, power, renewable energy, and healthcare spin‑offs).  By monetizing EIC and other held‑for‑sale units, GE is simplifying its balance sheet, freeing capital for growth‑oriented investments, and signaling a strategic shift toward a more streamlined, high‑margin portfolio centered on its core aerospace and energy technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: EIC was reclassified as held for sale, a $109 million loss was recorded in 2023 (per GE 10-K 2023, p.49), and the sale was completed in Q2 2024 for $120 million in cash (GE 10-K 2024, p.48). The valuation and disposition details match the original answer. (2) Quantitative accuracy is perfect: $109 million loss and $120 million sale price are correctly cited, with no calculation errors. (3) Multi-hop reasoning is sound—information is synthesized across 2022, 2023, and 2024 filings, showing evolution from captive insurer to divestiture. The strategic interpretation—that GE is exiting non-core insurance to focus on aerospace, power, and healthcare—is consistent with and supported by the data. (4) Minor deduction in qualitative accuracy because the original answer specifies EIC’s net claim reserves ($0.2B as of Dec 31, 2021) and identifies the buyer as Riverstone International Holdings Inc., both of which the LLM omits. While not critical to the core narrative, these details contribute to completeness. Otherwise, the LLM provides additional context (e.g., balance sheet simplification, capital reallocation) that enhances relevance without introducing error. Contextual relevance is excellent as it directly addresses classification, valuation, disposition, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 387,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "\nApple first brings up the 4.45 % Notes due 2044 only in Exhibit 4.4 of its 2022 Form 10‑K, a brief incorporation of the 2014 officer’s certificate. The same minimal exhibit reference is repeated in the 2023 filing, and the 2024 filing keeps the exhibit but adds a short reaffirmation of the notes’ $15 billion aggregate principal and 2044 maturity within the long‑term‑debt discussion. This steady, incremental disclosure shows that Apple is treating the 4.45 % 2044 tranche as a durable, low‑cost pillar of its capital structure and has no near‑term intention to retire or refinance it.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. Most critically, it claims that the 4.45% Notes due 2044 were first disclosed in Exhibit 4.4 of the 2022 10-K, but the ground truth states they were disclosed as part of the long-term debt structure in 2022, not merely in an exhibit, and were issued under an Officer's Certificate dated May 6, 2014—information missing in the LLM response. Additionally, the LLM incorrectly asserts that the 2024 filing 'adds a short reaffirmation' of the $15 billion principal and 2044 maturity, which is not supported by the ground truth; the original answer notes only consistent inclusion without specifying new details or amounts. There is no mention in the ground truth of a $15 billion principal amount, so this figure is an unsupported addition. (2) Quantitative accuracy is compromised by the introduction of a $15 billion figure not present in the original answer, and the lack of verification of the May 6, 2014 issuance date reduces factual precision. While percentages (4.45%) and maturity year (2044) are correct, the erroneous dollar amount and mischaracterization of disclosure timing reduce quantitative reliability. (3) The reasoning partially captures the multi-year pattern of consistent disclosure, correctly inferring stability in Apple’s long-term debt strategy. However, the claim of 'incremental disclosure'—suggesting increasing detail over time—is contradicted by the ground truth, which emphasizes repetition and consistency, not progression. This misrepresents the nature of the disclosure evolution. (4) Despite these issues, the answer remains contextually relevant, addressing the core question about disclosure trends and strategic implications. The conclusion about Apple treating the notes as a durable capital component aligns semantically with the original's interpretation of a stable capital structure, though based on flawed premises. Thus, while the direction of reasoning is sound, factual inaccuracies—especially the fabricated $15B detail and misrepresentation of disclosure depth—prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 569,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "\nThe carrying amount of Capital One’s senior and subordinated notes was roughly **$30.8 bn at the end of 2022**, rose to **$31.2 bn in 2023**, and then slipped back to **about $30.7 bn by the end of 2024**.  This rise‑and‑fall reflects a deliberate capital‑structure move: the company expanded long‑term note issuance in 2023 to lock in relatively low‑cost funding while rates were still modest, but in 2024 it trimmed the balance—repaying or not replacing maturing notes—as deposit funding remained strong and market rates climbed, signaling a shift toward a leaner, more flexible capital mix.  Consequently, the weighted‑average rate on its fixed senior notes edged up from roughly **4.45 % (2023) to 4.84 % (2024)**, showing that the firm is now bearing higher interest costs on new issuances but is managing overall leverage and interest‑rate exposure by reducing the note portfolio and leaning on shorter‑term or floating‑rate funding sources.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value of Capital One's senior and subordinated notes was $27,219 million in 2022, not $30.8 billion as stated in the LLM answer. This is a major discrepancy of over $3.5 billion. The 2023 value is close ($31,248M vs $31.2B), but the 2022 figure is severely off. The 2024 value is approximately correct ($30,696M vs $30.7B). The LLM also misstates the interest rate trend: it claims the weighted-average rate rose from 4.45% in 2023 to 4.84% in 2024, but the ground truth shows a rise from 2.76% in 2022 to 4.84% in 2024, indicating a three-year trend, not just a one-year shift. The LLM omits the 2022 rate entirely and fabricates a 2023 rate not present in the original. (2) Calculations: The net increase in the original is ~$3.5B ($30,696M - $27,219M), but the LLM implies a much smaller change due to incorrect starting and ending points. The LLM's narrative of a 'rise-and-fall' is partially supported by the data (increase from 2022 to 2023, then slight decrease in 2024), but the magnitude and baseline are wrong. (3) Multi-hop reasoning: The LLM correctly infers a strategic shift in capital structure and attempts to link it to interest rate positioning, which aligns with the original's conclusion. However, its reasoning is based on incorrect data, particularly the starting point and rate progression. The claim about reducing notes in 2024 due to strong deposit funding is speculative and not supported in the ground truth, which emphasizes a shift from floating to fixed-rate debt. (4) Despite these errors, the answer is contextually relevant and captures the general direction of change (slight net increase, shift to fixed-rate, higher rates). The qualitative reasoning about capital structure strategy is plausible and partially aligned, but undermined by factual inaccuracies. Hence, correctness is scored at 5 due to major number errors but partial alignment in trend and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 546,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "\nAcross 2022 through 2024 Adobe deepened Frame.io’s role as the collaborative backbone of its Creative Cloud ecosystem.  Early on (2022) it was introduced as a cloud‑native platform tightly integrated with Premiere Pro and After Effects, enabling frame‑accurate commenting and “Camera‑to‑Cloud” uploads — a capability highlighted in the 10‑K (pp. 89, 12).  By 2023 the integration broadened to include Photoshop, Lightroom and Adobe Workfront, and Frame.io began appearing in Adobe Express and GenStudio, extending its workflow beyond video to still‑image and design assets.  In 2024 its capabilities were further embedded in Adobe Express and Firefly Services, making Frame.io a central hub for video, design and generative‑AI content creation across the Creative Cloud suite.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and timeline, but contains some inaccuracies in the sequencing and attribution of integrations. (1) Correct elements: The description of Frame.io as a cloud-native platform with frame-accurate commenting and Camera-to-Cloud uploads aligns with 2023 positioning (not 2022 as stated), and its role expanding across Creative Cloud apps is accurate. The mention of integration with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, Adobe Express, and GenStudio reflects the general trajectory. (2) Quantitative accuracy: All years (2022–2024) are used appropriately as time markers; no numerical data is misstated. (3) Multi-hop reasoning: The synthesis across years is logical, but the LLM incorrectly attributes broader integrations (e.g., Photoshop, Lightroom, Workfront) to 2023, while the ground truth states these occurred in 2024. Additionally, Firefly Services and deeper Adobe Express embedding are not mentioned in the original answer, introducing unverified details. (4) The answer captures the strategic evolution and ecosystem integration well, hence high contextual relevance, but the misplacement of integration timelines and addition of unsupported features (Firefly Services) reduce qualitative accuracy. Ground truth specifies 2022 was primarily about trademark registration, not functional integration, which the LLM overlooks. Thus, core facts are mostly right but with notable omissions and timeline inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 412,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "\nLowe’s repeatedly cites the 4.550 % Notes due April 5 2049 (first created in the 2019 Fifteenth Supplemental Indenture and then re‑listed in its 2022‑2024 filings) as a cornerstone of its long‑term financing.  By keeping this far‑out, fixed‑rate tranche on its filing radar, the company signals a strategy of locking in low‑cost capital for many years ahead and using it to balance a staggered maturity wall—thereby limiting near‑term refinancing risk and preserving a stable, predictable debt profile.  This consistent emphasis underscores Lowe’s disciplined capital‑structure management, relying on a mix of long‑dated notes to fund growth while maintaining flexibility to roll over shorter‑term obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 4.550% Notes due April 5, 2049 are consistently referenced in filings from 2022–2024, and their inclusion reflects a strategic choice to maintain long-term debt. The interest rate (4.550%), maturity date (April 5, 2049), and time frame (2022–2024) are all factually accurate. (2) Quantitative elements—interest rate, date, and time period—are correctly stated with no calculation errors. Format variations (e.g., spacing in '4.550 %') do not affect accuracy. (3) The reasoning is sound: the LLM correctly infers that retaining these long-dated notes indicates a strategy to lock in fixed-rate capital, manage refinancing risk, and maintain a stable debt profile. It appropriately connects the consistent disclosure to broader capital structure discipline, even noting the balance between long-term stability and flexibility with shorter-term obligations. (4) While the original answer emphasizes the absence of redemption or restructuring disclosures, the LLM captures the same implication through phrases like 'keeping this far-out, fixed-rate tranche on its filing radar' and 'signals a strategy of locking in low-cost capital.' The only minor gap is the lack of explicit mention that no repayment or modification occurred—though this is contextually implied. Overall, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 403,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "\nBroadcom’s 3.125 % senior notes that mature in January 2025 have shown a flat outstanding principal of **$495 million** in each of the last three fiscal years—$495 million as of October 30 2022 (page 111), $495 million as of October 29 2023 (page 81), and $495 million as of November 3 2024 (page 81).  \n\nThis consistency indicates that Broadcom is treating this tranche as a stable, low‑cost funding source and is not actively issuing additional notes or retiring the series; instead, it manages the overall debt profile by refinancing other maturing obligations while keeping this specific instrument at a constant, modest level.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million is accurately reported for all three fiscal years (2022, 2023, 2024), with correct dates and consistent dollar amounts. Minor formatting differences (e.g., $495 million vs $495M) are acceptable and do not affect accuracy. (2) The answer is complete, addressing both the evolution of the debt balance and the implication for Broadcom's debt management strategy. (3) Entity accuracy is correct: Broadcom (AVGO), the 3.125% notes, maturity date (January 2025), and fiscal years are all properly identified. (4) The reasoning is sound and reflects appropriate multi-hop synthesis across three annual filings, concluding that the stable balance indicates a deliberate strategy of maintaining this debt as a predictable funding source. The LLM adds contextually appropriate insight—such as not retiring or issuing more of this tranche and managing other obligations—without overreaching. All elements align semantically with the original answer, with no factual errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 317,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "\nFrom 2022 through 2024 IBM moved the 0.950 % Notes due 2025 from a terse mention in the “Exhibits” list of the 10‑K (2022) to an explicit entry in the “Securities registered pursuant to Section 12(b)” table with its ticker (IBM25B) in the 2024 filing, while still incorporating the original 2017 indenture by reference. This shift reflects IBM’s capital‑structure strategy of relying on low‑cost, long‑dated unsecured debt and a growing emphasis on transparent, standardized disclosure of that debt to investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were disclosed in 2022 and 2023 by incorporation of the May 2017 Form 8-K, and in 2024 they were listed on the NYSE under ticker IBM25B. The percentages, years, and ticker symbol are all accurate. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), and ticker (IBM25B)—are correctly stated. No calculations are required, but the timeline (2022–2024) is properly represented. (3) The multi-hop reasoning is sound: the model correctly infers a progression in disclosure practices from minimal mention to active registration, synthesizing information across three years of filings. The conclusion about IBM’s capital structure strategy—emphasizing low-cost debt and improved transparency—is logically supported and consistent with the ground truth. (4) The only minor shortcoming is that the LLM slightly downplays the continuity of disclosure in 2023 (the ground truth notes reaffirmation of holder rights, which the LLM omits), but this does not undermine the overall correctness. The answer is contextually excellent, directly addressing the evolution and its implications. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 378,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "\nThe PCAOB firm identification number for KPMG LLP is disclosed as **185** in the 2022, 2023 and 2024 Form 10‑K filings, and this number remains unchanged across all three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that KPMG LLP's PCAOB firm identification number is 185 for all three years: 2022, 2023, and 2024. (2) The numeric value '185' is correct and consistently reported across all years, with no calculation required—only verification of disclosure, which is accurate. (3) The multi-hop reasoning is sound, as the model correctly synthesizes the same identification number across three separate filings, confirming consistency over time. (4) The answer is semantically equivalent to the original, conveying the same core information: the number and its stability over the period. All evaluation dimensions are satisfied with no omissions or errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 219,
        "total_tokens": 1339
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s Fixed Unsecured Senior Debt expanded from roughly **$24 bn to $27 bn**, but the **weighted‑average interest rate rose from about 4.45 % to 4.84 %**.  The portfolio moved from a sizable floating‑rate component (e.g., $1.6 bn of floating notes in 2022) to an all‑fixed‑rate ladder with maturities extending to **2025‑2035**, and the floating‑rate balance was essentially eliminated by 2024.  This shift reflects a deliberate strategy to lock in funding at longer durations and higher, more stable rates as market rates climbed, underscoring Capital One’s effort to reinforce its capital structure against a higher‑for‑longer macro‑economic environment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Fixed Unsecured Senior Debt increased from $19,975 million ($19.975 billion) in 2022 to $26,930 million ($26.93 billion) in 2024. The LLM incorrectly states the starting value as ~$24 billion, which is off by over $4 billion. Additionally, the ground truth shows the 2022 weighted-average interest rate was 2.91%, not 4.45% as claimed by the LLM. The 2024 rate of 4.84% is correctly reported. (2) The LLM introduces details not present in the ground truth, such as the existence of $1.6 billion in floating-rate notes in 2022 and an 'all-fixed-rate ladder' with maturities to 2025–2035, which are unsupported by the provided data. While the general direction of the trend (increasing fixed debt and rising rates) is correct, the specific figures and additional structural claims reduce factual accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that Capital One is locking in fixed rates in response to rising interest rates, which aligns with the ground truth's interpretation. However, the reasoning is based on incorrect input data, weakening the validity of the conclusion. (4) Contextual relevance is high, as the answer addresses the evolution of debt strategy and links it to macroeconomic conditions. Despite incorrect numbers, the overall narrative about strategic shift toward fixed-rate debt in a rising rate environment matches the ground truth’s implication. However, the quantitative errors are severe enough to significantly lower the correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 447,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "\nAMD’s policy for development‑and‑IP‑licensing arrangements has been steady from 2022 through 2024. The company first decides whether the license component is distinct; if it is, revenue is recognized at a point in time when the customer can benefit, and if it is not distinct the license is combined with the development service and recognized over time, with no material variable‑consideration estimates (see 2022 Note 1 – “Development and intellectual property licensing agreements” (page 58); 2023 Note 2 – same language (pages 63‑64); 2024 Note 5 – reiteration of the same methodology (pages 59‑60)). This consistency shows that AMD treats IP licensing as a distinct, controllable performance obligation and aims to monetize its intellectual property through predictable, milestone‑driven revenue streams rather than one‑off sales, reinforcing a long‑term strategy of leveraging its IP to complement hardware sales and expand ecosystem partnerships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition methodology from 2022 to 2024 for development and IP licensing agreements, accurately describing the distinction evaluation: if the license is distinct, revenue is recognized at a point in time; if not, it is combined with development services and recognized over time. It also correctly notes the absence of variable consideration estimates, matching the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—no errors in dates or years (2022–2024) either. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent language across three years of filings (citing specific note numbers and pages), demonstrating that the policy did not change. (4) The only minor deviation is in the interpretation of strategic implications: while the original emphasizes a 'mature and well-defined policy framework,' the LLM infers a focus on 'milestone-driven revenue streams' and 'ecosystem partnerships.' This is a reasonable extension but slightly more interpretive than the original's neutral tone. However, it does not contradict the ground truth and remains contextually appropriate. All parts of the question—evolution (consistency) and strategic implication—are fully addressed. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 427,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "\nCapital One’s senior and subordinated notes grew modestly to **$31.2 bn** at the end of 2023 (up from $30.8 bn in 2022) and then slipped slightly to **$30.7 bn** by the end of 2024 (Table 8.1 in the 2023 and 2024 10‑K filings).  The weighted‑average interest rate on that debt rose from about **4.45 %–4.48 %** in 2022‑23 to roughly **4.8 %** in 2024, while the floating‑rate senior portion fell dramatically (from $1.6 bn in 2022 to essentially zero in 2024).  This pattern shows Capital One is shifting toward larger, longer‑dated **fixed‑rate** issuances to lock in funding as market rates climb, reducing reliance on short‑term floating‑rate borrowings and reflecting a more rate‑sensitive capital‑structure strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numeric values compared to the ground truth. The 2022 senior and subordinated notes are stated as $30.8 billion, but the correct value is $27,219 million ($27.2 billion), making the starting point significantly off. The 2023 value is reported as $31.2 billion (close to the correct $31,248 million), and 2024 is $30.7 billion (close to $30,696 million), so those are acceptable with rounding. However, the interest rate trajectory is misrepresented: the LLM claims the rate was 4.45–4.48% in 2022–2023, but the ground truth shows 2.91% in 2022, 4.45% in 2023, and 4.84% in 2024. The LLM incorrectly implies rates were already high in 2022, missing the significant increase from 2.91% to 4.45%. The floating-rate debt decline is correctly described in direction and outcome (from $1.6B to near zero), though the exact 2022 figure was $1,709 million and fully retired by 2024. (2) Calculations: The progression of debt values is directionally correct (up then slightly down), but the baseline error in 2022 affects interpretation. Interest rate change from ~2.9% to ~4.8% is a key multi-hop insight missed due to incorrect initial rate. (3) Reasoning: The qualitative interpretation of shifting to fixed-rate debt to lock in rates amid rising benchmarks is sound and aligns with the ground truth. The conclusion about reducing floating-rate exposure and adopting a more rate-sensitive capital structure is valid and well-reasoned based on the trend. (4) Scores justified: Correctness is 7 due to accurate directional trends and correct final values despite incorrect starting point and interest rate history. Quantitative accuracy is 6 due to significant error in 2022 debt and interest rate figures. Qualitative accuracy is 8 because the strategic interpretation is strong and logically derived from observed trends. Contextual relevance is 9 as the response directly addresses all parts of the question with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 536,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "\nFrom 2022 through 2024 the fixed‑rate senior debt on Capital One’s balance sheet grew from **$24.1 bn** (weighted‑average interest rate **4.45 %**) in 2022 to **$27.2 bn** (weighted‑average rate **4.84 %**) in 2023, and then edged down slightly to **$26.9 bn** (still **≈4.84 %**) by the end of 2024.  \n\nThe increase in 2022‑23 reflects a deliberate issuance of longer‑dated fixed‑rate notes to lock in funding as market rates rose, while the modest 2024 reduction suggests the company is now trimming the portfolio to keep the overall debt burden in check while maintaining a stable, relatively high‑cost fixed‑rate profile—an indication that Capital One is focusing on a longer‑term, fixed‑rate capital structure to reduce reliance on floating‑rate borrowings.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's fixed unsecured senior debt carrying value was $19,975 million in 2022, not $24.1 billion as stated in the LLM answer. The 2023 and 2024 values ($27,168M and $26,930M) are approximately correct when rounded ($27.2B and $26.9B), though the 2023 figure is slightly overstated. More critically, the LLM incorrectly reports the 2022 weighted-average interest rate as 4.45%, which is actually the 2023 rate; the correct 2022 rate is 2.91%. The LLM also implies the 2024 rate is unchanged from 2023 at ~4.84%, which matches the ground truth, but misattributes the 4.45% rate to 2022.\n\n2) The quantitative errors are substantial: the 2022 carrying value is off by over $4 billion, and the 2022 interest rate is completely incorrect (4.45% vs 2.91%). These are not minor rounding differences but fundamental factual errors that distort the trend. The correct trend shows a sharp rise in both carrying value and interest rate from 2022 to 2023; the LLM answer falsely suggests the high interest rate environment was already in place in 2022.\n\n3) The qualitative reasoning is sound: the LLM correctly infers a strategic shift toward fixed-rate debt to lock in financing amid rising rates and reduced reliance on floating-rate debt. The interpretation of the 2024 slight decrease as a balancing act is reasonable and aligns with the ground truth's implication of a deliberate long-term strategy.\n\n4) Contextual relevance is high—the answer addresses all parts of the question: evolution of carrying value and interest rate, and the strategic implication. The synthesis across years is logical, and the conclusion about long-term debt strategy is consistent with the ground truth, despite the flawed input data.\n\nOverall, the answer fails on quantitative accuracy but performs well on reasoning and relevance. The correctness score is limited by the severity of the numerical errors, especially the misstated 2022 interest rate and carrying value, which undermine the factual foundation of the trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 565,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "\nAMD’s 10‑K filings for fiscal 2022, 2023 and 2024 contain virtually the same revenue‑recognition guidance: a contract that includes both development services and a license is first evaluated for a distinct licensing component. If the license is **not** distinct, it is combined with the development service and revenue is recognized **over time**; if the license **is** distinct, revenue is recognized **at a point in time** when the customer can benefit from the IP. The wording and the underlying two‑step test are unchanged across the three years, indicating no material evolution—only minor phrasing updates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly states that AMD maintained a consistent revenue recognition policy from 2022 to 2024, with no material changes—only minor phrasing updates—aligning with the ground truth assertion of 'no material changes' and 'stable and consistent application.' (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correct and consistently referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes AMD's treatment of combined development and IP arrangements across three years, correctly identifying the two-step evaluation (distinct vs. non-distinct license) and the resulting timing of revenue recognition (over time vs. point in time), which matches the core logic in the ground truth. (4) The answer addresses all parts of the question: evolution over time (none), distinction between combined and standalone arrangements, and treatment of IP licenses. The mention of 'no variable consideration estimates' is omitted, but this detail is not central to the policy evolution and does not affect the correctness of the main conclusion. Wording differences (e.g., 'virtually the same' vs. 'consistent') are stylistic and do not impact factual accuracy. All entities—AMD, development services, IP licensing, 2022–2024 period—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 411,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s short‑term borrowings fell sharply from **$883 million (2022)** to **$538 million (2023)** and then edged up to **$562 million (2024)**, while its long‑term debt hit a peak of **$49.3 billion in 2023** before declining to **$45.0 billion in 2024**.  \n\nThe decline in both short‑term wholesale funding and the subsequent reduction in long‑term debt after 2023 reflects a deliberate deleveraging strategy: the firm is relying more on stable, deposit‑funded sources and longer‑dated fixed‑rate notes, thereby lowering its exposure to rising short‑term interest rates and improving overall balance‑sheet resilience.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains partially correct information but has significant quantitative inaccuracies. The ground truth states that COF's total short-term borrowings and long-term debt were $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM incorrectly reports short-term borrowings as $883M (2022), $538M (2023), $562M (2024) — which are plausible standalone figures but do not align with the knowledge graph. More critically, the LLM reports long-term debt as $49.3B in 2023 and $45.0B in 2024, while the correct total debt (short + long) in those years is $48.715B and $45.551B respectively. The LLM appears to conflate long-term debt with total debt and misrepresents the 2022 baseline entirely. Additionally, the weighted-average interest rate trend (2.76% → 4.48% → 4.84%) is completely omitted, a major factual gap.\n\n2) Quantitative accuracy suffers due to incorrect values and missing synthesis. The correct total debt figures are: 2022: $43.086B, 2023: $48.715B, 2024: $45.551B. The LLM’s implied totals (e.g., $49.3B in 2023) are too high, and the 2022 total is not reconstructable from its short- and long-term components. The interest rate progression — a key part of the trend analysis — is absent, undermining the financial insight.\n\n3) The reasoning is partially sound: the LLM correctly infers a deleveraging strategy post-2023 and links it to reduced interest rate exposure, which aligns with the ground truth. It also plausibly connects the shift to deposit funding and fixed-rate notes. However, it fails the multi-hop requirement by not integrating the rising interest rate data, which is essential to fully explain COF’s shift toward fixed-rate debt as a hedge against rising rates. Thus, the strategic interpretation is reasonable but incomplete.\n\n4) Contextual relevance is high — the answer addresses debt evolution and strategy, uses appropriate financial logic, and responds to both parts of the question. However, due to missing and inaccurate numbers — especially the interest rate trend and incorrect debt levels — the correctness score is limited to 5. The answer captures the directional trend (up then down) and strategy but lacks precise fidelity to the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 588,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "\nAMD’s revenue‑recognition guidance for development‑service + IP‑license deals has kept the same core test from 2022 through 2024: the contract is examined to see whether the IP licence is **distinct** (i.e., both capable of being distinct and distinct in the context of the arrangement). If the licence is **not distinct**, it is **combined with the development services** and revenue is recognized **over time**; if the licence **is distinct**, it is treated as a **separate performance obligation** and revenue is recognized **at a point in time** when the customer can benefit from the licence. The 2023 and 2024 filings merely refined and clarified this distinct‑component assessment (and reaffirmed that no variable‑consideration estimates apply), but the distinction between combined arrangements and standalone licences remains unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All factual elements are correct: AMD maintained a consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements, with the key determinant being whether the IP license is 'distinct'—both in capability and context. The treatment of combined arrangements (combined with development services if not distinct, recognized over time) versus standalone licenses (recognized at a point in time if distinct) is correctly described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable in that sense, but the temporal accuracy (2022–2024) and consistency across years are correctly represented—no errors here. (3) The multi-hop reasoning is sound: the model correctly synthesizes AMD’s policy across three years and distinguishes between combined and standalone arrangements, aligning with the ground truth. It also correctly notes that variable consideration estimates were consistently absent. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'increased emphasis on the Gaming segment in 2023 and 24' as context for potential business shifts, though this is contextual and not central to the accounting policy itself. The LLM captures the core accounting logic and evolution (or lack thereof) accurately. Wording differs slightly (e.g., 'refined and clarified' vs. 'reiterated'), but this reflects appropriate paraphrasing and does not distort meaning. Overall, the answer is factually complete, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 461,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "\nThe repeated citation of the “Certificate of Designations of Series B Convertible Participating Preferred Stock” in the 2022, 2023 and 2024 Form 10‑K filings shows that the instrument remains a formally recognized and active component of Visa’s charter and capital‑structure documentation. Its continued presence—along with the related conversion and voting rights provisions—indicates that the Series B preferred stock continues to be used (e.g., for litigation‑related holdbacks, conversion adjustments, and stakeholder voting) and has not been retired or superseded, underscoring its ongoing relevance to Visa’s governance and financing arrangements.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that the Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently referenced across Visa's 2022, 2023, and 2024 filings, indicating its ongoing relevance and formal recognition in Visa’s capital structure. There are no numeric values, dates, or calculations in the LLM answer that contradict the ground truth; thus, quantitative accuracy is perfect (score: 10). The answer correctly identifies the entity (Visa), the instrument (Series B Convertible Participating Preferred Stock), and the time frame (2022–2024), satisfying entity accuracy. However, the LLM omits key details present in the ground truth: it does not mention the specific exhibit numbers (Exhibit 4.5 in 2022, Exhibit 4.4 in 2023 and 2024) or the consistent filing date of June 21, 2016, which are central to the original answer’s conclusion about the instrument being static and unmodified. This lack of specificity weakens the qualitative accuracy (score: 7), as it fails to fully support the inference of long-term stability with the same documentary references. While the LLM correctly infers ongoing relevance and governance importance, it introduces speculative uses such as 'litigation-related holdbacks' and 'conversion adjustments' that are not present or implied in the ground truth, slightly undermining reasoning rigor. Nonetheless, the overall reasoning is sound and contextually appropriate, and the answer directly addresses the question about stability and relevance, earning a high contextual relevance score (9). The correctness score is 7 because the core facts are right, but important evidentiary details are missing, and minor unsupported inferences are added.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 470,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "\nRTX’s ownership in the IAE collaboration was steady through the three years – a 61 % program‑share and 49.5 % legal stake in International Aero Engines AG and a 59 % program‑share/ownership interest in IAE LLC (see 2022 10‑K page 126; 2023 10‑K page 102; 2024 10‑K page 101).  However, the filings began to disclose the **net** program‑share after allocating sub‑collaborator portions – 57 % for IAE and 51 % for IAE LLC – reflecting a more precise accounting of RTX’s economic exposure (2023 & 2024 pages 102‑101).  Because RTX is identified as the primary beneficiary and consolidates both IAE and IAE LLC, its effective control and economic exposure to the V2500 engine program remain fully dominant, highlighting Pratt & Whitney’s strategic positioning as the lead developer and commercial driver of the V2500 engine within the multi‑partner alliance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several inaccuracies in quantitative details compared to the ground truth. While it correctly states that RTX (via Pratt & Whitney) maintained a 61% program share and 49.5% ownership interest in IAE across 2022–2024, it incorrectly introduces IAE LLC with a 59% program-share/ownership interest and claims a net program-share of 51% for IAE LLC—entities and figures not present in the original answer or supported by the context provided. The ground truth specifies a single net program share interest of 57% after sub-collaborator participation for IAE, not split across two entities. This misrepresentation of structure and numbers undermines quantitative accuracy. However, the core idea—that RTX’s stake and economic exposure remained stable—aligns with the original answer, and the conclusion about Pratt & Whitney’s strategic positioning as dominant and unchanged is reasonable. The reasoning is logically sound in interpreting stable stakes as indicating no strategic shift, and the use of multi-year 10-K references shows proper synthesis. The answer adds contextual detail (primary beneficiary, consolidation) that enhances understanding, but the introduction of IAE LLC and associated percentages reflects either misinterpretation or unsupported inference. Thus, while the qualitative reasoning and relevance are strong, the quantitative inaccuracies reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 389,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "\nMedtronic continued to grant Non‑Employee Director Deferred Unit Awards in fiscal 2022, 2023 and 2024, citing the agreement in the 2022 filing under the 2008 Stock Award and Incentive Plan, updating the reference in the 2023 filing to the Amended and Restated 2013 Stock Award and Incentive Plan, and retaining the same form in the 2024 filing.  This consistent use of deferred equity—without a fundamental redesign—reflects a long‑term compensation strategy that aligns director interests with shareholders by tying a substantial portion of director pay to performance‑linked, long‑term equity that vests over time.  The periodic plan amendments show that the company refreshes the underlying plan language to stay current with governance updates while preserving the core deferred‑unit structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error in the core claim about plan transition: it states that Medtronic updated the reference from the 2008 Plan to the Amended and Restated 2013 Plan in 2023, which directly contradicts the ground truth. According to the original answer, the Non-Employee Director Deferred Unit Award Agreement remained tied to the 2008 Stock Award and Incentive Plan in all three years (2022, 2023, and 2024), with no shift to the 2013 Plan. This misrepresentation undermines the entire analysis of Medtronic's long-term strategy. While the LLM correctly identifies the continuity of the deferred unit award form and the use of equity to align director-shareholder interests, the erroneous claim about plan migration leads to flawed reasoning. The contextual relevance is high because the answer addresses the question's structure and intent, and the qualitative reasoning about alignment with shareholders is sound in isolation, but it is based on incorrect premises. Quantitative accuracy is low because the key factual detail (plan name and year) is wrong, despite correct fiscal years being cited. The model fails the multi-hop requirement to accurately synthesize across filings and plans, instead inventing a plan update that did not occur for this specific award.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 360,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "\nLockheed Martin’s variable‑rate swaps grew from about $0.5 billion of notional exposure in 2020‑21 to roughly $1.3 billion by the end of 2022, and that $1.3 billion level was maintained at both 2023‑ and 2024‑year‑end (the 2024 filing notes the same $1.3 billion figure for 2024 and 2023).  The steady‑state $1.3 billion notional shows that after an initial expansion to hedge a larger share of its fixed‑rate debt, the company has now settled into a consistent hedge‑coverage strategy, using swaps primarily to convert fixed‑rate borrowings into variable‑rate obligations and to protect the fair‑value of that debt against rising interest rates.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer contains a significant error in the timeline of notional amounts. According to the ground truth, LMT had $500 million in 2022, rising to $1.3 billion in 2023 and remaining there in 2024. However, the LLM claims the increase to $1.3 billion occurred by the end of 2022 and was maintained in 2023 and 2024. This misrepresents the timing of the increase—shifting it one year earlier—and incorrectly implies no change in 2023. Additionally, the LLM references '2020-21' data not mentioned in the original answer, introducing extraneous and unsupported information.\n\n2) Quantitatively, the $500 million and $1.3 billion figures are correct in value but misaligned with the correct years. The original answer specifies 2022 = $500M, 2023 = $1.3B, 2024 = $1.3B. The LLM states $0.5B in '2020-21' and $1.3B by end of 2022—this is factually inconsistent. The tripling from $500M to $1.3B is accurate in magnitude, but the timing error undermines the progression narrative.\n\n3) The qualitative reasoning about LMT's risk management strategy—shifting to more active hedging and then stabilizing—is sound and aligns with the ground truth. The interpretation that the company moved to hedge fixed-rate debt and then maintained a steady position is logically supported and correctly infers strategic intent from the data pattern, despite the timeline error.\n\n4) Contextually, the answer is highly relevant, addressing both the evolution of swap usage and the strategic implications. It correctly identifies the purpose of the swaps (converting fixed to variable, protecting fair value) and draws appropriate conclusions about risk management maturity. The core strategic insight is preserved, even if the timeline is flawed.\n\nOverall, the answer gets key numbers and strategic interpretation right but fails on precise temporal alignment, which is critical in multi-year financial analysis. Hence, correctness is reduced to 7 due to the material timing inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 530,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s charter repeatedly required that directors may be removed **only for cause** and that any amendment to those provisions needs the affirmative vote of at least 80 % of the voting stock—a standard that appears verbatim in the 2022, 2023 and 2024 Form 10‑K filings (see ABBV_10k_2022.pdf p. 46; ABBV_10k_2023.pdf p. 27; ABBV_10k_2024.pdf p. 27).  This three‑year consistency shows that AbbVie has deliberately maintained a stable, robust board‑protection framework, underscoring a strategic posture that prioritizes takeover defense and board continuity over any shift in governance posture.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that AbbVie maintained the 'removal only for cause' provision from 2022 to 2024, which matches the original answer's claim of consistency across all three years. (2) The quantitative detail about the 80% supermajority requirement for amending governance provisions is correctly reported and not present in the ground truth but is factually accurate and adds value without contradicting it—this specificity strengthens the answer. The cited page numbers and document years (2022 p.46, 2023 p.27, 2024 p.27) are precise and support verifiability. (3) The reasoning correctly synthesizes multi-hop information across three years of 10-K filings, identifies the persistence of the provision, and draws a logical conclusion about AbbVie’s strategic posture toward takeover defenses and board continuity. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of the governance provision and the strategic implication of this consistency. The conclusion about a 'stable, robust board-protection framework' is semantically equivalent to the ground truth’s 'stable and deliberate governance strategy' and is well-supported. No factual errors, omissions, or inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 363,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "\nAbbVie’s short‑term cash allocation fell sharply from **$21 million in money‑market funds and time deposits at the end of 2022** (see ABBV_10‑K 2022, p. 96) to **about $10 million by the end of 2023** (ABBV_10‑K 2023, p. 85) and **remained roughly $10 million through 2024** (ABBV_10‑K 2024, p. 84).  \n\nThis reduction indicates that the company is deliberately scaling back its low‑yielding cash‑equivalent holdings and relying more on operating cash flow, commercial‑paper issuance and debt financing to fund acquisitions, dividends and share‑repurchases, while retaining only a modest cash buffer to preserve liquidity amid fluctuating cash balances.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then dropped to $10 million in 2024. However, the LLM incorrectly states that the amount was $21 million in 2022 (reversing the trend), $10 million in 2023, and remained at $10 million in 2024. This misrepresents the actual trajectory of the allocation. (2) The numbers are not accurate: the LLM swaps the 2022 and 2023 values and omits the increase in 2023. While the $10 million figure for 2024 aligns with the ground truth, the prior years are incorrect, leading to a flawed interpretation of the trend. (3) The reasoning is partially sound in that it infers a strategic shift in liquidity management, but it is based on incorrect data. The conclusion about reducing low-yielding holdings may have merit, but the ground truth shows an initial increase before the decline, suggesting a more dynamic and responsive strategy than the LLM's narrative of a continuous 'scaling back.' The LLM fails to acknowledge the rise in 2023, which is a critical part of the multi-hop analysis. (4) The contextual relevance is fair—the answer addresses short-term liquidity strategy and ties it to broader financial activities like dividends and acquisitions—but due to the incorrect data sequence, the qualitative insight is compromised. The citation of specific 10-K pages adds apparent credibility but does not compensate for factual errors. Overall, the answer is partially correct in direction but fails on core factual accuracy, especially in the time-series evolution of the allocation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 471,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "\nAbbVie’s charter has repeatedly required that directors can be removed *only for cause* and that any amendment to those removal‑for‑cause provisions must be approved by holders of at least 80 % of the voting stock (see the 2022 Form 10‑K, p. 46; the 2023 Form 10‑K, p. 27; and the 2024 Form 10‑K, p. 104). The language and scope of this provision have not changed across the three years. This steady application shows that AbbVie is intentionally preserving board stability and making it difficult for an outside party to replace directors without cause—an explicit, long‑term defensive strategy to deter hostile takeovers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that AbbVie maintained the 'removal only for cause' provision from 2022 to 2024, which matches the original answer's claim of consistency across all three years. (2) The LLM correctly identifies the 80% supermajority requirement for amending the provision, a specific quantitative detail not present in the original answer but consistent with the actual 10-K filings and reinforcing the anti-takeover mechanism. This additional detail enhances accuracy without introducing error. (3) The reasoning is sound: the unchanging language over three years is correctly interpreted as a deliberate, long-term strategy to ensure board stability and deter hostile takeovers, which is a valid inference supported by the original answer's conclusion about strategic continuity and anti-takeover defense. (4) All entities—AbbVie, the years 2022–2024, the governance provision, and the strategic implication—are correctly identified and synthesized across time periods. The answer addresses both parts of the question: the evolution (or lack thereof) and the strategic implication. Semantic equivalence is strong, with the LLM providing slightly more granular detail (80% threshold) while preserving and enhancing the core meaning of the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 372,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved PowerVia from a announced breakthrough for its upcoming Intel 18A (originally 20A) node to a core element of its advanced‑node roadmap—cancelling the Intel 20A generation, re‑branding the effort as Intel 18A, and extending the backside‑power concept to the next node, Intel 14A. The 2024 disclosures confirm that PowerVia‑enabled Intel 18A will enter high‑volume manufacturing in 2025 (e.g., Panther Lake) and will be a differentiator for performance‑per‑watt and density, supporting Intel’s IDM 2.0 strategy of offering the technology both internally and to external foundry customers. This progression shows Intel’s strategy to make backside power delivery a cornerstone of its leadership in advanced process nodes and to leverage it across its hybrid manufacturing and foundry business.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Intel's PowerVia strategy and aligns with the general timeline and strategic intent described in the ground truth. It correctly identifies PowerVia as a key technology introduced for advanced nodes, its shift from Intel 20A to Intel 18A, and the planned high-volume manufacturing (HVM) in 2025. The mention of Panther Lake and IDM 2.0 adds relevant context not in the original but consistent with public knowledge, enhancing completeness without introducing error. However, there are notable deviations: the claim that Intel 'cancelled' Intel 20A and rebranded it as Intel 18A is not supported by the ground truth, which describes a realignment or shift in focus rather than a cancellation or rebranding. Additionally, the extension of PowerVia to Intel 14A is not mentioned in the original answer and represents an unsupported extrapolation. While the 2025 HVM date is correct, the original does not specify Panther Lake as the vehicle, making that detail potentially accurate but unverified by the ground truth. The strategic interpretation about performance-per-watt, density, and foundry offerings is consistent with the original’s emphasis on external foundry and practical implementation. Quantitative accuracy is high—dates (2025) are correct, and no erroneous calculations are present. Qualitatively, the reasoning is mostly sound but includes assumptions beyond the provided data. Contextual relevance is excellent, directly addressing the question’s focus on roadmap evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 426,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Medtronic’s expected‑volatility assumption in the Black‑Scholes model rose from **23.0 % (2022) → 24.1 % (2023) → 24.3 % (2024)**.  This steady increase—driven by a growing blend of historical and implied volatility—shows the company is progressively incorporating higher market‑observed volatility into its option‑pricing, reflecting a more dynamic, market‑responsive approach to valuing its non‑qualified stock options.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly focuses on numerical values for expected volatility (23.0%, 24.1%, 24.3%) which are not present in the original answer and not supported by the ground truth. The original answer does not provide specific percentage values for expected volatility in any year, so these numbers are fabricated. This is a critical factual error. (2) Quantitative accuracy is low because the percentages cited (23.0%, 24.1%, 24.3%) have no basis in the ground truth, and no numerical volatility assumptions were given in the original answer. There is no way to verify or support this progression. (3) Qualitatively, the LLM captures the correct directional evolution—shifting from purely historical volatility in 2022 to incorporating implied volatility from market-traded options in 2023 and 2024—and correctly infers that this reflects a more market-responsive approach. This shows partial multi-hop reasoning: it identifies the methodological shift, though it invents numbers to support it. (4) Contextually, the answer stays focused on the question about MDT's volatility assumptions and what they suggest about non-qualified stock option valuation. The conclusion about a 'more dynamic, market-responsive approach' aligns with the original answer’s interpretation. However, the invention of precise percentages severely undermines factual correctness, warranting a low overall score despite correct conceptual understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 401,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "\nFrom 2022 through 2024 Intel progressed PowerVia from an early‑stage concept in the Intel 18A roadmap (first detailed on page 6) to a fully articulated, high‑volume‑manufacturing‑ready backside‑power solution that will debut with the 18A node (Panther Lake) slated for 2025 production (as outlined on page 10). By repeatedly positioning PowerVia together with RibbonFET as the twin breakthroughs that deliver up to ~10 % performance‑per‑watt gains and denser transistor scaling, Intel signaled that this architecture is central to its advanced‑node and IDM 2.0/foundry strategy, underpinning the next generation of leadership products and its broader advanced‑process roadmap.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it incorrectly states that PowerVia was part of the Intel 18A roadmap from the beginning (in 2022), while the ground truth confirms it was first introduced under Intel 20A. This misrepresents the timeline and node association. Second, the performance-per-watt improvement is cited as ~10%, but the original answer specifies up to 15% over Intel 3, which is a significant discrepancy. Third, the LLM claims PowerVia evolved from a concept in the 18A roadmap, but in reality, Intel 20A was canceled in favor of 18A, with PowerVia carried forward—this reversal of events undermines the factual narrative. (2) Quantitatively, the 10% figure is incorrect versus 15%, and the assertion that PowerVia was initially on 18A conflicts with the 2022 introduction under 20A. The 2025 HVM date for Panther Lake is correct and aligns with the ground truth. (3) The multi-hop reasoning is partially sound—Intel did position PowerVia as central alongside RibbonFET and for advanced nodes—but the failure to accurately trace the transition from 20A to 18A and the misattribution of initial node placement indicates flawed synthesis across years. (4) Despite these errors, the answer captures the strategic importance of PowerVia and its role in Intel's roadmap, maintaining high contextual relevance. However, due to key factual and quantitative inaccuracies in node evolution and performance metrics, the correctness score is reduced to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 411,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "\nFrom 2022 through 2024 the Black‑Scholes inputs used for MDT’s non‑qualified stock‑option grants changed only modestly: the expected life stayed close to six years (6.0 → 6.1 years), the risk‑free rate rose sharply from 0.90 % (2022) to 2.70 % (2023) and 4.16 % (2024) as interest rates increased, the dividend yield edged up from 1.95 % to 2.92 % and 3.18 %, and volatility inched upward from 23.04 % to 24.05 % and 24.29 %. This incremental evolution—maintaining a stable exercise horizon while slowly adjusting volatility, rates and yield to reflect current market conditions—indicates that MDT bases its volatility estimate on a blend of historical and implied market data and treats employee exercise behavior as relatively persistent over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details not present in the original answer. The ground truth does not provide specific numerical values for expected life (6.0 → 6.1 years), risk-free rates (0.90%, 2.70%, 4.16%), dividend yields (1.95%, 2.92%, 3.18%), or volatility figures (23.04%, 24.05%, 24.29%)—these numbers are fabricated or hallucinated. The original answer focuses on the qualitative shift in volatility estimation methodology (adding implied volatility in 2023 and 2024), which is the central evolution. The LLM fails to mention this key methodological change—the core of the original answer—and instead invents a narrative around numerical trends that are not supported by the ground truth. While the LLM correctly identifies the use of Black-Scholes and general factors like employee exercise behavior and volatility, it misrepresents the nature of the evolution. The reasoning is partially sound in linking assumptions to market conditions, but it is based on false data. The contextual relevance is high because it addresses the question’s structure and topic, but the lack of the key point about implied volatility adoption severely undermines correctness. The answer misses the multi-hop insight that MDT integrated market-traded option data into its model, which is the critical development. Thus, despite plausible framing, the answer is factually incorrect on key points and omits the most important information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 403,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2024 the collateral that ExxonMobil reports as “not offset against the derivatives” – which is recorded in the “Other assets, including intangibles – net” line – fell sharply from **$1.49 billion (2022)** to **$0.80 billion (2023)** and then to **$0.49 billion (2024)**.  This decline shows the company is relying less on external collateral to support its derivative positions and is instead managing exposure through tighter netting and offsetting of contracts, indicating a more efficient and lower‑risk approach to derivative exposure management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024), which match the ground truth of $1,494 million, $800 million, and $491 million when rounded to the nearest hundred million. Minor formatting differences ($1.49 billion vs $1,494 million) are acceptable and do not affect factual accuracy. 2) Quantitatively, all figures are accurate and correctly associated with the respective years. The trend of a sharp decline is correctly identified. 3) The reasoning is sound: the LLM correctly infers that the decline suggests reduced reliance on external collateral and improved netting efficiency. While the original answer emphasizes 'strategic reduction in derivative exposure' or 'lower volatility in commodity markets,' the LLM's interpretation of 'tighter netting and offsetting' and 'more efficient, lower-risk approach' is semantically consistent and logically valid. The only minor gap is that the LLM does not mention potential external factors like market volatility or hedging strategy shifts, which slightly reduces qualitative depth. 4) The answer is fully contextually relevant, addressing both the quantitative change and its implications for derivative exposure management. The synthesis across three years and correct attribution to 'Other assets, including intangibles - net' confirms accurate multi-hop reasoning. Overall, the answer is factually correct, well-reasoned, and complete with only slight variation in explanatory nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 416,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value of NEE’s gas‑linked options was essentially unchanged – the asset side stayed at about **$100 million** while the liability rose only modestly from **≈ $97 million (2022)** to **≈ $102 million (2024)**, leaving a near‑neutral net position.  The valuation relied on Level‑3 inputs, especially implied volatilities, which moved from a weighted‑average of roughly **50 % in 2022‑23** to **≈ 52 % in 2024**, with the upper bound of the volatility range tightening from **233 % to 150 %**; implied‑correlation assumptions stayed broadly similar.  This shows that NEE is maintaining a modest, largely hedged exposure to gas‑price movements and is fine‑tuning its volatility assumptions to current market conditions, reflecting a cautious risk‑management stance in its gas‑derivative positioning.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both fair value figures and volatility assumptions. According to the ground truth, in 2022, NextEra Energy's 'Options - primarily gas' had $356 million in assets and $347 million in liabilities, not $100 million in assets and $97 million in liabilities as stated by the LLM. The LLM incorrectly claims the asset value was already $100 million in 2022, when in fact it dropped to that level only in 2023 after starting at $356 million. This misrepresents the entire trend. Additionally, the LLM states implied volatility was around 50% in 2022–2023, but the ground truth shows it started at 36% in 2022, rising to 50% in 2023 and 52% in 2024 — a key upward trend that the LLM mischaracterizes as flat. (2) The calculation of change over time is therefore fundamentally flawed: the correct narrative is a sharp decline in exposure (from ~$350M to $100M) alongside rising volatility assumptions, indicating de-risking amid increasing market uncertainty. The LLM instead suggests stable exposure and slightly increasing volatility, which contradicts the data. (3) The multi-hop reasoning is weak: the model fails to synthesize the correct values across years and misaligns the timeline, leading to an incorrect conclusion about risk positioning. While it correctly identifies the use of Level 3 inputs and discusses volatility ranges and correlation, these details are not in the ground truth and appear fabricated or misattributed. (4) Despite incorrect numbers and reasoning, the answer remains contextually relevant — it addresses fair value, volatility, and risk positioning for gas derivatives — hence a moderate contextual relevance score. However, due to severe quantitative errors and flawed logic, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 490,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "\nFrom the 2022 10‑K (page 50), the 2023 10‑K (page 50) and the 2024 10‑K (page 51), Unsecured Notes – 35A consistently show a **$750 million face amount** and an **annual debt‑service requirement of $19.875 million** (≈ 2.65 % coupon, maturing 07/15/30).  No change in either the principal size or the yearly interest‑plus‑principal payment is reported across the three years.  \n\nThis stability indicates that SPG’s long‑term debt strategy is to **maintain a large, low‑cost, fixed‑rate unsecured issuance and to extend maturities rather than refinance or downsize the issue**, preserving liquidity and a predictable capital‑structure while supporting ongoing growth initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer contains a significant quantitative error: it reports the face amount as $750 million and annual debt service as $19.875 million, whereas the ground truth specifies $750,000 and $19,875. This is a discrepancy of 1,000x, likely due to misreading 'thousands' in the 10-K (common in SEC filings where amounts are often reported in thousands). Despite correct relative stability and no changes over time, the magnitude of the financial obligation is severely overstated.\n\n2) Calculations: The implied coupon rate of ≈2.65% is mathematically accurate only if the numbers were in millions, but with the correct base ($19,875 / $750,000 ≈ 2.65%), the percentage is coincidentally accurate due to proportional scaling. However, this does not excuse the fundamental misrepresentation of scale.\n\n3) Multi-hop reasoning is sound—LLM correctly identifies consistency across 2022–2024 filings and synthesizes this into a conclusion about SPG’s long-term debt strategy. It adds contextual insight (maturity date 07/15/30, strategy of maintaining fixed-rate debt, liquidity preservation) not in the original answer, which enhances qualitative reasoning.\n\n4) Entity accuracy (SPG, Unsecured Notes - 35A, years 2022–2024) and contextual relevance are perfect. The answer directly addresses all parts of the question and provides additional relevant detail (maturity date, coupon implication).\n\n5) The core factual error in scale (thousands vs. millions) severely impacts quantitative accuracy, but the qualitative logic and structure are strong. Hence, correctness score is reduced to 7 due to major numerical inaccuracy, though not complete failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 451,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments repeatedly elevated embedded‑processing as a core strategic pillar—highlighting its 19 % YoY revenue growth and a jump in operating‑profit margin in 2021‑22, maintaining roughly 19 % of total sales in 2023, and in 2024’s MD&A reaffirming heavy investment in capacity and risk management to capture growth in industrial and automotive markets. This three‑year progression demonstrates TI’s deliberate deepening of embedded‑processing to diversify its portfolio, generate higher‑margin cash flow, and cement its long‑term position as a leading supplier in the high‑growth semiconductor segments.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth does not mention any '19% YoY revenue growth' or 'jump in operating-profit margin in 2021-22'—these figures are absent from the original answer and cannot be verified from the provided knowledge. Similarly, the claim that embedded processing made up 'roughly 19% of total sales in 2023' is not supported by the original answer, which does not provide any revenue percentages. The 2024 mention of 'MD&A reaffirming heavy investment in capacity and risk management' introduces details (e.g., risk management) not present in the original. (2) Quantitative accuracy is severely compromised: none of the percentages or financial metrics (19% growth, 19% of sales) appear in the ground truth, and there is no mention of 2021–2022 margins or revenue breakdowns. These numbers are either fabricated or misattributed. (3) While the LLM correctly identifies the multi-year strategic emphasis on embedded processing and links it to long-term positioning, it fails to accurately represent the nature of the evolution. The original answer stresses *consistency* in language and strategy across 2022–2024, not a 'deepening' or increased investment as implied. The reasoning incorrectly suggests progression and intensification, whereas the truth indicates stability and reinforcement. (4) Contextual relevance is fair—the answer addresses the right company, time frame, and strategic theme, and draws a reasonable conclusion about long-term positioning. However, the incorrect data and flawed reasoning undermine the qualitative and overall correctness scores. The answer appears plausible but is factually misaligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 477,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "\nFrom 2022 through 2024 CMCSA moved shared‑data wireless plans from a niche add‑on tied only to broadband subscriptions toward a core component of its bundled video‑and‑Internet packages.  Early on the offering gave customers unlimited, shared‑data or per‑gigabyte choices with device‑purchase financing; by 2023‑24 the company broadened the menu to include prepaid unlimited “NOW” plans, extended financing periods (up to 48 months for international customers), and promoted the plans as part of integrated bundles that combine broadband, X1/Sky Q video and streaming services, giving subscribers a wider range of payment and plan options.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of CMCSA's shared data plan strategy from 2022 to 2024 and correctly notes the continuation of shared data plans within bundled offerings. It accurately mentions the introduction of prepaid unlimited plans under the NOW brand in 2024 and references the availability of unlimited, shared, and per-gigabyte options. However, there are significant factual inaccuracies: (1) The claim that shared-data plans evolved 'from a niche add-on' is unsupported by the ground truth, which states shared data plans were consistently offered as part of bundles across all three years, not as a growing component. (2) The LLM incorrectly states that financing periods were extended to 'up to 48 months' and mentions 'international customers,' which is not supported—ground truth specifies 24-month financing and focuses on residential (presumably U.S.) customers with no mention of international expansion. (3) The integration with 'X1/Sky Q video and streaming services' adds detail not present in the original answer, which only references broadband bundling. (4) The ground truth does not mention any change in device financing terms from 2022–2023, contrary to the implication of broadening in 2023–24. While the core idea of expanding plan flexibility in 2024 is correct, the specific quantitative and qualitative details around financing and positioning are inaccurate. The answer is contextually relevant and addresses the question's focus on bundling and plan options, but contains key factual errors that reduce correctness. Quantitative accuracy is low due to incorrect timeframes (48 months vs. 24 months) and unsupported expansions. Qualitative accuracy is moderate due to correct high-level trends but flawed reasoning on strategic shift and bundling scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 486,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nMastercard’s Class A treasury‑stock balance grew from $51.35 billion at year‑end 2022 to $60.43 billion at year‑end 2023 and to $71.43 billion at year‑end 2024 – an additional $9.1 billion of repurchases in 2023 and $11.0 billion in 2024.  The accelerating buy‑back trend shows that the company is deploying a larger share of its excess cash to retire its own equity, underscoring a capital‑allocation strategy that prioritizes returning capital to shareholders and supporting the stock price.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the trend in Mastercard's Class A Treasury Stock investment from 2022 to 2024 with accurate figures, though there is a minor discrepancy in the 2022 value. The ground truth reports $(36,658) million for 2022, while the LLM states $51.35 billion. This appears to be a data error in the LLM answer, as $51.35 billion does not match the ground truth. However, the 2023 and 2024 values ($60.43 billion and $71.43 billion) align closely with the ground truth of $(60,429) million and $(71,431) million, respectively (differing by only $1 million, likely due to rounding). (2) The LLM calculates the year-over-year increases as $9.1 billion (2023) and $11.0 billion (2024), which are accurate based on its stated values. However, using ground truth numbers, the actual increase from 2022 to 2023 was $23,771 million ($60,429 - $36,658), not $9.1 billion. This suggests the LLM used an incorrect starting point. Despite this, the direction and acceleration of buybacks are correctly interpreted. (3) The multi-hop reasoning is sound: the model correctly identifies the increasing magnitude of treasury stock (interpreted as buybacks), synthesizes the trend across three years, and infers the strategic intent behind capital allocation. (4) The qualitative and contextual accuracy is excellent—the answer correctly interprets the implication of growing treasury stock as a sign of shareholder-friendly capital return via buybacks, matching the ground truth's conclusion. The wording differs but the semantic meaning is equivalent. The only significant issue is the incorrect 2022 figure, which affects quantitative accuracy but not the overall correctness of the trend or interpretation. Hence, a score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 479,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "\nRevenue from Repair and other services fell from **$1.169 billion in 2022 to $1.132 billion in 2023**, and remained flat at **$1.132 billion in 2024**. This modest decline followed by a plateau shows that General Dynamics’ service business has largely stabilized—there is little growth in repair and other services over the 2022‑2024 period, indicating a mature, steady‑state trajectory rather than an expanding one.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all financial figures: $1.169 billion in 2022 (equivalent to $1,169 million), $1.132 billion in 2023 and 2024 (equivalent to $1,132 million), matching the ground truth exactly. The statement that revenue declined slightly from 2022 to 2023 and remained flat in 2024 is accurate.\n\n2) Quantitative accuracy is perfect: all dollar amounts and years are correct. The implied percentage decline is approximately 3.2% ((1,169 - 1,132)/1,169 ≈ 0.0316), which aligns with the ground truth's 'about 3.2%' decline. The LLM does not explicitly state the percentage but describes the change as a 'modest decline', which is semantically reasonable.\n\n3) The reasoning is sound: the LLM correctly identifies the trend (decline followed by stabilization) and draws a logical conclusion about the service business trajectory. The interpretation differs slightly in tone—'stabilized' and 'steady-state' vs. 'stagnation or potential contraction'—but both reflect limited growth. The LLM's characterization as 'mature, steady-state' is a slightly more positive interpretation than the ground truth's 'stagnation or contraction', but it is still within reasonable analytical range given the data.\n\n4) The answer is fully contextually relevant, addressing both parts of the question: the revenue change over time and what the pattern reveals about the business trajectory. It synthesizes multi-year data correctly and provides a coherent qualitative assessment. The only minor gap is the absence of the explicit 3.2% figure, but this does not detract significantly from the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 440,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "\nBased on the disclosed tables, CVS’s residential‑mortgage‑backed‑securities (RMBS) position fell from **$721 million in fair value with $89 million of unrealized losses in 2022** (2022 10‑K, page 145) to **$614 million in fair value and $60 million of unrealized losses in 2023** (2023 10‑K, pages 145 & 149). The 2024 filing further shows only **$71 million of RMBS in the separate‑account portfolio** (2024 10‑K, page 158), indicating a continued shrinkage of the exposure.  \n\nThis multi‑year trend reflects a deliberate de‑risking of the RMBS holdings—fair value has declined while the magnitude of unrealized losses has remained modest or improved—signaling that CVS is positioning the asset class with a more defensive, low‑risk profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, CVS's RMBS fair value in 2022 was $629 million with $10 million in unrealized losses, but the LLM states $721 million and $89 million, respectively—both figures are incorrect and not minor discrepancies. The 2023 values ($614 million fair value, $60 million unrealized losses) match the ground truth and are correctly cited. The 2024 value of $71 million is accurate and correctly interpreted as a sharp reduction. (2) Calculations: While no explicit math is performed, the trend description misrepresents the 2022 baseline, leading to flawed trajectory analysis. The claim that 'unrealized losses have remained modest or improved' overlooks the ground truth's key point that losses increased from $10M to $60M in 2023, indicating deterioration, not improvement. (3) Multi-hop reasoning is partially sound—the model correctly identifies a declining trend in RMBS exposure over three years and infers de-risking, which aligns with the ground truth. However, due to incorrect 2022 data, the reasoning is based on flawed premises for that year. (4) Contextual relevance is high: the answer addresses all parts of the question—evolution across years, fair value, unrealized losses, and risk positioning—and cites specific 10-K pages, showing appropriate sourcing. Despite incorrect initial numbers, the conclusion about de-risking is directionally correct, but the flawed data reduces overall correctness. Hence, correctness score is 6: partially correct with significant factual errors in key metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 435,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "\nFrom 2022 through 2024 Linde kept its on‑site atmospheric‑gas supply contracts as long‑term, total‑requirement agreements (typically 10‑20 years) that contain minimum‑purchase obligations and price‑escalation clauses indexed to external price indices.  The contractual framework did not change materially, but the pricing became more variable – consideration now fluctuates with those indices – yet, in each year the variable components were treated as constrained and were recognized only when measurable, a practice reflected in the “Contracts with Customers” disclosures for 2022, 2023 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core elements of Linde's contractual structure for atmospheric gases from 2022 to 2024: long-term on-site contracts (10–20 years), minimum purchase requirements, price escalation clauses tied to external indices, and the treatment of variable consideration as constrained. All entities (Linde, atmospheric gases, on-site agreements, variable pricing) and timeframes (2022–2024) are accurate, and there are no numerical or date inaccuracies—quantitative accuracy is perfect. However, the LLM misses a key evolution highlighted in the ground truth: the increased transparency and explicit clarification around variable pricing components that emerged in 2023 and was reinforced in 2024 under ASC 606, particularly regarding the practical expedient for revenue recognition aligned with invoicing. While the LLM notes that variable components were constrained and recognized when measurable across all three years, it fails to capture the progression in disclosure detail and the growing emphasis on revenue recognition alignment, which is central to the question about 'evolution' in pricing mechanisms. This omission reduces qualitative accuracy, as the multi-hop synthesis across years to show a trend in disclosure and accounting practice is incomplete. The answer remains contextually relevant and factually sound on surface-level contract terms but underrepresents the nuanced shift in financial reporting and transparency. Thus, while factually correct, it lacks depth in capturing the temporal evolution in disclosure and accounting treatment emphasized in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 441,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "\nBetween 2022 and 2024, NextEra Energy’s net fair‑value exposure to forward gas contracts fell from roughly $300 million to $250 million (after a peak of about $300 million in 2023).  This reduction reflects a deliberate scaling back of speculative gas‑price positions and a shift toward regulated, cash‑flow‑stable operations, indicating a more conservative stance on natural‑gas market risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative evolution of NextEra Energy's net exposure. It incorrectly states that net exposure in 2022 was 'roughly $300 million' and 'fell from roughly $300 million', when the ground truth shows it was $160 million in 2022. While it correctly identifies the 2023 peak at about $300 million and the 2024 decline to $250 million, the starting point is wrong, distorting the trend. The calculation of net exposure in 2022 (assets $191M - liabilities $31M = $160M) is not reflected at all. (2) The LLM misrepresents the direction of change from 2022 to 2023: it implies a decrease or stability, when in fact exposure nearly doubled. This invalidates the calculation and comparative logic across years. (3) The reasoning about a 'deliberate scaling back' and 'more conservative stance' only partially aligns with the ground truth. While the 2024 decline supports reduced exposure, the full 3-year trend includes a major expansion in 2023, which the LLM omits, leading to an incomplete and misleading interpretation. The ground truth suggests a strategic expansion followed by partial contraction, not a consistent reduction. (4) Despite these errors, the answer is contextually relevant, addressing both the numerical trend and risk positioning, and correctly notes the 2024 decline. However, the failure to accurately represent the 2022 baseline and the 2022–2023 increase—critical for multi-hop synthesis—severely undermines correctness. Minor phrasing like 'speculative positions' and 'regulated operations' adds interpretation not in the original, but the core flaw is quantitative inaccuracy affecting qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 465,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings Broadcom continues to list Industrial Fiber Optics in the “Industrial” end‑market table (page 5 of each filing), grouping it with optocouplers, sensors, motion‑control encoders, LEDs and Ethernet PHYs.  The discussion evolved from a simple product catalog entry to a strategic emphasis on high‑speed, low‑latency connectivity for factory‑automation, renewable‑energy and automotive‑electronics applications, and was tied to the company’s broader industrial product portfolio and infrastructure‑software ecosystem (see page 6’s fiber‑optic component description and page 17’s note on industrial‑product diversification).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Industrial Fiber Optics was consistently listed under the Industrial end market across 2022–2024 and grouped with similar products like optocouplers, sensors, motion-control encoders, LEDs, and Ethernet ICs (referred to as 'Ethernet PHYs'—semantically equivalent). It accurately reflects the application markets: factory automation, renewable energy, and automotive electronics. However, the claim that the discussion evolved 'from a simple product catalog entry to a strategic emphasis' and was 'tied to the company’s broader industrial product portfolio and infrastructure-software ecosystem' introduces interpretation not present in the ground truth. The original answer emphasizes *stability* in positioning with *no significant expansion or contraction*, whereas the LLM implies a strategic evolution or elevation, which is unsupported. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored 10 by default as no errors exist. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes product groupings and applications across years but overinterprets subtle shifts in language as strategic evolution, failing to emphasize the *consistent* and *stable* role highlighted in the ground truth. (4) Contextual relevance is high—the answer addresses the evolution question and ties in relevant product groupings and applications. However, the qualitative inaccuracy in reasoning and slight misrepresentation of strategic trajectory justify a 7 in correctness and qualitative accuracy. Semantic equivalence is mostly preserved but with a notable deviation in the conclusion about strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 477,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes‑31B listed in the filings kept the same terms – a fixed 3.25 % interest rate, a $750 million face amount and a maturity date of 11/30/26 – as shown on pages 50 (2022 & 2023) and 51 (2024).  This unchanged tranche, together with the overall reduction in total unsecured indebtedness in 2024, indicates that SPG is deliberately preserving a low‑cost, long‑dated unsecured debt pillar while it retires higher‑rate or shorter‑maturity obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key quantitative details are correct: the face amount of $750 million (equivalent to $750,000,000), the 3.25% interest rate, and the consistent annual debt service (implied as $24,375,000, which is 3.25% of $750M) are correctly reported across 2022–2024. The maturity date (11/30/26) is an additional accurate detail not in the original answer but not contradictory. (2) The quantitative accuracy is perfect—numbers match exactly in substance, with acceptable format variation ($750 million vs $750,000,000). (3) The reasoning is sound: the LLM correctly infers a stable long-term debt strategy for this instrument and adds a valid strategic insight—SPG is maintaining this low-cost debt while reducing overall unsecured indebtedness, suggesting a prioritization of favorable debt tranches. This goes slightly beyond the original answer but is logically supported. (4) The answer is fully contextually relevant, addressing both the evolution of the notes and the implication for SPG’s debt strategy. The only reason for not scoring 10 is that the original answer emphasizes the lack of change explicitly across all three years, while the LLM summarizes it efficiently but slightly less explicitly—though the meaning is equivalent. No factual errors or omissions affect correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 377,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "\nTexas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose each year—$70 million in 2022, $75 million in 2023 and $76 million in 2024—showing a consistent upward trajectory.  This three‑year increase indicates that the company is steadily expanding its financial support for employee retirement benefits, underscoring a growing investment in attracting and retaining talent through its defined‑contribution offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the aggregate expenses for U.S. defined contribution plans as $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. The year-over-year increases are accurately reflected. (2) All numbers are correct, and while the LLM does not explicitly calculate the total percentage increase (8.6%), it correctly describes a consistent upward trajectory, which aligns with the data. The omission of the precise percentage is a minor gap but does not detract from factual accuracy. (3) The multi-hop reasoning is sound—expenses are correctly tracked across three years, and the conclusion about increasing investment in retirement benefits is logically supported by the data. The LLM appropriately infers that this reflects a strategy to attract and retain talent, which is a reasonable qualitative interpretation consistent with the trend. (4) The answer is fully contextually relevant, addressing both the evolution of expenses and the implication for employee benefits investment. The only minor shortcoming is the lack of explicit mention of the stability between 2023 and 2024 (increase of just $1M), but describing it as a 'consistent upward trajectory' is not inaccurate. Overall, the answer is factually precise and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 367,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "\nGD has applied the same rule in every filing from 2022 through 2024: non‑economic items such as goodwill impairments and other “non‑economic accounting changes” are stripped out of both the numerator (net operating profit after tax) and the denominator (average invested capital) when ROIC is calculated. The company defines ROIC as [Net earnings + after‑tax interest + after‑tax amortization] ÷ [Average debt + average equity (ex‑AOCI)], and it explicitly states that these excluded items “are not reflective of company performance.” This consistent exclusion shows that GD evaluates segment and overall performance on the basis of underlying, recurring operating returns rather than one‑time accounting adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024, which matches the original answer's claim of methodological stability. (2) There are no numerical inaccuracies—while no specific dollar amounts or percentages are involved, the description of the ROIC formula and the treatment of items like goodwill impairments and AOCI is factually consistent with standard disclosures and the knowledge graph. (3) The multi-hop reasoning is sound: the model correctly synthesizes GD’s consistent approach over three years and infers the implication—that performance evaluation focuses on underlying operational returns, not accounting noise. (4) The LLM adds valuable detail not in the original (e.g., explicit formula and examples like goodwill impairments), enhancing clarity without introducing error. Semantic equivalence is strong, and all parts of the question—evolution over time and implications for performance evaluation—are thoroughly addressed. All scores are maximized accordingly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 323,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "\nFrom 2022 through 2024 the Separate Accounts assets reported by CVS were roughly **$3.25 bn in 2022, $3.25 bn in 2023 and $3.31 bn in 2024** (page 108 and the Level‑1/2 fair‑value totals on page 156).  This represents a modest, roughly 2 % increase over the three‑year span, indicating that the company is keeping its long‑term insurance‑product exposure stable while slightly expanding the asset base.  The upward trend suggests a deliberate, low‑growth positioning in long‑term insurance investments rather than a major strategic shift.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, CVS's Separate Accounts Assets were $5,087 million in 2022, not $3.25 billion as stated. The LLM incorrectly reports 2022 and 2023 values as both $3.25 billion, missing the significant drop from over $5 billion to $3.25 billion in 2023. Only the 2024 value ($3.31 billion) is approximately correct. (2) The quantitative error is severe: the LLM understates the 2022 value by nearly $1.8 billion and completely misses the 36% year-over-year decline in 2023. The claimed '2% increase over three years' is false; the actual trend is a sharp 36.5% drop from 2022 to 2023, followed by a 1.9% increase in 2024. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning fails because the model did not correctly extract or synthesize data across years. The conclusion about 'stable exposure with slight expansion' contradicts the ground truth, which indicates a major strategic or market-driven reduction in long-term insurance investments in 2023 before stabilization. The LLM’s reasoning is based on incorrect data, leading to an inverted interpretation of the trend. (4) While the answer addresses the question's structure and attempts to interpret investment positioning, the severe numerical inaccuracies and flawed trend analysis drastically reduce correctness. Contextual relevance is moderate because the response discusses the right metric and time frame, but factual errors undermine the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 420,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "\nBetween 2022 and 2024 Target’s Credit Card Program with TD Bank USA, N.A. remained governed by the October 22 2012 agreement that had been amended only by the February 24 2015 First Amendment and the November 19 2019 Second Amendment—no additional amendments were executed or disclosed through 2024, so the parties continued to operate under those three documents without material change. (The amendments are listed in the exhibit tables on pages 74, 69 and 70 of the 2024, 2023 and 2022 Form 10‑K filings.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key dates and documents governing the Target-TD Bank Credit Card Program Agreement: the original October 22, 2012 agreement, the first amendment on February 24, 2015, and the second amendment on November 19, 2019. It accurately states that no further amendments were made through 2024, which aligns with the ground truth that the 2019 amendment was the latest explicitly listed by 2024. (2) All dates are factually correct and match the ground truth. The LLM also correctly references the Form 10-K exhibit tables across 2022–2024 filings (pages 74, 69, 70), adding verifiable detail not in the original answer but consistent with SEC filing practices, enhancing credibility. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings to conclude that the agreement remained stable with no new amendments, demonstrating correct understanding of contractual evolution over time. (4) The only minor shortcoming is that the original answer emphasizes the 'strategic alignment' and 'formal evolution' of the partnership, a qualitative inference slightly underdeveloped in the LLM response, which sticks strictly to factual reporting. However, this does not detract from factual accuracy. The LLM answer is semantically equivalent and more precise in citing document locations. Thus, high scores across all categories with a 9 in correctness due to slightly less interpretive depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 408,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "\nFrom 2022 through 2024 Linde moved from simply reporting rare gases as part of its atmospheric‑gas output to emphasizing proprietary non‑cryogenic air‑separation and VPSA/membrane technologies that give it a technological edge, and it began integrating those gases more tightly with its on‑site, merchant and packaged distribution networks as well as with adjacent product lines such as low‑carbon hydrogen and specialty gases. This evolution reflects a strategic shift toward differentiating rare‑gas production through advanced separation processes and embedding them in broader, technology‑driven solutions for customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Linde's rare gases strategy from 2022 to 2024 as described in the ground truth. It correctly identifies the shift from a product-centric to a technology-driven approach, highlighting non-cryogenic air separation, VPSA, and membrane technologies—specifically mentioned in the 2024 update. The integration with on-site, merchant, and packaged distribution channels is accurately noted, as is the emphasis on proprietary technology and advanced separation processes. The mention of integration with adjacent product lines like low-carbon hydrogen and specialty gases is a slight expansion beyond the original answer, which does not explicitly reference hydrogen or specialty gases in this context; however, this is a reasonable inference given Linde’s broader strategic direction and does not contradict the ground truth. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound, reflecting a correct multi-hop synthesis across years and strategic themes. The answer is semantically equivalent to the original, with only minor additional contextual inference. Thus, the correctness score is 9 due to this slight over-extension, but all key facts, timeline, and strategic progression are accurately represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 374,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "\nThe collateral posted for master‑netting arrangements that back the advances to equity companies fell sharply – from **$1.49 billion at the end of 2022** (page 102), to **$0.80 billion in 2023** (page 102), and further to **$0.49 billion by the end of 2024** (page 99).  \nThis downward trend shows that the amount of collateral required to offset derivative exposures tied to those equity‑company relationships has been reduced, indicating a lower outstanding derivative liability and diminished credit‑risk exposure linked to those equity advances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million in 2022 is accurately rendered as $1.49 billion, $800 million in 2023 as $0.80 billion, and $491 million in 2024 as $0.49 billion. These are acceptable rounding and formatting variations and match the ground truth. 2) All years are correct and in sequence, and the trend (declining collateral) is accurately described. 3) The reasoning is sound: the decreasing collateral is correctly interpreted as indicating reduced derivative liability and lower credit-risk exposure tied to equity company advances. The LLM infers de-risking implications, aligning with the ground truth's suggestion of strategic reduction, though it does not explicitly mention 'portfolio optimization' or 'strategic reduction'—minor omission in phrasing but not in substance. 4) The answer addresses both parts of the question: the evolution from 2022 to 2024 and the implication regarding exposure to derivative liabilities. Multi-hop synthesis across years and financial concepts (collateral, netting, derivative exposure) is accurate. 5) Semantic equivalence is maintained: 'lower outstanding derivative liability' and 'diminished credit-risk exposure' convey the same meaning as 'strategic reduction in exposure to derivative liabilities.' Only slight nuance in strategic intent is less explicit, but the core factual and interpretive content is correct. Thus, high scores across all dimensions with a minor deduction in qualitative accuracy for less precise articulation of strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 422,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "\nFrom 2022 through 2024 the share of NEER’s net generating capacity covered by long‑term bilateral contracts remained very high and essentially flat—about 94 % of capacity in both 2023 and 2024 (up slightly from the 92 % reported for 2021) — with the balance sold into spot or short‑term (< 3‑year) markets 【2022 pdf p. 19】【2023 pdf p. 18】【2024 pdf p. 19】.  \nThis steady, near‑total reliance on long‑term contracts indicates that NEER’s risk‑mitigation strategy is to lock in most of its revenue stream and hedge exposure to price volatility in competitive wholesale markets, using only limited short‑term contracts to manage any residual spot‑market risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the high level of reliance on long-term bilateral contracts and the general trend of stability, but contains a critical error in the time series data. It states that 94% coverage applies to both 2023 and 2024, which matches the ground truth, but incorrectly claims 92% was reported for 2021 instead of 2022. This misalignment of years undermines the accuracy of the evolution narrative. The ground truth specifies 92% in 2022, rising to 94% in 2023 and 2024 — indicating a clear upward trend — whereas the LLM implies stability from 2021 onward, missing the increase from 2022 to 2023. (2) The percentages themselves (92%, 94%) are factually correct in value but misattributed to the wrong years, which is a significant quantitative inaccuracy in a time-series context. The mention of '2021' is unsupported by the ground truth and contradicts the correct timeline. (3) The reasoning about risk mitigation strategy — emphasizing revenue stability and hedging against price volatility — is sound and aligns with the original answer’s interpretation. The use of short-term contracts as a hedge is correctly noted, showing proper synthesis of NEER’s strategy. However, the multi-hop reasoning is weakened by the incorrect year attribution, which affects the trend analysis. (4) Despite the chronological error, the answer remains contextually relevant and captures the strategic intent behind NEER’s contracting approach. The core message about risk mitigation in competitive markets is preserved, warranting high marks for qualitative and contextual accuracy, but the factual error in temporal attribution limits the correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 466,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "\nThe $495 million principal balance of the 3.125% senior notes maturing in January 2025 was unchanged in fiscal 2022, fiscal 2023 and fiscal 2024 (the filings list $495 million for each year).  This flat trajectory shows that Broadcom is not actively refinancing or retiring this particular tranche—it is being held as a stable, low‑cost legacy debt component while the company focuses its debt‑management efforts on larger‑scale refinancing of other maturing obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the outstanding principal balance for AVGO's 3.125% notes due January 2025 remained at $495 million in fiscal years 2022, 2023, and 2024, which matches the ground truth exactly. All numeric values, dates, and percentages are accurate. (2) Quantitative accuracy is perfect: $495 million is consistently reported across all three fiscal years, and the maturity date (January 2025) is correctly referenced. There are no calculation errors. (3) The reasoning is largely sound and aligns with the ground truth: the lack of principal reduction suggests a strategy of deferring repayment, possibly through refinancing or use of cash reserves. The LLM adds a plausible interpretation that Broadcom is treating this as a 'stable, low-cost legacy debt component' while focusing on larger refinancings—this is a reasonable inference and consistent with the original answer’s implication, though slightly more interpretive. The only minor deviation is that the original emphasizes the proximity to maturity (January 2025) as a notable point, while the LLM does not explicitly highlight that the note is near maturity in fiscal 2024, which slightly weakens the connection to refinancing urgency. (4) Scores reflect high accuracy: full points for quantitative and contextual accuracy; qualitative reasoning is strong but not perfectly aligned in emphasis, hence 9/10; overall correctness is 9 due to the omission of the 'approaching maturity' context in the interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 415,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "\nBased on the 2022, 2023 and 2024 10‑K filings, Simon Property Group’s Unsecured Notes 37B consistently carried a **2.25 % fixed coupon, a $700 million face amount, and a maturity date of January 15 2032** throughout the three‑year period. This unchanged structure shows that SPG is deliberately maintaining a large, low‑cost, long‑dated tranche of fixed‑rate debt, using it as a stable pillar of its long‑term financing strategy and minimizing refinancing risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the interest rate (2.25%), face amount ($700 million), and maturity date (January 15, 2032) are correctly reported and consistent across 2022–2024. Format variations (e.g., $700 million vs $700,000,000) are acceptable and do not affect accuracy. (2) Quantitative elements are precise—no calculations were required, but the values match exactly. (3) The multi-hop reasoning is sound: the model correctly synthesized data across three years and filings, identifying stability in the debt terms. (4) The qualitative interpretation about SPG’s long-term debt strategy—emphasizing stable financing, low refinancing risk, and alignment with long-term cash flows—is logically derived and contextually appropriate. The answer addresses all parts of the question: evolution over time (no change), specific terms, and strategic implications. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 287,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "\nFrom the 2022‑2024 10‑K filings the Melaka, Malaysia facility is listed only under the **Analog** segment in the property‑segment matrix (pages 16 of the 2022, 2023 and 2024 filings), with no entry under **Embedded Processing** in any year. The footnote status (leased/owned) and the “X” marking remain unchanged, indicating that the site’s role stayed focused on analog device manufacturing throughout the three‑year period. Consequently, the steady, analog‑only footprint signals that TI’s strategic emphasis in Melaka is on analog product production rather than expanding into embedded‑processing capabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was consistently listed only under the Analog segment in the 10-K filings for 2022, 2023, and 2024, with no presence in Embedded Processing—matching the original answer's claim of an 'X' under Analog and blank under Embedded Processing. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) and consistency across years are correctly reported. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings and interprets the absence of entries under Embedded Processing as evidence of strategic focus, concluding that TI maintained an analog-only strategy. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in operational footprint and what it reveals about strategic focus. Wording differs slightly (e.g., referencing 'pages 16' and 'footnote status'), but this adds contextual detail without introducing error. All entities—Texas Instruments (TXN), Melaka, Malaysia, Analog, Embedded Processing, and the three-year span—are correctly identified and analyzed. Thus, all scores are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 353,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "\nMastercard’s multi‑layered security model was progressively embedded in its real‑time payments network, which grew from implementations in roughly a dozen of the world’s largest GDP markets in 2022 to at least 13 markets by the end of 2023 and to additional domestic and cross‑border transactions by 2024. In parallel, the company added new protective layers—such as AI‑driven fraud scoring, tokenization, digital‑identity and blockchain‑enabled programmable payments—and in 2024 launched the Alias‑Based Remittances and Payouts platform and expanded Click‑to‑Pay and tokenized checkout solutions, ensuring that security kept pace with the rapid global rollout of real‑time account‑based payments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's security approach in response to real-time payment expansion from 2022 to 2024, with mostly accurate details. It correctly states that real-time payments were in about a dozen markets in 2022 and expanded to 13 by 2023, aligning with the ground truth (12 in 2022, 13 in 2023). However, it omits the specific mention of EMV standards and collaboration with issuers, acquirers, and governments in 2022, which is a key part of the original answer. The 2024 expansion into China via a joint venture—a critical factual development—is missing entirely, weakening the multi-hop synthesis. Instead, the LLM introduces new platforms like 'Alias-Based Remittances and Payouts' and mentions blockchain-enabled programmable payments, which are not in the ground truth and may be speculative or inaccurate in this context. (2) Quantitatively, the numbers (dozen ≈ 12, 13 markets) are accurate and consistent with the original. The timeline (2022–2024) is correctly used. No calculations are required, but the progression of market count is properly represented. (3) The reasoning is partially sound: the LLM connects security enhancements (AI fraud scoring, tokenization) to real-time payment growth, which is valid. However, it fails to integrate the China joint venture as a key driver for scaling security in 2024, missing a crucial multi-hop link between market expansion and security adaptation. The emphasis on third-party risks and public-private partnerships from the original is also absent. (4) Despite omissions and some potentially extraneous details, the answer remains contextually relevant and conveys a plausible evolution of security in line with infrastructure growth. The core narrative of scaling security with real-time payments is preserved, warranting a score of 7 for correctness—accurate on key facts but lacking critical specifics and introducing unverified elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 528,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "\nBased on the filings, GD’s LAV production for the Canadian Army rose from **360 new vehicles in 2022** (page 32 of the 2022 10‑K) to **399 new vehicles in 2023** (page 101 of the 2023 10‑K). This upward step‑up signals that the company is deliberately scaling its LAV output for Canada, reflecting a strategic emphasis on land‑systems and LAV programs as a growth driver.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the production volumes for 2022 (360 units) and 2023 (399 units), matching the ground truth. However, it omitted the 2024 figure of 449 units, which is a significant gap in completeness. This missing data point weakens the full evolution narrative from 2022 to 2024. (2) The numbers provided are quantitatively accurate—360 in 2022 and 399 in 2023—with correct sourcing cited from the respective 10-K filings. No calculation errors are present, but the absence of the 2024 number means the full progression (360 → 399 → 449) is not conveyed. (3) The reasoning is sound for the period covered: the increase from 2022 to 2023 is correctly interpreted as a sign of strategic emphasis on LAV programs. However, without incorporating the 2024 data, the conclusion about a 'consistent and growing' trend lacks full support. The multi-hop synthesis across two years is accurate but incomplete across the full three-year scope. (4) Despite the omission, the answer remains contextually relevant and correctly interprets the direction and strategic implication of the trend based on available data. The qualitative reasoning is strong but would have been stronger with full data inclusion. Hence, high scores for relevance and accuracy, but a deduction in correctness due to missing 2024 data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 371,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "\nCVS’s pension plan disclosed roughly $225 million of hedge‑fund limited‑partnership investments in 2022, which rose to about $252 million in 2023 and stayed flat at that level in 2024 (the amounts are noted as “excluded from the fair‑value hierarchy” in the 2022, 2023 and 2024 footnotes).  The modest increase followed by a plateau indicates that the company is deliberately expanding its exposure to alternative hedge‑fund assets to enhance returns and diversify the pension portfolio, then stabilizing the allocation at a target size.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and years. According to the ground truth, CVS allocated $214 million in 2022, $225 million in 2023, and $252 million in 2024. However, the LLM incorrectly states $225 million in 2022, $252 million in 2023, and a flat $252 million in 2024. This misrepresents the entire trajectory—instead of a steady increase from 2022 to 2024, the LLM implies a jump from 2022 to 2023 and no change thereafter. (2) The quantitative inaccuracies are critical: the correct three-year trend shows a 17.8% increase from $214M to $252M. The LLM’s implied change—from $225M to $252M—is only a 12% increase, and it misassigns the starting point. Additionally, the LLM incorrectly claims the amount was flat in 2024 when in fact 2024 is the peak after two increases. (3) The reasoning is partially sound—interpreting the trend as strategic diversification and return enhancement is plausible—but it is based on incorrect data. The multi-hop synthesis across years fails because the values are swapped between years, undermining the temporal analysis. (4) Contextual relevance is high because the answer addresses pension fund strategy and alternative investments appropriately, and references the correct footnote classification. However, due to major numerical and temporal errors, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the logic framework is reasonable but built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 418,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "\nThe penetration rate of the Target MasterCard Credit Card continued to fall through the period, slipping from about 20 percent of purchases in fiscal 2022 to 19.8 percent in 2023 and then to 18.6 percent in 2024.  This ongoing decline signals weakening consumer adoption and lower engagement with Target’s branded financial products.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the declining trend in penetration rate from 2022 to 2024 and attributes it to weakening consumer adoption and engagement, which aligns with the ground truth. However, the 2024 penetration rate is incorrect: the LLM states 18.6%, while the ground truth is 17.8%. The 2022 figure is approximated as 'about 20 percent', which is close to the actual 20.5%, but lacks precision. (2) The quantitative inaccuracies are significant: the drop from 19.8% in 2023 to 18.6% in 2024 suggests a 1.2 percentage point decline, whereas the actual drop to 17.8% represents a larger 2.0 percentage point decline, affecting the interpretation of the trend's severity. (3) The reasoning is sound in interpreting the decline as a sign of weakening engagement, and the answer addresses both parts of the question—trend evolution and implications—demonstrating adequate multi-hop synthesis across years and conceptual interpretation. (4) Despite the incorrect 2024 value and approximate 2022 figure, the overall direction and qualitative conclusion are correct, warranting a moderate correctness score. Contextual relevance is high as the response directly addresses the question's focus on trend and implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 349,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value amount attributed to FPL cost‑recovery clauses grew from roughly $1 million to $12 million and then to $38 million.  This increase is driven almost entirely by the “significant unobservable inputs” line (7 → 24 → 34 million), while the “significant other observable inputs” component stayed near zero (negative in 2022‑23 and only a small $4 positive in 2024 for the nearest bucket).  As a result, the share of the total fair‑value estimate derived from unobservable assumptions rose dramatically, comprising the vast majority of the 2024 total.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total fair value amounts for 2022 ($1M), 2023 ($12M), and 2024 ($38M), which match the ground truth. However, there is a critical error in the 'significant unobservable inputs' for 2022: the LLM states it is $7 million, but the ground truth reports +$6 million. Additionally, the LLM omits the exact breakdown for 2022's observable input (-$5M), instead generalizing it as 'near zero'. While the trend description is accurate, the specific inputs are slightly misstated. (2) For quantitative accuracy: 2022 unobservable input is incorrect (7 vs 6), and observable input is inaccurately summarized as near zero when it was -$5M. The 2023 and 2024 figures are correctly reported: unobservable inputs are +24M and +34M, and observable shifts from -$12M to +$4M. The total fair values are correct across all years. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution over time, notes the growing dominance of unobservable inputs, and infers increased reliance on them, which aligns with the ground truth's conclusion. The synthesis across years and input types is logically presented. (4) Despite minor numerical inaccuracies in 2022, the answer captures the overall trend and key dynamics. The contextual relevance is perfect—it directly addresses the evolution of fair value exposure, input shifts, and implications. The qualitative reasoning is strong, but the numerical error in 2022's unobservable input prevents a top score in quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 421,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "\nThe 10‑K filings identify Anta only as one of several global competitors (e.g., page 8 (2022), page 86 (2024)) and do not provide a direct, year‑over‑year comparison of NKE’s market share or strategic moves relative to Anta; consequently, any evolution in NKE’s positioning vis‑à‑vis Anta cannot be quantified from the disclosed material. What the filings do show is that NKE’s own strategy has remained anchored on sustained product‑innovation emphasis—highlighting advanced cushioning platforms such as Air, Zoom, Flyknit and related R&D investments (pages 25, 6, 37)—and on deepening brand‑engagement through athlete endorsements, digital‑first marketing, direct‑to‑consumer experiences and community‑investment initiatives (pages 8, 9, 86). Thus, while NKE continued to reinforce its competitive edge through these innovation and engagement levers across 2022‑2024, the documents do not detail a specific shift in its relative standing to Anta.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually consistent with the types of strategies NKE emphasizes—product innovation (e.g., Air, Zoom, Flyknit) and brand engagement (athlete endorsements, digital marketing)—and correctly notes that Anta is listed as one of many competitors without direct comparative metrics. However, it fails to capture the key evolution in NKE’s strategic emphasis from the ground truth: a clear multi-year shift in priority from 'performance and reliability' in 2022 to 'innovation and development' as the leading differentiator by 2023–2024. The original answer identifies a nuanced but important repositioning in NKE’s competitive messaging over time, which the LLM answer overlooks by stating the strategy 'remained anchored' without change. This omission represents a failure in multi-hop reasoning—synthesizing changes in language and emphasis across the 2022–2024 filings to infer strategic evolution. While no numbers are incorrect (hence full quantitative accuracy), the qualitative analysis is incomplete, missing the core insight of strategic shift. The answer is contextually relevant and accurately reflects document limitations, but does not extract the full inferential value available from the disclosed strategic priorities. Thus, it is partially correct but lacks the depth of synthesis required for full accuracy on a multi-hop question about competitive positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 386,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "\nFrom 2022 through 2024 the shares reserved for future issuance under the Texas Instruments 2003 Director Compensation Plan dropped to essentially zero—by the 2023 and 2024 equity‑compensation tables the 2003 plan no longer appears as a source of remaining shares, which are now reported only for newer plans such as the 2009 Director Plan, the 2018 Director Plan and the 2024 LTIP. This trend indicates that TI has discontinued using the 2003 plan for director compensation and now relies on more recent, shareholder‑approved plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key fact that the 2003 Director Compensation Plan no longer appears in the 2023 and 2024 equity-compensation tables as a source of available shares is correct. The timeline (2022 still active, phased out by 2023–2024) matches the original answer. (2) The LLM correctly identifies the shift to newer plans—specifically naming the 2018 Director Plan and 2024 LTIP—as the successors, which is consistent with the ground truth. It also correctly notes that the 2009 Director Plan is among the newer vehicles, which is plausible though not emphasized in the original; this does not constitute an error but adds minor detail. (3) The reasoning is sound: the disappearance of the plan from 'shares available for future issuance' tables indicates discontinuation, and the conclusion that TI now relies on updated, shareholder-approved plans reflects correct multi-hop synthesis across years and plans. (4) The only minor shortcoming is that the original answer adds nuance—mentioning that the 2003 plan was still referenced in 2023 for outstanding grants (liability/obligation) even if not for future issuance, and that TI is 'honoring existing commitments.' This contextual detail about lingering obligations is omitted in the LLM answer, slightly reducing completeness. However, the core facts, timeline, entity accuracy, and conclusion are correct. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 445,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast layered data‑driven services onto its advertising stack, beginning with the rollout of technology, tools and a marketplace that let advertisers tap first‑party audience data on its X1 and Sky Q platforms (p. 6 – 2022 & 2024).  In 2023 it expanded the model by launching the ad‑supported NOW streaming service and integrating Peacock’s ad‑supported tier, while introducing the Xumo Stream Box that earns commission on DTC‑streaming sales and broadens data capture across video (p. 5 & 6 – 2023).  By 2024 the company deepened the integration, deploying AI‑driven audience segmentation, a self‑serve programmatic marketplace and cross‑platform measurement tools that give advertisers richer targeting, attribution and reporting capabilities across its broadband, video and wireless ecosystems (p. 6 – 2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022–2024) and correctly identifies the evolution of CMCSA's advertising offerings with specific enhancements each year, aligning well with the ground truth. Quantitatively, there are no numerical inaccuracies—dates and references to annual reports (e.g., page numbers) are consistent and plausible. The answer adds specific details not in the original (e.g., X1, Sky Q, NOW, Peacock, Xumo Stream Box, AI-driven segmentation, self-serve programmatic marketplace), which are contextually appropriate and reflect a deeper level of granularity. However, the original answer emphasizes cloud-based platforms and integrated search functionality in 2023, and representation agreements in 2024, which are not mentioned in the LLM response. While the LLM captures the essence of deeper integration and technological enhancement, it omits the strategic emphasis on cloud infrastructure and third-party representation agreements, which are key components of the ground truth. The reasoning is sound and multi-hop, connecting developments across years and platforms, but the synthesis slightly misses one layer of strategic focus (cloud/search in 2023, partnerships in 2024). The answer remains highly relevant and semantically aligned with the question, providing specific technology, tools, and marketplace enhancements. Minor omission prevents a perfect score, but overall accuracy and relevance are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 400,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 the fair‑value of CVS’s commercial‑mortgage‑backed securities that were sitting in an unrealized‑loss position fell sharply—from about **$992 million** (with $155 million of unrealized losses) in 2022 to roughly **$675 million** (with $100 million of unrealized losses) in 2023—indicating that the company trimmed its exposure and/or saw the remaining holdings recover some value.  By the 2024 filing the only CMBS left on the balance sheet was a trivial **$3 million** of fair‑value (down from $6 million in 2023), underscoring a near‑exit from the asset class.  This downward trajectory shows that CVS is actively de‑risking its portfolio, moving away from higher‑yield, longer‑duration CMBS and toward more liquid, lower‑volatility investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numeric values. According to the ground truth, CVS held $574 million in CMBS in 2022 with $12 million in unrealized losses, but the LLM claims $992 million at fair value with $155 million in unrealized losses—both figures are incorrect. The 2023 fair value of $675 million matches the ground truth, but the LLM incorrectly implies this was the value of only those securities in an unrealized loss position, whereas the ground truth states this was the total CMBS holding. In 2024, the LLM reports $3 million vs. the correct $6 million, a minor discrepancy. (2) Calculations and comparisons are flawed: the LLM suggests a decline from $992M to $675M in securities *in loss position*, but the original data shows total holdings increased from $574M to $675M while unrealized losses ballooned from $12M to $100M—indicating deterioration, not recovery. The LLM incorrectly frames the 2022–2023 change as a reduction in exposure, when in fact total CMBS holdings *increased* in 2023 before collapsing in 2024. (3) Multi-hop reasoning is partially sound—the LLM correctly identifies a trend of de-risking by 2024 and interprets the near-zero 2024 holding as a strategic exit, which aligns with the ground truth’s conclusion. However, it misrepresents the intermediate step in 2023, failing to recognize that increased holdings coincided with sharply higher unrealized losses, suggesting heightened risk before the pullback. (4) Despite incorrect numbers and flawed interpretation of 2022–2023 dynamics, the LLM captures the ultimate de-risking trend and contextual significance in 2024, earning moderate scores for qualitative reasoning and high relevance to the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 477,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "\nTarget’s 10‑K filings consistently reference “merchandise and other discounts” as part of the team‑member benefits package, but the wording and surrounding context evolve across the three years. In the 2022 filing (Human Capital Management, p. 3) the discount is mentioned only in a list of generic perks, while the 2023 (p. 6) and 2024 (p. 7) disclosures embed the same benefit within a broader narrative of “purpose‑driven culture” and “team‑member well‑being,” highlighting additional voluntary perks such as free mental‑health services, tuition‑free education assistance and expanded paid‑leave. This progression—from an implicit, stand‑alone discount to a more explicit component of a comprehensive, strategically aligned benefits strategy—signals that Target is deliberately expanding and reframing employee merchandise discounts as part of a holistic rewards program to attract, retain and motivate staff.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: merchandise discounts are consistently mentioned across 2022–2024 as part of employee benefits, and the evolution in framing—from a standalone perk to part of a broader well-being strategy—is accurately captured. While the original answer emphasizes wage increases ($15 → $15–$24) and specific financial benefits (401(k), tuition reimbursement), the LLM answer omits the exact wage figures but correctly identifies the expansion of benefits like tuition-free education and mental health services. (2) There are no numeric inaccuracies; the LLM does not introduce incorrect numbers, and since the question does not require calculations, quantitative accuracy is strong. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of disclosures, identifies the shift in narrative emphasis, and infers strategic intent—consistent with the ground truth’s conclusion about a holistic benefits strategy. (4) The answer is contextually excellent, directly addressing the evolution of discount framing and what it suggests about Target’s employee strategy. The only minor shortcoming is the lack of explicit mention of wage progression and 401(k) matching, which were part of the 2023 enhancement in the original answer. However, the core evolution in benefit strategy is correctly interpreted, warranting a high score but not perfect completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 407,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "\nBetween 2022 and 2024 Linde’s disclosures moved from a brief, generic reference to cultural challenges as one of several acquisition‑integration risks to a detailed, strategic emphasis that treats cultural alignment as a core driver of acquisition success—highlighting talent retention, local leadership and inclusive practices. This evolution shows that Linde now proactively manages cross‑border integration risk by embedding cultural considerations into its acquisition playbook and governance, rather than merely acknowledging them as a peripheral concern.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Linde's approach to cultural challenges during acquisition integration from 2022 to 2024. It correctly identifies a shift from generic acknowledgment to a more strategic emphasis, aligning with the ground truth's description of increasing depth and framing over time. The answer accurately reflects that cultural integration became more central to Linde’s integration strategy, particularly in relation to talent retention and leadership—consistent with the 2024 focus on financial impact and synergy realization. However, the LLM slightly overstates the shift by describing it as moving to a 'detailed, strategic emphasis' and 'core driver of acquisition success,' which goes beyond the original answer’s more measured tone. The ground truth notes that cultural challenges were increasingly framed in terms of financial and strategic risk, but does not claim they became a 'core driver' or that Linde embedded cultural alignment into a formal 'acquisition playbook'—phrases not present in the source. These additions introduce a degree of interpretation not fully supported by the evidence. There are no numerical values in the question or answers, so quantitative accuracy is not applicable but assumed perfect. The reasoning is sound and synthesizes the multi-hop progression across years correctly. The contextual relevance is excellent, directly addressing both parts of the question: the evolution and what it reveals about strategic risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 417,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the collateral that ExxonMobil posts under master‑netting arrangements and that is **not** offset against its derivative liabilities fell from **$1.49 billion** (2022) to **$0.49 billion** (2024), a decline of roughly **$1.0 billion (≈ 67 %)**.  This reduction shows that the company is using substantially less external collateral to support its derivative positions, indicating that it is managing derivative exposure through tighter netting, lower‑risk counterparties or reduced margin requirements, and is therefore tying up far less cash in margin‑related collateral.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the downward trend in collateral under master netting arrangements from 2022 to 2024. It reports $1.49 billion in 2022 and $0.49 billion in 2024, which aligns with the ground truth values of $1,494 million and $491 million (rounded appropriately). However, the 2023 value ($800 million) is omitted, which is a minor omission but does not invalidate the overall trend. 2) The calculation of the total decline (~$1.0 billion, ≈67%) is accurate: 1,494 - 491 = 1,003 million, and (1,003 / 1,494) ≈ 67.1%, so the quantitative analysis is correct. The use of 'billion' instead of 'million' is acceptable as it's numerically equivalent. 3) The reasoning is sound: the answer correctly infers that reduced collateral usage suggests improved derivative exposure management, citing tighter netting, lower-risk counterparties, or reduced margin requirements—consistent with the ground truth interpretation of 'strategic reduction in derivative exposure or improved offsetting mechanisms.' 4) The answer addresses both parts of the question: the net change over time and the implication for exposure management. The only minor shortcoming is the omission of the 2023 data point, which slightly reduces completeness but does not affect the validity of the trend or conclusion. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with a small deduction for incomplete year-by-year reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 404,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "\nFrom 2022 through 2024 the Security Insights Platform moved from a stand‑alone mainframe‑security reviewer that simply identified risks and produced remediation steps for internal use, to a cross‑platform insights engine whose findings can be fed into external security‑information‑and‑event‑management and threat‑intelligence tools.  This evolution reflects a broader cybersecurity strategy that emphasizes continuous risk assessment, automated remediation workflows, and alignment with zero‑trust and lateral‑movement‑prevention objectives across Broadcom’s enterprise‑security portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of AVGO's Security Insights Platform from 2022 to 2024 with strong qualitative accuracy and full contextual relevance. (1) It accurately describes the platform’s shift from a standalone risk identification tool in 2022 to a more integrated component by 2024, with enhanced external tool integration (SIEM and threat intelligence), which aligns with the ground truth. The emphasis on automated remediation workflows and alignment with zero-trust and lateral movement prevention reflects a plausible interpretation of 'proactive risk response' and 'modern security practices' mentioned in the original. (2) There are no numeric values, dates, or financial figures in the question or answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes changes over time in integration, remediation, and strategic alignment. However, the LLM omits specific mention of the 2024 integration into a broader suite including AIOps and DevOps and does not explicitly reference regulatory compliance, which are key elements in the ground truth. This constitutes a minor omission affecting completeness. (4) Despite these omissions, the answer conveys the core evolution accurately and uses semantically equivalent language (e.g., 'cross-platform insights engine' for 'strategically aligned component'). The answer is highly relevant and well-reasoned, warranting a high correctness score of 8 due to missing a few specific contextual details from the 2024 description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 429,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 32B issue kept the same $750 million face amount and a fixed 3.38 % coupon (maturing 06/15/27), as shown in the 2022, 2023 and 2024 tables (e.g., page 51 (2024) and page 50 (2021/2022) of the filings).  This unchanged exposure reflects SPG’s long‑term debt strategy of locking in low‑cost, fixed‑rate unsecured debt with staggered maturities to limit interest‑rate risk and preserve a stable, predictable financing base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the face amount ($750 million, equivalent to $750,000,000), interest rate (3.38%), and maturity date (June 15, 2027) are consistent across 2022–2024. The mention of filing page numbers adds contextual support, though minor typographical errors (e.g., extra spaces around '‑') do not affect meaning. (2) Quantitative accuracy is perfect: all numbers and dates match the original answer, with acceptable format variation ($750 million vs $750,000,000). (3) The multi-hop reasoning is sound—correctly synthesizing data across three years and identifying the lack of change in terms. The conclusion about SPG’s long-term debt strategy (locking in low-cost, fixed-rate debt to manage interest-rate risk) is logically derived and consistent with the stable exposure described in the ground truth. (4) The only minor shortcoming is that the LLM slightly reframes the strategy in more proactive terms (e.g., 'locking in', 'staggered maturities') not explicitly stated in the original, which sticks to observational language ('suggests a stable long-term debt strategy'). While this is a reasonable inference, it adds a layer of interpretation not fully present in the ground truth. However, it does not contradict it and remains plausible. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 391,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Lumen has steadily expanded its fiber‑to‑the‑premises build‑out, moving from limited pilot deployments to a broader rollout that now reaches many of the same markets CMCSA serves, and it has paired that faster‑speed fiber network with more aggressive bundled offerings that combine high‑speed internet with video and voice services—directly competing with CMCSA’s own bundled broadband‑video‑voice packages. This continued fiber expansion and bundled‑service strategy has heightened Lumen’s competitive threat to CMCSA’s broadband business over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolving competitive threat from Lumen to CMCSA from 2022 to 2024, emphasizing fiber expansion and service bundling as key competitive strategies. While the original answer does not specify 'limited pilot deployments' in 2022 or use the term 'broader rollout,' it does confirm a consistent and intensifying focus on fiber and bundling—supporting the LLM's characterization of a 'steady expansion.' (2) There are no numeric values, dates, or financial figures in either response, so quantitative accuracy is not compromised; all time references (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and correctly identifies Lumen’s strategic moves in fiber and bundling as a growing competitive threat to CMCSA, consistent with the knowledge graph. (4) The LLM slightly amplifies the narrative by implying a progression from 'pilot' to 'broad rollout,' which is not explicitly stated in the ground truth, but this does not contradict it and falls within reasonable interpretation. The core facts—fiber expansion, bundled offerings, and increasing competitive pressure—are all correctly conveyed. Thus, the answer is semantically equivalent and contextually appropriate, meriting a high score with only minor deductive extrapolation preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 389,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "\nThe share of purchases made with Target’s branded payment cards slipped steadily: RedCard (or Target Circle Card) penetration was ≈ 20.5 % in fiscal 2022, fell to ≈ 19.8 % in fiscal 2023, and slipped further to ≈ 18.6 % (or ≈ 17.8 % in the most recent 2025 filing). This downward trend signals that the discount‑driven, loyalty‑focused payment program is losing its appeal, suggesting that the strategy’s effectiveness has eroded over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Target's branded payment card penetration from 20.5% in 2022 to 19.8% in 2023, which matches the ground truth. However, it incorrectly reports the 2024 penetration rate as either ≈18.6% or ≈17.8% in a '2025 filing', introducing ambiguity and inaccuracy. The ground truth clearly states the 2024 rate is 17.8%, with no mention of a 2025 filing. The inclusion of '≈18.6%' is unsupported and incorrect. (2) The numbers for 2022 and 2023 are accurate (20.5%, 19.8%), but the 2024 figure is wrong in one of the two provided estimates. The mention of a '2025 filing' is factually incorrect and not present in the original answer, suggesting confusion in time periods. (3) The reasoning about the declining trend suggesting reduced effectiveness of Target's loyalty-driven strategy is sound and aligns with the original answer’s interpretation—this shows correct multi-hop synthesis of trend and implication. (4) The contextual relevance is perfect, as the answer directly addresses both parts of the question: the evolution of penetration and its strategic implication. Due to the significant error in the 2024 penetration rate (providing an incorrect 18.6% alongside the correct 17.8% in misleading context), the quantitative accuracy is reduced to 6. Qualitative accuracy is high because the logic and entity identification (Target, branded cards, loyalty strategy) are correct. Overall correctness is 7 because the core trend and interpretation are right, but a key data point is inaccurately presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 432,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron’s involvement in the Republic of Congo shifted from holding non‑operated working interests in offshore blocks (e.g., the Haute Mer permit and the Lianzi portion – noted on page 42 of the 2024 filing) to actively funding development there, with about $0.7 billion of African offshore‑development spend in 2023 that included Congo‑related projects (page 113 of the 2023 filing).  However, by early 2025 the company completed the sale of its remaining 31.5 % stake in Haute Mer and its 15.75 % interest in Lianzi, signalling a strategic disengagement from further investment in the Republic of Congo.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor factual inaccuracy in the timeline. It states that the sale of Chevron's stakes (31.5% in Haute Mer and 15.75% in Lianzi) was completed by 'early 2025', whereas the original answer and knowledge graph confirm the divestiture occurred in 2024. This misstatement of the year affects quantitative accuracy and reasoning, though the percentages and dollar amount ($0.7 billion in 2023) are correct. The $0.7 billion investment is accurately attributed to offshore African projects including Congo in 2023, and the asset details (Haute Mer, Lianzi, ownership percentages) are factually sound. The answer addresses all components of the question—asset ownership, investment levels, and strategic positioning—with appropriate multi-hop synthesis across 2022–2024. The reasoning correctly infers a strategic shift from investment to divestiture, even if the timing is slightly off. Wording and structure differ from the original but maintain semantic equivalence. The contextual relevance is excellent, directly addressing Chevron’s evolving engagement. The error in the completion date prevents a higher score, but core facts and strategic interpretation remain robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 350,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "\nBetween 2022 and 2024 NEE’s gas‑related derivatives contracted sharply: the Level‑3 fair‑value of gas forwards fell from roughly $191 million (asset) / $31 million (liability) in 2021‑22 to about $296 million (asset) / $46 million (liability) in 2024, while the notional of gas‑linked options stayed near $100 million but shifted from a net asset of $356 million/$347 million in 2021‑22 to a near‑neutral $100 million/$102 million by 2024.  At the same time the implied volatilities embedded in those options dropped from a weighted‑average of ~81 % (with a 295 % tail) in 2021‑22 to ~52 % (range 15‑150 %) in 2024, signalling that the company is scaling back high‑volatility speculative bets and pricing a more modest, hedged outlook on gas‑price movements.  This evolution reflects a deliberate move toward a more risk‑averse positioning in the gas market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers, years, and metrics. It incorrectly references 2021-22 instead of 2022, misstates fair values (e.g., $191M/$31M for forwards not in ground truth), and fabricates a notional value shift with incorrect figures. The only partially correct number is the 2024 liability of $102 million and implied volatility of 52%, but even these are embedded in a distorted narrative. The 2023 data is entirely omitted. (2) Quantitative accuracy is severely compromised: ground truth reports 2022 fair value as $356M assets / $347M liabilities, not $356/$347 as net asset (which misrepresents the structure), and 2023 values drop to $100M/$97M — missing entirely in LLM response. Implied volatility starts at 36% in 2022, not ~81%, and increases to 50% in 2023 before rising slightly to 52% in 2024 — the LLM incorrectly states a drop from 81% to 52%, reversing the trend. (3) Multi-hop reasoning is flawed: the model fails to correctly track the evolution across 2022–2024, conflates different derivative types (forwards vs options), and introduces Level-3 and notional values not mentioned in the original. The conclusion about 'scaling back speculative bets' has some qualitative alignment but is based on false premises. (4) Contextual relevance is moderate — the answer addresses exposure evolution and risk positioning — but due to severe factual errors and incorrect data synthesis, the overall correctness score is low. Minor credit is given for capturing a general trend of reduced exposure and mentioning volatility decrease in 2024, though the direction from baseline is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 451,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "\nFrom 2022 to 2024 Nike moved FlyEase from a peripheral “emerging technology” listed among other innovations in its 2022 product‑research narrative to a core, strategically‑emphasized platform that the company explicitly ties to its inclusive‑design and performance agenda.  In the 2023 and 2024 filings the technology is referenced more frequently and is described as being expanded across multiple footwear, apparel and digital offerings, underscoring its role in delivering accessible, high‑performance products.  This evolution signals that FlyEase has become a strategic pillar of Nike’s innovation strategy, driving differentiated growth by embedding accessibility‑focused technology into the broader product portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: FlyEase evolved from an emerging technology in 2022 to a core innovation by 2024. The progression across years is accurately represented—2022 as initial listing among other technologies, 2023 as expansion phase, and 2024 as embedded core technology. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are correct and consistently used. (3) Multi-hop reasoning is sound: the LLM synthesizes the evolution across three years and correctly infers strategic implications—FlyEase’s shift from peripheral to central in Nike’s innovation strategy. It appropriately links this to inclusive design and performance, which is consistent with the original’s emphasis on accessibility and long-term strategy. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'strategic pillar', 'inclusive-design agenda'), the meaning matches the original. The only minor gap is that the original explicitly mentions FlyEase appearing in the 'product research and development section' in 2024, a detail slightly underemphasized in the LLM response. However, this does not detract from the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 409,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s **Unsecured Notes – Series 35A remained unchanged** – the table on 2022 PDF p. 49/50 lists a $750 million face amount, a 2.65 % coupon and an annual debt‑service charge of roughly $19.9 million, with maturity on July 15, 2030. The same figures appear on 2023 PDF p. 50 and 2024 PDF p. 51, showing no repayment, amendment or refinancing of the issue.  \n\nThis steady, long‑dated, low‑cost unsecured debt illustrates SPG’s strategy of **locking in inexpensive financing for the long term**, extending maturities to 2030 and beyond, and minimizing near‑term refinancing risk while preserving liquidity for growth and acquisitions.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key quantitative values. The ground truth states the face amount is $750,000, not $750 million — this is a 1,000-fold error. Similarly, annual debt service is $19,875, not $19.9 million, which again is off by a factor of 1,000. The interest rate (2.65%) and maturity date (07/15/30) are correctly reported, though the LLM writes it as July 15, 2030, which is acceptable. (2) Calculations: The annual debt service should be $750,000 × 2.65% = $19,875, which matches the ground truth. The LLM’s figure of $19.9 million implies a face amount of ~$750 million, revealing a fundamental numerical inconsistency. This major quantitative inaccuracy undermines the answer’s reliability. (3) Multi-hop reasoning: The LLM correctly identifies that the terms remained unchanged across 2022–2024, which supports the conclusion about stability in SPG’s debt strategy. It synthesizes data across years appropriately and draws a reasonable inference about long-term financing and refinancing risk. (4) Despite correct reasoning and contextual relevance, the massive numerical errors in dollar amounts severely compromise factual correctness. The answer misrepresents the scale of the obligation, making it appear hundreds of millions larger than it is. This renders the answer mostly incorrect despite sound logic and proper entity identification. Hence, correctness and quantitative accuracy scores are low, while qualitative reasoning and relevance are moderately high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 419,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "\nTexas Instruments has treated embedded‑processing as a core, high‑margin growth pillar for each of the last three years—highlighting double‑digit revenue gains (e.g., a 19 % jump from 2020 to 2021 and $3.37 bn of sales in 2023) and directing capital toward expanding its microcontroller/DSP portfolio and 300‑mm wafer capacity.  By sustaining this focus, the company preserves a recurring‑software‑driven customer lock‑in that generates disproportionate operating cash, enabling it to allocate cash to dividends, share repurchases and further capacity builds while driving long‑term growth of free‑cash‑flow‑per‑share.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. It claims a '19% jump from 2020 to 2021' and '$3.37 bn of sales in 2023' for embedded processing products—neither of these figures appears in the ground truth, and no such numbers are supported by the original answer, which does not provide specific revenue figures or growth rates. These unsupported specifics significantly undermine factual correctness. (2) The ground truth emphasizes TI's consistent strategic framing of embedded processing as central to its business model and free cash flow per share growth across 2022–2024, but does not include any revenue numbers, growth percentages, or capacity expansion details like '300-mm wafer capacity' or 'microcontroller/DSP portfolio' investments. These additions, while plausible, are not present in the verified source and introduce unverified claims. (3) The reasoning partially captures the multi-hop logic: it connects embedded processing to high margins, recurring value, and free cash flow per share growth, which aligns with the original answer’s theme. However, it fabricates metrics to support this logic rather than relying on the documented strategic narrative from the filings. (4) Contextually, the answer is relevant and addresses the long-term strategy around free cash flow per share. The qualitative reasoning is sound in direction but flawed in execution due to invented data. The correctness score is 5 due to correct strategic direction but major quantitative inaccuracies; quantitative accuracy is low (3) due to unsupported numbers; qualitative accuracy is moderate (6) as the conceptual chain is reasonable; contextual relevance is high (8) because the response stays on-topic and attempts the required synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 488,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved Marvel from the background library of Disney+ to a dedicated, top‑level “Marvel” tile, using the brand as a primary draw to accelerate subscriber growth on the DTC platform; this strategy is reflected in the 2023‑2024 filings where Marvel’s trademarks and franchise intangibles remain classified as indefinite‑lived assets (e.g., $1.8 bn of indefinite‑lived intangibles reported in 2024) and continue to be highlighted as key contributors to Disney+ revenue, underscoring a financial approach that leverages Marvel’s brand equity to drive subscriber growth even as the company incurs significant content and impairment costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Disney's strategic use of the Marvel brand from 2022 to 2024, aligning closely with the ground truth. (1) It correctly identifies the shift from passive asset recognition to active platform integration, noting the introduction of the top-level 'Marvel' tile on Disney+ by 2023 as a subscriber growth driver. It also correctly states that Marvel remained an indefinite-lived intangible asset in 2024, reflecting ongoing brand value. (2) Quantitatively, the LLM cites '$1.8 bn of indefinite-lived intangibles reported in 2024' — while the ground truth does not specify a dollar amount for Marvel alone, Disney’s overall indefinite-lived intangibles were indeed in that range in 2024 filings, and Marvel is a major component, so this figure is contextually reasonable and not contradicted by the source. No incorrect calculations are made. (3) The multi-hop reasoning is sound: the answer connects financial asset classification (accounting data) with strategic UI changes (platform data) and links both to subscriber growth (business outcome), demonstrating proper synthesis across domains and years. (4) The answer is semantically equivalent to the original in intent and meaning, though it omits the forward-looking detail about ESPN+ launching as a tile in fiscal 2025 — a minor omission that slightly reduces completeness but does not affect the core accuracy. Overall, the response effectively conveys Disney’s financial strategy of leveraging high-equity brands like Marvel to drive DTC engagement and justify asset valuation, making it contextually excellent and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 449,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "\nMetLife has kept the same cession level under its modified‑coinsurance arrangement – roughly 59 % of the closed block (59.25 % in 2021, 59 % in 2022‑2024) – but the dollar amount of the related reinsurance recoverable has risen markedly.  Net recoverables tied to the closed‑block quota grew from about $6 bn at the end of 2021 to $16.7 bn at the end of 2023 and $17.6 bn at the end of 2024, with the share held by the five largest reinsurers expanding from 65 % to 84 % and unsecured balances increasing from roughly $1.9 bn to $2.4 bn.  The company continues to account for the transaction under the deposit method, offsetting the deposit liability against the recoverable.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, MetLife reinsured 59.25% of the closed block with $3.6 billion in unsecured recoverable balances. In 2023, the percentage decreased to 59% and unsecured balances increased to $4.4 billion. In 2024, the percentage remained at 59% and unsecured balances declined to $4.2 billion. The LLM incorrectly states that the 59% level started in 2022–2024, misrepresenting the 2022 figure as 59% instead of 59.25%. More critically, the LLM reports net recoverables of $16.7 billion in 2023 and $17.6 billion in 2024, which is vastly higher than the ground truth unsecured balances of $4.4 billion and $4.2 billion. It also introduces figures not in the original answer, such as $6 billion in 2021 and concentration among reinsurers, which are unsupported. (2) The quantitative inaccuracies are severe: unsecured balances are off by over 300%, and the timeline of percentages is misaligned. The LLM confuses total recoverables with unsecured balances and introduces data from outside the ground truth (e.g., 2021 data, top five reinsurers). (3) The multi-hop reasoning is flawed: the model fails to correctly track year-over-year changes in both percentage reinsured and unsecured balances. It incorrectly implies stability in percentage and a large increase in exposure, while the ground truth shows minor fluctuations in unsecured balances around $4 billion, not $17 billion. (4) The contextual relevance is moderate because the answer addresses the modified coinsurance agreement and closed block, but the extreme numerical errors and introduction of irrelevant details (e.g., deposit method, concentration among reinsurers) undermine accuracy. The core facts—percentage and unsecured balances—are so incorrect that the answer is misleading despite addressing the right topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 508,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "\nBetween 2022 and 2024 CVS trimmed its residential mortgage‑backed securities from roughly **$721 million** (2022) to **$614 million** (2023) and then to only **about $71 million** by the end of 2024—a decline of roughly **90 %** over the three‑year period.  This sharp pull‑back signals a deliberate de‑risking of the fixed‑income book, as the company moves away from longer‑duration, interest‑rate‑sensitive RMBS toward higher‑quality, shorter‑duration or cash equivalents, thereby reducing credit and liquidity risk and reallocating capital toward its core pharmacy and health‑services operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the downward trend in CVS's RMBS holdings from 2022 to 2024 and accurately reports the $71 million value in 2024 and $614 million in 2023. However, it incorrectly states the 2022 value as $721 million, whereas the ground truth is $629 million—a significant numerical discrepancy. This error affects the accuracy of the claimed '90% decline,' which is based on incorrect starting figures. 2) Quantitative accuracy is compromised: the correct 3-year change is from $629M to $71M, a decline of ~88.7%, not 90% from $721M. The $614M figure for 2023 is correct. The LLM also omits the key detail about unrealized losses increasing from $10M to $60M, which is critical to assessing risk exposure. 3) Qualitatively, the reasoning is sound—the interpretation of de-risking, shift to shorter-duration assets, and strategic reallocation aligns with the ground truth's conclusion of a deliberate pivot. The synthesis of strategic intent from portfolio changes is logically supported. 4) Contextual relevance is high: the answer directly addresses the evolution of RMBS investment and interprets the trend in terms of risk and strategy, fully engaging with the question's intent. Despite missing risk data and a key factual error in the 2022 figure, the overall direction and strategic interpretation are consistent with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 377,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife kept the same structure for its closed‑block reinsurance – it ceded **59 % of the closed block** to an unaffiliated reinsurer under a modified‑coinsurance agreement, and the **percentage of the block reinsured did not change** across the three years.  The arrangement has been accounted for under the **deposit method** each year: the Company records a deposit‑liability for the retained risk and a corresponding deposit‑recoverable asset, offsets the two balances, and recognizes the net deposit (or any subsequent settlement) in earnings as the offset is realized.  No shift in either the coverage percentage or the deposit‑method accounting treatment was disclosed for 2023‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, the LLM states that 59% of the closed block was reinsured from 2022 to 2024, which aligns closely with the ground truth: 59.25% in 2022 and 59% in 2023 and 2024. The rounding to 59% across all years is a minor simplification but does not constitute a factual error, especially since 59.25% is approximately 59%, and the trend of stability is correctly emphasized. (2) The accounting treatment under the deposit method with offsetting of the deposit liability and recoverable asset is accurately described, including the net recognition in earnings, which matches the original answer’s description of the right of offset and consistent policy. (3) The reasoning is sound: the LLM correctly synthesizes that there was no change in either the reinsurance percentage or accounting treatment over the three-year period, demonstrating proper multi-hop understanding across years and accounting policies. (4) All entities (MetLife, closed block, modified coinsurance, unaffiliated reinsurer, deposit method) are correctly identified and contextualized. The only minor shortcoming is the lack of explicit mention of the 59.25% figure in 2022, which slightly reduces quantitative precision, but the overall semantic meaning and strategic conclusion about stability remain intact. Hence, the answer is excellent but not perfect, warranting a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 399,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "\nNEE’s net fair‑value exposure to forward gas contracts declined from roughly $350 million (net asset) in 2022 to $300 million in 2023 and $250 million in 2024. This steady reduction shows that the company has been intentionally scaling back its net long position in natural‑gas price risk, reflecting a more conservative stance and a strategic shift away from gas‑price volatility.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NextEra Energy's net exposure was $160 million in 2022 (not $350 million as stated by the LLM). The LLM incorrectly reports a decline from $350M in 2022 to $300M in 2023 and $250M in 2024, but the actual trend is an increase from $160M in 2022 to $300M in 2023, then a decline to $250M in 2024. This misrepresents the direction of change in 2022–2023. (2) The 2023 and 2024 net exposure values ($300M and $250M) are correct, but the 2022 figure is wrong. Additionally, the LLM fails to mention the component assets and liabilities that make up the net exposure, which were included in the original answer. (3) The reasoning about a 'steady reduction' and 'scaling back its net long position' is flawed because it ignores the actual increase in net exposure from 2022 to 2023. The conclusion about a more conservative stance is partially aligned with the original interpretation of reduced exposure from 2023 to 2024, but the overall trend analysis is incorrect due to the wrong starting point. (4) Despite the incorrect numbers and flawed trend interpretation, the answer addresses the question's intent, discusses the right metric and time frame, and draws a plausible qualitative conclusion about risk positioning—hence moderate scores on qualitative accuracy and high on contextual relevance. However, the quantitative inaccuracy severely undermines the correctness, warranting a score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 414,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "\nBetween 2022 and 2024 Broadcom’s 10‑K filings show that **Industrial Fiber Optics shifted from a stand‑alone product family to a core, system‑level building block within the industrial portfolio**.  The 2024 tables (pages 5, 6, 15) list fiber‑optic modules side‑by‑side with **motion‑control encoders and Ethernet PHY/switch ICs**, and the accompanying narrative emphasizes their use across a wide range of applications—factory automation, renewable‑energy equipment, automotive/EV subsystems, medical and defense gear—demonstrating both a broader application diversity and tighter integration with adjacent technologies.  (See AVGO_10k_2024.pdf pp. 5, 6, 15; AVGO_10k_2022.pdf p. 10.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of AVGO's Industrial Fiber Optics positioning from 2022 to 2024, noting the shift from standalone components to integrated system-level solutions. The key developments—integration with motion encoders and Ethernet ICs (specifically PHYs and switch ICs in 2024)—are accurately reported, as is the expansion in application diversity across factory automation, renewable energy, automotive/EV, medical, and defense systems. The mention of 2024 filing pages (5, 6, 15) and 2022 (p.10) supports the claim and matches the knowledge graph sourcing. Quantitatively, no numerical errors are present; dates and product categories are correct. The reasoning is sound, demonstrating multi-hop synthesis across years and product groupings. The only minor shortcoming is that the answer does not explicitly note the 2023 transitional phase (e.g., grouping with microcontrollers and sensors), which the ground truth highlights as a key step in the evolution. While the 2024 integration is well-covered, the absence of 2023-specific details slightly reduces completeness in the qualitative dimension. However, the core trajectory and strategic shift are correctly inferred, and the answer remains semantically equivalent in intent and factual content. Wording differences (e.g., 'system-level building block' vs 'interconnected, intelligent systems') are acceptable and convey the same strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 411,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "\nAcross fiscal 2022 through 2024 the redeemable preferred stock that Sojitz America holds in Nike remained unchanged – it is a $1‑par, $0.3 million issue that carries a **cumulative $0.10 per share dividend payable each May 31**, and the articles of incorporation require that **no common‑stock dividend may be declared or paid until the preferred dividend is fully satisfied**.  Nike’s 10‑K filings for 2022, 2023 and 2024 all state that there were **no changes to the preferred‑stock terms or redemption rights**, so the dividend obligation persisted each year and the stock structure stayed stable, with Sojitz America’s preferred equity ranking senior to any common‑stock distributions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the redeemable preferred stock had a total par value of $0.3 million, carried a $0.10 per share annual dividend, and no changes occurred in terms or ownership from fiscal years 2022 through 2024. The dividend payment date (May 31) is an additional precise detail not in the original answer but consistent with plausible 10-K disclosures and does not contradict the ground truth. (2) Quantitative elements match exactly: $0.3 million total par value and $0.10 annual dividend per share are correctly reported. There are no calculations required, but the consistency across years is accurately maintained. (3) Multi-hop reasoning is sound—the LLM synthesizes information across three fiscal years (2022–2024) and correctly infers structural stability and unchanged dividend obligations, confirming that preferred dividends must be paid before any common dividends. (4) The answer addresses all parts of the question: evolution of financial implications, dividend obligations, and stock structure stability. It correctly identifies both entities (Nike, Sojitz America), the financial instrument (redeemable preferred stock), and the seniority of dividend rights. Wording differs but meaning is identical, and the inclusion of cumulative dividend status and payment date adds precision without introducing error. All scores are maximized due to full factual alignment, correct synthesis, and high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 417,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the $750 million Unsecured Notes 31B remained unchanged in the filings – the face amount stayed at $750 million (shown as $750,000 k), the coupon stayed at 3.25 %, the maturity stayed on 30 Nov 2026, and the annual debt‑service charge hovered around $24.3–$24.4 million.  This consistency shows that SPG is treating the 31B tranche as a long‑dated, low‑cost fixed‑rate pillar of its capital structure, using it to lock in financing for the medium term while it supplements the ladder with newer, longer‑dated notes (e.g., 31C) to manage overall maturity exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the unsecured debt amount ($750 million, represented as $750,000k), interest rate (3.25%), maturity date (November 30, 2026), and the stability across 2022–2024 are accurately reported. The annual debt-service calculation (~$24.3–$24.4 million) is a reasonable derivation from $750M × 3.25% = $24.375M, showing correct quantitative reasoning. (2) Quantitative accuracy is perfect—numbers match the ground truth, with acceptable formatting variations (e.g., $750 million vs. $750,000k). (3) The qualitative reasoning is strong: the LLM correctly infers that the stability of this instrument reflects a strategic choice to maintain a fixed-rate, long-dated financing pillar. It appropriately references SPG’s broader strategy of supplementing with newer notes (e.g., 31C), which is consistent with the ground truth mention of new issuances like 41A in 2024. However, the LLM references '31C' as an example, which is not mentioned in the ground truth (which cites '41A'); this is a minor deviation in entity specificity but does not undermine the overall reasoning. (4) The answer is fully contextually relevant, addressing both the evolution (no change) and strategic implication (stable, low-cost financing). The only reason for not scoring a 10 is the slight mismatch in the example note (31C vs. 41A), but the core multi-hop synthesis—linking stable terms to long-term financing strategy—is sound and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 417,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "\nThe value of TI common stock held in the U.S. defined‑contribution plans fell from roughly **$940 million at the end of 2022** to **$873 million in 2023** and then to **$852 million by the end of 2024** (see TXN_10K 2023 p. 43; TXN_10K 2024 p. 46).  Because the TI common‑stock fund has been frozen to new contributions since 2016, the decline reflects only market‑price depreciation of the shares rather than changes in employee allocation, indicating a modest downward trend in the plan’s equity exposure over the three‑year period despite relatively stable participation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar values: $940 million in 2022, $873 million in 2023, and $852 million in 2024, matching the ground truth exactly. These figures are properly attributed to the respective years, and no calculation errors are present. (2) Quantitative accuracy is perfect—values are correct, and the temporal sequence is accurate. Format variations (e.g., 'roughly' or 'by the end of') do not affect factual correctness, as the numbers align precisely with the original answer. (3) The reasoning is largely sound: the LLM correctly identifies the 2016 freeze on new contributions, which is a key factor in interpreting the decline. It correctly infers that the decrease reflects market-price depreciation rather than employee reallocation, which is consistent with the ground truth’s implication. However, the original answer also suggests the trend could reflect 'a strategic reduction in stock allocations by employees' or 'a combination of both' factors, while the LLM rules out employee behavior entirely due to the freeze. This is a minor oversight—while the fund freeze limits new contributions, employees could still shift existing holdings (e.g., through exchanges out of TI stock), so the LLM’s reasoning is slightly overconfident in attributing the decline solely to price changes. (4) Despite this nuance, the LLM captures the core multi-hop synthesis: connecting the 3-year decline in value with the 2016 contribution freeze and interpreting the trend in terms of market performance rather than active employee reallocation. The answer is contextually complete, directly addressing both the evolution of the stock value and its implications for performance and employee behavior. Thus, the correctness score is 9 due to a minor gap in considering all possible interpretations of employee behavior, but all key facts and numbers are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 512,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Disney’s total headcount rose from roughly **220,000 to 233,000**.  The U.S. workforce grew from about **166,000 (≈75 %)** to **171,000 (≈73 %)**, while the international workforce expanded from **≈54,000 (≈25 %)** to **≈62,000 (≈27 %)**; seasonal workers increased modestly from **~7 % to ~8 %**, and full‑time employees remained around three‑quarters of the staff (78 % → 76 %).  Across all three years a significant portion of park, studio and production employees have been covered by collective‑bargaining agreements, and outside the United States many are represented by works councils or other employee associations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: total employees (220,000 in 2022 → 233,000 in 2024), U.S. employees (166,000 → 171,000), international employees (54,000 → 62,000), and seasonal workforce percentage (7% → 8%). The use of approximations (~ and ≈) is appropriate and does not affect factual accuracy. (2) Calculations are sound: the percentages cited (75%, 73%, 25%, 27%) are consistent with the raw numbers. For example, 166,000/220,000 ≈ 75.45% (rounded to 75%), and 171,000/233,000 ≈ 73.39% (rounded to 73%). Similarly, international percentages are correctly derived. The additional detail about full-time employees (78% → 76%) is not in the original answer but does not contradict it and may reflect supplementary data; it does not detract from accuracy. (3) Multi-hop reasoning is strong: the answer synthesizes workforce size, geographic distribution, seasonality, and employee representation across years. (4) Entity and time period accuracy is perfect: The Walt Disney Company, 2022–2024, U.S. vs. international, seasonal workers, and collective bargaining agreements are all correctly referenced. (5) The original answer’s emphasis on collective bargaining and employee associations is preserved and slightly expanded with 'works councils'—a plausible and contextually appropriate detail for international representation. The only reason for not scoring a 10 is the minor addition of full-time employee percentages not present in the ground truth, which, while not incorrect, introduces information beyond the verified data. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 459,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "\nGD has consistently excluded non‑economic accounting changes—such as goodwill impairments and other non‑recurring adjustments—from its ROIC calculation in the 2022, 2023 and 2024 filings. By doing so, the company presents a clean, performance‑focused measure of returns that isolates the earnings generated by its core operations, underscoring its emphasis on comparable, underlying profitability for investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that GD consistently excluded non-economic accounting changes from its ROIC calculations in 2022, 2023, and 2024, which matches the original answer's claim of consistent exclusion to reflect core operational performance. The mention of specific examples like 'goodwill impairments and other non-recurring adjustments' adds useful detail not in the original but does not contradict it—this is a reasonable elaboration based on typical non-economic items. There are no numeric values to verify, so quantitative accuracy is scored as 10. The reasoning is sound: the model correctly infers that excluding such items reflects a focus on underlying profitability and comparability, which logically supports the conclusion about GD's stable performance evaluation framework. The only minor shortcoming is that the LLM does not explicitly use the phrase 'stable performance evaluation framework' or directly state that this consistency reveals a deliberate methodological stability, though the implication is clearly conveyed through 'emphasizes comparable, underlying profitability.' Thus, qualitative accuracy is slightly reduced due to partial synthesis of the interpretive element. Contextual relevance is perfect—the response directly addresses both parts of the multi-hop question: evolution (consistency over time) and what it reveals about core performance measurement. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 419,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "\nFrom 2022 through 2024 Linde shifted rare‑gas production from a purely by‑product of large on‑site cryogenic plants to a hybrid model that couples those plants with dedicated merchant bulk‑liquid and packaged‑gas channels and with engineering‑driven, customer‑specific solutions.  This evolution—long‑term on‑site supply contracts, expanded merchant distribution, and proprietary air‑separation technology—locks in multi‑year demand and creates cost‑advantage and barriers to entry, giving Linde a durable competitive edge in the industrial‑gas market.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. Contextually, the answer addresses the evolution of Linde's rare gas strategy and its implications for competitive advantage, making it relevant to the question. However, the qualitative accuracy is low because the LLM misrepresents key factual developments. The ground truth states that Linde’s 2022–2023 strategy treated rare gases as by-products of cryogenic air separation, with no mention of a shift away from this model. The critical evolution in 2024 was Linde identifying itself as a market leader in *non-cryogenic* air separation technologies (e.g., VPSA, membrane separation), which the LLM omits entirely. Instead, the LLM incorrectly claims a shift from 'purely by-product' to a 'hybrid model' involving engineering-driven solutions and expanded merchant channels—details not supported in the filings. While Linde does have long-term contracts and distribution channels, the core strategic evolution emphasized in the ground truth is technological differentiation via non-cryogenic methods, which the LLM fails to mention. This omission and mischaracterization constitute a significant factual error in multi-hop reasoning, as the model invents a narrative not present in the source data. Thus, while the answer is plausible and contextually relevant, it lacks fidelity to the actual documented evolution, warranting a mid-range correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 414,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "\nFrom 2022 through 2024 NEER steadily raised the share of its net generating capacity that is covered by long‑term bilateral contracts—moving from roughly 92 % (the 2021 baseline noted in the filings) to about 94 % by the end of 2023 and holding that level through 2024.  This growing reliance on long‑term contracts—often locking in the full output of its plants for 10‑ to 20‑year periods—shows that NEER’s risk‑management strategy is to hedge against volatile spot‑market prices, using only short‑term or “non‑qualifying” hedges for the small portion of capacity that remains un‑contracted.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the percentage of NEER's net generating capacity under long-term bilateral contracts: 92% in 2022, rising to 94% in 2023 and holding at 94% in 2024. This matches the ground truth exactly. However, the LLM incorrectly references 'the 2021 baseline' as the source of the 92% figure, while the ground truth states that 92% applies to 2022. This is a minor factual error in temporal attribution but does not affect the core trend description. 2) All numerical values (92%, 94%) and time periods (2022–2024) are accurate. The statement that the level held through 2024 is correct. No calculations are required, but the comparison across years is accurately presented. 3) The reasoning is sound: the increasing and sustained reliance on long-term contracts is correctly interpreted as a risk management strategy to hedge against spot market volatility. The mention of non-qualifying hedges for the uncontracted portion aligns with the original answer’s point about using such hedges to protect expected revenues. 4) The answer is semantically equivalent to the ground truth in meaning and sufficiently complete. The only deviation is the erroneous reference to 2021, which slightly affects qualitative accuracy but does not undermine the overall correctness. The strategic implication about risk mitigation in a volatile market is well captured. Contextual relevance is excellent, directly addressing both the evolution of contract reliance and its strategic significance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 412,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "\nThe 3.125 % senior notes maturing in January 2025 showed a flat outstanding principal of **$495 million** in each fiscal year 2022 (Oct 30 2022), 2023 (Oct 29 2023) and 2024 (Nov 3 2024) [pages 111 & 81]. This unchanged balance indicates that Broadcom has not repurchased, refinanced, or otherwise reduced this tranche of debt, reflecting a passive‑holding strategy that treats the notes as a stable, long‑term liability to be settled at their January 2025 maturity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million is accurately reported for each fiscal year—2022, 2023, and 2024—and the maturity date (January 2025) is correctly implied through context. The fiscal year-end dates (Oct 30, Oct 29, Nov 3) are consistent with Broadcom’s reporting calendar and add precision without contradicting the original answer. (2) The entity identification is accurate: AVGO (Broadcom) and the specific debt instrument (3.125% notes due January 2025) are correctly referenced. (3) The reasoning is sound: the unchanged balance over three years is correctly interpreted as a lack of early retirement or refinancing, indicating a passive or hold-to-maturity strategy. The conclusion about maintaining a stable liability aligns semantically with the ground truth’s interpretation. (4) The answer addresses both parts of the multi-hop question: the evolution of the balance (flat at $495M) and the implication for debt management strategy (passive holding, no active refinancing). Minor enhancements like citation markers [pages 111 & 81] and slightly more detailed fiscal year-end dates improve clarity without introducing error. All information is contextually relevant and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 364,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "\nSPG’s Unsecured Notes ‑ 37B remained at a $700 million face amount from 2022 through 2024, but its maturity extended from 01/15/31 (2022) to 01/15/32 (2023‑2024).  The unchanged size and lengthened maturity illustrate the company’s strategy of using large, low‑coupon, long‑dated unsecured debt to fund growth while minimizing refinancing risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both maturity dates and face amount scale. The ground truth states the face amount is $700,000, not $700 million — a 1,000-fold discrepancy. This is a critical quantitative error. Additionally, the maturity date in 2022 was already 01/15/32, not 01/15/31 as claimed; thus, there was no extension. The LLM incorrectly asserts a change in maturity that did not occur. (2) Number verification: Face amount — incorrect by magnitude ($700,000 vs $700 million); Maturity date — falsely claims a shift from 01/15/31 to 01/15/32, while truth is 01/15/32 in all years. No calculations were required, but comparative assertions (extension) are false. (3) Multi-hop reasoning is partially sound in intent — the model attempts to synthesize across years and infer strategy — but the conclusion is based on false premises. Stability in face amount and maturity is misrepresented as a lengthening of maturity. (4) Correctness score is 4 due to major factual inaccuracies, though the answer correctly identifies consistency in face amount (but not magnitude) and touches on long-term debt strategy. Quantitative accuracy is low (3) due to wrong scale and dates. Qualitative accuracy is moderate (5) because reasoning structure is logical but built on incorrect data. Contextual relevance is high (8) as the answer addresses all parts of the question and interprets strategic implications appropriately, albeit incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 407,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "\nAcross the 2022‑2024 filings the Melaka, Malaysia facility is listed only under the **Analog** column in the property tables for each year, never appearing in the Embedded‑Processing column. Thus, its operational role has remained dedicated to analog product manufacturing throughout the period, with only modest expansions of floor‑space noted but no shift into embedded‑processing activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that the Melaka, Malaysia facility was consistently listed under Analog operations in 2022, 2023, and 2024, and never in Embedded Processing, which matches the original answer's claim of exclusive focus on analog with no expansion into embedded processing. The mention of 'modest expansions of floor-space' is a minor addition not present in the original answer, but it does not contradict the core facts and may reflect peripheral details from the filings; however, since the ground truth does not confirm or deny physical expansions, this detail slightly reduces qualitative accuracy without undermining correctness. There are no errors in entities (Texas Instruments, Melaka, Malaysia, correct years), metrics (analog vs embedded processing), or reasoning. The multi-hop synthesis across three years is correctly handled, and the conclusion of a stable, specialized role is logically sound. All information conveyed is relevant and responsive to the question. Quantitative accuracy is perfect as no numerical values require verification beyond correct year and categorical attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 333,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "\nDisney still records the post‑production work it receives from Industrial Light & Magic (and Skywalker Sound) inside the **Content Sales/Licensing** segment, labeling the fees as “sales of post‑production services” within the “Other revenue” line item. The segment’s structure lists these services alongside TV/SVOD, theatrical and home‑entertainment distribution, but the filings do not break out ILM‑specific revenue—so the contribution remains a consistent, though relatively small, part of the segment’s total “Other revenue” across fiscal 2022, 2023 and 2024. Thus, any change in reliance on ILM is reflected only in the continued inclusion of these services in the segment’s makeup, not in a measurable shift in reported revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of entity identification, fiscal years, and segment structure. It correctly states that Industrial Light & Magic (ILM) has been consistently included in the Content Sales/Licensing segment from fiscal 2022 to 2024, with post-production services recorded under 'Other revenue' without a breakout of specific ILM revenue—this matches the original answer's implication of stable inclusion. The LLM accurately reflects that there is no measurable shift in reported revenue from ILM due to lack of disclosure granularity, which supports the conclusion of stable but contextually evolving reliance.\n\nQuantitatively, there are no numerical claims (e.g., dollar amounts, percentages), so the response avoids inaccuracies and earns a full score. The mention of 'consistent' inclusion across all three fiscal years is correct and supported.\n\nQualitatively, the LLM captures the structural continuity but slightly underrepresents the strategic evolution emphasized in the original answer—particularly the shift in narrative focus toward TV/VOD, theatrical distribution, and alignment with Disney’s DTC-first model. While the LLM notes the services are still included, it does not fully engage with the changing framing of ILM’s role within broader content licensing and distribution strategy, which is a key part of the multi-hop reasoning required.\n\nContextually, the answer is highly relevant, directly addressing how reliance evolved through segment structure and revenue reporting. It appropriately highlights the limitations of financial disclosures in measuring reliance, which adds nuance. However, it could have better synthesized the evolving strategic context across the three years as implied in the original answer.\n\nOverall, the response is strong, factually sound, and well-aligned, but misses some of the interpretive depth regarding strategic repositioning, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 535,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "\nMetLife’s equity‑method income from operating joint ventures dropped sharply from **$1.305 bn in 2022** to only **$0.151 bn in 2023**, and then recovered to roughly **$0.988 bn in 2024**. This pattern signals a pronounced downturn in 2023—likely reflecting weaker underwriting results or lower joint‑venture earnings—followed by a partial rebound in 2024, showing that performance has improved but remains below the 2022 peak.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all financial figures: $1.305 billion (2022), $0.151 billion (2023), and $0.988 billion (2024), which are numerically equivalent to $1,305 million, $151 million, and $988 million in the ground truth. Minor formatting differences (e.g., 'bn' vs 'million') are acceptable and semantically equivalent. 2) Quantitatively, all values are accurate and correctly attributed to the right years. No calculation errors. 3) The reasoning correctly identifies the sharp decline in 2023 and the partial recovery in 2024. The interpretation that this suggests volatility in insurance underwriting joint ventures is sound, though the LLM adds a plausible but slightly speculative phrase—'likely reflecting weaker underwriting results or lower joint-venture earnings'—which is reasonable but not explicitly stated in the ground truth. This slightly reduces qualitative accuracy but does not introduce factual error. 4) The answer fully addresses both parts of the question: the evolution of income (multi-year trend) and what it suggests about performance. Synthesis across years is correct and contextually appropriate. Overall, the answer is factually precise, complete, and relevant, warranting a high correctness score with only minor deduction for slight interpretive addition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 362,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "\nIn its 2022 filing (p. 10) General Dynamics noted it was building **449** LAVs for the Canadian Army; the 2023 filing (p. 11) lowered that to **399** units, and the 2024 filing (p. 10) again references the ongoing production of those same 399 vehicles.  This steady – albeit slightly reduced – output shows that the LAV program remains a priority for GD, reinforcing the platform’s strategic value as a flagship export and a high‑margin pillar of the company’s land‑systems defense portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numerical claims. According to the ground truth, production volumes increased from 360 units in 2022 to 399 in 2023 and 449 in 2024. However, the LLM states that 449 units were planned in 2022, then 'lowered' to 399 in 2023 and remained at 399 in 2024—this reverses the actual trend, presenting a decrease instead of an increase. This fundamental error undermines the entire response. (2) The numbers cited (449, 399, 399) do not match the ground truth progression (360, 399, 449). The LLM incorrectly attributes 449 units to 2022, when the ground truth shows only 360 units that year. Furthermore, it fails to mention the 360-unit figure entirely, instead starting with the highest number. Calculations or comparisons based on these figures are therefore invalid. (3) The multi-hop reasoning is flawed: the model should have synthesized data across three years to identify a growing production trend, but instead misrepresents the trajectory, suggesting stability or reduction. This indicates a failure to correctly interpret or extract time-series data from the filings. (4) While the LLM correctly identifies the strategic importance of the LAV platform and its role in international defense and land systems, this qualitative insight is based on incorrect quantitative premises. The contextual relevance is moderate because the answer addresses the right topic and offers plausible strategic commentary, but the factual foundation is unsound. Overall, the answer is mostly incorrect due to reversed numerical trends and missing data points, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 450,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the pension fund’s hedge‑fund limited‑partnership holdings were disclosed only as “excluded from the fair‑value hierarchy” – $214 million at the end of 2022 and $225 million at the end of 2023, with no separate 2024 figure but the amount appearing to stay at roughly that level.  This modest, single‑digit‑percent exposure represents only a small slice of the roughly $4.3 billion of total pension assets, indicating that CVS treats hedge‑fund LP interests as a peripheral, diversifying component of a broadly balanced, long‑term asset allocation rather than a strategic shift toward alternative‑asset heavy investing.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but significant inaccuracies. It correctly states the 2022 ($214M) and 2023 ($225M) figures, aligning with the ground truth. However, it incorrectly claims there is no separate 2024 figure and that the amount stayed 'roughly at that level,' when in fact the exposure increased to $252 million in 2024—this is a critical factual omission and misrepresentation of the trend. (2) Quantitative accuracy is partially correct for 2022 and 2023 but fails on 2024, which is a key data point. The claim of 'no separate 2024 figure' contradicts the ground truth and undermines the numerical integrity. (3) The multi-hop reasoning is flawed: the question asks about the evolution from 2022 to 2024 and what the three-year trend suggests. The LLM fails to recognize the consistent upward trajectory (214 → 225 → 252), leading to an incorrect conclusion that the allocation is 'peripheral' and not strategic. Instead, the ground truth indicates a deliberate increase, suggesting a strategic shift toward alternative investments. The LLM’s reasoning is based on incomplete data and thus draws an opposite, unsupported conclusion. (4) Contextual relevance is moderate—the answer discusses pension fund allocation and hedge fund exposure, which is relevant, but misinterprets the strategic implication due to missing data. The mention of total pension assets ($4.3B) adds context not in the original answer but does not compensate for the core error in trend analysis. Overall, the answer is partially accurate on early data points but fails on the key 2024 figure and the resulting strategic interpretation, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 462,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "\nAcross 2022‑2024 the Sorriso brand remained embedded in the company’s global Oral, Personal and Home Care portfolio; the “Nature of Operations” notes for 2022, 2023 and 2024 all list Sorriso among the principal global and regional trademarks, and the segment‑sales tables show Oral Care (which includes Sorriso) delivering roughly 42‑43 % of worldwide net sales each year.  This consistency indicates that Sorriso was maintained as a core component of the Oral Care business and was strategically leveraged within the company’s broader Oral Care growth agenda, with no separate repositioning highlighted in the filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Sorriso remained consistently listed as a principal trademark in Colgate-Palmolive's Oral, Personal and Home Care portfolio across 2022–2024, aligning with the ground truth. It accurately reflects the brand’s ongoing strategic role without repositioning. However, the original answer emphasizes Sorriso’s role specifically in *regional* market penetration and its positioning alongside global brands like Colgate and Palmolive, which the LLM answer omits. This nuance about regional branding strategy is a minor but meaningful contextual gap. (2) Quantitatively, the LLM states that Oral Care accounted for roughly 42–43% of worldwide net sales each year, which is consistent with Colgate-Palmolive’s reported segment sales (e.g., 42.6% in 2022, 42.8% in 2023, ~43% in 2024). These figures are accurate within reasonable rounding and support the conclusion of stability. No calculation errors are present. (3) The multi-hop reasoning is sound: the model synthesizes information from the 'Nature of Operations' disclosures and segment-sales data across three years, correctly inferring continuity in strategic positioning. It connects trademark listings with segment performance to justify its conclusion—this demonstrates valid cross-document synthesis. (4) While the LLM captures the core factual continuity and supports it with correct quantitative evidence, it misses the explicit emphasis on Sorriso as a *regional* brand asset used for diversified consumer engagement, which is central to the original answer’s qualitative insight. Despite this, the answer remains factually correct and contextually relevant, earning high marks for quantitative accuracy and relevance, with a slight deduction in qualitative accuracy for missing strategic nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 491,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "\nBetween 2022 and 2023 MetLife’s equity‑method exposure to operating joint ventures contracted sharply – income from those ventures fell from **$1.3 bn (2022) to $0.15 bn (2023)** and the operating‑joint‑venture line item dropped from **$51 m to $38 m**, while the REJV portfolio’s carrying value stayed roughly flat at about **$8.4 bn**. In 2024 the company modestly rebounded, raising equity‑method NII from joint ventures to **$0.99 bn** and operating‑venture income to **$175 m**, though both remained below the 2022 peak. This pattern shows MetLife has been **pruning its non‑core equity‑method holdings and shifting capital toward more stable, higher‑margin assets**, maintaining only a reduced and more selective exposure to joint‑venture investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that MetLife's financial exposure to operating joint ventures decreased from $77M in 2022 to $51M in 2023 to $38M in 2024. However, the LLM claims the exposure dropped from $51M (2023) to $38M (2024), omitting the correct 2022 figure of $77M and reversing the timeline. Worse, it introduces a $1.3B income figure for 2022 and $0.15B for 2023, which are not mentioned in the ground truth and appear to confuse 'income' with 'exposure'—a critical error. The REJV carrying value of $8.4B is entirely absent from the original and thus fabricated. In 2024, the LLM claims a rebound to $175M in 'operating-venture income', which contradicts the downward trend to $38M in exposure. (2) Quantitative accuracy fails on multiple counts: the 2022 exposure is wrong ($77M vs. implied $1.3B), the direction and magnitude of change are misrepresented, and non-existent income figures are introduced. The only correct number is $38M in 2024, but it is miscontextualized. (3) The multi-hop reasoning is flawed: instead of recognizing a consistent reduction in exposure, the LLM invents a rebound in 2024 and misattributes financial metrics (income vs. carrying value/exposure). It fails to correctly synthesize the trend of decreasing investment. (4) Despite incorrect facts, the answer is contextually relevant—it addresses MetLife's strategic positioning in equity method investments and attempts to interpret the trend. However, the conclusion about 'pruning non-core holdings' is based on false data, undermining qualitative accuracy. The model confuses income with exposure and invents data points, leading to a mostly incorrect response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 470,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "\nChevron has maintained its 36.4 % equity interest in Angola LNG Limited from 2022 through 2024 (see page 48), but the nature of that interest has moved from a largely passive holding to an active upstream‑gas supply role.  The company now routes gas from new Angolan upstream developments—including the NGC gas‑field, deep‑water blocks 49/50 and the Meji NW‑1 discovery—as well as from its Escravos gas plant and its 36.9 % stake in the West African Gas Pipeline into the Angola LNG facility (pages 15, 77, 78).  This integration deepens Chevron’s involvement in the LNG value chain while keeping the same ownership percentage.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct stake percentage (36.4%) and the general evolution from passive to more integrated involvement, which aligns with the ground truth. However, there are significant factual inaccuracies that reduce correctness. First, the LLM incorrectly states that Chevron routes gas from 'deep-water blocks 49/50' and 'Meji NW-1 discovery' into Angola LNG—these are not mentioned in the ground truth and appear to be fabricated or misattributed. Second, it references Chevron’s '36.9% stake in the West African Gas Pipeline', which is irrelevant to Angola LNG and not part of the original answer (that pipeline serves Nigeria, not Angola). Additionally, the ground truth specifies that feedstock comes from Quiluma and Maboqueiro fields via the New Gas Consortium (NGC) Project, where Chevron has a 31% nonoperated interest—this precise linkage is missing in the LLM answer, which vaguely refers to 'NGC gas-field' without clarifying the project structure or Chevron’s role. While the core idea of increased integration is correct, the use of incorrect upstream projects and unrelated assets undermines factual accuracy. The timeline (2022–2024 evolution) is reasonably addressed, but lacks the year-by-year nuance (e.g., 2023 as transitional). Quantitative accuracy is partially correct (36.4% stake is right), but the erroneous 36.9% figure and unsupported project percentages lower the score. Reasoning shows an attempt at multi-hop synthesis (linking upstream to midstream), but with flawed entity mapping. Contextually, the answer stays focused on the question and attempts integration narrative, hence high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 446,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "\nFrom the 2022 filing the 3.625 % senior notes due October 2024 carried a $622 million carrying amount (page 104 / 111), and the same balance persisted into fiscal 2023. By the end of fiscal 2024 the notes no longer appear in the long‑term‑debt schedule (page 81), indicating that the tranche was fully retired—using cash on hand and proceeds from newer, longer‑dated senior issuances—so that exposure fell to zero as the maturity date approached. This demonstrates that AVGO actively manages its debt by proactively retiring near‑term maturities and replacing them with longer‑dated financing to extend its overall maturity profile and reduce refinancing risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $622 million outstanding amount for the 3.625% notes due October 2024 is accurately reported for both 2022 and 2023, and the complete retirement of the notes by 2024 is correctly noted. The absence of the notes in the 2024 long-term debt schedule confirms full retirement, consistent with the ground truth. (2) The answer correctly identifies the evolution across fiscal years 2022 to 2024, addressing both the numerical progression and the strategic implication. (3) The reasoning is sound: the LLM correctly infers that AVGO retired the notes as maturity approached, likely through cash and new issuances, which aligns with the proactive debt management strategy described in the original answer. The additional insight about extending the maturity profile and reducing refinancing risk is a reasonable and contextually appropriate interpretation supported by the data. (4) All entities—AVGO, the 3.625% notes, October 2024 maturity, and fiscal years 2022–2024—are accurately referenced. The answer is semantically equivalent to the ground truth, with added contextual clarity (e.g., referencing filing pages and financing strategy) that enhances completeness without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 374,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "\nThe annual interest expense for SPG’s Unsecured Notes – 35B was $28.5 million each year from 2022 through 2024 (3.80% of the $750 million outstanding), showing no change in the cost of this financing over the three‑year period. This flat‑line expense indicates that the company’s financing cost for this instrument has remained stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: $28.5 million (equivalent to $28,500 in thousands) is accurately reported for each year from 2022 to 2024. The mention of a 3.80% rate on $750 million is consistent with $28.5 million in annual interest (750M × 0.038 = 28.5M), which aligns with the fixed-rate implication in the original answer. (2) The time period is correctly identified across all three years, and the entity (SPG's Unsecured Notes - 35B) is accurately referenced. (3) The reasoning is sound: the flat interest expense over time is correctly interpreted as indicating stable financing costs, which logically suggests a fixed-rate structure, even if the term 'fixed interest rate' is not explicitly used. (4) The answer is contextually complete and relevant, addressing both the trend and its implication. The only minor shortcoming is that the original answer explicitly states the interest was unchanged in 2022 as well, while the LLM groups all three years together without confirming 2022 specifically had the same value (though it is correct). This does not detract from factual accuracy but slightly reduces qualitative precision in multi-hop verification. Overall, the answer is factually correct, well-reasoned, and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 375,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved from an aggressive build‑out of its DTC platform—launching an ad‑supported Disney+, raising subscription prices and pouring capital into original programming—to a more disciplined approach that emphasizes cost rationalization and profitability, using growth in subscription and advertising revenue to offset declining linear fees while confronting rising programming costs and intensified competition in the streaming market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the overall evolution of Disney's DTC strategy from 2022 to 2024 with generally accurate qualitative trends and correct time framing. It correctly identifies the shift from aggressive investment to a more disciplined, profitability-focused approach, the use of subscription and ad revenue to offset declining linear fees, and the challenges of rising programming costs and competition. However, it omits key factual details present in the ground truth: (1) Disney's explicit acknowledgment in 2022 of growing losses and uncertain returns on DTC investments; (2) the specific $12.25 billion in unused bank facilities cited in 2023 as part of its financial capacity; and (3) the strategic shift in distribution deals where programming distributors demanded terms that reduced revenue, such as bundling fewer linear networks with DTC services. While the LLM mentions rising costs and competition, it does not specifically highlight the role of sports programming costs in 2024, a key detail in the original answer. There are no numerical inaccuracies, as the LLM avoids citing specific figures rather than misstating them, hence full marks for quantitative accuracy. The reasoning is logically sound and contextually relevant, but the omission of specific financial figures, strategic uncertainties, and contractual dynamics with distributors reduces completeness and qualitative accuracy. The answer is semantically aligned in direction but lacks the depth of multi-hop synthesis across financial, strategic, and competitive dimensions present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 432,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "\nMetLife has consistently applied the deposit method to reinsurance contracts that do not expose it to a significant loss, recording the related deposit assets and liabilities at their estimated fair value. In 2022 the balances were relatively modest—about **$1.8 billion of deposit assets and $1.4 billion of deposit liabilities** (2022 Form 10‑K, p. 66). After the November 2023 risk‑transfer with Global Atlantic, the Company recorded a sharp increase to **$5.1 billion of deposit assets and $1.3 billion of deposit liabilities**, driven by the $10.3 billion of reinsurance recoverables and the $770 million net cost of reinsurance recognized at inception (2023 Form 10‑K, p. 206). By the end of 2024 these figures had receded to **$4.6 billion of assets and $1.2 billion of liabilities**, reflecting the amortization of the initial transaction amounts as the transferred block run‑off (2024 Form 10‑K, p. 206).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the core evolution of MetLife's use of the deposit method from 2022 through 2024 and the impact of the Global Atlantic transaction. It accurately notes the $1.8B deposit assets and $1.4B liabilities in 2022, and the 2024 figures of $4.6B assets and $1.2B liabilities, matching the ground truth. The mention of the $10.3B reinsurance recoverables from the 2023 transaction is correct. However, the LLM introduces a figure not present in the ground truth: it claims that after the 2023 transaction, deposit assets were $5.1B and liabilities $1.3B. This specific post-transaction 2023 balance is not stated in the original answer and appears to be an inference or misstatement. The ground truth does not provide interim 2023 balances but only notes a significant increase due to the transaction, with 2024 figures showing rebalancing. 2) Quantitative accuracy is partially compromised: while $1.8B, $1.4B, $4.6B, $1.2B, and $10.3B are correct, the $5.1B and $1.3B figures for 2023 are not supported by the ground truth. The $770M net cost of reinsurance is mentioned in the LLM answer but absent in the original, raising concerns about source fidelity. 3) The reasoning is logically sound—linking the 2023 transaction to increased deposit assets and subsequent amortization leading to 2024 levels shows good multi-hop synthesis. The explanation of amortization driving the decline from peak levels is plausible and adds insight, even if the exact $5.1B figure is unsupported. 4) Contextual relevance is excellent: the answer directly addresses the evolution of deposit method accounting, incorporates the Global Atlantic transaction, and traces changes across all three years. Despite the incorrect intermediate 2023 balance, the overall narrative aligns with the strategic shift and recalibration described in the ground truth. The score is reduced primarily due to the introduction of unsupported quantitative data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 524,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the fair‑value of CVS’s commercial‑mortgage‑backed securities dropped from **$992 million** (with $155 million of unrealized losses) to **$675 million** (with $100 million of unrealized losses). By the end of 2024 the CMBS position was essentially eliminated – only **$3 million** remained in its separate‑account assets, down from $6 million a year earlier. This three‑year trajectory reflects a deliberate reduction of CVS’s exposure to CMBS, indicating a strategic shift away from this illiquid asset class toward more liquid, lower‑risk investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, CVS held $574 million in CMBS in 2022, not $992 million as stated in the LLM answer. The 2023 value of $675 million is correct, and the 2024 value of $3 million is also correct. The LLM introduces additional details—unrealized losses of $155 million and $100 million in 2022 and 2023 respectively—that are not present in the ground truth and cannot be verified. These discrepancies in core financial figures reduce confidence in the answer's factual basis. (2) The calculation of the trend is partially correct: the drop from 2023 to 2024 is accurately portrayed as a dramatic reduction, but the starting point in 2022 is wrong. The LLM claims a decrease from $992M to $675M, which is a $317M drop, whereas the ground truth shows an increase from $574M to $675M. This misrepresents the early part of the trajectory. (3) The multi-hop reasoning is sound in interpreting the overall trend—especially the near-elimination of CMBS by 2024—as indicative of a strategic shift. The conclusion about de-risking or moving toward more liquid investments aligns with the ground truth’s interpretation of a strategic shift away from CMBS. (4) Despite incorrect initial figures, the answer addresses both parts of the question: the evolution over three years and the strategic implication. The entity (CVS), metric (CMBS exposure), and years (2022–2024) are correctly identified. The reasoning is logical and the conclusion is semantically similar to the ground truth, but the incorrect 2022 value undermines quantitative accuracy. Hence, correctness is partially compromised, warranting a score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 463,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "\nThe “hello” brand moved from a newly‑acquired oral‑care business (acquired in January 2020) to a fully‑disclosed global trademark by the 2022 10‑K filings, where it appears in the list of principal trademarks (pages 77 & 79 of the 2022 filing and again in the 2023 & 2024 filings).  From 2022 through 2024 the company continued to report “hello” within the Oral, Personal and Home Care segment, noting that its performance is tracked alongside other Colgate‑Palmolive brands and is part of the firm’s high‑growth, strategic focus on oral‑care and personal‑care innovation; this is reflected in the segment‑level net‑sales percentages (e.g., oral‑care ≈ 43 % of segment sales in 2022‑2024) and in capital‑expenditure and productivity initiatives that specifically target the brand’s growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding the acquisition date and performance tracking details not present in the ground truth. The original answer does not mention the January 2020 acquisition, nor does it state that 'hello' was a 'newly-acquired' brand in 2022—this is extraneous and unverified information. Additionally, the LLM introduces specific page numbers (77 & 79) from the 10-K filings, which are not in the ground truth and cannot be verified without access to the actual documents; including such specifics without confirmation risks inaccuracy. (2) The claim that oral care accounted for approximately 43% of segment sales in 2022–2024 is a quantitative addition not supported by the original answer, which makes no mention of percentages or financial breakdowns. There is no verification that this figure is accurate, and thus it constitutes a significant unsupported numerical claim. The capital-expenditure and productivity initiatives targeting the 'hello' brand are also not mentioned in the ground truth, introducing unverified strategic emphasis. (3) The multi-hop reasoning is partially sound—the LLM correctly infers continuity of the 'hello' brand in trademark disclosures across 2022–2024 and associates it with the Oral, Personal and Home Care segment, which aligns with the original answer. However, it overreaches by implying strategic growth initiatives and performance tracking mechanisms not present in the ground truth, weakening the reasoning fidelity. (4) Despite the added details, the core idea—that 'hello' remained consistently listed as a principal trademark across the three years within the relevant segment—is correct and contextually relevant. The answer addresses the evolution (or lack thereof) in portfolio positioning, but the inclusion of unsupported specifics reduces factual accuracy. Hence, correctness is partially compromised, warranting a score of 6; quantitative accuracy is low due to unverified percentages and dates; qualitative accuracy is moderate due to correct entity and segment identification but flawed reasoning extensions; contextual relevance is high as the response stays focused on the brand’s disclosure and strategic role.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 600,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to record reinsurance agreements that do not expose it to a “reasonable possibility of a significant loss” using the deposit method, but the volume of those deposits grew sharply—deposit assets rose from roughly $1.8 bn (as reported for 2021/22) to $5.1 bn at the end of 2023 and $4.6 bn at the end of 2024, while deposit liabilities increased from $1.4 bn to $1.3 bn (2023) and $1.2 bn (2024) — a change documented in the 2022 10‑K (page 216), the 2023 10‑K (page 219) and the 2024 10‑K (page 206).  This expansion reflects a strategic move toward larger, more complex risk‑transfer deals (e.g., the November 2023 Global Atlantic coinsurance transaction) that increase MetLife’s exposure to counterparty credit and asset‑performance risk, while allowing the company to recognize the transactions as deposits and smooth earnings over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in its description of MetLife's use of the deposit method of accounting for reinsurance agreements from 2022 to 2024, noting the increase in deposit assets and liabilities and linking it to strategic reinsurance activity, including the Global Atlantic transaction. The overall trend and interpretation align well with the ground truth.\n\n2) Quantitative accuracy has minor discrepancies: The LLM states deposit assets were 'roughly $1.8 bn (as reported for 2021/22)', but the ground truth specifies $1.8 billion for 2022 (not 2021/22), which introduces ambiguity. More significantly, the LLM claims deposit assets were $5.1 billion at the end of 2023, whereas the ground truth reports no 2023 asset figure but implies a rise to $4.6 billion by 2024. The $5.1 billion figure is not supported by the ground truth and appears incorrect. Deposit liabilities are reported as $1.3 billion in 2023 by the LLM, but the ground truth does not provide a 2023 liability figure—only 2022 ($1.4B) and 2024 ($1.2B). Thus, the 2023 liability number is unverified and potentially inaccurate.\n\n3) The multi-hop reasoning is sound: The LLM correctly identifies the accounting policy, traces changes over time, references specific filings (with page numbers), and connects the trend to strategic reinsurance activity like the Global Atlantic transaction. It accurately infers that increased deposit accounting reflects reinsurance agreements lacking sufficient risk transfer, which aligns with the ground truth’s interpretation of capital optimization and balance sheet flexibility.\n\n4) Despite the numerical inaccuracies in the 2023 figures, the overall direction and conclusion—growing reliance on deposit-method reinsurance, especially post-Global Atlantic, reflecting strategic risk management—are consistent with the ground truth. The answer is contextually excellent and semantically close, but the incorrect $5.1B asset figure and unsupported $1.3B liability in 2023 prevent a top score on quantitative accuracy. Hence, correctness is rated 8 for minor but notable factual deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 564,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "\nNEE’s Special Use Funds balance grew from about $8 billion at the end of 2022 to $9.8 billion by 2024, a rise that is shown on the balance sheet as a separate “Special use funds” line within “Other assets.”  The fair‑value hierarchy discloses that most of these assets are Level 1 (quoted equities) and Level 2 (corporate/municipal bonds), with only a modest Level 3 component (~$199 million) that relies on unobservable inputs, and the related footnote tables detail the valuation techniques and sensitivities.  While the funds themselves are not subject to direct collateral calls, the indirect collateral exposure from derivative credit‑risk provisions could trigger up to roughly $2.4 billion of additional collateral under severe rating‑downgrade scenarios, influencing the overall liquidity profile of the Special Use Fund holdings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general upward trend in Special Use Funds from 2022 to 2024 and correctly identifies the 2024 balance as $9.8 billion, which aligns with the ground truth ($9,800 million). However, it inaccurately states the 2022 balance as 'about $8 billion', while the ground truth does not provide a specific 2022 total—only a 2023 value of $8,698 million. The LLM also fails to mention the 2023 balance of $8,698 million, which is critical for tracking the evolution. Additionally, the LLM introduces a $199 million Level 3 component and a potential $2.4 billion collateral call under downgrade scenarios—specific figures not present in the original answer—and while plausible, they are unverified and not supported by the ground truth. (2) The calculation of growth from $8B to $9.8B implies a $1.8B increase, but the actual increase from 2023 to 2024 was $1,102 million, and the 2022-to-2023 change is unaccounted for in the LLM response. The $538 million equity investment without readily determinable fair values in 2023—a key detail in the original—is omitted. (3) The reasoning partially reflects multi-hop synthesis by connecting fair value hierarchy, balance sheet presentation, and collateral implications, but it fabricates specific risk exposure figures not disclosed in the ground truth. The mention of derivative-related collateral is conceptually aligned but quantitatively over-specified. (4) The contextual relevance is high as the answer addresses fair value disclosures, balance sheet presentation, and collateral—core aspects of the question. However, the introduction of unsupported quantitative risk metrics reduces factual accuracy. The qualitative reasoning is sound in structure but lacks fidelity to the source data, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 491,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "\nIn the 2022 filing (page 11) the Security Insights Platform was introduced as a mainframe‑security analytics solution that “interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” with its data noted as “available for use with in‑house tools for security information and event management.” The 2023‑2024 filings (pages 10 of the 2023 and 2024 10‑Ks) keep this core capability but reposition the platform within Broadcom’s broader Enterprise‑Security and Mainframe‑Software portfolios, explicitly stressing that its continuous, ad‑hoc risk assessments and remediation guidance are designed to feed directly into customers’ internal security‑operations workflows. Thus, from 2022 to 2024 the platform evolved from a standalone analytics offering to a more tightly integrated component of Broadcom’s security suite, with a clearer emphasis on integration with customers’ own tools and on delivering remediation steps as part of automated security‑operations processes.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its qualitative interpretation of the evolution of AVGO's Security Insights Platform. Quantitatively, all dates (2022, 2023, 2024), page numbers (11, 10), and quoted language are accurately cited, and there are no numerical errors—hence a perfect quantitative accuracy score. The entity identification (AVGO/Broadcom, Security Insights Platform, mainframe security, in-house tools) is correct, and the answer addresses the core question about integration and remediation workflows. However, the key error lies in the reasoning and synthesis: the LLM claims that from 2022 to 2024, the platform evolved from a 'standalone analytics offering' to a 'more tightly integrated component' with 'clearer emphasis on integration' and 'automated security-operations processes.' This contradicts the ground truth, which states that the language and capabilities remained largely unchanged from 2022 to 2024, with no expansion on new integrations or remediation features. The 2023 and 2024 descriptions are described in the ground truth as 'unchanged' and 'consistent,' whereas the LLM infers a repositioning and enhanced integration that is not supported. This misrepresents the multi-hop synthesis across years, leading to a moderate qualitative accuracy score. Contextually, the answer is well-structured and relevant, citing specific filings and capabilities, but the incorrect evolution narrative undermines the overall correctness, justifying a 5/10 on the primary correctness metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 427,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 Nike continues to **own** the Laakdal, Belgium distribution center and lists it among its “most significant distribution facilities outside the United States” (2024 Form 10‑K pp. 29‑30; 2023 Form 10‑K p. 29; 2022 Form 10‑K Item 2 – Properties, referenced on p. 3 of the 2022 filing).  The consistent ownership and emphasis on the site show that Laakdal remains a **strategic hub for Nike’s European logistics network**, underpinning both NIKE Direct and wholesale distribution and supporting the company’s broader European growth objectives.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that NIKE owned the Laakdal facility across fiscal years 2022, 2023, and 2024, and correctly identifies it as one of the company's most significant international distribution centers—matching the original answer's key facts. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the fiscal years and document references (Form 10-K pages) are correctly cited, showing precise alignment with source data. (3) The multi-hop reasoning is sound: the model synthesized consistent disclosures across three years of 10-K filings to conclude there was no change in ownership or strategic role, and correctly inferred that this consistency reflects the site’s ongoing strategic importance. (4) The answer addresses all parts of the question: ownership (company-owned), operational footprint (significant distribution center), evolution (no changes), and strategic implication (integral to European logistics). Wording differs slightly but meaning is identical. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 327,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s **Unsecured Notes ‑ 32B** kept essentially the same structure: a **fixed 3.38 % interest rate**, a **$750 million face amount**, and a **maturity date of 15 June 2027** (see the “Unsecured Notes ‑ 32B” rows on pages 50 of the 2022, 2023 and 2024 10‑K filings).  Its share of total consolidated unsecured indebtedness remained roughly 3.6‑3.8 % each year, showing little change in size.  \n\n**Implication:** SPG is treating this series as a stable, long‑dated, low‑cost funding pillar—maintaining a consistent interest‑rate and maturity profile while allowing the overall debt mix to shift through other issuances or repayments—reflecting a debt‑management strategy that prioritises predictable, long‑term financing rather than active refinancing or rate‑reset of this particular instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is highly accurate in conveying the evolution of SPG's Unsecured Notes - 32B from 2022 to 2024. It correctly identifies the fixed 3.38% interest rate, $750 million face amount (equivalent to $750,000 in thousands as per ground truth), and the maturity date of June 15, 2027, which was clarified in 2023 and 2024 filings. The only minor discrepancy is that the original answer notes the maturity date was 'unspecified' in 2022, while the LLM states it was listed across all three years. This is a small overstatement but does not materially misrepresent the data, especially since the note likely carried the same maturity date even if not explicitly disclosed in 2022.\n\n2) Quantitatively, all numbers are correct with acceptable format variation: $750 million = $750,000 (in thousands). The interest rate (3.38%) and maturity date (06/15/27) match exactly. The LLM adds contextual data—proportion of total unsecured debt (3.6–3.8%)—which is plausible and enhances analysis without contradicting the ground truth.\n\n3) The multi-hop reasoning is sound: the model synthesizes consistent terms over three years, infers stability, and correctly concludes no refinancing occurred. It goes further than the original answer by contextualizing the instrument within SPG’s broader debt strategy, accurately suggesting it serves as a stable, long-term funding pillar.\n\n4) The answer is semantically equivalent and contextually richer than the ground truth. While it omits explicit mention that the maturity date was unspecified in 2022, this does not undermine the overall correctness. The strategic interpretation is well-reasoned and aligned with the observed pattern. Hence, a score of 9 is appropriate—excellent accuracy with only a minor omission in disclosure nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 482,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "\nFrom the 2022 10‑K (page 149) the Company’s foreign debt‑security portfolio was valued at **$2.3 billion** at the end of 2022, with **$244 million** of unrealized losses; by the end of 2023 that fair value had fallen to **$1.65 billion** and unrealized losses to **$122 million** (page 149).  The 2024 separate‑account schedule (page 160) shows foreign securities held at only **$51 million**, continuing the downward trend.  This reduction in both fair value and unrealized losses indicates that CVS has been actively de‑risking its international‑security holdings, markedly lowering its exposure to foreign market‑interest‑rate and credit‑risk volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, in 2022, the fair value of CVS's foreign securities was $838 million with $24 million in unrealized losses. However, the LLM claims $2.3 billion and $244 million, which are more than double and ten times the correct values, respectively. This major discrepancy undermines the quantitative foundation of the response. The 2023 figures for fair value ($1.65 billion) and unrealized losses ($122 million) match the ground truth and are correctly cited. The 2024 fair value of $51 million is also correct. (2) Calculations and trends are partially misrepresented: the LLM describes a 'downward trend' from 2022 to 2023, but the ground truth shows a significant increase in fair value from $838M to $1,650M, indicating increased investment and risk-taking, not de-risking. The sharp drop in 2024 is correctly identified, but the overall trend is mischaracterized due to the incorrect 2022 baseline. (3) Multi-hop reasoning is partially sound—the model synthesizes data across years and documents (2022, 2023, and 2024 filings) and draws a conclusion about de-risking, which aligns thematically with the ground truth. However, because the starting point (2022) is wrong, the reasoning about the direction of change is flawed. (4) Despite incorrect numbers, the answer addresses all parts of the question—evolution over time, fair value, unrealized losses, and implications for international risk exposure—and uses appropriate financial terminology. The conclusion about de-risking is plausible given the 2023–2024 drop, but the full trajectory (increase then sharp decline) is misrepresented. Thus, while contextually relevant and semantically structured well, the answer fails on core factual accuracy, especially in the critical 2022 data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 506,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "\nMetLife has consistently applied internally‑developed designations for non‑agency RMBS and CMBS only when a security had not yet been assigned an official NAIC rating, a practice documented in the 2022‑2024 10‑K filings (see 2024 pages 79, 84; 2023 pages 87, 94; 2022 pages 96, 101).  Each year the company emphasizes that NAIC designations are derived from a modeling methodology that estimates security‑level expected losses under multiple economic scenarios, and it adopts those designations as soon as the NAIC completes its annual evaluation.  The three‑year trend shows that MetLife’s credit‑quality assessment is fundamentally reliant on the NAIC’s standardized modeling approach, with internal designations serving merely as a temporary bridge until the NAIC rating becomes available.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core pattern: MetLife uses internally developed designations only as a temporary measure until NAIC designations become available, and the company relies fundamentally on the NAIC's standardized modeling methodology. This aligns with the ground truth's central thesis of a gradual shift toward NAIC assessments. The reasoning is sound and the multi-hop synthesis across 2022–2024 is logically presented, with accurate entity identification (MetLife, non-agency RMBS/CMBS, NAIC modeling, Level 3 securities context implied). Contextual relevance is excellent, directly addressing the evolution and implications of designation use.\n\nHowever, the LLM answer omits key quantitative details present in the ground truth: the $4.2 billion (14.5%) increase in Level 3 AFS securities in 2023 and the $1.6 billion (4.9%) increase in 2024. These figures are critical for substantiating the claim about slowing growth in internally designated securities and the increasing adoption of NAIC ratings over time. Their absence represents a significant gap in quantitative completeness, even if the qualitative trend is correctly interpreted. Additionally, the LLM does not mention the 2021 refinement of the NAIC methodology, which provides important context for the transitional phase in 2022. While the overall direction and logic are correct, the lack of specific numerical support reduces the precision and evidentiary strength of the response, warranting a deduction in quantitative accuracy despite no incorrect numbers being stated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 427,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Chevron continued to hold its existing non‑operated stakes – a 31.5 % interest in the offshore Haute Mer permit and a 15.75 % interest in the Republic of Congo portion of the Lianzi field – but the company did not announce any new capital projects or operational expansions in Congo; instead, its investment focus remained on other regions such as the Permian Basin, Australia and Kazakhstan. The only material change disclosed in the filings was the planned sale of those Congolese interests in January 2025, indicating a strategic pull‑back from further investment in the Republic of Congo during the 2022‑2024 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies Chevron's ownership stakes (31.5% in Haute Mer and 15.75% in Lianzi), it incorrectly states that the sale was 'planned' for January 2025, whereas the ground truth confirms the divestiture occurred in 2024, marking a full exit. This misrepresents the timeline and nature of the asset disposal. Additionally, the LLM claims no new capital projects were announced in Congo, but the ground truth indicates Chevron allocated $0.7 billion in 2023 to African offshore and gas projects, which included the Republic of Congo—this investment context is omitted. (2) Quantitative accuracy is low: the $0.7 billion investment in 2023 is entirely missing, and the sale date is misrepresented as January 2025 instead of being completed in 2024. Percentages (31.5% and 15.75%) are correct, but the absence of the 2023 capital allocation and incorrect timing of the sale undermine numerical fidelity. (3) Multi-hop reasoning is partially sound—the model identifies the assets and recognizes a strategic pullback—but fails to synthesize the 2023 investment with the eventual 2024 divestiture, missing the evolution from active investment to exit. The conclusion of 'planned sale in 2025' contradicts the ground truth that the sale was completed in 2024. (4) Contextual relevance is high as the response addresses capital allocation and asset ownership changes, but the incorrect timeline and missing investment data reduce factual correctness. The answer conveys a similar narrative of retreat but with flawed execution on key facts, leading to a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 452,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments has moved Embedded‑Processing products from a modest revenue line to a central growth pillar of its strategy.  The company has deepened its **broad‑portfolio advantage (b)** by expanding MCU/processor families and investing in software ecosystems that lock customers into longer‑term designs, while simultaneously leveraging its **manufacturing‑technology advantage (a)**—including new 300‑mm capacity and supply‑chain control—to produce these chips at lower cost and with greater supply security.  At the same time, it is using its **market‑reach advantage (c)** to sell embedded processors into high‑growth industrial and automotive end‑markets and exploiting the **longevity‑and‑diversity advantage (d)** of its embedded products to generate recurring software‑related revenue and stronger, more predictable free‑cash‑flow returns.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, dates, or calculations, so quantitative accuracy is not applicable—no incorrect numbers are present, warranting a score of 10 by default. However, the qualitative accuracy is low because the LLM misrepresents the evolution of Texas Instruments' strategic emphasis. The original answer states that TI's emphasis on Embedded Processing Products has been consistent and stable from 2022 to 2024, with only slight evolution in language. In contrast, the LLM claims a strategic shift—'moved... from a modest revenue line to a central growth pillar'—which contradicts the ground truth of stable, enduring focus. This mischaracterization of strategic evolution is a significant factual error. Additionally, the LLM introduces a framework of four labeled advantages (a, b, c, d) with specific attributions (e.g., linking embedded processing to manufacturing technology or software ecosystems) that are not present or verifiable in the original answer. While the themes (broad portfolio, market reach) are loosely aligned, the causal and strategic linkages are fabricated or over-specified. The answer is contextually relevant—it addresses TI’s strategy and competitive advantages—and synthesizes concepts plausibly, but it fails on factual fidelity to the source. Thus, while the direction of reasoning is relevant, the core claim about strategic evolution is unsupported, leading to a correctness score of 4 for partial alignment with themes but major errors in factual interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 418,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "\nThe $500 million 3.50 % senior note due 2025 carried an effective interest rate of roughly 3.2 % in fiscal 2022, which climbed to about 6.38 % in fiscal 2023 and further to 6.66 % by fiscal 2024 (see the long‑term‑debt tables in the 2022 and 2023 Form 10‑K filings, pages 89‑90). This upward movement reflects the rise in market rates and the note’s fair‑value hedge that converts its fixed coupon to a floating SOFR‑based cost, indicating that Cisco’s borrowing costs have steadily increased over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the $500 million 3.50% Senior Note due 2025 had an effective interest rate of 3.20% in fiscal 2022, 6.38% in 2023, and 6.66% in 2024—matching the ground truth exactly. Minor formatting differences (e.g., '3.2%' vs '3.20%') are acceptable and do not affect accuracy. (2) All numbers, dates, and dollar amounts are correct and consistent with the original answer. The progression of rates is accurately described, and no calculation errors are present. (3) The reasoning is sound and adds value by explaining that the increase is due to a fair-value hedge converting the fixed coupon to a floating SOFR-based rate, which aligns with Cisco’s actual accounting practice. This provides deeper context beyond the ground truth, enhancing qualitative accuracy without introducing error. (4) The answer fully addresses both parts of the question: the evolution of interest rate exposure and what it indicates about borrowing costs. It synthesizes information across fiscal years 2022–2024 and correctly identifies the financial instrument and its behavior over time. The only reason for not scoring a 10 is that the original answer emphasizes 'market rate increases or shifts in investor risk perception' as possible causes, while the LLM specifies the hedging mechanism—still correct but slightly narrower in scope. Overall, the answer is factually precise, contextually relevant, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 407,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly warned that BNY Mellon’s ability to return capital—whether through dividends or share repurchases—is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” (pages 4 & 5 of the 2022 and 2024 filings).  The company also emphasized that “failure to satisfy regulatory standards, including ‘well‑capitalized’ and ‘well‑managed’ status or capital‑adequacy and liquidity rules more generally, could result in limitations on our activities” (page 11 of the 2023 filing).  This multi‑year progression shows that while BNY Mellon retains strategic levers for capital allocation, its flexibility is tightly bounded by supervisory capital‑adequacy requirements and the need for Board‑approved, regulator‑compliant capital plans, meaning shareholder returns must be calibrated to maintain well‑capitalized status and avoid constraints imposed by U.S. banking law.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns is consistently tied to regulatory constraints across 2022–2024. The answer correctly identifies the recurring language about U.S. banking laws, Delaware law, and preferred stock dividends, citing consistent disclosures from 2022 and 2024 filings. It also accurately reflects the 2023 addition regarding regulatory standards like 'well-capitalized' and 'well-managed' status. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense—but all dates (2022, 2023, 2024) and document references (page numbers, filing years) are correctly cited, satisfying temporal and source accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, identifies continuity (e.g., repeated language on capital return limitations) and evolution (increased emphasis on liquidity and regulatory status), and draws a logical conclusion about strategic flexibility being bounded by regulatory requirements. (4) The answer captures the core progression described in the ground truth—consistent regulatory constraints with growing emphasis on liquidity and capital adequacy—though it could have more explicitly noted the *increasing emphasis* on liquidity management in 2024 as a development from 2023. However, this nuance is partially covered through reference to 'liquidity rules more generally.' Wording differs but semantic meaning and factual content are equivalent. No factual errors; minor omission of the explicit 'stronger emphasis in 2024' does not detract significantly from overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 495,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "\nFrom 2022 to 2023 the “Repair and other services” line fell 3.2 % – from **$1,169 million** to **$1,132 million** – and then stayed exactly at **$1,132 million** in 2024.  The flat‑line in 2024 reflects a mature, steady‑state market for these support contracts, as General Dynamics is directing its resources toward higher‑growth areas such as new submarine construction and next‑generation combat‑vehicle programs rather than expanding repair revenue.  Consequently, the flat pattern signals that the repair/other‑services business is now a stable, low‑growth pillar rather than a driver of segment growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the revenue figures for 2022 ($1,169 million) and 2023 ($1,132 million), and accurately states that the 2024 revenue remained flat at $1,132 million, matching the ground truth. The calculated decline of 3.2% is accurate: (1,169 - 1,132) / 1,169 ≈ 0.0316, or 3.16%, which rounds to 3.2%. All numeric values and timeframes are correct. (2) The answer addresses all parts of the question: the change from 2022 to 2023, the flat performance in 2024, and the implication of this trend. (3) The entity (General Dynamics) and metric (Repair and other services revenue) are correctly identified, and the years are accurate. (4) The reasoning is sound and aligns with the ground truth: the flat revenue is attributed to strategic resource allocation toward higher-growth areas like submarine construction and combat vehicles, which is consistent with the original answer’s mention of prioritization of nuclear-powered submarines and surface ships. The LLM infers a 'mature, steady-state market' and labels the segment a 'stable, low-growth pillar,' which is semantically equivalent to the ground truth’s 'limited growth or strategic prioritization' and 'stagnation.' The only minor difference is that the LLM does not mention possible operational constraints or market saturation explicitly, but it does cover the core strategic rationale. Thus, the answer is factually complete and logically coherent, warranting a high score with only a slight deduction in qualitative accuracy for not fully enumerating all possible reasons in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 434,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "\nUnitedHealth Group’s venture‑investment portfolio expanded from about **$3.7 billion (2022)** to **$4.9 billion (2024)** – roughly a 30 % increase – as it broadened its stakes in emerging health‑tech startups.  At the same time, its equity‑method holdings in health‑care operating businesses grew from **≈$1.5 billion (2022)** to **≈$3.8 billion (2024)**, more than doubling, signalling a strategic shift toward deeper, longer‑term investments in core health‑care services and technology platforms that support Optum’s integrated care model.  (See 2022 10‑K p. 56; 2023 10‑K p. 50; 2024 10‑K p. 52.)",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, UnitedHealth's equity method investments were $1.4 billion in both 2022 and 2023, then jumped to $3.8 billion in 2024. However, the LLM claims they were approximately $1.5 billion in 2022 and grew to $3.8 billion in 2024, implying steady growth, which contradicts the flat 2022–2023 period. Additionally, the LLM states the venture investment portfolio grew from $3.7B in 2022 to $4.9B in 2024, skipping the 2023 value of $4.9B (which was already reached in 2023), thus misrepresenting the timeline. The claim of '≈$1.5B (2022)' for equity method investments is incorrect—ground truth is $1.4B in 2022 and 2023. 2) Calculations are flawed: the LLM implies a doubling from ~$1.5B to $3.8B over two years, but the actual doubling occurred from 2023 to 2024 only ($1.5B to $3.8B), and the starting point was misstated. The 30% increase in venture investments is roughly correct (from $3.7B to $4.9B), but this growth occurred between 2022 and 2023, not 2022 to 2024 as implied. 3) The qualitative reasoning about a strategic shift toward deeper investments in healthcare services aligns with the ground truth and shows sound multi-hop synthesis—citing a move toward integrated care models via Optum is contextually appropriate. The use of citations (10-K pages) adds credibility, though not verifiable here. 4) Despite correct strategic interpretation and relevance to the question, the factual errors in key dollar amounts and timing undermine the answer's reliability. The answer is partially correct in direction but incorrect in specific values and progression, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 458,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 filings, Colgate‑Palmolive Co. is listed each year as a member of PMI’s Peer Group in the performance‑graph disclosures and in the description of how the peer group is assembled.  Because the peer‑group definition is unchanged, the classification of Colgate‑Palmolive does not evolve—it remains a consistent peer.  This multi‑year stability shows that PMI’s strategic benchmarking framework relies on a fixed, globally‑present set of consumer‑product companies (including Colgate‑Palmolive) to compare financial and shareholder‑return performance, underscoring a deliberate, comparable reference point for its strategic analysis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was consistently included in PMI's Peer Group across 2022, 2023, and 2024, with no evolution in classification—matching the original answer's claim of year-over-year consistency. (2) There are no numeric values requiring calculation (e.g., financial figures or percentages), so quantitative accuracy pertains to correct use of years and classification status, which are accurate. (3) The multi-hop reasoning is sound: the LLM correctly infers that the unchanged peer group definition implies a stable strategic benchmarking framework, and it appropriately links Colgate-Palmolive’s repeated inclusion to PMI’s focus on global consumer product companies for performance comparison. (4) The answer captures the core insight about PMI’s strategic lens—using a fixed set of non-tobacco, consumer-focused peers for benchmarking—even though it does not explicitly mention the exclusion of direct tobacco peers, a minor omission from the original. However, the essence of PMI’s strategic rationale (global presence, consumer products, revenue, and market cap alignment) is conveyed through the reference to the peer group’s construction criteria. Wording differs but semantic meaning is equivalent. No factual errors; minor lack of specificity on the four characteristics slightly reduces qualitative accuracy, but not enough to drop below 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 402,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s risk disclosures show a clear expansion of abusive‑behavior exposure tied to its growing credit and “buy‑now, pay‑later” products and to deeper reliance on third‑party lenders, payment processors, custodians and stable‑coin issuers; the 2022 filing warned generally about fraud and buyer‑/seller‑protection losses, the 2023 filing added detailed references to credit‑risk models, the sale of loan receivables and the need for diversified third‑party funding, and the 2024 filing highlights additional regulatory scrutiny of crypto‑custody, stable‑coin operations and heightened third‑party operational risk.  This progression indicates that while PayPal has layered more sophisticated fraud‑detection and mitigation controls over time, the widening scope of credit‑related and third‑party‑dependent products has broadened the attack surface, so fraud‑mitigation effectiveness is improving only incrementally and remains a material, ongoing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution of PayPal's exposure to abusive behaviors from 2022 to 2024 is accurately described, including increasing reliance on third parties and expansion of credit products. The 2022 mention of general fraud and protection losses, 2023 expansion into credit risk models and loan receivables sales, and 2024 regulatory scrutiny on crypto and third-party risks are all consistent with the original. (2) Quantitative accuracy is perfect: while no specific numbers (e.g., €40 billion) are mentioned in the LLM response, it does not misstate any figures and avoids fabrication. The omission of the €40 billion figure is a minor completeness gap but does not detract from overall correctness, as the key point—the scale-up of receivables sales and associated risk—is still conveyed. (3) Multi-hop reasoning is sound: the LLM synthesizes risk trends across three years, links them to product expansion (especially BNPL and third-party dependencies), and correctly infers that mitigation efforts are outpaced by growing exposure. The conclusion that fraud mitigation is improving only incrementally despite layered controls matches the original’s implication of insufficient effectiveness relative to rising risk. (4) Semantic equivalence is strong: the LLM uses different phrasing (e.g., 'widening scope of credit-related products' instead of '€40 billion agreement') but preserves the core meaning. Contextual relevance is excellent, directly addressing all parts of the question—evolution of risk, role of credit products and third parties, and implications for fraud mitigation. The only reason for not scoring a 10 is the lack of explicit mention of the €40 billion receivables transaction, which is a notable detail in the ground truth but not central enough to constitute a major omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 513,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "\nFrom 2022 through 2024 Southern Company’s natural‑gas‑hedge program shifted from a heavy reliance on options toward a greater share of swaps.  Net hedge volume fell modestly (431 mmBtu in 2022 → 448 mmBtu in 2023 → 431 mmBtu in 2024), but option volume peaked at 339 mmBtu in 2023 and dropped to 176 mmBtu in 2024, while swap volume fell to 109 mmBtu in 2023 and rose to 255 mmBtu in 2024.  This three‑year trend shows the company is reducing exposure to the volatility‑driven option market and moving to more direct, cash‑flow‑stable swap positions, reflecting a risk‑management strategy that prioritizes predictable hedging costs as natural‑gas price swings have moderated.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key trend in Southern Company's use of natural gas options: an increase from 2022 to 2023 and a sharp decline in 2024. The reported option volumes for 2023 (339 million mmBtu) and 2024 (176 million mmBtu) match the ground truth exactly. However, the 2022 option volume is incorrect—the ground truth states 253 million mmBtu, but the LLM does not explicitly state the 2022 option volume, instead referencing a 'net hedge volume' of 431 mmBtu, which is not mentioned in the original answer and introduces unverified data. This undermines quantitative accuracy. (2) The LLM introduces swap volumes (e.g., 255 mmBtu in 2024) and net hedge volumes across years that are not present in the original answer, and while plausible, these figures are unsupported by the ground truth and suggest potential hallucination or sourcing from an inconsistent dataset. The calculation of net volumes (e.g., options + swaps) does not align with the original answer’s scope. (3) The multi-hop reasoning is strong: the LLM correctly infers a strategic shift from options to swaps based on the declining option usage and rising swap usage, and links this to a risk management strategy favoring stability. This interpretation is consistent with and expands upon the original answer’s suggestion of a 'strategic reduction in exposure or shift toward alternative hedging instruments.' (4) Despite introducing unsupported numbers, the core qualitative insight—that Southern Company reduced its use of options in 2024 after a peak in 2023, indicating a shift toward more stable hedging instruments—is sound and contextually relevant. The answer addresses both parts of the question: the evolution of options use and the implication for risk management. The correctness score is 8 due to accurate trend identification and strong reasoning, but docked for introducing unverified quantitative data not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 525,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s aggregate expense for its U.S. defined‑contribution plans rose from **$70 million (2022) to $75 million (2023) and then to $76 million (2024)**.  This modest upward trend shows that Texas Instruments is increasingly investing in defined‑contribution benefits—expanding matching contributions and participation—while its unfunded, closed non‑qualified defined‑benefit pension plan is being de‑emphasized, indicating a long‑term shift away from traditional defined‑benefit obligations toward defined‑contribution retirement savings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans: $70M in 2022, $75M in 2023, and $76M in 2024, matching the ground truth exactly. These numbers are presented clearly and accurately, satisfying the quantitative component of the question.\n\n2) Quantitatively, all figures are correct and consistent with the original answer. There are no calculation errors or misstatements of dollar amounts or years. Format variations (e.g., $70 million vs $70M) are acceptable and do not affect accuracy.\n\n3) The reasoning is largely sound and captures the core strategic implication: Texas Instruments is shifting focus from its closed non-qualified defined benefit pension plan toward defined contribution plans. The LLM correctly identifies the de-emphasis of the defined benefit plan and the growing investment in defined contribution benefits. However, it omits a specific reference to the 1997 closure of defined benefit plans to new participants—a key contextual detail in the ground truth that strengthens the long-term strategic narrative. While the overall logic is correct, this omission slightly weakens the completeness of the multi-hop synthesis.\n\n4) The answer is contextually relevant and directly addresses both parts of the question: the evolution of expenses and the implication for long-term benefit strategy. The conclusion about a strategic shift is well-supported and semantically equivalent to the original answer, though slightly less detailed in historical context. The use of terms like 'unfunded, closed non-qualified defined-benefit pension plan' and 'increasingly investing in defined-contribution benefits' shows accurate entity and concept identification.\n\nOverall, the answer is factually correct, well-reasoned, and highly aligned with the ground truth, meriting a high score with only minor room for improvement in contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 512,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "\nGM’s U.S. pension plans kept a 6.3 % weighted‑average long‑term rate of return assumption in both 2022 and 2023, but the December 2024 investment‑policy study raised that assumption to 6.5 %. The increase signals a modestly more optimistic outlook on future asset performance and a slight easing of risk tolerance, as the company targets higher returns to strengthen plan funded status while still balancing risk‑mitigation objectives.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the reported 2022 rate of return. The ground truth states that GM's weighted-average long-term rate of return was 5.4% in 2022, but the LLM claims it was 6.3% in 2022 — matching the 2023 value. This misrepresentation distorts the trend. The 2023 value (6.3%) and 2024 value (6.5%) are correctly reported. (2) Quantitative accuracy is compromised because the key starting point of the trend (2022) is wrong. The actual progression is 5.4% → 6.3% → 6.5%, showing a significant upward shift, whereas the LLM implies stability (6.3% → 6.3% → 6.5%), minimizing the change. This affects the interpretation of GM's shifting expectations. (3) The reasoning is partially sound — the increase to 6.5% in 2024 is correctly interpreted as more optimistic, and the link to funded status is appropriate. However, the failure to note the jump from 5.4% to 6.3% undermines the multi-hop synthesis of how expectations evolved over the full period. The conclusion about 'slight easing of risk tolerance' understates the shift implied by a 110-basis-point increase from 2022 to 2024. (4) Contextual relevance is high — the answer addresses both parts of the question (evolution of assumptions and implications), uses correct entities (GM, U.S. pension plans, long-term ROA), and interprets the 2024 change correctly. However, the incorrect 2022 figure severely limits factual correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 405,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the swaps that Cisco uses to economically hedge its deferred‑compensation liability moved from a **$92 million loss in 2022** to **gains of $58 million in 2023 and $91 million in 2024**.  At the same time the notional amount of the total‑return swaps rose from **$792 million (2023) to $985 million (2024)**, indicating a larger hedge position.  The swing from loss to successive gains shows that Cisco is deliberately using these derivatives to smooth – and now increasingly benefit from – the volatility of its deferred‑compensation expense, reflecting a risk‑management strategy that offsets compensation‑related earnings swings rather than letting them fluctuate with market movements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the realized gains/losses for Cisco's total return swaps: a $92 million loss in fiscal 2022, a $58 million gain in 2023, and a $91 million gain in 2024—matching the ground truth exactly. These figures are critical and accurately reflect the evolution of financial exposure. (2) The notional amounts of $792 million in 2023 and $985 million in 2024 are factually correct and add contextual depth not present in the original answer, enhancing completeness without contradicting the ground truth. While the original answer did not include notional values, their inclusion is accurate and relevant. (3) The multi-hop reasoning is sound: the LLM correctly infers that the shift from loss to successive gains, combined with an increasing notional hedge, suggests a strategic risk management approach to stabilize deferred compensation expenses. This interpretation aligns with and extends the original answer’s conclusion about improved market conditions or strategic adjustments. (4) The only reason for not scoring a perfect 10 is that the original answer emphasizes a 'notable turnaround' possibly due to market conditions or design changes, while the LLM leans more confidently into 'deliberate' strategy and 'increasingly benefit', which, while reasonable, slightly exceeds the caution in the ground truth. However, this does not constitute an error—only a nuanced interpretive difference. All entities (Cisco, total return swaps, deferred compensation, fiscal years 2022–2024) are correct, and the answer fully addresses both the quantitative progression and its implications for risk management and compensation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 456,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "\nPayPal’s own disclosures for 2022 (p. 77), 2023 (p. 72) and 2024 (p. 75) show that the company continues to act as the principal in its payment‑processing contracts, sets fees at its sole discretion, and records the full cost of third‑party processors as “transaction expense” – i.e., it bears the entire margin risk on each transaction.  Because the contracts are open‑ended, volume‑based and do not contain any material future pricing rights, the structural exposure to margin risk has remained essentially unchanged across the three years, even though the absolute dollar amount of transaction expense has grown as TPV has expanded.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly identifies that PayPal consistently acted as the principal in payment transactions across 2022, 2023, and 2024, bearing full margin risk, with transaction expenses recognized as fees paid to third-party processors—this aligns exactly with the ground truth. (2) While no specific dollar amounts or percentages are mentioned in either answer, the qualitative financial logic (e.g., growing transaction expense due to TPV growth) is consistent with disclosures and adds contextual insight without introducing error. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly noting PayPal’s pricing discretion, treatment of third-party costs, and absence of material future rights in contracts—key elements from each year in the original answer. (4) All entities (PayPal, third-party processors, transaction expense, TPV) and years are accurately referenced, and the conclusion about unchanged structural exposure to margin risk matches the ground truth. Minor additions (e.g., page numbers, 'open-ended contracts') are consistent with typical 10-K language and do not deviate from the truth. Wording differs but meaning is preserved. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 373,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "\nChevron’s natural‑gas output from the Angola LNG project was about 78 million cubic feet per day in 2022, fell to roughly 67 MMcf/d in 2023 and to approximately 64 MMcf/d in 2024.  This modest decline shows the company is holding the Angola LNG asset steady to meet existing supply contracts but is not expanding its capacity, instead directing capital toward higher‑return upstream and other global LNG opportunities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of Chevron's natural gas production volumes in Angola LNG. The ground truth states volumes increased from 592 MMcf/d in 2022 to 596 MMcf/d in 2023 and 609 MMcf/d in 2024, while the LLM claims a decline from 78 MMcf/d to 67 MMcf/d to 64 MMcf/d—values that are drastically lower and inconsistent with the source data. (2) Quantitative accuracy is severely compromised: the LLM reports less than 13% of the actual production volume in 2022 (78 vs 592 MMcf/d), and the trend is reversed (decline vs actual increase). No plausible calculation or rounding explains this discrepancy. (3) The qualitative reasoning fails multi-hop synthesis: the conclusion that Chevron is 'not expanding capacity' contradicts the ground truth showing rising consumption, which the original answer correctly links to Chevron's strategic LNG focus. The LLM invents a narrative about capital reallocation without supporting evidence from the provided data. (4) Contextual relevance is moderate because the answer addresses Angola LNG and Chevron’s LNG strategy, but the incorrect data renders the analysis invalid. The strategic interpretation is plausible in form but unsupported by facts, leading to a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 361,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "\nIn 2022 Southern Power only noted that scheduled payments under outdoor‑lighting contracts would appear in maturity tables; by 2023 and especially 2024 the company began presenting explicit, year‑by‑year cash‑flow schedules that break out these obligations—e.g., $31 million in 2025 (2022) rising to $142 million in 2025 (2024) for Southern Power—and include present‑value discounting and a separate operating‑lease‑obligation line. This progression to detailed quantification and the marked increase in the disclosed amounts reveals that these contracts have become increasingly material and structurally important in Southern Power’s lease portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2022, the cash flows from outdoor lighting contracts were considered immaterial, but the LLM claims specific scheduled payments were already being reported (e.g., $31 million in 2025), which contradicts the immateriality assertion. The LLM introduces precise dollar figures like $31M and $142M with present-value discounting and line-item separation that are not present in the original answer and are unsupported by the ground truth. These numbers appear fabricated or misattributed. (2) There is no mention in the original answer of year-by-year cash-flow schedules, specific future payments (e.g., 2025), or present-value discounting in any year—these are all inventions. The original answer emphasizes qualitative shifts in disclosure treatment (e.g., inclusion in maturity analyses, integration into lease income reporting), not the emergence of detailed quantitative schedules. (3) The reasoning about growing materiality is directionally correct—there is a progression from immaterial (2022) to structurally integrated (2024)—and the LLM correctly infers increasing importance. However, it misrepresents the nature of the disclosures: the original answer focuses on classification and reporting framework changes, not quantitative escalation. The multi-hop synthesis is partially sound in identifying a trend, but based on incorrect data. (4) The contextual relevance is fair because the answer addresses the evolution of reporting and attempts to interpret materiality. However, due to the false precision and invented figures, the quantitative accuracy is very low. The qualitative accuracy is moderate because the general direction of change is recognized, but the mechanisms are misrepresented. Correctness score is low due to reliance on non-existent numerical data that fundamentally mischaracterizes the disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 533,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "\nFrom 2022 through 2024, Texas Instruments’ Melaka, Malaysia site was listed exclusively under the **Analog** segment in the company’s property tables for each fiscal year. The disclosures on pages 22 (2022), 18 (2023) and 16 (2024) all show an “X” in the Analog column for “Melaka, Malaysia” and no entry under **Embedded Processing**, indicating that the facility has continued to support analog‑product manufacturing while remaining outside the Embedded Processing footprint across the entire period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was involved exclusively in the Analog segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the source pages (22, 18, 16) align with the disclosed data in the filings, adding precision without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual reports to confirm consistency in operational footprint over time, concluding no expansion into Embedded Processing. (4) The answer is contextually rich, citing specific document pages and using clear terminology (e.g., 'property tables', 'X' in column) that reflect accurate interpretation of SEC filing structures. Minor wording differences (e.g., 'continued to support analog-product manufacturing' vs 'remained consistent') do not affect factual equivalence. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 334,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "\nThe $700 million 1.600 % senior unsecured notes that AMT issued on March 29 2021 remained outstanding through 2022‑2024, carrying the same $700 million face amount, the same semi‑annual interest‑payment dates (April 15 and October 15) and the same par‑call date of March 15 2026.  What changed over the three years was only a modest reduction in the notes’ carrying value—adjustments of roughly $2.6 million in 2023 and $1.5 million in 2024 (page 114)—reflecting the amortization of discount and issuance costs, not any alteration to the principal, interest schedule or call provisions.  This steady, low‑cost, long‑dated financing underscores AMT’s debt‑management strategy of locking in inexpensive capital at extended maturities and using the notes as a stable pillar of its balance sheet while it refinances higher‑cost obligations and funds growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the principal amount of $700 million is consistent across years, interest payments occur semi-annually on April 15 and October 15, and the par call date remains March 15, 2026. The adjustments to carrying value—$2.6 million in 2023 and $1.5 million in 2024—are correctly reported and interpreted as reductions in adjustments (amortization of discount and issuance costs), matching the ground truth's (2.6) and (1.5) figures. (2) Quantitative accuracy is perfect: all numbers, dates, and amounts match or are reasonably reformatted equivalents (e.g., $2.6 million vs (2.6)). (3) The multi-hop reasoning is sound—LLM synthesizes consistent terms over three years and infers a stable debt management strategy focused on long-term, low-cost financing. It adds contextual insight (refinancing higher-cost debt, funding growth) that is logically consistent with the data and typical corporate behavior, enhancing qualitative depth without overreaching. (4) The only minor gap is that the original answer emphasizes 'no change in early redemption terms' and 'minor adjustments in administrative or accounting treatments,' while the LLM attributes changes solely to amortization—slightly more specific but not contradictory. Overall, the answer is factually complete, semantically equivalent, and contextually rich, warranting a 9 due to slight interpretive expansion beyond the ground truth's cautious tone.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 413,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "\nCisco kept its $2 bn, 5.90 % senior note due 2039 on the books throughout FY2022‑FY2024 (effective rate ≈ 6.11 % each year), but the makeup of its long‑term debt shifted markedly: total senior debt rose from about $8.5 bn (FY2023) to $20.25 bn (FY2024) after the February 2024 $13.5 bn issuance, dropping the note’s share from roughly 23 % to under 10 % of overall debt. Because the new issuances carried much lower coupons (2.5 %‑5 % with effective rates well below 6 %), the portfolio‑wide weighted‑average effective interest rate fell even though the 5.90 % note’s own rate remained unchanged, revealing Cisco’s strategy of extending maturities and diversifying with low‑cost, staggered fixed‑rate debt while hedging interest‑rate exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative data. According to the ground truth, Cisco's total long-term debt was $8,416 million in 2022, $19,621 million in 2024, with short-term debt decreasing slightly from $499M to $488M. The LLM incorrectly states total senior debt as $8.5B in FY2023 and $20.25B in FY2024, which does not align with the ground truth. Additionally, the LLM introduces a $13.5B issuance in February 2024 and lower-coupon debt (2.5%-5%) not mentioned or supported by the original answer. The 5.90% Note amount is correctly stated as $2B and effective rate as ~6.11%, which matches the ground truth. However, the claim that the note’s share dropped from 23% to under 10% is unsupported — based on ground truth numbers, the 5.90% Note was $2B out of $8,915M total debt ($8,416M long-term + $499M short-term) in 2022 (~22.4%) and $2B out of $20,109M in 2024 (~9.9%), so this percentage shift is approximately correct, but the underlying totals are misstated. (2) The LLM invents specific new debt instruments and interest rate ranges (2.5%-5%) and an issuance date (February 2024) not present in the original answer, which only states that long-term debt increased. The weighted-average interest rate decline is inferred but not confirmed in the ground truth, which only mentions the 5.90% Note’s rate remained steady. (3) The multi-hop reasoning is partially sound — the LLM correctly infers that increasing total debt while holding a fixed-note constant reduces its relative weight, and connects this to a strategy of diversifying low-cost debt. However, it adds unsupported details about new issuances and hedging strategies not derivable from the original answer. (4) The contextual relevance is high — the answer addresses the evolution of the 5.90% Note, its role in total debt composition, and draws a strategic conclusion. However, the correctness score is low due to major quantitative inaccuracies and fabrication of specific financial events. The qualitative accuracy is moderate due to logical reasoning but flawed inputs. Quantitative accuracy is poor due to incorrect base figures and invented data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 584,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "\nGeneral Dynamics’ Canadian‑LAV build‑rate has been trimmed each year: the 2022‑23 10‑K notes 449 new LAVs being produced, the 2023‑24 filing reports 399, and the 2024 filing cites 360 units for the eight‑variant programme (plus 66 additional LAVs on the LRSS track).  This downward trend shows a modest scaling‑back of the Canadian‑specific output, yet the company continues to highlight LAV production as a core element of its Land Systems segment and as a platform for export and modernization (e.g., Ajax, Piranha, autonomous‑vehicle upgrades).  Consequently, while the volume is easing, GD’s strategic focus remains on preserving and expanding its market‑leading position in light‑armored‑vehicle manufacturing and integrating those capabilities into broader land‑forces and autonomous‑systems initiatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer reverses the production volume trend, claiming a decline from 449 units in 2022 to 360 in 2024, while the ground truth shows an increase from 360 (2022) to 399 (2023) to 449 (2024). This inversion of the actual progression is a major factual error. Additionally, the LLM incorrectly assigns the 66 LRSS LAVs as separate from the 360-unit 2024 total, whereas the ground truth indicates the 449 units in 2024 already include or are in addition to the 66 LRSS units (implying the total is at least 449, not 360). (2) Quantitative accuracy is severely compromised: the numbers are all present (360, 399, 449, 66) but assigned to the wrong years. The LLM states 449 in 2022, 399 in 2023, and 360 in 2024 — exactly the reverse of the truth. This suggests a misreading of the data. Calculations are not required, but the comparison over time is fundamentally flawed. (3) The multi-hop reasoning fails because the model misaligns time-series data across filings. It incorrectly infers a 'scaling-back' due to reversed numbers, leading to a conclusion opposite to the ground truth: instead of indicating a strengthening strategic focus, the LLM claims a 'downward trend' and 'scaling-back'. While it correctly identifies the LRSS program and GD's broader strategic emphasis on land systems, the reasoning is based on incorrect data synthesis. (4) Contextual relevance is moderate — the answer addresses the right topic (LAV production for Canada, strategic focus, LRSS program), uses correct entity names (General Dynamics, LRSS, Land Systems), and discusses strategic implications. However, the core factual error in the trend direction undermines the entire analysis, warranting a low correctness score despite some relevant context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 477,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth’s Medicare Advantage risk‑adjustment payments were repeatedly squeezed by CMS benchmark freezes and more frequent RADV audits, which led to retrospective payment reductions and heightened funding pressure. In response, the company progressively tightened its pricing and benefit design, withdrew from low‑margin counties, intensified medical‑cost and operating‑expense management, and invested in data‑analytics and compliance controls to improve risk‑adjustment accuracy and protect margins.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, capturing the core evolution of UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 and the company's strategic responses. It correctly identifies ongoing CMS benchmark freezes and RADV audits as key drivers of payment pressure, which aligns with the ground truth's emphasis on CMS changes to risk adjustment methodologies. The strategic responses—tightening pricing and benefit design, withdrawing from low-margin counties, cost management, and investing in data analytics and compliance—are consistent with the original answer’s description of recalibrating bids, selective market participation, and cost control. While the LLM answer does not explicitly break down the response year-by-year (2022, 2023, 2024), it effectively synthesizes the multi-year trend and response pattern. The mention of RADV audits and data-analytics investments adds specificity not explicitly in the ground truth but is contextually plausible and enhances, rather than contradicts, the original. There are no numerical inaccuracies (quantitative accuracy is perfect, though no specific numbers are cited), and all entities (UnitedHealth, CMS, Medicare Advantage, risk adjustment) are correct. The reasoning is sound and semantically equivalent to the original, though slightly less structured in its chronological progression. Hence, a minor deduction in qualitative accuracy for less explicit multi-hop year-over-year synthesis, but high marks for correctness and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 427,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "\nPYPL’s balance of the 2.850 % fixed‑rate notes has been essentially flat from 2022 through 2024, staying at roughly **$1.5 billion** each year (as shown in the debt tables for 2022‑2023 【page 107】 and for 2023‑2024 【page 108, 111】).  At the same time the company added new senior unsecured issuances in 2023‑2024 (e.g., the ¥‑denominated 2023 notes and the May‑2024 $1.3 billion tranche of 5.15 %/5.5 % notes 【page 104, 111】), but it did not increase or retire the legacy 2.850 % series.  This continuity indicates that PYPL is preserving a stable, low‑cost, long‑dated funding pillar while supplementing its capital structure with newer debt to manage maturity timing and take advantage of favorable market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.5 billion carrying value of the 2.850% notes is accurately reported for 2022–2024, and the mention of the May 2024 $1.3 billion issuance at 5.15%/5.5% matches supplementary data. Format variations (e.g., $1.5 billion vs $1.5B) are acceptable. (2) The answer correctly identifies that PYPL did not retire or increase the 2.850% notes, maintaining a constant exposure—this matches the ground truth’s claim of a consistent $1.5 billion carrying value. (3) The reasoning is sound: the LLM correctly infers that maintaining this fixed tranche while issuing new debt indicates a strategic effort to preserve a stable, low-cost, long-term funding component, which aligns with the original answer’s conclusion about strategic intent. (4) Minor deduction in qualitative accuracy due to the addition of extraneous detail (e.g., ¥-denominated notes and specific coupon rates of new issuances) not present in the ground truth, which focuses solely on the 2.850% notes’ stability. However, these details do not detract from correctness and may be contextually valid. The answer fully addresses both parts of the question: the evolution (flat exposure) and the strategic implication (preservation of a stable liability structure). Semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 390,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "\nChevron’s involvement in Angola LNG Limited deepened markedly from 2022‑2024: the company added frontier deep‑water licences (Blocks 49 and 50), secured approval of the Owowo Stage‑1 development plan and had proved reserves recognised for the New G as Consortium project, thereby expanding the associated‑gas base that can be fed to the Angola LNG plant (pp. 14, 77, 49).  This multi‑year progression shows Chevron’s long‑term natural‑gas monetisation strategy in Angola – using its growing upstream stake and reserve base to lock in a dedicated LNG export outlet, secure international sales contracts and generate sustained cash flow from gas rather than oil alone.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, there are no errors: while the original answer notes Chevron's consistent 36.4% stake in Angola LNG Limited (which the LLM omits), it does not contradict it—this is a minor omission rather than an inaccuracy. The LLM correctly identifies the expansion into Blocks 49 and 50 and references the New G as Consortium Project, consistent with the ground truth. (2) The mention of Owowo Stage-1 and proved reserves is not in the original answer and may reflect overreach or inclusion of extraneous details not confirmed in the ground truth; however, these do not contradict known facts and may be contextually relevant. (3) The multi-hop reasoning is sound: the LLM correctly infers that upstream expansion (Blocks 49/50, Q&M fields) supports increased gas supply to the Angola LNG plant, thus integrating upstream growth with LNG monetization—this matches the core insight of the original answer about evolving toward an integrated hub. (4) The conclusion about Chevron’s long-term strategy—using growing upstream assets to secure LNG export capacity and generate sustained gas-based cash flow—is semantically equivalent to the original’s emphasis on transitioning from a standalone facility to an integrated monetization hub. The only notable gap is the absence of the explicit 36.4% ownership continuity, which is a factual detail present in the ground truth but not contradicted. Overall, the answer captures the strategic evolution accurately and contextually, warranting a high score with minor deduction for incomplete completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 443,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "\nSouthern Company’s trust portfolio shows a clear upward trend in both domestic‑equity and private‑equity exposures.  In the 2022 fair‑value table (page 283 of the 2023 10‑K) the company held $829 million of domestic‑equity assets and $161 million of private‑equity assets; by the 2024 filing (pages 273‑274) those figures had risen to $1.10 billion of domestic‑equity and $181 million of private‑equity investments.  This progression indicates that Southern Company is deliberately increasing its allocation to higher‑return alternative assets—particularly private equity—within its trust holdings, reflecting a long‑term capital‑allocation strategy that seeks to boost portfolio yields and diversify risk while still meeting regulatory funding requirements.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It incorrectly states that in 2022, Southern Company held $829 million in domestic equity and $161 million in private equity, which are actually the 2023 figures from the ground truth. The correct 2022 values are $1,016 million (domestic equity) and $150 million (private equity). The LLM misattributes the 2023 data as 2022 data, likely due to referencing the 2023 10-K (which reports 2022 year-end values on page 283), but fails to correctly label the year. It correctly reports the 2024 figures as $1.10 billion (~$1,100 million) domestic equity and $181 million private equity, which aligns with the ground truth ($1,099 million and $181 million — acceptable rounding). (2) Calculations and comparisons are partially correct: the upward trend from 2023 to 2024 is accurate, but the baseline (2022) is wrong, distorting the overall trend. The claim of a 'clear upward trend' in both categories is misleading because domestic equity actually decreased from 2022 to 2023 before rebounding. (3) Multi-hop reasoning is partially sound — the model correctly identifies the strategic shift toward private equity and links it to long-term capital allocation, which is consistent with the ground truth. However, due to the incorrect temporal assignment of data, the synthesis across years is flawed. (4) Contextual relevance is high — the answer addresses both parts of the question (evolution of investments and strategic implications) and uses appropriate financial terminology. Despite incorrect starting values, the conclusion about increasing private equity allocation is directionally correct. However, the quantitative inaccuracies are severe enough to undermine confidence in the analysis, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 488,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the eliminations/reclassifications subtracted $107 million, $151 million and $296 million from GM’s consolidated net sales (and revenue), progressively deepening the deduction each year. This expanding drag reflects growing internal adjustments—more cross‑segment sales between Automotive, Cruise and GM Financial are being eliminated and re‑classified—indicating that the company’s segment‑level reporting is becoming increasingly consolidated and complex.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Eliminations/Reclassifications were $105 million in 2022, $107 million in 2023, and $296 million in 2024. However, the LLM incorrectly states $107 million for 2022 (should be $105M), $151 million for 2023 (should be $107M), and correctly reports $296 million for 2024. These errors affect the trend interpretation, as the increase from 2022 to 2023 is overstated. (2) The calculation of the trend is partially correct in identifying a progressive increase, but the magnitude of change is misrepresented due to wrong intermediate values. The correct progression is +$2M (2022–2023) and +$189M (2023–2024), whereas the LLM implies a steady rise from $107M to $151M to $296M, which distorts the actual pattern. (3) The qualitative reasoning about increasing complexity in segment reporting and consolidation due to cross-segment eliminations is sound and aligns with the ground truth's interpretation. Mentioning Automotive, Cruise, and GM Financial adds plausible context, though not explicitly in the original answer. (4) Despite incorrect numbers for 2022 and 2023, the answer captures the overall upward trend and provides a reasonable explanation, earning moderate scores. Quantitative accuracy is penalized heavily due to two out of three numbers being wrong, but contextual relevance and logical interpretation remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 398,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "\nNetflix’s Performance Bonus Plan was most recently amended and restated in a December 9 2022 8‑K filing (Exhibit 10.5†), and that version remained the governing document through 2024. The plan is formally integrated with the company’s broader compensation framework—its terms are tied to the 2020 Stock Plan’s option and RSU agreements and to the Executive Officer Severance Plan, both of which were documented in subsequent 2023 filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and exhibit numbers are correct: the December 9, 2022 filing date for the amended and restated plan (Exhibit 10.5†) is accurately cited, and the absence of further changes through 2024 is consistent with the original answer. The reference to the 2022 8-K filing matches the knowledge graph's indication that the 2023 version was filed in 2022. (2) The answer correctly notes that the same version governed through 2024, which matches the 'carried forward without further changes' point in the ground truth. (3) Qualitatively, the LLM correctly identifies the integration of the Performance Bonus Plan with other compensation frameworks, specifically naming the 2020 Stock Plan and Executive Officer Severance Plan, and notes their documentation in 2023 filings—this reflects accurate multi-hop reasoning across compensation documents. (4) The only minor omission is that the LLM does not explicitly mention the 2022 status of the plan as a historical exhibit (Exhibit 10.6†) from 2014, which would have fully closed the 2022–2024 evolution narrative. However, since the focus is on the evolution and the key update occurred in late 2022 (filed in 2023), this does not undermine the core accuracy. The answer is semantically equivalent in substance and highly contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 383,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "\nBK’s “Business Relationships and Related Party Transactions Policy” is cited in all three 10‑K filings, but the way it is presented tightens over time: the 2022 filing merely notes its inclusion, the 2023 filing explicitly calls it out as a separate governance item, and the 2024 filing integrates it into the broader “Corporate Governance and Board Information” section while still linking it to director‑independence disclosures.  Across the years BK continues to list the same board committees (Audit, Corporate Governance, Nominating & Social Responsibility, and HR & Compensation) and to emphasize director independence, indicating a consistent corporate‑governance framework with only incremental wording refinements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor discrepancy in the characterization of the evolution of disclosure. The ground truth states that the policy was consistently disclosed within 'Corporate Governance and Board Information' under Item 13 across all three years, with consistent linkage to director independence and committee structures. The LLM answer suggests a progressive tightening: that 2022 'merely notes' the policy, 2023 'explicitly calls it out as a separate governance item,' and 2024 'integrates' it—this evolution is not supported in the ground truth, which emphasizes consistency rather than a shift in presentation style. However, all key entities are accurate: the policy name, the three years (2022–2024), the relevant board committees (Audit, Corporate Governance/Nominating/Social Responsibility, and Human Resources/Compensation), and the connection to director independence are correctly identified. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is contextually relevant, addressing both the evolution of disclosure and what it reveals about governance consistency. The reasoning is mostly sound but slightly overstates changes in presentation, leading to a small deduction in qualitative accuracy. Overall, the semantic meaning is close to the original, with only a nuanced misinterpretation of the nature of the disclosure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 399,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "\nUnitedHealth’s held‑to‑maturity debt‑security portfolio shrank each year: fair value fell from **$679 M (2022) → $596 M (2023) → $508 M (2024)**, and the corresponding carrying values moved from **$696 M → $603 M → $512 M**.  The consistent decline signals a deliberate reduction of the company’s long‑dated fixed‑income holdings—likely to free cash for share‑repurchases, acquisitions or other strategic uses—while the narrowing gap between carrying and fair value reflects a more market‑aligned valuation stance as interest‑rate movements reduced unrealized gains.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value in 2022 was $643 million, not $679 million as stated; carrying value in 2022 was $641 million, not $696 million. The 2023 and 2024 values for fair value ($596M, $508M) and carrying value ($603M, $512M) match the ground truth. The incorrect 2022 figures undermine the accuracy of the trend analysis, even though the direction (decline) is correct. (2) Calculations: The percentage decline from the incorrect baseline magnifies the error. For example, using $679M to $508M implies a 25.2% drop, whereas the true decline from $643M to $508M is 21.0%. These discrepancies affect the precision of any inferred strategy based on magnitude. (3) Reasoning: The LLM correctly infers a strategic reduction in held-to-maturity securities and notes the narrowing gap between fair and carrying values, which aligns with the ground truth’s implication of more market-aligned (observable) valuations. However, it introduces speculative uses of freed cash (e.g., share repurchases, acquisitions) not supported in the original answer. The ground truth emphasizes a shift away from Level 3 inputs, indicating improved valuation transparency—a key qualitative insight missing in the LLM response. (4) Despite missing this key point about Level 3 inputs and introducing unsupported speculation, the LLM captures the overall trend and offers plausible interpretation, earning moderate scores for qualitative accuracy and high for contextual relevance. The primary failure is in quantitative accuracy, dragging down the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 450,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to delinquent BNPL loan receivables shifted from an internal credit‑risk focus to an explicit portfolio‑sale strategy.  In the 2022 filing the company warned that defaults on its BNPL credit products could rise if underwriting or economic conditions deteriorated and that it might need third‑party funding to purchase or fund those receivables.  In June 2023 it entered into a multi‑year agreement to sell up to €40 bn of U.K. and European BNPL receivables—including a forward‑flow arrangement for future originations— and began selling a substantial majority of the portfolio in October 2023, while noting that the sale of future receivables is conditional and could be delayed.  By 2024 the filing reiterates that the success of this sale structure is critical to mitigating credit and funding risk, and it again highlights that any failure to manage fraud, abusive behavior or bad transactions could increase loss rates.  Together, these disclosures show a progressive risk‑mitigation approach: first quantifying the BNPL credit risk, then off‑loading the bulk of that risk through bulk sales and conditional forward‑flow arrangements, and finally tying the strategy to ongoing monitoring of fraud‑related losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk disclosures on BNPL defaults, the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, the conditional nature of the sale, and the continued emphasis in 2024 on fraud and abuse risks. The mention of a forward-flow arrangement and the October 2023 start of sales adds detail consistent with plausible extensions of the original answer. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, and no incorrect numbers or dates are introduced. The use of '€40 bn' is an acceptable format variation. (3) Multi-hop reasoning is sound—LLM synthesizes information across 2022, 2023, and 2024 filings, correctly tracing the evolution from risk acknowledgment to strategic offloading and conditional risk mitigation. The conclusion about a 'progressive risk-mitigation approach' accurately reflects the strategic shift. (4) The only minor shortcoming is that the original answer notes the 2024 filing emphasizes that unmet conditions could delay benefits, while the LLM frames this as part of the 'success... critical' narrative—slightly less precise on the uncertainty aspect, but still within acceptable semantic range. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 382,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "\nChevron’s Myanmar upstream output has been declining sharply: crude‑oil production fell from about 17 kbbl/d in 2022 to 15 kbbl/d in 2023 and to roughly 4 kbbl/d in 2024, while natural‑gas output dropped from ≈94 MMcf/d in 2022 to ≈87 MMcf/d in 2023 and to only ≈22 MMcf/d in 2024.  This reduction mirrors Chevron’s announced strategic shift to exit the country—​a planned, orderly transition begun in January 2022 that is pulling back from its non‑operated interest in the Yadana, Badamyar and Sein gas fields and reallocating capital to higher‑return projects elsewhere.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. While it correctly states that Chevron's upstream production in Myanmar declined from 17 kbbl/d in 2022 to 15 kbbl/d in 2023, it incorrectly claims production dropped to 'roughly 4 kbbl/d in 2024' and provides natural gas figures (e.g., 94 MMcf/d in 2022, 22 MMcf/d in 2024) that are not present in the ground truth. The original answer states Chevron completely withdrew from Myanmar in April 2024, meaning production was zero, not 4 kbbl/d or 22 MMcf/d. These numbers are fabricated or hallucinated. (2) The dates are partially correct—the exit occurred in April 2024, but the LLM mentions a 'planned transition begun in January 2022' which is not supported in the ground truth. The strategic shift is correctly identified as an exit related to portfolio optimization, though the LLM elaborates with unverified details about Yadana, Badamyar, and Sein fields and 'reallocating capital to higher-return projects,' which, while plausible, are not in the original answer. (3) The multi-hop reasoning is partially sound—linking declining production to strategic exit is logical and aligns with the question—but the synthesis includes unsupported details not present in the source. (4) The contextual relevance is high because the answer addresses both parts of the question (production evolution and strategic shift), but the correctness score is low due to major quantitative errors that undermine the factual basis of the response. Minor wording differences would be acceptable, but invented metrics and incorrect 2024 production levels constitute significant deviations from ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 460,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "\nThe Personal‑Electronics market that includes PC & notebooks fell from about 24 % of TI’s total revenue in 2022 to roughly 15 % in 2023, then edged back up to roughly 20 % in 2024.  This contraction (and modest recovery) shows that PC & notebook sales have become a smaller, less‑central component of TI’s Personal‑Electronics business, reflecting a strategic shift away from consumer‑grade computing toward higher‑margin industrial and automotive analog/embedded‑processing markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue contribution percentages for the Personal Electronics segment (24% in 2022, 15% in 2023, 20% in 2024), which aligns with the ground truth. While the original answer specifies that PC & Notebooks is a subcategory within Personal Electronics and notes its declining priority, the LLM correctly infers that the segment's overall decline reflects reduced emphasis on PC & Notebooks. The modest recovery in 2024 is accurately reflected. (2) All numeric values and years are correct and match the ground truth. The percentages are reported accurately with acceptable phrasing (e.g., 'roughly' is permissible as the original does not specify exact decimal points). No calculation errors. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the trend across three years and links the declining share to a strategic shift. It correctly identifies the move toward industrial and automotive markets as a strategic priority, which is consistent with the original answer. However, it slightly generalizes by not explicitly mentioning that PC & Notebooks remains a listed subcategory but lower in priority compared to mobile and portable electronics—this minor omission prevents a perfect score. (4) The answer is contextually relevant, directly addressing both the evolution of revenue contribution and the implied strategic positioning. The conclusion about shifting to higher-margin markets is well-supported and semantically equivalent to the original. Overall, the answer is factually correct, well-reasoned, and only lacks a small detail about the internal prioritization within the segment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 454,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "\nDuring 2022 through 2024 GM recorded **no accrual** for its indemnification to Stellantis; the only known contingent exposure is from ongoing European consumer class actions alleging emissions violations of the legacy Opel/Vauxhall models (and, to a far lesser extent, potential future Takata‑related recall reimbursements), which the company cannot presently estimate and considers remote. Consequently, the indemnification obligations have not materially evolved—no new liabilities have been recognized, and any future exposure remains uncertain and immaterial to the financial statements.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key developments in GM's indemnification obligations from 2022 to 2024, particularly in 2023 and 2024 disclosures. (1) In 2023, the ground truth states GM disclosed actual indemnification for losses tied to pre-sale representations, emissions claims, product liabilities, and recalls, with an immaterial amount already paid. The LLM incorrectly claims 'no accrual' and omits the fact that an immaterial indemnification was paid, which contradicts the original answer. (2) In 2024, GM disclosed accruals (albeit immaterial) related to European Commission and UK CMA investigations into end-of-life vehicle practices from the Opel era. The LLM denies any accruals, stating 'no accrual,' which is factually incorrect even if the amount is immaterial. (3) The LLM correctly notes that future exposure (e.g., Takata-related recalls) is considered remote and that emissions-related class actions are unquantifiable, aligning with the ground truth. (4) The core error lies in qualitative accuracy: the LLM concludes obligations 'have not materially evolved,' while the ground truth describes increasing specificity and emerging regulatory risks over time—indicating evolution in disclosure and risk profile, even if financial impact remains immaterial. This reflects a failure in multi-hop reasoning: synthesizing changes in disclosures across years. (5) Quantitative accuracy is high because no specific dollar figures are misstated (and 'immaterial' is correctly interpreted), but the denial of any accrual is a factual inaccuracy. (6) Contextual relevance is strong—the answer addresses indemnification, legacy Opel/Vauxhall matters, and future exposures—but omits key regulatory investigations and misrepresents the accrual status. Overall, the answer captures the immateriality theme but fails to reflect the evolving nature of disclosures and obligations, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 521,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "\nThe 1.450% Senior Notes due 2026 were first issued in September 2021 (Supplemental Indenture No. 10) and were later increased through supplemental indentures in 2022‑2024 that added to the outstanding principal and extended the maturity schedule. This multi‑year pattern shows American Tower’s debt‑management strategy of incremental, laddered refinancing—maintaining a low‑cost senior‑note base while steadily extending maturities and diversifying its overall debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the 1.450% Senior Notes due 2026 were consistently referenced across 2022–2024 without any refinancing or material modification. However, the LLM incorrectly claims that the notes were 'increased through supplemental indentures in 2022–2024' and that the maturity schedule was extended—both of which contradict the stability emphasized in the original answer. There is no mention in the ground truth of any increase in principal or extension of maturities. (2) Quantitatively, the initial issuance date (September 2021) and the interest rate (1.450%) are correct, and the reference to Supplemental Indenture No. 10 aligns with the original. However, the claim of incremental increases and maturity extensions introduces false numerical implications (e.g., changing principal amounts and dates) not supported by the data. (3) The multi-hop reasoning is flawed: instead of recognizing the consistent documentation of the same debt instrument across years as evidence of stability, the model infers an active refinancing strategy that is not present in the filings. This misinterprets the purpose of supplemental indentures, which in this case were for administrative updates, not structural changes. (4) Contextual relevance is moderate because the answer addresses the right topic (debt management strategy) and references the correct notes and indenture, but the conclusion about 'laddered refinancing' and 'diversifying debt profile' is unsupported and contradicts the actual pattern of stability. The model fails to synthesize the key insight—continuity across filings—leading to a fundamentally incorrect strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 472,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "\nFrom 2022 through 2024 the company repeatedly refreshed the award documents under its 2019 Long‑Term Incentive Plan, filing new forms of Performance Share Unit Agreements and Restricted Stock Unit Agreements each year (2022 forms filed as Exhibit 10.21/10.22, 2023 forms as Exhibit 10.26/10.27, and a 2024 RSU agreement as Exhibit 10.29). These updates introduced revised performance metrics, deferred‑stock‑unit provisions and an amended executive‑severance plan, demonstrating a progressive evolution of the plan’s compensation framework across the three years.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies that significantly affect factual correctness. (1) It claims the company filed new forms of Performance Share Unit Agreements and Restricted Stock Unit Agreements *each year* from 2022 to 2024, including specific exhibit numbers (e.g., 2024 RSU as Exhibit 10.29), but the ground truth does not support annual updates or these specific exhibit references—this is a major fabrication or misattribution. (2) The introduction of a '2024 RSU agreement' is incorrect; the ground truth highlights a 2022 Form of Performance Share Unit Agreement used in 2024, not a new 2024 RSU form. (3) The mention of 'revised performance metrics, deferred-stock-unit provisions and an amended executive-severance plan' is not supported by the original answer, which only notes the introduction of a new Deferred Stock Unit Agreement for Directors in 2023 and continued use of the 2019 plan with updated forms. (4) The ground truth emphasizes the *expansion* of the plan to directors in 2023 via a specific deferred stock unit agreement and the use of newer forms like the 2022 PSU agreement in 2024, but the LLM incorrectly frames this as annual refreshes with new forms each year. (5) While the LLM correctly identifies the ongoing use of the 2019 plan and mentions performance and stock unit agreements, it fails to accurately represent the *evolution*—particularly the director-level expansion in 2023—which is a key part of the multi-hop reasoning. (6) The answer is contextually relevant and attempts to describe an evolving compensation framework, but the specific details are factually flawed. Quantitative accuracy is low due to incorrect years and exhibit numbers. Qualitative accuracy is moderate because the general direction (ongoing use and updates) is plausible, but the reasoning and entity usage are not fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 506,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "\nFrom 2022 through 2024 the Combat Systems segment’s weapons‑systems revenue climbed from **$2.0 bn (2022) → $2.44 bn (2023) → $2.93 bn (2024)**, and the segment’s share of total company revenue rose from **≈18 % (2022) to ≈20 % (2023)**, reflecting a steady increase in sales of missile‑related products.  This growth is tied to GD’s expanding focus on **aerostructures, control actuators and hypersonic rocket cases** for both legacy and next‑generation missiles, positioning the company as a key supplier of the structural core for future strategic and tactical missile systems.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Combat Systems accounted for 20% of revenue in 2023 and declined to 19% in 2024, but the LLM claims it rose from ~18% in 2022 to ~20% in 2023 and implies continued growth, which contradicts the source. The dollar figures provided—$2.0B (2022), $2.44B (2023), $2.93B (2024)—are not present in the original answer and cannot be verified against the ground truth; thus, they are fabricated or hallucinated. (2) The quantitative inaccuracies are severe: no revenue numbers were mentioned in the original answer, so the LLM invented precise figures and trends unsupported by the source. Even if the percentages were approximated, the directionality is wrong—Combat Systems revenue share declined slightly in 2024, not increased. (3) The qualitative reasoning partially aligns: the LLM correctly identifies a strategic focus on aerostructures and next-gen missile subsystems and mentions relevant technologies like control actuators and hypersonic rocket cases (which may be contextually plausible but not in the ground truth). However, it fails the multi-hop synthesis by misrepresenting the revenue trend and overemphasizing growth, leading to an incorrect strategic interpretation. (4) The contextual relevance is moderate—the answer addresses the evolution of aerostructures in Combat Systems and strategic positioning, so it stays on topic. However, due to major factual and numerical errors, the correctness score is low. The answer creates a narrative of strong growth, while the truth indicates stable focus despite slight revenue share decline, undermining the validity of the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 462,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "\nAcross the 2022‑2024 filings, PMI repeatedly lists Jackpot alongside other local brands such as Fortune in the Philippines, positioning it as a value‑oriented, locally‑relevant cigarette that complements its premium international brands (e.g., Marlboro) and helps maintain market‑share leadership in the country. This multi‑year emphasis indicates that Jackpot is a strategic pillar for PMI’s regional portfolio—providing a foothold in the Philippine market, shielding PMI from local‑brand competition, and serving as a platform for future transition toward reduced‑risk products while reinforcing the company’s broader strategy of balancing premium and price‑sensitive offerings across its Asia‑Pacific footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Jackpot is consistently identified as a key local brand in the Philippines alongside Fortune across 2022–2024, and PMI maintains strategic emphasis on it despite its broader smoke-free transition. The LLM correctly captures the multi-year continuity and strategic rationale. (2) There are no numeric values in the question or answer requiring verification (e.g., financial figures, percentages), so quantitative accuracy is not applicable in a problematic sense—no numbers were misstated. (3) The multi-hop reasoning is sound: the LLM synthesizes Jackpot’s role over time and connects it to PMI’s broader regional and product strategy, including market-share maintenance, competitive shielding, and transition potential to reduced-risk products. It accurately infers that traditional cigarettes remain relevant even as PMI pushes IQOS and ZYN. (4) While the original answer emphasizes PMI’s global restructuring and explicit expansion to 95 smoke-free markets by 2024—details not mentioned in the LLM response—the core strategic implication (continued relevance of local cigarette brands amid smoke-free ambitions) is correctly interpreted and well-articulated. The LLM adds value-oriented positioning and strategic function (e.g., platform for transition) that are reasonable inferences consistent with the ground truth. Only minor lack of explicit mention of Swedish Match integration and exact smoke-free market count prevents a perfect 10, but these omissions do not detract from the central correctness. Hence, correctness is scored 9 for excellent alignment with minor contextual gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 462,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "\nChevron kept its upstream footprint in the Republic of Congo on the books throughout 2022‑2024, as shown by the country’s inclusion in the list of global operating locations in the 2022 filing (CVX_10K‑2022 p. 33).  The company continued to allocate capital to develop and sustain its offshore blocks in the area, but by early 2024 it began pruning non‑core stakes, completing the sale of its 31.5 % non‑operated interest in the Haute Mer permit and its 15.75 % interest in the Lianzi field in January 2025 (CVX_10K‑2024 p. 41).  This disposition signals a strategic shift to re‑deploy capital toward higher‑return projects while exiting peripheral assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies Chevron's continued operational presence in the Republic of Congo in 2022 and notes capital deployment in offshore projects in Africa in 2023, though it does not explicitly quantify the $0.7 billion investment linked to the region as stated in the original answer. This is a minor omission but does not distort the overall picture. (2) Quantitatively, the percentages (31.5% and 15.75%) and the January 2025 sale date are correct, matching the ground truth. The only slight gap is the lack of explicit mention of the $0.7 billion investment in 2023 being partially allocated to Congo, which weakens quantitative completeness slightly. (3) The reasoning is sound: the LLM correctly traces a strategic shift from maintaining operations to divesting assets, supported by proper citations and logical synthesis across years. The mention of 'early 2024' as the start of pruning is a bit imprecise since the sale occurred in January 2025, but the filing reference (CVX_10K-2024 p.41) correctly reflects forward-looking disclosures made in 2024 about a transaction completed in early 2025. (4) The answer is contextually excellent—directly addresses capital deployment and asset disposition, uses correct entities (Chevron, Haute Mer, Lianzi, Republic of Congo), and conveys the same strategic narrative of exit from upstream assets. Minor deduction from 10 due to incomplete mention of the 2023 capital figure, but overall factual and semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 426,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "\nSouthern Company continued to classify its outdoor‑lighting contracts as operating leases with initial terms of up to ten years and month‑to‑month renewals, a treatment that remained unchanged from 2022 through 2024.  The contracts are considered immaterial (particularly at Mississippi Power), and the lease‑income recorded under “operating leases” fell from $208 million in 2022 to $164 million in 2023 and $136 million in 2024, reflecting both the expiration of initial terms and a modest increase in the weighted‑average discount rate (4.51 % → 4.68 % → 4.73 %), which lowered the present‑value of the scheduled payments.  Revenue from these leases is reported in the lease‑income table, and the maturity schedules show scheduled cash flows through 2028; after applying the discount, operating‑lease obligations declined slightly from $1.49 billion in 2023 to $1.45 billion in 2024 across the subsidiaries.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical data (e.g., lease income of $208M in 2022, declining to $136M in 2024; discount rates increasing from 4.51% to 4.73%; operating lease obligations of $1.49B and $1.45B) that are not present in the original answer and are unverifiable from the ground truth. These figures are likely fabricated or hallucinated, as the original answer explicitly states that outdoor lighting contracts were considered immaterial in 2022 with no significant value disclosed. The absence of any financial figures in the ground truth makes the inclusion of precise dollar amounts and percentages in the LLM response factually incorrect. (2) The quantitative inaccuracies are severe: the LLM asserts declining lease income and specific discount rates and obligations, none of which are supported by the original answer. There is no mention of revenue allocation trends or present-value calculations in the ground truth, making these additions unsupported. (3) The qualitative reasoning partially aligns with the original answer in noting that outdoor lighting contracts were treated as operating leases and considered immaterial at Mississippi Power. It also correctly infers ongoing treatment across subsidiaries. However, it fails to capture the key evolution described in the original answer: the shift in disclosure practices from immateriality in 2022, to inclusion in maturity analyses in 2023, to expanded disclosures including initial terms and integration with wholesale revenues in 2024. Instead, the LLM focuses on fabricated financial trends rather than the actual change in accounting transparency and standardization. (4) The contextual relevance is moderate because the answer addresses the right topic (treatment of outdoor lighting contracts as operating leases) and mentions subsidiaries, but it misrepresents the nature of the change—focusing on financial declines and discounting rather than disclosure and classification improvements. The multi-hop synthesis is flawed because it does not connect the evolution of disclosure practices across years and subsidiaries as required. Correctness is low due to major factual and quantitative errors, despite some correct contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 598,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "\nCisco’s 3.50 % senior note due 2025 carried a roughly $500 million carrying amount in each of fiscal 2022, 2023 and 2024, but its effective interest rate climbed from **3.20 % in FY 2022 to 6.38 % in FY 2023 and 6.66 % in FY 2024**. This upward shift reflects rising market rates and the accretion of discount/premium and hedge adjustments, indicating that the note’s market‑derived yield—and thus Cisco’s borrowing cost—has increased even though the coupon rate remains unchanged.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the carrying amount of $500 million is correctly reported for all three fiscal years (2022, 2023, 2024), and the effective interest rates—3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024—match the original answer exactly. (2) Quantitative accuracy is perfect: all percentages and dollar amounts are correct, with no calculation or transcription errors. The format variations (e.g., 'FY 2022' vs 'fiscal year 2022') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years for the same debt instrument, tracking both carrying amount and effective rate over time. (4) The qualitative interpretation is strong—the explanation that the rising effective rate reflects higher market rates and adjustments like discount accretion or hedging is consistent with and expands upon the ground truth’s conclusion about market conditions and debt valuation. The added context about the coupon rate remaining fixed enhances clarity without introducing error. All parts of the question are addressed: evolution over time, carrying amount, effective rate, and implications for debt valuation and market conditions. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 368,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s **Unsecured Notes – 35A** stayed constant at a **$750 million issue, 2.65 % coupon, maturing 07/15/30**, appearing in the debt tables for 2022 (p. 50), 2023 (p. 50) and 2024 (p. 51).  Its absolute size did not change, but because total consolidated unsecured indebtedness fell from **$20.0 bn (2022)** to **$21.0 bn (2023)** and then to **$19.4 bn (2024)**, the note’s share of the overall unsecured portfolio hovered only around **3–4 %** of the total.  \n\nThis multi‑year stability shows that SPG is using the 35A tranche as a **low‑cost, long‑dated anchor** in a broader strategy of extending maturities, diversifying funding sources, and taking advantage of favorable market rates to issue new notes while keeping a modest, predictable portion of debt on the books.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies the consistent $750 million face value, 2.65% coupon, and July 15, 2030 maturity date for Unsecured Notes - 35A across 2022–2024, which matches the ground truth. However, there is a critical error in the reported total unsecured indebtedness: the LLM states it decreased from $20.0 billion in 2022 to $21.0 billion in 2023 and then to $19.4 billion in 2024. This is logically inconsistent (increase from 2022 to 2023, then decrease), and more importantly, contradicts the ground truth, which does not provide specific portfolio totals or suggest such fluctuations. The claim that the 35A note represented '3–4%' of the portfolio is unsupported by the original answer and based on potentially incorrect totals, undermining quantitative accuracy.\n\n2) The calculation of the note’s percentage share (3–4%) is based on erroneous total debt figures. For example, stating total unsecured debt rose from $20.0B to $21.0B and then fell to $19.4B introduces data not in the ground truth and misrepresents the trend. The original answer makes no mention of these totals or percentages, focusing instead on the stability of the 35A note relative to other strategic debt actions. Thus, the inclusion of these numbers reduces quantitative accuracy.\n\n3) The reasoning about SPG using the 35A note as a 'low-cost, long-dated anchor' while selectively managing other debt aligns well with the ground truth’s conclusion about a 'deliberate strategy to maintain stable long-term financing commitments.' The synthesis of stability in this instrument alongside broader refinancing activity (e.g., new 2024 issuance) shows sound qualitative reasoning and contextual understanding of debt management strategy.\n\n4) Despite the fabricated debt totals, the core insight—that the persistence of the 35A note reflects a strategic choice for stability amid active portfolio management—is semantically equivalent to the original answer. The LLM adds interpretive context (e.g., 'anchor,' 'favorable market rates') that is reasonable but not explicitly confirmed. The error in quantitative data prevents a higher score, but the strategic interpretation remains relevant and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 585,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments has shifted Embedded‑Processing from a peripheral product line to a strategic growth pillar, pouring capital into dedicated fabs (e.g., the 300‑mm Lehi plant and CHIPS‑Act‑supported capacity expansion) to deepen its manufacturing‑technology advantage, expanding the microcontroller/DSP/processor portfolio and leveraging longer‑life‑cycle devices that lock customers into software ecosystems, while using its global channel network to sell more of these parts into high‑growth industrial and automotive markets.  This focus simultaneously strengthens each of TI’s four sustainable competitive advantages—lower‑cost, controllable supply chain; a broader, higher‑value product portfolio; wider market reach; and diversified, low‑dependency product/market mix—thereby driving the long‑term free‑cash‑flow‑per‑share growth that the company treats as its ultimate performance metric.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning when compared to the ground truth. (1) The original answer states that Texas Instruments maintained a consistent strategic emphasis on Embedded Processing Products from 2022 to 2024, using identical language each year to describe the value of its broad portfolio. The LLM incorrectly claims a strategic 'shift' from 'peripheral product line to a strategic growth pillar,' which contradicts the stability emphasized in the ground truth. (2) There are no quantitative figures (e.g., dollar amounts, percentages, dates) in the original answer, so the LLM's introduction of specific capital investments, the 300-mm Lehi plant, and CHIPS Act funding is unsupported and factually unverifiable from the provided truth. These details are likely hallucinated. (3) The multi-hop reasoning is flawed: the original answer links the sustained role of Embedded Processing to TI's four sustainable competitive advantages through consistent messaging, while the LLM fabricates a causal mechanism involving manufacturing investments and software ecosystems, which are not mentioned in the ground truth. (4) While the LLM correctly identifies that Embedded Processing relates to TI's competitive advantages and long-term value, this general thematic relevance does not compensate for the significant factual and representational inaccuracies. The core claim of strategic evolution is false—the truth emphasizes consistency, not change. Thus, despite some contextual alignment with TI's business model, the answer fails on correctness, quantitative accuracy, and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 446,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast broadened the flexibility of its wireless shared‑data offering: the 2022 filing describes a basic model that let customers pool data on unlimited, shared‑data or per‑gigabyte plans, and by 2024 the company added prepaid unlimited “NOW” data plans and longer‑term device‑financing for international customers (2024 10‑K, p. 5).  At the same time it expanded internationally, launching wireless service in the United Kingdom through an MVNO agreement with Virgin Media O2 (2023‑2024 10‑K, p. 5), giving UK subscribers the same tiered‑pricing and shared‑data options that were later rolled out domestically.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of CMCSA's evolution in wireless shared data plans—increased flexibility and international expansion—but contains several factual inaccuracies and misrepresentations that affect correctness. (1) In 2022, the ground truth states that shared data plans were offered exclusively as part of bundled residential broadband services in the U.S., but the LLM implies broader availability and choice among unlimited, shared, and per-gigabyte plans earlier than documented. This overstates 2022 flexibility. (2) The claim that tiered pricing and shared-data options were 'rolled out domestically' after being launched in the UK is factually reversed: domestic U.S. offerings predated international expansion, and the UK launch under an MVNO with Virgin Media O2 is accurate (per 2023–2024 10-K), but the sequencing and scope of plan availability are misrepresented. (3) The introduction of prepaid unlimited NOW brand plans in 2024 is correct and aligns with the original answer, as is the emphasis on increased flexibility by 2023–2024. (4) However, the LLM incorrectly attributes device-financing expansion to international customers without support in the ground truth, which does not mention financing terms. (5) While the international expansion is correctly noted, the original answer specifies that shared data plans continued alongside new options, whereas the LLM overemphasizes parity between UK and domestic offerings. Quantitative accuracy is acceptable—no explicit numbers are wrong, but dates (2022, 2023, 2024) are used appropriately. Qualitative accuracy is moderate: reasoning shows multi-hop synthesis (bundling, flexibility, international move), but logic is flawed in sequencing and emphasis. Contextual relevance is high—the response stays focused on plan flexibility and international growth as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 500,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "\nFrom 2022 to 2024 PayPal’s exposure to abusive behavior moved beyond isolated fraud‑related losses to a layered risk profile that now includes the rapid expansion of credit products (e.g., BNPL and merchant financing), intensified scrutiny from U.S. and foreign regulators (CFPB, AUSTRAC, SEC, German FCO), and the emergence of new digital‑asset threats such as the PYUSD stablecoin. This evolution signals that managing the payments ecosystem requires ever‑more sophisticated, continuously updated fraud‑detection models, external audit and compliance oversight, and coordination of third‑party funding, custodial and cross‑border risks.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of increasing risk complexity in PayPal's ecosystem from 2022 to 2024 and correctly identifies the expansion of credit products (e.g., BNPL) as a key factor. However, it introduces several unsupported details not present in the ground truth, significantly affecting factual accuracy. (1) The mention of 'PYUSD stablecoin' as a digital-asset threat is not referenced in the original answer and does not align with the documented risk evolution. (2) Regulatory bodies like CFPB, AUSTRAC, SEC, and German FCO are named without evidence from the ground truth, which does not mention regulatory scrutiny as part of the abusive behavior progression. (3) The original answer specifies a concrete €40 billion multi-year agreement to sell U.K. and European BNPL loan receivables in 2023 — a key quantitative and strategic detail — but the LLM omits this entirely, despite referencing BNPL expansion. (4) The original highlights specific fraud tactics evolving over time: fictitious accounts (2022), third-party fraud in loan portfolios (2023), and account takeovers/synthetic identity fraud (2024), along with legal uncertainty around loan receivables from FDIC-insured banks in 2024. The LLM vaguely references 'new digital-asset threats' and 'external audit and compliance oversight' without accurately tracing this progression. (5) While the LLM concludes that risk management requires more sophisticated models — which aligns semantically with the original — it fails to accurately synthesize the multi-hop evolution across years, products, and fraud types. Quantitative accuracy is partially met due to the absence of incorrect numbers (no numbers are stated), but the omission of the €40 billion figure and lack of temporal specificity reduces precision. Qualitative accuracy suffers due to incorrect entity inclusion (regulators, PYUSD) and missing key fraud mechanisms. Contextual relevance is high as the response stays focused on PayPal’s risk evolution and credit products. Overall, the answer reflects a plausible but factually divergent narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 559,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "\nGilead’s El Segundo, California site has moved from a mainly clinical‑trial manufacturing location in 2022 to a central commercial hub for its cell‑therapy portfolio by 2024, with targeted capacity expansions that underpin the sharp rise in cell‑therapy sales (from $1.06 billion in 2023 to $1.97 billion in 2024) and enable production of existing CAR‑T products (Yescarta, Tecartus) and upcoming candidates (2024 10‑K, pp. 11, 40; 2023 10‑K, p. 11).",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth states that GILD consistently used El Segundo for both clinical and commercial manufacturing from 2022 to 2024, with no indication of a shift from 'mainly clinical' to 'central commercial hub.' The LLM incorrectly implies an evolution in the facility's role that is not supported by the original answer. (2) The financial figures cited—$1.06 billion in 2023 and $1.97 billion in 2024 in cell therapy sales—are not present in the ground truth and cannot be verified from the provided information. There is no mention of sales growth or specific revenue figures in the original answer, making these numbers fabricated or misattributed. Additionally, the claim about 'targeted capacity expansions' and their direct link to sales growth is unsupported. (3) The multi-hop reasoning is flawed: while the LLM attempts to connect facility utilization with business outcomes (sales), it invents a narrative of transformation and expansion not present in the source. The original answer emphasizes continuity, not evolution or scaling. The mention of CAR-T products (Yescarta, Tecartus) and 10-K page references adds specificity but does not align with the neutral, descriptive tone of the ground truth, which does not discuss sales trends or strategic shifts. (4) The contextual relevance is moderate because the answer addresses El Segundo’s role in cell therapy manufacturing and ties it to GILD’s strategy, but the qualitative accuracy is low due to incorrect characterization of the facility’s evolving role and unsupported numerical claims. The correctness score is 4 due to partial entity and timeline accuracy (correct company, location, general focus on cell therapy), but major errors in facts and reasoning undermine the overall reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 506,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "\nThe 2.750 % Senior Notes were first disclosed in the 2022 10‑K (Exhibit 4.6) as a $ 2.75 billion issue maturing on May 18 2024. In the 2023 10‑K the same 2024‑maturity tranche was still listed, but the exhibit schedule now also highlighted newer senior‑note issuances – 1.375 % due 2027, 1.600 % due 2030 and 1.750 % due 2032 – indicating that the company had begun issuing longer‑dated debt. By the 2024 10‑K the 2024‑maturing 2.750 % notes were no longer part of the active debt schedule, while the 2027, 2030 and 2032 maturities remained the longest‑dated senior obligations. This shift shows Costco’s deliberate strategy of laddering its senior‑note portfolio and extending maturities to spread repayment risk and reduce near‑term refinancing pressure.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, the LLM incorrectly states that the 2.750% Senior Notes were no longer listed in the 2024 10-K, implying they matured and were removed, which contradicts the ground truth that the same maturity date (May 18, 2024) was consistently reported across all three years. The ground truth confirms no refinancing or extension occurred, but the LLM infers a strategic shift that is not supported by the data. (2) The dollar amount of $2.75 billion is not present in the original answer and cannot be verified from the provided truth; thus, its inclusion introduces unverified detail. (3) The mention of new notes (1.375% due 2027, 1.600% due 2030, 1.750% due 2032) appears in the LLM answer but is absent from the ground truth, indicating fabrication or misattribution not supported by the knowledge graph. (4) The reasoning is flawed: the LLM concludes Costco implemented a maturity laddering strategy, while the ground truth explicitly states the company maintained a static approach with no changes to this debt instrument. This misrepresents the core finding. (5) While the LLM addresses the question's structure and attempts multi-hop analysis across years, the synthesis is based on incorrect premises. Contextual relevance is moderate because the response discusses debt management strategy and evolution over time, aligning with the question’s intent, but the factual foundation is unsound. Overall, the answer is mostly incorrect due to invented details and erroneous conclusions, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 443,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "\nChevron’s Angola LNG gas output (measured as oil‑equivalent) slipped from about 70 kbbl/d in 2022 to 67 kbbl/d in 2023 and 64 kbbl/d in 2024, while the natural‑gas flow remained essentially flat at roughly 48‑49 MMcf/d over the same period. This modest decline shows the company is primarily sustaining and optimizing its existing African LNG assets rather than expanding capacity. Consequently, the trajectory reflects a strategic focus on cash‑generating, mature projects and a re‑allocation of capital to higher‑return upstream opportunities elsewhere.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that Chevron's natural gas production volumes from Angola LNG increased from 7,107 MMcf/d in 2022 to 7,148 MMcf/d in 2023, and further to 7,569 MMcf/d in 2024 — a clear upward trend. In contrast, the LLM claims gas flow remained 'essentially flat at roughly 48–49 MMcf/d' and even reports declining oil-equivalent output (in kbbl/d), which contradicts the verified data. These numbers are not only wrong but significantly understated (e.g., ~48 MMcf/d vs actual >7,100 MMcf/d — off by more than an order of magnitude). (2) The quantitative inaccuracies are severe: the correct values are over 7,100 million cubic feet per day, not 48–49. This suggests confusion between raw gas volumes and processed LNG or oil-equivalent metrics, or possibly misattribution to a different asset. There are no valid calculations or comparisons that align with the ground truth. (3) The multi-hop reasoning fails completely. The LLM draws a conclusion about Chevron maintaining or optimizing rather than expanding, which contradicts the actual growth trajectory indicating strategic emphasis on gas production in Africa. The synthesis is based on fabricated data, leading to an invalid strategic interpretation. (4) The contextual relevance is low but not zero — the answer addresses Chevron, Angola LNG, and African production strategy — so partial credit is given for topic alignment, but factual correctness is almost entirely absent, warranting a correctness score of 1.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 430,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the notional amount of Cisco’s total‑return swaps that hedge deferred‑compensation liabilities grew from **$651 million (FY22) to $792 million (FY23) to $985 million (FY24)**, and the swaps’ impact on earnings shifted from a **$92 million loss in FY22 to gains of $58 million in FY23 and $91 million in FY24**.  This expansion and the swing from loss to consistent gains show that Cisco is deliberately scaling and refining its market‑linked hedging of deferred‑compensation obligations to better align compensation expense with market performance and to curb earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the financial impact of Total Return Swaps-Deferred Compensation: a $92 million loss in FY22, $58 million gain in FY23, and $91 million gain in FY24, matching the ground truth exactly. These numbers are presented accurately with correct signs and magnitudes. However, the LLM introduces additional data—specifically the notional amounts ($651M, $792M, $985M)—which are not present in the original answer. While these figures may be factually correct based on external filings, they were not part of the ground truth derived from the knowledge graph, making this an addition rather than a misstatement. (2) All reported financial impacts are quantitatively accurate and consistent with the ground truth. The progression from loss to increasing gains is correctly captured. The notional amounts, while plausible, cannot be verified against the provided ground truth and thus represent unconfirmed extras. (3) The reasoning is sound: the LLM correctly infers that the shift from loss to gains indicates strategic refinement in hedging deferred compensation, aligning with market performance and reducing earnings volatility. This interpretation is consistent with and expands upon the original answer’s suggestion of strategic shift or improved market conditions. The multi-hop synthesis across three fiscal years is accurate and logically interpreted. (4) The answer is highly relevant, addressing both the evolution of financial exposure and its implications for strategy and volatility. The only deviation from strict equivalence is the inclusion of notional amounts, which enhances detail but isn't required. Overall, the answer matches the ground truth in all critical factual aspects and provides a slightly more detailed analysis, warranting a high score with minor deduction for introducing unverified data not in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 509,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "\nFrom 2022 to 2024 Lowe’s deepened its supplier‑sustainability framework: the 2022 Vendor Code of Conduct was expanded in 2023 with a risk‑based wood‑sourcing policy, new country‑risk tiers and a formal grievance process, and was further refined in 2024 through broader digital supplier monitoring; the company also broadened third‑party validation by requiring independent certifications such as ENERGY STAR and WaterSense and by reporting its environmental performance via CDP, SASB and TCFD, earning a spot on the Dow Jones Sustainability Index for five straight years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Lowe's supplier practices from 2022 to 2024. It accurately captures the progression: starting with the Vendor Code of Conduct in 2022, policy updates in 2023 (risk-based wood sourcing, country risk tiers, grievance process), and further refinements in 2024 (enhanced monitoring). The mention of third-party certifications like ENERGY STAR and WaterSense is consistent with the original answer’s reference to expanding independently certified products. Additionally, reporting through CDP, SASB, and TCFD and inclusion in the Dow Jones Sustainability Index add relevant context about transparency and recognition, though these specific programs were not mentioned in the ground truth. The only minor discrepancy is the introduction of 'digital supplier monitoring' and the broader list of certifications/reporting frameworks, which extend beyond the documented wood sourcing and human rights focus in the original answer. While plausible and contextually relevant, they slightly expand the scope beyond the environmental and human rights supplier practices emphasized in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect), and all dates and entities (Lowe's, years, policies) are correct. The reasoning is sound and reflects proper multi-hop synthesis across years and policy domains. The answer is highly relevant and conveys the core evolution accurately, warranting a high score with a small deduction for added details not present in the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 433,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "\nFrom 2022 through 2024 the threat from wireless telecoms to Comcast’s broadband and wireless services grew sharper as carriers rolled out 5G and fixed‑wireless broadband, bundled those wireless offerings with video and voice packages, and used aggressive pricing to win subscribers; the filings repeatedly cite AT&T, T‑Mobile, Verizon, Frontier, BT and Virgin Media (and new subsidized fiber/fixed‑wireless entrants) as the main rivals that now compete with Comcast’s cable‑based broadband and MVNO‑based wireless services.  This evolution—driven by advanced 4G/5G and fixed‑wireless technologies and by bundled product strategies—has intensified competition across both the U.S. and European markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of competitive threats from 2022 to 2024. It accurately captures the intensifying threat from wireless telecoms due to 5G and fixed-wireless broadband deployment, bundling strategies, and aggressive pricing. The named competitors AT&T, T-Mobile, and Verizon are correctly identified as key U.S. rivals, which matches the original answer. However, the LLM adds 'Frontier, BT, and Virgin Media' as well as 'new subsidized fiber/fixed-wireless entrants'—entities not mentioned in the ground truth for this specific competitive evolution timeline. While Frontier, BT, and Virgin Media may be relevant in broader competitive contexts, their inclusion here slightly overextends the documented scope of the filings' focus on major wireless carriers. The answer correctly emphasizes technological capabilities (4G/5G, fixed wireless) and bundling strategies, including integration with video and voice, which aligns with the 2024 emphasis on bundling DTC streaming services. There are no numerical inaccuracies (quantitative accuracy is perfect), and the timeline (2022–2024) is properly framed. The reasoning is sound and reflects multi-hop synthesis across years and strategies. The only minor shortfall is the addition of extra competitors not cited in the ground truth, which slightly affects qualitative accuracy. Overall, the answer is factually strong, contextually relevant, and semantically equivalent in meaning, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 424,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal repeatedly disclosed that it “bears full margin risk” on each payment transaction, recognizing transaction fees gross of processor costs and treating volume‑based discounts and customer incentives as reductions of revenue rather than expenses.  The company’s tiered, volume‑based pricing model and its practice of limiting incentives—concluding that such discounts do not confer a material future right—reflect a deliberate effort to curb margin erosion despite continued reliance on third‑party processors.  This multi‑year pattern shows that PayPal’s control over pricing and cost management is constrained by the need to cover processor fees and incentive payouts, making its margin performance largely dependent on transaction volume and the mix of higher‑margin services rather than on negotiating lower processor costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth, earning a high correctness score. (1) It correctly states that PayPal 'bears full margin risk' from 2022 to 2024, accurately reflecting the consistent exposure to margin risk. It correctly identifies that transaction fees are recognized gross of processor costs and that incentives (discounts, rebates) are treated as revenue reductions, not expenses—this matches the original answer’s emphasis on revenue recognition practices. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the LLM or original answer, so quantitative accuracy is not applicable in a traditional sense; however, all referenced financial treatments (e.g., gross recognition, revenue reductions) are correctly described, warranting a perfect score on quantitative accuracy by proxy. (3) The multi-hop reasoning is largely sound: the LLM synthesizes PayPal’s pricing discretion, treatment of incentives, and reliance on third-party processors across years. However, it omits specific 2024 developments mentioned in the ground truth—namely, contractual compensation from sellers for fraud or counterfeiting as a new revenue stream affecting margins. This is a meaningful but not critical omission. (4) The LLM concludes that margin performance depends on volume and service mix rather than processor cost negotiation, which is a reasonable inference but slightly overemphasizes constraint compared to the original answer’s portrayal of 'disciplined, centralized control.' The original answer stresses PayPal’s consistent control, while the LLM frames it as constrained—this is a nuanced but important difference in interpretation. Despite this, the answer remains contextually precise, fully addressing the question’s focus on pricing strategy, processor use, and incentives. Thus, high scores are justified across all dimensions, with a slight deduction in qualitative accuracy and overall correctness for the omitted 2024 detail and interpretive tilt.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 547,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "\nCostco treats free‑rent and step‑rent lease incentives as lease‑incentives that are recognized on a straight‑line basis over the full lease term (the non‑cancelable period plus any renewal options it is reasonably certain to exercise). The present‑value of those payments—net of the free‑rent incentive—is recorded as the right‑of‑use asset and lease liability, and the asset is subsequently amortized over that same term; this methodology has been applied consistently from FY 2022 through FY 2024.  In the 2024 filing the company adds quantitative detail—e.g., weighted‑average remaining lease terms of 19 years (operating) and 23 years (finance) and discount rates of 2.67 % and 4.59 %—showing that the ROU asset of $2.617 bn reflects the straight‑line amortization of lease payments after accounting for free‑rent periods.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core consistency in Costco's accounting treatment of free-rent periods from FY 2022 to 2024, correctly stating that free-rent and step-rent provisions are recognized on a straight-line basis over the lease term (including reasonably certain renewal options) and that the right-of-use (ROU) asset is based on the present value of lease payments net of incentives. This aligns with the ground truth's description of a stable policy. However, the LLM introduces specific quantitative details—such as weighted-average remaining lease terms (19 and 23 years), discount rates (2.67%, 4.59%), and ROU asset value ($2.617 billion)—that are not present in the original answer and cannot be verified against the provided ground truth. These numbers may be factually correct in actual filings, but since they are absent from the ground truth, their inclusion constitutes a quantitative overreach, reducing quantitative accuracy. Additionally, the original answer highlights a qualitative evolution: in FY 2023, Costco clarified that rent increases tied to price indices or sales volume were treated as variable lease payments, a nuance not mentioned in the LLM response. While the LLM correctly emphasizes policy consistency, it misses this incremental disclosure refinement, indicating a partial failure in multi-hop synthesis across years. The contextual relevance is high, as the response directly addresses lease term assumptions and ROU asset valuation. Wording differences are acceptable under semantic equivalence, but the addition of unverified metrics and omission of the 2023 variable lease payment clarification prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 451,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "\nPayPal’s margin‑risk profile stayed essentially unchanged from 2022 through 2024.  The company continues to record transaction revenue on a gross basis and expense the fees paid to payment processors, meaning it bears the full margin risk on every payment.  Its contracts remain open‑ended, auto‑renewing and tier‑priced, but the pricing structure does not create any material future right, so the nature of the risk—being principal and exposed to processor fees—has not shifted, only the scale of transactions has altered the absolute level of exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core continuity in PayPal's margin risk exposure from 2022 to 2024, accurately stating that PayPal bears full margin risk, records revenue on a gross basis, and expenses payments to third-party processors. It correctly notes the persistence of tiered, volume-based pricing without material rights and the open-ended, auto-renewing nature of contracts, which aligns with the ground truth. However, the LLM omits two key qualitative developments: (1) the 2023 clarification on user incentives being recognized as revenue reductions or amortized over time, which introduced variability into the margin structure, and (2) the 2024 adoption of ASU 2023-07, which enhanced segment-level expense disclosures and affected how margin risk can be analyzed across business units. These omissions reduce completeness and qualitative accuracy, as they represent meaningful operational nuances in how margin risk evolved, even if the fundamental model remained stable. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer remains highly relevant to the question. The reasoning is sound but incomplete in synthesizing all multi-hop elements across the three years, particularly the incremental reporting and accounting changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 357,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "\nCisco’s 5.90 % senior note was fully‑utilized at a constant $2 billion of principal in fiscal 2022, 2023 and 2024, and its reported effective interest rate remained steady at about 6.11 % each year. This flat‑line shows the company is not refinancing that long‑dated tranche but is instead keeping it as a stable, higher‑cost pillar while supplementing its balance sheet with newer, lower‑coupon senior notes (2 %–5 % range) and interest‑rate swaps, thereby holding overall long‑term financing costs steady or gradually reducing them.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2 billion (i.e., $2,000 million) outstanding balance on the 5.90% Note across fiscal years 2022, 2023, and 2024, and that the effective interest rate remained constant at 6.11%, matching the ground truth exactly. These figures are reported accurately with acceptable formatting variations (e.g., $2 billion = $2,000 million). (2) All numeric values—principal amount, coupon rate (5.90%), effective rate (6.11%), and time period (2022–2024)—are factually correct and consistent with the original answer. No calculations were required beyond recognition of stability, which is correctly interpreted. (3) The multi-hop reasoning is sound: the model infers from the stable principal and effective rate that Cisco did not refinance or modify the note, and further synthesizes this with broader context about the company’s debt strategy—specifically, the use of newer, lower-coupon notes and interest rate swaps to manage overall financing costs. While this broader context (e.g., 2%–5% new notes, use of swaps) is not explicitly in the ground truth, it does not contradict it and represents a reasonable, contextually plausible extension based on typical corporate financing behavior. (4) The answer is semantically equivalent to the ground truth in its core claims and adds interpretive depth without introducing inaccuracies. The only minor limitation is that the original answer emphasizes the consistency of this specific debt instrument within broader portfolio changes, while the LLM answer goes slightly beyond by speculating on strategic use of swaps and lower-coupon debt—still logically consistent but not fully verifiable from the provided truth. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative accuracy, and a 9 overall due to the slight extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 509,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "\nThe 10‑K filings show Kobalt moving from a simple trademark listing to a strategic brand element. In the 2022 IP section (LOW‑10K‑2022, p. 8) Kobalt is merely identified as one of the company’s private‑brand product names. By 2023 the disclosure (LOW‑10K‑2023, p. 11) begins to frame private brands—including Kobalt—as part of Lowe’s “value‑oriented private brands” that support its omnichannel and localization goals, and the 2024 filing (LOW‑10K‑2024, p. 7) explicitly ties Kobalt to initiatives that boost space productivity and localized assortments within the Total‑Home strategy. Thus, Kobalt’s positioning evolved from a passive IP mention to a deliberate lever in Lowe’s private‑brand growth agenda.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no numbers to misstate, it is scored as 10 by default. The contextual relevance is high because the response directly addresses the evolution of Kobalt’s positioning across fiscal years 2022–2024 and cites specific sections of the 10-K filings. However, the qualitative accuracy is low because the LLM misrepresents the substance of the disclosures. The ground truth states that Kobalt’s mention remained consistent and stable across the three years, with no increase in prominence. In contrast, the LLM claims a clear evolution from a 'passive IP mention' to a 'strategic brand element' tied to specific initiatives like space productivity and the Total-Home strategy—assertions not supported by the original answer. The knowledge graph indicates no explicit shift in tone or strategic framing of Kobalt in the IP disclosures, whereas the LLM infers a progression that isn't reflected in the ground truth. This reflects a failure in multi-hop reasoning: while the LLM may have drawn plausible inferences from document language, it contradicts the verified synthesis that there was no change in prominence. Thus, despite correct entity identification (Kobalt, Lowe's, correct years), the core conclusion about strategic evolution is factually incorrect, warranting a correctness score of 4—partially correct in context and entities, but significantly flawed in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 407,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes – 37B kept the same terms in the company’s 10‑K filings – a fixed 2.25 % coupon, a $700 million face amount and a maturity of January 15 2032 (see SPG 2022 10‑K p. 50; SPG 2023 10‑K p. 50; SPG 2024 10‑K p. 51).  The lack of any material change in interest rate, size or maturity shows that Simon Property Group is deliberately maintaining a long‑dated, low‑cost unsecured debt position, using stable, long‑term financing to lock in favorable rates and support its growth strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the interest rate (2.25%), face amount ($700 million, correctly interpreted as $700,000,000), and maturity date (January 15, 2032) are consistent across 2022–2024, matching the original answer. The format variation ($700 million vs $700,000) is acceptable and common in financial reporting. (2) Quantitative accuracy is perfect—no calculations were required, but all numbers and dates are correctly reported. (3) The multi-hop reasoning is sound: the model correctly synthesized data from three consecutive 10-K filings (2022, 2023, 2024), confirming stability over time, and drew a logical inference about Simon Property Group’s long-term financing strategy. (4) The qualitative interpretation—that SPG is maintaining a long-dated, low-cost debt structure to lock in favorable rates—aligns with and expands upon the original answer’s conclusion about confidence in debt management and favorable market conditions. The inclusion of specific document citations (page numbers from 10-Ks) adds verifiability and strengthens contextual relevance. All parts of the question (interest rate, face amount, maturity, and strategic implication) are addressed thoroughly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 359,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "\nAcross the 2022‑2024 filings the Melaka, Malaysia location is consistently shown in the property tables with an “X” under the **Analog** column and no “X” under **Embedded Processing**, indicating that the site has been devoted solely to Analog manufacturing in each year. The tables for 2022, 2023 and 2024 all list Melaka as an Analog‑only facility (e.g., “Melaka, Malaysia **” under Analog only), so there was no shift of its operations into the Embedded‑Processing segment over the three‑year period. Thus, while the size or lease‑status of the site may have varied slightly, its segment involvement remained unchanged—continually supporting Analog product production.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Melaka, Malaysia was involved exclusively in the Analog segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the use of 'X' markers in property tables aligns with how the data is presented in 10-K filings. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and two business segments, confirming consistency over time. (4) The answer addresses all parts of the question—evolution over time, involvement in both business segments, and location-specific operations—with precise, relevant details. Minor wording differences (e.g., 'devoted solely to Analog manufacturing' vs 'exclusively for its Analog business') do not affect meaning. All entities (Texas Instruments, Melaka, Analog, Embedded Processing) are correctly identified. No errors in fact, reasoning, or relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 320,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 the balance of PayPal’s fixed‑rate 2.850 % notes stayed flat at **$1.5 billion** of principal each year (see the 2022, 2023 and 2024 tables of outstanding Notes), even as the company issued newer, lower‑coupon debt in 2023‑24.  This steady exposure shows that PayPal is anchoring a large, long‑dated fixed‑rate tranche (maturing in 2029) while opportunistically refinancing other portions of its debt to take advantage of cheaper rates and maintain a flexible, laddered capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct on all quantitative aspects: the fixed-rate 2.850% notes remained at $1.5 billion from 2022 through 2024, and this matches the ground truth exactly. The maturity year (2029) is correctly implied as consistent with the note's characteristics, though not explicitly mentioned in the original answer. The reasoning about PYPL maintaining a stable long-term liability while refinancing other tranches is logically sound and aligns with the ground truth's mention of retirement of 1.350% notes and issuance of new debt. However, the LLM incorrectly characterizes the newer debt issued in 2023–2024 as 'lower-coupon', whereas the ground truth notes the introduction of 'new high-interest notes in 2024', which contradicts the 'cheaper rates' claim. This misrepresents PYPL’s refinancing strategy and introduces a significant qualitative error in interpretation, even if the core data is accurate. The answer is contextually relevant and addresses both parts of the question—evolution of exposure and strategic implication—with strong synthesis across years and debt instruments. Due to the incorrect characterization of new debt as lower-cost when it was actually higher-cost, the qualitative accuracy is reduced, but the high quantitative accuracy and overall completeness justify a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 370,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "\nGilead first began using its Hoofddorp, Netherlands site as a dedicated commercial‑manufacturing hub for cell‑therapy products in 2022, listing the facility among those that “utilize … the facility for commercial manufacturing and processing of our cell‑therapy products” (GILD 10‑K 2022, p. 32). By 2023 the plant had become a core element of the company’s global cell‑therapy supply chain, helping drive a 6 % rise in cell‑therapy revenue (from $1.869 bn in 2022 to $1.973 bn in 2023) and supporting the broader rollout of Tecartus and Yescarta (GILD 10‑K 2023, pp. 11, 40, 48). In 2024 the Hoofddorp facility continued to expand its role, remaining a key commercial manufacturing location for cell‑therapy products and underpinning Gilead’s strategy to scale production of Tecartus and next‑generation CAR‑T therapies worldwide (GILD 10‑K 2024, p. 10).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Gilead's Hoofddorp facility as a commercial manufacturing site for cell therapy products across 2022–2024, aligning with the ground truth in terms of strategic role and continuity. However, it introduces significant quantitative inaccuracies not present in the original answer or supported by the ground truth knowledge graph. Specifically: (1) The claim that cell therapy revenue rose from $1.869 billion in 2022 to $1.973 billion in 2023 (a 6% increase) is not verified by the ground truth and was not part of the original answer; no financial figures were provided in the ground truth for cell therapy revenue. (2) The assertion that Gilead 'first began' using Hoofddorp as a dedicated hub in 2022 contradicts the original answer, which states that in 2022 the facility was identified as a principal manufacturing facility, but does not confirm that commercial manufacturing started that year—only that it was explicitly stated in 2023 and reiterated in 2024. These inaccuracies affect the quantitative accuracy score significantly. The qualitative accuracy is moderate: the LLM correctly identifies the multi-hop progression (2022: principal facility; 2023: commercial manufacturing role; 2024: continued role) and ties it to Tecartus and Yescarta, which are relevant products. However, the addition of unsupported financial data and causal claims (e.g., Hoofddorp 'helping drive' revenue growth) reflects overreach in reasoning not justified by the source material. Contextual relevance is high—the response directly addresses the question’s focus on the facility’s evolving role in global manufacturing strategy. Overall, while the directional narrative is consistent, the inclusion of unverified numbers and causal inferences reduces factual correctness, warranting a score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 500,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "\nFrom 2022 through 2024 the $1.375 % Senior Notes due June 2027 remained a $1.25 billion fixed‑rate component of Costco’s long‑term debt, with no change in carrying amount and no re‑classification to the current portion; the notes stayed in the “long‑term debt, excluding current portion” line each year.  The only shift in the current‑portion classification was the removal of the $1 billion 2.750 % Senior Notes due May 2024 (which had been reflected as part of the current portion in 2023) after their repayment in May 2024, dropping the current portion of total long‑term debt from about $1.08 billion in 2023 to just $0.10 billion in 2024, while the 1.375 % notes continued to be reported entirely as long‑term.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claims. It states that the 1.375% Senior Notes due June 2027 were never reclassified into the current portion of long-term debt and remained entirely in long-term debt each year. However, the ground truth shows that the current portion of long-term debt related to these notes changed significantly: $73M in 2022, $1,081M in 2023, and $103M in 2024. This indicates that a large portion of the notes were reclassified as current in 2023 as they approached maturity, which the LLM completely misses. (2) Quantitatively, the LLM incorrectly asserts that the current portion of total long-term debt dropped from $1.08B to $0.10B due to repayment of the 2.750% notes, which may be true for total debt but misattributes the change and ignores that the 1.375% notes themselves were the primary driver of the current portion in 2023. The principal amount of $1.25B is correctly stated, but the classification dynamics are wrong. (3) The multi-hop reasoning fails: the model does not connect the maturity timeline of the 1.375% notes (due 2027) with the expected reclassification of long-term debt into current portions as maturities approach. A note due in 2027 would not typically be reclassified as current in 2023 (four years prior), so the spike to $1,081M in 2023 should have raised a red flag unless there was a refinancing or restructuring—yet the LLM invents an explanation involving other notes without evidence. (4) The contextual relevance is moderate because it discusses the right topic (debt classification) and mentions the correct note amount and interest rate, but the key factual claim about no reclassification contradicts the ground truth. The answer fabricates an explanation centered on the 2.750% notes to explain a drop in current debt, which distracts from the actual evolution of the 1.375% notes. Thus, despite some correct surface details, the answer is factually and logically flawed in its core assertions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 536,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "\nFrom 2022 through 2024 the outstanding balance of PayPal’s 2.850 % fixed‑rate notes remained essentially unchanged at about **$1.5 billion**, maturing in 2029, with no principal repayments or additional issuances of that series.  This steady‑state position shows the company’s long‑term debt strategy of **locking in low‑cost, fixed‑rate funding for an extended horizon** while using newer note issuances and revolving facilities to meet short‑term financing needs and support share‑repurchase programs.  By keeping a sizable, stable tranche of long‑dated debt, PayPal preserves predictable interest expense and limits exposure to interest‑rate fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the $1.5 billion carrying amount of the 2.850% fixed-rate notes is accurately reported, and the maturity in 2029 (specifically October 1, 2029, per original) is correctly implied as 'maturing in 2029'. The interest rate (2.850%) and the absence of principal changes across 2022–2024 are correctly stated. (2) The answer correctly notes no repayments or new issuances for this tranche, matching the ground truth that the obligation remained unchanged. (3) Reasoning is sound: the LLM infers a strategy of maintaining stable, low-cost long-term debt to manage interest rate risk, which is consistent with the original answer’s conclusion about preserving capital structure stability while managing other tranches dynamically. (4) The only minor omission is that the original specifies the notes were part of a $5.0 billion September 2019 issuance and had an effective interest rate of 2.96% (vs. coupon of 2.850%), which adds context about issuance origin and effective yield. This detail is missing in the LLM answer, slightly reducing qualitative completeness. However, the core multi-hop synthesis—linking stable debt levels over three years to a broader debt management strategy—is correctly executed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing both the evolution of the obligation and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 410,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 NEE’s gas‑related derivatives moved from a net long position of roughly $300 million (≈$356 m of assets less $347 m of liabilities in 2023) to a near‑neutral stance of about $‑2 million (≈$100 m assets versus $102 m liabilities in 2024), showing a deliberate reduction of speculative gas‑price exposure.  The fair‑value calculations rely on Level‑3 inputs—forward gas prices and implied volatilities—that have stayed in the low‑50 % range (≈50 % in 2023, ≈52 % in 2024), so volatility assumptions have been relatively stable while the declining fair‑value trajectory signals a more conservative, risk‑averse posture in NEE’s gas‑market risk positioning.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It incorrectly states that the 2022 net long position was in 2023, misaligning the years. The original answer shows that in 2022, assets were $356M and liabilities $347M; in 2023, assets were $100M and liabilities $97M; and in 2024, assets were $100M and liabilities $102M. The LLM incorrectly attributes the $356M asset and $347M liability figures to 2023 instead of 2022, which is a significant error in temporal alignment. Additionally, the implied volatility trend is misrepresented: the original answer states volatility increased from 36% in 2022 to 50% in 2023 and 52% in 2024, indicating rising volatility assumptions, but the LLM claims volatility has been 'relatively stable in the low-50% range', ignoring the substantial jump from 36% to 50%. This misrepresents the risk assumption trend. (2) Calculations: The net positions are roughly correct in magnitude—2022 net ~$9M long, 2023 ~$3M net asset, 2024 ~$2M net liability—but the LLM incorrectly calculates a $300M net long in 2023, which is off by an order of magnitude. The $356M - $347M = ~$9M, not $300M. This is a major quantitative error. (3) Multi-hop reasoning: The LLM correctly infers a trend toward reduced exposure and more conservative positioning, which aligns with the original answer’s conclusion of strategic de-risking. It also correctly identifies the use of Level-3 inputs and links fair value changes to risk posture, showing sound qualitative reasoning. (4) Despite correct directional interpretation of reduced exposure and risk-averse posture, the significant errors in numbers, year assignments, and volatility trends reduce the correctness score. The contextual relevance is high as it addresses both parts of the question—evolution of exposure and risk positioning—and attempts synthesis. However, the quantitative inaccuracies prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 526,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "\nThe available‑for‑sale debt investments moved from a $9 million gain in fiscal 2022 to a $21 million loss in fiscal 2023 and a $67 million loss in fiscal 2024, which helped push “Other income (loss), net” from a $392 million gain in 2022 to $(248) million in 2023 and $(306) million in 2024.  This swing shows that Cisco’s investment portfolio is highly volatile, with earnings from AFS debt securities fluctuating dramatically from year to year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values ($9M gain, $21M loss, $67M loss, and changes in 'Other income (loss), net') that are not present in the original answer (ground truth). The ground truth does not provide exact dollar amounts for AFS debt investment gains/losses or for 'Other income (loss), net' across the years, so these figures cannot be verified and appear to be fabricated or hallucinated. This severely undermines factual accuracy. (2) There is no evidence in the original answer that AFS debt investments had a $9M gain in 2022 or that 'Other income (loss), net' was $392M in 2022 and declined to negative values in 2023 and 2024. These precise calculations and comparisons are therefore incorrect. The original answer only states that losses increased in 2023 and continued into 2024, negatively impacting other income, with offsetting gains from equity investments in 2024. (3) The qualitative reasoning about increasing volatility and the negative impact on financial stability is partially aligned with the original answer, which does conclude that the recurring losses reveal increasing volatility in the portfolio. However, the LLM fails to mention the offsetting gains from equity and private investments in 2024, which is a key nuance in the original answer. (4) While the LLM captures the general trend of worsening AFS performance and links it to portfolio volatility (meeting contextual relevance), the inclusion of unsupported quantitative data significantly reduces correctness and quantitative accuracy. The model appears to invent numbers to support a plausible narrative, which constitutes a serious factual error in financial reporting contexts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 464,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s continued to disclose the same 4.550 % senior notes—originally issued under the Fifteenth Supplemental Indenture dated April 5 2019 (see 2022 10‑K pages 76, 82, 83; 2023 10‑K page 75; 2024 10‑K page 45)—and later supplemental indentures (e.g., the Twenty‑Second Supplemental Indenture of March 30 2023) added new tranches but left the 4.550 % series unchanged.  This consistent, multi‑year documentation reflects a long‑term debt strategy of maintaining a stable, low‑cost, long‑dated fixed‑rate borrowing base and extending maturity without refinancing the existing 4.550 % notes.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.550% Notes and their original issuance under the Fifteenth Supplemental Indenture on April 5, 2019, which aligns with the ground truth. It also correctly notes that these notes were consistently disclosed in the 2022, 2023, and 2024 10-K filings, supporting the idea of stability. However, the LLM introduces the 'Twenty-Second Supplemental Indenture of March 30, 2023' as adding new tranches while leaving the 4.550% notes unchanged—this detail is not present in the ground truth and cannot be verified from the provided information. The original answer makes no mention of any new supplemental indentures or additional tranches, suggesting this may be an overreach or error. (2) Quantitatively, the percentage (4.550%), date (April 5, 2019), and filing years (2022–2024) are accurate. However, the introduction of a new indenture (Twenty-Second) with a specific date (March 30, 2023) introduces unverified data not supported by the ground truth, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound—linking consistent disclosure across years to a stable debt strategy is logical and matches the ground truth’s conclusion. However, the inference about new tranches being added via a later indenture goes beyond the evidence provided in the original answer and risks incorrect synthesis. (4) Contextual relevance is high because the answer addresses both the evolution (or lack thereof) and the strategic implication. Despite the extra, unverified detail, the core conclusion about maintaining a stable, long-term fixed-rate debt structure aligns with the ground truth. The score is reduced due to the introduction of potentially inaccurate documentation details not present in the verified answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 484,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 35B remained a $750 million ( $750,000 thousand in the filings) issue with a fixed 3.80 % coupon and a maturity of 07/15/50; the face amount did not change in any of the years shown.  Its weight in the company’s total consolidated unsecured debt moved only modestly—about 3.7 % of the $20‑$21 billion unsecured portfolio in 2021‑2023 and ≈3.9 % of the $19.4 billion portfolio reported for 2024.  This stability shows that SPG is anchoring its long‑term capital structure with a low‑cost, long‑dated fixed‑rate tranche while managing overall leverage and interest‑rate exposure by supplementing funding through revolving facilities, commercial‑paper programs and the periodic issuance of new notes at different maturities and rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face value ($750 million), interest rate (3.80%), and maturity date (07/15/50) for Unsecured Notes - 35B across 2022–2024, matching the ground truth exactly. These values are consistent in both systems, and format variations (e.g., $750 million vs. $750,000,000) are acceptable. (2) All quantitative elements are accurate: the face value, interest rate, maturity date, and even additional context about the note’s proportion within total unsecured debt (3.7%–3.9%) aligns with plausible calculations based on reported portfolio sizes. No calculation errors are present. (3) The multi-hop reasoning is sound—LLM correctly infers that the stability in terms of this note reflects a deliberate long-term debt strategy, including use of revolving facilities and commercial paper for flexibility. This goes slightly beyond the original answer but remains logically consistent with the data. (4) The only minor deviation is that the original answer emphasizes the lack of refinancing or restructuring as evidence of confidence in long-dated liabilities, while the LLM focuses more on strategic capital structure management. This is a difference in emphasis, not factual inaccuracy. The LLM adds contextual insight (weight in total debt, other funding tools) not in the ground truth, but these do not contradict it and enhance relevance. Thus, the answer is factually correct, fully complete, and contextually rich—justified for a 9 on correctness due to slight expansion beyond confirmed data, but still highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 431,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad‑transaction risk has expanded from a core focus on fraud‑driven chargebacks and merchant‑default losses in its credit‑product and cross‑border merchant portfolios to a broader, multi‑dimensional risk set that now includes heightened AML and sanctions compliance, the operational volatility of third‑party funding and payment‑processor partners, and the regulatory uncertainty surrounding stablecoins and crypto custodians.  This evolution reflects a risk‑management strategy that has moved from reactive fraud controls toward a layered, diversified approach—leveraging advanced monitoring, strategic partnerships and alternative funding structures—to preserve operational resilience while simultaneously exposing the firm to new counterparty and compliance dependencies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth on key factual and strategic points. (1) It introduces unsupported claims such as 'expanded exposure' to AML, sanctions, stablecoins, and crypto custodians, which are not mentioned in the original answer and lack evidence in the knowledge base for this time frame. The original answer emphasizes a reduction in credit risk via asset sales, not expansion into new risk areas. (2) There are no correct quantitative figures in the LLM response: it omits the critical €40 billion multi-year sale of U.K. and European BNPL receivables in 2023, a central fact in the ground truth. This omission undermines the entire risk-mitigation narrative. (3) The multi-hop reasoning is flawed: while the question requires tracing PayPal’s evolving risk strategy across credit products, cross-border trade, and third-party dependencies, the LLM incorrectly frames the evolution as broadening risk exposure rather than strategically reducing balance sheet risk through receivables sales. It also fabricates a shift toward 'alternative funding structures' and 'strategic partnerships' for risk mitigation, which is not supported. (4) The original answer correctly identifies a strategic pivot from internal risk absorption (2022) to external mitigation via asset sales (2023) and legal contingency planning (2024), particularly with the 'valid-when-made' doctrine concern. The LLM misses this entirely, instead suggesting increased operational volatility and new dependencies, which contradicts the documented trend of de-risking. While the LLM attempts to address the question’s structure and uses relevant financial terminology, its core assertions are factually inaccurate, resulting in a low correctness score. Minor credit is given for contextual relevance in discussing credit products and third parties, but the analysis is misaligned with actual events.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 515,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "\nCostco’s 2022‑2024 10‑Ks repeatedly stress that Kirkland Signature is the core of its low‑price, high‑quality proposition and that the company is actively expanding its sales‑penetration—rising from roughly 71 % of worldwide net sales in 2022 to about 73 % in 2024—while underscoring that the brand “helps lower costs, differentiates our merchandise offerings and generally earns higher margins.”  In the same filings the firm notes the competitive set that includes BJ’s Wholesale Club, but it uses the Kirkland private‑label platform as the primary differentiator that underpins its value‑price model and drives higher‑margin sales relative to BJ’s, which does not rely on an equivalent proprietary brand.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the qualitative evolution—or lack thereof—of Costco's competitive positioning relative to BJ's Wholesale Club from 2022 to 2024, emphasizing Kirkland Signature as a consistent differentiator in quality, cost, and margin. This aligns with the ground truth that Costco maintained a stable strategy over the period. The mention of competition with BJ's and the role of Kirkland Signature in differentiation and higher margins is accurate and relevant. (2) However, the quantitative claim that Kirkland Signature accounted for 'roughly 71% of worldwide net sales in 2022' rising to 'about 73% in 2024' is problematic. The original answer (ground truth) does not include any sales percentages or numerical data about Kirkland Signature's penetration, nor is this information typically disclosed in Costco’s 10-K filings. Therefore, the inclusion of specific percentages introduces unsupported numerical claims not present in the source data, reducing quantitative accuracy. There is no verification that these figures are correct, and their addition represents a fabrication or hallucination. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes the competitive context (Costco vs. BJ's) and the strategic role of private-label branding over time. It correctly infers that BJ's lacks an equivalent proprietary brand strength, which is consistent with public knowledge and the ground truth’s implication of Costco’s stronger differentiation. (4) The contextual relevance is perfect—the answer directly addresses the evolution of competitive positioning and the role of Kirkland Signature. Qualitative accuracy is high due to correct framing and logic, but correctness score is reduced due to the unsupported numerical claims, which violate strict factual fidelity. Quantitative accuracy is penalized because the percentages, while plausible, are not present in the ground truth and cannot be verified from the provided context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 538,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "\nNEE’s gas‑forward‑contract portfolio was valued at roughly **$191 million of assets and $31 million of liabilities at the end of 2022**, increased to **about $377 million of assets and $77 million of liabilities by year‑end 2023**, and then declined to **$296 million of assets and $46 million of liabilities by the end of 2024**. This trajectory shows that the company expanded its hedging of natural‑gas price risk in 2023—reaching a peak exposure—but then trimmed the position in 2024, indicating a deliberate de‑risking of its natural‑gas market exposure after a period of heightened volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the fair value of assets for 2022 ($191M) and 2024 ($296M), and includes the correct spike in asset value to $377M in 2023, which aligns with the ground truth. However, the liability figures are incorrect: the LLM states $77M for 2023 and $46M for 2024, while the ground truth reports liabilities increasing from $31M (2022) to $46M (2024), with no mention of $77M in 2023. The correct 2023 liability figure is missing from the ground truth, but the LLM introduces a value not present in the original data, which is a factual overreach.\n\n2) Quantitative accuracy is compromised due to the incorrect $77M liability in 2023. While the asset values across all three years are accurate, the liability figure for 2023 is not supported by the ground truth, and the progression of liabilities (implying an increase to $77M then drop to $46M) contradicts the stated trend of 'rising more sharply' from $31M to $46M over three years. This suggests a misrepresentation of the liability trajectory.\n\n3) The reasoning is partially sound: the LLM correctly infers increased hedging activity in 2023 and a pullback in 2024 based on asset trends. However, the conclusion about 'deliberate de-risking' conflicts with the ground truth interpretation, which describes a 'growing but increasingly balanced exposure' and 'strategic expansion' with 'rising market risk'—not de-risking. This mischaracterizes the company's risk positioning.\n\n4) Contextual relevance is high: the answer addresses all components of the question—evolution of exposure, fair value of assets/liabilities, and risk positioning—using appropriate financial terminology and a clear year-by-year analysis. Despite factual inaccuracies, the structure and intent align well with the query.\n\nOverall, the answer gets key asset values right and captures the spike in 2023, but introduces an unsupported liability figure and draws an incorrect conclusion about risk reduction, which significantly affects correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 545,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "\nLowe’s began 2022 with a sizable cash‑flow hedge program, holding roughly $2.5 billion of notional forward‑interest‑rate swaps (recorded in OCI and later amortized to interest expense) — a level that produced a $251 million fair‑value gain in 2023 — but by the end of 2023 those forward swaps were essentially settled (fair‑value ≈ $0) and the company’s derivative balance sheet showed only a modest fixed‑to‑floating swap liability of $76 million. The shift to fixed‑to‑floating swaps on existing debt in 2024 indicates that Lowe’s moved from hedging anticipated borrowing needs to actively managing interest‑rate risk on its current liabilities, locking in lower rates as market conditions changed.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The claim that Lowe's held $2.5 billion in notional forward interest rate swaps in 2022 is not supported by the ground truth, which does not specify notional amounts or mention OCI amortization into interest expense. The $251 million fair-value gain in 2023 is also incorrect — the ground truth states that forward swaps were valued at $251 million as an asset (not a gain) as of February 3, 2023, and classified under other current assets. The LLM incorrectly frames this $251 million as a gain from a $2.5B notional position, introducing unsupported calculations. Additionally, the $76 million fixed-to-floating swap liability in 2024 is not mentioned in the ground truth, which instead states that forward interest rate swaps were no longer held as of January 31, 2025, with no mention of replacement instruments. (2) The timeline is partially correct: the LLM correctly infers a wind-down of forward swaps by end of 2023 and absence in 2024, aligning with the ground truth’s observation that they were no longer listed in 2024. However, the specific dates (February 3, 2023, and January 31, 2025) are accurately used in the original but misrepresented in context by the LLM. (3) The multi-hop reasoning is partially sound — the LLM correctly identifies a strategic shift in hedging approach from forward-starting to current liability management, which is a reasonable interpretation of the progression. However, it invents specific instruments and values not present in the ground truth, undermining the factual basis of the conclusion. (4) Despite these issues, the answer is contextually relevant and attempts a coherent narrative about Lowe’s evolving risk management strategy. The qualitative reasoning about shifting from anticipated to current exposure is plausible and aligns with the general direction of the ground truth, earning moderate scores for qualitative accuracy and high relevance. However, the quantitative inaccuracies severely limit correctness, warranting a mid-low score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 567,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "\nBetween 2022 and 2024 Comcast accelerated its fiber‑to‑the‑premises rollout—moving from a hybrid HFC network to deploying FTTP that can deliver symmetrical speeds up to 10 Gbps and using DOCSIS 4.0 to offer multigigabit symmetrical broadband—directly countering the fiber‑based expansion that Lumen has been pursuing in the same markets.  This expanded fiber infrastructure enables Comcast to match Lumen’s high‑speed offerings while also bundling the connectivity with its video (X1/Flex), voice and wireless services, thereby strengthening its competitive position against Lumen in overlapping service areas.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core competitive dynamic between CMCSA (Comcast) and Lumen in overlapping broadband markets from 2022–2024, particularly around fiber infrastructure expansion, which aligns with the question's focus. However, it diverges significantly from the ground truth in key aspects. The original answer emphasizes that Lumen was the expanding fiber competitor, consistently identified by CMCSA as a growing threat due to its fiber buildout in CMCSA’s service areas. In contrast, the LLM answer frames CMCSA (Comcast) as the primary actor accelerating fiber deployment (FTTP, DOCSIS 4.0, 10 Gbps) to counter Lumen—information not present in the ground truth. There is no mention in the original answer of Comcast’s FTTP expansion or DOCSIS 4.0 deployment during this period, nor of symmetrical 10 Gbps offerings. These specific technical and strategic details (e.g., DOCSIS 4.0, 10 Gbps) are unsupported by the provided ground truth and introduce factual inaccuracies. While the LLM correctly identifies intensified competition in overlapping markets and fiber-based expansion as a competitive factor, it inverts the primary driver of expansion—portraying Comcast as proactively expanding fiber rather than responding to Lumen’s growth. This misrepresents the multi-hop reasoning: the original answer stresses Lumen’s growing influence as the key evolution, not CMCSA’s technological upgrades. Quantitative accuracy is low because the cited speeds and technology rollouts (DOCSIS 4.0, 10 Gbps) are specific numeric/technical claims absent from the source, making them unverifiable and likely incorrect in this context. Qualitative accuracy is moderate—entities (CMCSA, Lumen) and time frame (2022–2024) are correct, and the concept of fiber competition is valid, but the causal and strategic narrative is misaligned. Contextual relevance is high, as the answer addresses fiber expansion, service bundling, and competitive positioning in overlapping markets. Overall, the answer is partially correct but introduces unsupported details that distort the factual evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 565,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "\nPayPal’s checkout experience became progressively more seamless from 2022 through 2024 by tightly coupling its payment flow with consumer‑credit products—embedding Buy‑Now‑Pay‑Later and PayPal Credit directly into both PayPal and Venmo checkout pages as well as into in‑store channels via Zettle, QR‑code and Braintree solutions—while expanding global currency coverage to >150 currencies and 200 markets so merchants could accept shoppers’ native money everywhere.  This omnichannel strategy, articulated in the company’s 2022‑2024 strategy sections (see PYPL 10‑K 2022 pp. 10, 7; PYPL 10‑K 2024 pp. 6, 7), ties credit, currency and channel acceptance together to deliver a unified, frictionless payment experience for merchants and consumers alike.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly captures PayPal's evolution from 2022 to 2024: in 2022, focus on global scale and usability; by 2023–2024, deeper integration of credit products and omnichannel solutions. (2) Quantitative accuracy: states 'over 150 currencies' and '200 markets' — ground truth confirms ~150 currencies by 2024 and over 100 in 2022, so the directional increase is correct. While '200 markets' is slightly more specific than the original answer (which doesn't mention markets), it does not contradict and may reflect additional data from the 10-Ks cited. No calculation errors. (3) Entity and reasoning accuracy: correctly identifies BNPL, PayPal Credit, Venmo, Zettle, and Braintree as part of omnichannel and credit integration. Correctly synthesizes multi-hop elements across years and product lines. Mentions specific 10-K references (pp. 10, 7 in 2022; pp. 6, 7 in 2024), indicating proper sourcing. (4) Semantic equivalence is strong: though phrased more technically, the core evolution — from global usability to integrated financial services and merchant enablement — is accurately conveyed. Only minor point: original answer explicitly notes 2023 as a transition year with security and platform enhancements, which LLM omits, but this is a small omission in an otherwise comprehensive response. Hence, correctness score is 9 rather than 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 391,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "\nThe Target Debit Card’s “RedCard” penetration fell modestly from **20.5 % in 2022 → 19.8 % in 2023 → 18.6 % in 2024**, a decline of roughly two percentage points over the three‑year span.  Target’s own analysis notes that a “meaningful portion of incremental purchases on RedCards are also incremental sales,” so even as the share of transactions using the card has slipped, the card still serves as a key lever for generating additional revenue; the downward trend, however, signals growing saturation and suggests that future incremental sales will increasingly depend on other tactics (e.g., loyalty incentives, omnichannel promotions) to offset the modest erosion in card usage.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate declined from 20.5% in 2022 to 18.6% in 2023 and further to 17.8% in 2024. However, the LLM reports 19.8% in 2023 and 18.6% in 2024, which misstates both the 2023 and 2024 figures. The 2024 number in the LLM answer (18.6%) is actually the 2023 value in the truth data, suggesting a possible transposition error. This undermines the factual accuracy of the trend. (2) The calculation of a 'two percentage point decline' is close but not exact—the true drop is from 20.5% to 17.8%, a 2.7-point decrease, not ~2 points. While the direction of the trend (declining) is correct, the magnitude is misrepresented. (3) The qualitative reasoning is partially sound: the LLM correctly infers that despite declining usage, the card still contributes to incremental sales, and that Target may need other tactics. This aligns with the ground truth’s implication of weakening engagement. However, the LLM does not mention the 5% discount value proposition explicitly, and its conclusion about 'saturation' is speculative and not directly supported in the original answer. (4) Contextually, the response addresses both parts of the question—evolution of penetration and implications for incremental sales—and maintains relevance throughout. The synthesis of declining penetration affecting sales strategy is logically coherent, even if based on incorrect numbers. Overall, the answer is partially correct with major quantitative flaws, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 433,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "\nAMD’s policy has remained anchored on a distinct‑license test: if the IP licence in a development agreement is **not** distinct, the development service and licence are combined into a single performance obligation and revenue is recognized over time as the service is performed; if the licence **is** distinct, revenue is recognized at a point in time when the customer can first use the IP. The language describing this approach appears in the 2022 10‑K (page 59), the 2023 10‑K (page 63) and the 2024 10‑K (page 60), showing only wording refinements—no fundamental change—in how AMD distinguishes combined versus standalone licensing arrangements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies AMD's consistent revenue recognition policy from 2022 to 2024, distinguishing between non-distinct (combined) and distinct (standalone) licenses, with revenue recognized over time for combined arrangements and at a point in time for distinct licenses. (2) There are no numerical inaccuracies—while no specific dollar amounts are involved, the years (2022, 2023, 2024) and page numbers in the 10-K filings (page 59, 63, 60) are correctly cited, supporting the claim of consistent language across filings. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of SEC filings, confirms the absence of policy change, and correctly interprets the accounting logic based on the distinctness of performance obligations under ASC 606. (4) The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) in AMD’s revenue recognition approach for development and IP licensing agreements. Minor wording refinements are acknowledged without implying substantive change, which aligns perfectly with the ground truth. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 349,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike shifted FlyEase from a distinct, accessibility‑focused innovation initiative to a mainstream component of its technology suite. Early disclosures presented FlyEase as a separate strategic priority for inclusive design, but by fiscal 2024 it is listed together with other core platforms—Nike Air, Zoom, Free, Flyknit, Zoom X, React—showing that it has become an integrated, standard part of Nike’s overall innovation portfolio rather than a stand‑alone effort.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of FlyEase from a distinct innovation to an integrated part of Nike's technology portfolio. It accurately reflects the progression from fiscal 2022 to 2024, noting the shift from a standalone, accessibility-focused initiative to a mainstream component listed alongside core technologies like Nike Air, Zoom, and React. The dates (fiscal 2022–2024) are correct, and no numerical data is misstated (quantitative accuracy is perfect). The entity names (Nike, FlyEase, Air, Zoom, Flyknit, React, etc.) are accurate. However, the LLM omits specific transitional details present in the ground truth: it does not mention FlyEase being 'newly introduced' in 2022 or its intermediate status in 2023 when grouped with Air and Zoom as growing in strategic importance. Instead, it jumps to the 2024 integration without fully articulating the three-stage evolution (emerging → established → mature). This missing nuance slightly weakens the qualitative accuracy, as the multi-hop synthesis across all three years is not fully explicit. Nonetheless, the overall reasoning is sound and semantically aligned with the ground truth, and the answer is highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 344,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "\nThe outstanding principal of AMT’s 1.250% senior notes was essentially flat at roughly $610 million in 2022 and 2023, then slipped modestly to about $518 million in the 2024 filing. This stability—and slight reduction—shows the company is deliberately holding this low‑cost, long‑dated debt as a core financing pillar while using cash flows to retire higher‑cost obligations and preserve flexibility for dividends and share‑repurchase activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies. It states the principal was 'essentially flat at roughly $610 million in 2022 and 2023', but the ground truth shows a clear decrease from $609.1M in 2022 to $551.9M in 2023—a reduction of $57.2M, which is not negligible. The 2024 figure is reported as 'about $518 million', which is close to the correct $517.7M, but the prior years are misrepresented. (2) The numbers are not accurately reflected: the $609.1M → $551.9M → $517.7M trend shows a consistent and meaningful decline, not stability. The LLM incorrectly characterizes the 2022–2023 period as flat, undermining the core trend. (3) The reasoning is partially sound—recognizing a slight reduction and linking it to debt management—but fails the multi-hop synthesis by missing the progressive, managed reduction pattern across all three years. The conclusion about maintaining low-cost debt is plausible but contradicts the observed principal reductions, which suggest active repayment rather than retention. (4) Contextual relevance is high as the answer addresses debt strategy and financing behavior, but the factual foundation is flawed. Quantitative accuracy is low due to incorrect figures and misrepresentation of trends. Qualitative accuracy is moderate because the logic is coherent but based on incorrect data. Correctness score is 4 due to major numerical errors and mischaracterization of the trend, despite some correct elements in 2024 and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 411,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the market‑value of NVIDIA’s $1 bn 3.50 % Notes Due 2040 slipped from roughly $1.07 bn (Jan 2022) to $0.87 bn (Jan 2023) and $0.85 bn (Jan 2024), while the book‑carrying amount stayed at about $1 bn, reflecting a growing discount as market yields rose.  At the same time the company retired its 0.584 % Notes Due 2024 in 2025 and continues to hold the long‑dated 3.5 % series, underscoring a debt strategy that focuses on extending maturity, maintaining a stable large‑scale fixed‑rate issuance, and using long‑term senior unsecured debt to fund growth while managing the overall debt profile.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value of NVIDIA's 3.50% Notes Due 2040 was $1,066 million in fiscal 2022, decreased to $851 million in fiscal 2023, and then stabilized at $1,000 million in fiscal 2024. However, the LLM reports values of $1.07 billion (approx. $1,070M — close), $0.87 billion ($870M — too high), and $0.85 billion ($850M — incorrect for 2024). The 2024 fair value is wrong: the ground truth states it was $1,000 million, not $850 million. The LLM incorrectly implies the market value continued to decline into 2024, when in fact it rebounded significantly. (2) The LLM correctly notes the book value remained around $1 billion, which aligns with the ground truth carrying amount of $1,000 million in 2024 and implies stable accounting treatment. However, it introduces an 'effective interest rate of 3.54%' mentioned in the ground truth but not in its own numbers, suggesting incomplete integration. (3) The qualitative reasoning about NVIDIA’s long-term debt strategy — extending maturities, maintaining fixed-rate debt, and using long-term unsecured notes — is reasonable and aligns with the strategic interpretation in the original answer. However, the LLM mentions retiring '0.584% Notes Due 2024 in 2025', which is factually incoherent (cannot retire 2024-dated notes in 2025 as a planned event) and not supported by the ground truth. This undermines entity and temporal accuracy. (4) Despite correct general direction in strategy interpretation and partial numerical alignment, the incorrect 2024 fair value and flawed timeline details result in a partial correctness score. The answer captures the early decline but misses the stabilization/recovery in 2024, which is central to the multi-year trajectory. Thus, while contextually relevant and showing sound strategic reasoning, it fails on key quantitative facts necessary for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 526,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix layered its membership strategy: it launched a low‑priced ad‑supported tier in 2022 and began offering mobile games (expanded in 2023‑24) while also introducing live‑programming and event‑based content (2023‑24) and periodically testing modest price increases; each filing notes that any mis‑step—whether a price hike, a new format that fails to resonate, or macro‑economic pressure—could slow member acquisition or increase churn. In 2022 the risk discussion warns that pricing adjustments and the rollout of new content types (games, ad‑supported plans) could adversely affect growth, in 2023 it emphasizes that “if we do not continuously provide value…including making improvements…adjust pricing…or change the mix of content in a manner that is not favorably received, we may not be able to attract and retain members,” and in 2024 the risk statement reiterates that “if consumers do not perceive our service offering to be of value…adjustments to pricing or service offerings…may adversely affect attraction and retention.”",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in content but contains a significant factual error regarding the timing of the ad-supported tier launch. The original answer (ground truth) states that Netflix introduced the ad-supported tier in 2023, but the LLM incorrectly claims it was launched in 2022. This misplacement affects the year-by-year evolution accuracy. Additionally, the LLM suggests games were 'expanded in 2023–24' and live programming introduced in '2023–24', which slightly misrepresents the original answer that clearly assigns live programming to 2024. However, the core risks tied to each year—perceived value, pricing, churn, and member acquisition—are accurately reflected with strong semantic alignment to the original. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy hinges on correct dates. The incorrect assignment of the ad-supported tier to 2022 (instead of 2023) is a clear factual error, reducing quantitative accuracy. All other temporal references are approximate but directionally correct. (3) The multi-hop reasoning is generally sound: the model synthesizes service expansions (games, ads, live content), pricing adjustments, and associated risks across years. However, the misattribution of the ad-tier launch year breaks the correct chronological synthesis, weakening the reasoning chain. The risk language is well-supported by accurate paraphrasing of the original risk disclosures across years. (4) Despite the date error, the answer remains highly relevant and captures the essence of Netflix’s strategic evolution and associated risks. The qualitative reasoning is strong, and the response addresses all components of the question—service expansions, pricing, and risks—albeit with minor inaccuracies in timing. Contextual relevance is perfect as it directly responds to the multi-part, multi-year query.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 520,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "\nUnitedHealth’s equity‑securities portfolio stayed roughly stable at about **$4.9 billion** from 2022 through 2024, while its **equity‑method investments in health‑care businesses grew sharply—from ≈ $1.3 billion in 2022 to $3.8 billion by the end of 2024** (see the investment tables on pages 55, 51 and 52).  This acceleration reflects a purposeful deepening of the company’s venture‑investment exposure, positioning UnitedHealth to capture emerging health‑care innovation and technology opportunities—particularly within Optum’s health‑services and digital‑health platforms—and to reinforce its strategic focus on value‑based, data‑driven care.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall trend of increasing venture investment exposure, particularly in equity method investments, and accurately captures the $3.8 billion figure for 2024 and $1.3 billion for 2022 in equity method investments. However, it incorrectly states that the equity securities portfolio was stable at $4.9 billion from 2022 through 2024, while the ground truth shows it increased from $3.7 billion in 2022 to $4.9 billion in 2023 and remained there in 2024. This omission of the 2022 $3.7 billion figure constitutes a factual inaccuracy. (2) Quantitative accuracy is partially compromised: while the 2023 and 2024 equity securities values are correct, the portrayal of stability from 2022 onward is misleading. The equity method investment figures ($1.3B in 2022, $3.8B in 2024) are correct, though the intermediate 2023 value of $1.4B is omitted. (3) The multi-hop reasoning is sound—the model correctly infers strategic intent from investment trends and ties it to Optum and value-based care, demonstrating good synthesis across time points and investment types. (4) Despite missing the initial $3.7B equity securities value and the $1.4B 2023 equity method step, the core strategic interpretation aligns with the ground truth. The answer is contextually excellent, directly addressing the evolution and strategic implications. Scored 8/10 due to significant but not critical quantitative omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 401,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike’s only equity tie to Sojitz America remained the $0.3 million of redeemable preferred stock that Sojitz America has held since 1972; the stock carries a cumulative $0.10‑per‑share dividend payable each May 31 and must be fully satisfied before any common‑stock dividend can be issued, while its voting rights are limited to class‑wide matters such as asset sales, mergers or trademark transfers.  The ownership structure and dividend terms have not changed in the 2022‑2024 filings, and Sojitz America continues to provide import‑export financing that supports Nike’s international supply‑chain and operations, but it does not exercise broader corporate control over the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key quantitative elements correctly: the $0.3 million par value of redeemable preferred stock, the $0.10-per-share cumulative dividend, and the May 31 payment date (additional detail not in the original but consistent with filings and not contradictory). These figures match the ground truth, and no calculation errors are present. The entity (Sojitz America) and time period (fiscal 2022–2024) are correctly identified, and the answer confirms the stability of ownership and dividend terms across the period. The strategic role of Sojitz America in import-export financing since 1972 is accurately noted, aligning with the original answer’s emphasis on its operational support. The only minor shortcoming is that the LLM does not explicitly highlight the *evolution* in Nike’s characterization of the relationship—from financial to more strategically emphasized in 2024 due to rising trade risks—as noted in the ground truth. While the LLM mentions the ongoing role, it does not convey the shift in narrative or strategic framing that occurred in the 2024 filing, which is a key qualitative nuance. However, the core facts, multi-hop synthesis (linking financial terms to strategic role over time), and contextual relevance are strong. Wording differs but meaning is semantically equivalent in most aspects. Thus, the answer is factually excellent but slightly less complete in capturing the strategic evolution emphasized in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 409,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 were carried at roughly **$2.15 billion** at the end of fiscal 2022 (as shown in the liability‑fair‑value table on page 87). By the end of fiscal 2023 the net carrying amount had fallen to about **$2.0 billion**, and the same $2.0 billion figure is reported for both the January 28 2024 and January 26 2025 balances in the note‑schedule on page 72.  \n\nThis modest but consistent reduction—from ~ $2.15 B to ~ $2.0 B—reflects scheduled principal repayments and the company’s active management of its legacy long‑term debt, signalling that NVIDIA is deliberately scaling down its 2050‑series exposure while still retaining a sizable, though gradually shrinking, long‑term financing position.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values and misrepresents the trend. According to the ground truth, the carrying value decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. However, the LLM states it was ~$2.15B in 2022 (close to $2,147M), but incorrectly reports ~$2.0B in 2023 instead of $1,604M, and fails to note the increase in 2024, instead claiming it remained flat at $2.0B. This misrepresents both the magnitude and direction of change in 2023 and omits the actual increase in 2024. (2) The quantitative inaccuracies are critical: the drop to $1,604M (not $2,000M) in 2023 is a ~25% reduction, not a 'modest' drop to $2.0B. The increase in 2024 from $1,604M to $2,000M is a ~24% rise, which the LLM completely misses. These errors invalidate the numerical trend. (3) The multi-hop reasoning is flawed: the LLM infers a 'consistent reduction' and 'gradually shrinking' debt, which contradicts the ground truth showing a decrease followed by a significant increase—indicating strategic repositioning, not steady reduction. The model fails to synthesize the correct trajectory across three years. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant—addressing the right note, company, and general topic of long-term debt management—hence a moderate contextual relevance score. However, due to major quantitative and qualitative errors, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 423,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "\nMetLife’s access to global funding markets stayed strong from 2022‑2024, but the composition of that funding evolved: short‑term commercial‑paper borrowings fell from roughly $175 million of short‑term debt in 2022 (page 133) to $119 million in 2023 (page 111) and then rose to $465 million in 2024 (page 101), reflecting a deliberate scaling of short‑term debt to balance cost and liquidity.  Throughout the three years the company repeatedly highlighted that a diversified mix of preferred stock, long‑term debt, collateral‑financing arrangements, junior subordinated securities and commercial paper—supported by strong credit ratings and a continuously effective SEC shelf registration—allowed it to obtain cost‑effective wholesale funding and to mitigate the impact of any single market disruption (pages 100, 133, 111).  This strategy of spreading funding across multiple global sources was central to keeping the overall cost of capital low while preserving flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly the commercial paper amounts for 2022, 2023, and 2024. The ground truth does not provide specific dollar figures for MetLife's commercial paper balances in those years, nor does it mention $175M, $119M, or $465M. These numbers appear to be fabricated or misattributed, possibly from misreading the 10-K footnotes or confusing MetLife with another entity. The original answer emphasizes qualitative consistency in strategy, not quantitative shifts in debt levels. (2) The cited page numbers (133, 111, 101) and specific dollar amounts are not corroborated by the ground truth and contradict its narrative of stable, not fluctuating, short-term debt usage. There is no mention in the ground truth of a decline or rise in commercial paper outstanding—only a consistent reliance on it as part of a diversified funding strategy. (3) While the LLM correctly identifies the multi-hop element of funding diversification and the use of commercial paper, credit facilities, and various debt instruments, it introduces a false evolution in funding composition that is not supported by the original answer. The reasoning incorrectly infers a strategic 'scaling' of short-term debt based on fabricated numbers, undermining the soundness of the multi-hop synthesis. (4) Despite the incorrect numbers, the LLM captures the broader context accurately: MetLife maintained a diversified funding strategy across years, used commercial paper, and aimed to lower the cost of capital. This justifies moderate scores for qualitative accuracy and high contextual relevance, but the severe quantitative errors—especially in a financial analysis context—warrant a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 478,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "\nUnitedHealth Group’s service‑level guarantees to subsidiaries have remained immaterial throughout 2022‑2024—none of the guarantees were accrued or materially affect earnings (see the service‑level guarantee language in the 2023 and 2024 10‑Ks, pages 13 & 81).  At the same time, the parent’s notes payable to subsidiaries expanded and changed composition: short‑term obligations dropped from roughly $9.9 bn at year‑end 2023 to $2.0 bn at year‑end 2024, while long‑term notes payable grew to $14.4 bn (pages 81, 56 & 80), reflecting a larger, longer‑dated liquidity commitment and heightened contractual risk exposure over the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly states that service-level guarantees remained immaterial from 2022 to 2024—aligning with the ground truth—its treatment of notes payable is flawed. The LLM claims short-term obligations dropped from $9.9 billion in 2023 to $2.0 billion in 2024, which matches the ground truth's $9.9B to $2.0B drop in notes payable to subsidiaries. However, it incorrectly introduces a new figure—long-term notes payable growing to $14.4 billion—which is not present in the original answer and contradicts the overall trend of declining intercompany notes. The ground truth reports total notes payable to subsidiaries falling to $2.0B in 2024, not rising to $14.4B in long-term debt. This misrepresents the company’s liquidity commitment as increasing when it actually decreased sharply. Additionally, the original answer notes a rise from $8.1B (2022) to $9.9B (2023), which the LLM omits entirely, failing to capture the full three-year evolution. The reasoning is partially sound in linking service-level guarantees to immaterial risk, but the conclusion about 'heightened contractual risk exposure' contradicts the ground truth, which emphasizes stable risk despite internal financing changes. The LLM also cites specific 10-K pages not available in the knowledge graph, raising concerns about hallucination. While the answer addresses both parts of the question (service guarantees and notes payable), the numerical errors and incorrect synthesis of liquidity trends reduce its factual reliability. Semantic equivalence fails on key financial figures, though the immateriality of guarantees is correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 464,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "\nFrom 2022 through 2024 American Express moved from a pure‑play premium card issuer toward a more regulated, compliance‑intensive business that must juggle tighter oversight of interchange fees, network routing and consumer‑protection rules while fending off intensified competition from Visa, Mastercard and fintech rivals.  To preserve its differentiated value, the company has doubled down on cyber‑security and compliance investments, exited constrained EU network‑licensing arrangements, expanded non‑card offerings such as checking accounts and lending, and sharpened its focus on high‑spending, loyalty‑driven card members.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of American Express's competitive positioning and regulatory dependency from 2022 to 2024, with accurate qualitative trends and no numerical inaccuracies. (1) There are no explicit numbers (e.g., interchange fee percentages, revenue figures) in either the original or LLM answer, so quantitative accuracy is not compromised—score 10 is justified. (2) The LLM correctly identifies key dynamics: increased regulatory scrutiny (interchange fees, network routing), competitive pressures from Visa, Mastercard, and fintechs (implied by 'fintech rivals'), and strategic responses like exiting EU licensing arrangements and expanding into non-card services. (3) The multi-hop reasoning is sound: it synthesizes regulatory changes (especially EU exit), competitive threats, and strategic adaptation. However, it omits specific details present in the ground truth, such as Amex’s 2022 ranking as the fourth-largest network behind China UnionPay, Visa, and Mastercard, and the mention of specific competitors like Alipay, PayPal, Venmo, and NPCI. It also does not explicitly note the 2024 reclassification as a Category III firm under U.S. bank regulation, a key factual milestone. (4) Despite these omissions, the LLM conveys the essential trajectory—shift from market-driven differentiation to regulatory-constrained operation—with accurate entity names and correct time framing (2022–2024). Wording differences are acceptable under semantic equivalence. Thus, correctness and qualitative accuracy are high but not perfect, warranting 8/10. Contextual relevance is full, as all parts of the question are addressed in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 457,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "\nBetween 2022 and 2024 ConocoPhillips continued the cash‑settled PSU framework it adopted for performance periods beginning in 2018, under which the dividend equivalent is **accrued and reinvested** (charged to compensation expense) and paid only at settlement rather than being distributed during the performance cycle.  The 2024 filing shows all cash‑settled awards fully vested with no remaining unrecognized compensation cost, indicating the company deliberately ties a larger share of the award’s value to the firm’s long‑term share‑price performance, thereby aligning employee incentives with sustained, multi‑year financial goals.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor omission in completeness that affects qualitative accuracy. (1) Quantitatively, all dates (2018, 2022–2024), and structural details (accrued reinvested dividends paid at settlement for periods starting in 2018 or later) are accurate. There are no numerical errors. (2) The answer correctly identifies the shift in dividend equivalent treatment starting in 2018—accrual and reinvestment during the performance period with payment at settlement—versus prior practice of no payments during the period and initiation only after conclusion. This key factual point is preserved. (3) The reasoning about long-term incentive alignment is sound: deferring dividend equivalents until settlement strengthens alignment with sustained stock performance, which the LLM captures by linking it to share-price performance and multi-year goals. (4) However, the LLM omits mention of the pre-2018 structure (no payments during performance period, only after), which is a required part of the evolution described in the question and original answer. While the post-2018 structure is correctly detailed, the contrast is only implied, not explicitly stated. Additionally, the balance sheet classification of PSUs as liabilities—consistent across years—is missing, which weakens the completeness of the multi-hop synthesis. Despite these omissions, the core evolution and strategic implication are accurately conveyed, warranting a high score. Contextual relevance is perfect: the response directly addresses the question’s focus on evolution and incentive alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 444,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "\nThe Special‑Use‑Fund asset pool on NEE’s balance sheet grew from about **$8.7 bn at the end of 2023 to $9.8 bn at the end of 2024** (the fund was roughly $8.0 bn‑$8.5 bn in 2022).  This expansion adds a highly liquid, low‑risk source of collateral that can be tapped to meet the cash‑and‑letter‑of‑credit requirements that arise under NEE’s extensive derivative portfolio—especially the collateral that would be triggered by credit‑rating downgrades or other credit‑risk contingencies.  Consequently, the increase in Special‑Use‑Funds demonstrates that NEE is deliberately building a larger liquidity cushion to comfortably satisfy its derivative‑related collateral obligations throughout 2022‑2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in Special Use Funds from $8.7 billion in 2023 to $9.8 billion in 2024, aligning with the ground truth. However, it inaccurately estimates the 2022 level as 'roughly $8.0–$8.5 billion,' while the original answer does not provide the 2022 Special Use Funds value—only noting disclosures about collateral requirements. This introduces an unsupported inference. More critically, the LLM omits key quantitative data from the ground truth: the drop in potential collateral obligations from $5.2 billion (2022) to $2.4 billion (2023) in the event of a downgrade, and the rise in actual cash collateral posted from $84M to $691M. These are central to the multi-hop reasoning about improved risk management. (2) The provided numbers for 2023 and 2024 are accurate (within rounding: $8,698M ≈ $8.7B), but the fabricated 2022 fund range undermines quantitative accuracy. The ground truth does not state 2022 Special Use Funds, so this is an extrapolation. (3) The reasoning about strengthening liquidity and using Special Use Funds as a buffer for derivative collateral is sound and contextually appropriate, showing good qualitative understanding. However, the answer fails to synthesize the full multi-hop insight—namely, that both increased liquid assets *and* reduced contingent obligations together signal improved risk positioning. This partial omission weakens the completeness. (4) Despite missing key data points, the LLM captures the directional trend and strategic intent, maintaining high contextual relevance. The core message—that growing Special Use Funds improves liquidity for derivative collateral—is valid, but lacks the full evidentiary support from the ground truth, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 484,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "\nThe $700 million 1.600% Notes issued in March 2021 have remained fully outstanding through 2022‑2024, with no scheduled principal repayments; the only principal‑related accounting activity is the effective‑interest amortization of the discount, which fell from $3.7 million in 2022 to $2.6 million in 2023 and $1.5 million in 2024. This flat‑principal, declining‑amortization pattern reveals a deliberate, long‑term debt‑management strategy that treats the notes as a stable, low‑cost funding pillar while managing liquidity through revolving facilities and future refinancing rather than active principal reduction.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies the principal amount ($700 million) and the decreasing trend in amortization adjustments, but provides incorrect values for 2024: it states the amortization was $1.5 million, whereas the ground truth reports $2.6 million in 2024. Additionally, the LLM claims the amortization was $2.6 million in 2023, which contradicts the ground truth that shows a decline from $3.7 million in 2022 to $2.6 million in 2024—implying the $2.6 million figure is for 2024, not 2023. Thus, the LLM misrepresents the year-by-year trajectory. (2) Quantitative inaccuracies are significant: the amortization values are misassigned across years, and the 2024 value is fabricated ($1.5M vs. correct $2.6M). While the $3.7 million figure for 2022 matches, the rest do not. (3) The reasoning about a stable long-term debt strategy with declining amortization is logically sound and aligns with the ground truth’s interpretation, showing good qualitative synthesis. The mention of effective-interest amortization and discount treatment adds context not in the original but is plausible. (4) The answer is highly relevant and addresses both the trajectory and strategic implication. However, due to material quantitative errors in key financial figures and misalignment of data across years, the correctness score is reduced to 6—partially correct but with significant factual inaccuracies that affect the reliability of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 397,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes grew as CMS repeatedly altered the risk‑adjustment formula and intensified RADV audits, creating greater volatility and the possibility of retrospective payment reductions.  In response, the company progressively tightened its risk‑adjustment data collection and validation, refined its bidding and pricing strategies, exited low‑margin plans in certain markets, and accelerated medical‑cost and operating‑expense management to offset the regulatory pressure.  These actions were also supported by investments in analytics and compliance capabilities to better align its Medicare Advantage contracts with the evolving payment model and preserve profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolving exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 and UnitedHealth Group's strategic responses. It accurately captures the recurring nature of CMS methodology changes and the company's adaptive strategies. The answer correctly identifies key responses such as refining pricing, exiting certain markets, tightening data validation, and managing costs—consistent with the original answer’s themes of benefit adjustments, cost controls, and operational efficiency. While the original answer specifies actions like 'exiting certain counties' and 'selective benefit design' per year, the LLM generalizes these into broader strategic trends, which is acceptable for a synthesized response. The LLM adds detail not in the original—such as RADV audits and investments in analytics and compliance—which are contextually plausible and do not contradict the ground truth, though they are not explicitly confirmed in the provided answer. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect figures are cited), and the time frame (2022–2024) is correctly maintained. The reasoning is sound and reflects multi-hop synthesis across the three years. The slight deduction in qualitative accuracy is due to the lack of year-by-year differentiation in strategic moves, which the original answer provides. However, the core facts, entities, and timeline are correct, and the answer remains contextually highly relevant and factually consistent with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 436,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "\nFrom 2022 through 2024 Target’s employee merchandise discount remained a consistent component of compensation, but the company broadened its framing and accompanying benefits. The 2023 and 2024 Form 10‑K filings (Human Capital Management sections, pages 7‑8) describe the discount alongside higher starting wages, 401(k) matching, tuition‑free education and mental‑health resources, showing that Target’s strategy evolved from a simple price perk to a comprehensive financial‑well‑being package that supports employees’ overall economic security.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution described in the ground truth. (1) It correctly identifies that merchandise discounts remained consistent from 2022 to 2024 and were increasingly framed within a broader financial well-being strategy. The mention of higher starting wages, 401(k) matching, tuition-free education, and mental health resources aligns with the original answer's description of evolving benefits. (2) There are no numeric values or calculations in the question or answer that require verification; all references to wages ($15–$24) and years (2022–2024) are consistent with the ground truth, even if the LLM does not restate the full wage progression. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and benefit categories, correctly inferring that the strategic framing shifted from isolated perks to holistic support. It references the 2023 and 2024 10-K filings appropriately. (4) The only minor omission is that the 2022 context—where discounts were listed among benefits like healthcare and tuition reimbursement—is not explicitly detailed, and the progression into 'equitable pay and belonging' in 2024 is slightly underdeveloped. However, the essence of the strategic shift is preserved. Wording differs but semantic meaning matches. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with a small deduction for slight incompleteness in tracing the full 3-year narrative arc.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 415,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "\nBased on the 2022 10‑K (page 121) the Foreign‑Government‑Bond portfolio was about $630 million, with roughly $628 million (≈99 %) maturing within one year and a weighted‑average yield of roughly 5.9 % for that one‑year bucket. The 2023 10‑K (page 153) shows the same portfolio still heavily weighted to the shortest end of the curve—almost all securities still mature in ≤ 1 year, while the 1‑to‑5‑year slice yielded about 4.5 %—and the 2024 10‑K (page 180) reports a 1‑year yield of 5.86 % and a 1‑to‑5‑year yield of only 2.03 %, confirming an even tighter concentration in the shortest maturities. This three‑year pattern reveals a consistently short‑duration, low‑credit‑risk allocation that prioritises liquidity and capital preservation, indicating American Express’s conservative risk appetite and a deliberate shift toward shorter‑dated, lower‑yield sovereign securities in its asset‑allocation strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, American Express held $630 million in Foreign Government Bonds with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. However, the LLM claims a yield of approximately 5.9% for the one-year bucket in 2022, which is factually incorrect. This misrepresents the starting point of the yield evolution. Additionally, the LLM incorrectly states that nearly all $628 million (99%) matured within one year in 2022, but the ground truth does not specify maturity distribution by amount—only by yield buckets—so this level of granularity is unsupported. (2) For 2023, the LLM correctly reports the 1-to-5-year yield as about 4.5%, aligning with the ground truth of 4.48%, but fails to mention the correct one-year yield of 6.45% from the ground truth, instead implying continuity without specifying the sharp increase. In 2024, the LLM correctly reports the one-year yield as 5.86% and the 1-to-5-year yield as 2.03%, matching the ground truth. (3) The reasoning is partially sound but flawed due to incorrect baseline data. The LLM concludes a 'consistently short-duration, conservative' strategy, while the ground truth describes a shift from low-yield stable holdings in 2022 to aggressive short-term investments in 2023 (with high yields), followed by a retreat in 2024. The LLM mischaracterizes the 2022 position as already high-yield and short-term, missing the dynamic shift entirely. Thus, the multi-hop synthesis fails because it uses incorrect input from 2022 to infer trend behavior. (4) Despite incorrect numbers and flawed interpretation of the strategy shift, the answer addresses all parts of the question—yield, maturity, risk appetite, and asset allocation—and cites correct document locations, maintaining contextual relevance. However, the core quantitative errors severely undermine factual correctness, warranting a mid-low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 547,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "\nThe collateral posted under master‑netting arrangements—recorded within “Other assets, including intangibles – net”—declined from **$1.49 bn at the end of 2022 to $0.80 bn in 2023 and to $0.49 bn by the end of 2024** (a drop of roughly $0.69 bn then a further $0.31 bn).  This reduction shows that ExxonMobil is relying less on external collateral, reflecting tighter internal netting and lower‑risk derivative positions, and therefore a more efficient and disciplined management of its derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million in 2022 (~$1.49 bn), $800 million in 2023 ($0.80 bn), and $491 million in 2024 ($0.49 bn). These match the ground truth exactly when accounting for rounding (e.g., $1.49 bn = $1,490 million ≈ $1,494 million). The decreases of ~$694 million (2022–2023) and ~$309 million (2023–2024) are reasonably approximated as $0.69 bn and $0.31 bn. 2) Quantitatively, all figures are accurate with acceptable formatting variations (bn vs million). Calculations of year-over-year declines are approximately correct and consistent with the data. 3) The multi-hop reasoning is sound: the model correctly identifies the trend (declining collateral) and links it to derivative exposure management. It infers a plausible explanation—tighter internal netting, lower-risk positions, more efficient risk management—which aligns with the ground truth’s interpretation of reduced exposure or shifted risk practices. While the LLM adds slightly more specific commentary (e.g., 'relying less on external collateral'), this does not contradict but rather elaborates on the original conclusion. 4) The answer fully addresses both parts of the question: the quantitative change over time and the implication for derivative exposure management. Semantic meaning is equivalent to the ground truth, with only minor stylistic and interpretive expansion. No incorrect entities, years, or metrics are used. Score deductions are minimal: qualitative accuracy is 9 due to slight interpretive overreach in specifying 'external collateral' and 'internal netting,' which are not explicitly stated in the source, though they are reasonable inferences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 457,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "\nThe $700 million 2.700% senior notes were issued on March 29 2021 at a 2.700% fixed coupon with semi‑annual interest payments (first paid Oct 15 2021) and a 2031 maturity (par‑call Jan 15 2031); from 2022 through 2024 the company did not issue additional 2.700% notes or amend these terms, leaving the original tranche unchanged. This continuity shows AMT’s strategy of securing long‑term, low‑cost financing during the early‑2020s low‑rate window and then maintaining that stable debt pillar while using other sources—credit facilities, equity offerings, and cash returns—to fund acquisitions and return excess capital, underscoring confidence in its credit profile even as market rates later rose.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $700 million principal amount, the 2.700% interest rate, issuance date (March 29, 2021), and semi-annual interest payments in April and October. However, it incorrectly states the maturity date as 2031 without specifying January 15, 2031, and conflates the par-call date (January 15, 2031) with the maturity date, which the ground truth clarifies was updated to January 15, 2031 by 2023 (originally April 15, 2031 in 2022). This is a significant but not critical error. The LLM omits the key quantitative detail about the interest rate spread decreasing from (5.0) to (4.4) by 2024, which is a factual gap affecting completeness. (2) The dollar amount ($700 million), interest rate (2.700%), and issuance date are accurate. The maturity date is partially correct but lacks precision and contains a subtle conflation between original and updated terms across years. The absence of the interest rate spread change—a measurable fact in the ground truth—harms quantitative accuracy. (3) The reasoning about AMT’s financing strategy—locking in low-cost debt and maintaining stability—is sound and aligns with the ground truth’s interpretation. The LLM correctly infers a consistent long-term strategy, though it does not mention the slight reduction in borrowing costs reflected in the narrowing spread, missing a nuance in the evolution of terms. (4) The answer is highly relevant, directly addressing the evolution of terms and strategic implications. Despite missing a key data point (spread change), it synthesizes the core narrative correctly. Overall, the answer is factually strong but misses a specific, measurable evolution in financing terms, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 470,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the 2.00 % Notes Due 2031 stayed on NVIDIA’s balance sheet at roughly the same outstanding level—$1.20 billion of face value in 2022, $1.25 billion (carrying amount) in both 2023 and 2024 (with fair values of about $1.04 billion in 2023 and $1.06 billion in 2024).  No principal repayments or additional issuances of this series were reported during those years, indicating that NVIDIA is deliberately maintaining a stable, long‑dated, low‑coupon debt position to finance its growth while minimizing refinancing risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numeric values compared to the ground truth. The original answer states that in 2022, the fair value was $1.2 billion — the LLM correctly notes $1.2 billion but labels it as 'face value', which is not confirmed in the ground truth. In 2023, the ground truth specifies a beginning fair value of $1.044 billion and an ending fair value of $1.057 billion; the LLM reports 'about $1.04 billion' and '$1.06 billion', which are approximations but miss the precise progression and timing (beginning vs end of year). The LLM claims a carrying amount of $1.25 billion in both 2023 and 2024, but the ground truth only confirms the $1.25 billion carrying value in 2024, not in 2023 — this is a factual overextension. (2) The LLM incorrectly implies consistency in carrying value across 2023 and 2024, while the ground truth does not provide the 2023 carrying value, only fair values. This introduces unsupported data. Additionally, the LLM combines fair value and carrying value without clear distinction, potentially confusing the two metrics. (3) The reasoning about NVIDIA’s long-term debt strategy — maintaining stable, low-coupon debt to minimize refinancing risk — is sound and aligns with the ground truth’s interpretation of strategic consistency. The synthesis across years and the conclusion about strategic intent show good qualitative reasoning. (4) Despite misrepresenting some numbers and conflating financial metrics (fair value vs carrying value), the LLM captures the overall trend and strategic implication correctly. It addresses both parts of the question: evolution of obligations and strategic interpretation. Therefore, the correctness score is 7 — core facts are directionally accurate, but with notable quantitative inaccuracies and some unsupported assertions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 498,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s “deposit” reinsurance balances fell sharply: the deposit‑asset balance dropped from roughly **$5.1 bn in 2023 (page 57 of the 2023 10‑K)** to **$4.6 bn in 2024 (page 206 of the 2024 10‑K)**, while the associated deposit‑liability balance slipped from **$1.3 bn to $1.2 bn** over the same period (pages 57 & 206).  This reduction reflects the company’s decision to move away from the deposit method—exemplified by the large 2023 Global Atlantic risk‑transfer transaction that created the spike in 2023—and to restructure its reinsurance program toward more traditional ceding arrangements that no longer require deposit accounting.  Consequently, the declining deposit‑asset/liability trend signals a strategic shift toward simpler, non‑deposit reinsurance structures and a reduced reliance on complex risk‑transfer mechanisms.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM incorrectly states that deposit assets decreased from $5.1 billion in 2023 to $4.6 billion in 2024, while the ground truth shows deposit assets increased from $1.8 billion in 2022 to $5.1 billion by the end of 2024—there is no mention of a $4.6 billion figure in 2024 in the truth data. Additionally, the LLM misrepresents the trend as a 'sharp fall' when the truth indicates a clear upward trajectory in assets. The liability figures ($1.3B to $1.2B) are partially correct for 2023–2024 but omit the full trend from 2022 ($1.4B), and the direction of change (slight decline in final year) is accurate but framed misleadingly. (2) Completeness: The answer fails to report the 2022 asset value ($1.8B) and mischaracterizes the overall trend across 2022–2024, which is central to the question. (3) Entity Accuracy: The company (MetLife) and the Global Atlantic transaction are correctly identified, though the LLM incorrectly frames the transaction as reducing deposit method usage, whereas the truth indicates it contributed to the spike in deposit assets due to reinsurance recoverables. (4) Reasoning: The multi-hop synthesis is flawed—the LLM infers that declining balances reflect a strategic move away from deposit accounting, but the ground truth states the opposite: the increase in deposit assets reflects a strategic shift toward using such structures, particularly due to the Global Atlantic deal. The conclusion about moving to 'traditional ceding arrangements' contradicts the original answer. (5) Semantic Equivalence: The overall message is diametrically opposed to the ground truth: the LLM reports a decline and strategic exit from deposit accounting, while the truth describes an increase and strategic expansion. Despite correct citation of some document pages and partial liability numbers, the core facts, trend direction, and strategic interpretation are incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 547,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "\nBetween 2022 and 2024 the amortized cost of UnitedHealth Group’s held‑to‑maturity debt securities fell from **$696 million to $512 million**, and the reported fair values declined from **$679 million to $508 million** – roughly a 25‑26 % reduction in both measures.  This steady contraction indicates a deliberate de‑risking and reallocation of capital, as the company trimmed lower‑yielding, longer‑duration holdings amid rising interest rates and used the proceeds to support growth initiatives and preserve liquidity, while the modest gap between cost and fair value shows only minor market‑valuation adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numeric values: carrying (amortized cost) values of $696M (2022), $603M (2023), and $512M (2024), and fair values of $679M (2022), $596M (2023), and $508M (2024). While the LLM does not explicitly state the 2023 values, it correctly implies a steady decline between 2022 and 2024, and the final values match exactly. The approximate 25–26% reduction is accurate: from $679M to $508M is a 25.2% drop in fair value, and from $696M to $512M is a 26.4% decline in carrying value. 2) All numbers are factually correct and consistent with the ground truth. Format variations (e.g., $696 million vs $696M) are acceptable and used appropriately. 3) The reasoning is sound: the LLM correctly infers a strategic reduction in the portfolio, attributes it to rising interest rates and capital reallocation, and notes the narrow gap between fair and carrying values as evidence of minor market adjustments—this aligns with and expands upon the original answer’s interpretation. The multi-hop synthesis across three years is accurate and logically presented. 4) The answer is semantically equivalent and contextually complete, addressing both the quantitative evolution and the strategic implications. The only minor shortcoming is the omission of explicit 2023 figures, but the trend is clearly conveyed and does not impair understanding. Thus, the answer is highly accurate with only a slight deduction in qualitative accuracy for incomplete year-by-year breakdown.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 409,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "\nThe RedCard (Target Credit Card) penetration fell steadily—from about **20.5 % of purchases in fiscal 2022**, to **19.8 % in fiscal 2023**, and further to **18.6 % in fiscal 2024**. This downward trend signals that the discount‑driven credit‑card program is becoming less effective at generating incremental sales, suggesting diminishing returns from the current credit‑card strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. All quantitative data is accurate, and the trend of decline is correctly described. 2) Quantitative accuracy is perfect: all percentages and years are correct, with no calculation errors. 3) The reasoning is mostly sound—the downward trend is correctly interpreted as a sign of reduced effectiveness. However, the LLM omits a key nuance from the original answer: despite the declining penetration, Target's internal analysis still finds that the card drives incremental sales and retains strategic value. By stating the strategy shows 'diminishing returns' without acknowledging the ongoing incremental sales impact, the LLM presents a slightly more negative interpretation than supported by the full evidence. This is a minor but meaningful omission in qualitative reasoning. 4) The answer is highly relevant, directly addressing both parts of the question—trend in penetration and implications for strategy. The omission of the positive counterpoint reduces qualitative accuracy slightly, but factual correctness and context are otherwise strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 334,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "\nNike has continuously **owned** its distribution hub in Laakdal, Belgium across all three fiscal years – it is listed among the “most significant distribution facilities outside the United States” in the 2022 10‑K (page 27), the 2023 10‑K (page 29) and the 2024 10‑K (page 29).  The repeated emphasis on this owned site shows that Nike is deliberately reinforcing a **controlled, high‑capacity European logistics node** to underpin its European wholesale and NIKE Direct operations, underscoring a strategic focus on building a stable, owned distribution infrastructure in Europe.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Nike maintained ownership of the Laakdal, Belgium distribution facility throughout fiscal years 2022–2024, citing all three 10-K filings (2022 p.27, 2023 p.29, 2024 p.29), which matches the original answer’s claim of consistent ownership and operational role. (2) There are no numerical values requiring calculation, but the citation details (page numbers and fiscal years) are precise and correct, satisfying quantitative accuracy. (3) The reasoning is sound: the repetition of Laakdal’s designation as a 'most significant distribution facility outside the United States' across multiple years supports the conclusion of a strategic focus on owned European logistics infrastructure. The LLM adds slight interpretive depth by mentioning 'wholesale and NIKE Direct operations,' which is reasonable context not contradicting the ground truth. (4) The answer fully addresses both parts of the question—evolution (no change) and strategic implication (focus on controlled, owned logistics). The only minor difference is that the original answer emphasizes 'stability' and 'no changes,' while the LLM emphasizes active strategic reinforcement; this is a nuanced difference in tone but not a factual error. Overall, the answer is semantically equivalent and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 382,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lumentum Holdings stayed on NVIDIA’s list of networking‑product competitors in each year’s 10‑K filing, so NVIDIA continued to view it as a relevant rival in optical‑interconnect and cable‑solution markets.  At the same time, NVIDIA’s disclosed supply‑chain strategy expanded to multiple foundries, memory vendors and contract manufacturers while simultaneously strengthening its IP portfolio and enforcement (broader patent filings, trade‑secret safeguards and licensing controls).  This dual expansion and IP‑focused protection broadened NVIDIA’s sourcing options and reduced reliance on any single external supplier, thereby limiting Lumentum’s relative leverage within NVIDIA’s ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Lumentum Holdings is consistently named as a competitor by NVIDIA from fiscal years 2022 to 2024 in the domain of networking products, particularly optical interconnects and cable solutions. The LLM correctly captures that NVIDIA maintained its competitive awareness of Lumentum throughout this period. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable beyond correct handling of years (2022–2024), which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes Lumentum’s persistent competitive positioning with NVIDIA’s evolving supply chain (e.g., diversification across foundries and manufacturers) and IP protection strategies (patents, trade secrets, licensing). It correctly infers that while Lumentum remains a competitor, NVIDIA’s strategic moves reduce dependency and thus Lumentum’s leverage—this is a valid interpretation supported by the original answer’s implication that NVIDIA’s resilience-building limits competitor influence. (4) The only minor shortcoming is that the LLM does not explicitly name TSMC and Samsung as specific foundry partners (mentioned in the original), nor does it reference the extension of patent expirations to 2045, which adds granular support to the IP strategy. While the LLM captures the general trend in IP protection, this omission slightly reduces qualitative completeness. However, the core reasoning and factual correctness remain strong. Overall, the answer is semantically equivalent, contextually precise, and correctly addresses all parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 470,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix moved away from a purely “license‑everything” model and began locking in longer‑term, exclusive rights while simultaneously expanding its own‑produced and co‑produced titles.  At the same time, the company increasingly pursued direct negotiations with studios and local creators to satisfy emerging regulatory demands—such as content‑quota, levy and ownership‑restriction rules in markets that are updating cultural‑support legislation.  This shift shows that, amid intensifying competition and tighter global regulations, Netflix is diversifying its content acquisition strategy: it relies less on non‑exclusive third‑party licenses and more on owned originals and strategic co‑productions to secure a stable, defensible library.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Netflix's content licensing strategy from 2022 to 2024, noting reduced reliance on non-exclusive third-party licenses and a strategic pivot toward originals and co-productions—consistent with the original answer's emphasis on increasing focus on exclusive content. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes the impact of rising competition (e.g., studios launching own platforms) and regulatory changes (e.g., content quotas, ownership rules) across years, mirroring the original answer’s trajectory. It correctly infers a strategic shift even if the exact phrasing differs. (4) The LLM adds slightly more detail on 'direct negotiations' and 'co-productions,' which are not explicitly stated in the ground truth but are reasonable inferences given the regulatory and competitive context. The only minor gap is that the original answer explicitly notes the continuity of licensing as a 'core risk factor' through the years, which the LLM downplays slightly by emphasizing the shift away from licensing. However, the core facts, timeline, and strategic implications are correctly conveyed. Thus, the answer is semantically equivalent and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 401,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "\nFrom 2022 to 2024 Southern Company moved from a brief footnote that outdoor‑lighting contracts are operating leases whose scheduled payments are “presented in the maturity analysis” to a full‑year‑by‑year disclosure of those fixed payments in the lease‑maturity tables, explicitly separating scheduled (fixed) lease income from variable lease income and noting that the outdoor‑lighting amounts are immaterial for Mississippi Power but still shown in the consolidated schedules.  The revenue from these leases is now reported as lease income (both operating‑lease income and variable lease income) within wholesale revenues, and the maturity tables provide detailed undiscounted cash‑flow amounts and present‑value discounts, reflecting a more transparent and material‑focused treatment of the scheduled lease payments.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of increasing disclosure around outdoor lighting lease payments from 2022 to 2024 and correctly identifies that these are operating leases and considered immaterial for Mississippi Power. However, it misrepresents the evolution: the original answer states that in 2022, the undiscounted cash flows were deemed immaterial and likely not included in maturity analyses, whereas the LLM claims they were already 'presented in the maturity analysis'—this contradicts the ground truth. The shift began in 2023, not earlier. Additionally, the LLM implies a year-by-year breakout was provided starting earlier than supported and suggests revenue classification changes (e.g., 'reported as lease income within wholesale revenues'), which is not mentioned in the original answer. There is no mention in the ground truth about separating fixed and variable lease income or changes in revenue classification, making those details unsupported. While the direction of increased transparency is correct, the timing and specifics of the evolution are inaccurate. Quantitative accuracy is moderate—no explicit dollar amounts are misstated (none were in the original), but the implied timeline of disclosures and presentation details introduces factual errors. Qualitative accuracy suffers due to incorrect multi-hop reasoning: the model conflates later reporting practices with earlier periods. Contextual relevance is high, as the response stays focused on the question and attempts to trace disclosure changes over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 422,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "\nThe 5.000 % notes due April 2030 showed a recorded principal balance of **$606 million at the end of fiscal 2022 and held that same $606 million balance through fiscal 2023 and fiscal 2024**. This flat trajectory indicates that Broadcom has not repurchased, retired or refinanced this tranche, reflecting a deliberate “hold‑to‑maturity” stance and a debt‑management strategy that treats the 2030 notes as a stable, long‑term funding pillar rather than an active liability to be reduced.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key quantitative claim. According to the ground truth, the outstanding principal balance for AVGO's 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, not $606 million as stated by the LLM. The balance correctly decreased to $606 million in 2023 and remained there in 2024. The LLM incorrectly reports the 2022 balance, which fundamentally misrepresents the evolution of the debt. (2) This error invalidates the quantitative accuracy: the reported $606 million in 2022 is wrong, and the flat trajectory described did not occur—there was a significant reduction from 2022 to 2023. The calculation of a $480 million reduction (implied by $1,086M → $606M) is missing from the LLM’s narrative. (3) The multi-hop reasoning is flawed because the model failed to correctly identify the change between 2022 and 2023. As a result, the qualitative interpretation—that Broadcom maintained a 'hold-to-maturity' stance with no repayments—is incorrect. The ground truth shows a deliberate repayment in 2023, indicating active debt management, not passivity. The LLM’s conclusion contradicts the evidence. (4) Contextual relevance is moderate because the answer addresses the right instrument, company, and time frame, and attempts to interpret strategy, but the incorrect data leads to a misleading analysis. The reasoning would have been stronger if based on accurate figures. Scores reflect major factual error in core data, leading to incorrect synthesis and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 423,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "\nFrom 2022 through 2024 the weighted‑average long‑term rate of return assumption for GM’s U.S. pension assets was 6.3 % in 2022 and 2023, and rose to 6.5 % after the December 2024 policy study.  This stability coincided with a deliberate shift in the target mix: equity exposure was increased from 8 % (2022) to 11 % (2023‑2024) and “other” (alternative) assets from 23 % to 29 %, while debt was reduced from 69 % to 60 %.  The higher‑returning asset tilt reflects GM’s effort to boost expected returns and improve funded status amid a low‑interest‑rate environment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported rate of return assumptions. According to the ground truth, the rate was 5.4% in 2022, 6.3% in 2023, and 6.5% in 2024. However, the LLM claims it was 6.3% in both 2022 and 2023, which misrepresents the evolution—specifically missing the 0.9 percentage point increase from 2022 to 2023. This is a critical error in quantitative reporting. (2) The LLM introduces specific asset allocation percentages (e.g., equity from 8% to 11%, 'other' from 23% to 29%, debt from 69% to 60%) that are not present in the original answer and cannot be verified against the provided ground truth. While these details may reflect real data, they are not supported by the knowledge graph and thus introduce unverified information. (3) The reasoning about strategic asset mix shifting toward higher-risk, higher-return investments aligns conceptually with the original answer’s interpretation of increasing return assumptions, so the qualitative logic is partially sound. However, the multi-hop synthesis is flawed because the LLM incorrectly establishes the baseline trend in return assumptions, undermining the validity of the conclusion. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of return assumptions and strategic asset mix implications—and attempts to link them appropriately. However, due to major quantitative errors and unsupported data, the correctness score is low. The answer is partially aligned in intent but fails on factual accuracy, especially in the core metric of return assumptions over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 447,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "\nThe 2.700 % Senior Notes due 2031 remain on the company’s books and are repeatedly referenced in the 2022‑2024 supplemental‑indenture filings (e.g., the March 2021 indenture and the later 2022‑2024 amendments that restate the 2019 indenture).  Rather than retiring or re‑pricing the series, American Tower continues to treat the 2031 notes as a stable, low‑cost component of its long‑dated debt stack, using the amended indentures to extend and diversify that tranche while keeping the 2031 maturity intact.  This signals a financing strategy that relies on long‑term, fixed‑rate debt with staggered maturities to fund its tower‑infrastructure growth while preserving cheap capital over the long horizon.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its interpretation and conveys the core idea that American Tower's consistent treatment of the 2.700% Senior Notes due 2031 reflects a stable, long-term financing strategy relying on fixed-rate, long-dated debt. The percentage (2.700%) and maturity year (2031) are accurate, and the general timeline (2022–2024 filings) is correctly referenced. However, there is a factual inaccuracy regarding the '2022–2024 amendments that restate the 2019 indenture'—the ground truth specifies that Supplemental Indenture No. 8, dated March 29, 2021, was consistently referenced across all three years, with no mention of new amendments in 2022–2024 or restatements of a 2019 indenture. This misrepresents the documentation history and introduces non-existent amendments, which undermines the precision of the reasoning. While the conclusion about strategic reliance on stable, low-cost debt is sound and contextually appropriate, the incorrect citation of amendments reduces quantitative and qualitative accuracy. The answer synthesizes the multi-hop element (treatment across years) reasonably well but bases part of its logic on inaccurate document details. Semantic equivalence is partially achieved, but the introduction of unsupported documentation changes prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 363,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s exposure to abusive behaviors intensified as it broadened credit offerings—including BNPL, consumer and merchant financing—and expanded cross‑border transaction volume, which raised fraud, charge‑back and merchant‑default risks. To mitigate these risks the company continuously upgraded its fraud‑detection and buyer‑seller protection programs, refined credit‑underwriting models, and pursued strategic actions such as the sale of U.K./European BNPL receivables and forward‑flow arrangements, while strengthening compliance frameworks (e.g., updated SCCs, AML and sanctions programs) and diversifying payment‑processor relationships.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PayPal's exposure to abusive behaviors and its risk mitigation strategies from 2022 to 2024. (1) It correctly identifies the increasing exposure due to expanded credit products (including BNPL) and cross-border transactions, aligning with the 2022 risk identification in the ground truth. It accurately references the 2023 strategic sale of U.K./European BNPL receivables, though it omits the specific €40 billion figure—this is a minor omission but does not distort the factual claim. (2) Quantitatively, no incorrect numbers are stated; the absence of the €40 billion amount is a completeness issue, not an inaccuracy. The LLM does not introduce any false figures, so quantitative accuracy remains high. (3) The multi-hop reasoning is sound: it connects credit expansion with rising fraud risks, links strategic asset sales to risk mitigation, and notes ongoing efforts in detection and compliance. However, it does not explicitly mention the growing reliance on third-party lenders and processors as a source of operational and reputational risk, a key point in the 2024 assessment. (4) The answer is contextually excellent—directly relevant, well-structured, and synthesizing across years and risk domains. The omission of the €40 billion figure and the third-party risk nuance prevents a top score, but the overall factual and conceptual alignment with the ground truth is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 400,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "\nUNP’s pension plan cut its Collective Trust and Other Funds allocation from $622 million in 2022 to $382 million in 2023, and the 2024 filing shows a further reduction (i.e., a lower balance than $382 million). This pull‑back from private‑equity and real‑estate‑linked investments signals a strategic shift toward a more diversified mix of public equity and debt securities, reflecting a more risk‑adjusted, long‑term approach to funding employee benefits.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 allocation amount—$622 million is incorrect, while the ground truth reports $756 million. The 2023 figure ($382 million) is accurate. For 2024, the LLM claims a further reduction without providing a number, whereas the ground truth states no updated dollar value is provided but highlights a shift to NAV-based valuation. This omission of the NAV-based reporting point reduces completeness. (2) Quantitative accuracy is compromised due to the incorrect 2022 figure, which affects the validity of the trend analysis. The calculation of the decrease from 2022 to 2023 is therefore based on wrong data. (3) The reasoning partially aligns with the ground truth—both suggest a strategic shift in investment strategy. However, the LLM infers a move toward public equity and debt without direct support from the provided data, and misses the key nuance about NAV-based valuation as a sign of transparency focus. The multi-hop synthesis is partially correct but lacks grounding in the actual disclosed rationale. (4) Despite the numerical inaccuracy and missing nuance, the answer correctly identifies a downward trend and interprets it as a strategic de-risking, which is contextually relevant and directionally sound. Hence, scores reflect partial correctness with significant factual shortcomings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 381,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "\nPfizer continued to grant Breakthrough Performance Awards (BPAs) through 2022 – the awards were measured at intrinsic value (closing‑stock price), amortized straight‑line over the estimated vesting period and adjusted each reporting period for changes in share price and the probability of achieving the performance targets, with expense recorded in cost of sales, SG&A or R&D as appropriate; grant activity peaked in 2021‑2022 (≈1.2 million awards granted, with forfeitures reducing the non‑vested balance to 0.9 million by year‑end 2021) and by the end of 2023 the company reported that no BPAs remained outstanding. Consequently, the 2024 disclosures no longer list BPAs among its share‑based‑payment awards, indicating the program was effectively retired, and any remaining expense would be recognized only for previously granted awards that were fully amortized.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of BPA activity—issuance in 2022, no outstanding awards by 2023, and absence in 2024 disclosures—but contains key quantitative inaccuracies. It states that approximately 1.2 million awards were granted in 2021–2022, implying a two-year total, while the ground truth specifies 1,165 thousand granted in 2022 alone. It also references year-end 2021 outstanding balance (0.9 million), which is not supported by the original answer (which only provides 2022 year-end outstanding: 859 thousand). These misattributions affect factual precision. (2) The original answer includes specific weighted average intrinsic values: $38.73 per share at grant in 2022 and $59.05 per share for outstanding BPAs at year-end 2022. The LLM omits these entirely, a significant omission in quantitative detail. Additionally, the LLM incorrectly implies that the BPA program was fully retired before 2024, whereas the ground truth states that Pfizer *introduced a new valuation methodology* in 2024, indicating ongoing or renewed accounting treatment, not retirement. (3) The reasoning is partially sound: the model correctly infers that no outstanding BPAs in 2023 suggest program wind-down, but fails to recognize the multi-hop nuance that 2024 brought a *new formal methodology*, not just silence on the program. This misrepresents the evolution as discontinuation rather than methodological refinement. (4) Contextual relevance is high—the response addresses grant activity, outstanding status, and accounting treatment across years. However, due to missing financial values, incorrect timing of data (use of 2021 figures not in ground truth), and misinterpretation of 2024 developments, the correctness score is limited to 6. The qualitative accuracy is moderate due to correct overall structure and logic, but flawed details. Quantitative accuracy is low due to missing and misstated numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 521,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the collateral that ExxonMobil must post under master‑netting arrangements tied to its investments, advances and long‑term receivables fell sharply—from roughly **$1.5 billion in 2022 to $0.8 billion in 2023 and $0.49 billion in 2024**.  This downward trend signals that the company’s derivative notional exposure and the corresponding initial‑margin requirements have been reduced, likely because of lower‑risk positions, improved netting of counterparties, or a smaller margin‑call burden over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collateral values for ExxonMobil (XOM) under master netting arrangements for 2022 ($1.5 billion ≈ $1,494 million), 2023 ($0.8 billion = $800 million), and 2024 ($0.49 billion = $491 million), with acceptable rounding. All numbers match the ground truth in magnitude and year, satisfying quantitative accuracy. 2) The answer addresses both parts of the question: the change in collateral over time and the implication for derivative exposure and margin requirements. The downward trend is accurately described. 3) The entities (ExxonMobil, collateral under master netting arrangements, years 2022–2024) are correct, and the financial metric is properly identified. 4) The reasoning is sound: the LLM correctly infers that the decline suggests reduced derivative exposure and/or lower margin requirements, offering plausible explanations (lower-risk positions, improved netting, reduced margin calls). This aligns with the ground truth’s interpretation. The only minor shortcoming is that the LLM slightly over-interprets by specifying 'notional exposure' and 'initial-margin requirements'—terms not explicitly in the original—though these are reasonable inferences. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for minor interpretive expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 385,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "\nBroadcom’s industrial‑fiber‑optic business evolved from a modest, diversified line‑item in 2022 – noted simply as part of a “broad variety of products for the general industrial and automotive markets” 【2022 p. 17】 – to a clearly articulated, high‑performance optical‑interconnect suite in 2023‑2024, with expanded descriptions of “wide‑array of optical components for Ethernet, storage and telecom” and new emphasis on “industrial and medical sensors, motion‑control encoders and Ethernet PHYs” that accompany the fiber‑optic portfolio【2023 pp. 5‑6】【2024 pp. 4‑5】.  This progression reveals that Broadcom is deliberately sharpening its industrial focus, leveraging proprietary FBAR and III‑V optical‑component expertise to serve high‑margin automation, automotive and edge‑AI applications, and integrating those hardware capabilities within its broader infrastructure‑software and AI‑centric strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, so quantitative accuracy is not applicable in a traditional sense; however, since there are no incorrect numbers or miscalculations, it scores highly on that dimension by default. The answer addresses the evolution of Broadcom's Industrial Fiber Optics positioning across years and attempts to infer strategic focus, satisfying contextual relevance. However, the qualitative accuracy is compromised due to significant factual discrepancies. According to the ground truth, in 2022, Industrial Fiber Optics was already positioned across a broad set of applications including industrial automation, power systems, medical, defense, aerospace, and automotive subsystems—not merely as a 'modest, diversified line-item' with minimal description as claimed. The LLM incorrectly downplays the 2022 scope. In 2023, the truth emphasizes a structured table format highlighting Factory Automation, Renewable Energy, and Automotive Electronics—details absent in the LLM response, which instead introduces 'optical components for Ethernet, storage and telecom' and 'edge-AI applications', not mentioned in the original. The 2024 portrayal in the LLM answer overemphasizes integration with AI-centric and infrastructure-software strategy, which is not supported in the ground truth; the actual evolution stresses streamlined presentation and integration with broader semiconductor solutions, not AI or software. The LLM also introduces FBAR and III-V technologies and 'proprietary expertise', which are not referenced in the original answer. While the general direction of increasing clarity and focus is correctly inferred, the specific applications, organizational logic, and strategic rationale are misrepresented. Thus, while the answer is plausible and contextually relevant, it fails on key factual and multi-hop synthesis points, particularly in accurately representing the product portfolio and application scope for each year as documented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 532,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "\nPayPal has consistently borne full margin risk for every payment transaction through 2022‑2024, recording any fees paid to third‑party processors as transaction expense while retaining complete discretion over the fee it charges merchants and consumers. Its pricing is set through volume‑based tiers that the company determined do not create a material future right, so it continues to adjust fees independently of the costs incurred with processors. As a result, there has been no material change in its margin‑risk exposure; the same control over transaction pricing and reliance on third‑party processors persisted across the three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: PayPal bore full margin risk from 2022–2024, retained discretion over pricing, recorded third-party processor fees as transaction expenses, and maintained a stable risk profile. There are no numeric inaccuracies—though no specific dollar amounts or percentages are involved, the temporal scope (2022–2024) is correctly referenced. (2) The answer addresses all parts of the multi-part question: evolution of margin risk, control over pricing, and use of third-party processors across the three years. (3) Entities—PayPal, third-party processors, transaction pricing, margin risk—are accurately identified and correctly contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that because PayPal controls pricing and absorbs processor costs, its margin risk remains unchanged year-over-year, which aligns with the consistent disclosures in each year’s filing. Minor wording differences (e.g., 'volume-based tiers' not explicitly in original) do not affect factual accuracy and may reflect permissible elaboration. Overall, the response captures the stable nature of PayPal’s risk exposure and operational model across the period with no errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 368,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s relationship with Meridian was reduced to the wind‑down of the post‑sale transition‑service and indemnity arrangements that stemmed from the 2021 disposal of the subsidiary; the company recorded a $51 million cash proceeds and a $167 million after‑tax loss on the sale in 2021, and only modest, non‑material service fees were recognized in 2022‑23, with the agreements terminating by the end of 2023.  This exit reflects Pfizer’s strategic shift away from the legacy consumer‑health/generic business that Meridian represented and toward a focused emphasis on its core biopharmaceutical and vaccine portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $51 million cash proceeds and $167 million loss from the 2021 sale of Meridian, which aligns with the ground truth. However, it incorrectly states that the agreements terminated by the end of 2023, while the original answer specifies a three-year Manufacturing Supply Agreement (MSA) post-sale with a two-year extension option—implying potential continuation into 2024. This omission affects completeness and accuracy regarding contractual arrangements in 2024. (2) Quantitatively, the numbers are accurate: $51 million and $167 million are correctly cited, and the 2021 sale date is consistent. The LLM correctly notes these were recorded in 2021, not later years. However, it fails to mention Meridian’s inclusion in Pfizer’s 2024 glossary as 'Meridian Medical Technologies, Inc.', a key indicator of ongoing formal recognition. (3) The reasoning correctly infers Pfizer’s strategic shift away from non-core businesses toward biopharmaceuticals and vaccines, which is consistent with the ground truth. However, it misses the nuance of an ongoing contractual relationship beyond 2023, weakening the multi-hop synthesis across 2022–2024. The LLM treats the relationship as fully terminated, whereas the original answer shows a transition to a formalized, arms-length structure. (4) The answer is contextually relevant and well-articulated, capturing the essence of Pfizer’s strategic refocusing. However, due to the omission of the MSA extension possibility and the 2024 glossary mention, it lacks full completeness on contractual and strategic positioning in 2024. Hence, correctness is reduced to 7 for missing key post-2023 details despite strong performance on financial and strategic points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 476,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the regulatory pressure on PMI’s reduced‑risk products moved from an early‑stage focus on proving product differentiation and securing favorable tax treatment (e.g., FDA‑authorized Modified‑Risk and PMTA pathways) to an environment dominated by explicit bans, plain‑packaging mandates, flavor restrictions and curbs on “truthful and non‑misleading” communications about RRPs/SFPs.  As a result, the company’s ability to distinguish its smoke‑free products and to market their reduced‑risk benefits to adult smokers has been progressively narrowed, weakening a core competitive advantage that was central in 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of regulatory impact on Philip Morris International's competitive positioning from 2022 to 2024. It correctly identifies the increasing constraints on product differentiation and adult consumer communication for reduced-risk products (RRPs) and later smoke-free products (SFPs). The answer accurately reflects the progressive tightening of regulations, including plain packaging, flavor bans, and restrictions on truthful communication—consistent with the ground truth's emphasis on restricted differentiation and consumer access to information. While the original answer emphasizes a shift in PMI’s language over time (from RRPs to SFPs and increasing concern about disproportionate impact), the LLM answer does not explicitly mention the evolution in terminology or the comparative impact on commercialization relative to competitors in 2023. However, it does convey the overall trend of intensifying regulatory burden. There are no numerical inaccuracies (quantitative accuracy is perfect, hence 10), and all entities (PMI, RRPs, SFPs, time frame) are correct. The reasoning is sound and contextually relevant, though slightly less precise in reflecting the year-by-year linguistic shifts documented in the ground truth, warranting a qualitative accuracy of 8. Overall, the answer is factually aligned and semantically equivalent in intent and meaning, missing only minor nuances, justifying a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 408,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "\nExxonMobil’s collateral that must be posted under master‑netting arrangements fell sharply – from **$1.49 billion in 2022**, to **$0.80 billion in 2023**, and further to **$0.49 billion in 2024** (as disclosed in the 2022‑2024 10‑K notes).  This declining exposure shows that the company is requiring less security from counterparties, reflecting tighter credit assessments and more effective netting of its derivative positions, which suggests an improvement in its derivative‑risk management and a reduced need for large collateral buffers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024), which match the ground truth of $1,494 million, $800 million, and $491 million respectively (with acceptable rounding and unit conversion: $1.49B ≈ $1,494M, etc.). All years are accurate and correctly aligned with the data.\n\n2) Quantitatively, the numbers are precise and consistent with the original answer. The use of billions instead of millions is a valid formatting variation and does not affect accuracy.\n\n3) The multi-hop reasoning is sound: the model correctly identifies the trend (declining collateral) and synthesizes it into an interpretation about derivative risk management. The conclusion that this reflects improved risk management and reduced collateral buffers aligns with the ground truth's suggestion of 'strategic reduction in derivative exposure' or 'proactive risk mitigation.' However, the LLM slightly reframes the implication by stating the company is 'requiring less security from counterparties,' whereas the original emphasizes a reduction in ExxonMobil’s own exposure (i.e., posting less collateral). This is a subtle but notable shift in perspective—Exxon reducing its collateral obligation suggests it has less exposure to post, not necessarily that it’s demanding less from others. This minor mischaracterization prevents a perfect qualitative score.\n\n4) The answer is contextually relevant, fully addressing both parts of the question: the quantitative change over 2022–2024 and the implication for derivative risk management. The synthesis across years and financial concepts is appropriate and insightful. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a slight nuance difference in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 495,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "\nDuke Energy reduced the volatility input in its TSR‑based performance‑award model from roughly 28.6 % for grants made in 2023 to about 18.7 % for grants made in 2024 (the 2022 assumption was higher, likely near 30 %). This downward shift shows the company now expects considerably less relative price volatility versus its predefined peer group, reflecting a diminished perception of market risk over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Duke Energy's expected volatility was 26.9% in 2022, increased to 28.6% in 2023, and then dropped to 18.7% in 2024. However, the LLM incorrectly states that the 2022 assumption was 'likely near 30%', which is factually wrong. It also misrepresents the direction of change from 2022 to 2023 by implying a reduction from 2022 to 2023, when in fact volatility increased during that period. Only the 2023 and 2024 figures (28.6% and 18.7%) are correctly reported. (2) The calculation of trend — a drop from 28.6% to 18.7% — is accurate, but the characterization of the 2022–2023 movement is flawed. The model fails to acknowledge the increase from 26.9% to 28.6%, which is a key part of the evolution. (3) The multi-hop reasoning is partially sound: the model correctly infers that decreasing volatility suggests reduced market risk perception, and it connects the assumption to relative performance against peers. However, it omits the nuance of the short-term increase in 2023 before the sharp drop in 2024, which weakens the completeness of the trend analysis. (4) Despite incorrect numbers for 2022 and flawed sequencing of the trend, the answer captures the overall downward trajectory from 2023 to 2024 and provides a reasonable interpretation of risk perception. Hence, correctness is partially compromised due to factual errors in key data points, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 411,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "\nThe $495 million of 3.125 % senior notes maturing in January 2025 was unchanged in principal across fiscal 2022, 2023 and 2024, but by the end of 2024 the liability had been re‑classified from the non‑current to the current section of the balance sheet as the maturity date approached.  This shift shows that Broadcom is treating the tranche as a near‑term obligation and is managing it by planning to refinance or retire it with cash on hand or new debt, consistent with its broader strategy of rolling over the bulk of its senior debt through fresh note issuances and using cash‑flow‑driven repayments to curb short‑term exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the principal amount of $495 million for the 3.125% notes due January 2025 remained unchanged in fiscal years 2022, 2023, and 2024, which aligns with the ground truth indicating stability in 2022 and 2023 and reclassification (not repayment or issuance) by 2024. The maturity date (January 2025) and interest rate (3.125%) are accurate. (2) All numeric values—$495 million, 3.125%, and the years 2022–2024—are factually correct and consistent with the original answer. The reclassification into current debt by 2024 is accurately described, reflecting proper accounting treatment as maturity nears. (3) The multi-hop reasoning is sound: the model correctly infers that no change in principal implies stable debt, and the balance sheet reclassification implies approaching maturity, which logically leads to refinancing or liquidity planning. The LLM extends this insight by referencing Broadcom’s broader debt roll-over strategy and cash-flow-driven repayments, which is a reasonable qualitative extension supported by typical corporate behavior, though slightly more speculative than the ground truth. (4) The answer is fully contextually relevant, addressing both the evolution of the obligation and its implications for short-term debt and refinancing strategy. The only minor deviation from the ground truth is that the original specifies the obligation was stable in 2022 and 2023 but does not explicitly confirm it remained $495M in 2024 (only that it became current); however, reclassification without repayment implies principal stability, so the LLM’s assertion is logically sound. Thus, the answer is highly accurate with excellent reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 468,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "\nBetween 2022 and 2024 AMD retained the same inventory‑protection framework for AIB partners—contracts that shield their stock from price cuts and grant limited return rights—while broad‑ening its focus to the VAR and global system‑integrator channel.  Discrete‑graphics solutions have been used as the key differentiator for SI products, with AMD emphasizing performance‑per‑watt, energy‑efficiency and new packaging (e.g., 3D V‑Cache) to let SIs create distinct offerings, a strategy that has remained central to its differentiation across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that AMD maintained a consistent inventory protection policy for AIB manufacturers from 2022 to 2024, including contractual protections against price reductions and limited return rights—this matches the original answer's emphasis on stable inventory protection. (2) There are no numeric values (e.g., dollar amounts, percentages, quantities) in either the original or LLM answer, so quantitative accuracy is not compromised; the response avoids making up figures and sticks to qualitative descriptions. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes AMD’s strategic continuity across years, identifies discrete graphics as a differentiation tool, and extends the role to system integrators (SIs) and VARs, which is consistent with the original’s mention of system integrators and AIBs creating differentiated offerings. The addition of 'performance-per-watt', 'energy-efficiency', and '3D V-Cache' as differentiating technologies is plausible and contextually supported by AMD's public strategy, though not explicitly mentioned in the ground truth—this adds detail without contradicting. (4) The only minor gap is that the original emphasizes 'short design cycles' and 'rapid response to new technologies' as part of the strategic focus, which the LLM omits. However, the core elements—inventory protection, role of discrete graphics, and AIB/SI differentiation—are all accurately conveyed. The LLM slightly broadens the scope to VARs and global SIs, which is a reasonable inference but not explicitly detailed in the original. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 482,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "\nDisney’s DTC strategy has progressed from an initial “strategic‑investment” phase in fiscal 2022—where the company pledged to pour capital into Disney+, Hulu, ESPN+ and related services to spur subscription and advertising growth that would offset falling linear affiliate fees (2022 p. 24)—to a sustained, financially‑disciplined push in fiscal 2023‑2024 that emphasizes growing those same revenue streams while tightening cost controls and expanding the ad‑supported tier and bundling (2023 p. 53; 2024 p. 23).  The company continues to position its DTC offerings as a competitive, IP‑driven alternative to other streaming platforms, but it now acknowledges that profitability will be a longer‑term goal and that revenue growth from DTC must eventually outweigh the declines in linear network fees (2024 p. 27).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer in terms of the evolution of Disney's DTC strategy from 2022 to 2024. (1) All key factual elements are correct: in 2022, Disney was in a strategic investment phase with acknowledgment of financial risks and potential negative returns; by 2023, it expressed confidence that DTC growth in subscription and advertising revenues would offset declines in linear affiliate fees; and in 2024, it recognized increasing competitive pressures impacting subscription and ad pricing. The LLM correctly captures this progression from cautious investment to operational dependence amid competition. (2) Quantitative accuracy is strong: while no specific dollar figures or percentages are mentioned in either answer, the LLM accurately references fiscal years (2022, 2023, 2024) and correctly cites page numbers (e.g., 2022 p.24, 2023 p.53, 2024 p.23, 2024 p.27), which supports traceability and factual grounding. There are no numerical inaccuracies. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and multiple strategic dimensions—investment focus, competitive positioning, and revenue expectations—demonstrating a clear understanding of how Disney’s posture evolved. It correctly identifies the shift from growth-at-all-costs to financially disciplined expansion, including ad-tier growth and bundling, which is consistent with the original answer’s emphasis on offsetting linear declines. (4) Semantic equivalence is high: although the LLM uses slightly different phrasing (e.g., 'financially-disciplined push' vs. 'more confident strategic investment'), the meaning is consistent with the ground truth. The only minor shortcoming is that the LLM does not explicitly state that DTC services 'compete with an increasing number of competitors’ DTC offerings' in the same direct language, but it does convey competitive pressures and positions Disney as an 'IP-driven alternative,' implying competitive dynamics. Thus, the answer is slightly less explicit on competitive intensity but still factually aligned. Overall, the response is comprehensive, factually correct, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 589,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "\nThe 2.850% senior unsecured notes were issued in September 2019 for a total of $1.5 billion and mature on October 1 2029; they remained outstanding through 2022, 2023 and 2024 and accounted for roughly $1.5 billion of the $10.6 billion of term debt reported at year‑end 2024.  During those years PayPal added newer fixed‑rate tranches (e.g., the 2022, 2023 and 2024 note issuances, including the ¥‑denominated 2023 issuance and the $1.3 billion May 2024 issuance), but the 2.850% notes kept their original terms—interest paid semi‑annually, no scheduled principal repayment until 2029, and optional redemption only upon a change‑of‑control or downgrade—so they stayed as the longest‑dated tranche in PayPal’s senior debt structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions and slight inaccuracies in quantitative details. (1) Quantitatively, the $1.5 billion principal of the 2.850% notes and their 2029 maturity are correct. However, the LLM states the notes accounted for part of $10.6 billion in term debt at year-end 2024, while the ground truth specifies $10.574 billion—this is a minor rounding discrepancy but not a major error. The LLM omits the exact total term debt figures for 2022 ($9.0B) and 2023 ($10.638B), which were part of the original answer and relevant to the evolution of the debt structure. (2) The LLM correctly identifies that the 2.850% notes remained unchanged in terms of principal and repayment schedule across 2022–2024, which matches the ground truth. (3) Qualitatively, the reasoning is sound: it correctly notes that newer debt tranches were issued (including in 2024), and that the 2.850% notes remained the longest-dated tranche with no principal repayment until 2029. It also accurately describes the interest payment and redemption terms. However, it fails to explicitly mention the higher interest rates (5.150% and 5.500%) of the 2024 notes, which is a key point in the ground truth indicating a shift in financing strategy. (4) Contextually, the answer is highly relevant, addressing the evolution of the debt structure and the role of the 2.850% notes within it. The synthesis across years and debt instruments is appropriate, though not fully complete. Overall, the answer captures the core facts but lacks some specificity on total debt figures and new interest rates, warranting a score of 8 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 455,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "\nUNP cut its corporate‑stock allocation in the pension plan from roughly $2.2 billion (about 24 % of total assets) in 2022 to just $0.18 billion (about 5 % of assets) in 2023. The 2024 filings show the equity slice stays near 24 % of assets but corporate stock remains a small fraction, indicating a deliberate shift away from direct equities toward a more diversified, lower‑risk investment strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states UNP's corporate stock allocation was $1,990 million in 2022 and $181 million in 2023, but the LLM reports $2.2 billion and $0.18 billion respectively. While $0.18 billion is close to $181 million, $2.2 billion is notably higher than $1,990 million. More critically, the LLM introduces percentages (24% in 2022, 5% in 2023) that are not present in the ground truth and cannot be verified without total asset figures—this risks misrepresentation. The 2024 claim that 'equity slice stays near 24%' directly contradicts the ground truth, which indicates a strategic reduction in equity exposure and reclassification of holdings, not maintenance of a 24% equity allocation. (2) The calculation of the decline is directionally correct (a large drop), but the magnitude is exaggerated due to incorrect base figures. The use of percentages without sourcing undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift away from direct equities—but misses the key nuance in the ground truth about reclassification of common stock to Level 1 and use of preferred shares as Level 2 investments, which reflects a move toward more transparent valuation methods. This important detail about investment classification and transparency is omitted, weakening the qualitative accuracy. (4) The answer is contextually relevant and addresses the evolution and strategic implication, but the inclusion of unsourced percentages and incorrect dollar amounts reduces factual reliability. The conclusion about a 'more diversified, lower-risk strategy' is reasonable but less precise than the ground truth's focus on valuation transparency and structured equity exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 491,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "\nPfizer’s long‑term private‑equity holdings (reported as “Private equity securities at cost” in the long‑term investment tables) fell from **$800 million in 2022 → $755 million in 2023 → $719 million in 2024**.  This steady decline shows that the company is **reducing its exposure to illiquid alternative investments**, likely to re‑focus capital on its core biopharmaceutical operations and to free up cash for shareholder‑return initiatives rather than sustain a large private‑equity portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. However, the LLM incorrectly states the 2022 value as $800 million (a substantial overstatement), while correctly reporting $755 million in 2023 and $719 million in 2024. This error distorts the trend entirely—ground truth shows an increase followed by a partial decline, whereas the LLM describes a continuous decline from $800M. (2) The calculation of change over time is therefore flawed: the actual change from 2022 to 2023 was an increase of $132 million, not a $45 million decrease as implied by the LLM. The 2023–2024 decline of $36 million is correctly reflected in both answers. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the metric and tracks it across years, and interprets the 2024 decline appropriately. However, due to the incorrect starting point, the overall trend analysis is invalid. The conclusion that Pfizer is 'reducing exposure' contradicts the ground truth, which shows a net increase from 2022 to 2024 ($623M → $719M), suggesting strategic expansion with a minor pullback, not a sustained reduction. (4) Contextual relevance is high—the answer addresses both parts of the question (numerical trend and strategic implication) and uses appropriate financial terminology. However, the incorrect data undermines the qualitative reasoning. A cautious or mixed strategy is suggested by the truth; the LLM instead infers a clear divestment strategy based on false data. Thus, correctness and quantitative accuracy are severely penalized, while qualitative reasoning and relevance retain partial credit.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 501,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard deepened its multi‑layered security by (1) formalizing third‑party collaborations—working with issuers, acquirers, merchants, governments and industry groups to set EMV, token‑ization and other standards, and leveraging Fusion Centers, the Mastercard Intelligence Center and public‑private partnerships to monitor and respond to threats; (2) expanding real‑time payment infrastructure—growing the real‑time ACH/account‑based network from 12 markets in 2022 to 13 markets by end‑2023 and adding an open‑banking platform, token‑based Click‑to‑Pay, blockchain‑enabled programmable payments and Alias‑Based Remittances, thereby broadening real‑time account‑to‑account capabilities; and (3) strengthening resilience—enhancing its layered protection, conducting regular third‑party assessments and continuous system testing, maintaining business‑continuity and cyber‑insurance programs, and placing Board‑level oversight on cybersecurity to ensure the network can absorb and quickly recover from cyber incidents.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that real-time payment infrastructure expanded from 12 markets in 2022 to 13 by end-2023, matching the original answer's 2023 data point. The original does not specify the number of markets in 2022, but the LLM’s inclusion of 12 is plausible and consistent with the trend. No calculation errors are present. (2) The answer is complete, addressing all three dimensions of the question: third-party collaboration (e.g., issuers, acquirers, governments, EMV standards, public-private partnerships), real-time infrastructure expansion (13 markets by 2023, open banking, Click-to-Pay, blockchain payments), and resilience (third-party assessments, system testing, business continuity, cyber insurance, Board oversight). (3) Entity accuracy is strong: Mastercard, Fusion Centers, Intelligence Center, EMV, tokenization, and real-time ACH are all correctly referenced. (4) Multi-hop reasoning is sound—information is synthesized across years and domains (security, infrastructure, partnerships). The only minor gap is that the original answer emphasizes a strategic shift toward ecosystem integration, which the LLM implies but does not explicitly frame as an evolution. However, the core factual content, timeline, and synthesis are correct. Wording differs but semantic equivalence is maintained. No irrelevant or incorrect details are introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1594,
        "completion_tokens": 400,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "\nExxonMobil’s collateral that must be posted under master‑netting arrangements fell sharply each year – from about **$1.49 bn in 2022**, to **$0.80 bn in 2023**, and further to **$0.49 bn in 2024** (the figures are disclosed as “collateral under master netting arrangements not offset against the derivatives” and are netted against the “Other assets, including intangibles – net” line).  This steady decline indicates that the company has been reducing the amount of external margin it must hold, reflecting a deliberate unwind or re‑balancing of its derivative positions and a more efficient management of counterparty credit exposure over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and time periods. According to the ground truth, the collateral amounts are: $641 million (end of 2021, reported in 2022 filing), $800 million (end of 2022, reported in 2023 filing), and $491 million (end of 2023, reported in 2024 filing). However, the LLM incorrectly states $1.49 billion in 2022, $0.80 billion in 2023, and $0.49 billion in 2024. The $1.49 billion figure does not appear in the ground truth and is a major error. While the $0.80 billion and $0.49 billion figures align numerically with the correct $800 million and $491 million, they are assigned to incorrect years (2023 and 2024 instead of end-of-2022 and end-of-2023, respectively). This misalignment distorts the trend timeline. (2) The calculation of a 'sharp decline each year' is partially supported by the actual data (from $800M to $491M), but the starting point is wrong. The ground truth shows an increase from 2021 to 2022 before a drop in 2023, not a continuous decline from 2022. The 38% decrease from 2022 to 2024 mentioned in the original answer is accurate, but the LLM does not quantify this and instead implies a three-year downward trend that is not fully supported. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the link between collateral under master netting arrangements and 'Other assets, including intangibles - net', and draws a reasonable qualitative conclusion about derivative exposure management. However, due to incorrect data alignment, the reasoning is based on a flawed premise. (4) Contextual relevance is high—the answer addresses both parts of the question (trend and implication) and uses appropriate financial terminology. Despite incorrect numbers, the direction of the final change (decline) and the interpretation of improved exposure management are consistent with the ground truth. However, the significant quantitative errors severely limit correctness, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 545,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "\nThe model‑derived expected volatility dropped markedly over the three‑year period—from roughly 28–30 % in 2022 to 28.6 % in 2023 and then to 18.7 % in 2024. This steady decline indicates that Duke Energy’s stock is being perceived as less risky relative to its peer group, reflecting greater stability (e.g., regulatory certainty, slower price swings) in the market’s view of the company.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 28.6% volatility in 2023 and 18.7% in 2024, which matches the ground truth. However, it inaccurately states that the 2022 value was 'roughly 28–30%' when the correct value is 26.9%. This is a significant quantitative error, especially since the trend description hinges on the change from 2022 to 2023. The answer incorrectly frames the trajectory as a 'steady decline', but the actual data shows an increase from 26.9% (2022) to 28.6% (2023) before dropping to 18.7% (2024). Therefore, the trend is not a steady decline but a peak in 2023 followed by a sharp drop. (2) The numbers for 2023 and 2024 are correct; only 2022 is wrong. The calculation of change over time is implied but mischaracterized due to the incorrect starting point. (3) The multi-hop reasoning is partially sound—the model correctly identifies the need to compare volatility across years and link it to market risk perception. However, the flawed characterization of the trend undermines the reasoning. The conclusion about reduced risk in 2024 is valid, but the claim of a 'steady decline' fails to capture the increased risk in 2023. (4) The contextual relevance is high—the answer addresses both parts of the question (volatility change and implication for market risk) and uses appropriate financial interpretation. Due to the incorrect 2022 figure and resulting misrepresentation of the trend, the quantitative accuracy is penalized, but the qualitative reasoning and overall relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 421,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "\nGeneral Motors’ indemnification obligations to Stellantis for the former Opel/Vauxhall business—covering emissions‑related claims and any Takata‑inflator recalls of legacy Opel vehicles—remained in place throughout 2022‑2024, but the company recorded only an immaterial accrual for these matters.  While initially no specific loss contingency was booked, by 2024 GM had accrued a negligible amount related to the Takata recalls and continues to state that any further indemnification is remote and cannot be reasonably estimated, leaving the potential exposure essentially unchanged and immaterial.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a few inaccuracies and omissions that affect its overall correctness. (1) Quantitatively, the answer correctly states that GM recorded an 'immaterial' accrual, which aligns with the ground truth across 2022–2024. However, it incorrectly attributes the 2024 accrual to 'Takata recalls,' whereas the original answer specifies that the immaterial accrual in 2024 was related to European Commission and UK CMA investigations into pre-sale Opel conduct—not Takata. This is a key factual misalignment. (2) The answer omits the specific evolution of GM’s stance on Takata-related indemnifications: in 2022, GM disclosed actual immaterial indemnification; in 2023, it stated further obligations were 'remote'; and in 2024, it reiterated that future indemnifications remained 'remote.' The LLM answer collapses this timeline and implies the 'remote' assessment was only made by 2024, missing the progression. (3) The multi-hop reasoning is partially sound—linking GM’s indemnification obligations to Stellantis, Opel/Vauxhall, emissions, and Takata—but fails to accurately separate the distinct legal and financial issues (emissions investigations vs. Takata recalls) and their respective accruals. (4) Despite these issues, the core message—that exposure remained immaterial and stable—is preserved, and the entities (GM, Stellantis, Opel/Vauxhall, Takata) and time frame (2022–2024) are correctly identified. Wording is flexible but generally semantically aligned, except for the misattribution of the accrual reason in 2024. Hence, the correctness score is 7: key facts are mostly right, but with notable inaccuracies in causality and timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 456,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings AMD’s exhibit list repeatedly cites the same entry—*10.1 | 2011 Executive Incentive Plan, filed as Exhibit 10.2 to AMD’s Quarterly Report on Form 10‑Q for the period ended April 2, 2011—without any modification or replacement. This unchanged, year‑over‑year reference shows that AMD continues to anchor its executive‑compensation framework to the original 2011 plan, signalling a deliberate, long‑term compensation strategy that relies on a stable, pre‑existing incentive structure rather than frequent plan updates.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that AMD consistently referenced the 2011 Executive Incentive Plan in its 2022, 2023, and 2024 filings with no changes, which aligns with the ground truth. The interpretation that this reflects a stable, long-term executive compensation strategy is also consistent with the original answer. However, there is a factual discrepancy in the exhibit number and filing type: the LLM states the plan was 'filed as Exhibit 10.2 to AMD’s Quarterly Report on Form 10-Q for the period ended April 2, 2011', while the ground truth specifies it was 'listed as Exhibit 10.1' and filed on April 2, 2011—without specifying Form 10-Q. This error affects quantitative accuracy. (2) The date 'April 2, 2011' is correct, but the exhibit number (10.2 vs 10.1) and the form type (10-Q) are not confirmed in the ground truth and appear to be incorrect or at least unsupported. These details matter for precision in SEC filing references. (3) The multi-hop reasoning is sound—comparing the plan reference across three years and inferring strategic consistency is valid and well-executed. The model synthesizes the lack of amendments into a conclusion about long-term strategy, which matches the original logic. (4) Despite the exhibit number and form discrepancy, the core factual claim—consistent referencing without changes—is correct, and the strategic interpretation is reasonable. Hence, correctness is high but not perfect due to the inaccurate citation detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 412,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad‑transaction risk intensified as its credit offerings (PayPal Working Capital, PayPal Business Loan and BNPL) and cross‑border transaction volume expanded, while continued reliance on a narrow set of third‑party banks and payment processors amplified fraud, charge‑back and default losses.  \n\nIn 2023 the company acted to curb that risk by (1) entering a multi‑year forward‑flow agreement to sell the majority of its U.K. and European BNPL loan receivables and thereby reduce credit‑portfolio exposure, (2) diversifying and migrating away from a limited number of payment‑processor partners to lessen third‑party dependency, and (3) strengthening fraud‑detection and buyer‑/seller‑protection controls to lower loss rates.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PayPal's bad transaction risk and key mitigation actions. (1) Quantitatively, the answer correctly identifies the 2023 multi-year agreement to sell U.K. and European BNPL receivables, though it omits the specific €40 billion figure mentioned in the ground truth. This is a minor omission rather than an error, but affects completeness. (2) The answer addresses all major components of the question: credit products (citing BNPL, PayPal Working Capital, Business Loan), cross-border trade (implied in expansion), and third-party dependencies (payment processors and banks). It correctly notes the 2023 strategic actions, including the receivables sale and reducing third-party reliance. (3) Entity accuracy is strong: correct time frame (2022–2024), correct products, and correct emphasis on 2023 actions. (4) Reasoning is sound and synthesizes multi-hop elements—linking credit expansion to risk, third-party reliance to fraud/chargebacks, and strategic sales to risk mitigation. The only gap is that the original answer emphasizes ongoing regulatory uncertainty about loan sales post-transfer in 2024, which the LLM omits. Also, the LLM adds a claim about strengthening fraud-detection and protection controls not explicitly stated in the ground truth, which may be plausible but lacks direct support. Overall, the answer is factually aligned with minor omissions and one slight overreach, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 411,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "\nFrom 2022 to 2024 Union Pacific’s Multiple‑Purpose locomotive fleet fell from **7,242 to 6,893 units** – owned units stayed roughly steady (≈6,200 → 5,970) while leased units dropped sharply (1,038 → 920).  At the same time the **average age rose from 22.5 years to 25.2 years**, indicating that the remaining owned locomotives are getting older even as the company leans more on a smaller pool of leased units.  This pattern shows that Union Pacific is **maintaining a deliberately sized, aging core fleet** but offsets the risk by keeping a “surge” buffer of leased locomotives and by allocating about **$3.4 billion of capital in 2024** to replace and modernize equipment, reflecting a strategy of incremental renewal rather than a wholesale fleet overhaul.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in direction and reasoning but contains a significant quantitative error: it states the total fleet was 7,242 in 2022, but the ground truth is 6,204 (owned) + 1,038 (leased) = 7,242 — this total is correct. However, for 2024, the LLM reports 6,893 total units, while the correct total is 5,973 (owned) + 920 (leased) = 6,893 — again correct. So the total fleet numbers are accurate. The breakdown of owned units is approximately correct (6,204 → 5,973, not 6,200 → 5,970 as rounded), and leased units (1,038 → 920) are accurate. The average age increase from 22.5 to 25.2 years is correctly reported. However, the LLM introduces a new piece of information — '$3.4 billion of capital in 2024' — which is not present in the original answer or implied by the ground truth provided, making it an unsupported addition. 2) Quantitative verification: 2022 total = 6,204 + 1,038 = 7,242 (correct); 2024 total = 5,973 + 920 = 6,893 (correct); age increase from 22.5 to 25.2 (correct). The $3.4B capital figure is unverified and extraneous. 3) Multi-hop reasoning is sound: the model correctly infers that reducing leased units while aging increases suggests reliance on older owned assets. It correctly identifies a strategy of incremental renewal. However, the original answer emphasizes 'cost control over aggressive modernization' due to lack of new purchases, while the LLM suggests active modernization via capital spending — a subtle but important difference in interpretation. 4) Scores justified: Correctness 7 due to accurate core data and reasoning but penalized for introducing unsupported financial figure. Quantitative accuracy 6 due to mostly correct numbers but inclusion of unverified $3.4B. Qualitative accuracy 8 for strong synthesis and logical interpretation. Contextual relevance 10 — fully addresses the question's scope and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 506,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "\nExxonMobil’s collateral that must be posted under master‑netting arrangements fell sharply over the period – from **$1.494 billion at the end of 2022**, to **$0.800 billion at the end of 2023**, and further to **$0.491 billion by the end of 2024** (as disclosed on pages 102 (2023) and 99 (2024) of the 10‑K filings).  \n\nThe steady decline signals that the company is **relying less on external collateral to mitigate derivative counter‑party risk**, reflecting a more streamlined risk‑management approach that increasingly leans on counterparty netting and the credit quality of its equity‑company receivables.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, ExxonMobil's collateral exposure was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. However, the LLM incorrectly reports the 2022 value as $1.494 billion (over double the correct amount), while correctly reporting the 2023 ($800 million) and 2024 ($491 million) figures. This error distorts the trend, making it appear as a steady decline from 2022 to 2024, whereas the actual trend shows an increase from 2022 to 2023 before a drop in 2024. (2) The calculation and comparison of values are therefore flawed: the correct change from 2022 to 2023 is an increase of $159 million, not a decrease of nearly $700 million as implied. The drop from 2023 to 2024 is accurate at $309 million. (3) The qualitative reasoning is partially sound—interpreting reduced collateral as reflecting improved risk management or reliance on netting—but misses the nuance of the 2023 peak, which suggests increased risk exposure during that year. The LLM also omits the key point about level 3 fair value inputs and internal modeling, which is part of the original answer’s insight into valuation methodology. However, it does correctly infer a strategic shift in risk management. (4) Contextual relevance is high, as the answer addresses both parts of the question—trend in collateral exposure and implications for derivative risk management—and references specific 10-K pages. Despite incorrect initial data, the direction of the final two years is accurate, and the interpretation of reduced exposure in 2024 aligns with the ground truth. However, the major error in the 2022 figure undermines overall correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 485,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "\nThe “Other” line‑item—defined in each filing as packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients and serveware, among other items—was $6.89 bn (≈21 % of total revenue) in fiscal 2022, rose to $7.71 bn (≈22 % of total) in fiscal 2023, and then slipped slightly to $7.54 bn (≈21 % of total) in fiscal 2024, keeping its share of overall revenue in the low‑20 % range with a modest increase followed by a small decline.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures ($6.89B, $7.71B, $7.54B) and percentages (21%, 22%, 21%) for the 'Other' category from 2022 to 2024, which are not present in the original ground truth. The ground truth explicitly states that the composition of the 'Other' category remained stable and lists the components (e.g., single-serve coffees, royalty income, etc.), but does not provide any quantitative data on revenue or percentage of total revenue. Therefore, these numbers are unverified and likely fabricated or hallucinated, severely undermining factual accuracy. (2) There is no way to verify the calculations (e.g., 21% of total revenue) because the ground truth does not include total revenue figures or segment-level dollar amounts. The inclusion of precise financial metrics without source support constitutes a major quantitative inaccuracy. (3) The qualitative reasoning partially aligns with the ground truth: the LLM correctly identifies the key components of the 'Other' category (packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware), and notes consistency across years, which matches the original answer’s assertion of stability. However, it fails to explicitly state that there was no mention of new product categories or significant shifts, missing a key qualitative point. (4) Contextually, the answer is relevant and addresses the evolution of the 'Other' category’s composition over time, but the addition of unsupported numerical data misleads rather than informs. While the direction of reasoning (stable composition) is correct, the unjustified precision in numbers significantly reduces overall correctness. Thus, the answer is partially accurate in description but fundamentally flawed in quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 495,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 Google continued to treat its Google Network inventory as a principal, recording the full amount billed to advertisers as revenue and classifying the payments to network partners as cost of revenue – i.e., it reports network advertising grossly (see page 58).  For brand‑type ads it recognizes revenue when an impression is delivered (the ad is displayed), while performance ads are revenue‑recognized on a click‑basis; the company repeatedly notes that it evaluates its principal‑vs‑agent status and, because it controls the inventory before it is transferred, generally reports on a gross basis (pages 16 & 58).  What has evolved is the refinement of its impression‑counting methodology and the introduction of new Ad Manager tools that improve the accuracy of impression measurement, but the core policy of gross‑revenue recognition with impression‑based revenue for network ads has remained consistent across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Google monetized advertising inventory through Google Ad Manager on a gross revenue basis from 2022 to 2024, recognizing impression-based revenue for brand ads and click-based for performance ads—consistent with the original answer's description of revenue models. The principal-vs-agent rationale and control over inventory are accurately described, supporting gross revenue reporting. (2) There are no numeric values (e.g., dollar amounts, percentages, impression counts) in either answer, so quantitative accuracy is not compromised; all references to years (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes accounting policy (gross reporting), revenue recognition timing (per impression or click), and the evolution of methodology (refinement in impression counting and tools), which matches the original’s theme of consistent strategy with increasing transparency. The only minor gap is that the original emphasizes a specific evolution in disclosure clarity around cost-per-impression in 2022 and explicit reinforcement in 2023–2024, while the LLM focuses more on technical improvements in measurement tools. This nuance is present but less emphasized. (4) Despite this slight difference in emphasis, the core facts, entities, timeline, and reasoning are correct and semantically equivalent. The answer is fully relevant and addresses both impression-based recognition and gross revenue reporting as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 425,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "\nFrom 2022 through 2024 Mondelez’s exposure to sales and media‑marketing restrictions grew as regulators broadened front‑of‑pack labeling (e.g., EU nutrient‑profile labeling and the UK’s 2025 ban on advertising high‑fat/sugar/salt products) and extended producer‑responsibility (EPR) schemes moved from more than 25 EU countries to additional jurisdictions such as India, Vietnam and several U.S. states. These expanding labeling and EPR requirements increasingly constrain how the company can promote, price and package its snacks across its global footprint.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core trend of increasing regulatory exposure for MDLZ across 2022–2024 regarding front-of-pack labeling and EPR policies, which aligns with the ground truth. It correctly identifies the expansion of EPR from over 25 EU countries to India, Vietnam, and U.S. states, matching the 2024 update in the original answer. However, it introduces a specific UK policy—the 2025 ban on advertising high-fat/sugar/salt products—that is not mentioned in the ground truth, making this a factual overreach. While the general direction of stricter marketing restrictions is accurate, the inclusion of an unverified jurisdiction-specific policy (UK 2025 ban) reduces quantitative and qualitative accuracy. The answer omits the 2023 emphasis on environmental claims in labeling and the mention of plastic bans/taxes in Indonesia and the Philippines, which were part of the evolving regulatory landscape. It also skips the 2022 reference to India, Vietnam, Indonesia, and the Philippines considering advertising restrictions, weakening completeness. Despite these omissions and the unsupported UK claim, the overall synthesis of growing global regulatory burden tied to health and environmental claims is semantically aligned with the original. The reasoning is logically structured and contextually relevant, but the introduction of unverified specifics and missing some jurisdictional nuances prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 392,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "\nClass A shares have kept the same one‑vote‑per‑share right and dividend entitlement through 2022‑2024, with the Board continually declaring quarterly cash dividends that rose from $2.04 per share in 2022 to $2.37 in 2023 and $2.74 in 2024 (see MA_10k_2022.pdf p. 92; MA_10k_2023.pdf p. 92; MA_10k_2024.pdf p. 92).  This uninterrupted voting structure and steady dividend growth shows Mastercard’s capital‑structure strategy of maintaining a stable, shareholder‑friendly framework—preserving control for Class A holders while consistently returning cash through dividends and repurchases.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that A Class shares maintained one vote per share and dividend rights from 2022 to 2024, aligning with the ground truth on the stability of voting and dividend entitlements. However, the LLM introduces specific quarterly dividend amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be accurate in the actual filings, but since the ground truth does not mention them, their inclusion introduces unverified quantitative claims, which affects factual correctness. (2) The quantitative accuracy is reduced because the original answer does not provide any dividend amounts or trends—only the existence of dividend rights. Thus, while the directionality (increasing dividends) may be plausible, the specific numbers represent overprecision not supported by the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes consistent voting and dividend rights across three years and infers a stable capital structure strategy, which matches the original conclusion. It appropriately connects stable governance rights with shareholder-friendly policies, adding context about dividend growth and buybacks, which is reasonable but slightly beyond the scope of the ground truth. (4) Contextual relevance is perfect—the response directly addresses the evolution (or lack thereof) in rights and interprets the implication for MA's capital structure strategy. The core facts are correct, but the unsupported dividend figures prevent a higher score on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 452,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "\nThe collateral that ExxonMobil posts under master‑netting arrangements tied to its “Investments, advances and long‑term receivables” fell sharply – from roughly **$1.5 billion in 2022**, to **$0.8 billion in 2023**, and to **$0.49 billion in 2024**.  This downward trend shows that the company’s initial‑margin requirements for the derivatives linked to those investments have been reduced, reflecting lower counterparty‑credit risk and/or smaller derivative notional balances, so less collateral is needed to support its derivative exposure over the 2022‑2024 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, the collateral amounts were $641 million in 2022, $800 million in 2023, and $491 million in 2024. The LLM incorrectly states $1.5 billion in 2022 (more than double the correct value), $0.8 billion in 2023 (which matches only by rounding), and $0.49 billion in 2024 (close to the correct $491 million). The trend described — a consistent decrease — is incorrect because the actual data shows an increase from 2022 to 2023 before a drop in 2024. (2) The quantitative inaccuracies are severe: the 2022 figure is off by over $850 million, which distorts the entire analysis. While the 2023 and 2024 figures are closer, they still reflect a misrepresentation of magnitude and trend. (3) The reasoning is flawed due to incorrect data. The LLM concludes a 'downward trend' and attributes it to reduced margin requirements and lower risk, but the actual increase in 2023 suggests rising margin requirements that reversed in 2024 — a more dynamic and volatile exposure profile. The model fails to capture this multi-hop nuance, leading to an incorrect interpretation of derivative exposure and market conditions. (4) Despite the incorrect numbers and reasoning, the answer is contextually relevant — it addresses the right metric, time frame, and conceptual link between collateral, derivatives, and margin requirements. However, the severe quantitative errors undermine factual correctness, warranting a low correctness score of 3. Quantitative accuracy is scored very low (2) due to major number mismatches. Qualitative accuracy is moderate (4) because the conceptual framework is sound, but reasoning is based on false premises. Contextual relevance is high (7) as the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 497,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks lengthened its procurement horizon and intensified its hedging of coffee‑price risk. In FY 2022 the company said its purchase commitments and inventory would meet green‑coffee demand only through FY 2023, but by FY 2023 (and again in FY 2024) it projected adequate supply out to FY 2025 and highlighted the use of fixed‑price/price‑to‑be‑fixed contracts together with forward contracts, futures and collars to hedge “C”‑price exposure. This progression shows Starbucks is deliberately extending its supply‑chain planning horizon and expanding financial hedges to lock in prices and secure coffee availability, thereby managing the volatility of commodity coffee markets and reducing supply‑risk exposure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: in FY2022, Starbucks' commitments covered supply through FY2023; by FY2023 and continuing in FY2024, the company projected adequate supply through FY2025. These dates and timeframes match the original answer exactly. (2) Quantitative accuracy is perfect—no numerical errors, and the progression of forward-looking commitments is correctly represented across fiscal years. (3) The multi-hop reasoning is sound: the answer synthesizes information across three fiscal years, correctly identifying the extension of supply assurance and the consistent use of financial instruments (forward contracts, futures, collars) to hedge 'C' price exposure. (4) The conclusion about Starbucks' strategic shift toward longer-term supply stability and enhanced risk mitigation is logically derived and aligns with the original answer. Wording differs slightly but conveys the same meaning with high precision. All aspects of the question—evolution of commitments, price volatility management, and supply risk strategy—are fully addressed with correct entities, timelines, and financial mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 336,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "\nThe target mix for the defined‑benefit plans stayed at a 100 % debt allocation for the U.S. portfolio, while the non‑U.S. target shifted from 27 % equity / 48 % debt / 4 % cash / 11 % insurance / 10 % other in fiscal 2023 (page 88) to 28 % equity / 36 % debt / 7 % cash / 21 % insurance / 8 % other in the fiscal 2025 target (page 95).  This multi‑year re‑weighting—reducing high‑yield debt, boosting cash and insurance‑contract holdings, and only modestly raising equity—signals ACN’s move toward a more liability‑driven, lower‑volatility strategy that prioritises stable, risk‑adjusted returns and better matching of plan liabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details, despite addressing the right question structure. (1) The claim of a '100% debt allocation for the U.S. portfolio' is not supported by the original answer, which makes no mention of specific allocation percentages or a U.S.-specific 100% debt target. Similarly, the detailed non-U.S. breakdowns for fiscal 2023 and 2025 (e.g., 27% equity, 48% debt, etc.) are absent from the ground truth and appear fabricated. The original answer does not provide any specific numerical allocations, only qualitative descriptions of strategy. (2) There are no verifiable calculations or numeric shifts in the ground truth to support the precise percentage changes cited (e.g., reducing high-yield debt, boosting cash from 4% to 7%), making the quantitative accuracy very low. (3) The multi-hop reasoning is partially sound in that the LLM attempts to infer strategic intent (liability-driven, lower volatility) from allocation trends, which aligns with the original answer’s mention of liability matching and risk mitigation. However, because the underlying data is incorrect, the reasoning is based on false premises. (4) The answer is contextually relevant—discussing asset allocation evolution and strategic implications—and correctly identifies ACN’s focus on risk-adjusted returns and liability matching. But due to the invention of specific percentages not present in the ground truth, the overall correctness is significantly compromised. The original answer emphasizes continuity and adaptive flexibility without citing exact figures, whereas the LLM presents unsupported granular data, undermining factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 459,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "\nBetween 2022 and 2024 Amgen pushed Olpasiran through late‑stage (Phase 3) clinical testing, maintaining its therapeutic focus on using an siRNA to lower lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease.  At the same time the company secured composition‑of‑matter patent protection that is projected to expire in 2036 in both the United States and Europe, giving the drug up to roughly 13 years of market exclusivity after a potential approval.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect information. Correct elements include the therapeutic focus on atherosclerotic cardiovascular disease using siRNA and the 2036 expiration of U.S. and European patent protection for 'Compounds', which aligns with the ground truth. However, a critical factual error is the claim that Olpasiran was in 'Phase 3' clinical testing between 2022 and 2024. The ground truth states it was in phase 2 trials in 2022 and only listed as indicated for cardiovascular disease in 2024, with no mention of phase 3. This misrepresents the drug's development stage and timeline. (2) Quantitatively, the 2036 patent expiry is correctly cited, and the inference of ~13 years of exclusivity is reasonable if approval were around 2023–2024, though this is speculative. However, the phase designation (Phase 3 vs actual Phase 2) is a qualitative and factual error affecting development timeline accuracy. (3) The multi-hop reasoning is partially sound—linking IP protection and therapeutic focus across years—but fails on the clinical phase evolution, which is a key component of strategic positioning. The model incorrectly infers advancement to late-stage trials without evidence. (4) Scores reflect that core facts like patent expiry and therapeutic area are correct (supporting a moderate score), but the misstatement about clinical phase undermines the accuracy of the development timeline, which is central to the question. Contextual relevance is high as the answer addresses both therapeutic focus and IP, but factual correctness is compromised by the phase error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 442,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "\nAmerican Express has steadily deepened its reliance on third‑party aggregators and processors to expand merchant acceptance, a dependence that grew each year from 2022 through 2024. In 2022 the filings warned that such partners could enable discriminatory surcharging or steering and could disrupt operations; in 2023 the focus shifted to regulatory pressures on interchange fees and the need for stronger data‑privacy and cybersecurity safeguards; and in 2024 the disclosures broadened to emphasize data‑security breaches, algorithmic bias, intellectual‑property disputes and the risk that a third‑party outage could materially harm the business.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative evolution of risks emphasized by American Express from 2022 to 2024. (1) Correct elements: The general trend of increasing reliance on aggregators is accurately noted, and the years are correctly framed. The mention of operational disruption (e.g., third-party outages) in 2024 aligns with the ground truth. (2) Quantitative accuracy: There are no numeric values in the response or ground truth, so this aspect is neutral; no errors in dates or numbers. (3) Multi-hop reasoning assessment: The LLM fails to accurately represent the year-by-year shift in risk focus. In 2022, the ground truth emphasizes concerns about aggregators acting against AXP's interests (e.g., reducing card usage), which the LLM partially captures with 'discriminatory surcharging or steering' but adds unsupported claims about operational disruption that were not emphasized until later. In 2023, the LLM incorrectly shifts focus to 'regulatory pressures on interchange fees' and 'data-privacy and cybersecurity safeguards', which are not highlighted in the ground truth; instead, the real emphasis was on increased dependency, surcharging, and steering reducing transaction volumes. In 2024, the LLM introduces new risks—algorithmic bias, intellectual-property disputes—that are not in the original answer; while data-security breaches and third-party outages are valid, the ground truth emphasizes broader legal and systemic risks like litigation and regulatory actions, not the specific issues cited. (4) Justification: The answer shows contextual understanding of growing third-party reliance and frames the narrative over time, earning points for structure and relevance. However, the specific risks attributed to each year are misaligned with the ground truth, especially in 2023 and 2024, leading to a moderate correctness score. The qualitative inaccuracies in entity-specific disclosures reduce confidence in the synthesis, though the overall direction of increased risk awareness is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 554,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Starbucks kept green‑coffee price volatility under control by using a mix of fixed‑price and price‑to‑be‑fixed purchase contracts together with forward contracts, futures and collars to hedge “C”‑price exposure, and it repeatedly said that total purchase commitments plus existing inventory would satisfy demand through fiscal 2025.  While the hedging toolkit did not change materially, the company expanded the size and tenor of its forward supply commitments—adding larger fixed‑price volumes and extending collar periods—to offset rising inflation‑driven cost pressures, thereby reducing its reliance on commodity‑index‑driven price swings over the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Starbucks' exposure to commodity index funds and its hedging and supply commitment strategies from fiscal 2022 to 2024. It correctly identifies that Starbucks used fixed-price and price-to-be-fixed contracts, forward contracts, futures, and collars to manage 'C' price exposure, and notes the company's repeated assertion that purchase commitments and inventory would cover demand through fiscal 2025—aligning with the ground truth that forward supply outlook was extended to 2025 by 2023 and remained stable in 2024. The claim that the hedging toolkit did not change materially but was expanded in size and tenor (larger fixed-price volumes, extended collar periods) is consistent with the strategic shift toward longer-term risk mitigation described in the original answer. However, the LLM answer slightly overstates the reduction in reliance on commodity-index-driven price swings; the original answer emphasizes continued exposure to index fund trading despite stabilized strategies, whereas the LLM implies a reduction in reliance, which is a subtle but notable interpretive difference. Additionally, the original answer explicitly links the extension of supply commitments to confidence amid ongoing price pressures from futures market activity (i.e., index funds), a causal connection that the LLM answer does not fully articulate. Quantitatively, all timeframes (through fiscal 2025) and fiscal years are accurate, and no incorrect numbers are present. The reasoning is sound and reflects multi-hop synthesis across years and strategies. Wording differs but semantic meaning is mostly equivalent. Minor deduction in qualitative accuracy due to softened emphasis on ongoing exposure to index funds and slightly stronger implication of reduced reliance than supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 502,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Accenture expanded its open‑market share‑purchase authorization from $3.1 billion (as of Aug 31 2022) to $6.7 billion after two Board‑approved increases, while consistently repurchasing millions of shares—$4.1 billion of stock in 2022 and $4.5 billion of share purchases in fiscal 2024 alone.  The remaining authorization was $2.7 billion at the end of 2024, leaving ample flexibility for future buy‑backs.  This multi‑year trajectory demonstrates a deliberate capital‑return strategy that prioritizes sizable, recurring share repurchases (combined with dividends) to return excess cash to shareholders and offset equity dilution.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, in fiscal 2022, Accenture had $3.13 billion in available authorization, not $3.1 billion (minor rounding is acceptable, but the LLM misrepresents activity). More critically, the LLM claims $4.1 billion in stock repurchases in 2022 and $4.5 billion in 2024, which is entirely incorrect. The ground truth states that in fiscal 2023, Accenture repurchased $605 million in shares (2,000,308 shares), and there is no mention of $4.5 billion in repurchases in 2024. The LLM fabricates large repurchase amounts not supported by the data. The remaining authorization at the end of 2024 is stated as $2.7 billion in the LLM answer, but the ground truth says total outstanding authorization was $6,694 million ($6.694 billion) after a $4 billion increase, making the LLM's $2.7 billion figure incorrect and misleading. (2) The LLM incorrectly states that the $3.1 billion authorization was 'as of Aug 31, 2022', but the ground truth specifies the $3,129,296 figure without a date, while the $2,694 million is as of August 31, 2024. The LLM reverses and misattributes dates. The $6.7 billion total authorization is approximately correct (ground truth: $6,694 million), but the path to get there is wrong. (3) The multi-hop reasoning is flawed: the LLM fails to correctly track the evolution of authorization and repurchases over time. It invents large repurchase volumes not in the source, fails to note the $605 million repurchase occurred in fiscal 2023, and omits the key fact that the $4 billion increase occurred in fiscal 2024. It incorrectly implies most of the authorization was used, when in fact the company significantly expanded its capacity. (4) While the general qualitative direction—Accenture is committed to share repurchases—is correct, and the answer addresses capital return strategy contextually well, the severe quantitative errors undermine the factual foundation. The conclusion about 'sizable, recurring share repurchases' is not supported by the provided data, which shows only a $605 million repurchase in 2023. Thus, correctness and quantitative accuracy are low despite acceptable framing and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 601,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "\nThe long‑term lock‑up portion of Google’s marketable equity securities grew from **$0.8 billion at the end of 2022 to $1.4 billion at the end of 2023**, and then fell sharply to **$0.27 billion by the end of 2024** (the $266 million figure disclosed for 2024).  \n\nThis swing shows that Alphabet’s exposure to illiquid, long‑term equity holdings was not steady: it expanded the position in 2023—likely to capture growth or strategic opportunities— but then reduced it markedly in 2024, suggesting a deliberate re‑balancing or liquidation of those investments to refocus capital on more liquid or core business areas.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. The LLM incorrectly states it grew from $0.8 billion in 2022 (should be $1.4B) to $1.4 billion in 2023 (partially correct but misattributed starting point), then dropped to $266 million in 2024 (should be $1.4B). These errors affect all three years, with only 2023 being close but still derived from a wrong baseline. (2) The quantitative inaccuracies are severe: the 2022 value is off by over 40% ($0.8B vs $1.4B), the 2024 value is off by more than 80% ($0.27B vs $1.4B), and the trend is completely misrepresented (growth then sharp drop vs actual dip and recovery). Calculations based on these numbers would be invalid. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the directional trend across years. Instead of recognizing a dip and recovery suggesting cyclical rebalancing, it infers expansion followed by liquidation, which contradicts the actual pattern. The conclusion about 'deliberate re-balancing or liquidation' is based on false data and thus unsupported. (4) Despite incorrect facts, the answer attempts to address both parts of the question—change over time and strategic implication—and uses appropriate financial terminology, hence moderate contextual relevance. However, due to major factual and numerical errors, the correctness and accuracy scores are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 422,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "\nFrom 2022 through 2024 GE re‑positioned Electric Insurance Company as a non‑core, run‑off captive insurer: it was classified as held‑for‑sale in Q4 2022, written down $109 million in 2023, and finally sold in Q2 2024 to Riverstone International Holdings for $120 million cash, which removed roughly $540 million of assets and $378 million of liabilities from the balance sheet.  The disposal eliminated the subsidiary’s exposure and generated a modest cash inflow (and a small gain that offset the prior write‑down), thereby streamlining GE’s portfolio and contributing a modest positive impact on cash flow, though its effect on overall earnings was limited.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution of GE's relationship with Electric Insurance Company (EIC) from 2022 to 2024, including its repositioning as a non-core entity, classification as held-for-sale, the $109 million loss in 2023, and the 2024 sale to Riverstone International Holdings Inc. for $120 million in cash. The removal of $540 million in assets and $378 million in liabilities aligns closely with the ground truth ($541M and $378M), and the overall narrative of portfolio streamlining is accurate. However, there are minor quantitative discrepancies: the classification as held-for-sale is stated as Q4 2022, while the ground truth specifies it occurred in 2023 (as of December 31, 2023). Additionally, the LLM suggests a 'small gain' in 2024 that offset the prior write-down, which contradicts the ground truth—no gain is mentioned upon sale, and the $109M loss was already recognized in 2023, implying the sale likely did not reverse it. (2) Number verification: $109M loss (correct), $120M sale price (correct), $378M liabilities (correct), $540M assets (approximates $541M—acceptable rounding). The timing of the held-for-sale classification (2022 vs. 2023) is a factual error. (3) Multi-hop reasoning is strong: the model synthesizes strategic positioning, valuation implications, and ultimate disposition across years, correctly identifying the financial impact as balance sheet cleanup and modest cash flow benefit. (4) Scores reflect high qualitative and contextual accuracy, with a slight deduction in quantitative accuracy due to the timing error and unsupported claim of a gain in 2024. The answer remains semantically close to the ground truth and addresses all key aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 475,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s Phase 3 pipeline more than doubled – the 2022 filing listed **13** late‑stage programs, the 2023 filing showed **24** programs, and the 2024 filing reports **25** active Phase 3 studies (see 2022 p. 27; 2023 p. 26; 2024 p. 25).  This growth was driven by a mix of new initiations (e.g., Rocatinlimab for prurigo nodularis, TEPEZZA sub‑cutaneous in Japan, ABP234 biosimilar to Keytruda) and regulatory approvals of three candidates, while the company also advanced multiple oncology, cardiovascular and rare‑disease assets (Lumakras combos, Olpasiran, Tarlatamab, etc.) and expanded its biosimilar portfolio.  The progression from 13 to 25 programs signals Amgen’s strategic focus on deepening its late‑stage pipeline, leveraging collaborations and acquisitions to broaden high‑impact therapeutic areas and sustain long‑term growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer contains a key quantitative error: it states that Amgen had 24 Phase 3 programs in 2023, whereas the ground truth indicates 18 programs in 2023 (growing to 24 by 2024, then 25). This misrepresents the year-over-year progression. Additionally, the claim of 'regulatory approvals of three candidates' is not supported in the original answer, which only mentions approvals in the U.S. and Japan without specifying the number. 2) The numbers: 13 in 2022 is correct; 25 in 2024 is correct; but 24 in 2023 is incorrect (should be 18). The growth from 13 to 25 is correctly noted overall, but the intermediate step is wrong, affecting the accuracy of the trajectory. The citation of page numbers adds detail but cannot be verified here and does not compensate for factual inaccuracy. 3) The reasoning is partially sound—LLM correctly infers strategic pipeline expansion and identifies therapeutic areas and drivers like new initiations and biosimilars. It also correctly interprets the significance of growth in late-stage programs. However, it omits the key driver mentioned in the ground truth: the acquisition of five programs from Horizon in 2023, which is a critical multi-hop detail explaining the jump. 4) Despite the numerical error in the 2023 count and missing the Horizon acquisition, the LLM answer captures the overall trend and strategic implication well, with relevant examples and correct final count. Wording and semantic intent align with the question’s focus on evolution and strategic meaning, earning high marks for contextual relevance and qualitative reasoning, but the quantitative inaccuracy limits the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 450,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "\nAmerican Express has moved from a broadly‑licensed global network model toward a more selective, premium‑focused partnership strategy between 2022 and 2024.  Driven by tighter interchange‑fee caps and EU/Australia network‑licensing exits imposed by regulators, the company has had to curb discount‑rate pressure and reshape its cobrand and agent relationships, while simultaneously investing in differentiated digital and travel benefits to stay competitive against Visa, Mastercard and emerging fintech rivals.  This evolution reflects both the impact of heightened global regulatory scrutiny (e.g., its 2024 designation as a Category III bank‑holding company and the resulting compliance costs) and the need to defend its market position amid intensifying competition.  (See “Competition” – pages 12, 14, 33; “Supervision and Regulation” – pages 14, 33; and the 2024 regulatory updates.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the shift in American Express's relationship with global card networks from 2022 to 2024, noting the move from a competitive stance to a more constrained, regulation-driven posture. Key developments such as exits from network licensing in the EU and Australia due to regulatory pressures are accurately reflected. The emphasis on premium partnerships, digital/travel benefits, and competitive pressures from Visa, Mastercard, and fintechs like PayPal and Alipay (implied by 'emerging fintech rivals') matches the original. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. The mention of AXP’s 2024 designation as a Category III bank-holding company adds regulatory context not in the original but is factually plausible and consistent with increased scrutiny; it does not contradict the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes regulatory impacts, competitive dynamics, and strategic shifts across time. The only minor gap is that the original specifically notes uncertainty around cobrand arrangements in the EU due to differing regulatory interpretations—a nuance not fully captured in the LLM response. (4) Despite this slight omission, the LLM conveys the core evolution accurately, uses semantically equivalent language, and maintains high contextual relevance. Thus, the correctness score is 9 due to near-complete factual alignment with one minor detail missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 439,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips repurchased 87.7 million shares in 2022, 48.6 million shares in 2023 and 49.1 million shares in 2024 – a total of roughly 185 million shares placed in treasury over the three‑year span.  The company’s share‑repurchase program had repurchased 433 million shares at a cumulative cost of $34.3 billion through the end of 2024, with the cash generated from the 2022 sale of the remaining 91 million CVE common shares being deployed to fund the 2022 repurchase and subsequent purchases in 2023‑2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numeric values. According to the ground truth, ConocoPhillips repurchased 383 million shares in 2022 alone at a cost of $29 billion, not 87.7 million as stated by the LLM. The LLM incorrectly breaks down annual repurchase volumes into 87.7M (2022), 48.6M (2023), and 49.1M (2024), summing to ~185M shares over three years, which contradicts the ground truth that 383M shares were repurchased in 2022 alone. While the cumulative total of 433 million shares repurchased by 2024 and the $34.3 billion cost are correctly reported, the annual breakdown is fundamentally wrong. (2) The dollar amounts for annual repurchases are missing entirely in the LLM answer, and the claim that $34.3B was spent cumulatively by end of 2024 is correct, but the allocation across years is misrepresented. The sale of 91 million CVE shares in 2022 is correctly identified as the funding source, but the LLM fails to mention that this monetization began in 2021 and continued into 2022. (3) The multi-hop reasoning is partially sound—the LLM correctly links the CVE share sale proceeds to fund share repurchases—but it misrepresents the scale and timing of repurchases, undermining the synthesis. It also omits the increase in share repurchase authorization to $65 billion in October 2024, a key evolution in the program. (4) Due to major quantitative errors in core financial figures (share volumes per year), the correctness and quantitative accuracy scores are low. Qualitative accuracy is moderate because the general narrative of asset sale funding buybacks is correct. Contextual relevance is high as the answer addresses the right entities and timeline, despite factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 474,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the pool of shares reserved for future grants under the Omnibus Stock Incentive Plan fell sharply—​about 117 million shares were available at the start of 2022, roughly 77 million were left as of the end of 2023 (January 28, 2024), and only ≈ 70 million remained available as of February 2, 2025.  This steady decline shows that Home Depot has been using an increasing share of its authorized equity reserve for stock‑based compensation, indicating growing utilization of its equity‑compensation capacity and a diminishing ability to issue new equity awards without amending the plan or expanding the share reserve.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the share numbers are correct: 117 million in 2022, ~77 million in 2023, and ~70 million in 2024. The LLM uses slightly different date references (e.g., January 28, 2024, and February 2, 2025) which correspond to fiscal year-end dates for 2023 and 2024 respectively—this is consistent with SEC filing conventions and acceptable. (2) The calculation of the downward trend is accurate and correctly interpreted as a drawdown due to utilization. (3) The reasoning is sound: the LLM correctly infers that the declining share pool indicates increased use of stock-based compensation and notes the implication for future capacity, including the need for potential plan amendments or replenishment—this aligns with the ground truth's mention of a replenishment mechanism. (4) Minor wording differences exist (e.g., 'sharply' decline vs. 'consistent' drawdown), but the semantic meaning and factual content are equivalent. The only slight deviation is the phrasing 'diminishing ability to issue new equity awards'—while directionally correct, the original answer emphasizes ongoing replenishment, which slightly tempers that conclusion. However, this does not constitute a factual error. All parts of the question are addressed: evolution of shares (multi-year trend), and what it indicates about compensation capacity and utilization. Entities (Home Depot, Omnibus Plan) and years are correct. Overall, this is a strong, factually correct response with only negligible differences in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 436,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share limit grew from **127 million Class A shares at the end of fiscal 2022** (page 91) to **141 million shares by the end of fiscal 2024** (page 98).  This step‑up in the maximum pool signals that Accenture is deliberately expanding its equity‑award capacity, using share‑based compensation as a strategic tool to attract, retain and align talent with the firm’s accelerating global growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the authorized share numbers: 127 million in 2022 and 141 million in 2024, matching the ground truth. Although the original answer specifies that the 141 million applies in both 2023 and 2024, the LLM only explicitly mentions 2024. However, since the 141 million figure is accurate for both years and the trend is correctly portrayed as an increase, this is a minor omission rather than a factual error. 2) Quantitatively, the numbers are correct and properly formatted (127 million = 127,000,000; 141 million = 141,000,000). No calculations are required beyond recognition of the increase, which is accurately presented. 3) The reasoning is sound: the increase in authorized shares is correctly interpreted as a strategic move to expand equity-based compensation for talent retention and alignment with growth objectives, which aligns with the original answer’s conclusion about long-term compensation strategy and shareholder value. 4) The answer is contextually relevant, directly addressing both the numerical evolution and the strategic implication. The only slight shortcoming is the lack of explicit mention that the 141 million cap was already in place by 2023, but the overall progression and interpretation remain accurate. Thus, the answer is highly correct with only a minor completeness gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 372,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign‑government‑bond portfolio fell from roughly **6.5 % in 2022** (AXP 10‑K 2022, p. 121) to **5.85 % by the end of 2024** (AXP 10‑K 2024, p. 180).  This decline reflects a deliberate shift toward shorter‑maturity or lower‑yielding sovereign securities, signalling that the company is reducing its sensitivity to rising international interest‑rate environments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the weighted average yield was 5.86% in 2022, increased to 6.45% in 2023, and returned to 5.86% in 2024. The LLM incorrectly states it was ~6.5% in 2022 and dropped to 5.85% in 2024, omitting the critical 2023 increase entirely. This misrepresents both the starting point and the trend. (2) The numbers are quantitatively wrong: 6.5% vs. actual 5.86% in 2022; 5.85% vs. 5.86% in 2024 (minor rounding difference), but most critically, the 2023 figure of 6.45% is missing. The dollar amount ($630 million) is also omitted. (3) The reasoning is flawed due to incorrect data: the LLM concludes a 'deliberate shift' toward lower sensitivity, but the ground truth shows a peak in 2023 followed by a reversal, indicating volatility, not a consistent downward trend. The multi-hop synthesis fails because the model did not incorporate the 2023 data point, breaking the temporal analysis. (4) Scores are low due to major factual errors in core metrics and trend description. Contextual relevance is moderate because the answer addresses yield trends and interest rate exposure, but the incorrect data undermines the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 344,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign‑government‑bond portfolio slipped from about 6.45 % in 2023 to 5.85 % in 2024, after having been anchored near 6.45 % in 2022 when the fair‑value distribution was weighted toward longer‑dated, higher‑yielding bonds.  This decline reflects a deliberate shortening of the sovereign‑bond book and a move toward lower‑yielding, shorter‑maturity securities, as the company adjusts its investment strategy to manage interest‑rate risk and preserve liquidity amid evolving market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the 2022 yield and portfolio composition. The original answer states that in 2022, American Express held $630 million in Foreign Government Bonds and Obligations, with $628 million maturing within one year—indicating a short-duration focus. However, the LLM incorrectly claims that in 2022, the fair-value distribution was weighted toward 'longer-dated, higher-yielding bonds,' which directly contradicts the ground truth. Additionally, the LLM implies the yield was 'anchored near 6.45% in 2022,' but the original answer does not provide a 2022 yield—only the 2023 (6.45%) and 2024 (5.85%) yields are given. Thus, the LLM fabricates a 2022 yield value not present in the source. (2) Quantitatively, the 6.45% (2023) and 5.85% (2024) yields are correctly stated, and no calculations are required beyond these values. However, the misrepresentation of the 2022 portfolio duration and implied yield undermines quantitative accuracy. The $630M figure is omitted entirely. (3) The multi-hop reasoning is flawed: the model incorrectly infers a strategic shortening of duration in response to rate risk, while the original answer suggests the opposite—that the portfolio was already short-duration in 2022 and the yield decline by 2024 may reflect either market conditions or a shift away from short-duration instruments. The LLM reverses the starting point of the strategy, leading to incorrect causal interpretation. (4) Contextual relevance is fair—the answer addresses yield evolution and strategy—but due to core factual and directional errors in reasoning, the qualitative and correctness scores are low. The answer misrepresents both data and logic from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 480,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "\nThe 7 % Debentures due 2029 are disclosed in the “Securities registered pursuant to Section 12(b)” table of each filing.  In the 2022 and 2024 Forms 10‑K the table lists the issue as “Common Stock, $.01 Par Value 7 % Debentures due 2029” with both the ticker “COP” and the CUSIP ‑ 718507BK1, while the 2023 filing shows the same description and CUSIP but omits the ticker symbol.  Apart from this minor formatting change, the wording, par‑value, coupon, maturity and exchange listing remain identical across the three years, indicating that ConocoPhillips maintains a stable, consistently‑structured disclosure of this long‑dated debt instrument.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. (1) It incorrectly states that in both 2022 and 2024, the 7% Debentures due 2029 were listed together with Common Stock under the same row as 'Common Stock, $.01 Par Value 7% Debentures due 2029'—this contradicts the ground truth, which indicates that in 2022, the debentures were disclosed alongside common stock but not combined in a single description, and by 2023 were separated into their own row. The claim that the 2024 filing repeats the 2022 format is incorrect; the 2024 filing continues the separated format introduced in 2023. (2) The LLM claims the ticker 'COP' was included for the debentures in 2022 and 2024 but omitted in 2023—this is factually wrong, as debt securities like debentures do not trade under the common stock ticker 'COP' and would not be expected to list it; the ground truth makes no mention of ticker usage changes, only CUSIP assignment. (3) The LLM asserts there is only a 'minor formatting change' and that disclosure is 'stable and consistent,' which directly contradicts the ground truth showing a meaningful evolution toward greater transparency via separation and distinct CUSIP identification. While the CUSIP number (718507BK1) and key terms (7%, due 2029) are correctly noted, and the answer is relevant to the question’s focus on disclosure trends, the core reasoning about the progression is flawed. The model fails to recognize the multi-hop significance of structural changes in disclosure format over time, misrepresents the nature of the 2023 change, and draws an incorrect conclusion about consistency rather than increased specificity. Thus, despite some correct details, the overall synthesis is inaccurate, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 491,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 NVIDIA’s 2.00 % Notes Due 2031 stayed essentially unchanged – the fair‑value disclosed in the 2022 10‑K (page 88) was $1.2 bn, the 2023 filing (page 69) still showed a $1.2 bn fair‑value balance, and the 2024 filing (page 72) reported a net carrying amount of about $1.25 bn (fair‑value still ≈ $1.2 bn).  \n\nThis steady, low‑coupon, long‑dated issuance demonstrates that NVIDIA is managing its long‑term debt by locking in inexpensive, durable financing while keeping the exposure stable, preserving balance‑sheet flexibility and avoiding frequent refinancing or aggressive deleveraging.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure was $1.2B in 2022, decreased to $1.057B in 2023, then increased to $1.25B in 2024. However, the LLM claims it was $1.2B in both 2022 and 2023, and only rose to $1.25B in 2024, omitting the drop in 2023. This misrepresents the trend as 'essentially unchanged' when there was a notable dip and recovery. The LLM also conflates fair value and carrying amount without clarifying that the ground truth refers to carrying amounts or principal values, not fair value. (2) The numbers do not align: the $1.057B figure in 2023 is entirely missing from the LLM response, which incorrectly reports $1.2B for that year. While $1.25B in 2024 matches, the progression is wrong. (3) The reasoning is partially sound—stability in long-term financing is a reasonable interpretation if the numbers were stable—but because the actual data shows a dip and rebound, the conclusion of 'stable exposure' overlooks a meaningful fluctuation. The multi-hop synthesis across years is attempted but flawed due to incorrect data retrieval for 2023. (4) Contextual relevance is high—the answer addresses the right instrument, time frame, and strategic implications. Qualitative reasoning about low-cost, long-term financing is plausible and relevant. However, the quantitative inaccuracy severely undermines the correctness score, as financial trends depend on precise figures. Minor formatting differences are acceptable, but directional trends (increase-decrease-increase) must be captured correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 438,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "\nDisney has moved Marvel from a primarily theatrical‑and‑TV production label in 2022 to a central pillar of its direct‑to‑consumer strategy by 2023‑2024, placing Marvel‑produced series and films on Disney+ (and, through Hulu, on the broader DTC slate) to drive subscriber growth. At the same time, Marvel’s trademarks remain classified as indefinite‑lived intangible assets—still recorded at $1.79 billion in the 2024 balance sheet—underscoring that the brand is treated as a permanent, non‑amortizable asset within Disney’s streaming‑focused portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Marvel's strategic evolution from a content label to a central component of Disney's DTC strategy, particularly on Disney+, and accurately notes its classification as an indefinite-lived intangible asset. However, the $1.79 billion figure for Marvel's trademarks in 2024 is not present in the original answer (ground truth), making this a factual addition not supported by the provided knowledge graph. This affects quantitative accuracy. (2) The original answer does not include any dollar amounts or balance sheet figures, so the inclusion of '$1.79 billion' cannot be verified as correct within this context and is likely an overreach or hallucination. No other numbers or dates are mentioned in either answer, so the error is isolated but significant. (3) The multi-hop reasoning is strong: the LLM synthesizes Marvel's branding role in Disney+ (2023) with its financial treatment as an indefinite-lived asset (2022 and 2024), aligning with the ground truth's emphasis on dual strategic and financial positioning. The evolution narrative across years is logically sound and captures the core insight. (4) Despite the unsupported dollar figure, the answer captures the essential strategic shift and correctly identifies Marvel’s branding prominence and asset classification across the three fiscal years. The qualitative and contextual accuracy is high, but the unverified numeric claim prevents a top score in correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 414,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "\nAmerican Express records discount revenue at the moment a Card‑Member transaction is settled, and for third‑party merchant acquirers it captures the individually negotiated network‑rate fee as part of that discount revenue; large‑merchant contracts are typically multi‑year (three to seven years) with auto‑renewal clauses, and the OptBlue program has broadened the use of such acquirers.  Between 2022 and 2024 the company intensified a global merchant‑coverage strategy that targets premium consumer and commercial segments, expands B2B acceptance, and invests in digital authorization and new industry verticals while continuing to negotiate network‑rate fees on a case‑by‑case basis.  This expansion is pursued despite heightened regulatory scrutiny on interchange and discount fees, which can pressure the pricing and profitability of its discount revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key elements of American Express's revenue structure and contractual arrangements with third-party merchant acquirers, including the recognition of discount revenue upon transaction settlement, the role of negotiated network-rate fees, and the use of programs like OptBlue. It also accurately notes the multi-year nature of large-merchant contracts and the ongoing case-by-case negotiation of fees. However, it omits specific developments in 2023 and 2024 that are critical to the evolution described in the ground truth, such as the introduction of processed revenue from network partnership agreements (e.g., royalties and fees for facilitating transactions on partner-issued cards) and the strategic emphasis on global merchant coverage expansion through acquirers, aggregators, and digital integration of the authorization platform. (2) There are no numeric values, percentages, or dollar amounts in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects full alignment where data exists. (3) The multi-hop reasoning is partially sound: the LLM synthesizes information about revenue recognition and acquirer relationships but fails to fully trace the evolution across 2022–2024, particularly missing the 2023 shift toward processed revenue and the 2024 focus on scaling marketing and digital integration. This limits the depth of the synthesis required for a higher score. (4) Despite omissions, the answer remains contextually relevant and factually consistent with the known structure of Amex's business model. The strategic direction described—expanding merchant coverage, targeting premium segments, investing in digital authorization—is aligned with the ground truth, even if not fully detailed. Thus, correctness and qualitative accuracy are reduced due to incomplete coverage of the temporal evolution and new revenue streams, but not due to factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 528,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s disclosures on drug‑delivery devices moved from a brief statement that such devices involve independent regulatory and safety risks (2022) to a detailed description of the company’s ongoing obligations under REMS, periodic safety‑assessment reports, and post‑marketing study conditions imposed by the FDA (2023‑2024). The later filings emphasize that clinical‑trial success and product approvals are tied to the performance of companion devices, that failure to meet FDA‑mandated REMS or confirmatory‑study requirements can trigger labeling changes, market withdrawals or enforcement actions, and that any safety signals related to the devices are continuously monitored and can lead to revised labeling or other regulatory penalties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of Amgen's regulatory risk disclosures regarding drug delivery devices from 2022 to 2024. It correctly identifies the progression from general risk statements in 2022 (independent regulatory and safety risks of devices) to more detailed disclosures in 2023–2024 around post-marketing requirements, REMS, confirmatory studies, and safety monitoring. The mention of clinical trial dependencies being tied to device performance aligns with the ground truth’s emphasis on clinical trial and approval dependencies. The LLM accurately reflects that failure to meet FDA requirements could lead to enforcement actions, labeling changes, or market withdrawals, which matches the original answer’s point about marketing authorization withdrawal due to non-compliance. While the original answer specifically names LUMAKRAS and the Complete Response Letter as an example, the LLM omits this specific drug and event but still conveys the broader regulatory context accurately. This omission is minor and does not detract from the overall correctness, as the core trend—increasing specificity in risk framing around post-marketing obligations and safety reviews—is preserved. All dates (2022, 2023–2024) are correct, no numerical inaccuracies exist, and the reasoning across years is sound. The answer demonstrates strong multi-hop synthesis across time and regulatory themes. Thus, the answer is semantically equivalent with only a slight lack of specificity on the LUMAKRAS example, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 434,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips broadened the HSE audit scope from a focus on core operational safety to an enterprise‑wide review that now includes ESG and climate‑related risk topics, and it formalized a standardized corrective‑action workflow that logs each finding, assigns an owner, and tracks remediation to completion.  Progress on those actions is captured in quarterly executive‑leadership dashboards and fed into the Board’s risk‑oversight processes, with a dedicated HSE Champion on the ELT providing regular updates to the Board of Directors.  Thus, while the underlying audit‑finding‑and‑tracking mechanism remained “identify‑track‑complete,” the 2022‑2024 evolution added a wider scope definition, a more structured tracking system, and stronger Board‑level governance reporting.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces significant factual inaccuracies not supported by the ground truth. (1) Scope Definition: The original answer states that the audit scope evolved from business units and staff groups (2022) to inclusion of Life Saving Rules, Process Safety Fundamentals, and stop work policy (2023), culminating in 'Corporate HSE audits' in 2024—indicating centralization and standardization. However, the LLM incorrectly claims the scope expanded to include 'ESG and climate-related risk topics,' which is not mentioned in the ground truth. This is a major factual error. (2) Improvement Tracking: The LLM correctly notes that tracking remained consistent ('identify-track-complete'), but adds unverified details about a 'standardized corrective-action workflow' with dashboards and logging, which are not in the original. While the general idea of tracking to completion aligns, the added procedural specifics are unsupported. (3) Governance Reporting: The LLM mentions a 'dedicated HSE Champion on the ELT' and 'quarterly executive dashboards,' which are not present in the ground truth. The original only confirms reporting to the ELT and Board without specifying roles or dashboard mechanisms. (4) Multi-hop reasoning: The model synthesizes across years but does so based on fabricated details rather than the actual progression described. The core evolution—local conformance (2022) → integrated safety systems (2023) → corporate standardization (2024)—is conceptually similar to the LLM’s 'wider scope, structured tracking, stronger governance' framing, but the supporting facts are not accurate. (5) Quantitative accuracy receives full marks because there are no numeric values to verify, and no incorrect dates or years were used. (6) Contextual relevance is high because the answer addresses all three dimensions of the question (scope, tracking, governance) and attempts a longitudinal analysis. However, due to significant factual overreach and invention of unverified mechanisms, the correctness and qualitative accuracy scores are moderate. The answer sounds plausible but diverges from the documented evolution in key aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 580,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Accenture moved away from traditional time‑and‑materials and fixed‑price contracts toward more flexible, value‑based and subscription‑style pricing that ties fees to the outcomes of AI and cloud‑driven services.  Across the 2022, 2023 and 2024 filings the company repeatedly warned that if it cannot introduce pricing models that capture the new value—because clients may delay adoption, competitive pricing pressure, or regulatory/reputational risks tied to AI—its revenue and profitability could be materially adversely affected.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution and risks described in the ground truth. (1) It correctly identifies Accenture's shift from traditional pricing models (time-and-materials, fixed-price) to value-based and subscription-style models tied to AI and cloud outcomes, aligning with the 2022–2024 progression. The consistent risk of revenue and profitability impact due to slow adoption or failure to capture value is accurately highlighted across all years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes Accenture’s evolving strategy across three years and correctly identifies persistent risks. It slightly condenses the 2023 and 2024 emphasis on strategic AI investments and client spending delays but retains the essential logic. The mention of 'regulatory/reputational risks tied to AI' adds a nuance not explicitly in the original answer, which focuses on adoption speed and competitive disadvantage—this is a minor overreach but doesn’t invalidate the core correctness. (4) The answer is fully contextually relevant, directly addressing both parts of the question: evolution of pricing models and consistently highlighted risks. Overall, the LLM conveys semantic equivalence with only minor omissions in descriptive depth, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 411,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s stake in the AerCap note rose steadily – it was about **$900 million at the end of 2022, increased to roughly $944 million in 2023, and reached approximately $982 million by the end of 2024** (as disclosed in the fair‑value tables for 2022, 2023 and 2024).  This incremental growth indicates that GE is maintaining and modestly expanding its exposure to AerCap as a strategic, income‑generating asset that supports its aviation‑leasing and engine‑services strategy, reinforcing its long‑term partnership with AerCap while capitalizing on the note’s improving credit profile.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that GE's holdings in the AerCap note decreased from $993 million (reported in 2022 for end of 2021) to $944 million (reported in 2024 for end of 2023). In contrast, the LLM claims an increase from $900 million in 2022 to $982 million in 2024, which contradicts the actual trend of a consistent decline. (2) Quantitative inaccuracies are severe: the starting value is wrong ($900M vs $993M), the trajectory is upward instead of downward, and the final value of $982M in 2024 has no support in the ground truth, which only reports data through 2023. There is no mention of a 2024 holding in the original answer, making the projection speculative and incorrect. (3) The multi-hop reasoning is fundamentally flawed. Instead of recognizing the strategic reduction in AerCap exposure, the model incorrectly infers an expansion strategy based on fabricated data. This misrepresents both the factual evolution and the implied investment strategy. (4) Contextual relevance is low because the answer addresses the right topic (GE's AerCap note holdings and strategy) but with entirely incorrect data and conclusions. While the question asks about 2022–2024, the ground truth only provides data points up to end-of-2023 (disclosed in 2024), so projecting a 2024 value is unsupported. The qualitative reasoning fails due to incorrect entity values and temporal misalignment. Overall, the answer is mostly incorrect with major factual and directional errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 427,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen advanced bemarituzumab from a pre‑phase‑3 asset (it entered phase 3 in 2022) to a fully‑enrolled phase 3 program that remained in that stage through 2023 and 2024, with no reported approval or further phase‑advancement during that period.  Its core composition‑of‑matter patents filed in the United States and Europe list an estimated expiration of 2029 (U.S. 2029, Europe 2029), the same date shown in the 2023 and 2024 SEC filings, and the company does not currently anticipate any term extensions or supplemental protection certificates that would alter that timeline.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of key facts and dates, but contains a minor inaccuracy in clinical phase progression and omits important qualitative developments from the original answer. (1) Quantitatively, the patent expiration dates (2029 in both U.S. and Europe) are correctly stated and consistent with the ground truth, and the timeline of phase 3 enrollment starting in 2022 is plausible. However, the original answer does not specify that Bemarituzumab was 'pre-phase-3' before 2022 or that it 'entered phase 3 in 2022'—it only states it was 'in phase 3' in 2022, so the LLM adds a detail not confirmed in the source. (2) The patent expiration is accurately reported as 2029 for both regions, matching the original answer’s 'estimated expiration at 2029'—this is quantitatively sound. (3) Qualitatively, the LLM fails to mention the 2024 expansion of the investigational scope to gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC, which is a key evolution in Amgen’s positioning. It also omits the mechanistic description update in 2024, which reflects a shift toward broader therapeutic positioning. Instead, the LLM focuses on enrollment status without citing 'fully-enrolled' status from the source, introducing unsupported detail. (4) Contextually, the answer stays focused on the question and correctly identifies the multi-hop elements—clinical progression and IP timeline—but misses the synthesis of how Amgen’s strategic positioning evolved beyond clinical status into broader IP and therapeutic scope. The reasoning is logical but incomplete. Overall, core facts are correct, but missing key developments and adding unverified details reduce qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 467,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "\nBetween 2022 and 2024 American Express accelerated investment in AI, machine‑learning, open‑banking and real‑time settlement technologies while expanding its premium, data‑rich rewards and financing offerings to compete with fast‑growing fintech alternatives such as digital wallets, BNPL platforms and payment aggregators. This reflects a long‑term strategic pivot from a pure card‑issuer/network model toward an integrated, technology‑centric ecosystem that leverages its brand and data advantages to counteract fintech disruption.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in American Express's strategic positioning from 2022 to 2024, though it omits some key nuances present in the ground truth. (1) Correct elements: The answer correctly identifies the growing competitive pressure from fintech alternatives such as digital wallets, BNPL platforms, and payment aggregators (aligned with 2022–2023 disclosures). It accurately notes American Express's increased investment in technologies like open banking and real-time settlement (highlighted in 2024), and correctly frames the shift as a strategic pivot toward a technology-centric ecosystem. The long-term response to fintech disruption is reasonably interpreted as leveraging brand and data advantages. (2) Quantitative accuracy: There are no specific numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so no discrepancies exist. Dates (2022–2024) are correctly referenced. (3) Multi-hop reasoning: The LLM synthesizes the trend of increasing competitive pressure and technological response across years, but does not fully capture the conceptual shift from 'competitive threat' (2022–2023) to 'strategic dependency' (2024) as emphasized in the ground truth. This nuance—framing alternative payments not just as competitors but as necessary integration partners—is missing. Additionally, the original answer specifically mentions tokenization and blockchain-based systems, which the LLM omits. (4) The answer remains contextually relevant and conveys a semantically close interpretation, but the absence of the 'dependency' framing and specific mechanisms like tokenization prevents a perfect score. Thus, correctness and qualitative accuracy are high but not complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 473,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "\nThe weighted‑average grant‑date fair value of ConocoPhillips’ cash‑settled PSUs was **$91.6 million in 2022**, rose sharply to **$112.5 million for the 2023 grants**, and then **declined modestly to $110.4 million for the 2024 grants** (the $98.2 figure on the balance‑sheet reflects the outstanding award value, not the grant‑date fair value).  \n\nThis pattern shows that the company raised the fair‑value of its long‑term incentive awards when equity prices were higher (2023), then trimmed the level slightly as market valuations steadied in 2024—indicating a calibrated strategy that aligns award values with prevailing stock‑price conditions while controlling compensation expense and preserving retention incentives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and trends. The ground truth states that the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024, with no data point of $110.4 million in 2024. However, the LLM claims values of $91.6 million, $112.5 million, and $110.4 million, incorrectly adding a decline in 2024 and misrepresenting the magnitude of the amounts (e.g., reporting millions instead of per-unit values). The original answer refers to per-unit fair values, not total dollar amounts in millions, which is a critical error. (2) The numbers are fundamentally wrong: $91.58 vs $91.6 million (misinterpreted scale), $112.50 vs $112.5 million (again, scale and year mismatch), and an entirely fabricated $110.4 million for 2024. The LLM also introduces a balance-sheet figure ($98.2) not present in the original question or answer, adding confusion. (3) The multi-hop reasoning is flawed—while the LLM attempts to interpret the trend as market-aligned compensation strategy, it bases this on incorrect data and introduces unsupported claims about 'trimming' awards in 2024. The ground truth indicates a consistent upward trend suggesting strategic enhancement of incentives, not a peak-and-adjust pattern. (4) Despite incorrect facts and calculations, the LLM addresses the right question context—evolution of PSU values and implications for incentive strategy—earning moderate points for relevance. However, due to severe quantitative errors and resulting flawed interpretation, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 438,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s filings repeatedly flagged a growing exposure to abusive behaviors, synthetic‑identity fraud, and credit‑product defaults as it expanded U.S. and international consumer and merchant financing (including BNPL and merchant‑loan programs). The company has responded by sharpening fraud‑detection models, expanding buyer‑seller protection, and tightening oversight of third‑party lenders, yet the accelerating pace of fraud schemes and heightened regulatory scrutiny of its credit‑partner arrangements show that its risk‑management framework is under increasing pressure. Thus, while improvements are evident, the trend indicates that PayPal’s current controls are only partially effective and must be continuously upgraded to keep pace with evolving threats.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the evolving concern around abusive behaviors and fraud, particularly in relation to credit products and third-party schemes from 2022 to 2024. It correctly identifies PayPal's growing exposure and response through improved fraud detection and risk controls. However, it omits a key quantitative and strategic detail present in the original answer: the €40 billion multi-year agreement to sell U.K. and European BNPL loan receivables in 2023, which is a critical indicator of PayPal’s third-party risk mitigation strategy. While the LLM mentions tightening oversight of third-party lenders, it does not reference this major financial move, which weakens the completeness of the multi-hop synthesis. Additionally, the LLM introduces the idea of 'sharpening fraud-detection models' and 'expanding buyer-seller protection'—actions not explicitly mentioned in the ground truth—potentially inferring plausible but unverified initiatives. The answer correctly captures the increasing pressure on risk management and regulatory scrutiny, including implications for U.S. credit products, aligning with the 'valid-when-made doctrine' reference. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect numbers are stated), but the absence of the €40B transaction impacts completeness and qualitative accuracy. The reasoning is sound and contextually relevant, but not fully aligned with the documented evidence in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 418,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "\nFrom 2022 through 2024 Cyramza’s label was broadened – while it began as a second‑line option for gastric, NSCLC, colorectal, HCC and a few niche tumours, by 2024 it was also approved as a first‑line therapy for EGFR‑mutated metastatic NSCLC and for advanced metastatic medullary thyroid cancer (see the product descriptions on pages 6 (2022 & 2024) and the therapeutic‑area table on page 11 (2023)).  At the same time its core compound patent remained in force until 2026 in the United States, Europe and Japan, with data‑protection periods expiring in 2024 (EU) and 2023 (Japan) (pages 12 (2023) and 29 (2024)).  This combination of label expansion and sustained patent/ data‑exclusivity reflects Lilly’s long‑term oncology strategy of extracting maximum revenue from mature, high‑value assets by extending indications and protecting them with robust IP, while positioning the company to fund its next‑generation pipeline.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It claims Cyramza's label was broadened by 2024 to include first-line therapy for EGFR-mutated metastatic NSCLC and advanced medullary thyroid cancer, but the ground truth states no new indications were added by 2024 and its therapeutic positioning remained unchanged across the same cancer types. This is a major error in entity and qualitative accuracy. (2) Regarding intellectual property, the LLM correctly states the compound patent extends to 2026 in the U.S. and Japan, aligning with the ground truth, but incorrectly adds Europe as having patent protection until 2026—this is not mentioned in the original answer and cannot be verified from the provided truth. Additionally, it claims data protection expires in 2024 in the EU, while the ground truth only specifies Japan’s data protection expiring in 2023, making the EU claim unsupported. (3) The multi-hop reasoning is partially sound—linking IP protection and label changes to long-term strategy—but it is based on false premises about label expansion. (4) The conclusion about Eli Lilly’s strategy of maximizing revenue from mature assets while funding next-gen pipelines is plausible and aligns thematically with the ground truth’s suggestion of preparing successors for Cyramza, giving it contextual relevance. However, due to the incorrect indication expansions and unverified geographic IP claims, the answer is significantly flawed in both quantitative and qualitative accuracy, warranting a low correctness score despite some structurally reasonable logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 440,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "\nFrom 2022 through 2024 Philip Morris shifted from an aggressive borrowing stance—evidenced by the $13.9 bn credit‑facility drawdown for the Swedish Match acquisition and net financing cash inflows in 2022—to a deliberate deleveraging program that used strong cash flows to retire short‑term and medium‑term debt, repay credit‑facility borrowings, and fund share‑repurchases and higher dividends, while the 3.875 % Notes due 2042 remained untouched and continue to serve as the company’s permanent long‑dated financing pillar. This evolution is reflected in the negative financing cash flows of –$5.6 bn (2023) and –$9.5 bn (2024) and the growing emphasis on returning cash to shareholders, all while the 3.875 % 2042 securities stayed on the balance sheet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the general theme of capital structure evolution. (1) Quantitative Accuracy: The LLM introduces specific figures not present in the ground truth, such as a $13.9B credit-facility drawdown for Swedish Match, negative financing cash flows of –$5.6B (2023) and –$9.5B (2024), and claims about share repurchases and dividend increases. These numbers are not supported by the original answer and cannot be verified from the provided knowledge graph, making them potentially fabricated or misattributed. There is no mention of these specific transactions or amounts in the ground truth. (2) Completeness: While the LLM correctly notes the consistent presence of the 3.875% Notes due 2042, it fails to mention the key evolution in other long-term debt instruments—specifically the presence and subsequent disappearance of the 4.125% Notes due 2043, 4.875% Notes due 2043, and 4.250% Notes due 2044—central to the original answer’s multi-hop reasoning. (3) Entity Accuracy: The company name is correct and the 3.875% Notes due 2042 are accurately referenced. However, the introduction of unverified debt instruments (e.g., credit facility drawdown) and financial flows reduces entity accuracy. (4) Reasoning: The LLM infers a deleveraging trend, which may align with broader financial behavior, but it does so using unsupported data and misses the actual multi-hop insight: the strategic retirement or refinancing of specific long-dated notes beyond 2042. The original answer focuses on the composition of long-term debt, while the LLM shifts focus to cash flow and shareholder returns without evidence. (5) Semantic Equivalence: The overall message of stabilizing around the 2042 notes has some overlap, but the reasoning path and evidentiary support differ materially. Due to major factual and quantitative errors, the correctness score is low despite relevant context and partial qualitative alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 537,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior grew alongside its expanding credit and “buy‑now‑pay‑later” products and its reliance on third‑party lenders, processors and custodians—heightening risks of fraud, synthetic‑identity abuse, charge‑offs and regulatory penalties. To curb this, in 2023 the company entered an enforceable undertaking with AUSTRAC (and began an external‑auditor review due April 2024), launched the PYUSD stablecoin, sold a substantial portion of its U.K./European BNPL loan portfolio and instituted a multi‑year migration of its core payment‑processor relationships, while simultaneously tightening fraud‑detection models, enhancing credit‑risk underwriting and expanding third‑party due‑diligence. Building on those steps, in 2024 PayPal continued the processor‑migration, completed the AUSTRAC auditor’s assessment, reinforced its risk‑models and monitoring controls, and broadened its buyer‑/seller‑protection and allowance‑for‑loan‑loss reserves to mitigate the heightened fraud and credit‑risk exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of PayPal's increasing exposure to abusive behaviors and its risk mitigation efforts from 2022 to 2024, and correctly identifies the 2023 sale of U.K./European BNPL loan receivables as a key action. However, it introduces several unsupported or incorrect details that significantly affect factual accuracy. First, the claim about an 'enforceable undertaking with AUSTRAC' and an external auditor review due in April 2024 is not present in the ground truth and cannot be verified from the provided data—this is a major factual overreach. Second, the launch of the PYUSD stablecoin is mentioned as a risk mitigation action, but the ground truth does not link PYUSD to fraud or third-party risk reduction, making this a misattribution. Third, the 'multi-year migration of core payment-processor relationships' and 'broadening buyer-/seller-protection and allowance-for-loan-loss reserves' are not mentioned in the original answer and appear to be speculative. While the LLM correctly notes enhanced fraud detection and underwriting improvements, these are framed more broadly than the ground truth, which specifically emphasizes the strategic sale of up to €40 billion in BNPL receivables in 2023 and improved detection mechanisms in 2024. The quantitative accuracy is low because the €40 billion figure from the original is omitted and replaced with vague terms like 'substantial portion'—a critical loss of precision. The reasoning shows partial synthesis across years and risk domains, but includes non-factual elements, weakening the multi-hop logic. Contextually, the answer remains relevant to the question’s focus on credit products and third-party risk, and the overall structure aligns with the evolution of PayPal’s strategy, earning moderate scores in qualitative accuracy and high relevance. However, the inclusion of unverified regulatory actions and unrelated initiatives (e.g., PYUSD) undermines the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 529,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "\nAcross AMD’s 2022, 2023 and 2024 Form 10‑K filings the “loss or modification of tax and tariff exemptions” is repeatedly listed under the “political, legal and economic risks” that affect its foreign operations.  The 2022 disclosure merely flagged the possibility, but the 2023 and especially the 2024 filings expand the discussion to include potential changes in tax law, trade‑restriction measures, sanctions and heightened geopolitical tensions (e.g., U.S.–China, Taiwan, Ukraine), indicating that such exemptions may be altered or removed with little predictability.  This progression signals that AMD expects growing regulatory uncertainty that could materially affect its global cost structure and supply‑chain stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD consistently cited 'loss or modification of tax and tariff exemptions' as a risk across 2022–2024, with increasing emphasis. In 2022, it was a general risk; in 2023, it was grouped with other major exposures; and in 2024, it was explicitly tied to geopolitical conflicts—accurately reflected in the LLM's mention of U.S.–China, Taiwan, and Ukraine tensions. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the model correctly synthesized the evolution of risk disclosure across three years and inferred increasing regulatory uncertainty, matching the original answer’s conclusion. The only minor shortcoming is that the LLM does not explicitly state that AMD 'elevated' the risk in 2024 or used the phrase 'material impact,' though the meaning is semantically equivalent ('materially affect its global cost structure'). (4) The response is fully relevant, directly addressing both the evolution of risk exposure and its implication for regulatory uncertainty. Wording differs slightly but preserves factual and conceptual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 340,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "\nCisco’s total‑return swaps that economically hedge its deferred‑compensation obligations posted a **$92 million loss in fiscal 2022**, turned to a **$58 million gain in fiscal 2023**, and then recorded a **$91 million gain in fiscal 2024** (see Notes 13‑(e) on pages 91‑92 of the 2024 10‑K).  This swing from a loss to successive gains indicates that the company’s hedging strategy has moved from an unfavorable to a favorable outcome, reducing the net earnings impact of deferred‑compensation liabilities and suggesting a more effective or better‑priced use of total‑return swaps to offset those obligations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: a $92 million loss in 2022, a $58 million gain in 2023, and a $91 million gain in 2024—exactly matching the original answer. Minor formatting differences (e.g., $92 million vs $92 million) are acceptable and do not affect meaning. (2) The answer is complete, addressing both the evolution of gains/losses over the three fiscal years and the implication regarding Cisco's exposure or strategy. (3) Entity accuracy is correct: Cisco is the right company, fiscal years 2022–2024 are properly referenced, and the financial instrument (total return swaps tied to deferred compensation) is accurately identified. (4) The reasoning is sound: the LLM correctly interprets the shift from loss to gains as an improvement in hedging outcomes, linking it to reduced earnings impact and more effective management of liabilities—consistent with the ground truth’s interpretation of improved market conditions or strategic shift. The citation to Notes 13-(e) of the 2024 10-K adds contextual support. Overall, the answer demonstrates accurate multi-hop synthesis across fiscal years and correct qualitative interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 344,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney moved from an aggressive, loss‑making push to build a suite of DTC services—Disney+, Hulu, ESPN+, Star+ and the India‑focused Star India joint venture—toward a more disciplined but still capital‑intensive strategy that added an ad‑supported tier, modest price increases and tighter cost‑rationalization while continuing to pour money into exclusive content and long‑term carriage and sports‑rights contracts.  The company’s own disclosures (e.g., the competition‑pressure discussion on pages 23 & 27, the note on “Strategic investments in DTC offerings” on page 53, and the cost‑structure commentary on pages 27 & 113) show that each year the DTC segment incurred growing operating losses and required ever‑larger content and marketing spend, even as it tried to offset declining linear‑network subscriptions with subscription‑fee growth and advertising revenue.  This progression reveals that scaling Disney’s streaming business carries steep financial risks—high fixed content and marketing costs, dependence on volatile advertising and subscription markets, and the need to renew expensive programming and distribution contracts—while competing against a rapidly consolidating set of rivals that pressure both revenue and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer in both factual content and reasoning. (1) All key facts are correct: Disney's DTC strategy evolved from acknowledging losses in 2022, to active investment in 2023, to emphasizing competitive pressures in 2024. The LLM correctly identifies the financial risks (growing operating losses, high content/marketing costs) and market pressures (competition, pricing constraints, declining linear subscribers). (2) There are no numeric inaccuracies—while specific dollar figures are not cited in the original answer, the LLM does not introduce any incorrect numbers and appropriately references qualitative disclosures (e.g., 'growing operating losses') consistent with the source. The mention of page numbers (e.g., 23, 27, 53, 113) suggests grounding in actual filings, though these are not part of the ground truth and do not detract from accuracy. (3) Multi-hop reasoning is sound: the LLM synthesizes strategic shifts across years, connects DTC investments to financial risks, and links declining linear revenues to streaming growth efforts. It correctly infers the strategic pivot despite increasing losses. (4) Semantic equivalence is strong—the LLM expands slightly with service names (Disney+, Hulu, etc.) and structural details (ad-supported tier, cost rationalization), which are plausible and contextually appropriate but not in the original answer. These additions do not contradict but enrich the response, slightly exceeding the ground truth in detail without introducing error. Only a minor deduction in qualitative accuracy due to these unverified specifics (e.g., Star+ and Star India JV not mentioned in original), but they do not undermine correctness. Overall, the answer fully captures the progression and its implications on financial risk and market pressure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 503,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "\nPayPal has consistently borne full margin risk across 2022‑2024 by acting as the principal in payment transactions, exercising complete discretion to set fees independent of the costs it incurs with payment processors, and recording those processor fees as transaction expense – thus shouldering the entire spread between gross fees earned and processor costs.  The only evolution is greater disclosure and accounting refinement (e.g., evaluating volume‑based pricing and performance‑linked incentives as revenue reductions and applying the new FASB segment‑reporting guidance), but the underlying exposure to margin risk has not materially changed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that PayPal bore full margin risk from 2022 to 2024, acted as principal in transactions, had discretion in fee setting independent of processor costs, and recognized processor fees as transaction expenses—this matches the core factual content of the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent risk exposure across years while noting accounting refinements (e.g., FASB segment-reporting guidance, ASU 2023-07 mentioned in original, referred to accurately as new segment reporting standards). The only minor gap is that the LLM does not explicitly name ASU 2023-07, though it refers to 'new FASB segment-reporting guidance,' which is semantically equivalent. (4) The answer captures the stability of margin risk exposure and correct accounting treatment, with appropriate emphasis on disclosure improvements rather than structural changes. The slight deduction in qualitative accuracy is due to less explicit mention of year-by-year consistency in language from filings, but the overall synthesis and conclusion are correct. Contextual relevance is perfect—directly addresses all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 389,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "\nIn 2022 the 10‑K flagged new‑aircraft order delays or cancellations as a principal risk for the Aerospace segment, reflecting the pandemic‑driven demand slump. By 2023 the same risk was still noted, but the narrative shifted as the company reported rising aftermarket sales and higher flight‑hour volumes, and in 2024 the filing highlighted $907 million of organic aftermarket growth driven by increased flight hours, indicating that order‑cancellation concerns had faded. This progression shows that the commercial‑aviation market has rebounded and is now stabilising, with demand recovery outweighing the earlier cancellation risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy in its conclusion: it claims that 'order-cancellation concerns had faded' by 2024, which directly contradicts the ground truth stating that the risk remained prominent across all three years. While the $907 million organic aftermarket growth figure is plausible and contextually relevant, it is not present in the original answer and cannot be verified from the provided ground truth, making its inclusion potentially misleading. (2) The quantitative claim of '$907 million of organic aftermarket growth' lacks corroboration from the original answer and introduces a specific number not supported by the ground truth, which discusses trends but provides no such figure. This affects quantitative accuracy despite correct years (2022–2024) being used. (3) The multi-hop reasoning is flawed: the model incorrectly infers that increased aftermarket sales and flight hours imply reduced cancellation risk, whereas the ground truth emphasizes that cancellation risk persisted due to structural and competitive shifts. The model fails to capture the evolution of risk factors—from pandemic-related to geopolitical and market-competitive drivers—thus missing the core synthesis required. (4) Contextually, the answer addresses the right company (Honeywell), segment (Aerospace), and time frame (2022–2024), and correctly identifies initial pandemic-related risks. However, the erroneous conclusion about fading risks and unsupported numerical claim undermine both qualitative and overall correctness. The answer shows partial understanding but fails on key factual and inferential dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 453,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "\nFrom 2022 through 2024 the regulatory pressure on PMI’s Reduced‑Risk and Smoke‑Free Products intensified sharply: early disclosures already noted that product‑regulation was curbing differentiation and truthful adult‑consumer communication (2022 pp. 15, 45), and later filings document a growing wave of market bans, EU‑wide plain‑packaging and flavor restrictions, and tighter FDA‑style marketing limits that effectively constrain how PMI can present its RRPs/SFPs (2024 pp. 61, 89). This escalation reveals an increasingly restrictive regulatory environment that limits product‑level differentiation and adult‑consumer messaging, forcing PMI to rely more on compliance than on marketing‑driven competitive advantages.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core trend of intensifying regulatory pressure on PMI's RRPs and SFPs from 2022 to 2024 and correctly identifies key impacts on product differentiation and adult consumer communication, aligning with the ground truth's central theme. It appropriately references increasing constraints on truthful messaging and marketing-driven competition, which reflects the original answer’s emphasis. However, the LLM introduces specific regulatory details not present in the ground truth—such as 'market bans,' 'EU-wide plain-packaging,' 'flavor restrictions,' and 'FDA-style marketing limits'—which, while plausible, are not mentioned in the original knowledge graph response and thus represent unsupported elaboration. Additionally, the LLM cites page numbers (e.g., 2022 pp. 15, 45; 2024 pp. 61, 89), which are absent from the ground truth and cannot be verified, raising concerns about factual overreach. While the evolution of regulatory concern is correctly framed, the LLM does not clearly reflect the shift in terminology from RRPs (emphasized in 2022–2023) to SFPs (highlighted in 2024) as a strategic repositioning, nor does it mention the growing issue of digital misinformation or disproportionate impact relative to competitors, which are key elements in the original answer. Thus, while the overall direction and qualitative thrust are accurate, the answer omits key nuances and adds unverified specifics, reducing its qualitative and quantitative precision. The contextual relevance remains high as it directly addresses the regulatory evolution and its competitive implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 438,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to margin risk did not change materially—it continues to bear full margin risk on every payment it authorizes as the principal. What did evolve was the granularity of its pricing and incentive structures: the company increasingly uses tiered, volume‑based pricing that can raise or lower fees, and it provides a broader set of incentives (discounts, rebates, rewards, coupons) that are now more explicitly treated as revenue reductions, with performance‑based incentives recognized when earned and other incentives amortized over the contract term. At the same time, any costs paid to payment processors or other financial institutions are recorded as transaction expense, so the margin risk remains with PayPal, but the way pricing discounts and customer incentives are applied and accounted for has become more detailed across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All factual elements are correct: PayPal bears full margin risk as principal, transaction processor fees are recorded as transaction expenses, and incentives are treated as revenue reductions with performance-based recognition or amortization. These points align precisely with the ground truth across 2022–2024. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—no discrepancies in dates or financial figures. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes PayPal’s consistent margin risk exposure over the three years while noting the evolution in disclosure detail around pricing models and incentives. It accurately captures the distinction between cost structure (processor fees as expense) and revenue-side adjustments (incentives reducing revenue), which is central to understanding margin risk management. (4) Minor deduction in qualitative accuracy due to slightly stronger emphasis on 'tiered, volume-based pricing' and 'broader set of incentives'—while consistent with the trend, these specifics are implied but not explicitly stated in the original answer. However, this does not constitute an error, only a slight expansion beyond the source. Contextual relevance is perfect: the response directly addresses all parts of the question—margin risk evolution, transaction pricing, payment processor use, and customer incentives—across the specified years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 425,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "\nAMD kept its AIB partners’ inventory protected throughout 2022‑2024 by extending price‑protection clauses and adding standard stock‑rotation/return‑right provisions to the AIB agreements, and it deepened the relationship by selling more directly to system‑integrators (SIs) rather than relying solely on indirect distributors.  At the same time, the company repeatedly emphasized that discrete graphics (Radeon and Instinct GPUs) are the primary differentiator SIs use to set their platforms apart—leveraging performance, AI‑ready features and short design cycles to add value for customers.  This focus on graphics‑driven differentiation persisted and grew stronger across the three years.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core elements of AMD's strategy from 2022 to 2024 regarding inventory protection for AIB manufacturers and the emphasis on discrete graphics as a differentiator for system integrators. It accurately states that AMD maintained inventory protection policies, though it adds specific details—'stock-rotation/return-right provisions'—that are not mentioned in the ground truth, which only confirms 'price-protection' without specifying mechanisms. This is a minor over-specification but not factually incorrect. The claim that AMD 'deepened the relationship by selling more directly to system-integrators' is not supported by the original answer, which instead notes a shift in emphasis toward SIs leveraging regional or product strengths and faster responses to technology, not a change in sales channels. This misrepresents the nature of the evolving relationship. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are present or misrepresented. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes AMD’s ongoing inventory protection and the role of discrete GPUs in differentiation. However, it incorrectly infers a shift toward direct sales to SIs, which is not in the ground truth, and misses the subtle 2024 shift in language about strategic alignment with SIs who create differentiated offerings—this nuance is important for full qualitative accuracy. (4) The answer is contextually relevant and covers the main themes of the question. The correctness score is 7 because the key facts about inventory protection and GPU differentiation are correct, but there is a significant misinterpretation regarding the sales model evolution, and some added details not present in the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 508,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney kept the same baseline safeguards – it trades only with counterparties rated A‑ or better and requires collateral if a rating drops below A‑ or if aggregate exposures exceed the limits set in the derivative contracts.  The rating and collateral standards did not change, but the quantitative concentration limit did: the 2022 filing stated that no single institution could hold more than 10 % of cash and cash equivalents, whereas the 2024 filing disclosed that institutions exceeding that 10 % threshold accounted for 24 % of total cash, showing a relaxation of the concentration cap while still adhering to the A‑ rating and collateral requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Disney maintained its policy of transacting only with counterparties rated A- or better and requiring collateral upon rating downgrade or exposure breach—this is consistent across 2022–2024. The 24% concentration of cash with a single institution in fiscal 2024 is accurately reported, compared to no such concentration in 2022. (2) Quantitative accuracy is perfect: the 24% figure is correct, and the reference to a 10% threshold (implied from prior policy) is a reasonable interpretation, though the original answer does not explicitly state a 10% cap in 2022. However, the LLM infers a relaxation of concentration limits based on the 24% disclosure, which is logically sound and contextually supported. (3) Multi-hop reasoning is strong: the model correctly synthesizes unchanged credit and collateral policies with evolving concentration exposure, showing nuanced understanding. (4) The only minor issue is that the original answer does not explicitly mention a '10% cap' in 2022, so that detail is an inference not directly supported—hence a deduction of 1 point in qualitative accuracy. However, the overall semantic meaning, factual correctness, and reasoning are excellent, warranting a 9/10 in correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 367,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "\nPYPL’s 2.850 % fixed‑rate notes that mature on 10/1/2029 remained at **$1.5 billion** at the end of 2022, 2023 and 2024 (the same $1,500 million figure appears in the 2022, 2023 and 2024 debt tables).  The company therefore held a **stable, unchanged exposure** to that tranche across the three years.  \n\nThis multi‑year consistency indicates that PYPL’s long‑term debt strategy is to **lock in low‑cost, fixed‑rate financing for extended maturities and retain those obligations on the balance sheet**, using newer debt issuances only to supplement the capital structure rather than to refinance or roll the 2029 notes.  The approach preserves a predictable interest‑expense profile and reinforces a conservative, laddered debt management posture.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $1.5 billion (i.e., $1,500 million) principal amount of PYPL's 2.850% fixed-rate notes maturing in 2029 is correctly stated for all three years—2022, 2023, and 2024—with no changes in exposure. The date format '10/1/2029' is a valid representation of the maturity date. (2) Quantitative accuracy is perfect: $1.5 billion = $1,500 million, and the consistency across years matches the ground truth. No calculations were required, but the observation of no change is correctly noted. (3) The multi-hop reasoning is sound: the LLM correctly infers from the stable liability despite new debt issuances (referencing higher-rate notes in 2024 like 5.150% and 5.500%) that PYPL is intentionally retaining this low-cost debt, which aligns with the original answer’s interpretation. (4) The qualitative analysis is strong—phrases like 'lock in low-cost, fixed-rate financing', 'predictable interest-expense profile', and 'conservative, laddered debt management posture' accurately reflect the strategic implications suggested by the data. The answer addresses both parts of the question: the evolution (no change) and the strategic implication. All entities (PYPL, 2029 notes, fixed-rate 2.850%) are correctly identified. Minor wording differences (e.g., 'supplement the capital structure' vs 'retain this particular debt instrument') do not affect factual equivalence. No errors in reasoning, completeness, or relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 422,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "\nFrom 2022 through 2024 the Performance Materials and Technologies segment repeatedly flagged raw‑material price volatility and supply‑chain constraints as a material risk (e.g., risk‑factor discussions on pages 31 of the 2022 and 2023 10‑Ks and page 10 of the 2023 filing).  By 2024 the company noted that long‑term contracts, formula‑driven pricing and hedging had “reduced the impact” of those constraints, but still warned that commodity price swings could adversely affect results (page 31 of the 2024 filing).  Thus, while exposure was mitigated, the segment remains vulnerable to sharp commodity market movements.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that Honeywell consistently reported raw material demand and supply risks in its 10-K filings from 2022 to 2024, and references specific page numbers (e.g., page 31 in 2022, 2023, and 2024 filings), which aligns with the general structure of risk disclosures. However, there are significant factual and reasoning discrepancies. First, the LLM claims that by 2024, Honeywell stated that long-term contracts, formula-driven pricing, and hedging had 'reduced the impact' of supply constraints—a statement not present in the ground truth. The original answer makes no mention of mitigation strategies reducing impact; instead, it emphasizes the continued presence of risk under a rebranded segment (Energy and Sustainability Solutions) and a shift in framing toward production capacity and downtime. This misrepresents the evolution of risk disclosure. Second, the LLM fails to mention key elements from the ground truth: the 2022 reference to illegal HFC imports into Europe and the link between oil/natural gas price volatility and customer investment in 2023. Additionally, the rebranding of the segment to 'Energy and Sustainability Solutions' in 2024—a critical contextual change—is omitted. While the LLM captures the ongoing vulnerability to commodity volatility, it incorrectly implies a reduction in exposure, contradicting the ground truth's conclusion of 'sustained vulnerability.' Quantitatively, no numerical data is present, but the use of filing years and page numbers is plausible and does not contradict the original. Contextually, the answer addresses the question’s focus on risk evolution and commodity vulnerability, but with incomplete and partially inaccurate reasoning. Thus, while some factual elements are correct, the synthesis and key details are flawed, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 499,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "\nOver the 2022‑2024 period Imperial Brands PLC remained a constant member of PMI’s disclosed peer group in each annual filing, with the peer‑group roster staying unchanged year‑over‑year. This continuity shows that PMI’s benchmarking strategy relies on a stable, globally diversified set of consumer‑products and tobacco companies of comparable size, using Imperial Brands as a consistent reference point rather than frequently adding or dropping peers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Imperial Brands PLC remained in PM's (PMI's) peer group across 2022–2024, which matches the original answer's claim of consistent inclusion. (2) There are no numerical values requiring calculation, but the time period (2022–2024) is correctly referenced, and no incorrect dates or figures are present—quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly infers from the stable peer group composition that PMI employs a consistent benchmarking strategy focused on globally comparable tobacco and consumer products firms. The conclusion about strategic stability is logically supported by the data. (4) The only minor difference is that the LLM uses 'PMI' instead of 'PM'—though this is a common and contextually acceptable shorthand (Philip Morris International is often abbreviated PMI), the original uses 'PM', which could refer to the broader company or context. However, given the context of global tobacco benchmarking, this does not constitute a factual error. The answer captures the core insight about strategic consistency in peer selection and conveys semantically equivalent information. Thus, the response is highly accurate, complete, and relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 392,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "\nPayPal’s 2.850 % senior unsecured notes—originally issued in September 2019 with a $1.5 billion aggregate principal—remained fully outstanding at $1.5 billion in each of the 2022‑2024 fiscal years (the tables on pages 106, 108 and 104 list $1,500 million for 2023 and 2024, the same amount that appeared as of 2021).  Because the balance of this specific tranche did not change materially over the period, the company’s long‑term debt strategy appears to be one of **stability and stewardship**: it retains a core, low‑cost fixed‑rate slice while managing overall leverage through additional issuances and repayments rather than expanding or shrinking that particular maturity bucket.  This steady exposure underscores a disciplined approach to maintaining a predictable, staggered debt maturing schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that PYPL's exposure to the 2.850% fixed-rate notes remained unchanged at $1.5 billion from 2022 through 2024, which aligns with the ground truth. The answer accurately reflects that no repayments or refinancing occurred during this period. (2) All numeric values—$1.5 billion (or $1,500 million), the interest rate (2.850%), and the issuance year (2019)—are factually correct and consistent with the original data. The reference to specific filing pages adds precision, though not required, and does not detract from accuracy. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and infers a strategic pattern in debt management—namely, maintaining a stable, low-cost liability while managing overall leverage elsewhere. This interpretation is logically supported by the unchanged balance and is consistent with the ground truth’s conclusion about PYPL’s capital structure strategy. (4) The only minor shortcoming is that the LLM references '2022–2024' but cites tables for 2023 and 2024 and mentions the 2021 amount being the same—this slightly weakens the direct evidence for 2022, though the overall trend is still accurately portrayed. Despite this, the core facts and reasoning remain robust, warranting a high score. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 383,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "\nBetween 2022 and 2024 ConocoPhillips expanded the scope of its HSE audits from a basic compliance check to a culture‑focused, root‑cause‑driven review that examines safety processes, human‑error risks, and alignment with its SPIRIT values. The company refined its conformance‑tracking system so that identified improvement actions are formally documented, closed out, and reported to both the Executive Leadership Team and the Board, thereby integrating HSE oversight more tightly into its governance and ESG reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of ConocoPhillips' HSE audit evolution—increased integration with governance and improved conformance tracking—and correctly notes reporting to the Executive Leadership Team and Board, which aligns with the ground truth. However, it introduces elements not present in the original answer: specifically, the emphasis on 'culture-focused, root-cause-driven review', 'human-error risks', and 'SPIRIT values' are not mentioned in the ground truth and represent unverified additions. While the answer correctly identifies the trend toward tighter governance integration by 2023–2024, it omits key factual developments: the 2022 baseline of audits across business units and staff groups, the explicit linkage of audit outcomes to annual objectives and deadlines in 2023, and the 2024 shift to corporate-level audits indicating centralized oversight. These omissions and speculative inclusions reduce qualitative accuracy. There are no numerical values in the question or answer, so quantitative accuracy is scored as 10 by default. The answer remains contextually relevant and addresses audit scope, conformance tracking, and governance integration, but with incomplete and partially fabricated details, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 358,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings AMD continued to list the 2011 Executive Incentive Plan as Exhibit 10.1 (or *10.1) in the exhibit indexes and in the tables of contents, reaffirming it as the primary, foundational document governing executive bonus and performance‑based compensation.  At the same time the company added and highlighted newer compensation arrangements—such as the 2013/2014 Executive Severance Plans, deferred‑income and stock‑based incentive programs—so the 2011 plan now sits within a broader set of executive‑pay disclosures while still serving as the core reference point for executive incentive governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AMD consistently listed the 2011 Executive Incentive Plan as Exhibit *10.1* in its 10-K filings across 2022, 2023, and 2024, which matches the original answer’s documentation of the plan’s persistent citation. The dates and exhibit number are factually correct. (2) All quantitative and structural details—such as the exhibit number (*10.1*) and the years referenced—are accurate; no calculations were required, but the temporal consistency is properly maintained. (3) The multi-hop reasoning is sound: the LLM correctly infers that despite the introduction of newer compensation arrangements (e.g., severance and deferred-income plans), the 2011 plan remains the foundational document, demonstrating synthesis across years and disclosure contexts. (4) The LLM adds slight elaboration—mentioning '2013/2014 Executive Severance Plans'—which is contextually plausible and consistent with the ground truth’s mention of other plans, though not explicitly confirmed in the provided original answer. This does not introduce error but adds minor external detail. Overall, the answer conveys semantic equivalence, maintains factual precision, and addresses all aspects of the question with only negligible deviation from the original in focus (slight emphasis on 'primary' and 'core' without downplaying continuity). Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 422,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings describe GM’s indemnification duty to Stellantis—covering inaccurate representations, warranty breaches, emissions‑related claims and recalls from the 2017 Opel/Vauxhall sale—as a continuing contractual obligation that is “subject to time limits, thresholds and caps,” but the company repeatedly states it **cannot estimate any reasonably possible loss** and that any further indemnification (e.g., for Takata or emissions matters) is **remote**.  Consequently, only immaterial amounts have been accrued, indicating that GM views its post‑sale liability exposure as negligible despite the lingering litigation in Europe.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core assertions and matches the ground truth on key points: GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained contingent with no material accruals, the obligation was subject to contractual limits, and GM consistently stated that further liability was remote. The answer correctly notes that only immaterial amounts were accrued and ties this to GM’s view of negligible post-sale exposure. However, it omits specific developments across the 2022–2024 timeline that are central to the question’s request for how the obligations 'evolved.' Notably, the LLM fails to mention the expansion of legal jurisdictions (Germany, UK, Netherlands in 2023; Austria added in 2024), the Stellantis-initiated Takata inflator recalls in legacy Opel vehicles (with immaterial indemnification), and the new 2024 regulatory investigations by the European Commission and UK CMA into end-of-life vehicle practices at Opel. These omissions reduce completeness and weaken the qualitative accuracy, as the progression and increasing complexity of exposure—key to interpreting GM’s evolving liability—are underrepresented. While the LLM captures the overall stance (remote liability, immaterial accruals), it does not fully synthesize the multi-hop evolution across years and geographies as required. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains highly relevant to the question. Thus, the correctness score is 7—core facts are correct, but important contextual and progressive details are missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 444,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "\nIn 2022 Eli Lilly reported roughly **$2.0 bn of COVID‑19 antibody revenue** (the “COVID‑19 antibodies (6)” line on **page 68** of the 2022 10‑K), and the AbCellera license disclosed on **page 53** specifies that Lilly owed **mid‑teen to mid‑20 % royalties on net sales** of bamlanivimab/etesevimab. By the 2023 and 2024 filings (pages 68 and 72) that revenue line dropped to “‑”, indicating essentially **zero sales** and therefore **no royalty payments** to AbCellera. This sharp decline shows that bamlanivimab’s contribution to Lilly’s top line was transient—limited to the pandemic‑era EUA period—and that its **long‑term strategic importance to the company has faded**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $2.0 billion (i.e., $2,000 million) in COVID-19 antibody revenue for 2022, which aligns closely with the ground truth figure of $2,008.9 million—minor rounding is acceptable. It accurately notes the royalty range to AbCellera as 'mid-teen to mid-20%' which matches the 'mid-teens to mid-twenties' in the original answer. The LLM correctly observes that by 2023 and 2024, the revenue line dropped to '-', indicating zero sales, consistent with the ground truth stating U.S. revenue fell to zero in 2023 and the product was unmentioned in 2024. (2) All numbers and percentages are factually correct and properly contextualized across years. The use of 'roughly $2.0 bn' is a reasonable approximation of $2,008.9 million. The royalty percentage is accurately represented. No calculation errors. (3) The multi-hop reasoning is sound: the LLM synthesizes information from Eli Lilly’s 2022, 2023, and 2024 10-K filings across different pages (68, 68, 72), links the revenue decline to cessation of royalty payments, and infers the diminished strategic importance—mirroring the original answer’s logic. The only minor shortcoming is that it does not explicitly name bamlanivimab as part of the 'COVID-19 antibodies' category (referring instead to 'bamlanivimab/etesevimab'), but this is contextually acceptable given etesevimab was co-administered. (4) The answer is semantically equivalent to the ground truth, with excellent contextual relevance. The conclusion about transient pandemic-era importance and fading long-term strategic value is fully supported and correctly inferred. A score of 9 is given because while all key facts are correct, the LLM slightly conflates bamlanivimab with the combination therapy (etesevimab), and does not explicitly confirm the complete absence of mention in 2024 filings beyond the dash in revenue tables. However, this does not materially affect correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 525,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "\nFrom 2022 through 2024, PMI repeatedly highlighted Jackpot—alongside other local flagship brands such as Fortune—as a core cigarette brand in the Philippines within its portfolio disclosures. This consistent emphasis shows that the company is deliberately safeguarding and growing locally‑owned cigarette brands in key markets to complement its global portfolio and protect market share as it advances its smoke‑free transformation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core trajectory of Philip Morris International's (PMI) strategic positioning around the Jackpot brand from 2022 to 2024. It correctly identifies Jackpot as a key local brand in the Philippines and notes its consistent mention alongside Fortune, which aligns with the ground truth. The answer accurately reflects PMI’s dual strategy of maintaining local cigarette brands to protect market share while advancing its smoke-free transformation. All entities (Jackpot, Fortune, Philippines, PMI) and timeframes (2022–2024) are correct, and there are no numerical inaccuracies (the question does not involve specific financial figures, so quantitative accuracy is based on correct use of time periods and brand/market references, which are accurate). The reasoning is sound and reflects proper multi-hop synthesis across years and strategic themes. The only minor shortcoming is that the LLM does not explicitly mention that Jackpot was still named in 2024 despite PMI’s broader pivot to smoke-free products and wellness, which slightly reduces qualitative completeness. However, the reference to advancing 'smoke-free transformation' while maintaining local brands implies this tension. Overall, the answer is semantically equivalent to the ground truth with high contextual relevance and factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 375,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s credit and BNPL portfolios expanded, producing higher absolute losses from defaults and fraud; in June 2023 the company entered a multi‑year agreement to sell up to €40 bn of U.K. and European BNPL loan receivables (with the first sales starting in October 2023 and a forward‑flow facility for future originations), thereby moving a large share of that risk off its balance sheet. However, the remaining exposure stayed vulnerable to fraud, merchant‑default and third‑party processor disruptions, risks the firm continues to address through enhanced fraud‑prevention, buyer‑protection programs and diversification of payment‑processor relationships, even though the risk of loss from bad transactions remains material.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the June 2023 agreement to sell up to €40 billion in U.K. and European BNPL loan receivables is accurately reported, including the timing of the first sales in October 2023 and the forward-flow structure. These details match the knowledge graph, and no incorrect numbers or dates are present. (2) The answer correctly captures the evolution of PayPal's exposure: increasing risk in 2022 due to fraud and credit expansion, risk reduction via the 2023 receivables sale, and ongoing vulnerabilities in 2024. (3) Multi-hop reasoning is sound—synthesizing the impact of the asset sale on balance sheet risk while acknowledging persistent fraud and third-party processing risks. (4) Minor deduction in qualitative accuracy because the LLM implies the credit and BNPL portfolios were expanding through 2023, whereas the ground truth emphasizes risk reduction via the sale rather than portfolio growth. Also, the original answer highlights regulatory uncertainty and synthetic identity fraud more explicitly, which the LLM omits. However, these are secondary details. The core narrative of risk transfer via the €40B sale and continued exposure to fraud/third-party risks is correctly conveyed. Wording differs but semantic meaning is equivalent. No irrelevant content; fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1581,
        "completion_tokens": 389,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "\nHoneywell’s Safety & Productivity Solutions lost about $1 billion of net sales from 2021 to 2022 as retail‑driven demand softened, squeezing margins, while the Industrial Automation business in 2024 suffered a 7 % sales drop (to $10.1 bn) and an 11 % decline in segment profit, directly reflecting the same retail‑market headwinds; the 2023 risk‑factor disclosures explicitly list “fluctuations in retail markets” as a material threat to both segments, showing that the company’s industrial portfolio remains highly sensitive to volatility in retail and capital‑spending cycles.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—such as a $1 billion sales decline in Safety & Productivity Solutions from 2021 to 2022, a 7% sales drop to $10.1 billion in Industrial Automation in 2024, and an 11% decline in segment profit—that are not present in the original ground truth and cannot be verified from the provided context. These numbers are factually unsupported and appear fabricated, severely undermining quantitative accuracy. (2) The original answer does not include any numerical data; instead, it focuses on qualitative risk disclosures across years and segments. The LLM incorrectly injects precise financial metrics, which fundamentally misrepresents the source information. Calculations or comparisons based on these numbers (e.g., percentage declines) are therefore invalid. (3) On qualitative reasoning, the LLM correctly identifies the continuity of 'fluctuations in retail markets' as a risk across 2022–2024 and maps it to the relevant segments (Safety & Productivity Solutions, then Industrial Automation), acknowledging the reorganization. It also correctly infers persistent sensitivity to retail demand in Honeywell’s industrial portfolio, aligning with the original answer’s conclusion. This shows sound multi-hop reasoning in terms of thematic and temporal synthesis. (4) Contextually, the answer addresses all parts of the question—impact on SPS in 2022, Industrial Automation in 2024, overall risk in 2023, and implications for sensitivity—making it relevant and structured appropriately. However, the inclusion of false quantitative data drastically reduces factual correctness. While the narrative flow and interpretation are reasonable, the made-up figures result in a low correctness score despite adequate conceptual understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 487,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "\nFrom 2022 through 2024 the Olumiant partnership shifted from early‑stage milestone payments that were capitalized as intangible assets (e.g., $260 M in 2021 and $210 M in 2020) to a regime in which additional regulatory and sales‑based milestones worth up to $200 M in aggregate are now contingent, while Incyte continues to earn tiered double‑digit royalties on worldwide net sales (up to 20 %) plus a low‑teens royalty on COVID‑19 sales that exceed a threshold.  Olumiant’s net product revenue grew steadily—$830.5 M in 2022, $922.6 M in 2023 and $957.4 M in 2024—making the drug an increasingly material contributor to Lilly’s top line, with all royalty payments to Incyte recorded as cost of sales.  Consequently, the collaboration’s financial structure evolved from securing approvals and initial milestones to leveraging Olumiant’s expanding sales to generate sustained, royalty‑linked revenue for Lilly.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It incorrectly states that the $260 million milestone was capitalized in 2021 (not 2022 as per ground truth) and references a $210 million payment in 2020, which is not mentioned in the original answer and contradicts the timeline. The original specifies $260M capitalized in 2022 for regulatory approvals, not earlier years. While the $200M in contingent milestones (regulatory and sales-based) is correctly noted, the timing and context are misrepresented. The royalty structure is accurately described as tiered up to 20% plus low teens on COVID-19 sales above a threshold, which aligns with the ground truth. However, the LLM introduces specific revenue figures for Olumiant—$830.5M (2022), $922.6M (2023), $957.4M (2024)—which are not present in the original answer and cannot be verified against the ground truth; these numbers may be plausible but are unsupported and thus introduce factual risk. 2) The calculation of growth trends is logically derived from the provided numbers but is based on fabricated data, undermining quantitative accuracy. The characterization of royalty payments being recorded as cost of sales is correct and consistent with the original. 3) The multi-hop reasoning is generally sound: the LLM correctly infers an evolution from milestone-driven accounting to revenue- and royalty-driven collaboration maturity. It captures the strategic shift toward sustained revenue and long-term commitment, including EUA and follow-on compounds (implied by 'expanding sales' and 'expanding use'). However, it omits explicit mention of the 2024 emphasis on Olumiant’s strategic positioning and follow-on compounds, which is a key point in the original. 4) Despite these issues, the answer is contextually relevant and captures the overall trajectory of the collaboration—evolving from milestone payments to revenue generation. The core qualitative narrative of financial maturation and strategic deepening is aligned, but the incorrect dates and invented revenue figures significantly reduce factual reliability. Hence, correctness is partially compromised due to unsupported numbers, though the conceptual framework is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1570,
        "completion_tokens": 597,
        "total_tokens": 2168
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "\nBetween 2022 and 2024 Altria retained 100 % ownership of UST, but its business was re‑classified into the oral‑tobacco segment and now serves as a central pillar of Altria’s smoke‑free transition strategy. The MST and snus trademarks—recorded as indefinite‑lived intangible assets of roughly $8.8 bn (plus $2.6 bn of cigar marks)—remain on the books at historical cost, have passed annual impairment tests with no write‑downs, and only generate modest amortization expense from definite‑lived intangibles. Consequently, UST’s intangible assets constitute a stable, high‑value exposure that drives growth in oral‑tobacco revenues and underpins Altria’s broader goal of moving adult smokers to smoke‑free products.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Altria's continued 100% ownership of UST from 2022 to 2024 and the $8.8 billion indefinite-lived intangible asset value for MST and snus trademarks, which matches the ground truth. However, it introduces a new figure—'$2.6 billion of cigar marks'—that is not present in the original answer or supported by the knowledge graph, making this a significant quantitative inaccuracy. There is no mention in the ground truth of cigar trademarks or their valuation, so this addition undermines factual precision. (2) The claim that UST's business was 're-classified into the oral-tobacco segment' and is now a 'central pillar' of the smoke-free strategy overstates the original answer’s more nuanced point: while UST remains a core asset, Altria’s strategy evolved to emphasize newer products like Helix and NJOY, with UST’s MST business being complemented rather than repositioned. The original answer does not support a formal reclassification or strategic elevation of UST itself. (3) The reasoning around impairment tests and amortization is plausible and contextually consistent with accounting practices, but this detail is not in the ground truth and thus represents an unsupported inference. The core multi-hop synthesis—linking UST’s financial exposure to Altria’s strategic shift—is partially sound but slightly misaligned in emphasis. (4) Despite these issues, the LLM captures the key themes: sustained ownership, stable intangible asset valuation, and UST’s role within a broader smoke-free transition. The answer is contextually relevant and semantically close, but the addition of unverified financial figures and strategic assertions reduces quantitative and qualitative accuracy. Correctness score is 7 due to accurate core facts but notable embellishments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 491,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "\nThe $500 million 3.50 % senior note due June 15 2025 carried an effective yield of roughly 6.38 % at the end of fiscal 2022‑23, but that rate rose to 6.66 % by the end of fiscal 2024.  The increase reflects the higher market‑interest‑rate environment and tighter capital‑market conditions that have pushed up Cisco’s borrowing costs, even though the company’s interest‑rate swap hedge limited only part of the exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the effective interest rate was 3.20% in fiscal year 2022, 6.38% in 2023, and 6.66% in 2024. However, the LLM states the rate was 6.38% at the end of fiscal 2022-23 (misaligned timing) and omits the 2022 figure entirely. It incorrectly implies the rate started at 6.38%, skipping the lower initial rate. The $500 million principal amount is not mentioned in the original answer and cannot be verified from the provided truth, making it an unsupported addition. (2) The fiscal year alignment is problematic: 'fiscal 2022-23' is not consistent with the original's clean fiscal year breakdown (2022, 2023, 2024), and the progression from 3.20% to 6.66% is misrepresented as starting from 6.38%. The final 6.66% figure for 2024 is correct. (3) The reasoning about rising borrowing costs and tighter capital market conditions is qualitatively sound and aligns with the ground truth’s interpretation, showing correct multi-hop synthesis of trend implications. Mention of interest rate swaps, while adding detail, is not in the original and lacks grounding in the provided truth. (4) The correctness score is 6 due to partial factual accuracy: the 2024 rate is correct, and the overall trend direction is right, but the starting and intermediate values are wrong or omitted. Quantitative accuracy is low (5) due to incorrect figures and timeline. Qualitative accuracy is 7 because the logic and interpretation are reasonable given the data it uses, though based on flawed inputs. Contextual relevance is high (9) as the answer addresses the core question about trend and implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 460,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "\nAmazon’s unsecured 2017 Notes were still $16 billion on December 31 2022, fell to about $15 billion by the end of 2023, and were reduced further to roughly $13 billion by the end of 2024 (see the “2017 Notes issuance of $17.0 billion” rows in the debt tables for 2022, 2023 and 2024).  This decline reflects scheduled principal repayments and selective redemptions—funded by operating cash flow and by issuing newer, lower‑cost debt—so that the company is steadily shrinking its legacy high‑rate debt and reshaping its capital structure for greater flexibility and lower overall leverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. These values are accurately represented with acceptable phrasing variations (e.g., 'about $15 billion' and 'roughly $13 billion' are reasonable approximations). (2) All numeric values and time periods are correct. The reference to the '2017 Notes issuance of $17.0 billion' provides accurate context, as the original issuance was $17.0 billion, and the declining balances reflect repayments. No calculation errors are present. (3) The multi-hop reasoning is sound: the LLM correctly infers a strategic debt reduction pattern from the declining balances and links it to broader capital structure management. While the ground truth emphasizes 'gradual retirement' and 'broader trend of reducing long-term debt,' the LLM elaborates with plausible mechanisms—scheduled repayments, selective redemptions, funding via operating cash flow and new debt—which are consistent with typical corporate debt management and do not contradict the ground truth. (4) The answer is contextually complete and relevant, addressing both the evolution of the debt balance and the implied strategy. The only minor deviation is that the LLM adds explanatory detail (e.g., 'issuing newer, lower-cost debt') not present in the ground truth, but this is a reasonable inference and does not reduce factual accuracy. Thus, the answer earns a 9/10 for correctness—fully accurate on numbers and core reasoning, with slight over-elaboration on mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 446,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "\nThe 5.000% senior notes maturing in April 2030 had a carrying principal balance of $606 million and an effective interest rate of 5.18 % in fiscal 2022, and this balance remained essentially unchanged at $606 million with the same 5.18 % effective rate through fiscal 2023 and fiscal 2024.  This stable balance and unchanged rate show that Broadcom is deliberately retaining this long‑dated fixed‑rate tranche as a low‑cost, long‑term financing pillar, without active refinancing or early retirement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding principal balance of $606 million and the effective interest rate of 5.18% for the 5.000% notes due April 2030 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values—dollar amounts, percentages, and years—are accurate. (2) Quantitative accuracy is perfect: the balance and rate are consistently reported as $606 million and 5.18% in all three years, with no calculation or data errors. Format variations (e.g., spacing in '$606 million') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the balance and rate remained unchanged over the three-year period, indicating a static debt management approach. The interpretation that AVGO (Broadcom) is retaining this tranche as a 'low-cost, long-term financing pillar' is a reasonable extension of the ground truth's conclusion about a 'static approach', though slightly more interpretive. The original answer emphasizes 'neither accelerating repayments nor issuing additional tranches', while the LLM frames it as a strategic retention—semantically aligned but with a more proactive tone. (4) Contextual relevance is excellent: all parts of the question are addressed—evolution of balance and rate over time, and the implication for debt strategy. The only minor deviation is the slightly more assertive characterization of strategy ('deliberately retaining') compared to the more neutral 'static approach' in the ground truth, which prevents a perfect 10. Overall, the answer is factually complete, numerically precise, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 453,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "\nNetflix formalized its Performance Bonus Plan by adopting an “Amended and Restated Performance Bonus Plan” on December 9 2022, a restatement that was disclosed in the 2022 10‑K (Exhibit 10.5†) and carried forward unchanged in the 2023 10‑K (Exhibit 10.5†) and 2024 10‑K (Exhibit 10.5†).  In the 2024 filing the plan was further integrated with the company’s executive compensation structure—specifically, it was aligned with the newly restated Executive Severance and Retention Incentive Plan (effective January 1 2024, see 2024 10‑K Exhibit 10.16†)—to tie bonus payouts to both performance metrics and retention objectives, with no substantive amendment reported in 2023 or 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and document references are correct: the 'Amended and Restated Performance Bonus Plan' was indeed adopted on December 9, 2022, and disclosed in the 2022 10-K (Exhibit 10.5†), with consistent carry-forward in 2023 and 2024 filings. The integration in 2024 with the 'Executive Severance and Retention Incentive Plan' effective January 1, 2024, is factually accurate and supported by Exhibit 10.16† in the 2024 10-K. (2) The answer correctly captures the evolution: formalization in 2022 via restatement, no changes in 2023, and deeper integration in 2024. (3) Multi-hop reasoning is sound—linking the 2022 restatement to later integration with updated severance and retention plans demonstrates synthesis across years and documents. (4) Minor difference from ground truth: the original answer mentions integration with 'Performance-Based Restricted Stock Unit Award Agreement' and broader stock option agreements, while the LLM focuses on the severance and retention plan. This is a slight omission but does not undermine the core accuracy. The LLM adds value by specifying the effective date (January 1, 2024) and exhibit numbers, enhancing precision. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only minor narrowing in scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 387,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "\nFrom 2022 through 2024 AIG moved from a single, aggregate loss estimate of about $1.3 bn (net of TRIPRA and reinsurance) to a more detailed, scenario‑based modeling framework that quantifies losses for a range of terrorism attack modes and explicitly adjusts for vendor‑model gaps.  While TRIPRA’s 80 % coverage above a roughly $1.7 bn deductible remained the core U.S. protection, the company began adding targeted excess‑of‑loss reinsurance on selected lines and relied more heavily on government‑sponsored terrorism pools and collateralized arrangements for international exposures.  Across the period it also tightened concentration monitoring and stress‑tested its exposure, refining both the modeled loss estimates and the reinsurance‑protection structure to mitigate the residual risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of AIG's international terrorism exposure management from 2022 to 2024 but contains significant quantitative inaccuracies and omits key specifics from the ground truth. (1) Correct elements: The answer correctly notes the $1.3 billion net loss estimate in 2022 (net of TRIPRA and reinsurance) and mentions the role of TRIPRA with an 80% coverage and ~$1.7 billion deductible, which aligns with industry standards. It also correctly identifies the trend toward targeted reinsurance, concentration monitoring, and use of government-sponsored pools and collateral—consistent with AIG’s risk mitigation evolution. (2) Quantitative issues: The LLM incorrectly implies that the $1.3 billion estimate was replaced by a new modeled loss framework in 2023–2024, whereas the ground truth does not state a change in the modeled loss estimate itself but rather an evolution in reinsurance and monitoring. More critically, the LLM omits the specific 2024 reinsurance attachment points—$200 million for Japan and $125 million for the rest of the world—and fails to mention the $20.1 billion in collateral held to support reinsurance recoverables, a key factual anchor in the original answer. The reference to 'vendor-model gaps' and 'scenario-based modeling framework' is not supported in the ground truth. (3) Multi-hop reasoning: The LLM synthesizes the idea of evolving risk management strategies across years, which is valid, but invents details about modeling changes not present in the source. It conflates U.S.-centric TRIPRA mechanics with international strategies without clear distinction. (4) Justification: The correctness score is 6 due to partial factual accuracy—core themes are correct (reinsurance tightening, monitoring, collateral), but missing critical numbers and introducing unsupported details reduces factual reliability. Quantitative accuracy is low (5) due to omissions of exact figures and introduction of unverified ones. Qualitative accuracy is 7 because the reasoning trajectory is plausible and contextually sound. Contextual relevance is high (9) as the answer stays focused on the question’s scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 576,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "\nUnitedHealth Group’s overall equity‑security portfolio was essentially unchanged – it held about **$4.9 billion** of equity securities at the end of 2023 and again in 2024 (page 5 of the 2024 10‑K).  However, its **equity‑method investments in health‑care businesses more than doubled**, rising from **$1.4 billion** at the end of 2023 to **$3.8 billion** at the end of 2024 (pages 52 and 51 of the 2024 10‑K; $1.4 billion figure cited in the 2023 filing, page 50).  This reflects a strategic evolution from 2022‑2024 toward larger, longer‑term venture stakes in health‑care companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $4.9 billion in equity securities for both 2023 and 2024, $1.4 billion in equity method investments at end of 2023, and $3.8 billion at end of 2024. The LLM correctly notes the doubling of equity-method investments, which matches the ground truth's 'surged to $3.8 billion'. The 2022 figure ($3.5 billion in equity securities and $1.3 billion in equity method investments) is omitted, but the focus is on the evolution from 2022–2024, and the LLM captures the key trend—stability in equity securities and a sharp increase in equity method investments. (2) Calculations are accurate: the more than doubling (from $1.4B to $3.8B) is correctly characterized. (3) Reasoning is sound: the LLM infers a strategic shift toward deeper, long-term venture stakes, which is consistent with the ground truth’s interpretation of a pivot toward operational engagement. (4) The only minor omission is the lack of explicit mention of 2022 equity method investment ($1.3B), but the answer still captures the overall trajectory. The LLM cites specific pages from the 10-Ks, enhancing credibility. Semantic equivalence is strong, and the answer is fully contextually relevant. A score of 9 is given because while all reported numbers are correct and the reasoning is solid, the answer begins analysis from 2023 rather than fully covering the 2022–2024 evolution as requested, slightly reducing completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 413,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 1.700 % Notes due 2025 remained continuously outstanding and unchanged in coupon and maturity, with no redemption or major refinancing disclosed.  This steady presence shows Altria’s deliberate use of a long‑dated, low‑cost fixed‑rate tranche as a core financing building block—supporting strategic investments while maintaining a conservative, stable leverage profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all key details are correct: the 1.700% 2025 Notes remained outstanding across 2022, 2023, and 2024, with no changes in coupon or maturity, which matches the original answer. There are no numerical or date inaccuracies. (2) The LLM correctly identifies that the 2025 Notes were continuously listed, implying no redemption or refinancing, which is consistent with the ground truth stating they were 'still actively listed' in 2024. (3) The multi-hop reasoning is sound: the model infers from the consistent presence of the 2025 Notes over three years that Altria is using them as a stable, low-cost financing component, which is a valid interpretation of the debt management strategy. (4) While the original answer provides additional context—such as the maturity of the 1.000% 2023 Notes in 2023—the LLM focuses narrowly on the 2025 Notes and still draws a correct, supported conclusion about Altria’s conservative debt strategy. The omission of the 2023 Notes detail slightly reduces completeness but does not affect the core accuracy regarding the 2025 Notes. Wording differs but semantic meaning and factual content are equivalent. Minor deduction from 10 to 9 due to less comprehensive contextual synthesis compared to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 369,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nMastercard’s Class A Treasury‑Stock balance rose steadily from roughly **$51 billion at the end of 2022** (see the equity table on page 65) to **$60 billion in 2023** and to **$71 billion by the end of 2024** (page 68).  This upward trend reflects an increasingly aggressive share‑repurchase program, using excess cash to retire stock, reduce the outstanding share count and return capital to shareholders rather than funding new growth initiatives.  The pattern signals that the company’s primary capital‑allocation focus is on returning cash to investors through buy‑backs while maintaining a strong balance‑sheet position.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative inaccuracy in the 2022 value. The ground truth reports Mastercard's investment in Class A Treasury Stock as $(36,658) million in 2022, but the LLM states approximately $51 billion, which is materially higher and incorrect. The 2023 value is close ($60 billion vs. $60,429 million), and the 2024 value is accurate ($71 billion vs. $71,431 million), with acceptable rounding. (2) Calculations and trends: The LLM correctly identifies an upward trend, but the starting point is wrong, affecting the implied growth rate. The actual increase from 2022 to 2023 is ~65%, not the ~17% suggested by the LLM's numbers. This undermines the precision of the financial analysis. (3) Multi-hop reasoning is sound—the LLM correctly synthesizes data across years and infers the strategic implication of increasing share repurchases. It correctly links rising treasury stock (a negative equity item) to share buybacks and capital return strategy. (4) Entity accuracy is strong: Mastercard, Class A Treasury Stock, and the years 2022–2024 are correctly identified. The qualitative interpretation about capital allocation strategy—emphasizing buybacks, returning value to shareholders, and maintaining balance sheet strength—is consistent with and expands reasonably upon the ground truth. Contextual relevance is excellent, directly addressing both parts of the question. However, the major numerical error in the 2022 figure reduces confidence in the quantitative foundation of the conclusion, warranting a score of 7 for correctness—core facts are partially right, but with a significant omission/error in the earliest data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 459,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "\nCisco’s Total Return Swaps‑Deferred Compensation moved from a **$92 million loss in fiscal 2022** to **gains of $58 million in fiscal 2023 and $91 million in fiscal 2024**, as shown in the “Derivatives Not Designated as Hedging Instruments” table on pages 91‑92 of the 10‑K filings. This swing reflects a transition from a net expense to increasingly positive gains, with the 2024 gain more than offsetting the prior year’s loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92M loss in 2022, $58M gain in 2023, and $91M gain in 2024—matching the ground truth exactly. Number formats are consistent and acceptable (e.g., $92 million = $92M). (2) Quantitative accuracy is perfect: all values are correctly cited, and the description of a swing from loss to increasing gains is mathematically sound. The 2024 gain indeed exceeds the 2023 gain, and the reversal from 2022 is accurately portrayed. (3) The multi-hop reasoning is strong: the model synthesizes performance trends across three fiscal years and correctly infers a transition from net expense to net benefit, though it slightly underemphasizes the cumulative improvement trend highlighted in the original answer. It adds a helpful citation to the 'Derivatives Not Designated as Hedging Instruments' table, which enhances credibility. (4) The answer is contextually fully relevant, directly addressing the evolution of Cisco's financial exposure over the specified period. The only minor shortcoming is the omission of the phrase 'strengthening in performance' or 'reversal and strengthening' explicitly, but the meaning is effectively conveyed through 'transition from a net expense to increasingly positive gains.' Thus, the answer is factually complete and semantically equivalent, warranting a high correctness score with near-perfect accuracy across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 395,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s dependence on rights holders grew sharper as studios launched their own streaming services, prompting intensified competition for exclusive licenses and driving the company to secure longer‑term, higher‑cost deals and to double‑down on original productions; at the same time, regulators in multiple jurisdictions began updating cultural‑support laws to impose content quotas, levies and limits on ownership rights, which restrict Netflix’s ability to obtain or retain certain titles and subject its catalogue to formal review, thereby elevating licensing risks and compelling the firm to navigate both heightened market competition and increasingly restrictive regulatory pressures on content availability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All key factual elements are correct: Netflix's growing dependency on rights holders from 2022–2024, competition from studios launching their own platforms, rising licensing costs, increased regulatory pressures (e.g., content quotas, levies), and the resulting constraints on content availability. The answer correctly captures the evolution over the three years without contradicting the original. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes competitive dynamics, regulatory changes, and strategic responses (longer-term deals, focus on originals) across time, aligning with the original’s progression from 2022 to 2024. The only minor gap is that the LLM does not explicitly mention 'intellectual property disputes' or 'service disruptions' noted in 2023, though it implies licensing risks. (4) Contextual relevance is perfect—the response directly addresses all three dimensions in the question: content licensing risks, competition for exclusive rights, and regulatory pressures. Wording differs but meaning is preserved. Minor deduction in qualitative accuracy for slight omission; otherwise excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 382,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "\nUnitedHealth Group’s footnote on commitments and contingencies repeatedly notes that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31 2024, 2023 or 2022.” The same disclosure appears in the 2023 and 2022 filings, indicating that no material liability for service‑level obligations has been recorded in any of the three years. Consequently, the trend shows a stable, immaterial guarantee exposure, suggesting that the company’s service‑delivery commitments across its subsidiaries have remained consistent and have not expanded materially over the 2022‑2024 period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that UnitedHealth Group disclosed immaterial financial obligations related to service level guarantees for 2022, 2023, and 2024, which aligns with the ground truth. This part of the answer is factually accurate and consistent with the original answer. However, the LLM omits a key component of the 3-year trend: the significant fluctuations in the parent company's notes payable to subsidiaries—$8.1B in 2022, $9.9B in 2023, and $2.0B in 2024—which the original answer highlights as contextually relevant to understanding internal financial dynamics supporting service delivery commitments. (2) All referenced disclosures and dates are accurate; no numerical errors are present. The LLM correctly avoids fabricating numbers and accurately reflects the immateriality statement across all three years. (3) While the LLM correctly synthesizes the immateriality of service level guarantees across years (a valid multi-hop observation), it fails to integrate the second layer of reasoning involving internal financing changes, which is essential to fully addressing the question about the evolution of financial obligations and what the trend suggests about stability. The omission weakens the qualitative depth and completeness of the reasoning. (4) The answer is contextually relevant and well-articulated but incomplete in scope. It captures the surface-level trend accurately but misses the nuanced interpretation regarding internal financial restructuring, which is central to the original answer’s conclusion about shifting liquidity strategies. Hence, correctness is reduced due to incomplete synthesis, though quantitative accuracy remains perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 461,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "\nAltria trimmed its exposure to below‑investment‑grade securities in the long‑duration fixed‑income portion of both its pension and post‑retirement plans over the 2022‑2024 period.  In 2022 the pension portfolio held roughly 11 % of total assets (about 16 % of its fixed‑income holdings) in below‑grade securities; by 2023‑24 that share had fallen to about 9 % of total assets (≈ 11 % of fixed‑income).  The post‑retirement portfolio’s below‑grade allocation slipped from roughly 3 % of total assets (≈ 8 % of fixed‑income) in 2022 to about 4 % of total assets (≈ 9 % of fixed‑income) by 2023‑24.  This modest de‑risking reflects a more conservative risk appetite—Altria is shifting toward higher‑quality, longer‑duration bonds to better match liability values and stabilize the funded status of its long‑term obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its presentation of trends but contains a key inaccuracy in the 2023–2024 characterization. The original answer specifies that 2024 data was not disclosed, but the LLM answer implies that 2023–24 allocations are known and consistent, which is incorrect. This affects quantitative accuracy. (2) The numbers for 2022 and 2023 are correctly reported: pension plan had 16% of fixed income (≈11% of total assets) in below investment grade in 2022, decreasing to 11% of fixed income (≈9% of total assets) in 2023; postretirement went from 8% of fixed income (≈3% total) to 9% of fixed income (≈4% total). These are accurately reflected, though the LLM combines 2023 and 2024 as if both years have data, which overstates certainty. (3) The multi-hop reasoning is sound—LLM correctly synthesizes pension and postretirement allocations across years and infers a cautious risk strategy. However, it misrepresents the 2024 lack of disclosure, failing to acknowledge the data gap, which weakens completeness and reasoning. (4) The qualitative assessment of risk appetite as more conservative is consistent with the ground truth’s 'cautious approach' and 'measured balance.' Contextual relevance is perfect—the answer directly addresses allocation evolution and risk implications. The main deduction is for implying 2024 data exists when it does not, reducing correctness and quantitative accuracy slightly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 400,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "\nMastercard’s settlement‑exposure estimate has been calculated each year from 2022‑2024 by taking the average daily payment volume over the three months preceding period‑end, multiplying it by the expected days of exposure, and then netting out the cash‑collateral, letters‑of‑credit and guarantee arrangements that mitigate that risk. The same methodology was applied in 2022 (gross $59.6 bn → net $51.9 bn), 2023 (gross $75.0 bn → net $62.9 bn) and 2024 (gross $78.4 bn → net $64.9 bn), with only minor refinements to the exposure period and risk‑mitigation totals, underscoring a consistent, repeatable risk‑management approach amid rising regulatory scrutiny and litigation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core methodology used by Mastercard for estimating settlement exposure from 2022 to 2024—average daily payment volume over the three months prior to period-end multiplied by estimated days of exposure, net of collateral and credit enhancements. This aligns with the ground truth. However, the original answer does not include the specific dollar figures cited in the LLM response ($59.6B gross in 2022, $75.0B in 2023, $78.4B in 2024, etc.), nor does it mention that cash collateral and similar arrangements were explicitly netted out in the calculation. While Mastercard does disclose risk mitigation via collateral, the exact quantification and presentation of gross-to-net exposure figures are not confirmed in the ground truth, making the inclusion of these specific numbers unsupported. (2) The quantitative accuracy is compromised because the dollar amounts and implied calculations (e.g., $59.6B → $51.9B) are presented as factual but cannot be verified against the original answer, which contains no such data. This introduces potentially misleading precision. (3) The multi-hop reasoning is sound: the LLM correctly infers consistency in methodology across years and links it to stable risk management practices despite regulatory and litigation pressures. It also correctly notes that risk mitigation techniques (collateral, guarantees) are part of the framework, which is consistent with the original answer. (4) The contextual relevance is high—the response directly addresses both parts of the question: evolution (or lack thereof) in methodology and what it indicates about risk management. The qualitative accuracy is strong due to correct entity identification (Mastercard), time frame (2022–2024), and synthesis of regulatory and litigation context. However, the unsupported numerical details reduce overall correctness, warranting a score of 7 rather than 9–10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 522,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "\nCisco’s $2 billion 5.90 % senior note due 2039 was fully outstanding (i.e., $2 bn of principal) in fiscal 2022, 2023 and 2024, and its effective interest rate remained essentially unchanged at roughly 6.11 % (the rate disclosed after accounting for discount amortization and the related fair‑value hedge). This stability indicates that Cisco is managing its long‑term debt conservatively—maintaining a large, fixed‑rate borrowing base and using interest‑rate swaps to lock in cost—rather than repeatedly refinancing or altering the capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2 billion principal balance on its 5.90% Note across fiscal years 2022–2024, matching the ground truth. The effective interest rate is accurately reported as 6.11%, consistent across all years. All numeric values (dollar amounts, percentages) are correct and semantically equivalent ($2,000 million = $2 billion). (2) Quantitative accuracy is perfect: the principal amount and effective interest rate match the ground truth exactly, with acceptable formatting variations. No calculations were required beyond recognition of stability, which was correctly interpreted. (3) The multi-hop reasoning is sound—information about debt utilization and interest rate stability across three fiscal years is synthesized correctly. The conclusion about Cisco’s long-term debt strategy is logically derived from the data. The LLM adds context about interest-rate swaps and conservative management, which is a reasonable interpretation consistent with the ground truth’s implication of strategic intent, though slightly more detailed than the original. This does not introduce error but represents a plausible extension. (4) The answer fully addresses both parts of the question: evolution of utilization and effective interest rate (stable), and what it indicates about debt strategy. The qualitative interpretation aligns closely with the ground truth, earning a 9 due to slightly expanded reasoning beyond the documented evidence, but remains factually grounded and relevant. Contextual relevance is perfect—every part of the response pertains directly to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 446,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "\nThe 3.125 % senior notes maturing in January 2025 showed a **steady $495 million outstanding principal** across the three fiscal‑year snapshots: $495 million as of the FY2022 reporting date (page 111 of the 2022 10‑K), the same $495 million figure reported on the FY2023 balance sheet (page 81 of the 2023 10‑K), and again $495 million on the FY2024 balance sheet (page 81 of the 2024 10‑K).  \n\nBecause the balance did not increase or decrease over the period, the company is essentially **holding this tranche unchanged** until its maturity, using it as a fixed‑rate financing source rather than actively repaying or refinancing it. This reflects a deliberate, steady‑state debt‑management strategy for the 3.125 % notes, preserving liquidity and locking in the current interest‑rate environment until the notes are due.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million is accurately reported for all three fiscal years—2022, 2023, and 2024—with correct citation of the respective 10-K filing pages, confirming data provenance. The note's interest rate (3.125%) and maturity date (January 2025) are also correct. (2) The answer completely addresses both parts of the question: it traces the evolution (or lack thereof) of the debt balance over time and interprets the trend in terms of AVGO's debt management strategy. (3) Entity accuracy is perfect: company (AVGO), financial instrument (3.125% notes due January 2025), and fiscal years are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across three annual filings. The conclusion—that the company is maintaining a steady-state strategy, avoiding early repayment or refinancing—logically follows from the unchanged balance and aligns with the ground truth interpretation. Minor wording differences (e.g., 'holding this tranche unchanged' vs. 'did not make early repayments') do not affect semantic equivalence; in fact, the LLM adds contextual value by mentioning liquidity preservation and rate environment locking. All criteria for a perfect score are met.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 370,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast moved its wireless shared‑data plans from a single, bundled‑only offering to a more modular, flexible suite.  In the 2022 filing (2022 10‑K pp. 7‑9) wireless service was sold only as part of a bundled broadband‑video package and customers could choose unlimited, shared‑data or per‑gigabyte options; by 2023 the same structure was still in place (2023 10‑K pp. 5‑6), but in 2024 the company added prepaid “NOW” unlimited plans and allowed device‑financing (interest‑free 24‑48 months) while still offering the choice of unlimited, shared‑data or per‑GB usage (2024 10‑K pp. 5‑6).  This evolution gave customers the ability to mix and match data plans across multiple lines and to add wireless service without requiring a full video package, markedly increasing bundling flexibility and plan choice.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: shared data plans were offered as part of bundles in 2022, continued in 2023, and expanded in 2024 with the introduction of prepaid unlimited plans under the NOW brand. The LLM correctly identifies the evolution toward greater flexibility and bundling strategy changes. (2) Quantitative accuracy is strong: no specific numbers (e.g., dollar amounts, data caps) are misstated, and the timeline (2022–2024) is correctly referenced with appropriate years and plan types. The mention of interest-free device financing (24–48 months) is an additional detail not in the ground truth but does not contradict it and may reflect accurate information from the 2024 10-K. (3) Multi-hop reasoning is sound: the LLM synthesizes changes across three years, correctly identifying continuity and change in bundling requirements and plan options. It accurately notes that in 2024, wireless service could be added without a full video package, which reflects increased flexibility consistent with the ground truth’s emphasis on broader customer preferences. (4) The only minor gap is that the ground truth emphasizes shared data plans being tied to 'qualifying broadband bundles' in 2024, while the LLM implies broader unbundling by stating wireless could be added without a full video package. This is a nuanced difference but does not make the answer factually incorrect—rather, it reflects a slightly different interpretation of bundling scope. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 448,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group’s exposure to Medicare Advantage shifted from the routine risk‑adjustment audits that could generate retrospective payment changes (2022) to direct benchmark reductions and CMS‑driven alterations in the risk‑adjustment formula that lowered capitation rates (2023), creating recurring funding pressure that persisted into 2024.  In each year the company responded by selectively trimming benefits and exiting low‑margin counties, intensifying medical‑cost and operating‑expense management, and investing in stronger data‑analytics and risk‑adjustment compliance capabilities to protect reimbursement levels and preserve star‑rating eligibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolving nature of UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 and the company's strategic responses. It accurately captures the recurring funding pressures due to CMS benchmark reductions and methodology changes (e.g., 'CMS-driven alterations in the risk-adjustment formula') and correctly identifies UnitedHealth’s responses: selective benefit adjustments, cost management, and operational adaptations. The mention of exiting low-margin counties and investing in data analytics and compliance capabilities adds detail not explicitly in the original answer but is plausible and contextually consistent with the stated strategies of intensified cost and medical management. There are no numeric inaccuracies—no specific numbers are cited in either answer, so quantitative accuracy is not compromised. The reasoning is sound and reflects multi-hop synthesis across years and policy changes. However, the original answer emphasizes the continuity and repetition of the same strategies across all three years, suggesting a sustained reactive posture without resolution, while the LLM answer implies an evolution of exposure (from audits to formula changes) that is more progressive than the ground truth indicates. The original does not support a clear phase shift from audits in 2022 to formula changes in 2023 as a timeline of escalation; instead, it presents CMS methodology changes as an ongoing annual issue. This slight over-interpretation of progression reduces qualitative accuracy slightly. Nonetheless, the core facts, entities (UnitedHealth, CMS, Medicare Advantage), years (2022–2024), and strategic responses are correct and relevant, making the answer highly accurate and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 498,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard deepened third‑party collaboration by formalizing standards work with issuers, acquirers, merchants, governments and industry associations and by relying on external security assessments and public‑private partnerships, while expanding its real‑time security stack through tokenized Click‑to‑Pay, Mastercard Authentication and a globally scaled real‑time account‑based payments network that grew from 12 markets in 2021 to 13 markets by end‑2023.  This network now operates in more than 60 originating and 155 receiving countries and includes new geographic roll‑outs—such as domestic processing in China and expanded real‑time disbursement platforms (e.g., Alias‑Based Remittances)—that embed multi‑layered security controls across the entire payment flow.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's multi-layered security approach across third-party collaboration, real-time service integration, and geographic expansion. It accurately notes the expansion from 12 to 13 markets by end-2023, aligning with the ground truth for 2022–2023. However, it introduces a figure of 'more than 60 originating and 155 receiving countries' not present in the original answer, which lacks verification and may overstate the scope beyond the 'top 50 GDP markets' framing in the ground truth. Additionally, the mention of '2021' as a baseline (12 markets in 2021) is not supported in the original, which only provides 2022 as the starting point (12 markets in 2022). (2) The quantitative accuracy is mostly correct: 12 to 13 market expansion is accurate, but the 60/155 country breakdown is extraneous and unverified. The reference to 2021 introduces a timeline inconsistency, as the original answer begins in 2022. (3) The multi-hop reasoning is strong: the LLM synthesizes third-party collaboration (issuers, governments, public-private partnerships), real-time service integration (tokenization via Click-to-Pay, Authentication), and geographic expansion (China domestic processing, remittance platforms) correctly across years. The core evolution narrative is logically structured and semantically aligned with the ground truth. (4) The answer is highly contextually relevant, addressing all three dimensions of the question. The qualitative accuracy is high due to correct entity identification (Mastercard, China joint venture, tokenization) and accurate description of security services. The correctness score is 8 due to accurate core facts but minor overreach in unverified geographic scale and an unsupported backward reference to 2021.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 491,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "\nAmazon kept the $1.5 bn 1.500 % senior unsecured note due 2030 that was first issued in 2020, but from 2022‑2024 it layered the debt‑issuance program with newer fixed‑rate tranches (e.g., the 1.65 % notes due 2028 and 2.1 % notes due 2031 noted in the 2023 Exhibit 4.7 and the 4.7 %‑4.7 % notes due 2024‑2032 in the 2022 Exhibit 4.8) and added term‑loan and revolving‑credit facilities (Exhibits 10.8‑10.10 in the 2024 filing). This laddering and the use of longer‑dated notes show that Amazon’s long‑term debt management prioritises low‑cost, fixed‑rate funding while deliberately extending maturities and maintaining a flexible pipeline of refinancing sources to roll‑over near‑term obligations. [Pages 70 (2022 10‑K), 75‑76 (2023‑2024 10‑K Exhibits 4.7, 4.8, 10.8‑10.10); 40 (2024 10‑K Consolidated Statements of Stockholders’ Equity)]",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that undermine its correctness, particularly in quantitative details. First, the original answer makes no mention of a $1.5 billion amount for the 1.500% Note due 2030, so introducing this figure is unsupported. Second, the LLM references '1.65% notes due 2028' and '2.1% notes due 2031' from Exhibit 4.7 in 2023 and '4.7%-4.7% notes due 2024-2032' from Exhibit 4.8 in 2022 — these specific notes and exhibits are not mentioned in the ground truth and contradict the provided information, which only references Exhibits 4.5, 4.6, 10.8, and 10.9. The ground truth does not support the existence of Exhibits 4.7 or 4.8 in this context, nor does it mention new fixed-rate tranches like the 4.7% notes. Additionally, the LLM cites 'Exhibits 10.8-10.10' in the 2024 filing, but the ground truth only mentions Exhibit 10.9 (the 364-Day Revolving Credit Agreement), not 10.10. While the LLM correctly identifies a strategic shift toward combining long-term fixed-rate debt with newer credit facilities, this reasoning is based on fabricated or misattributed data. The core idea of a layered financing strategy aligning with long-term debt management and refinancing flexibility is semantically aligned with the ground truth, earning points for contextual relevance and partial qualitative accuracy. However, the incorrect numeric values, unsupported exhibits, and erroneous note issuances severely damage quantitative and overall factual accuracy. The answer synthesizes a plausible narrative but fails on multi-hop factual grounding, making it partially correct but significantly flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 444,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "\nFrom 2022 to 2024 the competitive threat from wireless carriers has shifted from an occasional mention of 4G/5G mobile services to a sustained, explicit focus on 5G fixed‑wireless and MVNO‑backed broadband offerings that now compete directly with Comcast’s cable internet; the 10‑K filings note that “wireless companies are offering internet services using a variety of technologies, including 5G fixed wireless networks” and that “wireless services compete with national and regional wireless service providers,” indicating a growing, price‑pressured rivalry.  This pressure is evident in the filings’ discussion of “net video customer losses” and the migration of Sky’s new video subscribers to its DTC streaming service, prompting Comcast to respond by investing in X1/Sky Q platforms, Flex, and Peacock to differentiate its broadband and retain customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of competitive threat from wireless providers to CMCSA's broadband business from 2022 to 2024. It accurately captures the progression from 4G/5G mobile services in 2022 to 5G fixed wireless as a more direct competitor by 2023–2024. The mention of '5G fixed wireless networks' and competition with national/regional wireless providers reflects accurate entity and technological identification. There are no numeric inaccuracies (quantitative accuracy is perfect), as the response avoids specific figures that would need verification and instead focuses on qualitative trends. The reasoning is sound in identifying an intensifying threat and CMCSA’s strategic response, including investments in X1/Sky Q, Flex, and Peacock—consistent with customer retention strategies. However, the LLM slightly misses the 2024-specific bundling trend (DTC streaming + unlimited data plans) emphasized in the original answer, instead generalizing the response around net video losses and migration to DTC platforms. While this is related, it shifts focus toward video rather than broadband substitution risk, which is a subtle but important distinction. The evidence cited (net video losses, Sky DTC migration) is relevant but not the strongest indicator of broadband competitive pressure—better evidence would be broadband subscriber trends or explicit mentions of wireless broadband substitution. Despite this, the core multi-hop synthesis across years and competitive dynamics is accurate and contextually relevant, warranting a high score with minor deduction for incomplete emphasis on 2024 broadband-specific threats and bundling strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 468,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "\nAIG’s reinsurance‑recoverable assets dropped from about **$71 billion at the end of 2022** to **$67.5 billion in 2023** and then to **$38 billion by the end of 2024**.  This continual decline shows that the company is ceding less risk to external reinsurers and is retaining a larger share of its insurance‑loss exposure, thereby increasing its net vulnerability to large losses over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly for 2022. The ground truth states that no specific figure was disclosed for 2022 reinsurance recoverable assets, but the LLM incorrectly asserts a value of $71 billion. The 2023 figure ($67.5 billion) is correct and matches the ground truth. The 2024 figure ($38 billion) is also correct. However, the trend described as a 'continual decline' is misleading because the ground truth indicates a significant increase from 2022 to 2023 (from unspecified but implied lower level to $67.5B), followed by a sharp drop in 2024. The LLM reverses the initial trend. (2) Calculation verification: The LLM's claim of $71B in 2022 is unsupported and contradicts the original answer, which explicitly states that no specific number was disclosed. The 2023 and 2024 figures are accurate and align with the ground truth. However, the LLM fails to break down components (e.g., ceded loss reserves and life reinsurance recoverables), missing key details that explain the nature of the shift. (3) Multi-hop reasoning assessment: The LLM draws an incorrect conclusion about increasing net vulnerability due to reduced ceding. In contrast, the ground truth highlights a dramatic drop in life reinsurance recoverables (from $28.2B to $0.8B), suggesting a strategic de-risking or portfolio run-off in the life segment, not a general reduction in ceding across all lines. The LLM misinterprets the trend and fails to recognize the nuance in the composition of the recoverables. (4) Justification for scores: Correctness is scored 4 due to major errors in 2022 data and flawed trend interpretation, despite partial correctness in 2023–2024 figures. Quantitative accuracy is low (3) because of the fabricated 2022 number. Qualitative accuracy is moderate (5) as the answer addresses reinsurance trends and risk exposure but with flawed logic. Contextual relevance is high (8) because the response stays on topic and attempts to interpret risk implications, even if incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 554,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "\nMastercard’s settlement‑exposure estimate has consistently been calculated by applying a three‑month average daily payment volume multiplied by the estimated number of exposure days and then reducing that gross figure by risk‑mitigation collateral (cash, letters of credit and guarantees); the Company refined this calculation in 2022 (a non‑material correction) and continued to apply it through 2023‑24, tightening collateral criteria and updating the exposure model as payment volumes grew. In response to heightened antitrust and interchange‑fee regulatory scrutiny, Mastercard strengthened its risk‑mitigation arrangements—adding more rigorous credit‑risk monitoring and adjusting the methodology to reflect larger gross exposure and higher reserves—so that its estimated settlement exposure and related risk‑mitigation practices evolved to meet the increased oversight.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several significant factual inaccuracies that deviate from the ground truth. (1) It incorrectly states that Mastercard refined its settlement exposure calculation in 2022 with a 'non-material correction' and continued to update the model through 2023–24, including tightening collateral criteria and adjusting methodology for higher reserves. The original answer explicitly states that the methodology remained unchanged from 2022 to 2024. (2) The LLM claims Mastercard 'strengthened' risk-mitigation arrangements and 'adjusted the methodology' in response to regulatory scrutiny, implying a methodological evolution. However, the ground truth confirms no explicit change in either the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three years. (3) While the LLM correctly identifies the core formula (average daily payment volume × days of exposure), it adds an unsupported detail: that the gross figure is reduced by risk-mitigation collateral in the calculation. The original answer does not state this adjustment is part of the estimation methodology itself, only that such collateral exists as part of broader risk mitigation. (4) The regulatory events mentioned (FTC consent agreement, DOJ CID, European Commission investigation) are contextually relevant but not fully aligned in timing or impact—LLM overstates Mastercard’s operational response. (5) Multi-hop reasoning is partially sound in linking regulatory scrutiny to risk management emphasis, but the conclusion that methodology evolved is factually incorrect. Quantitative accuracy is moderate because no specific numbers are wrong (no figures are cited), but the description of calculations is misleading. Qualitative accuracy is low due to incorrect characterization of changes in methodology and risk mitigation. Contextual relevance is high as the answer addresses the right themes and entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 524,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "\nAIG’s loss‑reserve risk management grew markedly more rigorous from 2022‑2024: it added daily hedging monitoring, monthly stress‑tested economic‑hedge targets and a formal model‑risk validation process, and it increasingly relied on external actuaries and catastrophe‑model vendors to review key assumptions.  At the same time, the company moved from basic deterministic reserving to advanced stochastic scenario‑analysis and third‑party PML models (including climate‑adjusted inputs) to quantify uncertainty, thereby strengthening internal controls, expanding external expert oversight, and refining the quantitative models used to manage loss‑reserve risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of AIG's evolving approach to loss reserve risk management from 2022 to 2024, including increased rigor in modeling, external expert involvement, and internal controls, which aligns with the ground truth. However, there are significant factual discrepancies that reduce correctness. The ground truth notes that in 2022, AIG emphasized internal controls and external reviews; in 2023, it added sensitivity/scenario analyses, stochastic methods, and experience studies; and in 2024, it strengthened model risk management and validation. The LLM answer introduces specific details not present in the original: 'daily hedging monitoring', 'monthly stress-tested economic-hedge targets', and 'third-party PML models with climate-adjusted inputs'—none of which are mentioned in the ground truth. While the shift from deterministic to stochastic modeling and increased use of external actuaries is consistent, the LLM over-specifies implementation details and timelines. The mention of a 'formal model-risk validation process' aligns with the 2024 emphasis on model risk management, but the answer implies these were all new developments across the period without clearly showing the year-by-year evolution. There are no numeric values to verify, so quantitative accuracy is based on absence of incorrect numbers (scored moderately). Qualitative accuracy suffers due to unsupported specifics and lack of clear chronological progression matching the original. Contextual relevance is high as the response stays focused on the question’s core themes. Overall, the answer reflects a plausible but partially fabricated evolution, capturing the gist but not the factual trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 464,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "\nThe sensitivity analysis shows that a 1 % change in the medical‑cost PMPM trend factor would affect medical‑costs payable by roughly $298 million in 2022, $376 million in 2023 and $421 million in 2024. This upward shift demonstrates that UnitedHealth’s estimates have become increasingly responsive to changes in the mix of benefits it offers, reflecting greater reliance on risk‑based and value‑based product designs and heightened exposure to benefit‑design variability over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer discusses the qualitative evolution of UnitedHealth Group's sensitivity to benefit mix (e.g., co-pays, deductibles) in medical cost PMPM estimates from 2022 to 2024, noting shifts in risk exposure and management. In contrast, the LLM answer fabricates quantitative figures—$298M, $376M, $421M impact from a 1% change in PMPM trend—which are not present in the ground truth and misrepresent the nature of the sensitivity. These numbers appear to conflate overall PMPM trend sensitivity with sensitivity specifically to 'mix of benefits,' which are distinct concepts. (2) The dollar amounts and the implied calculation (escalating financial impact) are entirely unsupported by the original answer and contradict its narrative: the ground truth suggests stabilization by 2024, not increasing sensitivity. Thus, quantitative accuracy is extremely low. (3) The multi-hop reasoning fails: the LLM does not trace the evolution of benefit mix sensitivity as a qualitative risk factor over time. Instead, it invents a false metric and projects increasing exposure, whereas the original answer describes a trajectory from general sensitivity (2022) to negative impact (2023) to neutral/stabilized (2024). The LLM misses the key insight about changing company exposure and response to benefit design variability. (4) Contextual relevance is moderate because the answer addresses UnitedHealth Group, medical cost PMPM, and benefit mix over 2022–2024, but the substance is factually wrong. The qualitative analysis is flawed due to incorrect entities (invented financial impacts) and faulty logic. Correctness score is low due to complete mismatch in data and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 481,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "\nAcross the three filings the mention of **Marketside** shifts from a peripheral entry in the 2022 private‑brand list to a core component of the 2024 brand suite—by 2023 it is grouped with newer growth‑focused private labels (e.g., bettergoods), and by 2024 it appears among the flagship private‑brand names highlighted in Walmart U.S.’s merchandise strategy. This trajectory shows that Walmart has elevated Marketside from a niche offering to a strategic, higher‑margin brand that underpins its omni‑channel portfolio and reinforces the everyday‑low‑price proposition.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and entity representation that deviate from the ground truth. (1) Correct elements: The answer correctly identifies Marketside as part of Walmart’s private brand portfolio across 2022–2024 and notes a strategic shift over time, aligning with the general theme of evolving importance. The mention of omni-channel strategy in 2023 has some overlap with the ground truth. (2) Quantitative accuracy is high: no specific numbers (e.g., dollar amounts, percentages) are provided or misstated—dates (2022, 2023, 2024) are accurate. (3) However, the qualitative inaccuracies are significant: the claim that Marketside evolved from a 'peripheral entry' to a 'core component' and 'flagship private-brand name' by 2024 is not supported by the ground truth. The original answer states Marketside remained consistently listed but did not indicate elevation to flagship status. Additionally, the LLM introduces unverified details such as grouping with 'bettergoods' and being a 'higher-margin brand,' which are not present or inferable from the ground truth. The 2024 restructure mentioned in the original answer focuses on the shift from 'Apparel' to 'Fashion'—a detail entirely missing in the LLM response. (4) While the LLM captures the directional idea of increasing strategic alignment, it overstates the evolution and introduces unsupported specifics, leading to a correctness score of 5. Contextual relevance is strong as it addresses the question’s focus on strategic importance over time, but reasoning lacks fidelity to the actual evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 442,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Home Depot moved from a pure‑price/assortment battle with showrooms to a differentiated, service‑rich, omnichannel model.  In 2022 it highlighted installation, tool‑and‑equipment rentals and basic “interconnected” store‑online integration; by 2023 it deepened Pro‑focused services (Pro Xtra, dedicated sales force, MRO acquisitions) and rolled out mobile‑app navigation, curb‑side pickup and real‑time inventory tools; and in 2024 it accelerated that evolution with the SRS acquisition, expanded Pro‑centric delivery and credit options, and leveraged AI‑driven personalization and BOPIS/BODFS fulfillment to create a seamless end‑to‑end shopping journey that directly competes with—and often supersedes—traditional showroom experiences.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of The Home Depot's competitive positioning from 2022 to 2024 with generally accurate qualitative trends and strong contextual relevance. It correctly identifies the shift from physical service expansion to omnichannel integration as a strategic differentiator against showrooms. However, there are some discrepancies in entity accuracy and unsupported details not present in the ground truth. For example, the mention of 'Pro Xtra', 'MRO acquisitions', 'SRS acquisition', 'AI-driven personalization', and 'BOPIS/BODFS' are not found in the original answer and lack verification from the provided knowledge graph. While these may be plausible real-world developments, they introduce unverified specifics that reduce factual accuracy. The ground truth emphasizes tool rentals (2022), self-service lockers, electronic shelf labels, and mobile app navigation (2023), and deeper digital integration with personalized experiences (2024)—elements partially reflected but not fully aligned. The LLM overemphasizes Pro-focused services and technological capabilities beyond what the original answer supports. Quantitatively, no incorrect numbers are present (e.g., no false figures for locations or financials), but the answer introduces named programs and acquisitions without numerical backing or mention in the ground truth, slightly affecting quantitative accuracy. The reasoning is logically sound and reflects multi-hop synthesis across years, but relies on external knowledge not confirmed in the source. Thus, while the overall trajectory and strategic narrative are correct, the inclusion of unverified specifics lowers the correctness and qualitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 464,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "\nThe $500 million 3.50 % senior note due June 15 2025 remained on Cisco’s balance sheet throughout fiscal 2022‑2024, but its **effective interest rate rose from about 3.20 % in FY 2022 (page 89 – 2022 table) to roughly 6.38 % in FY 2023 (page 89 – 2023 table) and to about 6.66 % in FY 2024 (page 89 – 2024 table)**.  \n\nThis increase reflects the combined effect of discount accretion, issuance‑cost amortization and fair‑value hedging adjustments as market rates climbed, even though the note’s nominal coupon stayed at 3.5 %. Consequently, Cisco’s borrowing cost for this tranche grew markedly, signalling that the company’s overall debt structure is becoming weighted toward higher‑yielding fixed‑rate securities in a rising‑rate environment, while the specific 3.50 % note itself has not changed in principal amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the outstanding amount of $500 million is correctly stated as constant across fiscal years 2022–2024, and the effective interest rates—3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024—match the original answer exactly. Minor phrasing like 'about' or 'roughly' does not detract from accuracy, as these are common in financial reporting contexts and do not misrepresent the data. (2) The answer is complete, addressing both the evolution of the effective interest rate and the unchanged principal, as well as interpreting the implications for Cisco's borrowing costs and debt structure. (3) Entity accuracy is perfect: Cisco, the 3.50% Note, and the correct fiscal years are all properly identified. (4) The reasoning is sound and adds value by explaining the drivers behind the rising effective rate—discount accretion, amortization of issuance costs, and fair-value hedging adjustments—linking them logically to broader market rate increases. This goes beyond the ground truth by providing mechanistic insight without introducing error. (5) Semantic equivalence is strong: the core facts, trends, and implications are conveyed with enhanced explanatory depth while remaining factually aligned. The multi-hop synthesis across three fiscal years is correctly executed, and the conclusion about increasing borrowing costs and shifting debt structure is valid and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 412,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast shifted from a pure‑HFC platform to a hybrid architecture that combined aggressive HFC upgrades (2 Gbps downstream rollout in 2022 and DOCSIS 4.0 deployments in 2023) with targeted fiber‑to‑the‑premises extensions and network virtualization, enabling it to offer multigigabit symmetrical speeds and bundled Wi‑Fi services that directly compete with Lumen’s fiber‑based offerings; meanwhile Lumen continued to expand its own FTTP footprint and to market symmetrical gigabit‑plus plans, so the competitive balance moved from Comcast’s HFC‑centric advantage to a race in which both carriers were racing to match each other’s fiber speeds and service bundles. Consequently, Comcast’s positioning evolved from “HFC‑based broadband leader” to a “hybrid‑network provider with fiber‑enhanced, multigigabit services” trying to keep pace with Lumen’s pure‑fiber expansion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right question contextually. (1) The ORIGINAL ANSWER states that Lumen was a consistent competitor expanding fiber infrastructure from 2022–2024, with increasing bundling and speed enhancements, but does not mention any specific speed targets (e.g., symmetrical gigabit) or DOCSIS 4.0 deployments by CMCSA. The LLM introduces specific technical details—such as '2 Gbps downstream rollout in 2022', 'DOCSIS 4.0 deployments in 2023', and 'multigigabit symmetrical speeds'—that are not present in the ground truth and cannot be verified from the provided knowledge. (2) There is no mention in the ground truth about Comcast shifting to a 'hybrid architecture' or 'fiber-to-the-premises extensions' during this period, nor any indication that the competitive dynamic evolved into a 'race' where CMCSA was trying to 'keep pace' with Lumen. Instead, the truth emphasizes Lumen’s ongoing fiber expansion as a persistent competitive pressure, not a shifting balance of advantage. (3) The multi-hop reasoning is partially sound in that it attempts to compare CMCSA and Lumen across years on infrastructure and service evolution, but it fabricates technical milestones and strategic shifts not supported by the source. (4) While the LLM answer is contextually relevant and structured well, the invented quantitative and qualitative details (e.g., specific technologies, deployment timelines, architectural shifts) severely reduce factual accuracy. The core idea—that Lumen’s fiber expansion posed a growing challenge—is aligned, but the execution adds unsupported specifics. Hence, correctness is partially compromised: some entities (CMCSA, Lumen, fiber expansion) are correct, but the narrative of competitive evolution is overstated and factually incorrect in key aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 505,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s reliance on third‑party acquirers, aggregators and processors has steadily increased—especially as it rolls out new debit‑card and digital‑payment offerings—so that it now depends more heavily on external partners to promote and maintain merchant acceptance of its cards (see 2022 p. 29, 2023 p. 29 and 2024 pp. 38, 52).  This deeper dependence amplifies the risk that merchants will steer or discriminate against Amex cards, and while Amex continues to embed non‑discrimination and “honor‑all‑cards” provisions in its merchant contracts, enforcing those clauses has become more difficult amid growing regulatory scrutiny and litigation over steering practices (2022 p. 29; 2024 p. 35‑38).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the increasing reliance on aggregators from 2022 to 2024, the associated risks of merchant steering, and challenges in enforcing non-discrimination clauses. All key years (2022, 2023, 2024) and their respective developments are addressed, though the mention of 2023 is slightly less explicit in the LLM answer—while the trend is implied, the specific 'increasingly relied' language from 2023 is not directly echoed, representing a minor omission. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; references to page numbers (e.g., 2022 p.29) are consistent and correctly cited, indicating proper sourcing. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and connects growing dependence on third parties to rising enforcement challenges and regulatory scrutiny. It correctly identifies the link between new product rollouts (e.g., Amex debit on its network) and increased risk of discrimination. (4) The answer is contextually relevant and semantically equivalent to the original, using slightly different phrasing (e.g., 'third-party acquirers, aggregators and processors' instead of just 'aggregators') but preserving factual accuracy. The only reason for not scoring a 10 is the slightly weaker emphasis on the 2023 escalation compared to the original’s explicit 'increasingly relied' and product-specific risk, though the overall trajectory is correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 439,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "\nFrom 2022 through 2024 J&J funneled all talc‑related claims into LTL Management LLC, which filed a Chapter 11 case in late 2021 that produced an automatic stay of the litigation; the stay was upheld briefly in 2022 but the Third Circuit reversed it in early 2023, causing the bankruptcy court to dismiss the LTL filing in July 2023 and prompting the Company to resume ordinary talc trials while simultaneously drafting a “pre‑packaged” Chapter 11 plan.  In 2024 the strategy was refined—LTL was split into three Texas LLCs (Red River, Pecos River and New Holdco), the proposed settlement fund was raised to roughly $8 billion (present‑value $6.475 bn over 25 years) and, in September 2024, Red River filed a new Chapter 11 petition to obtain a stay and implement that plan, even as the Company continued to negotiate a multi‑state settlement and defend or settle individual cases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative and entity details, undermining its correctness. (1) Correctness: The original answer states that LTL Management LLC filed for Chapter 11 in 2022 (after being created in October 2021), but the LLM incorrectly claims the filing was in late 2021 and that the automatic stay was upheld briefly in 2022—this misrepresents the timeline. The Third Circuit did reverse the stay in 2023, and the case was dismissed in July 2023, which the LLM correctly notes. However, the LLM introduces entities not present in the ground truth: Red River, Pecos River, and New Holdco—these are not mentioned in the original answer and appear to be fabricated or misattributed. (2) Quantitative Accuracy: The LLM claims a settlement fund of $8 billion (present value $6.475 billion over 25 years), which directly contradicts the original answer’s $2 billion reserve. This is a major error with no support in the ground truth. The $8B figure and 25-year structure are unsupported. (3) Reasoning: The multi-hop reasoning is partially sound in connecting bankruptcy dismissal to renewed litigation and settlement efforts, but the introduction of a new corporate structure (three Texas LLCs) and a pre-packaged plan not mentioned in the original answer reflects flawed synthesis. The claim that Red River filed in September 2024 is speculative and not in the ground truth. (4) Contextual Relevance: The answer stays on topic, addressing litigation handling, settlement attempts, and bankruptcy filings, and correctly identifies the shift toward negotiation in 2024, including multi-state settlements. However, the inclusion of unverified entities and financial figures reduces reliability. Overall, while the general narrative arc (bankruptcy → dismissal → shift to settlement) is directionally aligned, the specific facts, numbers, and entities are often incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 526,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "\nBetween 2022 and 2024 Home Depot shifted from treating store appearance as a generic competitive factor to a deliberate, multi‑year “store‑modernization” program that added clearer signage, refreshed layouts, electronic shelf‑labels, self‑service lockers and curb‑side pickup points so the physical outlet could serve as the hub of an omnichannel experience.  By fiscal 2024 these store‑enhancement investments were explicitly linked to the company’s interconnected‑retail strategy—using mobile‑app navigation, BOPIS/BODFS options and real‑time inventory visibility to blend the in‑store environment with online ordering, delivery and pickup, thereby turning store appearance into a coordinated extension of its digital capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Home Depot's competitive emphasis on store appearance from 2022 to 2024, noting the shift from a standalone factor to an integrated component of an omnichannel strategy. While the original answer does not use the term 'store-modernization program,' this is a reasonable interpretation consistent with the described enhancements (signage, layouts, electronic labels, self-service lockers, curbside pickup), which are plausible elements of such a program based on industry practices and are not contradicted by the ground truth. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the progression over time (2022 to 2024) and integrates store appearance with digital capabilities like mobile app navigation, BOPIS/BODFS, and real-time inventory—directly reflecting the original answer’s emphasis on mobile-optimized platforms, product search, and fulfillment options. (4) The LLM adds slightly more operational detail (e.g., electronic shelf labels, self-service lockers) not explicitly mentioned in the ground truth, but these are contextually appropriate and do not contradict it; they enhance rather than distort the narrative. The core message—that store appearance evolved into a digitally connected, omnichannel experience by 2024—is semantically equivalent and well-supported. Minor deduction in qualitative accuracy due to slight elaboration beyond the source, but overall reasoning and entity/timing accuracy (Home Depot, 2022–2024, interconnected retail) are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 474,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "\nAT&T’s relationship with Time Warner evolved from full ownership of the WarnerMedia entertainment suite—acquired in 2018 and expanded through the 2021 deal to combine WarnerMedia with Discovery—into a staged exit: the April 2022 Reverse‑Morris‑Trust spin‑off separated WarnerMedia, which then merged with Discovery to form Warner Bros. Discovery, reducing AT&T’s stake to a minority holding that was finally eliminated when it sold its remaining DIRECTV interest to TPG in September 2024 (see T_10k_2022.pdf pp. 5, 18; T_10k_2024.pdf p. 5). This multi‑year trajectory reveals that AT&T’s broader entertainment strategy shifted from vertical integration in content creation and distribution to a disciplined focus on its core telecom and connectivity businesses, using the divestiture of legacy media assets to streamline operations and refocus on 5G, fiber and broadband growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T completed the separation of WarnerMedia in April 2022 via a Reverse Morris Trust with Discovery, forming Warner Bros. Discovery; AT&T retained no ongoing ownership, and by 2023, Time Warner Inc. was no longer an active subsidiary; in 2024, AT&T sold its remaining interest in DIRECTV to TPG, finalizing its exit from entertainment. The dates (April 2022, September 2024) and entities (Discovery, TPG, Warner Bros. Discovery) are correctly identified. (2) Quantitative accuracy is perfect: no numerical errors, and the timeline references are precise. The mention of specific filings (T_10k_2022.pdf, T_10k_2024.pdf) adds verifiability. (3) Multi-hop reasoning is sound: the answer synthesizes information across years and entities—linking the 2018 acquisition, 2022 spin-off, and 2024 DIRECTV sale—to correctly infer AT&T’s strategic pivot. The only minor inaccuracy is the suggestion that AT&T retained a 'minority holding' post-2022, which is not supported by the ground truth—AT&T fully exited WarnerMedia ownership in 2022, with no residual stake. This slight overstatement reduces qualitative accuracy slightly. (4) The answer is contextually excellent, directly addressing ownership, integration, divestiture, and strategic implications. Overall, the response captures the core trajectory and strategic rationale with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 399,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "\nFrom 2022 through 2024 American Express has kept its status as the fourth‑largest general‑purpose card network, but intensifying competition from Visa, Mastercard and fast‑growing fintech payment platforms has forced the company to lean more heavily on premium, cobrand and travel‑centric value propositions.  At the same time, growing regulatory scrutiny—especially caps on interchange fees, network‑routing rules and the need to retain financial‑holding‑company status—has led the firm to exit its network‑licensing businesses in the EU and Australia and to operate under increasingly strict U.S. banking and consumer‑protection oversight, including its recent designation as a Category III firm in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express remained the fourth-largest card network (after China UnionPay, Visa, Mastercard), faced increasing competition in premium and cobrand segments, and exited network licensing businesses in the EU and Australia due to regulatory pressures. The mention of 2024 regulatory developments, including Category III designation, adds relevant context not in the original but does not contradict it. (2) There are no numeric inaccuracies—dates (2022–2024), geographic regions (EU, Australia), and regulatory themes (interchange fees, network routing, financial holding company status) are correctly cited. Format variations (e.g., 'Category III firm') are factually sound. (3) Multi-hop reasoning is strong: the model synthesizes competitive dynamics, regulatory evolution, and strategic exits across years and jurisdictions. It correctly infers that regulatory dependency increased, even if the term 'compliance-driven dependency' isn't used verbatim. (4) The only minor gap is that the original emphasizes 'uncertainty around cobrand arrangements in the EU' as a direct consequence, which the LLM answer omits. However, the broader impact on cobrand and premium strategies is acknowledged. Wording differs slightly (e.g., 'fintech payment platforms' not in original), but this does not reduce accuracy. Overall, the answer is semantically equivalent, contextually complete, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 414,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "\nThe $2.250 % Notes due 2050 were $808 million at the end of 2022, rose to $826 million in 2023, and returned to $808 million by the end of 2024.  This modest, essentially flat movement shows that Johnson & Johnson is keeping this long‑dated tranche steady while it trims its overall long‑term debt load, reflecting a disciplined capital‑structure strategy that prioritises balance‑sheet stability and controlled maturation of its long‑term obligations rather than aggressive expansion or retirement of this specific issuance.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and trend. According to the ground truth, the outstanding balance was $983 million in 2022, decreased to $826 million in 2023, and further declined to $808 million in 2024. However, the LLM incorrectly states the 2022 balance as $808 million (matching the 2024 value), then claims it rose to $826 million in 2023 before returning to $808 million in 2024. This reverses the actual downward trend and misrepresents the starting point. (2) The quantitative inaccuracies are critical: the initial balance is off by $175 million, and the direction of change in 2022–2023 is wrong (it decreased, not increased). The total reduction of $175 million over the period is completely missed due to the inverted numbers. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the balance changes across years. Instead of identifying a consistent reduction indicating a strategy to retire long-term debt, it infers a 'flat' movement and claims stability in this tranche, which contradicts the actual data. (4) While the answer attempts to interpret the company's debt management strategy and uses relevant financial terminology, the conclusions are based on incorrect data, undermining the qualitative and quantitative accuracy. Contextual relevance is moderate because the response addresses the right instrument and general topic of long-term debt strategy, but the factual foundation is unsound, leading to an incorrect overall assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 425,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign‑government‑bond portfolio fell sharply over the three‑year span – from roughly 7 % in 2022 to 6.5 % in 2023 and then to about 5.9 % by the end of 2024 (with the 1‑to‑5‑year bucket dropping from ~4.5 % to ~2 %).  This decline reflects a deliberate shift toward shorter‑dated, lower‑yielding securities, indicating that the company has reduced its exposure to higher international interest‑rate environments and is now less sensitive to future rate hikes abroad.  (See Note 4/Yield tables in the 2022, 2023 and 2024 10‑K filings, pages 120, 173 and 180.)",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in the quantitative details. According to the ground truth, in 2022, American Express held $630 million in foreign government bonds with a weighted average yield of 6.45% for short-term (within one year) instruments. The LLM incorrectly states the 2022 yield as 'roughly 7%', which is not accurate. In 2023, the ground truth specifies that short-term yields remained at 6.45%, while the 1–5 year maturity bonds dropped to 4.48%. The LLM misrepresents this by stating a portfolio-wide yield of 6.5% in 2023 and implies a 1–5 year yield of ~4.5%, which is close but not explicitly tied to the correct maturity bucket. In 2024, the ground truth reports short-term yields declined to 5.86% and 1–5 year yields fell to 2.03%. The LLM approximates this as 'about 5.9%' and '~2%', which is reasonably close for 2024 but misrepresents earlier years. (2) The dollar amount ($630 million) is omitted entirely in the LLM answer, which is a significant omission. Additionally, the LLM incorrectly implies a continuous decline from 7% to 6.5% to 5.9%, which does not reflect the stability of short-term yields between 2022 and 2023. (3) The reasoning about reduced exposure to international interest rate environments is plausible and aligns with the trend, though the conclusion about a 'deliberate shift toward shorter-dated securities' is speculative and not directly supported in the ground truth, which only notes declining yields without specifying duration strategy. The multi-hop synthesis across years is attempted but flawed due to incorrect baseline numbers. (4) Despite the numerical inaccuracies, the LLM captures the overall downward trend and interprets its implications reasonably, earning moderate scores for qualitative accuracy and high relevance. However, the quantitative inaccuracies—especially the incorrect 2022 yield and missing asset size—reduce the correctness score to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 525,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe shifted its free, online self‑service learning from a generic catalog on learning.adobe.com to a branded, enterprise‑focused learning platform—now referred to as **Adobe Digital Learning Services**—that is explicitly integrated into its Customer Success Account Management process. By pairing self‑service courses with skills‑assessment tools, personalized learning paths and Success‑Manager oversight, Adobe ties learning adoption directly to customer business outcomes, using enablement as a core lever for retention and expansion.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of Adobe's strategic evolution in customer learning and enablement from 2022 to 2024 and correctly identifies the importance of self-service learning in customer success and retention. However, it contains significant factual inaccuracies in entity and platform naming, as well as timeline representation. According to the ground truth, in 2022 the platform was hosted at www.training.adobe.com, and the rebranding to learning.adobe.com occurred in 2023—not the reverse as implied by the LLM's claim of a shift 'from a generic catalog on learning.adobe.com'. The LLM incorrectly states that the platform was rebranded as 'Adobe Digital Learning Services', a term not mentioned in the original answer and unsupported by the knowledge graph. Additionally, while the original answer notes integration with enterprise success initiatives starting in 2023 with skills assessments, the LLM overstates the integration by introducing 'Success-Manager oversight' and 'personalized learning paths' with no mention of these specific features in the ground truth. There is also no mention in the original answer of the Customer Success Account Management process. While the core idea—increased strategic integration of learning into customer success and retention—is valid and contextually relevant, the LLM fabricates specific branding and structural details, undermining qualitative accuracy. Quantitatively, there are no numbers or dates in the LLM response that conflict with the original (it omits specific years for changes), so quantitative accuracy is not penalized. The reasoning reflects a plausible interpretation but fails to accurately synthesize the documented multi-hop evolution: (1) 2022 launch at training.adobe.com, (2) 2023 rebrand to learning.adobe.com with skills assessments, (3) 2024 continued integration. Thus, while semantically aligned in broad theme, the LLM answer is factually imprecise on key details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 528,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "\nCisco’s 5.90 % senior notes due 2039 continued to carry a **$2 billion** principal balance in fiscal 2022, 2023 and 2024, and the notes’ **effective interest rate stayed essentially flat at about 6.11 %** each year (the 5.90 % coupon plus hedge‑accounting adjustments).  \n\nThis stability indicates that Cisco is maintaining a **steady, long‑dated fixed‑rate debt profile**, using interest‑rate swaps only to hedge market‑rate exposure rather than to refinance or increase leverage. The unchanged utilization and effective rate reflect a disciplined long‑term financing strategy that prioritizes predictable interest expense and preserves financial flexibility for other capital‑allocation priorities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the $2,000 million (i.e., $2 billion) outstanding balance and the stable 6.11% effective interest rate for Cisco's 5.90% Senior Notes across fiscal years 2022–2024, matching the ground truth exactly. The use of 'about 6.11%' is semantically acceptable as the rate was precisely 6.11% each year. (2) All numeric values—principal amount, coupon rate, effective interest rate, and time period—are factually accurate. The equivalence of $2 billion and $2,000 million is correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes consistent debt utilization and interest rate data over three years and correctly infers a strategic decision around long-term debt management. It appropriately references hedge accounting adjustments to explain the difference between coupon and effective rate, which aligns with typical SEC filing disclosures. (4) The qualitative interpretation adds value by contextualizing the stability as part of a disciplined capital allocation strategy, emphasizing financial flexibility and predictable interest costs—consistent with, and expanding reasonably upon, the ground truth’s conclusion about a deliberate long-term strategy. The only minor limitation is that it introduces the concept of interest-rate swaps without explicit confirmation in the ground truth, but this is a plausible and common practice and does not contradict the facts. Overall, the answer is factually correct, complete, and contextually well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 417,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "\nFrom 2022 to 2024, Boeing’s pension fund raised its target allocation to private‑equity (which includes special‑situation strategies) from 4% to 7% and its actual holding from 8% to 9% of total assets. This upward trend signals a deliberate increase in exposure to private‑equity, especially higher‑risk special‑situation investments, to boost long‑term returns and diversify the portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims Boeing's pension fund increased its target allocation from 4% to 7% and actual holding from 8% to 9% from 2022 to 2024, but the ground truth states that no specific dollar amounts or percentages were disclosed for Special Situation Strategies in any year. These figures are entirely fabricated. (2) The entity is also incorrect: the original answer refers to 'BA' (Boeing) in the context of its private equity investment vehicles, not its pension fund; the LLM incorrectly shifts focus to the pension fund, which is not mentioned in the ground truth. (3) The reasoning is flawed: the LLM asserts a strategic increase in exposure based on non-existent data, while the ground truth emphasizes strategic continuity due to consistent qualitative descriptions across years. (4) The original answer highlights the lack of quantitative disclosure and interprets the repeated mention of special situation strategies as evidence of stable allocation, whereas the LLM invents a trend that cannot be supported by the available data. Thus, the answer fails on factual accuracy, entity identification, reasoning, and proper synthesis of multi-hop information, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 362,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "\nGlobal sales of JNJ’s Interventional Solutions rose from roughly **$4.3 billion in fiscal 2022** (page 90) to **$6.35 billion in fiscal 2023** (page 90) and kept climbing in fiscal 2024, contributing to the **$31.9 billion total MedTech sales** reported for 2024 (page 93).  This upward trajectory—bolstered by the May 2024 acquisition of Shockwave Medical and other strategic buys—signals that Interventional Solutions has become a core, high‑growth pillar of JNJ’s MedTech portfolio, prompting continued investment and acquisitions after the segment’s integration.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported sales figures and timeline. According to the ground truth, JNJ's Interventional Solutions sales were $3,971 million in 2022, $4,300 million in 2023, and $6,350 million in 2024. The LLM incorrectly states $4.3 billion in 2022 (should be 2023), $6.35 billion in 2023 (should be 2024), and fails to report the correct 2022 figure. This misalignment in both values and years undermines the quantitative accuracy. (2) The LLM references a 'May 2024 acquisition of Shockwave Medical' as a driver of growth in 2024, but the original answer attributes the 2024 surge to post-acquisition integration following a late 2022 acquisition (likely referring to something else, not Shockwave in May 2024). This introduces an incorrect entity and timeline. Additionally, the LLM cites a $31.9 billion MedTech total for 2024 as context, which may be accurate but is not in the ground truth and distracts from the specific segment evolution. (3) The multi-hop reasoning is flawed: the LLM conflates the timing of the acquisition with the sales progression, reversing the cause-effect timeline. The ground truth emphasizes growth accelerating *after* integration post-late-2022 acquisition, while the LLM suggests growth in 2023 was already at $6.35B and driven by a 2024 acquisition, which is logically inconsistent. (4) Despite these issues, the LLM correctly identifies the upward trajectory and strategic importance of the segment, showing some qualitative understanding. However, due to major errors in numbers, years, and causal reasoning, the correctness score is low. Quantitative accuracy is severely compromised (score 2), qualitative reasoning is partially sound but based on wrong facts (score 4), and relevance is moderate as it addresses the right segment and strategic theme (score 6).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 505,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Walmart kept **“No Boundaries”** as a core private‑brand label across its grocery, general‑merchandise, home and health units, merely refreshing the product assortment while never repositioning the brand; the 2022 10‑K (p. 7) lists it with other private brands, the 2023 10‑K (pp. 6‑7) repeats the same roster and notes that only categorization revisions—not brand strategy—are adjusted, and the 2024 10‑K (p. 9) again references the brand as part of the expanding private‑label portfolio. This multi‑year consistency shows that Walmart’s general‑merchandise private‑label strategy is built around a single, value‑focused brand that can be stretched across categories to reinforce its everyday‑low‑price promise, drive traffic and margin, and maintain a coherent consumer perception of quality‑at‑a‑low‑cost.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the consistent presence of 'No Boundaries' as a private brand from 2022 to 2024 and references to Walmart's private-label strategy. However, it introduces significant factual inaccuracies: 'No Boundaries' is incorrectly stated to be present in 'grocery, home, health' units, while the ground truth specifies it is part of General Merchandise, specifically Apparel and Home, and later Fashion—categories that do not include grocery or health. This misplacement of the brand across business units undermines the accuracy of the synthesis. (2) Quantitatively, the answer correctly cites the 10-K pages (2022 p.7, 2023 pp.6-7, 2024 p.9) and correctly notes the brand's repeated listing, which aligns with the ground truth. There are no numerical calculations, so scoring focuses on correct citation and temporal alignment, which are mostly accurate. (3) The multi-hop reasoning is partially sound—correctly identifying continuity across years—but fails in entity mapping by assigning the brand to incorrect merchandise units. The conclusion that Walmart uses a single value-focused brand across all categories overreaches; the ground truth emphasizes strategic consistency within general merchandise, not cross-sector expansion. (4) Contextual relevance is high because the answer addresses branding evolution and strategy implications, but the incorrect domain assignment reduces its factual reliability. Correctness is penalized due to major entity misclassification despite correct temporal and strategic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 435,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "\nCisco’s available‑for‑sale debt investments generated a modest $9 million gain in fiscal 2022, then posted a $21 million loss in fiscal 2023 and a deeper $67 million loss in fiscal 2024, reflecting deteriorating market values. This worsening performance contributed to the rise in other‑income (loss) from $(248) million in 2023 to $(306) million in 2024, underscoring the negative impact of these securities on earnings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numeric values—$9 million gain in 2022, $21 million loss in 2023, and $67 million loss in 2024—that are not present in the original answer (ground truth). The ground truth does not provide any exact dollar amounts or gains/losses for any fiscal year; it only states that there were 'higher losses' in 2023 and 2024 that negatively impacted other income (loss), net. Therefore, all quantitative claims in the LLM answer are fabricated or hallucinated. (2) The LLM also claims that other income (loss) rose from $(248) million in 2023 to $(306) million in 2024 due to these losses. These figures are not mentioned or implied in the original answer and represent a significant addition of unverified data. There is no support in the ground truth for any specific figures related to other income (loss), net. (3) On qualitative reasoning, the LLM correctly identifies the trend of deteriorating performance in available-for-sale debt investments impacting other income negatively in both 2023 and 2024, which aligns with the original answer’s description of a 'consistent negative impact.' It also correctly attributes the impact to the same line item—other income (loss), net—showing appropriate multi-hop synthesis between investment performance and income statement impact. However, the addition of precise numbers undermines the factual basis of the response. (4) The contextual relevance is fair because the answer addresses the evolution of investment performance and its effect on other income across the requested fiscal years. But due to the complete lack of quantitative accuracy and inclusion of false specifics, the overall correctness score is low. While the directional trend (worsening losses) matches the ground truth, the unsupported numbers make the answer misleading and factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 502,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "\nBetween 2022 and 2024 American Express increasingly depended on third‑party merchant acquirers—such as the OptBlue program and GNS partners—to broaden card acceptance, especially among small‑ and midsize merchants whose agreements typically have no fixed term; these acquirers pay a negotiated network‑rate fee that is recorded as discount revenue.  As a result, third‑party acquirers have become a more strategic lever for expanding global merchant coverage and driving transaction growth across all merchant segments, with their role growing in importance from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of American Express's reliance on third-party merchant acquirers from 2022 to 2024. It correctly identifies the strategic expansion through programs like OptBlue and GNS, emphasizes the role in broadening acceptance among small- and midsize merchants, and notes the financial mechanism (network-rate fee recorded as discount revenue), which aligns with the 2023 detail in the ground truth. The answer also correctly conveys the growing strategic importance of these acquirers in expanding global merchant coverage and driving transaction growth across all segments. The only minor omission is the lack of explicit year-by-year progression—while the trend is acknowledged, the answer does not clearly differentiate American Express’s evolving emphasis in each year (e.g., 2022: expanded reach via indirect processing; 2023: financial integration via revenue recognition; 2024: strategic dependency for global scale). This slightly reduces qualitative accuracy but does not undermine factual correctness. All entities (OptBlue, GNS, third-party acquirers, discount revenue) are accurate, and there are no numerical or date inaccuracies (the time frame 2022–2024 is correctly referenced). The reasoning is sound and synthesizes multi-hop information across strategic, operational, and financial dimensions. The answer is fully contextually relevant and directly addresses the question’s focus on evolution, strategic importance, and merchant segment coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 417,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson has moved its multi‑year “enterprise‑wide initiative” from planning to execution, integrating and standardizing the processes and systems that support HR, IT, procurement, supply‑chain and finance.  The program, highlighted in the 2023 and 2024 10‑K filings (Item 9A), now provides a unified financial‑shared‑service platform that simplifies financial systems, streamlines cross‑functional workflows and aligns the design of the company’s financial control environment with the broader standardization effort across those functions.  This evolution is presented as a proactive enhancement—not a response to any control deficiency—and is monitored as part of the company’s disclosure‑control and internal‑control assessments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative from 2022–2024 focused on integrating and standardizing processes across HR, IT, procurement, supply chain, and finance, with a specific emphasis on enhancing financial shared services. The answer correctly characterizes the initiative as proactive, not driven by control deficiencies, and notes its integration with financial control environment design—consistent with the 2023 and 2024 10-K disclosures (Item 9A). (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense, but all years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolution of the initiative across years and functions, correctly linking shared services development with enterprise process standardization and control environment alignment. (4) Minor omission: the LLM does not explicitly mention that the initiative was already underway in 2022 as a strategic direction (the ground truth notes 2022 as the start of consistent emphasis), and slightly overemphasizes 'execution' and 'unified platform' without direct confirmation in the original answer. However, this does not contradict the source and is a reasonable interpretation. Wording differences (e.g., 'proactive enhancement' vs 'proactive effort') are acceptable under semantic equivalence. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 468,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "\nFrom 2022 through 2024 American Express shifted from a primarily closed‑loop, premium‑card issuer to a strategy that explicitly confronts the rise of alternative payment mechanisms.  The company’s own risk‑factor disclosures and competition commentary (pp. 12, 14, 31) highlight intensified pressure from digital wallets, open‑banking APIs and real‑time settlement platforms, prompting Amex to accelerate investments in AI/ML, tokenization, real‑time payment capabilities and partnership‑driven open‑banking initiatives while still leveraging its high‑spending customer base and Membership Rewards value proposition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: American Express's evolving positioning from 2022 to 2024 is accurately portrayed as a shift from viewing alternative payment mechanisms as threats to strategically adopting them. The mention of competitive pressures from digital wallets, open banking APIs, and real-time settlement systems matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes Amex’s changing strategic posture across years, correctly identifying the progression from competitive concern (2022) to strategic adaptation (2024), including specific technological responses like tokenization, real-time payments, and open banking partnerships. The reference to 'risk-factor disclosures and competition commentary' suggests grounding in actual 10-K filings, enhancing credibility. (4) The LLM adds value by specifying strategic tools (AI/ML, tokenization) and business assets (Membership Rewards) not explicitly mentioned in the ground truth, but these are contextually appropriate and do not contradict it. The only minor gap is that the original emphasizes a shift 'from external threats to essential components of its technological roadmap,' a conceptual framing slightly more explicit than the LLM’s version, which focuses on actions rather than philosophical shift. Still, the semantic meaning is equivalent. All parts of the question—competitive pressure, strategic adaptation, and technological innovations (open banking, digital wallets, real-time settlement)—are addressed thoroughly. Hence, high scores across all dimensions with a 9 on correctness due to slightly less explicit emphasis on the conceptual evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 514,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe deepened Frame.io’s role inside its Creative Cloud family: the platform was first launched as a cloud‑native collaboration hub for video and still‑asset review, then was tightly woven into Premiere Pro, After Effects, Photoshop and Lightroom with frame‑accurate commenting and Camera‑to‑Cloud upload, and finally positioned as the collaboration layer of the new Adobe GenStudio suite together with Firefly AI services.  This progression shows Adobe’s strategy of building an end‑to‑end, AI‑enhanced creative workflow—linking creation (Firefly, Stock, Substance) with collaborative review and publishing—so it can offer enterprises a single, integrated platform for large‑scale content production and distribution.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and timeline, aligning with the ground truth that Adobe deepened Frame.io's integration from 2022 to 2024 as part of its creative collaboration strategy. It correctly identifies Frame.io as a cloud-native platform integrated with Premiere Pro, After Effects, Photoshop, and Lightroom, and highlights frame-accurate commenting and real-time workflows, which matches the 2023 and 2024 developments. The mention of Camera-to-Cloud (implied by 'real-time upload') is consistent with the ground truth. However, there are two key inaccuracies: (1) The LLM claims Frame.io was positioned as part of a 'new Adobe GenStudio suite together with Firefly AI services,' which is not supported by the original answer or known public filings—there is no mention of 'GenStudio' or Firefly integration with Frame.io in the ground truth. (2) The original answer emphasizes Frame.io’s expansion into casting, location scouting, and marketing campaign management in 2024—specific non-post-production use cases—which the LLM omits, instead focusing on AI and Firefly, which were not part of the documented evolution. While the strategic interpretation of Adobe building an end-to-end workflow is reasonable and contextually relevant, the introduction of unverified elements (GenStudio, Firefly integration) reduces qualitative accuracy. Quantitatively, there are no numbers, dates, or financial figures in dispute, so quantitative accuracy is full. Contextual relevance is high as the answer addresses Adobe’s broader strategy in creative collaboration tools. The multi-hop reasoning is partially sound—linking acquisition, integration, and strategic intent—but introduces speculative synthesis not present in the source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 477,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "\nFrom the debt tables in the 10‑K filings, the 2017 senior‑note tranche shows a declining outstanding principal: ≈ $16 billion at the end of 2022, ≈ $15 billion at the end of 2023, and ≈ $13 billion at the end of 2024.  The reduction reflects scheduled repayments and/or early redemptions that Amazon has used to lower its leverage and manage interest‑cost exposure on that issuance.  This progression signals a deliberate debt‑management strategy of retiring higher‑cost notes as cash flow permits, thereby decreasing overall debt outstanding and improving the company’s balance‑sheet leverage over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the outstanding balance of Amazon's 2017 Notes at $16 billion (2022), $15 billion (2023), and $13 billion (2024), matching the ground truth exactly in value and year. Minor use of '≈' is acceptable given typical reporting conventions and does not detract from accuracy. 2) All numeric values are correct and consistent with the original answer; no calculations are required beyond recognition of the declining trend, which is accurately described. 3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a deliberate debt management strategy from the consistent reduction. It adds context—such as 'scheduled repayments and/or early redemptions' and 'improving balance-sheet leverage'—that is reasonable and aligns with financial logic, though slightly more detailed than the ground truth. 4) The answer is semantically equivalent and fully addresses both parts of the question: the evolution of the balance and the implication for debt strategy. The only reason for not scoring a 10 is that the original answer emphasizes 'gradual pay down' without speculating on 'higher-cost notes' or 'cash flow permits,' which, while plausible, are not explicitly supported in the ground truth. However, this does not constitute an error, just a slight expansion. All entities (Amazon, 2017 Notes, correct years) are accurate. Overall, the response is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 406,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "\nFrom 2022 through 2024 the language surrounding “upgrades and conversions” in Boeing’s Global Services segment shifted from a peripheral service note (2022) to a highlighted growth driver linked to backlog and digital offerings (2023) and finally to a core strategic pillar for sustaining aerospace platforms (2024).  This progression shows Boeing is deliberately expanding its focus on upgrading and converting existing aircraft to generate recurring, service‑based revenue and to offset volatility in new‑aircraft deliveries.  The three‑year trend signals a strategic pivot toward long‑term platform sustainment as a key engine of future profitability.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in identifying the strategic importance of 'Upgrades and Conversions' within Boeing's Global Services segment from 2022 to 2024, but introduces a narrative of evolution and progression that is not supported by the ground truth. (1) The original answer states that 'Upgrades and Conversions' were consistently listed as a core service across all three years with no indication of a shift in emphasis—from peripheral to central or otherwise. The LLM incorrectly asserts a trajectory: 'peripheral service note (2022)' → 'highlighted growth driver (2023)' → 'core strategic pillar (2024)'—which contradicts the ground truth of consistent, unchanged emphasis. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not violated—dates (2022–2024) are correct. (3) The multi-hop reasoning is flawed: while the LLM synthesizes across years, it fabricates a strategic evolution that the source data does not support. The ground truth emphasizes stability and continuity, not a pivot or shift. (4) Contextually, the LLM addresses the right segment and service offering and correctly infers Boeing’s interest in service-based revenue and fleet sustainment, which aligns with the broader strategic theme. However, the core factual claim about changing emphasis over time is unsupported, significantly reducing factual accuracy. Thus, while contextually relevant and logically plausible, the answer is not factually accurate in its central claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 417,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "\nJohnson & Johnson first disclosed in its 2021 filing (page 75) that, beginning January 1 2026, **all eligible U.S. non‑union employees—regardless of hire date—would accrue benefits under the new “Retirement Value” formula**, while benefits earned under the legacy “Final Average Pay” formula would remain unchanged for service prior to that date.  The company has repeatedly reiterated this timeline in the 2022‑2024 pension footnotes (pages 74, 77, 75), noting that the amendment does not affect any benefits already accrued under the older formula and that the change will be applied prospectively.  In its communications to employees and in the SEC filings, J&J has framed the 2026 implementation as a phased transition, providing advance notice through HR benefit guides and internal announcements, and has highlighted that the shift will broaden eligibility to the entire U.S. non‑union workforce while preserving prior‑service accruals under the previous structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of key facts and timeline: Johnson & Johnson did announce in 2021 that the Retirement Value formula would apply to all U.S. non-union employees starting January 1, 2026, regardless of hire date, and this was reiterated in 2022–2024 filings. The distinction between legacy Final Average Pay for pre-2026 service and the prospective application of Retirement Value is accurately conveyed. However, the LLM answer introduces a claim not present in the ground truth: that the 2026 change would 'broaden eligibility to the entire U.S. non-union workforce.' This is misleading. According to the original answer, employees hired after 2014 were already under the Retirement Value formula—so the 2026 change is not about broadening eligibility but standardizing the formula for pre-2015 hires going forward. This misrepresents the evolution of eligibility, which remained unchanged from 2022 to 2024. Additionally, while the LLM mentions 'phased transition' and 'HR benefit guides and internal announcements,' the original answer only confirms consistent SEC filing language, not specific communication methods like HR guides. These additions, though plausible, go beyond the documented evidence. Quantitatively, all dates and years (2021 announcement, 2026 implementation, 2014 hire cutoff) are correct, and the references to SEC filing pages align with expected reporting. The reasoning is mostly sound but fails to acknowledge that post-2014 hires were already under the new formula—a key nuance in the multi-hop synthesis across years. Contextually, the answer is highly relevant and addresses the core of the pension strategy evolution, but overstates the scope of the 2026 change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 466,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "\nThe 5.000 % notes maturing in April 2030 had an outstanding principal of **$606 million at the end of fiscal 2022**, and that amount remained essentially unchanged at **$606 million in fiscal 2023 and fiscal 2024**.  \n\nThis flat trajectory indicates that Broadcom is treating the 5 % 2030 notes as a stable, low‑cost long‑term funding pillar and is not actively refinancing or retiring them; instead, its debt‑management focus is on retiring higher‑coupon obligations and issuing new debt at lower rates while preserving this core issuance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key quantitative claim. According to the ground truth, AVGO's outstanding principal for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, not $606 million as stated by the LLM. The LLM correctly reports $606 million for 2023 and 2024, but misattributes the timing of the reduction. This error fundamentally undermines the answer’s validity. (2) The quantitative inaccuracies are severe: the LLM claims the balance was flat at $606M across all three years, while the truth is it decreased from $1,086M to $606M between 2022 and 2023, then remained flat. This represents a $480 million reduction incorrectly omitted from the narrative. (3) The multi-hop reasoning is flawed because the LLM fails to recognize the significant repayment in 2023, leading to an incorrect interpretation of Broadcom’s debt strategy. Instead of identifying a deliberate reduction in this instrument, the LLM concludes it is a 'stable, low-cost long-term funding pillar' with no active retirement—this contradicts the actual repayment event. (4) While the answer is relevant to the question and discusses debt management strategy, the incorrect data leads to an invalid conclusion. The contextual relevance is moderate because it addresses the right instrument and general strategic interpretation, but the reasoning is based on false premises. Minor note: 'AVGO' and 'Broadcom' are correctly associated. Overall, major factual and reasoning errors justify a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 423,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T finished the separation of its WarnerMedia unit—created after its 2018 purchase of Time Warner Inc.—by completing a Reverse Morris Trust transaction in April 2022 that distributed the business to shareholders and ended AT&T’s direct ownership; the spun‑off WarnerMedia was then merged with Discovery to form Warner Bros. Discovery, marking the divestiture of the former Time Warner assets.  During this period AT&T had already integrated Time Warner’s Turner, HBO and Warner Bros. brands into its WarnerMedia segment and restructured the combined media business around streaming (e.g., HBO Max) before the 2022 spin‑off.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key events: AT&T's 2018 acquisition of Time Warner forming WarnerMedia, the April 2022 Reverse Morris Trust transaction that spun off WarnerMedia to merge with Discovery (forming Warner Bros. Discovery), and the strategic exit from entertainment. The 2022 transaction date is accurate per the original answer, despite the question asking about 2022–2024 evolution—the completion in April 2022 is correctly stated. (2) Quantitatively, all dates (April 2022) and structural details (Reverse Morris Trust, formation of Warner Bros. Discovery) are correct. There are no numerical inaccuracies. (3) The reasoning is sound: the LLM correctly traces the integration of Turner, HBO, and Warner Bros. into WarnerMedia, the restructuring around streaming (HBO Max), and the eventual divestiture. However, the original answer notes that in 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV—the last piece of the entertainment strategy. This point is missing in the LLM response, representing a minor omission in completeness. (4) Despite this, the LLM captures the core multi-hop trajectory: acquisition → integration → restructuring → divestiture. Wording differs but semantic meaning matches. Contextual relevance is excellent, directly addressing integration, restructuring, and divestiture. The missing DIRECTV 2024 detail prevents a perfect 10, but overall accuracy is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 412,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "\nFrom 2022 through 2024 AIG moved from a largely TRIPRA‑centric, ad‑hoc private‑reinsurance approach to a more formalized, scenario‑driven program.  In 2022 it relied on a third‑party vendor model and limited private reinsurance to cover U.S. terrorism losses, while monitoring concentrations in New York City; by 2023 it was tracking larger reinsurance‑recoverable balances and stress‑testing the program, and in 2024 it introduced explicit geographic attachment points—$200 million for Japan and $125 million for the rest of the world—and expanded targeted reinsurance and government‑sponsored pool coverage to mitigate international terrorism exposure.  Throughout the period the company continued to refine its modeled loss scenarios, adjust for vendor‑model gaps, and strengthen reinsurance protections as part of its ongoing risk‑management framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $200 million attachment point for Japan and $125 million for the rest of the world in 2024 are accurately reported. The 2022 reference to New York City modeling and TRIPRA is consistent, though the ground truth specifies a $1.3 billion modeled loss for a five-ton bomb attack, which the LLM omits numerically but captures conceptually by referencing scenario modeling and vendor models. (2) Quantitative accuracy is excellent—no incorrect numbers are stated, and the dollar amounts for attachment points match exactly. The only minor omission is the specific $1.3 billion loss figure from 2022, which is not included in the LLM response, but this does not distort the overall picture. (3) Reasoning is sound: the LLM correctly synthesizes a progression from ad-hoc to structured risk management, identifies the evolution in reinsurance (private and pool-based), and correctly links geographic attachment points to a more segmented approach. The multi-hop synthesis across years and risk dimensions (modeling, reinsurance, geography) is well-executed. (4) The answer is contextually fully relevant, addressing all three components of the question—modeled loss scenarios, reinsurance protections, and geographic attachment points—across the 2022–2024 timeframe. The omission of the exact $1.3B figure prevents a perfect 10, but the conceptual and structural accuracy remains very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 410,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "\nEmerson continued to list pipe‑wrenches and related pipe‑working equipment in its **Safety & Productivity segment** (see page 73), but from 2022 through 2024 the portfolio was reshaped toward higher‑margin, technology‑enabled tools—adding battery‑hydraulic press/​crimp tools, diagnostic and inspection systems, and tighter integration with control software—while the company divested lower‑growth consumer lines such as InSinkErator and Climate Technologies (noted on pages 9 and 12).  The steady rise in Safety & Productivity earnings before interest and taxes ( $250 → $306 → $308 million , page 74) and the segment’s stable sales growth reflect a deliberate strategic shift to focus on professional‑grade, safety‑centric tools for plumbing and mechanical trades, positioning Emerson as a leading provider of advanced, high‑value equipment for the industrial tools market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Emerson's strategic shift from traditional pipe-working tools (e.g., pipe wrenches) toward advanced, technology-enabled tools such as battery-hydraulic press/crimp tools and diagnostic systems—consistent with the 2023 and 2024 developments in the original answer. The mention of divestitures (InSinkErator and Climate Technologies) adds contextual depth not in the ground truth but is factually correct and supports the strategic refocusing narrative. (2) Quantitatively, the EBIT progression ($250M → $306M → $308M) is accurately presented with correct year-over-year trends, though the original answer does not include these figures. Since they are plausible and support the reasoning without contradicting the ground truth, they enhance rather than detract. (3) The multi-hop reasoning is sound: the LLM synthesizes portfolio evolution, strategic divestitures, financial performance, and segment focus (Safety & Productivity) to infer Emerson’s strategic positioning in the professional tools market. (4) While the original answer emphasizes digital integration and modernization, the LLM captures the same strategic direction using different but semantically equivalent language (e.g., 'technology-enabled tools', 'tighter integration with control software'). The only minor gap is the lack of explicit mention of 'sewer inspection cameras' as a diagnostic tool, but 'diagnostic and inspection systems' is a valid generalization. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 440,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "\nCostco has consistently treated free‑rent periods as lease incentives that are amortized on a straight‑line basis over the full lease term (including any renewal options it is reasonably certain to exercise), with the right‑of‑use asset initially measured at the present value of lease payments net of those incentives using the company’s incremental borrowing rate. From 2022 through 2024 the core methodology has remained unchanged, but disclosures have become more detailed: 2022 first disclosed the straight‑line treatment and discount‑rate calculation, 2023 added quantitative lease‑asset balances and noted related impairment impacts, and 2024 expanded the ROU‑asset table, showing a modest decline in the ROU balance and a higher weighted‑average discount rate, thereby illustrating how accrued free‑rent incentives are gradually amortized and affect the recorded ROU‑asset valuation.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that disclosures became 'more detailed' from 2022 to 2024, when the ground truth indicates the opposite: the 2022 filing included specific disclosure about discounting future lease payments and ARO treatment, which was omitted in 2023 and 2024, reflecting reduced disclosure depth. The claim that 2023 'added quantitative lease-asset balances' and 2024 'expanded the ROU-asset table' is unsupported and contradicts the ground truth assertion of declining disclosure specificity. (2) There are no actual quantitative figures (e.g., ROU asset balances, discount rates, amortization amounts) in the original answer to verify numerical accuracy, but the LLM fabricates a narrative of increasing detail and data disclosure that does not align with the ground truth. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the consistent straight-line methodology for free-rent periods, it misinterprets the evolution of disclosure practices, inverting the trend (more detailed → less detailed). This undermines the core qualitative analysis. (4) Contextually, the answer addresses the right topic—accounting treatment and disclosure of free-rent periods and ROU assets—and correctly notes the use of incremental borrowing rates and straight-line amortization. However, the central claim about disclosure evolution is factually reversed, leading to a low correctness score. Semantic equivalence fails on the key dimension of disclosure trends, despite some accurate policy description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 439,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "\nMicrosoft’s 2.000 % senior unsecured notes were first added to its master indenture via the Tenth Supplemental Indenture dated Nov 3 2015 (Exhibit 4.13), which introduced a tranche maturing in 2020, and then expanded by the Eleventh Supplemental Indenture dated Aug 8 2016 (Exhibit 4.14), which added a second tranche that matured in 2023. These notes are referenced in the 2022, 2023 and 2024 Form 10‑K filings (page 105) as part of the same indenture series, and after the 2023 maturity the series was fully retired, with no newer 2.000 % notes listed in the 2024 filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual discrepancies affecting overall correctness. (1) QUANTITATIVE ACCURACY: The LLM incorrectly states that the 2.000% Notes were introduced in two tranches: one via the Tenth Supplemental Indenture on Nov 3, 2015, maturing in 2020, and another via the Eleventh Supplemental Indenture on Aug 8, 2016, maturing in 2023. The ground truth only confirms the 2023 maturity note under the Eleventh Supplemental Indenture in 2016; there is no mention of a 2020 tranche linked to a Tenth Supplemental Indenture in the ground truth. This introduces false documentation and timeline details. Additionally, the claim that the series was 'fully retired' in 2024 is contradicted by the ground truth, which states the note was still listed in the 2024 exhibit list as part of historical indentures—indicating it was not actively retired but matured. (2) COMPLETENESS: The answer addresses maturity timelines and indenture documentation across the three years, satisfying the question's scope. However, it adds unverified details (e.g., 2020 tranche) not present in the ground truth, reducing reliability. (3) ENTITY ACCURACY: Microsoft and the Eleventh Supplemental Indenture date (Aug 8, 2016) are correctly identified. However, the Tenth Supplemental Indenture (Nov 3, 2015) and the 2020 maturity tranche are not supported by the ground truth, introducing entity inaccuracies. (4) REASONING: The multi-hop synthesis across 2022–2024 is partially sound—recognizing continuity in filings—but incorrectly infers retirement post-2023, failing to reflect the ground truth's emphasis on the note's continued presence as a historical instrument. (5) SEMANTIC EQUIVALENCE: While the general idea of stability under the same indenture is partially conveyed, the added details and incorrect retirement conclusion reduce alignment. The answer is contextually relevant and well-structured but undermined by key factual errors in dates, tranches, and documentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 543,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "\nAmazon continues to record revenue from third‑party seller services when the selling‑related services are performed—i.e., when the product is shipped to a carrier or delivered to the customer—​a policy that is restated in the 2022 (page 20) and 2023 (pages 43‑44) Form 10‑K filings and carries forward into 2024. The revenue is generated by two components: (1) commissions, typically a percentage of the seller’s sale (or fixed fees), and (2) fulfillment and shipping fees (per‑unit, activity‑based or shipping charges) that have expanded as more sellers use Amazon’s fulfillment network, shifting the mix toward a larger share of fulfillment‑related revenue in the later years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Amazon recognizes revenue from third-party seller services when services are performed—specifically upon shipment or delivery—which is consistent across 2022, 2023, and 2024. This matches the Original Answer's statement about recognition timing being tied to service delivery. (2) The composition of revenue—commissions (percentage of sales or fixed fees) and fulfillment/shipping fees (per-unit or activity-based)—is accurately described, and the LLM adds a relevant qualitative insight about the shifting mix toward fulfillment-related revenue due to increased use of Amazon’s fulfillment network. While the Original Answer does not explicitly mention this shift in mix, it is a reasonable inference supported by Amazon's business trends and does not contradict the ground truth. (3) The LLM references specific Form 10-K pages (2022, p.20; 2023, pp.43–44), which enhances credibility and shows correct sourcing, though such detail was not in the Original Answer. (4) The evolution over time is correctly portrayed as consistent in timing of recognition, with increasing clarity in disclosures—implied by repeated restatements in filings. The only minor shortcoming is that the 2024 disclosure is not explicitly confirmed in the LLM answer with a citation or statement about lack of change, but the carry-forward is reasonably assumed. No numerical inaccuracies exist—there are no specific numbers to conflict, and all qualitative claims are factually sound. Multi-hop reasoning is solid: synthesizing policy consistency across years and components of revenue from multiple disclosures. Thus, the answer is semantically equivalent and slightly enriched, warranting a high score but not perfect due to the slight extrapolation on revenue mix shift without explicit support in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 511,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "\nAT&T’s 2022‑2024 Form 10‑K filings repeatedly list a “Guaranty of certain obligations of Southwestern Bell Telephone Co.” (Exhibit 4‑b), confirming that the company still backs those legacy Bell obligations. By maintaining this guarantee, AT&T consolidates the historical liabilities of the Bell entities under its own balance sheet, using them as a stable credit‑support mechanism and preserving financial flexibility for the group as a whole. This reflects a long‑term liability‑management strategy that shields legacy telecom assets from isolation and leverages their obligations to reinforce AT&T’s overall financing and credit profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that AT&T maintained its guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024, citing Exhibit 4-b in the 10-K filings—this matches the original answer's key evidence. All dates and exhibit references are factually correct. (2) There are no numeric values requiring calculation, so quantitative accuracy is fully satisfied. (3) The multi-hop reasoning is sound: the model correctly infers from the repeated inclusion of the exhibit that AT&T has a consistent, long-term strategy for managing legacy liabilities. It goes slightly beyond the original answer by interpreting the strategic rationale (e.g., credit-support mechanism, financial flexibility), but these inferences are reasonable and contextually supported. (4) The answer is contextually relevant and fully addresses the question about AT&T’s long-term liability management strategy. The only minor gap is that it does not explicitly state that there was 'no indication of reduction or restructuring'—a point emphasized in the original—but the emphasis on continuity implies this. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only slight expansion on interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 366,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "\nThe carrying amount of Johnson & Johnson’s 2.250% Notes due 2050 fell steadily — $983 million at the end of 2022 (2022 10‑K, p. 67), $826 million in 2023 (2023 10‑K, p. 71) and $808 million in 2024 (2024 10‑K, p. 72) — reflecting scheduled principal repayments and/or optional redemptions.  This reduction shows that J&J is actively trimming that tranche of long‑term debt, signaling a broader deleveraging and refinancing strategy aimed at lowering overall debt exposure and optimizing the cost‑structure of its long‑term financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all quantitative values—$983 million in 2022, $826 million in 2023, and $808 million in 2024—which match the ground truth exactly. The years and note details (2.250% Notes due 2050) are also accurate, and the effective interest rate of 2.29% is not mentioned in the LLM answer but is not contradicted either. (2) All numbers are factually correct and properly cited to the relevant 10-K pages, satisfying quantitative accuracy. There are no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three annual reports and infers a trend of declining carrying amount. However, the interpretation diverges slightly from the ground truth: while the LLM emphasizes 'active trimming' and 'deleveraging and refinancing strategy,' the original answer frames the change as a 'gradual decline' indicating a 'stable' and 'deliberate' long-term strategy with only minor reductions. The LLM's characterization as a 'steady fall' and 'active trimming' overstates the pace and intent compared to the more cautious tone of the ground truth. (4) Despite this interpretive difference, the core facts are correct, and the answer addresses both parts of the question—evolution of investment and strategic implication. The reasoning is logical and contextually appropriate, though slightly less nuanced than the original. Hence, correctness is high but not perfect due to interpretive overreach on strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 409,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "\nCostco kept its $1.25 billion, 1.375 % Senior Notes due June 2027 on the books throughout 2022‑2024; the company retired its nearer‑term 2.300 % notes (2022) and 2.750 % notes (2024) and replaced them with longer‑dated senior debt, leaving the 2027 note as a core, low‑coupon component of a now‑more staggered maturity profile (it represented about 21 % of the $5.79 billion long‑term debt outstanding at the end of 2024).  This shows that Costco’s capital‑management strategy focuses on extending debt tenor, locking in low‑rate financing, and using cash flows to retire higher‑coupon near‑term obligations, thereby preserving liquidity and maintaining a stable, low‑leverage capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. While it correctly states that the 1.375% Senior Notes due June 2027 remained at $1.25 billion (i.e., $1,250 million) across 2022–2024, it incorrectly claims total long-term debt was $5.79 billion in 2024. The ground truth reports total long-term debt as $5,919 million in 2024, not $5.79 billion. This discrepancy affects the accuracy of the 21% claim (1.25 / 5.79 ≈ 21.6%), which is not verifiable with correct data and appears fabricated. Additionally, the LLM introduces unverified details such as the retirement of 2.300% notes in 2022 and 2.750% notes in 2024, which are not present in the ground truth and cannot be confirmed. (2) The ground truth confirms total long-term debt decreased from $6,590M (2022) → $6,484M (2023) → $5,919M (2024), but the LLM omits these actual figures and instead invents a lower total debt figure for 2024. The calculation of the 21% proportion relies on this incorrect number and is therefore invalid. (3) The multi-hop reasoning is partially sound—preserving low-rate debt while reducing overall debt burden aligns with the ground truth’s interpretation of selective capital management. However, the LLM overreaches by asserting refinancing activity and strategic replacement with longer-dated debt, which is not supported by the provided ground truth. The ground truth only confirms stability in the 2027 notes and a general decline in total debt, without specifying which tranches were repaid. (4) Despite incorrect quantitative details and unsupported refinancing claims, the LLM captures the qualitative insight that Costco maintained its low-rate 2027 notes while reducing overall debt, suggesting a strategy of preserving favorable financing. This gives it moderate qualitative and contextual scores. However, the correctness score is reduced to 5 due to major quantitative errors and unsupported specifics that undermine factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 532,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "\nMastercard expanded its real‑time, account‑based payments infrastructure from a dozen markets in 2021‑22 (page 11) to 13 markets by the end of 2023 and introduced new VCN, Alias‑Based Remittances and open‑banking services in 2024 (pages 13, 39).  At the same time it deepened its multi‑layered security program—adding third‑party assessments, board‑level cyber‑risk oversight and continuous system testing—to protect the growing flow of transactions (pages 12, 13, 17).  The parallel rollout shows that the company deliberately couples each global scaling of payment capabilities with reinforced, governance‑driven security controls, using layered safeguards and proactive risk monitoring to manage settlement exposure as the network grows worldwide.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in its factual content but introduces some details not present in the ground truth. It accurately states that Mastercard expanded real-time payments from around 12 markets in 2021–2022 to 13 markets by end of 2023, aligning with the original answer. However, the ground truth does not mention 'VCN, Alias-Based Remittances, and open-banking services in 2024'—these are specific product additions not reflected in the knowledge graph, making them unsupported additions. (2) Quantitatively, the numbers are accurate: 12 markets referenced for 2021 (as of Dec 31, 2021), 13 by 2023. The LLM correctly tracks this progression. The mention of 'a dozen markets' is a valid approximation of 12. No calculations are required, and all dates align. (3) The multi-hop reasoning is sound—linking security evolution with infrastructure expansion across years. The LLM correctly identifies that security measures were deepened alongside expansion, citing third-party assessments and continuous testing, which matches the 2023 update in the ground truth. However, the addition of 'board-level cyber-risk oversight' is not mentioned in the original answer and cannot be verified from the provided truth, representing an overreach. The conclusion that security and infrastructure scaling are deliberately coupled is consistent with the original inference about intentional parallel development. (4) The answer is highly contextually relevant, directly addressing both parts of the question: evolution of security and infrastructure, and strategic implications. While the core facts and reasoning are correct, the inclusion of unverified product launches and governance details slightly undermines qualitative accuracy. Still, the central narrative of parallel, deliberate scaling with reinforced security is semantically equivalent to the ground truth’s conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 513,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Microsoft did not issue any new 4.000% Notes due 2021; the series remained part of the indenture first added in the 2011 Third Supplemental Indenture (Exhibit 4.6) and was not expanded in the 2022, 2023, or 2024 filings. Instead, the company used later supplemental indentures (Exhibits 4.7‑4.10) to add newer tranches with later maturities, reflecting a debt‑management strategy that rolls maturing obligations into longer‑dated, diversified securities rather than repeatedly refinancing the 2021 notes.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Microsoft did not issue new 4.000% Notes due 2021 in fiscal years 2022–2024 and accurately references the Third Supplemental Indenture (Exhibit 4.6) from 2011 as the original source. It also correctly notes the use of later supplemental indentures (Exhibits 4.7–4.10) for newer debt, which aligns with the broader context of Microsoft’s debt management strategy. However, the LLM incorrectly implies that the 4.000% Notes due 2021 were not referenced post-maturity in 2024 due to rollover or delayed settlement, when in fact the ground truth states they were still disclosed in the exhibit list despite maturity—suggesting ongoing disclosure obligations, not necessarily a strategic rollover. The LLM misattributes the continued presence of the note to refinancing strategy rather than transparency or disclosure requirements, which is a key nuance in the original answer. (2) Quantitatively, all dates (2022–2024), exhibit numbers (4.6–4.10), and percentages (4.000%) are accurate. There are no calculation errors. (3) The multi-hop reasoning is partially sound: the model correctly infers that newer tranches replaced older ones, but fails to synthesize the critical point that the 2021 notes were still disclosed post-maturity across all three years, including 2024, which indicates transparency and disciplined reporting, not active refinancing. This undermines the qualitative accuracy of the conclusion about debt strategy. (4) The answer is contextually relevant and well-structured, but misses a key factual implication—continued disclosure of a matured note—leading to an incomplete and slightly misleading interpretation of Microsoft’s long-term debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 473,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "\nAmazon’s repeated reference to the 1.500 % senior notes due 2030 signals that it treats this long‑dated, low‑coupon tranche as a cornerstone of its capital structure—using ultra‑cheap, decade‑long debt to lock in financing and diversify maturities. Compared with its higher‑coupon notes maturing in 2024‑2032, the 2030 note reflects a strategy of securing inexpensive, long‑term capital while extending the debt horizon and minimizing reliance on near‑term borrowings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core strategic implications of Amazon's consistent reference to the 1.500% Note due 2030 across multiple years. (1) All entities are correct: Amazon, the 1.500% Note due 2030, and comparison to other notes (e.g., 4.700% Notes due 2024 and 2032) are accurately referenced. The percentage (1.500%) and maturity year (2030) match the ground truth exactly. (2) Quantitative accuracy is perfect: no calculations are required, but the cited coupon rate and maturity are correct, and the comparison to higher-coupon instruments is factually sound. (3) The multi-hop reasoning is strong: the LLM correctly infers that Amazon is using this low-cost, long-dated debt as a strategic tool to diversify maturities, extend debt horizon, and reduce refinancing risk—consistent with the layered maturity profile described in the ground truth. It also correctly contrasts the 2030 note with newer, higher-yielding instruments, reflecting a balance between legacy cheap debt and current market-rate borrowings. (4) While the LLM answer is semantically equivalent in substance, it omits specific references to the 2022 introduction context and the 2060 maturity mentioned in the original, which slightly reduces completeness in multi-year synthesis. However, the core strategic message—locking in low-cost, long-term capital while managing a staggered maturity profile—is fully preserved. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 426,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T held a 41.3 % equity interest in SKY Mexico, which it accounted for under the equity‑method (recording its share of earnings and cash distributions and writing the investment down to zero as distributions exceeded its remaining basis).  In June 2024 the company sold the entire 41.3 % stake for cash, removing the investment from its balance sheet.  This three‑year trajectory shows AT&T’s deliberate exit from non‑core, capital‑intensive international pay‑TV assets, using equity‑method holdings as a vehicle to monetize the stake and refocus on its core U.S. telecom and streaming businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states AT&T's 41.3% ownership stake in SKY Mexico, its equity method accounting treatment, and the June 2024 exit via sale—key facts fully aligned with the ground truth. The only minor omission is the explicit mention of Vrio's sale in 2022 as context for continued ownership, and the absence of DIRECTV and Gigapower as comparative equity-method investments in 2023. However, these do not detract from the core accuracy. (2) Quantitatively, all numbers are correct: 41.3% stake, June 2024 exit date, and no incorrect calculations. The format '41.3 %' with spacing is acceptable. (3) The multi-hop reasoning is sound—correctly linking the 3-year evolution (holding, accounting, exit) to AT&T’s broader divestiture strategy in international pay-TV. The conclusion about refocusing on U.S. telecom and streaming aligns with the ground truth’s emphasis on strategic refocusing. (4) Scores reflect near-perfect factual accuracy, with a minor deduction in qualitative accuracy for slightly less contextual detail compared to the original, though semantic equivalence is maintained. Contextual relevance is full—answer directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 338,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "\nThe glide‑path targets moved steadily lower in growth exposure and higher in liability‑matched assets: 2022 target ≈ 15 % equity / 75 % fixed‑maturity / 10 % other; 2023 target ≈ 12 % equity / 78 % fixed / 10 % other; 2024 target ≈ 9 % equity / 80 % fixed / 11 % other. This step‑down in equity and step‑up in fixed‑income reflects AIG’s deliberate de‑risking—reducing return‑seeking assets as the U.S. pension plan’s funded ratio improved and increasing holdings of liability‑hedging securities to lock in the plan’s stronger funding position.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the de-risking trend and the shift from growth to liability-hedging assets, aligning with the ground truth's description of AIG's strategy. However, the specific target allocations for 2022, 2023, and 2024 (e.g., 15% equity in 2022, 12% in 2023, 9% in 2024) are not present in the original answer and appear to be fabricated or inferred without support from the ground truth. The original answer does not provide exact percentage breakdowns, only the qualitative trend of reducing growth assets and increasing liability-hedging assets as funded status improved. (2) Since the ground truth contains no numerical targets, the LLM's inclusion of precise percentages (15%, 75%, etc.) cannot be verified and likely represents over-specificity or hallucination. This significantly impacts quantitative accuracy. (3) The multi-hop reasoning is sound in concept—linking improved funded status to de-risking and glide path adjustments—and correctly synthesizes the strategic intent across years. The logic of reducing equity and increasing fixed-income as a de-risking move is consistent with liability-driven investing principles mentioned in the original. (4) While the qualitative reasoning and contextual relevance are strong, the unsupported numerical claims reduce factual correctness. The answer would score higher if it had avoided citing specific percentages absent from the source. Thus, correctness is partially compromised by quantitative inaccuracy, though the core strategic interpretation is valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 427,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "\nMastercard’s credit‑risk mitigation evolved from 2022‑2024 by tightening its risk‑standards and expanding the use of collateral‑based mitigation (cash, letters of credit and guarantees) while continuously revising its settlement‑exposure calculations—e.g., the net exposure rose from $55.7 bn (2022) to $62.9 bn (2023) after a non‑material methodology correction and the company regularly updated its risk‑management methodology (see Note 22 in the 2022‑2024 10‑K filings).  At the same time, heightened regulatory scrutiny—including the FTC’s Durbin‑Amendment investigation, the DOJ antitrust CID, and EU antitrust inquiries—prompted Mastercard to proactively engage with authorities and to adjust its risk‑mitigation framework to preserve financial stability.  This demonstrates a high degree of adaptability: the firm not only monitors and revises its exposure estimates but also modifies its risk‑control policies in response to emerging legal and regulatory pressures.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details not present in the ground truth. The claim that 'net exposure rose from $55.7 bn (2022) to $62.9 bn (2023)' and a 'non-material methodology correction' is not supported by the original answer or the knowledge graph. These specific figures and the explanation around them are absent in the ground truth, making this a significant fabrication or misattribution. There is no mention of settlement exposure amounts in the original, so these numbers cannot be verified and appear incorrect. (2) The qualitative aspects are more accurate: the LLM correctly identifies the evolution of risk standards, use of collateral (cash, letters of credit, guarantees), and the context of regulatory scrutiny including the FTC’s Durbin-related actions, DOJ antitrust investigation (referred to as CID), and EU antitrust inquiries. It also correctly notes Mastercard’s responsiveness and methodology updates, aligning with the original’s description of revising risk standards and exposure estimates. (3) The multi-hop reasoning is partially sound—linking regulatory pressures (FTC, DOJ, EU) to adaptive risk management shows synthesis across events and years. However, the inclusion of unsupported numerical data undermines the reasoning’s reliability. The LLM also references 'Note 22 in the 10-K filings' without confirmation from the ground truth, introducing unverified detail. (4) Despite the incorrect numbers, the core narrative about Mastercard adapting its credit risk framework amid increasing legal and regulatory challenges is consistent with the original. The answer addresses both parts of the question—evolution of strategies and implications for adaptability—and does so with relevant context. Thus, while the qualitative and contextual elements are strong, the quantitative inaccuracies severely impact overall correctness, warranting a moderate score of 6 for correctness, with lower quantitative accuracy (4), higher qualitative accuracy (7), and high contextual relevance (9).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 559,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "\nThe shares reserved for future issuance under the Omnibus Stock Incentive Plan fell sharply – from roughly **117 million** available at the beginning of fiscal 2022 (as disclosed in the 2022 filing) to about **77 million** as of January 28 2024 (the 2024 filing) and to **≈70 million** by February 2 2025 (the 2025 filing).  This decline shows that Home Depot has been using an increasing share of its equity reserve for awards (e.g., performance shares, RSUs, ESPP issuances) and is deliberately curtailing the pool of shares left for new grants, signaling a strategic move to limit dilution and place greater emphasis on cash‑based or restricted‑stock compensation rather than expanding equity‑based grants.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Quantitatively, the LLM answer is mostly accurate: it correctly reports the available shares as approximately 117 million in 2022, 77 million as of January 28, 2024 (which corresponds to the 2023 plan year), and 70 million as of February 2, 2025 (2024 data). These figures align with the ground truth, though the LLM mislabels the reporting dates slightly—referring to the 2024 and 2025 filings rather than correctly attributing the data to fiscal years 2023 and 2024, respectively. This is a minor issue in formatting but does not invalidate the numbers.\n\nHowever, the qualitative reasoning contains a significant error in interpretation. The ground truth states that the declining share availability suggests increased use of stock-based compensation to retain and motivate employees—indicating active issuance. In contrast, the LLM concludes that the company is 'curtailing the pool... to limit dilution' and shifting toward 'cash-based or restricted-stock compensation,' which contradicts the original inference. There is no evidence in the data provided to support a strategic reduction in equity grants or a shift away from stock-based compensation; the trend instead implies the opposite: ongoing and substantial use of equity awards.\n\nThus, while the LLM correctly identifies the numerical trend and addresses both parts of the question (evolution of shares and strategic implication), its reasoning misinterprets the strategic signal. This constitutes a major flaw in multi-hop synthesis: although the facts are pulled correctly, the conclusion drawn is logically inconsistent with the evidence. The contextual relevance remains high because the answer engages directly with the question’s requirements and uses appropriate financial terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 475,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "\nThe 3.625 % senior notes maturing in October 2024 had a carrying amount of **$622 million** in both fiscal 2022 and fiscal 2023 (see pages 110 and 81 of the 10‑K filings). By the end of fiscal 2024 the balance was no longer reported (the entry appears as “–” on page 81 of the 2024 filing), indicating that Broadcom **retired the issue**—likely using cash or new financing—to eliminate a near‑term maturity and reshape its debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $622 million obligation in fiscal years 2022 and 2023, and accurately notes that the balance dropped to $0 (reported as '–') by fiscal year 2024, matching the ground truth. All numeric values, dates (October 2024 maturity), and percentages (3.625%) are correct. (2) Quantitative accuracy is perfect: $622 million is consistent across 2022 and 2023, and the drop to zero in 2024 is correctly interpreted. Format variations (e.g., $622 million vs $622M) are acceptable and handled appropriately. (3) The reasoning is sound: the model correctly infers that the disappearance of the liability indicates retirement of the notes, likely via cash or refinancing, which aligns with the ground truth's conclusion about a deliberate debt management strategy to eliminate a near-term obligation. The only minor gap is that the LLM does not explicitly state that the obligation 'remained unchanged' in 2023 as a strategic pause, but this is implied. (4) The answer is contextually fully relevant, addressing both the evolution of the obligation and its implication for Broadcom's debt strategy. The reference to specific 10-K pages adds credibility, though not required. Overall, the answer is factually complete and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction in qualitative accuracy for less explicit articulation of the strategic progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 402,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "\nFrom 2022 onward AT&T moved from the 2018 acquisition of Time Warner toward a rapid divestiture: it completed a Reverse‑Morris‑Trust spin‑off of WarnerMedia (later merged with Discovery) in April 2022 and, by 2024, had agreed to sell its remaining stake in the DIRECTV joint‑venture that held the former WarnerMedia video assets, effectively exiting the entertainment business. This sequence shows AT&T is refocusing on its core telecom infrastructure—expanding 5G and fiber networks—rather than sustaining large‑scale media ownership.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic divestiture of WarnerMedia via a Reverse Morris Trust and the eventual exit from entertainment, aligning with the core narrative of T (AT&T) shifting focus back to telecom. However, it incorrectly states that the WarnerMedia spin-off was completed in April 2022, while the ground truth indicates this occurred in 2023. This is a significant factual error affecting quantitative accuracy. Additionally, the mention of selling the 'remaining stake in the DIRECTV joint-venture that held the former WarnerMedia video assets' conflates entities: DIRECTV was divested separately and did not hold WarnerMedia's core video assets (which went to Warner Bros. Discovery); the 2024 DIRECTV sale was part of broader asset rationalization but not directly tied to WarnerMedia's content. (2) The date error (2022 vs. 2023) undermines the timeline accuracy. No dollar amounts or percentages are mentioned, so those cannot be assessed. (3) The multi-hop reasoning is mostly sound—linking acquisition, divestiture, and strategic refocusing—but the incorrect timeline and slight mischaracterization of the DIRECTV transaction reduce precision. The model captures the broader strategic pivot but misaligns key events. (4) Despite the date and entity linkage issues, the answer conveys the essential strategic shift and is contextually relevant. The core message about refocusing on telecom (5G, fiber) over media ownership is accurate and well-supported. Hence, correctness is reduced primarily due to the incorrect year for the WarnerMedia separation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 438,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "\nEmerson has re‑positioned its pipe‑cutter line as a core component of the Safety & Productivity segment’s broader, digitally‑enabled tool suite, pairing the cutters with battery‑powered hydraulic drivers and diagnostic accessories (e.g., sewer‑inspection cameras and locating equipment) to deliver end‑to‑end safety and productivity solutions.  This evolution is evident in the segment’s rising earnings (250 → 306 → 308 million in 2022‑24) — highlighted on page 74 — and in the company’s 2024 announcement that it is exploring strategic alternatives for the segment, underscoring the strategic focus on integrating battery‑powered technology and diagnostics with its traditional pipe‑cutting products (see the segment description on page 73).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic shift toward integration with battery-powered tools and diagnostic systems, aligning with the ground truth's narrative of evolution from standalone tools to part of a smart ecosystem. However, it introduces significant factual inaccuracies not present in the original answer. (2) The financial figures (250 → 306 → 308 million) and references to 'page 74' and 'page 73' are not part of the ground truth and cannot be verified from the provided knowledge; these specific numbers and page citations are hallucinated. The claim that Emerson is 'exploring strategic alternatives' for the Safety & Productivity segment in 2024 is unsupported by the original answer and represents a major factual deviation. (3) The multi-hop reasoning is partially sound—correctly identifying the integration trend across years and linking pipe cutters with battery-powered and diagnostic tools—but fails to accurately represent the progression: it skips the 2022 standalone description and compresses the timeline without clearly differentiating year-by-year evolution. (4) While the qualitative direction of the answer is consistent with the ground truth and contextually relevant, the inclusion of fabricated financial data and strategic announcements severely undermines factual correctness, warranting a moderate score of 6 for overall correctness. Quantitative accuracy is low due to invented numbers, but qualitative reasoning and relevance remain reasonably strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 416,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "\nFrom 2022 through 2024 J&J repeatedly highlighted that it is executing a multi‑year, enterprise‑wide program to **integrate, simplify and standardize finance‑related processes and systems** across HR, IT, procurement, supply‑chain and the finance function itself.  The 2022 filing first described the initiative as a way to “support the growth of the Company’s financial shared‑service capabilities,” and subsequent 2023‑2024 disclosures noted that the effort had moved from planning to **implementation and alignment**, streamlining the design and operation of the financial control environment and reinforcing standardized financial systems.  \n\nThis consistent emphasis reveals that J&J’s **strategic focus is on creating a uniform, scalable financial operating model**—i.e., standardizing financial processes to drive efficiency, reduce complexity, and enable the shared‑service organization to support the company’s broader growth objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Johnson & Johnson's multi-year initiative to integrate, simplify, and standardize financial processes and systems is accurately described across 2022–2024. The 2022 emphasis on supporting financial shared-service capabilities, and the progression into implementation and alignment in 2023–2024, are correctly represented. (2) There are no numeric values (e.g., dollar amounts, percentages) in the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolution of the initiative across three years and correctly infers the strategic focus on standardization and efficiency. One minor omission: the original emphasizes that the initiative was *not* in response to internal control deficiencies—a point absent in the LLM answer, slightly reducing completeness. (4) Despite this, the LLM captures the core narrative and strategic implication: that J&J is building a scalable, standardized financial operating model. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing both parts of the question. The answer is slightly less complete than the original but remains factually and conceptually accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 377,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the Executive Health Plan is still listed as Exhibit 10.1 and is disclosed as “filed herewith” with no amendment or change in filing status. This uninterrupted presentation shows that Costco regards the plan as a permanent component of its executive compensation, reflecting a stable, long‑term strategy for providing health benefits to senior leaders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Costco consistently disclosed the Executive Health Plan as Exhibit 10.1 across fiscal years 2022, 2023, and 2024 with no amendments, which aligns with the ground truth. However, it omits the specific 'Period Ended' date (September 2, 2012) and 'Filing Date' (October 19, 2012), which are key quantitative details from the original answer. While the absence of amendments is correctly noted, the LLM incorrectly refers to the exhibit as 'Exhibit 10.1' instead of 'Exhibit 10.1*' (a minor but technically inaccurate detail per SEC filing conventions). (2) The missing dates represent a failure in quantitative accuracy—these are factual, verifiable data points that were present in the ground truth and should have been included. The LLM does not mention that the plan has not been updated since 2012, weakening the precision of the response. (3) The reasoning is sound: the model correctly infers that the lack of amendments indicates stability in executive benefit strategy, which is a valid conclusion from the consistent disclosure. It synthesizes the multi-hop requirement (tracking changes over time) adequately, though with less evidentiary support than the original. (4) Scores reflect that core facts are correct (hence a 7 on correctness), but the omission of exact dates and slight entity inaccuracy (exhibit number) reduce quantitative accuracy. Qualitative reasoning and relevance remain strong due to correct interpretation of strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 418,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares continued to carry a **one‑vote‑per‑share** right and dividend entitlement, while Class B shares remained non‑voting but retained dividend rights – a structure unchanged across the three years (see page 103 “Classes of Capital Stock” and page 104 “Ownership and Governance Structure”).  At the same time the company increased its cash dividend per share from **$2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024** (page 100 “Dividends”), reflecting a deliberate, steady rise in shareholder payouts.  This consistent voting‑rights framework coupled with a growing dividend policy demonstrates Mastercard’s governance strategy of **maintaining a stable, shareholder‑friendly control structure while progressively enhancing cash returns to investors**.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that MA's A Class Shares had one vote per share and standard dividend rights from 2022 to 2024, which aligns with the ground truth. However, the LLM introduces specific dividend payout amounts per share ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are not mentioned or implied in the original answer. These figures may be factually accurate in reality, but they are not part of the ground truth provided by the knowledge graph, making their inclusion a deviation. Since the original answer only states 'standard dividend rights' without referencing per-share amounts or increases, adding these specific numbers introduces unsupported quantitative detail. (2) The calculation of increasing dividends is logically consistent but not verifiable from the ground truth, which does not mention any changes in dividend payments—only that rights remained consistent. Thus, while the trend may be real, asserting a 'deliberate, steady rise' goes beyond the evidence in the original answer. (3) The multi-hop reasoning is sound in linking stable voting and dividend rights to a stable governance strategy. The LLM extends this to infer a 'shareholder-friendly' strategy with growing payouts, which is a reasonable interpretation but adds qualitative insight not present in the original. The core reasoning about consistency revealing stable governance aligns well. (4) The contextual relevance is high—the response directly addresses the evolution (or lack thereof) in rights and draws a conclusion about governance strategy. The qualitative accuracy is strong due to correct entity identification (MA, A Class Shares), correct time frame, and proper synthesis of rights. However, the quantitative accuracy is reduced because of the unsupported specific dividend figures, even though no calculation error is present. Overall, the answer is mostly correct with minor but notable over-specification in financial details not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 534,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "\nIn fiscal 2022 the Security Insights Platform introduced risk‑identification and assessment functions that could be fed into customers’ existing in‑house SIEM tools (page 74 of the 2022 10‑K). The 2023 filing (page 89) expanded the platform’s analytics with AI‑driven threat detection and broader risk‑scoring while continuing to deliver its insights for integration into internal security orchestration environments. By fiscal 2024 (page 10) the platform added behavior‑based, advanced‑correlation techniques to proactively identify lateral movement and ransomware threats, further embedding its risk insights into customers’ internal security operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that Broadcom's Security Insights Platform maintained consistent functionality from 2022 to 2024, with stable integration into in-house tools and no significant evolution in capabilities. However, the LLM answer fabricates advancements: it claims AI-driven threat detection was added in 2023 and behavior-based correlation techniques in 2024, none of which are supported by the ground truth. (2) There are no actual numbers (e.g., dollar amounts, percentages, user counts) in either answer, so quantitative accuracy hinges on correct representation of fiscal years and features. While the years (2022, 2023, 2024) are correctly identified, the attributed capabilities are not. (3) The multi-hop reasoning is flawed—the LLM incorrectly infers progression and enhancement across years, whereas the ground truth emphasizes stability and consistency, indicating the platform had matured and changed little. (4) Contextual relevance is moderate because the answer addresses the right company, platform, and general topic (integration with in-house tools and risk identification), but the core factual claims about evolution are unsupported and misleading. The LLM appears to have hallucinated technical enhancements not present in the source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 371,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "\nFrom 2022 through 2024 AIG shifted its loss‑reserve risk quantification from basic deterministic actuarial tables to a hybrid framework that layers stochastic scenario‑ and catastrophe‑model outputs (including climate‑change adjustments) on top of traditional frequency‑severity estimates.  At the same time, the company formalized a multi‑tiered limit structure and began routinely engaging independent actuarial and modeling experts to review, challenge and validate the assumptions behind its IBNR, ceded‑reserve and reinsurance‑recoverable estimates.  This external validation—highlighted in the “Critical Accounting Estimates – Loss Reserves” disclosures (2022‑2023 filings) and reinforced in the 2024 risk‑measurement and limits discussion—has become a core control for confirming the adequacy of AIG’s loss‑reserve liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of AIG's loss reserve risk management from 2022 to 2024. It accurately captures the increasing sophistication of methodologies (shift toward hybrid stochastic and deterministic models), the formalization of reviews, and the ongoing role of external experts in validating reserve estimates—consistent with the original answer’s emphasis on structured oversight and external validation. The mention of stochastic modeling, catastrophe modeling, and climate-change adjustments in 2024 is plausible and contextually supported, though the original answer does not explicitly reference 'climate-change adjustments' or 'multi-tiered limit structure,' which are minor additions not present in the ground truth. However, these do not contradict the source and may reflect reasonable inference. The core elements—use of internal controls, expanded modeling in 2023, ERM and second-line reviews in 2024, and reliance on external experts—are all semantically aligned. There are no numerical inaccuracies (quantitative accuracy is perfect, as no specific numbers are misstated). The reasoning is sound and reflects multi-hop synthesis across years. The only deduction is for slight over-specificity in modeling details not directly confirmed in the ground truth, but the overall qualitative and contextual accuracy remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 389,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "\nAcross 2022‑2024 Emerson kept electrical‑distribution equipment as a core component of its **Discrete Automation** business (the Industrial‑Solutions unit that also includes valves, actuators and related hardware).  Sales in that segment edged up to **$2.64 bn in 2023** but slipped to **$2.51 bn in 2024**, while earnings before interest and taxes fell from **$542 m to $466 m**, indicating a stable but modestly contracting footprint.  This pattern underscores Emerson’s strategic shift toward **discrete‑automation and integrated control solutions**, while reallocating resources away from peripheral segments such as Safety & Productivity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. Most critically, it incorrectly states that Electrical Distribution Equipment was part of the Discrete Automation segment in 2022, when the ground truth confirms it was under the Industrial Solutions segment and only moved to Discrete Automation in 2023. This misrepresents the core evolution the question asks about. Additionally, the financial figures cited ($2.64B in 2023, $2.51B in 2024, EBIT of $542M and $466M) are not present in the ground truth and cannot be verified; the original answer does not include any financial performance data for the segment, so their inclusion here is unsupported. (2) Quantitative accuracy is very low because the numbers appear fabricated or misattributed. There is no mention of segment revenue or EBIT in the ground truth, so these values are incorrect by default. Even if they were from another source, they distract from the actual qualitative evolution being asked about. (3) The multi-hop reasoning is flawed: the model fails to trace the correct organizational shift across years. It collapses the 2022–2024 evolution into a static placement within Discrete Automation, missing the reorganization entirely. The conclusion about a 'strategic shift toward discrete automation' is directionally plausible but based on incorrect premises and unsupported by the actual structural narrative. (4) Contextual relevance is moderate because the answer addresses Emerson's strategic focus in discrete automation, which is relevant, but it does so with incorrect entity placements and fabricated metrics, undermining its usefulness. The real insight—about Electrical Distribution Equipment transitioning from a general industrial product to a foundational automation component—is entirely missed due to the erroneous timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 497,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson has been phasing in the **Retirement Value formula** that it announced in January 2021 – a career‑average benefit that will fully replace the legacy **Final Average Pay** structure on January 1 2026.  The company has adjusted its pension accounting (e.g., a $1.8 bn reduction in the projected benefit obligation, revised discount‑rate assumptions and updated net‑periodic‑benefit‑cost disclosures) to reflect the new formula, indicating a long‑term strategy to make retirement liabilities more predictable and sustainable while aligning compensation with longer employee tenure and a more flexible, globally integrated workforce.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in conveying the evolution of Johnson & Johnson's pension plan structure from 2022 to 2024 and its implications for long-term workforce strategy. It correctly identifies the transition from the Final Average Pay to the Retirement Value formula, effective January 1, 2026, and notes the consistent communication of this change across the years. The strategic rationale—cost predictability, sustainability, alignment with tenure, and a globally integrated workforce—is semantically aligned with the ground truth’s emphasis on standardization, inclusivity, and long-term planning. However, the LLM introduces a specific quantitative claim not present in the ground truth: a '$1.8 bn reduction in the projected benefit obligation' and references to revised discount-rate assumptions and updated cost disclosures. These figures and details are not supported by the original answer and cannot be verified from the provided knowledge graph, representing a factual overreach. Additionally, while the 2021 announcement is contextually plausible, it is not mentioned in the ground truth, which focuses solely on disclosures from 2022–2024. Despite these issues, the core multi-hop reasoning—synthesizing consistent policy messaging across years to infer strategic intent—is sound and relevant. The answer addresses both parts of the question: the structural evolution and the strategic implication. Thus, the correctness score is reduced due to unsupported quantitative claims, but qualitative and contextual accuracy remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 424,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "\nDowny’s share of the Fabric & Home Care segment held essentially steady—about 5 % of segment net sales in 2022, 2023 and 2024—while the segment grew roughly 4 % annually and its market‑share was flat. This flat trend shows that Downy is a mature, reliable earnings contributor but not a primary growth engine, underscoring its strategic role as a stable, core brand within P&G’s portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the Fabric & Home Care segment's net sales contribution to P&G grew from 35% in 2022 to 36% in 2023 and 2024, but the LLM incorrectly claims that Downy’s share within that segment was about 5% across all three years—this 5% figure is not supported by the original answer and misrepresents the data. There is no mention in the ground truth of Downy’s specific percentage contribution to the segment, so asserting it held steady at 5% is a fabrication. (2) The quantitative inaccuracies are severe: the LLM invents a specific percentage (5%) for Downy’s segment share that does not appear in the original answer, and while it correctly notes stability over the three years, the underlying metric is wrong. Additionally, the claim of '4% annual growth' and 'flat market share' is not present or verifiable from the original answer, introducing unverified data. (3) The multi-hop reasoning is flawed—the question asks how Downy’s contribution evolved and what that implies; the original answer infers strategic importance from the brand’s stable role within a growing segment, but the LLM incorrectly narrows this to a fabricated percentage and draws a different conclusion about Downy being a 'mature, reliable earnings contributor but not a primary growth engine,' which is speculative and not in the ground truth. (4) Contextual relevance is moderate because the LLM addresses the right topic (Downy’s strategic role) and time frame, and correctly identifies stability, but fails on factual and quantitative accuracy, undermining the overall correctness. The conclusion is partially aligned but based on incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 469,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "\nThe carrying value of Capital One’s total senior and subordinated notes was about **$30.8 bn in 2022**, rose to **$31.2 bn in 2023**, and then slipped slightly to **$30.7 bn in 2024** (see Tables 8.1 in the 2023 filing and Table 9.1 in the 2024 filing).  \nThis pattern shows that the firm expanded its long‑term debt issuance in 2023—likely to fund growth or refinance maturing obligations—while in 2024 it trimmed the balance, indicating a more measured or de‑leveraging approach to its debt financing over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, the carrying value was $27,219 million in 2022, $31,248 million in 2023, and remained at $31,248 million in 2024. However, the LLM reports $30.8 billion (i.e., $30,800 million) in 2022, $31.2 billion ($31,200 million) in 2023, and incorrectly states a decrease to $30.7 billion ($30,700 million) in 2024. The 2022 figure is notably off by over $3.5 billion, and the reported decline in 2024 contradicts the ground truth, which shows no decrease—2023 and 2024 values are identical. (2) These numerical discrepancies severely undermine the answer’s reliability. While the LLM correctly identifies an increase from 2022 to 2023, it falsely claims a drop in 2024, leading to an incorrect interpretation of a 'de-leveraging' trend. The actual trend is stable at peak levels, not a pullback. (3) The multi-hop reasoning is flawed because the model fails to accurately extract and compare the correct values across years. It references specific tables (8.1 and 9.1), suggesting access to data, but misreports the figures. The conclusion about a 'measured or de-leveraging approach' is therefore based on incorrect data and contradicts the ground truth, which indicates a sustained strategic increase in debt financing. (4) Despite the incorrect numbers and reasoning, the answer is contextually relevant—it addresses the right company (Capital One/COF), the correct financial instrument (senior and subordinated notes), and attempts to interpret the trend in terms of financing strategy. Hence, it receives moderate scores for qualitative and contextual accuracy, but very low marks for quantitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 478,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T’s exposure to the Mexican pay‑TV market evolved from a 41.3 % equity stake in SKY Mexico—held as an equity‑method investment and reflected in the company’s 2022 and 2023 disclosures (see T‑10K 2022 p. 92; T‑10K 2023 p. 65)—to a full exit in June 2024 when the entire 41.3 % interest was sold for cash (T‑10K 2024 p. 61 notes the disposition and that SKY Mexico no longer appears in the equity‑method table).  Throughout 2022 and 2023 the investment was accounted for under the equity method, with AT&T recognizing its share of earnings and cash distributions that gradually reduced the carrying amount, setting the groundwork for a clean‑up of the position in 2024.  This three‑year trajectory illustrates AT&T’s broader Latin‑American divestiture strategy: it systematically monetized non‑core pay‑TV assets, shedding equity stakes that no longer aligned with its core telecom and streaming focus.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: T (AT&T) held a 41.3% stake in SKY Mexico throughout 2022–2023, accounted for it under the equity method, and fully exited in June 2024. These details match the original answer exactly. (2) Quantitative elements—41.3% ownership, June 2024 exit—are precise and correctly cited with reference to specific 10-K pages, demonstrating strong grounding in source material. Minor formatting (e.g., '41.3 %' with space) does not affect accuracy. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of filings, correctly identifying the continuity of equity method accounting in 2022–2023 and the final disposition in 2024. It also accurately infers the strategic rationale—divestiture of non-core Latin American pay-TV assets—as part of a broader strategic shift. (4) The answer addresses all parts of the question: ownership stake evolution, equity method treatment, exit event, and implications for T’s broader strategy. Wording differs slightly (e.g., 'systematically monetized non-core pay-TV assets' vs 'deliberate strategic shift to exit non-core international assets') but conveys the same strategic insight. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 365,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "\nBNY Mellon’s 2022 filing first warned that returning capital to shareholders “may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” In the 2023 and 2024 10‑Ks the same statement is retained but is now framed alongside explicit references to the “well‑capitalized” and “well‑managed” supervisory standards and to broader capital‑adequacy and liquidity rules, highlighting that any shortfall could restrict dividends, share repurchases or other capital‑return activities. The 2024 filing further connects these constraints to its regulatory capital disclosures (e.g., Pillar 3 and stress‑test results) and underscores the parent’s dependence on subsidiary dividends to fund any capital returns, making clear that deteriorating capital adequacy would directly limit future shareholder distributions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's disclosures from 2022 to 2024 consistently reference U.S. banking laws, Delaware law, and preferred dividend obligations as constraints on capital returns. The 2022 filing introduced the core language about limitations due to regulatory requirements and failure to pay preferred dividends, which the LLM correctly quotes and contextualizes. In 2023 and 2024, the firm maintained this language while expanding the context—this is accurately reflected in the LLM answer, which notes the inclusion of 'well-capitalized' and 'well-managed' standards, as well as increased emphasis on subsidiary dividends and strategic initiatives. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2023, 2024) are correct and consistently used—hence a score of 10. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, identifies evolving language, and correctly infers increasing regulatory and structural complexity, especially around the parent company’s reliance on subsidiary dividends and integration with Pillar 3 and stress-test disclosures. The only minor gap is that the LLM does not explicitly mention ESG-related regulatory pressures in 2023, which the ground truth includes as part of the expanded risk discussion—this is a small omission affecting completeness but not the overall correctness. (4) The answer is fully contextually relevant, directly addressing regulatory requirements, dividend policies, and capital adequacy across the three-year horizon. Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a minor omission in qualitative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 516,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "\nFrom 2022 to 2024 3M shifted structural adhesives out of a generic “adhesives” listing and placed them into a newly created **Industrial Specialties** sub‑division within the Safety & Industrial segment—grouping them with former Closure/Masking Systems, Industrial Adhesive & Tape products and related personal‑safety items.  This bundling signals that 3M now treats adhesives as a **core, cross‑selling platform** that can be packaged with other specialty industrial offerings, highlighting their strategic role as a growth‑driving, differentiator in industrial applications.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low due to significant factual inaccuracies in entity and strategic description. The LLM claims that Structural Adhesives were moved into a newly created 'Industrial Specialties' sub-division in 2022–2024 and bundled with Closure/Masking Systems, Industrial Adhesive & Tape products, and personal-safety items. This contradicts the ground truth, which states that in 2022, Structural Adhesives were grouped with industrial abrasives, autobody repair, and electrical materials; in 2023, packaging and closure systems were added slightly; and in 2024, the shift was toward specialized industrial applications like construction and maintenance—not a formal reorganization into an 'Industrial Specialties' division. The LLM invents a structural reorganization (creation of a new sub-division) and specific product bundling not present in the original data. While the general strategic interpretation—that adhesives play a growing, integrative role—is directionally aligned with the ground truth’s conclusion about adhesives being foundational in complex systems, the reasoning is based on fabricated organizational changes. Thus, while contextually relevant and addressing the question’s intent, the answer fails on factual entity accuracy and multi-hop synthesis, making it partially correct but significantly misleading in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 414,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "\nFrom 2022 through 2024 Lilly kept Cyramza positioned across a broad set of solid‑tumor indications—maintaining its second‑line uses in gastric, NSCLC, colorectal and HCC cancers and, in 2022‑23, adding a first‑line label for EGFR‑mutated metastatic NSCLC—while its intellectual‑property shield was already on the wane.  In the United States the compound patent was scheduled to expire in 2026 (with EU and Japanese compound patents also ending by 2026‑2028), and data‑protection periods were set to lapse in 2024 (EU) and 2023 (Japan), meaning that after those dates the product would lose its exclusive market rights in the key global markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding dates and intellectual property timelines. The ground truth states that Cyramza's data protection expired in Japan in 2023, followed by Europe in 2024, and U.S. biologics data protection in 2026. The LLM incorrectly states that data protection lapses occur in 2024 (EU) and 2023 (Japan), which aligns partially but misrepresents the U.S. timeline by conflating 'compound patent' with 'biologics data protection'—a key distinction not supported in the original answer. Additionally, the original answer does not mention any new first-line label for EGFR-mutated metastatic NSCLC in 2022–2023; instead, it states that therapeutic indications remained consistent from 2022 to 2024. This is a significant factual error. (2) Quantitative accuracy is compromised: the LLM introduces compound patent expirations in 2026–2028 for EU and Japan, which are not present in the ground truth. The original answer only references data protection expirations, not compound patents. There is no mention of 2028 or patent expirations beyond data exclusivity. (3) Multi-hop reasoning is partially sound—the model attempts to synthesize therapeutic positioning and IP timelines across regions—but fails in accuracy due to introducing unsupported details (e.g., new indication, patent vs. data protection). The core idea of declining IP protection while maintaining clinical use is conceptually aligned, but execution is flawed. (4) Contextual relevance is high as the response addresses both therapeutic indications and IP across global markets as asked. However, due to key factual errors in dates and indications, the correctness score is limited to 5—partially correct but with significant inaccuracies affecting reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 488,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "\nFrom 2022 to 2024 Capital One’s fixed unsecured senior debt rose from $24.1 bn to $27.2 bn in 2023, then slipped slightly to $26.9 bn in 2024, while the weighted‑average interest rate stayed near 4.45‑4.48 % in 2022‑23 and climbed to 4.84 % in 2024. This pattern shows the firm has been expanding its senior‑debt capacity, but as market rates increased it began issuing new notes at higher coupons, indicating a strategy of growing funding while bearing higher financing costs in a rising‑rate environment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Capital One's fixed unsecured senior debt carrying value was $19,975 million in 2022, not $24.1 billion as stated. The 2023 value is not provided in the ground truth, but the LLM reports $27.2 billion, which is inconsistent with the correct 2022 baseline and the 2024 value of $26,930 million. The correct trend is a steady increase from ~$19.98B to ~$26.93B, whereas the LLM suggests a rise from $24.1B to $27.2B then a slight drop, which misrepresents the trajectory. The interest rate in 2022 was 2.91%, not ~4.45–4.48% as claimed; the rate only reached 4.84% in 2024. Thus, the LLM incorrectly portrays stable high rates in 2022–2023 when in fact rates more than doubled over the period. (2) Calculations and comparisons are flawed: the model fails to capture the doubling of interest rates and misstates the starting debt value by over $4 billion. These are material errors. (3) Multi-hop reasoning is partially sound—the LLM correctly infers that rising rates led to higher financing costs and that the company is expanding debt capacity—but this reasoning is based on incorrect data, undermining the validity of the conclusion. The correct inference (per ground truth) is a strategic shift toward issuing more fixed-rate debt amid rising rates, not just a passive response. (4) Contextual relevance is high—the answer addresses all parts of the question and attempts synthesis across years and metrics. However, due to severe quantitative inaccuracies, the correctness and qualitative accuracy scores are low. Minor formatting variations (e.g., $26.9B vs $26,930 million) would be acceptable, but the core numbers themselves are wrong, especially the 2022 figures, which distort the entire trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 496,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "\nCisco hedges the compensation liability for its deferred‑compensation plans with total‑return swaps that are **not** accounted for as accounting hedges.  The swaps generated a **$92 million loss in FY 2022**, a **$58 million gain in FY 2023**, and a **$91 million gain in FY 2024** (recorded in operating expenses/other income).  At the same time the outstanding notional amount of these swaps rose from **$651 million (FY 2022)** to **$985 million (FY 2024)**, underscoring a growing but increasingly volatile exposure whose earnings impact swung sharply each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92 million loss in FY 2022, $58 million gain in FY 2023, and $91 million gain in FY 2024—matching the ground truth exactly. These numbers are presented with accurate signs (loss vs. gain) and fiscal years, satisfying the quantitative core of the question. (2) While the original answer does not include notional amounts ($651M in 2022, $985M in 2024), the LLM provides this additional context, which is factually consistent with typical disclosures and enhances the analysis without contradicting the ground truth. The inclusion of notional growth is not required by the question but adds relevant depth. (3) The multi-hop reasoning is sound: the LLM synthesizes the pattern of gains/losses over three years and correctly infers increasing volatility and exposure, aligning with the original answer’s conclusion about volatility. The only minor gap is that the original emphasizes the 'swing from loss to consistent gains' as evidence of volatility, while the LLM emphasizes rising notional and earnings swings—both valid, but the LLM slightly extends beyond the given data in interpretation. (4) All entities—Cisco, Total Return Swaps, Deferred Compensation, fiscal years 2022–2024—are correctly identified and contextualized. The answer is semantically equivalent and factually superior in detail, warranting a high score. Minor deduction in qualitative accuracy due to slight interpretive extension, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 413,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "\nFrom 2022 through 2024 Home Depot shifted its store‑appearance focus from a generic refresh to a purpose‑built omnichannel design—modern signage, streamlined navigation, self‑service lockers, curb‑side pickup zones and electronic‑shelf‑labeling that tie directly into its digital order flow (pages 8, 9, 10, 32).  These investments lifted customer‑satisfaction and conversion metrics, producing a 6.6 % YoY rise in online sales to 15 % of total net sales and offsetting a 1.8 % dip in comparable sales, thereby preserving the retailer’s market share against multichannel and pure‑online competitors (pages 32‑34, 39).  The stronger in‑store experience also helped maintain foot‑traffic‑driven cross‑selling, reinforcing its competitive positioning over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic evolution of The Home Depot's store appearance from 2022 to 2024, correctly identifying the shift toward an omnichannel experience and integration with digital capabilities. It appropriately references modern signage, navigation, pickup zones, and digital tools as part of the in-store upgrades, aligning with the ground truth’s emphasis on interconnected retail. However, the answer introduces specific quantitative claims not present in the original answer or implied by the knowledge graph: namely, a '6.6% YoY rise in online sales to 15% of total net sales' and a '1.8% dip in comparable sales.' These figures are not supported by the ground truth, which does not provide any numerical metrics on online sales growth or comparable sales trends. As such, the quantitative accuracy is low because the model fabricates precise percentages and performance metrics that cannot be verified from the source. While the qualitative reasoning about the strategic shift is sound and contextually relevant—correctly identifying the integration of physical and digital experiences—the inclusion of unsupported numbers undermines factual correctness. The model also omits the explicit year-by-year framing (2022, 2023, 2024) and the nuanced progression from standalone differentiator to hybrid enabler. Despite these issues, the answer remains focused on the question and draws a logical connection between store appearance and competitive positioning against online retailers, earning high marks for contextual relevance and moderate scores for qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 436,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 showed a flat carrying balance of roughly **$2.0 billion** at the end of fiscal 2022, fiscal 2023 and fiscal 2024 (the note schedule on page 72 lists a $2,000 million net carrying amount as of both Jan 28 2024 and Jan 26 2025, and the same figure is implied for the prior year).  This stability demonstrates that NVIDIA is keeping a sizable, long‑dated senior note as a permanent part of its capital structure—using it to fund ongoing growth while maintaining a conservative, low‑coupon long‑term debt position rather than retiring or refinancing the issue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values compared to the ground truth. It claims the carrying value was approximately $2.0 billion in all three fiscal years (2022, 2023, 2024), but the ground truth shows it was $2,147 million in 2022, decreased to $1,637 million in 2023, and then increased to $2,000 million in 2024. The LLM incorrectly reports stability across all years, missing the notable drop in 2023 and the increase from 2023 to 2024. This misrepresents the actual trend. (2) The numbers are off by hundreds of millions in two of the three years: $2,147M vs. reported ~$2,000M in 2022 (understated), $1,637M vs. $2,000M in 2023 (overstated by ~$363M), and correct at $2,000M in 2024. These are material errors. (3) The reasoning is partially sound in interpreting the stability in 2024 as a sign of strategic long-term debt positioning, but it fails the multi-hop synthesis because it does not acknowledge the intermediate decline in 2023, which the original answer identifies as a 'temporary reduction' followed by repositioning. The LLM assumes consistency where there was volatility. (4) Contextually, the answer is relevant and addresses the question's intent regarding long-term debt strategy, and uses appropriate financial terminology. However, due to major quantitative inaccuracies and incomplete trend analysis, the correctness score is low. The qualitative score reflects reasonable logic based on incorrect data, and contextual relevance is high because the framing around capital structure and long-term funding is appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 440,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "\nBetween 2022 and 2024 the Scotchgard litigation moved past the appellate reversal of summary judgment (2021‑22) into a phase where 3M settled only a handful of bellwether and class actions—most notably the $65 million New York settlement (2022) and the Michigan Wolverine settlement (June 2023), both judged immaterial—while the bulk of cases remained unresolved.  At the same time the exposure broadened geographically, with filings in dozens of states and many matters transferred to the AFFF multidistrict litigation, and the pool of defendants swelled to include dozens of co‑defendants such as DuPont, Chemours, Wolverine, Saint‑Gobain, Honeywell and various carpet and paper manufacturers.  Consequently, the litigation landscape evolved from a concentrated Minnesota‑centric MDL to a nationwide, multi‑forum battle with numerous co‑defendants and only modest settlement amounts recorded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers and dates are correct: the $65 million 2022 New York settlement and the June 2023 Michigan Wolverine settlement are accurately reported, and both are correctly described as immaterial. There are no calculation errors. (2) The LLM correctly identifies the expansion of litigation geographically, noting the shift from a Minnesota-centric MDL to a nationwide landscape, which matches the ground truth's mention of new cases in Alabama, Georgia, and dozens of states. It also correctly notes the transfer of cases to the AFFF multidistrict litigation, adding contextual precision not in the original but consistent with factual developments. (3) Entity accuracy is strong: 3M, DuPont, Chemours, Saint-Gobain, Honeywell, Wolverine, and carpet manufacturers are all correctly named as defendants, matching the original answer. The inclusion of paper manufacturers is a minor addition but plausible given Scotchgard’s use in treated paper products and does not contradict the ground truth. (4) The reasoning is sound and reflects multi-hop synthesis: the LLM connects settlements, geographic expansion, and increasing defendant pools into a coherent narrative of escalating legal complexity. The only minor shortcoming is that the original specifies Mohawk Industries as a named carpet manufacturer plaintiff, while the LLM generalizes to 'carpet manufacturers' without naming Mohawk. This is a slight omission in specificity but does not undermine the overall correctness. The LLM also adds context about the appellate reversal and bellwether trials, which, while not in the original, are factually plausible and enhance context without introducing error. Overall, the answer is semantically equivalent, highly relevant, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 498,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "\nFrom 2022 through 2024 the AbCellera partnership generated a single, large revenue spike in 2022 – $2.02 billion of net product revenue from sales of the COVID‑19 antibodies (bamlanivimab and bebtelovimab) under EUAs – after which no sales occurred in 2023 or 2024, so royalty payments (tiered at mid‑teens to mid‑twenties % of worldwide net sales and recorded as cost of sales) also ceased.  The collaboration began with an upfront license and included development‑milestone payments (a $50 million R&D expense recognized in 2020), but no additional milestone payments were reported after 2022, leaving the financial impact of the partnership essentially flat‑zero in 2023‑2024.  (Pages 71, 75, 75).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: $2.02 billion in net product revenue in 2022, zero sales in 2023 and 2024, tiered royalty structure in the mid-teens to mid-twenties % of worldwide net sales, no additional milestone payments after 2022. The mention of $50 million R&D expense in 2020 is consistent with the collaboration's early-stage payments, though not directly asked in the question. (2) Quantitative accuracy is perfect: dollar amounts, percentages, and years match the ground truth. Format variations (e.g., $2.02 billion vs $2.02B) are acceptable and clear. (3) Multi-hop reasoning is sound: the model correctly infers that no sales in 2023–2024 imply no royalties or milestones, and connects royalty payments to net sales cessation. The only minor omission is not explicitly stating that the royalty structure 'remained consistent' in years with no sales, which is a subtle but relevant detail in the original answer. (4) Contextual relevance is excellent—the response directly addresses all parts of the question: royalty structure, milestone payments, and net product revenue across the three years. The inclusion of EUAs and drug names (bamlanivimab, bebtelovimab) adds helpful context without straying off-topic. Overall, this is a factually correct, well-reasoned, and complete answer with only negligible omission of a minor detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 391,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Dawn brand helped lift the Fabric & Home Care segment’s net sales + 4 % (to $29.5 bn) and drove a 230‑basis‑point jump in the segment’s margin, expanding the segment’s share of total earnings from 31 % to 34 % of net earnings.  This growth was powered by higher pricing and a favorable product mix that kept Dawn’s market‑share leadership in dish‑care intact, underscoring the brand’s strategic importance as a core profit‑generating pillar within P&G’s portfolio.  In short, Dawn’s performance illustrates how P&G is using the brand to deliver pricing power and margin expansion, positioning it as a key growth engine for the company’s overall strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While the ground truth confirms Dawn remained a consistently highlighted brand in the Fabric & Home Care segment from 2022–2024, the LLM introduces unsupported quantitative claims. Specifically, it states that the segment's net sales grew +4% to $29.5 billion, but the original answer does not provide absolute sales figures or growth rates—only percentages of total company sales (35% in 2022, 36% in 2023–2024). There is no mention of a 230-basis-point margin expansion or earnings share increasing from 31% to 34% due to Dawn’s performance—the original answer notes earnings contributions of 31% in 2022 and 34% in 2023–2024, but does not attribute this change to Dawn or calculate it as a 230-basis-point 'jump' driven by the brand. (2) The dollar amount of $29.5 billion and the +4% growth are entirely fabricated and not present in the ground truth. The margin expansion and causal link to Dawn are also unsupported. The only correct numbers are the 31% and 34% earnings contributions, which align with the original answer, but the interpretation (e.g., '230-basis-point jump') and attribution to Dawn are incorrect. (3) The reasoning fails on multi-hop synthesis: while the LLM correctly identifies Dawn as strategically important, it invents a narrative of growth and margin expansion driven by Dawn, which the ground truth does not support. The original answer emphasizes consistency in positioning and contribution, not performance-driven growth or strategic repositioning. (4) The contextual relevance is moderate—the answer addresses the strategic importance of Dawn and ties it to segment performance, which is relevant. However, the qualitative accuracy is low due to incorrect causal claims and fabricated metrics. The correctness score is low because the core quantitative claims are false, even though the general theme of Dawn’s importance is directionally correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 527,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s short‑term borrowings fell sharply from $883 million (2022) to $538 million (2023) and then edged up to $562 million in 2024, while long‑term debt rose to $49.3 billion in 2023 before pulling back to $45.0 billion in 2024.  The firm also dramatically trimmed its floating‑rate unsecured senior debt, dropping from $1.6 billion in 2022 to $0.35 billion in 2023 and essentially to zero by 2024, reflecting a strategic shift toward higher‑fixed‑rate, longer‑dated funding and reduced exposure to floating‑rate market swings.  This three‑year trend shows a deliberate de‑leveraging of short‑term liquidity and a move away from floating‑rate senior debt, improving balance‑sheet stability but increasing the proportion of fixed‑rate cost in the debt mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key financial figures, particularly in the breakdown of short-term borrowings and total debt. While the trend direction for long-term debt is mostly correct (rise in 2023, decline in 2024), the actual values are off. Ground truth shows total short-term borrowings and long-term debt combined were $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM incorrectly reports long-term debt alone as $49.3B in 2023 and $45.0B in 2024, omitting or misrepresenting short-term borrowings. It separately states short-term borrowings as $883M (2022), $538M (2023), $562M (2024), which does not align with the ground truth total debt figures. These discrepancies suggest a failure to correctly report or aggregate the total debt figures across years. (2) Floating unsecured senior debt is approximately correct in magnitude and trend: ground truth is $1.709B (2022), $349M (2023), $0 (2024); LLM reports $1.6B, $0.35B, ~0 — close enough to be considered reasonably accurate with minor rounding. However, the LLM omits any mention of the rising weighted-average interest rate on fixed unsecured senior debt (2.91% → 4.45% → 4.84%), a key part of the original answer and relevant to interest rate exposure. (3) The reasoning and synthesis are partially sound: the LLM correctly infers a strategic shift toward fixed-rate debt and reduced floating-rate exposure, which is logically supported by the decline in floating-rate debt. However, it fails to incorporate the rising fixed-rate interest costs, weakening the depth of analysis. It also incorrectly implies de-leveraging of short-term liquidity as a primary trend, when in fact total debt increased in 2023 — a mischaracterization due to incorrect disaggregation. (4) Correctness score is 6 due to partially accurate numbers and correct directional trends in debt composition, but significant errors in total debt levels and omission of key interest rate data. Quantitative accuracy is 5 due to material errors in dollar amounts. Qualitative accuracy is 7 because the logic and interpretation are reasonable given the data it used, though incomplete. Contextual relevance is 9 — the answer addresses the right concepts and structure, just with flawed inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 606,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "\nCisco’s 5.90 % senior note—issued with a $2 billion principal and maturing on Feb 15 2039—has been on the books throughout fiscal 2022‑2024.  Its effective interest rate, net of discount amortization and the related fair‑value hedge, has remained essentially unchanged at about **6.1 %** each year.  However, the note’s share of the company’s overall debt grew markedly: while it represented roughly $2 billion of the ≈ $8.5 billion long‑term debt in FY 2022, the February 2024 issuance of $13.5 billion of new senior notes lifted total long‑term debt to ≈ $19.6 billion, so the 5.90 % note now accounts for about 10 % of the expanded long‑term‑debt balance.  The instrument continues to be classified as **long‑term debt** (non‑current) on Cisco’s consolidated balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor imprecision in wording. (1) Quantitatively: The $2 billion principal, 6.1% effective interest rate, and long-term debt figures (~$8.5B in 2022, ~$19.6B in 2024) align closely with the ground truth ($8,416M and $19,621M). The slight rounding (e.g., $8.5B vs $8,416M) is acceptable. The note's proportion decreasing due to new debt issuance is correctly inferred. (2) The mention of a 'February 2024 issuance of $13.5B' is not explicitly in the ground truth but is a reasonable inference from the increase in total debt—though this specific timing and amount isn't confirmed in the original answer, it doesn't contradict it. (3) Multi-hop reasoning is sound: the model correctly synthesizes that while the 5.90% Note remained constant, its relative weight decreased due to overall debt growth. (4) Entity accuracy is strong: Cisco, the 5.90% Note, effective interest rate (~6.1%), and long-term debt classification are all correctly identified. The answer addresses all parts of the question: debt composition (proportion within total debt), effective interest rate, and long-term classification. The only minor issue is the slightly stronger emphasis on the note's 'share growing'—which is incorrect; it actually shrinks as a percentage—but the text later corrects this by stating it now accounts for about 10%, which is consistent with dilution. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 420,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "\nThe 1.55 % Notes due 2028 showed a nearly flat book balance – $1.25 billion at the end of fiscal 2024 and $1.25 billion at the end of fiscal 2023 (the same $1.20 billion fair‑value amount disclosed for fiscal 2022 after adjusting for the remaining discount and issuance costs) – while the effective interest rate stayed at about **1.64 %** each year.  This steady, low‑cost financing reflects NVIDIA’s strategy of issuing long‑dated, fixed‑rate debt at minimal expense and then holding it as a stable pillar of its capital structure, using the notes to fund growth without markedly increasing leverage or altering the debt‑mix.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal 2022, decreased to $1,099 million in 2023, and then increased to $1,250 million in 2024. The LLM incorrectly states that the carrying value was $1.25 billion in both 2023 and 2024 and implies it was $1.20 billion in 2022, which misrepresents the trend—particularly the drop in 2023. This is a critical error as the question specifically asks about the evolution across years. (2) The effective interest rate is reported correctly as 1.64% in 2024, but the LLM claims it stayed at 'about 1.64% each year,' while the ground truth indicates an increase from an implied rate in 2022 to 1.64% in 2024, suggesting a rising trend. The model fails to capture this evolution. (3) The reasoning and synthesis are partially sound—the LLM correctly infers that NVIDIA uses long-term fixed-rate debt as a stable capital structure component—but it misses the strategic nuance in the ground truth about temporary reacquisition or market repositioning in 2023 and the rising borrowing costs. The model's conclusion downplays the dynamic management of debt, instead portraying it as static, which contradicts the actual trend. (4) Contextual relevance is high because the answer addresses the core elements of debt strategy and long-term financing, but the incorrect numbers and oversimplified trend undermine the qualitative and quantitative accuracy. The model appears to have conflated fair value with carrying value and ignored year-over-year fluctuations, leading to a misleading narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 460,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Google continued to report Pixel phone sales under the **“devices”** line of its **Google Subscriptions, Platforms & Devices** revenue category (see pages 8 & 25), treating them as part of the broader hardware‑revenue stream alongside other products.  At the same time the company **ramped up hardware‑innovation spending** – launching new Pixel 5a/6 models and expanding the Nest device line – and **increased capital investment** in its hardware infrastructure, as reflected by a rise in depreciation of property and equipment (from $13.5 bn in 2022 to $15.3 bn in 2024) and higher R&D outlays (pages 7, 57).  This shows a clear strategic shift toward greater emphasis on, and investment in, Pixel and related hardware innovation.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of Google's increased investment in hardware and Pixel devices from 2022 to 2024 and correctly identifies the 'devices' segment within the 'Google Subscriptions, Platforms & Devices' revenue category. However, it contains significant factual inaccuracies that reduce correctness. First, the claim that Pixel devices were reported under the 'devices' line throughout 2022–2024 is partially misleading: the original answer clarifies that the explicit categorization of Pixel under a distinct 'devices' segment began in 2023, not 2022, which marks a key strategic shift. The LLM answer fails to note this evolution and instead implies continuity, missing a critical multi-hop insight. Second, the LLM introduces specific financial figures—depreciation rising from $13.5B in 2022 to $15.3B in 2024 and references to R&D outlays and capital investment—that are not present in the original answer and cannot be verified against the ground truth. Since the ground truth does not include these numbers or cite pages 7, 8, 25, or 57, their inclusion suggests fabrication or hallucination, severely undermining quantitative accuracy. While the emphasis on hardware innovation aligns with the original answer, the LLM does not mention the integration of Pixel with AI and cloud capabilities in 2024, a key strategic development. The reasoning is plausible but not fully aligned with the documented progression from investment focus to ecosystem integration. Contextually, the answer is relevant and addresses revenue categorization and innovation investment, but with incorrect details and unsupported data. Thus, while the direction of the answer is reasonable, its factual foundation is partially unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 470,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "\nBNY Mellon’s 10‑K filings for 2022, 2023 and 2024 all contain the identical phrasing in Item 14 that “the information required…is included in the Proxy in the section ‘Item 3 – Ratification of KPMG LLP,’” and each filing lists KPMG’s PCAOB firm identification number (185) and includes KPMG’s consent as Exhibit 23.1. The wording, structure and referenced exhibit have not changed across the three years, indicating that the company has continued to ratify KPMG as its principal auditor without interruption and that its audit relationship with KPMG remains stable and unchanged.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: BNY Mellon consistently referenced the ratification of KPMG LLP in the Proxy across 2022, 2023, and 2024, used identical language, and included KPMG’s PCAOB identification number (185) and consent (Exhibit 23.1). (2) Quantitative elements—specifically the PCAOB number (185)—are correctly reported with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesized the consistency of disclosure format, content, and structure across three years to infer audit relationship stability. (4) The answer addresses both parts of the question: the evolution (no change) and what it reveals (stable audit relationship). Minor additional detail (Exhibit 23.1) enhances completeness without introducing error. Wording differs slightly from the original but conveys the same meaning with equal or greater precision. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 289,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "\nLLY’s private‑alternative‑investment holdings in its defined‑benefit and retiree‑health plans were about $8.9 bn in 2022, slipped modestly to $8.6 bn in 2023, and the 2024 filing shows a comparable total, keeping illiquid assets at roughly 60 % of plan assets. This stable, sizable exposure across the three years signals a deliberate long‑term strategy to maintain a meaningful allocation to private alternatives for diversification and long‑run return objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values. According to the ground truth, LLY's allocation to private alternative investments was $10,542.5 million in 2022, decreased to $10,335.2 million in 2023, and further declined to $10,051.0 million in 2024. However, the LLM reports $8.9 billion in 2022, $8.6 billion in 2023, and a 'comparable total' in 2024—values that are materially lower and inconsistent with the ground truth. These discrepancies suggest either a misreading of the data or use of an incorrect source. (2) The quantitative accuracy is poor: the correct figures are approximately $10.54B, $10.34B, and $10.05B, whereas the LLM reports $8.9B, $8.6B, and ~$8.6B—errors of over $1.5 billion in each year. Additionally, the ground truth shows a consistent downward trend, while the LLM describes a 'stable, sizable exposure', which contradicts the actual trajectory. The claim that illiquid assets represent 'roughly 60%' of plan assets is not supported by the provided ground truth, introducing unverified information. (3) The multi-hop reasoning is partially sound—the LLM attempts to interpret the strategic implication of sustained allocation to private alternatives—but it does so on incorrect numerical foundations. The conclusion about a 'deliberate long-term strategy' aligns thematically with the ground truth's interpretation, but the reasoning is undermined by inaccurate data. (4) Contextual relevance is moderate: the answer addresses the question's intent regarding investment strategy evolution and long-term implications, but the factual basis is flawed. Due to major quantitative errors and misleading trend characterization, the correctness score is low despite some structural alignment with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 484,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "\nAcross the three fiscal years Tampax remained classified under the **Feminine Care** sub‑category of P&G’s **Baby, Feminine & Family Care** segment.  In 2022 the brand was positioned as a market‑share leader (≈ 25 % global share) with an explicit emphasis on premium‑priced products; 2023‑2024 saw a shift toward **price‑driven growth and mix optimization**—net sales were essentially flat, but margin improved as higher pricing and a larger share of premium Tampax variants offset modest volume declines, while the company continued to treat Tampax as a core growth driver within the segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of the core evolution of Tampax's positioning, particularly regarding category classification and structural changes in P&G’s segment reporting. The ground truth shows a clear reclassification from 'Feminine Care' to 'Menstrual Care' in 2023 and the removal of 'Baby Care' in 2024, but the LLM incorrectly states that Tampax remained under 'Feminine Care' throughout all three years, missing this key evolution entirely. Additionally, the LLM introduces unsupported claims about Tampax having a '≈25% global share' and being a 'market-share leader', which are not in the original answer and lack grounding in the provided truth. The mention of 'price-driven growth and mix optimization' and 'margin improved' is speculative and not supported by the knowledge graph. (2) Quantitatively, the LLM invents a 25% global market share figure not present in the original answer; the 25% and 24% figures in the truth refer to segment-level net sales contribution, not Tampax's market share. The LLM confuses segment sales percentages (25% in 2022, 24% in 2023–2024) with brand-level market share, which is a critical factual error. No actual financial figures for Tampax itself are provided in the truth, so the LLM’s assertions about pricing, volume, and margin are unfounded. (3) The multi-hop reasoning is flawed: the question asks for evolution in category classification and product line emphasis, which requires tracking changes in segment structure and sub-category naming across years. The LLM fails to identify the rebranding from 'Feminine Care' to 'Menstrual Care' in 2023 and the removal of 'Baby Care' in 2024—key strategic shifts. Instead, it fabricates a narrative around pricing and product mix not present in the ground truth. (4) The contextual relevance is moderate because the answer discusses Tampax within the correct overall segment and addresses changes over time, but it misses the actual structural and classification changes that were central to the question. The focus on pricing and margins, while potentially relevant in another context, is not supported by the provided data and distracts from the actual evolution in portfolio positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 594,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s net derivative assets (liabilities) grew from about $31 million to $58 million and then to $69 million. The fair‑value measurement remained a discounted‑cash‑flow model, and the primary unobservable input—swap rates—narrowed from a 3‑5 % range (weighted average ≈ 4 %) in 2023 to a single 4 % estimate in 2024; default‑rate assumptions were incorporated in the DCF but were not separately disclosed for the derivatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's net derivative assets (liabilities) fair value was $19 million in 2022, not $31 million as stated. In 2023 and 2024, the value was $58 million in both years, but the LLM incorrectly reports $58 million in 2023 and $69 million in 2024. These quantitative errors severely undermine the answer's correctness. (2) The valuation technique in 2022 was not disclosed in the original answer, but the LLM claims it remained a discounted cash flow (DCF) model throughout, which is unsupported for 2022. Additionally, the LLM states that swap rates narrowed from a 3–5% range to a single 4% estimate in 2024, but the ground truth indicates the 3–5% range was maintained in 2024. The LLM also claims default rates were not separately disclosed, contradicting the original answer which explicitly lists default rates of 53–163% in 2023. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the shift in transparency starting in 2023, misrepresents the evolution of inputs, and invents a narrowing of swap rates and growth in derivative values not present in the data. (4) While the answer addresses the general topic and attempts to discuss valuation models and inputs, the numerous factual and numerical errors—especially in core financial figures and input ranges—result in a low correctness score. Contextual relevance is moderate because the structure and intent align with the question, but accuracy is poor.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 421,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "\nCisco’s available‑for‑sale (AFS) debt securities moved from a modest $9 million gain in fiscal 2022 to losses of $21 million in fiscal 2023 and $67 million in fiscal 2024, driving the overall “other income (loss), net” line from a $392 million gain in 2022 to $(306) million in 2024. This shift shows that the AFS portfolio, once a small source of earnings, increasingly generated negative contributions and highlighted rising credit‑ and interest‑rate‑related risks in Cisco’s investment holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that no specific performance metrics were provided for AFS debt investments in fiscal 2022, meaning there is no disclosed gain or loss (e.g., $9 million gain) for that year. However, the LLM asserts precise figures—$9M gain in 2022, $21M loss in 2023, $67M loss in 2024—which are not supported by the original answer and contradict the absence of disclosed data in 2022. Additionally, the claim that 'other income (loss), net' declined from $392M in 2022 to $(306)M in 2024 is unsupported; the original answer does not provide these specific totals. (2) Quantitative accuracy is very low because all cited dollar amounts are fabricated or misattributed. There are no numbers in the ground truth for 2022, and while 2023 and 2024 show negative impacts, they are described qualitatively (e.g., 'higher losses') without exact figures. The LLM invents precise numbers and performs calculations based on them (e.g., implying a $700M swing in other income), which cannot be verified and are inconsistent with the source. (3) The multi-hop reasoning is partially sound in structure—linking AFS investment performance to 'other income (loss), net' and interpreting increasing risk over time—but it fails because it builds on false quantitative premises. The conclusion about rising risks aligns with the original answer, but the path to that conclusion is flawed. (4) Contextual relevance is moderate: the LLM addresses the right metric, time frame, and direction of impact (negative trend), and attempts to interpret financial risk, which matches the question's intent. However, due to significant factual and numerical inaccuracies, the answer misrepresents the actual disclosures and undermines reliability. The core issue is fabrication of data not present in the source, leading to a low correctness score despite some alignment in narrative flow and topic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 529,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "\nStarbucks’ green‑coffee outlook tightened over the three years. In its 2022 filing the company said fixed‑price and price‑to‑fixed purchase commitments, backed by inventory, would keep supply adequate through **fiscal 2025**. By the 2023 filing the horizon had shifted to cover only through **fiscal 2023**, reflecting the nearer‑term nature of the commitments as the prior multi‑year plan expired. The 2024 filing again reaffirmed a **through‑fiscal 2025** outlook, underscoring the continued use of forward contracts, hedges and diversified sourcing to protect against commodity volatility and supply disruptions. This progression shows that Starbucks manages coffee‑supply risk through long‑term contractual commitments and active hedging, while periodically refreshing the horizon to align with market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in fiscal 2022, Starbucks projected supply adequacy through fiscal 2023. However, the LLM incorrectly states that in 2022, supply was adequate through fiscal 2025. Then, the LLM claims that by the 2023 filing, the outlook narrowed to only through fiscal 2023—this is backwards: the actual trend was an extension from 2023 to 2025, not a contraction. The LLM says the 2023 filing reduced the horizon, but in reality, the company extended it. Only the 2024 reaffirmation of adequacy through 2025 aligns with the truth, but this is inconsistent with the prior incorrect timeline. (2) The dates and timeframes are completely reversed: the progression should show increasing confidence (through 2023 → through 2025), but the LLM describes a tightening and then recovery, which contradicts the ground truth. No calculations are involved, but the temporal logic is broken. (3) The multi-hop reasoning fails: the model does not correctly synthesize the year-over-year evolution of Starbucks’ supply projections. It misattributes the timing of commitments and misrepresents the strategic trend. The conclusion about using long-term contracts and hedging has some plausibility, but it is based on incorrect premises. (4) The contextual relevance is moderate because the answer discusses sourcing strategy and risk mitigation, which are relevant, but the factual foundation is so flawed that the reasoning is invalid. Hence, correctness and quantitative accuracy are very low; qualitative accuracy is slightly higher due to appropriate use of sourcing-related concepts, but still poor due to incorrect synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 465,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "\nThe 2.00 % Notes Due 2031 have a net carrying amount of roughly **$1.25 billion** as of the end of fiscal 2024 (Jan 28, 2024) and again in fiscal 2025 (Jan 26, 2025), up from a **$1.05 billion** fair‑value level reported at the close of fiscal 2022 (Jan 29, 2023).  At the same time the company retired its near‑term 0.309 % 2023 and 0.584 % 2024 notes and issued new senior unsecured debt maturing in 2031 and beyond, deliberately extending the maturity profile of its long‑term financing.  This shift shows that NVIDIA is managing its debt by **locking in longer‑dated, low‑coupon capital** and reducing rollover risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1,200 million in fiscal 2022, decreased to $1,044 million in 2023, and increased to $1,250 million in 2024. The LLM incorrectly states that the amount was $1.05 billion (i.e., $1,050 million) at the end of fiscal 2022, which is close but not exact, and omits the 2023 value entirely. More critically, it claims the amount was $1.25 billion in both 2024 and 2025, but the ground truth does not include any data for fiscal 2025, making that claim unsupported. Additionally, the LLM refers to 'fair-value level' in 2022 but the ground truth does not specify valuation method, creating a potential mismatch. (2) The calculation and trend analysis are flawed: the ground truth shows a dip in 2023 followed by a rise in 2024, but the LLM implies a steady increase from 2022 to 2024, missing the intermediate decrease. This misrepresents the trend. (3) The qualitative reasoning about NVIDIA extending maturities and reducing rollover risk by issuing long-term, low-coupon debt is plausible and aligns with the general interpretation of such a strategy, even though this specific inference is not in the ground truth. The mention of retiring 2023 and 2024 notes adds context not in the original answer but may be consistent with broader filing data. However, this extra information is not directly responsive to the question about the evolution of exposure to the 2031 notes specifically. (4) The contextual relevance is high because the answer addresses the financial exposure trend and interprets it in terms of long-term debt strategy. However, the correctness score is reduced due to key numerical inaccuracies and omission of the 2023 figure, which breaks the multi-hop synthesis required across 2022–2024. While the final 2024 number ($1.25 billion) matches the ground truth ($1,250 million), the earlier discrepancies and the unsupported 2025 claim undermine full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 547,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "\nFrom 2022 through 2024, fall‑protection solutions stayed inside the Safety & Industrial segment but were moved out of the generic “Personal Safety” bucket and into the newly created **Industrial Specialties** division in 2024.  This re‑classification gave fall‑protection its own sub‑segment alongside adhesives, tapes and other specialty items, signalling a more pronounced strategic focus on industrial‑specialty safety products relative to the broader safety‑and‑industrial portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in its description of MMM's organizational changes, despite being contextually relevant and free of numerical errors. (1) The claim that Fall Protection Solutions were moved into a newly created 'Industrial Specialties' division in 2024 is incorrect according to the ground truth; there is no mention of such a formal reclassification or new division. Instead, the original answer notes only a 'slightly revised grouping' with closer alignment to industrial safety systems, not a structural shift into a new sub-segment. (2) The LLM incorrectly states that fall protection was moved 'out of the generic Personal Safety bucket'—the ground truth does not mention a 'Personal Safety' category in any year, nor does it support the idea of a formal bucket reorganization. (3) The assertion that fall protection gained 'its own sub-segment' contradicts the original answer, which emphasizes a lack of standalone highlighting and a more integrated presentation within broader industrial specialties. (4) While the LLM captures the general trend of increasing strategic emphasis on industrial specialties, this interpretation overstates the evidence. The original answer describes a subtle shift in presentation and framing, not a structural reorganization. The reasoning is therefore flawed in its multi-hop synthesis: it infers organizational changes not present in the source data. However, all dates (2022–2024) and the overarching segment (Safety & Industrial) are correctly identified, and there are no quantitative errors (no numbers involved). The answer is relevant to the question’s focus on evolution in positioning, but the qualitative inaccuracy in entity relationships and product categorization severely undermines factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 486,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "\nIn 2022 Lilly generated roughly $2.0 billion from bamlanivimab (about $2.01 billion in the U.S. and $14.7 million abroad); by 2023 and 2024 that revenue was essentially $0. The sharp drop shows that Lilly’s reliance on its COVID‑19 antibody portfolio has dramatically receded, making the portfolio only a trivial contributor to overall sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly states that Eli Lilly's revenue from bamlanivimab was approximately $2.01 billion in 2022 (with a breakdown of $2.01 billion in the U.S. and $14.7 million internationally, totaling ~$2.0257 billion, which rounds to the correct overall figure), and dropped to $0 in both 2023 and 2024. This matches the ground truth exactly in terms of trend and magnitude. The minor discrepancy in the total (attributing $2.0B to global revenue while breaking it into slightly higher components) is negligible and likely due to rounding; it does not affect factual accuracy. 2) All numbers and years are correct: $2.01 billion in 2022, $0 in 2023 and 2024. The LLM even provides additional granularity (U.S. vs. international) not in the original answer, which enhances precision. 3) The reasoning correctly infers that the sharp decline indicates reduced reliance on the COVID-19 antibody portfolio, aligning with the ground truth’s conclusion about waning demand and maturation of the pandemic response. The term 'trivial contributor' is a valid qualitative interpretation of $0 revenue. 4) The answer fully addresses both parts of the question: the revenue evolution (multi-year trend) and what it indicates about reliance on the portfolio. Synthesis across time and implications is sound. Only a minor deduction in qualitative accuracy due to slight over-precision in the international/U.S. split (not contradicted by ground truth but not verifiable), but overall reasoning is strong. Semantic equivalence is maintained, and contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 429,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks moved from short‑term hedging and purchase commitments that were projected to cover only through fiscal 2023 (2022 10‑K p. 12) to an explicit program that secures green‑coffee supply with fixed‑price and price‑to‑be‑fixed contracts and related forward, futures and collar hedges that are now expected to be adequate through fiscal 2025 (2024 10‑K pp. 6, 12).  This extension reflects a deliberate risk‑management strategy that locks in supply and uses commodity‑index‑fund‑linked futures and collars to blunt coffee‑price volatility and protect the company’s supply chain as market swings intensify.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Starbucks' evolving exposure to commodity index funds and the use of financial instruments like futures, forwards, and collars across fiscal years 2022–2024. The key progression—from securing supply through fiscal 2023 (as stated in the 2022 10-K) to adequacy through fiscal 2025 (per the 2024 10-K)—is accurately captured with correct page references, demonstrating proper sourcing. (2) There are no numeric inaccuracies; all fiscal years and time horizons (2022 to 2025) are correctly stated. The mention of 'fixed-price and price-to-be-fixed contracts' and hedging tools matches the original answer’s emphasis on forward contracts and collars. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports to show a strategic shift in risk management, correctly inferring that extending supply visibility reflects improved resilience. The only minor shortcoming is that the LLM does not explicitly reiterate that commodity index funds continued to influence price volatility throughout all three years—an element emphasized in the ground truth—though it is implied by referencing ongoing use of volatility-linked hedges. (4) The answer is fully contextually relevant, directly addressing both the evolution of exposure and what it reveals about risk management strategy. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the original answer with only slight omission of emphasis on persistent index fund influence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 436,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "\nFrom 2022 through 2024 Google kept using Google Ad Manager as the core platform for selling impression‑based ads on its Network partners, refining the way it counts impressions and cost‑per‑impression and continuing to record those revenues on a gross (principal) basis.  In January 2023 the company reassessed the useful lives of its servers and network equipment—extending them from four‑five years to six years— which reduced depreciation expense by roughly $3.9 bn in 2023 and lifted net income by about $3 bn, a one‑time boost to profitability that reflects the longer‑life accounting shift.  Because the new six‑year schedule lowers the ongoing depreciation burden on the infrastructure that supports Ad Manager, Google can sustain higher margins from impression‑based advertising even as capital spending rises in 2024, improving the long‑term profitability outlook of that business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google Ad Manager remained central to impression-based monetization from 2022–2024; in 2023, Google extended server depreciation from 4 to 6 years and network equipment from 5 to 6 years; this reduced depreciation by $3.9 billion and increased net income by $3.0 billion. These numbers match the original answer exactly, satisfying quantitative accuracy. (2) The LLM correctly identifies the impact of lower depreciation on infrastructure costs supporting Ad Manager and links it to improved long-term profitability, which reflects sound multi-hop reasoning across financial policy changes and advertising operations. (3) The answer captures the continuation of gross revenue reporting in 2024, though it does not explicitly state that this reinforces Ad Manager’s strategic importance—this minor omission prevents a perfect qualitative score. (4) Wording differs (e.g., 'one-time boost' vs 'change that directly affected'), but semantic meaning is equivalent. The LLM synthesizes infrastructure accounting changes with advertising profitability logically, demonstrating strong contextual relevance and factual correctness. Minor deduction in qualitative accuracy due to slightly less explicit emphasis on the multi-year optimization trend mentioned in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 379,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "\nUnder the 2019 Long‑Term Incentive Plan, BK has issued a new version of its Performance Share Unit (PSU) agreement each year from 2022 through 2024 (Exhibits 10.21, 10.26 and 10.29 in the 2022, 2023 and 2024 10‑K filings). The 2022 PSU agreement established the initial performance metrics and target payout for the 2022‑2023 performance cycle, the 2023 amendment refined those metrics and thresholds for the 2023‑2024 cycle, and the 2024 PSU agreement further adjusts the criteria and target levels to reflect the latest strategic priorities. This progressive updating demonstrates that BK’s executive compensation strategy centers on performance‑driven, long‑term equity incentives that are regularly recalibrated to align pay with measurable corporate outcomes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right question and demonstrating relevant reasoning structure. (1) Quantitative and entity inaccuracies: The LLM claims BK issued PSU agreements in 2022, 2023, and 2024 with exhibit numbers 10.21, 10.26, and 10.29, respectively. However, the ground truth states that in 2022, BK referenced the 2021 PSU agreement (Exhibit 10.45), in 2023 re-filed the 2019 plan (Exhibit 10.14), and in 2024 included the 2022 PSU agreement (Exhibit 10.18). The LLM incorrectly asserts annual new issuances and cites non-matching exhibit numbers, which are critical errors in document-based SEC analysis. (2) The timeline of agreements is misrepresented: the ground truth shows BK reused or referenced prior agreements rather than issuing new ones each year, indicating a more conservative, adaptive approach rather than active annual amendments. (3) Reasoning: While the LLM correctly infers that iterative updates reflect alignment of pay with performance, this conclusion is based on fabricated evidence. The actual progression—referencing old agreements and re-filing the base plan—suggests stability and reaffirmation, not active recalibration. (4) Contextual Relevance is high because the answer addresses executive compensation strategy and attempts multi-hop synthesis across years. However, due to incorrect exhibits, dates, and issuance claims, the factual foundation is flawed. Minor flexibility is allowed in wording, but exhibit numbers and years are precise identifiers and cannot be misstated. Thus, while the strategic interpretation is plausible, it is not supported by the actual data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 460,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 filings the Safety and Industrial segment kept the same core phrasing – “electrical products and materials for construction and maintenance, power distribution and electrical original‑equipment manufacturers (OEMs)” (see pages 13 & 107) – but in 2024 the segment was re‑structured with the creation of an “Industrial Specialties” division that bundles former closure, masking, adhesive‑tape and personal‑safety products (pages 110, 138).  This added granularity and separate categorization signals that 3M is deliberately sharpening its focus on electrical OEM markets, treating them as a distinct growth pillar within Safety and Industrial.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of 3M's product descriptions in the Safety and Industrial segment. The ground truth states that in 2022, electrical products were described as serving 'construction and maintenance, power distribution and electrical OEMs'; in 2023, the term was refined to 'electrical original equipment manufacturers (OEMs)'; and in 2024, it evolved to 'power distribution and electrical original equipment manufacturers (OEMs)'. However, the LLM claims the phrasing remained 'the same core' across all years, which directly contradicts the documented evolution. Additionally, the LLM introduces a structural change in 2024—the creation of an 'Industrial Specialties' division—which is not mentioned in the original answer and appears to be either misattributed or incorrectly inferred. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond correct year references (2022–2024), which are accurate. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the linguistic evolution in product categorization across the three years, which is central to the question. Instead, it focuses on a reorganization that is not supported by the ground truth, suggesting a failure to synthesize the correct information from the filings. (4) While the conclusion about increasing focus on electrical OEM markets aligns with the original answer’s interpretation, the reasoning is based on incorrect premises. The contextual relevance is moderate because the answer addresses the right segment and general strategic focus, but the factual foundation is weak, undermining the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 476,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "\nCapital One’s fixed unsecured senior debt grew from about **$24.1 bn in 2022** (weighted‑average rate ≈ 4.45 %) to **$27.2 bn in 2023** (weighted‑average rate ≈ 4.84 %), and then edged down to **$26.9 bn in 2024** while the rate stayed near **4.84 %**. This multi‑year pattern shows the firm deliberately expanded long‑term, fixed‑rate funding to support portfolio growth, then modestly reduced the balance in 2024 to fine‑tune leverage and lock in relatively low‑cost debt amid a shifting interest‑rate environment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's fixed unsecured senior debt carrying value was $19,975 million in 2022, not $24.1 billion as stated in the LLM answer. The 2023 value is close ($27,168M vs $27.2B), and 2024 is accurate ($26,930M vs $26.9B). However, the interest rates are completely incorrect: the LLM claims ~4.45% in 2022 and ~4.84% in 2023, while the truth shows 2.91% in 2022, 4.45% in 2023, and 4.84% in 2024. The LLM misattributes the 2023 rate to 2022 and fails to show the correct progression. (2) Calculations: The year-over-year changes in both carrying value and interest rate are misrepresented due to incorrect base values. The rate increase from 2.91% to 4.84% over three years reflects a meaningful trend in response to rising rates, which the LLM obscures by starting at 4.45%. (3) Multi-hop reasoning: While the LLM correctly identifies the slight decline in 2024 and attempts to interpret the strategy, its reasoning is based on flawed data. The conclusion about 'locking in relatively low-cost debt' contradicts the ground truth, which shows steadily increasing rates—indicating debt was locked in at *higher*, not lower, costs over time. (4) Despite incorrect numbers, the answer addresses all parts of the question (evolution across years, carrying value, rate, and strategic implication), and the general direction of growth followed by a small reduction is correct. The strategic interpretation has partial merit but is weakened by factual errors. Hence, correctness and quantitative accuracy are penalized heavily, while qualitative reasoning and contextual relevance remain moderate to high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 465,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "\nNVIDIA’s 3.50 % Notes Due 2040 were carried at a fair‑value of roughly **$1.07 billion at the end of FY 2022**, slipped to **$870 million by FY 2023** and to **$851 million by FY 2024**, mirroring the drop in market prices as interest rates rose.  The company continued to report the notes at their amortized cost (≈ $1 billion in FY 2025) and has not retired or refinanced them, indicating a deliberate long‑term debt strategy that relies on fixed‑rate, low‑coupon senior debt to fund growth while preserving cash and maintaining a stable capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and timeline. According to the ground truth, the fair value was $1,066 million in FY2022, $851 million in FY2023, and in FY2024, NVIDIA stopped reporting fair value and instead reported a carrying amount of $1,000 million. The LLM incorrectly states the FY2022 value as $1.07 billion (close but rounded up from $1,066M), but then reports $870 million for FY2023 (incorrect—should be $851M), and incorrectly claims $851 million as the FY2024 fair value. In reality, no fair value was reported in FY2024; instead, a carrying amount of $1,000 million was disclosed. The LLM also incorrectly references 'FY2025' (which is not part of the question or data), introducing a non-existent time point. (2) Calculations are not required here, but tracking values over time is central. The LLM misrepresents the progression by continuing to report fair value in FY2024 when the company had switched to carrying amount, which is a significant accounting change that the model fails to accurately capture. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic use of fixed-rate debt and connects rising interest rates to declining fair values. It also correctly notes that the debt was not retired or refinanced. However, it misses the key shift in accounting treatment from fair value to carrying amount in FY2024, which is central to the original answer’s conclusion about evolving debt management strategy. Instead, it incorrectly extends fair value reporting into FY2024. (4) The contextual relevance is high—the answer addresses valuation evolution and long-term strategy. Qualitative accuracy is moderate due to correct general reasoning about debt strategy but flawed entity/timing details. Quantitative accuracy is low due to incorrect figures and misattribution of values across years. Correctness score is 5 due to partial factual alignment but significant errors in key financial data and timeline representation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 541,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "\nThe 2017 $17 billion unsecured senior notes were still outstanding at the end of 2022 with a recorded balance of **$16 billion** (Note 6 – Debt, page 62).  By the end of 2023 the balance had been reduced to **$15 billion** (page 62), and the 2024 filing shows it down further to **$13 billion** (page 65).  \n\nThis steady decline—from $16 bn → $15 bn → $13 bn—indicates that Amazon is deliberately retiring a portion of the 2017 tranche, using operating cash and targeted refinancing to lower its overall debt load and interest‑expense outlook.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. Minor formatting difference ($16 billion vs $16.0 billion) is acceptable under semantic equivalence. 2) All numbers are accurate and consistent with the original answer; no calculation errors. The reduction trajectory (16→15→13) is correctly presented. 3) The reasoning is sound: the LLM identifies the consistent decline and infers a deliberate debt retirement strategy, aligning with the ground truth's conclusion. It adds contextual detail—'using operating cash and targeted refinancing'—which is plausible and consistent with Amazon's typical debt management but not explicitly confirmed in the ground truth. This slight elaboration does not contradict facts but introduces assumptions not present in the original, slightly reducing qualitative accuracy. 4) The answer fully addresses both parts of the question: the evolution of the balance and the implied strategy. Entity accuracy (Amazon, 2017 Notes, years 2022–2024) is perfect. Synthesis across years is correct and well-supported. Overall, the answer is factually excellent with only minor, acceptable over-elaboration in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 359,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "\nApple’s repeated disclosure of “Floating Rate Notes due 2019” in the 2022, 2023 and 2024 filings (see the officer’s certificate on page 56 of the 2024 10‑K and the same reference in the earlier filings) shows that the company still holds short‑term, floating‑rate debt whose interest resets with market rates. Because those notes are floating, any rise in benchmark rates will automatically increase the interest cost on that portion of Apple’s debt, adding to its overall interest expense – the company’s own sensitivity analysis indicates that a 100‑basis‑point rate increase would raise annual interest expense on its term debt by roughly $140 million, so a rising‑rate environment would directly boost Apple’s financing costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea that Apple's repeated disclosure of Floating Rate Notes due 2019 in its 2022–2024 filings suggests ongoing exposure to floating-rate debt, and correctly links this to increased interest expense sensitivity in a rising rate environment. However, it contains a significant factual inaccuracy: the claim that Apple 'still holds' these notes is misleading. The ground truth clarifies that the notes matured in 2019 and their inclusion is due to incorporation by reference of the 2014 Officer's Certificate, not active outstanding obligations. This misrepresents the nature of the exposure—disclosure obligation vs. current debt holding. The $140 million figure cited for a 100-basis-point increase is not present in the original answer and cannot be verified from the provided ground truth; thus, it introduces unverified quantitative data, reducing quantitative accuracy. While the reasoning about floating-rate sensitivity is sound, the failure to distinguish between historical disclosure mechanics and current debt holdings undermines the qualitative accuracy. The answer is contextually relevant and addresses both parts of the question—exposure and interest sensitivity—but with incorrect underpinning facts. Semantic equivalence is partially achieved, but key factual nuance is lost.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 367,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "\nThe Pixel line shifted from a modest, experimental hardware effort in 2022 – where device sales were a tiny slice of Google’s total revenue and R&D spend was spread across many early‑stage projects – to a more focused, AI‑centric roadmap by 2024, with the portfolio expanding (Pixel 5a/6, Nest Cams, Fitbit) and R&D and capital outlays increasingly tied to Pixel‑related hardware (see the “Google Subscriptions, Platforms, and Devices” discussion on p. 33 (2023) and the device‑revenue description on p. 5 (2022) and p. 57‑58 (2024)).  Consequently, device revenue grew from a low‑single‑digit percentage of total Google revenue in 2022 to a mid‑single‑digit share by 2024, while the company’s investment focus moved from generic hardware R&D to targeted, ecosystem‑lock‑in initiatives that showcase AI and cloud integration.  This progression signals that Google is treating the Pixel family as a strategic, long‑term growth pillar rather than a peripheral side‑business, using hardware to deepen user engagement with its AI and cloud services and to build a durable hardware presence in the market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Google's Pixel strategy from 2022 to 2024 with strong qualitative reasoning and contextual relevance. It correctly identifies the shift from experimental investment to a more strategic, AI-centric focus and acknowledges the Pixel line’s growing role in Google’s hardware ecosystem. However, there are notable quantitative inaccuracies: the claim that device revenue grew from a 'low-single-digit percentage' to a 'mid-single-digit share' of total revenue is not supported by the ground truth, which does not provide specific revenue percentages for 2022 or 2024. The original answer only states that Pixel became a distinct and measurable revenue stream under 'devices' in 2023 and 2024, without quantifying its share of total revenue. Additionally, the LLM introduces Nest Cams and Fitbit as part of the Pixel family, which is factually incorrect—these are separate product lines and not part of the Pixel family. The mention of specific page numbers (e.g., p. 33, p. 5, p. 57–58) also lacks verification from the ground truth, which does not reference such pages. Despite these issues, the answer correctly infers the strategic intent behind the shift—using Pixel to drive AI and cloud integration—and accurately reflects the maturation of the product line into a core revenue category. The multi-hop reasoning is sound in structure but based on some incorrect entity associations and unsupported numerical claims, which limits factual correctness. Semantic equivalence is partially achieved, but not fully due to the invented metrics and product scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 436,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "\nFrom 2022 through 2024 the pool of client securities that Schwab can pledge grew sharply – the “available‑to‑pledge” balance rose from roughly $120 bn (2021) to about $130‑140 bn in the latest filings – and the amount actually pledged stayed near $31‑35 bn, with a larger share used for OCC margin, client‑short‑sale collateral and short‑term borrowings.  At the same time the company’s securities‑lending book expanded (gross securities loaned ≈ $7 bn in 2021 and $7.5 bn in 2020, with collateral monitoring and rehypothecation disclosed), showing that Schwab is deliberately re‑using client collateral to meet margin‑lending requirements, fund short‑term liquidity and generate lending revenue.  This trend indicates that Schwab’s collateral‑management strategy is to maximize the utility of client‑held securities as a low‑cost source of funding and clearing‑house margin, while maintaining a sizable un‑pledged buffer to preserve flexibility and regulatory compliance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, which are not supported by the ground truth. (1) The ground truth does not provide any specific dollar values for pledged or available-to-pledge securities in 2022, 2023, or 2024, but the LLM asserts precise figures such as $120B (2021), $130–140B (2024), and $31–35B pledged—these numbers are fabricated or misattributed. (2) The LLM references data from 2020 and 2021 (e.g., $7.5B in 2020, $7B in 2021), which are outside the requested 2022–2024 timeframe and not mentioned in the original answer. (3) While the LLM correctly identifies the use of client securities for margin lending, securities lending, and OCC margin requirements by 2024, this is partially aligned with the ground truth, but the reasoning is built on false numerical foundations. (4) The qualitative insight about a strategy to maximize utility of client collateral has some semantic overlap with the ground truth’s conclusion about growing reliance for capital efficiency, but the LLM introduces unsupported concepts like 'short-term borrowings' and 'rehypothecation' not present in the original. (5) Multi-hop reasoning is attempted—linking margin lending, securities lending, and collateral use over time—but fails due to incorrect inputs. The answer is contextually relevant in structure and intent but lacks factual grounding, especially in numbers and timeframes, severely undermining correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 404,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 GE moved from occasional joint filings of long‑term‑care premium‑rate increases with the primary carriers to a systematic, quarterly updating of the net‑premium ratio and locked‑in cash‑flow assumptions that is reflected in the reserve adjustments reported on pages 20‑22 of the 2024 10‑K and the 2023 10‑K.  Each year the company “often collaborates with the primary insurers … to file proposed premium‑rate increases” and then locks those assumptions into reserves, adjusting them retroactively when experience deviates.  This progression shows that GE’s run‑off reinsurance risk‑management strategy relies on close partnership and continuous experience monitoring to lock‑in and periodically refresh its reserve assumptions, thereby containing volatility in reserve levels and capital requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of GE's evolving collaboration with primary insurers on long-term care premium rate increases and correctly identifies the increasing emphasis on collaboration from 2022 to 2024. However, it introduces specific details not present in the ground truth, notably the 'systematic, quarterly updating of the net-premium ratio and locked-in cash-flow assumptions' and references to 'pages 20-22 of the 2024 10-K and 2023 10-K', which are not mentioned or supported in the original answer. These additions imply a level of procedural regularity and documentation specificity that the ground truth does not confirm. While the original answer notes a progression toward more structured collaboration—formalized under reinsurance contracts in 2023 and reinforced with use of experience data in 2024—the LLM overreaches by asserting a quarterly process and direct linkage to reserve adjustments in specific 10-K pages, which constitutes a factual overstatement. The core idea of proactive risk management through tighter integration is semantically aligned, but the LLM's characterization of the mechanism (e.g., 'locked-in' assumptions, retroactive adjustments) goes beyond the source. There are no explicit numerical values to verify, so quantitative accuracy is assessed on structural precision (e.g., timeframes, processes), where the answer is partially accurate but contains unsupported specifics. The reasoning is logically coherent and contextually relevant, showing understanding of run-off reinsurance risk management objectives, but the qualitative accuracy is reduced due to unverified procedural claims. Overall, the answer reflects a plausible interpretation but includes speculative details, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 481,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "\nCVS trimmed its residential‑mortgage‑backed‑securities (RMBS) book from roughly **$721 million** in fair‑value (with **$89 million** of unrealized losses) at the end of 2022 to about **$614 million** (unrealized loss **$60 million**) by the end of 2023; the separate‑account portfolio held only **$71 million** of RMBS at the end of 2024.  This steady decline shows that the company is deliberately **de‑risking its structured‑credit exposure**, moving away from low‑yield, rate‑sensitive RMBS toward higher‑quality, shorter‑duration assets and thereby reducing its interest‑rate and credit‑risk footprint in the portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2024 RMBS exposure value. The ground truth states CVS's RMBS exposure increased to $714 million in 2024, not $71 million as claimed by the LLM. The LLM incorrectly reports $71 million, which is off by an order of magnitude. The 2022 ($721M) and 2023 ($614M) values are correct. (2) The LLM introduces additional details not in the ground truth—specifically unrealized losses of $89M in 2022 and $60M in 2023—which, while plausible, are not confirmed in the original answer and may be hallucinated. More critically, the 2024 figure is wrong: $71M vs. correct $714M, making quantitative accuracy severely compromised. (3) The reasoning is partially sound in interpreting a de-risking trend from 2022 to 2023, but the conclusion of a 'steady decline' contradicts the ground truth, which notes a rebound in 2024 (from $614M to $714M), indicating strategic rebalancing, not continued reduction. The LLM fails this multi-hop synthesis by misrepresenting the 3-year trend. (4) Contextual relevance is high—the answer addresses RMBS exposure, risk positioning, and structured credit—but correctness is undermined by the major numerical error in 2024 and unsupported details. The qualitative analysis is reasonable but based on incorrect data, leading to an inaccurate overall interpretation of CVS's risk strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 383,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "\nFrom 2022 to 2024 Capital One’s short‑term borrowings fell sharply from **$883 million** to **$538 million** in 2023 and then edged up modestly to **$562 million** in 2024, while its long‑term debt peaked at **$49.3 billion** in 2023 before declining to **$45.0 billion** in 2024.  This three‑year trajectory shows the firm deliberately trimmed leverage—relying more on its large deposit base and retained cash, and using excess liquidity to retire higher‑cost or maturing debt—resulting in a leaner capital structure and a stronger liquidity buffer.  The modest rebound in short‑term borrowings in 2024 suggests the company is maintaining a small, flexible wholesale funding line while continuing to manage overall debt levels prudently.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that COF's total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. However, the LLM incorrectly reports short-term borrowings as $883M, $538M, and $562M—values that are off by nearly an order of magnitude and not consistent with the total debt figures. It also reports long-term debt as $49.3B and $45.0B, which are close but still inaccurate (missing $0.556B in 2023 and $0.551B in 2024). More critically, the LLM fails to report the correct total debt figures by combining short-term and long-term components, instead treating them separately with incorrect values. (2) The calculation of total debt is incorrect: for example, in 2022, the LLM implies total debt of ~$883M + X (unreported), whereas the correct total is $43.086B. The trend direction (increase then decrease) is correct, but the magnitude and composition are wrong. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic deleveraging trend in 2024 and links it to liquidity management—but it misses critical insights from the ground truth, such as the rise in weighted-average interest rates from 2.76% to 4.84% and the elimination of floating unsecured senior debt by 2024. These omissions weaken the qualitative analysis. (4) The entity (COF/Capital One) and time frame (2022–2024) are correct, and the general narrative of debt reduction after a peak is directionally accurate, which supports a moderate contextual relevance score. However, due to major quantitative errors and missing key financial metrics, the overall correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 467,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the $3.50 % Notes Due 2050 stayed on NVIDIA’s balance sheet at a constant $2 billion carrying amount (the $2 bn figure is shown in the 2024‑2025 maturity schedule on page 70 and was unchanged from the prior year).  Market‑value disclosures (page 88) reflect that the fair value of the issue fell from roughly $2.3 bn in early 2021 to $2.15 bn by the end of fiscal 2022, but thereafter the book‑value remained steady at $2 bn through 2023 and 2024 with no repayments or additional issuances noted.  \n\nThis stability indicates that NVIDIA is deliberately maintaining a sizable, fixed‑rate, long‑dated debt tranche as a permanent component of its capital structure, using it to lock in low‑cost financing while relying on other sources (e.g., commercial paper, equity) for short‑term funding.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with an intermediate value of $1,637 million in fiscal 2023. The LLM incorrectly states that the carrying amount remained constant at $2 billion throughout the period, which contradicts the verified data. This error undermines the entire response. (2) The numbers provided in the LLM answer ($2 billion constant book value, $2.3 billion and $2.15 billion fair values) do not align with the ground truth figures. While fair value fluctuations may occur, the question specifically asks about the long-term liability (i.e., book value), which the LLM misrepresents as stable when it actually declined significantly. There is no mention of the actual reduction from $2,147M to $1,604M, nor the midpoint value in 2023. (3) The multi-hop reasoning is flawed because the model fails to track the liability trend across the three fiscal years as required. Instead, it asserts stability without supporting evidence from the correct time-series data. The conclusion about a 'permanent component' of capital structure contradicts the ground truth indication of a deliberate reduction in long-dated liabilities. (4) Despite the factual inaccuracies, the answer is contextually relevant—it addresses the right financial instrument, discusses capital structure implications, and references plausible aspects like fixed-rate financing. However, due to major errors in quantitative accuracy and reasoning, the overall correctness score is low. The qualitative reasoning would be stronger if based on accurate data, hence a moderate score there. Contextual relevance is fair because the structure and intent of the answer align with the question, even if the facts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 514,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "\nApple’s 0.45 % Notes due 2016 are mentioned only in the “Officer’s Certificate” (Exhibit 4.3) that was first filed in 2013 and is repeatedly reproduced in the 2022, 2023 and 2024 Form 10‑Ks.  None of the three filings reports a new issuance, amendment or repayment of that tranche – they simply restate the original indenture language and the amount outstanding.  This consistent, unchanged disclosure shows that Apple’s long‑term‑debt strategy is to keep a stable, low‑coupon senior‑unsecured ladder and to disclose the essential terms of legacy notes rather than the details of new borrowing, reflecting a conservative and transparent approach to its capital‑structure reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key details are correct: the 0.45% interest rate, maturity in 2016, and inclusion in the 2022, 2023, and 2024 10-K filings via Exhibit 4.3 (Officer’s Certificate) originally filed in 2013. There are no numerical or date inaccuracies. (2) The answer correctly notes that no new issuance, amendment, or repayment occurred in those years—only restatement of original terms—consistent with the ground truth. (3) The reasoning is sound: the LLM correctly infers that Apple maintains legacy debt disclosures for transparency and legal continuity, interpreting the pattern as part of a conservative, transparent capital structure reporting strategy. This matches the ground truth’s conclusion about disclosure strategy. (4) The only minor gap is that the LLM does not explicitly state that the notes *matured in 2016* (though it implies it by calling them 'legacy' and noting they were issued in 2013), which slightly weakens the completeness of the multi-hop synthesis. However, the core facts, entities, and logic are correct, and the answer captures the essential meaning and implication. Wording differs but is semantically equivalent and slightly more detailed in its interpretation of strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 359,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s total derivative exposure improved markedly: the net liability fell from roughly **$1.35 billion** (assets $1.96 bn vs. liabilities $3.32 bn) in 2022 to about **$0.66 billion** (assets $1.67 bn vs. liabilities $2.34 bn) in 2023, and the Level‑3 portion of that exposure was reduced to **≈ $70 million** by the end of 2024.  The valuation models continued to use observable market swap rates (≈ 4 % with a 3‑5 % range) and modest unobservable inputs such as default rates (~1 %) and loss‑severity ranges (30‑80 %), but weighted‑average yields and prepayment assumptions for its RMBS/CMBS holdings remained largely stable.  This multi‑year progression reflects a deliberate shift toward more market‑driven inputs and a reduction in reliance on highly subjective Level‑3 assumptions, indicating that the firm’s derivative risk has diminished and its modeling assumptions have become increasingly anchored in observable market data.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy and fails to reflect the ground truth data. (1) The numbers provided are completely inconsistent with the original answer: the LLM claims net derivative liabilities of $1.35B in 2022 and $0.66B in 2023, while the ground truth reports net derivative assets (liabilities) at $31M in 2022 and $58M in 2023—over 20x difference. The LLM’s mention of Level-3 exposure at ≈$70M in 2024 does not align with any specific figure in the ground truth, which states a fair value of $58M in both 2023 and 2024. (2) The significant unobservable inputs are misrepresented: the ground truth specifies a shift from 'default' (4%) in 2023 to 'swap rates' (4%) in 2024, but the LLM incorrectly states that swap rates were used throughout and that default rates (~1%) and loss severity were key inputs, which contradicts the source. Additionally, the LLM introduces RMBS/CMBS prepayment assumptions and yield stability not mentioned in the original answer. (3) The reasoning is flawed: the conclusion about reduced reliance on Level-3 assumptions and improved risk management based on shrinking liabilities is unsupported because the core data is wrong. The actual progression shows stable valuation ($31M → $58M → $58M) with a shift in risk driver, not a reduction in exposure. (4) While the LLM attempts to address the evolution of risk inputs and modeling assumptions, it fabricates data and misrepresents the nature of the change. The contextual relevance is moderate because it discusses derivative valuation and risk inputs, but the factual foundation is unsound, leading to an incorrect interpretation of Capital One's risk exposure and modeling evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 464,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "\nNVIDIA’s 1.55 % Notes Due 2028 grew from a $1.2 billion fair‑value amount when the issue was first reflected in the FY 2022 balance sheet (page 88) to a $1.25 billion carrying amount reported at the end of FY 2024 and again in FY 2025 (page 72).  The note’s effective rate of 1.64 % and a remaining maturity of about 3.4 years in FY 2025 show that the company has kept the instrument on its books at roughly the same size, using it as a low‑cost, long‑dated source of senior financing.  This steady‑state exposure reveals a strategy of extending NVIDIA’s debt maturity profile while locking in inexpensive long‑term funding to support ongoing investments and acquisitions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.2 billion exposure in 2022 and $1.25 billion in 2024, which aligns with the ground truth. However, it omits the $1.1 billion value for 2023, which is a significant data point showing a temporary decrease before the increase in 2024. This omission affects completeness and quantitative accuracy. Additionally, the LLM mentions the note being reported again in FY2025, which is outside the requested 2022–2024 scope and not in the original answer. (2) The numbers for 2022 and 2024 are accurate in amount and format ($1.2B and $1.25B), but the missing 2023 figure ($1.1B) constitutes a factual gap. The mention of an effective rate (1.64%) and remaining maturity (3.4 years in FY2025) adds detail not present in the ground truth and may be extraneous or unverified in this context. (3) The reasoning about NVIDIA’s long-term debt strategy—maintaining low-cost, long-dated financing—is logically sound and consistent with the trend, even if the full three-year progression is not fully articulated. The synthesis of stable debt levels supporting strategic capital structure is qualitatively accurate, though slightly overreaching without acknowledging the dip in 2023. (4) The answer remains highly relevant to the question, addressing both the evolution of exposure and strategic implications. However, the omission of the 2023 figure reduces the precision of the multi-hop analysis across the three fiscal years, which is central to the question. Overall, the answer captures the general trend and strategic interpretation but lacks full quantitative fidelity to the three-year progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 450,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "\nFrom 2022 through 2024 the company repeatedly disclosed that it remains exposed to “material trailing legal liabilities” stemming from the Alstom acquisition—particularly legacy anti‑competition and corruption investigations that have generated, and will continue to generate, cash outflows for settlements, judgments and penalties—as well as to ongoing shareholder suits tied to historical financial‑reporting matters; the 2023 and 2024 filings note that reserves have been set but the ultimate loss may exceed those estimates, underscoring the persistence of these contingent liabilities and their potential to materially affect GE’s results of operations and cash flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core factual progression of GE's trailing legal liabilities from 2022 to 2024 as described in the ground truth. It correctly identifies the two key sources of liability: legacy matters from the Alstom acquisition (specifically anti-competition and corruption issues) and shareholder lawsuits tied to historical financial reporting. The answer accurately reflects that these liabilities resulted in ongoing cash outflows and that reserves were set, but potential losses could exceed estimates—highlighting the contingent and persistent nature of the risks. It also correctly notes the material impact on financial results and cash flows, consistent with the original answer. There are no numeric inaccuracies; while no specific dollar amounts are mentioned in either answer, the qualitative financial impact is correctly characterized. The multi-hop reasoning is sound, connecting disclosures across years and linking Alstom legacy issues and shareholder litigation to ongoing financial and operational risks. The only minor shortcoming is that the LLM answer does not explicitly mention the reputational risk component emphasized in the original answer for both 2022 and 2024, nor does it reference 'exited businesses' as a source of contingent liabilities in 2024. However, the core financial and legal substance is preserved with high fidelity. Wording differs but semantic equivalence is strong, and all key entities (GE, Alstom acquisition, shareholder lawsuits, 2022–2024 timeline) are correctly identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 431,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "\nCVS’s hedge‑fund limited‑partnership exposure rose from **$225 million at the end of 2022 to $252 million at the end of 2023** and, based on the 2024 filing, remained essentially unchanged at that level through 2024.  This modest growth—and the fact that the investments are reported only at NAV and excluded from the fair‑value hierarchy—indicates that the company is deliberately expanding its alternative‑asset allocation to boost long‑term pension‑fund returns while keeping the exposure relatively stable and low‑profile.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, CVS's exposure was $214 million in 2022, increased to $225 million in 2023, and further to $252 million in 2024. However, the LLM incorrectly states that exposure was $225 million at the end of 2022 (overstating by $11 million) and claims it remained unchanged at $252 million through 2024, which misrepresents the continued growth into 2024. The correct trend is a consistent year-over-year increase, but the LLM implies stabilization after 2023, which contradicts the ground truth. (2) The dollar amounts and years are misaligned: the $225 million figure belongs to 2023, not 2022, and the 2024 value is omitted as a new high point. This affects the accuracy of the entire temporal analysis. (3) The qualitative reasoning about strategic expansion of alternative investments is partially sound and aligns with the upward trend, but the conclusion that exposure remained 'essentially unchanged' in 2024 undermines the correct inference of ongoing strategic growth. The mention of NAV reporting and exclusion from fair value hierarchy adds detail not in the original answer but does not contradict it; however, it doesn't compensate for the core factual errors. (4) Contextually, the answer addresses the question's intent regarding pension fund strategy, and the general direction of interpretation (gradual expansion of alternatives) is reasonable, but the flawed data leads to an incorrect characterization of the trend in 2024. Thus, while the answer shows relevant reasoning, it fails on key facts required for full correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 449,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "\nIn 2022 the Africa/Eurasia operating profit was roughly **$200 million** (consistent with the $203 million reported for 2021 and $206 million for 2020, indicating a stable but modest contribution). The 2022 Global Productivity Initiative allocated **about 5 % of its $32 million 2023 pretax restructuring charge**—≈ $1½–$2 million—to the region, earmarking those funds for efficiency and cost‑restructuring projects. By 2024 the company **increased its capital spending and depreciation & amortization in the region to $33 million and $8 million respectively**, signalling a shift toward greater investment and asset utilization to drive growth in Africa/Eurasia.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. First, it reports Africa/Eurasia operating profit in 2022 as approximately $200 million, which is close to the ground truth $203 million and acceptable within rounding. However, it incorrectly references 2021 and 2020 figures not mentioned in the original question or ground truth, introducing unsupported data. More seriously, the LLM states that only about 5% of the 2023 restructuring charge—approximately $1.5–$2 million—was allocated to Africa/Eurasia, whereas the ground truth specifies 10% of the total restructuring charges (estimated $20–$24 million) were allocated to the region. This is a major quantitative and qualitative error. Additionally, the LLM claims that depreciation and amortization in 2024 increased to $8 million, but the ground truth states it declined to $8 million from $9 million in prior years; the LLM incorrectly frames this as an increase and falsely claims capital spending rose to $33 million, a figure entirely absent from the ground truth. (2) Number verification: Operating profit (~$200M vs $203M) is acceptable. Restructuring allocation: LLM says ~$1.5–2M (5% of $32M), but ground truth says $20–24M (10% of total charges, implying total charges were $200–240M, not $32M). This suggests the LLM misidentified the total restructuring charge. Depreciation & amortization: LLM says $8M in 2024 (correct amount) but falsely claims it increased, when it actually decreased from $9M. Capital spending of $33M is completely fabricated. (3) Multi-hop reasoning is flawed: The model fails to correctly synthesize the 2022 Global Productivity Initiative’s regional allocation, misrepresents the scale of restructuring, and inverts the trend in depreciation, undermining the conclusion. Instead of reflecting cost optimization with reduced investment, the LLM incorrectly infers a growth investment shift. (4) Correctness score is low due to major factual and directional errors in key financial figures and strategic interpretation. Quantitative accuracy is very poor due to incorrect percentages, totals, and invented figures. Qualitative accuracy suffers from flawed logic and misinterpretation of trends. Contextual relevance is moderate because the answer addresses the right regions, years, and metrics, but with incorrect data and conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 626,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "\nAIG continued to model its international terrorism risk with a third‑party scenario‑based approach, adjusting for model gaps and focusing on New York City; a five‑ton‑bomb scenario net of the TRIPRA program and private reinsurance was estimated at about $1.3 bn as of Oct 2021, and the program relied on limited private reinsurance plus government‑sponsored pools for non‑U.S. exposures.  Its reinsurance protection featured attachment points such as a $150 m retention for Europe/Japan and a $350 m worldwide aggregate limit (e.g., the Validus Re cat‑bond structure), which remained essentially unchanged through 2024.  At the same time, total reinsurance recoverable assets fell sharply from $67.5 bn in 2023 to $38.0 bn in 2024, and the collateral posted to support those recoveries dropped from $70.1 bn to $20.1 bn, reflecting tighter limits and reduced reliance on reinsurer credit.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and contradictions with the ground truth. While it correctly notes AIG's use of third-party scenario-based modeling for international terrorism risk and mentions the $1.3 billion net loss estimate, it incorrectly dates this estimate to October 2021 instead of 2022, misaligning the timeline. The attachment points cited ($150M for Europe/Japan and $350M worldwide aggregate) contradict the ground truth, which states AIG retained core attachment points of $200M in Japan and $125M elsewhere—values not reflected in the LLM response. The claim about a 'Validus Re cat-bond structure' and a $350M worldwide limit is unsupported by the original answer and introduces unverified specifics. (2) The most significant quantitative error is the claim that reinsurance recoverable assets 'fell sharply' from $67.5B in 2023 to $38.0B in 2024. The ground truth states that recoverables reached $38.0B in 2024 with no data provided for 2023, and certainly not $67.5B. Additionally, the collateral drop from $70.1B to $20.1B is entirely fabricated. The only correct number is the $38.0B in reinsurance recoverables in 2024 and the $29.1B in ceded loss reserves, which the LLM omits despite mentioning the total. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a reduction in reinsurance reliance due to declining assets, whereas the ground truth indicates an *expansion* in reinsurance protections over 2022–2024. It also fails to connect the evolution across years properly—missing that 2023 involved active monitoring and targeted reinsurance purchases, and that the approach remained consistent while protections expanded. (4) Despite these issues, the answer is contextually relevant, addressing terrorism modeling, reinsurance structures, and financial metrics. It captures the use of TRIPRA and scenario modeling, and correctly identifies the $1.3B loss estimate (albeit with wrong timing). However, major factual and directional errors—especially the false decline in recoverables and incorrect attachment points—severely undermine correctness. The qualitative reasoning is partially sound but based on incorrect data, leading to an inaccurate narrative of reduced reinsurance reliance versus the actual expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 612,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "\nThe 2.00 % Notes due 2031 showed a $1.2 bn carrying amount in 2022, slipped to roughly $1.04 bn in 2023 (reflecting modest principal repayments or the amortization of debt‑discount adjustments), and then rose again to about $1.25 bn in 2024 (as the balance was restored after those reductions and interest accrual).  This pattern indicates that NVIDIA is not aggressively deleveraging its long‑term debt but is instead managing it through selective repayments and re‑issuances to keep the overall debt level stable while fine‑tuning interest expense and preserving liquidity for other strategic uses.  (See Note 7 “Long‑Term Debt” in the 2022‑2024 10‑K filings for the carrying‑amount schedule.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all key financial figures: $1.2 billion in 2022, $1.044 billion (rounded to $1.04 billion) in 2023, and $1.25 billion in 2024. These match the ground truth exactly or with acceptable rounding. The years and the note (2.00% Notes Due 2031) are accurately identified. 2) Quantitatively, all numbers are correct. The slight rounding of $1.044 billion to $1.04 billion is common and acceptable in financial reporting. No calculations are required beyond interpretation of trends, which are accurately described: decrease in 2023, return to near-original level in 2024. 3) The reasoning is sound and aligns with the ground truth: the trend suggests stability in long-term debt management rather than aggressive deleveraging. The LLM correctly infers that NVIDIA is maintaining a stable capital structure, possibly through re-issuances or reversal of amortization effects, and links this to strategic liquidity preservation. It even references the correct footnote (Note 7) in the 10-K, enhancing credibility. 4) The answer is contextually excellent—directly addresses the trend and its implications for long-term debt strategy. The only minor gap is that it does not explicitly mention R&D or operational investments as end uses (implied via 'strategic uses'), and the phrase 'balance was restored' is slightly vague compared to the ground truth’s emphasis on maintaining capital structure. However, the core insight—stable long-term liabilities to avoid refinancing risk—is effectively conveyed. Thus, the answer is factually and semantically equivalent to the ground truth with only slight differences in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 448,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "\nThe 1.05 % Notes due 2017 first appeared in Apple’s 2014 indenture and were listed in the Exhibit 4.4 tables of the 2022, 2023 and 2024 Form 10‑Ks; by the 2022 filing they were already matured, and later filings contain only historical references with no outstanding balance or new issuance. This shows that Apple has retired that tranche and moved on to newer note series, yet the same indenture framework remains in place, underscoring a long‑term, continuously‑visible debt‑issuance strategy that maintains structural continuity across fiscal years.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 1.05% Notes due 2017 were referenced in Apple's 2022, 2023, and 2024 10-K filings, and that they had already matured by 2022 (i.e., post-2017), with no outstanding balance or new issuance—this aligns with the ground truth. The mention of the 2014 indenture and Exhibit 4.4 adds specific document-level detail not in the original answer but does not contradict it. However, the LLM concludes that Apple 'has retired that tranche and moved on to newer note series,' which is a stronger claim than the original answer supports. The ground truth suggests the notes may have been rolled over, refinanced, or retained under the same indenture, leaving open the possibility of continuation under similar terms, whereas the LLM assumes retirement. This misrepresents the nuance in Apple's debt continuity. (2) Quantitatively, all dates (2017 maturity, 2022–2024 references), percentages (1.05%), and document references (Exhibit 4.4, Form 10-K) are accurate. No calculations are required. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the persistence of a matured debt instrument in recent filings and links it to structural continuity. However, it fails to fully capture the implication of 'long-term visibility' as a function of consistent disclosure of legacy instruments, instead interpreting the pattern as evidence of replacement rather than documentation continuity. (4) The answer is contextually relevant and well-structured, but the conclusion about retirement reduces qualitative accuracy. The original answer emphasizes transparency and stable disclosure; the LLM shifts toward obsolescence and replacement, which is plausible but not definitively supported. Hence, correctness is reduced to 7 for missing key nuance, despite strong factual grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 501,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "\nUnder the 2019 IDA agreement Schwab could migrate up to $10 bn of IDA balances each year, but only if at least 80 % were designated fixed‑rate and it maintained a $50 bn minimum IDA balance; the 2023 IDA agreement replaced this cap and the 80 % rule with new minimum/maximum balance thresholds (a floor tied to outstanding unmatured fixed‑rate obligations, with a $30 bn ceiling until Sep 2025 and a $60 bn floor thereafter) and gave Schwab discretion over how much of the balance could be fixed‑ versus floating‑rate. Because the revised limits required Schwab to keep larger minimum balances and eliminated the automatic migration right, the company did not move any IDA balances onto its balance sheet in 2023 or 2024, instead using the flexibility to buy down $5 bn of fixed‑rate obligations and to manage the program within the new balance constraints.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Schwab's IDA balance migration policy from 2022 to 2024, with accurate qualitative reasoning and strong contextual relevance. However, there are minor quantitative inaccuracies that prevent a top score. The original answer states that Schwab migrated $10.1 billion by year-end 2022 under the 2019 agreement, which allowed up to $10 billion annually—this implies a slight breach or exception to the cap, but the LLM does not mention this specific figure or the fact that the limit was exceeded, which is a key detail. Additionally, the LLM introduces specific numerical thresholds in the 2023 agreement—$30 billion ceiling until Sep 2025 and $60 billion floor thereafter, and an $80% fixed-rate requirement in 2019—which are not present in the original (ground truth) answer. While these may reflect real details, they are not supported by the provided ground truth, making them extraneous or potentially incorrect in this evaluation context. The original answer only states that the 2023 agreement introduced 'new minimum and maximum balance thresholds' without specifying amounts or the $5 billion buydown, which the LLM adds. These additions, while plausible, go beyond the verified facts. The core reasoning—transition from active migration under a cap to constrained off-balance sheet management with eliminated migration rights—is sound and correctly synthesized across years. The entity identification (Schwab, IDA agreements, 2019 vs 2023) and timeline (2022–2024) are accurate. The answer addresses all parts of the question: evolution over time, changes in limits, and balance requirements. Despite the unsupported specifics, the overall direction and strategic shift are correctly conveyed, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 488,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "\nFrom 2022 through 2024 the estimated losses for Bank BPH’s borrower‑litigation rose from **$1.36 bn (as of 31 Dec 2022)** to **$2.67 bn (as of 31 Dec 2023)** and then slipped slightly to **$2.46 bn (as of 31 Dec 2024)**.  To meet regulatory‑capital requirements we moved from a **$0.53 bn cash capital contribution in 2022** to a **$1.80 bn non‑cash inter‑company loan‑forgiveness contribution in 2023**, and **no additional cash contributions were needed in 2024**.  By the end of 2024 the Polish mortgage portfolio carried **no net carrying value**—its entire balance was offset by a valuation allowance that fully reflects the estimated borrower‑litigation losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer with only minor rounding differences that are acceptable under semantic equivalence. (1) Quantitatively, all key figures are correct within reasonable rounding: $1.36B vs $1,359M (2022 estimated loss), $2.67B vs $2,669M (2023), and $2.46B vs $2,461M (2024) are effectively equivalent. The $0.53B cash contribution in 2022 matches $530M, and the $1.80B non-cash contribution aligns with $1,797M. The statement that no additional contributions were needed in 2024 is correct. (2) The carrying value of the mortgage portfolio being reduced to zero by end-2024 is accurately reflected with the phrase 'no net carrying value' due to a full valuation allowance—this correctly implies a complete write-down. (3) Multi-hop reasoning is sound: the LLM synthesizes data across three years, connects capital actions to litigation developments, and correctly identifies the shift from cash to non-cash contributions in response to escalating losses. (4) The only minor shortcoming is the omission of the specific $1,014 million charge recorded in Q2 2023 as part of the settlement program, which is mentioned in the original answer but not in the LLM response. While not critical to the overall trajectory, it represents a small gap in completeness regarding the nature of the 2023 charge. However, the overall financial exposure and strategic handling are accurately portrayed. Wording differences (e.g., 'bn' vs 'million', 'net carrying value' vs 'dropped to zero') are semantically equivalent and acceptable. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 469,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 the fair‑value of CVS’s commercial‑mortgage‑backed securities that were in an unrealized‑loss position fell sharply—from about **$992 million** to **$675 million**—and the corresponding unrealized losses dropped from roughly **$155 million** to **$100 million**.  This contraction reflects a deliberate de‑risking of the portfolio, as the company trimmed lower‑yielding, longer‑duration CMBS holdings and shifted toward higher‑quality, shorter‑duration assets, underscoring a risk‑management strategy that prioritizes capital preservation and limits exposure to interest‑rate‑sensitive mortgage securities.  The 2024 disclosures show only a modest remaining CMBS position with limited unrealized losses, indicating that the trend of reducing and stabilizing exposure has been sustained.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, in 2022, CVS's total fair value of CMBS was $574 million with $12 million in unrealized losses, not $992 million and $155 million as stated by the LLM. The 2023 fair value is correctly reported as $675 million, but the LLM incorrectly claims unrealized losses dropped from $155M to $100M, whereas in reality they increased sharply from $12M to $100M. The LLM also fails to mention the dramatic drop in fair value to just $3 million in 2024, instead vaguely referring to a 'modest remaining position' without quantifying it. (2) Quantitative accuracy is severely compromised: the LLM invents numbers not present in the ground truth (e.g., $992M, $155M), misrepresents trends (portraying a decrease in unrealized losses when they actually surged), and omits the critical 2024 data point. Even allowing for format variations, these are not minor discrepancies but major fabrications. (3) The reasoning is partially sound in interpreting de-risking behavior, but it is based on incorrect data, undermining the validity of the conclusion. The LLM correctly infers a risk management shift toward capital preservation, but this insight is anchored to false premises. It also fails to make the correct multi-hop connection: that the sharp rise in unrealized losses in 2023 likely triggered the near-total exit in 2024. (4) Contextual relevance is moderate—the answer addresses the right topic (CMBS exposure and risk management) and attempts to explain strategic intent—but due to factual errors and omissions, it does not accurately reflect the evolution of CVS's exposure. The conclusion about sustained de-risking is directionally plausible but unsupported by the actual data trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 486,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Walmart’s Form 10‑K filings repeatedly list “Marketside” among its private‑brand portfolio in the U.S. segment (2022 pp. 6‑7; 2023 p. 6; 2024 p. 7), and by 2024 the brand is presented alongside newer private‑label lines such as “bettergoods” and “Freshness Guaranteed.” This three‑year progression shows Walmart is deliberately expanding and promoting Marketside and related private‑label grocery offerings to capture higher‑margin sales and strengthen its omni‑channel, value‑oriented strategy in the grocery segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that Walmart included Marketside in its private brand portfolio from 2022 to 2024, citing the correct years and consistent presence, which matches the original answer. The mention of 'bettergoods' as a newer brand introduced by 2024 is factually correct and supports the narrative of portfolio expansion. (2) There are no numeric values or calculations in this question, so quantitative accuracy is not applicable—however, the temporal references (fiscal years 2022–2024) are correct, earning full marks. (3) The reasoning is sound in identifying continuity and strategic expansion, but the LLM slightly overreaches by stating Walmart is 'deliberately expanding and promoting Marketside' without explicit evidence of active expansion *of Marketside itself*—the ground truth emphasizes *maintaining* Marketside while introducing new brands, not growing Marketside specifically. This nuance is missed, making the inference partially incorrect. (4) The answer remains highly contextually relevant, addressing both the evolution of Marketside and the broader private label strategy. The inclusion of 'Freshness Guaranteed'—not mentioned in the ground truth—is a minor discrepancy but does not materially distort the conclusion. Overall, the core facts are correct, but the interpretation slightly misrepresents the strategic emphasis, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 403,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s deepened supplier monitoring by updating its Vendor Code of Conduct and human‑rights policy, adding a risk‑based wood‑sourcing framework with new country‑risk tiers, a formal grievance process and expanded third‑party audits, and by requiring CDP and TCFD‑aligned reporting of supplier environmental performance.  It also set science‑based net‑zero targets (scope 1‑3 by 2050) with interim 2030 reductions of roughly 40‑42 % for scope 1‑2 and 22‑25 % for scope 3, and invested more than $400‑$550 million in energy‑efficiency, renewable‑energy, LED, HVAC and waste‑management projects to meet those goals.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of Lowe's supply chain sustainability evolution from 2022 to 2024 but introduces several inaccuracies and omits key details from the ground truth. (1) Quantitatively, the LLM incorrectly states investments as a range of '$400-$550 million', implying overlap or uncertainty, whereas the ground truth specifies distinct figures: over $550 million by 2022 and over $400 million through 2023—indicating cumulative, multi-year spending. The LLM conflates these, potentially double-counting or misrepresenting timing. Additionally, the LLM introduces specific science-based targets (e.g., 40–42% for scope 1–2 by 2030, 22–25% for scope 3), which are not present in the original answer and cannot be verified against the provided truth. (2) Qualitatively, the LLM correctly identifies policy enhancements such as the risk-based wood sourcing framework, country risk tiers, and a formal grievance process, aligning with 2023 and 2024 developments. It also correctly references the Vendor Code of Conduct and human rights policy. However, it adds unverified elements like 'expanded third-party audits' and 'CDP and TCFD-aligned reporting requirements for suppliers', which are not mentioned in the ground truth. The original answer emphasizes monitoring via internal systems and collaboration, not third-party audits or mandatory supplier disclosures. (3) The multi-hop reasoning is partially sound—linking policy updates across years and connecting investments to sustainability goals—but fails to accurately sequence or attribute specific actions to correct years. For example, the original answer notes that the forestry grievance process was introduced in 2023 and strengthened by 2024, while the LLM bundles it without temporal clarity. (4) Contextual relevance is high, as the response directly addresses supplier monitoring, policy changes, and investments in sustainability. Despite factual inaccuracies, the overall narrative aligns with the question’s intent. However, the inclusion of unsupported metrics and misrepresentation of investment figures reduces factual reliability, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 577,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "\nApple first listed the 2.40 % Notes due 2023 in the “Description of Securities” (Exhibit 4.3) of its 2022 Form 10‑K, where the issue was shown as a long‑term debt tranche that would mature in 2023 and therefore carried a current‑portion classification. When the 2023 filing was issued, the notes had been retired, so they no longer appeared in the debt schedule and were replaced by newer tranches (e.g., 2.40 % Notes due 2025). By the 2024 filing the 2.40 % 2023 series is completely absent, indicating that Apple has systematically rolled that maturity into later‑dated securities. This three‑year pattern reflects the company’s ongoing strategy of laddered, staggered maturities and proactive refinancing to maintain a low‑cost, long‑term debt profile while managing the near‑term portion of its obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims that the 2.40% Notes due 2023 were retired in 2023 and absent in 2024, but the original answer states they were consistently disclosed in filings for 2022, 2023, and 2024—even in 2024 despite maturity—indicating ongoing inclusion for transparency. The LLM incorrectly asserts the notes were 'retired' and 'completely absent' in 2024, which is factually wrong. (2) Quantitative accuracy fails: while the interest rate (2.40%) and maturity year (2023) are correct, the LLM fabricates the existence of '2.40% Notes due 2025' replacing the 2023 notes, which is not supported by the ground truth. There is no mention of refinancing or new tranches in the original answer. (3) Multi-hop reasoning is flawed: the LLM infers a refinancing strategy based on non-existent data, whereas the correct inference is about transparency and consistent disclosure of legacy debt. The model fails to recognize that continued listing of a matured note reflects disclosure policy, not refinancing. (4) Contextual relevance is moderate because it addresses debt management strategy, but the factual foundation is incorrect, leading to a misleading conclusion. The ground truth emphasizes transparency and stable disclosure, not refinancing or maturity laddering. Thus, the answer is factually and logically unsound despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 389,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s stake in the AerCap note rose steadily—​$900 million in 2022, $944 million in 2023 and $982 million in 2024 (see GE 10‑K 2022 p. 74; GE 10‑K 2023 p. 71; GE 10‑K 2024 p. 71/70).  This incremental growth shows that GE is deliberately expanding its exposure to structured leasing‑related debt securities, using the AerCap note as part of a broader strategy to diversify its financial‑instrument portfolio and secure stable, yield‑generating assets within its aviation financing operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, GE's holdings were $976 million in 2022, decreased to $944 million in 2023, then increased to $982 million in 2024. However, the LLM incorrectly states the 2022 value as $900 million (a $76 million error), while correctly reporting $944 million in 2023 and $982 million in 2024. This misrepresents the trend as a 'steady rise' when the actual data shows a decrease followed by a recovery. (2) The calculation of progression is flawed due to the incorrect starting point. The ground truth shows a decrease of $32 million from 2022 to 2023, then an increase of $38 million to 2024, indicating volatility. The LLM’s portrayal of consistent growth is factually incorrect. (3) The multi-hop reasoning is partially sound in that it attempts to interpret the trend in the context of GE’s investment strategy, but the conclusion is based on incorrect data. The LLM infers a deliberate expansion in exposure to structured leasing-related debt, whereas the ground truth suggests a more dynamic and fluctuating management approach with overall stability. This mischaracterizes GE’s strategy. (4) Despite the incorrect numbers and flawed trend interpretation, the answer remains contextually relevant by addressing both parts of the question—evolution of holdings and strategic implications—and referencing appropriate document sources. The qualitative reasoning would have been stronger if based on accurate data. The contextual relevance is high because the framework of analysis (trend interpretation and strategic inference) aligns with the question, even if the facts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 464,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "\nThe U.S. pension plan’s glide‑path targets moved from a 2022 allocation of **15 % equities, 75 % fixed‑maturity securities and 10 % other** (2022 target – p. 310 of the 2022 filing) to a 2024/2025 target of **9 % equities, 80 % fixed‑maturity securities and 11 % other** (2024‑25 target – p. 128 & 184 of the 2024 filing, also reflected in the 2023 target‑2024 table on p. 252).  This shift trims growth‑oriented equity exposure and raises the share of liability‑hedging fixed‑income assets, illustrating the plan’s de‑risking approach as its funded ratio improved over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all percentages and years are correct: the shift from 15% equities, 75% fixed-maturity, and 10% other in 2022 to 9% equities, 80% fixed-maturity, and 11% other for 2024/2025 is precisely reported. These figures reflect a reduction in growth assets (equities) and an increase in liability-hedging assets (fixed-maturity securities), consistent with de-risking. (2) The citations to specific pages in the filings (e.g., p. 310 of 2022 filing, p. 128 & 184 of 2024 filing) add verifiability and suggest correct sourcing. (3) The reasoning correctly identifies the de-risking strategy in response to improved funded status, which matches the ground truth’s emphasis on liability-driven investing and glide path mechanics. (4) While the LLM does not explicitly mention the *timing mechanism* of the glide path—i.e., that each year’s target is set based on the prior year’s December 31 funded status—it still captures the core evolution and strategic intent. This omission slightly affects completeness in multi-hop synthesis but does not undermine the factual or conceptual accuracy of the response. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 368,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments kept embedded‑processing at the core of its strategy—repeating the same four sustainable competitive advantages each year, earmarking capital for expanding microcontroller and processor capacity, and targeting industrial and automotive end‑markets as the primary growth engines.  The segment’s revenue and operating‑profit grew steadily (e.g., ≈ $3 bn in 2022, $3.37 bn in 2023 with > 38 % operating margin), delivering a reliable, high‑margin cash stream that consistently contributed a larger share of operating cash flow.  This multi‑year consistency shows that embedded‑processing is a stable, cash‑generating pillar that underpins the company’s long‑term free‑cash‑flow‑per‑share growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing from 2022 to 2024 and links it to long-term free cash flow per share growth, aligning with the ground truth's core message. The qualitative narrative about embedded processing being a stable, cash-generating pillar is semantically equivalent and well-reasoned. However, the LLM introduces specific financial figures—$3B revenue in 2022, $3.37B in 2023 with >38% operating margin—that are not present in the original answer and cannot be verified against the ground truth. Since the ground truth does not include any revenue or margin data for embedded processing, these numbers represent unsupported additions, reducing quantitative accuracy. (2) There is no indication in the original answer that such figures were disclosed, so including them as facts constitutes a factual overreach, even if they are plausible. The absence of these numbers in the ground truth means the LLM likely hallucinated or inferred them beyond available data. (3) The multi-hop reasoning is sound: the model correctly synthesizes the continuity of strategic emphasis across years and connects it to cash flow generation. It accurately reflects TI’s focus on industrial and automotive markets and capital allocation to capacity expansion, which are consistent with the original answer’s themes of customer reach and supply chain control. (4) Despite the unsupported numbers, the overall reasoning and strategic interpretation are strong and contextually relevant. The answer addresses both parts of the question—evolution of strategy and implications for cash flow—making it largely correct but penalized for introducing unverified quantitative claims. Hence, correctness is 7 (core facts right, minor but significant quantitative inaccuracies), quantitative accuracy is 6 (specific figures lack support), qualitative accuracy is 8 (logic and synthesis are strong), and contextual relevance is 9 (highly on-topic and comprehensive).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 546,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lowe’s IP strategy for its private‑brand portfolio—most prominently the Kobalt line—moved from a purely registration‑focused approach to actively leveraging those brands in its digital‑first sales model.  The 2024 10‑K (page 4) stresses “balancing our value‑oriented private brands with our national brands” and local‑market optimization, while the successive filings (pages 7, 8, 9, 10, 12, 38) document expanded trademark, copyright and patent protection for Kobalt and related private‑brand names and describe their integration into the omnichannel marketplace, online product tools and AI‑driven personalization.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general direction of Lowe's intellectual property strategy evolution—particularly the integration of private brands like Kobalt into digital initiatives—but diverges significantly from the ground truth in key qualitative aspects. (1) Correctly identifies Kobalt as a central private brand and notes a strategic shift toward digital integration by 2024, aligning with the ground truth’s observation about digital transformation language. However, it fabricates specific details not present in the original answer: there is no mention in the ground truth of 'AI-driven personalization', 'omnichannel marketplace', or 'remote customer support' being explicitly tied to private brands. (2) The LLM cites page numbers (e.g., pages 7, 8, 9, etc.) and claims expanded patent and trademark protection across filings, but the ground truth does not reference such quantitative IP filings or legal protections—only changes in disclosure emphasis. This introduces unsupported specifics. (3) The multi-hop reasoning is partially sound: it infers a strategic shift over time, but fails to report the key evolution in brand portfolio emphasis—specifically, the removal of 'RONA' and 'Reno Depot' from IP disclosures between 2022 and 2023, which is a central factual pivot in the original answer. Instead, it invents a 'registration-focused to digital-first' narrative not grounded in the evidence. (4) While the answer is contextually relevant and addresses both brand portfolio and digital transformation, it substitutes plausible-sounding but unverified details for the actual observed pattern of disclosure streamlining and repositioning. The mention of 'balancing value-oriented private brands' in the 2024 10-K is consistent, but the overall synthesis lacks fidelity to the documented evolution. Thus, the answer is partially correct but contains significant embellishments and misses core factual developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 518,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings IBM repeatedly identifies “client relationships and trust” as one of its principal competitive methods, but the framing shifts from a generic differentiator to a strategic pillar that underpins its hybrid‑cloud and AI agenda. By 2023‑2024 the company explicitly ties that trust to its ability to win in high‑value, rapidly‑growing hybrid‑cloud and AI markets—using long‑standing client confidence to differentiate from hyperscalers and niche rivals and to justify continued investment in ecosystem partnerships and responsible innovation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its high-level assessment that IBM consistently emphasized client relationships and trust as a competitive differentiator from 2022 to 2024, and that this evolved into a strategic pillar supporting its hybrid cloud and AI positioning. The answer correctly identifies the continuity and increasing strategic framing of trust, and appropriately links it to differentiation against hyperscalers and niche competitors. However, it omits specific, factually grounded details from the original answer that reflect multi-hop synthesis across the 10-K filings: (1) the 2022 emphasis on trust via industry expertise and secure, open platforms; (2) the 2023 expansion to include strategic partnerships with AWS, Microsoft, and SAP; and (3) the 2024 addition of cybersecurity partners like Palo Alto Networks, which signals a growing focus on security as part of trust. These specific entity-year-metric linkages are missing, weakening the qualitative accuracy despite correct general trends. There are no numerical inaccuracies (quantitative accuracy is perfect, hence score of 10), and the answer remains contextually relevant and well-reasoned at a conceptual level. The omission of concrete examples and partner names reduces completeness and precision in the multi-hop synthesis expected, warranting a 7 in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 382,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "\nFrom 2022 through 2024 the El Segundo, California site evolved from a primarily clinical‑trial manufacturing location into a full‑scale commercial hub for Gilead’s cell‑therapy portfolio.  The 2022 filing notes that the facility is used for “clinical and commercial manufacturing and processing of our cell therapy products,” and by 2024 it was delivering the bulk of commercial sales—$1.57 billion for Yescarta and $403 million for Tecartus in 2024—while still handling clinical‑trial material and complying with FDA REMS and chain‑of‑identity requirements (see GILD_10k_2022.pdf p. 33; GILD_10k_2024.pdf pp. 11 and 40).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim and contains significant factual errors. (1) The main assertion—that the El Segundo facility evolved from a primarily clinical site into a full-scale commercial hub—is contradicted by the ground truth, which states there was no significant change in the facility's role from 2022 to 2024. The original answer emphasizes continuity in both clinical and commercial manufacturing responsibilities across all three years, with no documented expansion or reduction. The LLM incorrectly infers a transformation that is not supported by the filings. (2) Quantitative inaccuracies include the claim that El Segundo was responsible for $1.57 billion in Yescarta and $403 million in Tecartus sales in 2024. The ground truth does not attribute specific revenue figures to the El Segundo facility, nor do the filings confirm that this site delivered the 'bulk' of commercial sales. These numbers may reflect total product revenues, but assigning them directly to El Segundo’s output is unsupported and constitutes a major factual overreach. (3) The multi-hop reasoning is flawed: while the LLM correctly cites that the 2022 filing mentions clinical and commercial manufacturing, it misinterprets the 2024 filing to imply a shift in role, when in fact the language reaffirms the same dual-purpose use. There is no evidence in the ground truth of an evolution in responsibilities. (4) Contextual relevance is moderate—the answer addresses the facility and time frame and mentions correct products (Yescarta, Tecartus) and compliance requirements (REMS, chain-of-identity)—but the central narrative is factually incorrect. The answer creates a story of evolution and scaling that is not present in the source data. Minor credit is given for correctly identifying the facility's general role in cell therapy manufacturing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 501,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s did not issue any new 4.550 % notes; the only 4.550 % tranche on its balance sheet remains the April 5 2049 notes that were originally sold under the Fifteenth Supplemental Indenture in April 2019.  During the same period the company added several fresh unsecured note series—e.g., the 4.000 % notes due 2025, 4.500 % notes due 2030, 5.000 % notes due 2040 (2020), and later 4.800 % due 2026, 5.150 % due 2033, 5.750 % due 2053 and 5.850 % due 2063 (2023)—creating a laddered maturity profile that stretches out to the mid‑2060s.  This multi‑year pattern signals a long‑term debt strategy of diversifying funding, extending average maturity and managing interest‑rate exposure while keeping the existing 4.550 % series as a stable, long‑dated pillar of its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that the 4.550% Notes due April 5, 2049, issued under the Fifteenth Supplemental Indenture on April 5, 2019, remained unchanged from 2022 to 2024—this matches the original answer’s core fact. (2) Quantitative accuracy is strong: all interest rates (4.550%, 4.000%, 4.500%, etc.), maturity dates (2025, 2030, 2040, 2053, 2063), and issuance years (2020, 2023) are factually correct and consistent with known filings. The absence of new 4.550% note issuances during 2022–2024 is accurately stated. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and instruments to infer a strategic laddered maturity profile and extended average debt maturity, which goes beyond the ground truth but is a valid and well-supported interpretation. It correctly infers that maintaining the 4.550% Notes as a stable, long-dated component reflects a broader strategy of capital flexibility and refinancing risk mitigation. (4) While the original answer focuses on consistency of reference and long-duration emphasis, the LLM adds contextual depth by citing specific new debt issuances and characterizing the laddered structure—this enhances qualitative accuracy without introducing error. The only reason for not scoring a 10 is that the original answer does not mention the other note series (e.g., 5.750% due 2053), so including them, while likely accurate, slightly exceeds the verified knowledge graph scope. However, this does not detract from correctness given their plausibility and relevance. Overall, the answer is factually solid, contextually rich, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 460,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "\nFrom 2022 through 2024 the exposure related to 3M’s Scotchgard‑derived PFAS liability shifted from a flood of new class‑action and state‑AG suits (e.g., the 2022‑2023 water‑provider and Michigan “PWS” settlements that were incorporated in the June 22 2023 settlement agreement [see MMM_10k_2023.pdf p. 114]) to a series of discrete settlements and dismissals—most notably the Wolverine‑related Scotchgard settlement that was finalized in June 2023 [see MMM_10k_2023.pdf p. 94]—while 2024 has seen only a handful of fresh filings (Missouri, Connecticut, Virginia, Minnesota) that remain pending or were recently dismissed [see MMM_10k_2024.pdf pp. 95‑100, 124‑131].  The company has recorded only immaterial accruals for these matters, indicating that although PFAS litigation remains ongoing, the resulting settlement costs have been financially negligible relative to 3M’s overall earnings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the trend in 3M's legal exposure and settlement costs from 2022 to 2024. (1) Quantitatively, it incorrectly claims that settlements were 'immaterial' and 'financially negligible,' directly contradicting the ground truth that a $65 million settlement was paid in 2022 and another $65 million finalized in 2024—substantial amounts that indicate escalating liability. The LLM also fabricates details such as a 'June 22, 2023 settlement agreement' and references to specific pages in 10-K filings without verifying the actual content, which undermines factual reliability. (2) The answer misstates the trajectory of litigation: rather than declining in 2024 with only 'a handful of fresh filings,' the ground truth shows expansion into Alabama and Georgia, with ongoing trials scheduled for 2026 and increasing plaintiffs (municipal utilities, property owners, carpet manufacturers). The LLM incorrectly implies litigation is winding down, when the trend is clearly one of growing geographic and legal complexity. (3) Multi-hop reasoning fails: the model does not correctly synthesize the evolution across years, misidentifies the nature of the Wolverine-related settlement (claiming it was finalized in June 2023 without noting its connection to earlier multi-party $65M contributions), and omits key jurisdictions like Canada and Illinois mentioned in 2023. (4) The conclusion that PFAS litigation has had a 'negligible' financial impact contradicts the ground truth’s clear indication of escalating liabilities. While the answer addresses the general topic and attempts to discuss trends, its core assertions are factually inverted—portraying de-escalation where there is escalation—resulting in a mostly incorrect assessment. Minor contextual elements (e.g., mention of class actions, state AG suits) are relevant but do not compensate for fundamental errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 519,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "\nFrom 2022 through 2024 the Foster City, California site moved beyond early‑stage process‑chemistry and clinical‑trial API production to become a broader R&D and manufacturing hub that develops and manufactures API for both clinical and commercial products across Gilead’s HIV, oncology and cell‑therapy portfolios.  Its manufacturing responsibilities grew to support new product launches and to feed material and technology into the company’s global production network in Ireland, Canada and the Netherlands, aligning the site tightly with Gilead’s worldwide operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers, it is scored as 10 by default. The qualitative accuracy is low because the LLM misrepresents the evolution of the Foster City facility. According to the ground truth, from 2022 to 2024, Foster City shifted toward a more focused role in early-stage R&D and clinical manufacturing (process chemistry, analytical methods, formulation, device development, and clinical API/drug product manufacturing), with commercial manufacturing being handled elsewhere. In contrast, the LLM claims Foster City expanded its role to include commercial manufacturing and became a broader hub for commercial API production—this is directly contradicted by the original answer, which indicates a narrowing, not broadening, of scope. The LLM also incorrectly states that Foster City feeds commercial material into global sites like Ireland, Canada, and the Netherlands, while the ground truth specifies that commercial-scale manufacturing was moved to other locations (e.g., La Verne, Oceanside, international sites), implying Foster City is not involved in commercial supply. The reasoning is flawed: it inverts the strategic shift (specialization vs. expansion) and fails to correctly synthesize the multi-hop information across years and operational domains. Contextual relevance is moderate because the answer addresses R&D, manufacturing, and global alignment as asked, but with factually incorrect content. Thus, the correctness score is low due to major factual and directional errors despite proper framing of the question's themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 448,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "\nAIG’s loss‑reserve oversight moved from a mainly internal, deterministic development process in 2022 to a formal risk‑appetite and limit structure by 2024, with ERM‑driven second‑line challenge and mandatory external actuarial and reinsurance‑expert reviews. At the same time, the company broadened its modeling—from simple development factors to stochastic, catastrophe‑PML and climate‑adjusted simulations—and began routinely validating those models and the related reinsurance‑recoverability estimates through independent third‑party reviews.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of AIG's loss reserve risk management from 2022 to 2024 with strong semantic equivalence to the ground truth. (1) It correctly identifies the progression from internal, deterministic methods in 2022 to a more structured, ERM-integrated framework by 2024, including second-line challenge and external reviews—aligning with the original answer’s emphasis on enhanced oversight and governance. (2) Quantitatively, no specific numbers (e.g., dollar amounts, percentages) are mentioned in either answer, so there are no discrepancies; dates (2022–2024) are used correctly. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time in oversight (internal → ERM-driven), modeling (deterministic → stochastic, catastrophe-PML, climate-adjusted), and external validation (routine third-party reviews), which matches the original’s trajectory from reactive to proactive governance. (4) Minor deduction in qualitative accuracy due to omission of 'sensitivity and scenario analyses' and 'experience studies' explicitly mentioned in 2023, though 'stochastic' and 'simulations' imply similar advancements. The phrase 'reinsurance-recoverability estimates' adds detail not in the original but does not contradict it—likely an inference from 'external expert reviews.' Overall, the answer is factually correct, contextually precise, and reflects a sophisticated understanding of the risk management evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 405,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "\nFrom 2022 through 2024 the Melaka, Malaysia site remained listed under the **Analog** column in TI’s property tables ( † in 2022, * in 2023, ** in 2024 ), indicating that the facility was still dedicated to analog‑chip manufacturing; the only change was the lease‑ownership notation, not the product focus. Because Embedded‑Processing was never checked for Melaka in any of the three years, the progression shows that TI’s regional manufacturing footprint in Melaka stayed anchored to its analog business and did not shift toward embedded‑processing production during this three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site remained dedicated to Analog manufacturing from 2022 to 2024, with no mention or indication of Embedded Processing activities—this matches the original answer's claim of exclusive Analog focus and no expansion into Embedded Processing. (2) There are no numerical values requiring calculation (e.g., financial figures or percentages), but the temporal scope (2022–2024) is correctly referenced, and the use of symbols (†, *, **) aligns with typical SEC filing notations for lease/ownership status, which does not affect the factual accuracy of the manufacturing focus. (3) The multi-hop reasoning is sound: the model correctly infers from the consistent placement of Melaka under the 'Analog' column across three years’ filings that the operational focus did not change, and the absence of Embedded Processing designation indicates no shift in product focus—this demonstrates proper synthesis across years and categories. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in operational footprint and what it indicates about manufacturing focus. Wording differs slightly but conveys the same factual conclusion: Melaka maintained a stable, specialized role in Analog manufacturing. All entities (Texas Instruments, Melaka, Malaysia, Analog, Embedded Processing) are correctly identified and contextualized. No errors in fact, reasoning, or relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 421,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "\nLowe’s began fiscal 2022 with a sizable cash‑flow hedge of roughly **$2.56 billion** in forward interest‑rate swaps (as disclosed in the 2022 10‑K), and the company continued to hold a comparable notional amount through fiscal 2023 (the swaps still showed a fair‑value of about $250 million). By fiscal 2024 the forward‑swap position was essentially **wound down to zero** (fair‑value reported as $‑), indicating that the contracts were terminated or rolled off as the targeted debt‑issuance windows were reached. This pattern shows that Lowe’s employed a **project‑specific, timing‑driven hedging strategy**—locking in rates for anticipated bond issuances and then retiring the swaps once those financings were executed.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It claims a notional amount of $2.56 billion in forward interest rate swaps in fiscal 2022, but the ground truth does not specify any notional amount—only that Lowe's referenced these swaps in relation to their impact on other comprehensive income. The $2.56 billion figure is unsupported by the original answer and appears to be fabricated or misattributed. Additionally, while the LLM correctly notes a $250 million fair value in 2023 (close to the true $251 million), it misrepresents this as a 'comparable notional amount,' conflating fair value with notional value—a critical financial distinction. By 2024, the LLM correctly states that the position was wound down to zero, aligning with the ground truth that no forward swaps were held. (2) The calculation and number verification fails on the $2.56 billion claim; no such figure appears in the ground truth. The $250 million approximation is acceptable given the $251 million actual value (minor rounding). However, presenting fair value as if it reflects notional exposure is factually misleading. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategy tied to anticipated debt issuances and recognizes the termination of swaps by 2024. It captures the idea of timing-driven hedging, which aligns with the ground truth’s implication of using swaps for forecasted issuances. However, it misses the key strategic shift emphasized in the original answer—moving from cash flow hedges (forecasted debt) to fair value hedges (existing debt) using fixed-to-floating swaps. This shift is central to the company's evolving hedging strategy and is entirely omitted in the LLM response. (4) The contextual relevance is high because the answer addresses the evolution over three years and attempts to interpret strategy. Qualitative accuracy is moderate due to correct timeline understanding but flawed financial interpretation. Quantitative accuracy is low due to the unsupported $2.56B figure and misrepresentation of fair vs. notional value. Correctness score reflects partial factual alignment but major errors in key financial data and incomplete strategic analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 595,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings IBM repeatedly incorporates “Exhibit 2 to the Form 8‑K filed on January 8 1998” as the governing document for the 6.50 % Debentures due 2028, using identical language and the same exhibit number each year. The unchanged citation shows that the terms of this debt series were set in 1998 and have not been amended or restated since, indicating a deliberately permanent, long‑term structure that is documented once and simply referenced in subsequent filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately stated: IBM consistently referenced the same 'Exhibit 2 to Form 8-K filed on January 8, 1998' across its 2022, 2023, and 2024 10-K filings for the 6.50% Debentures due 2028. The date (January 8, 1998), exhibit number (Exhibit 2), and percentage (6.50%) are all correct. (2) There are no numerical or date inaccuracies—quantitative elements match exactly, with acceptable formatting (e.g., '6.50 %' vs '6.50%'). (3) The reasoning is sound: the repeated citation of the same 1998 exhibit implies no amendments or refinancing, indicating a stable, long-term debt structure. This correctly synthesizes multi-hop information across three years of filings to infer continuity in documentation and terms. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosure and the implication of consistency regarding the debt’s structure. Wording differs slightly (e.g., 'deliberately permanent, long-term structure' vs 'stable and long-standing'), but the meaning is equivalent. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 332,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "\nReflective Signage began in 2022 as part of the broad “Premium large‑format graphic films” offering within 3M’s Transportation & Electronics segment.  By 2023 its contribution was reflected in the segment’s operating income rising from $973 million (2021) to $1,312 million (2022), underscoring growing revenue importance.  In 2024 the company reshaped the segment, creating a dedicated **Commercial Branding and Transportation** division that explicitly lists “Reflective signage for highway and vehicle safety” as a core product, signalling that 3M now treats reflective signage as a strategic, high‑visibility growth pillar of its portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual and reasoning errors. (1) It falsely claims that in 2022, Reflective Signage was part of 'Premium large-format graphic films,' which contradicts the ground truth stating it was a separate offering listed fifth. (2) The financial figures cited—$973 million (2021) and $1,312 million (2022)—are not present in the ground truth and are therefore unverified and likely fabricated; the original answer does not mention any operating income data related to Reflective Signage or the segment’s income, so this quantitative addition is unsupported. (3) The claim that 3M created a 'Commercial Branding and Transportation' division in 2024 with Reflective Signage as a core product is not supported by the original answer, which only notes a reordering of product listings within the existing Transportation and Electronics segment. (4) The ground truth focuses on the ordinal positioning of Reflective Signage within a list of offerings as an indicator of strategic emphasis, while the LLM invents structural reorganizations and financial impacts without evidence. (5) Multi-hop reasoning is flawed: the model incorrectly infers causation between segment income growth and Reflective Signage, and introduces entities (new divisions, financial metrics) not present in the source. While the answer attempts to address strategic importance, its factual foundation is unsound, leading to a low correctness score. Minor credit is given for recognizing that Reflective Signage gained strategic attention over time, which aligns loosely with the idea of sustained prominence, but this insight is overshadowed by inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 455,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "\nGilead moved the Hoofddorp, Netherlands plant from a mainly clinical‑stage cell‑therapy site in 2022 to a central commercial manufacturing hub for its cell‑therapy portfolio by 2024.  The facility began commercial production of Yescarta and Tecartus in 2022, and as sales of these products expanded—oncology‑cell‑therapy revenue grew from $1.869 bn in 2023 to $1.973 bn in 2024 (see the revenue table in the 2024 10‑K, page 40)—its role in the company’s supply chain became strategically critical for meeting demand.  (Hoofddorp is identified as a commercial manufacturing location for cell‑therapy products in the 2024 10‑K, page 11.)",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of Hoofddorp's increasing strategic role in commercial cell therapy manufacturing from 2022 to 2024, which aligns with the ground truth. However, there are significant factual inaccuracies that reduce correctness. First, the claim that Gilead 'began commercial production of Yescarta and Tecartus in 2022' at Hoofddorp is not supported by the ground truth, which only states that in 2022 the facility was identified as a principal manufacturing site—without specifying commercial production of those products. The original answer indicates the explicit commercial role emerged in 2023, not 2022. Second, the revenue figures cited ($1.869 bn in 2023 and $1.973 bn in 2024) are presented as oncology-cell-therapy revenue, but the ground truth does not provide these specific numbers or confirm their attribution to cell therapy alone, making this a fabrication or unsupported inference. While the 2024 10-K reference is plausible, the LLM invents a 'revenue table on page 40' and uses it to justify strategic importance—an unsourced quantitative claim. The qualitative reasoning about growing strategic importance is directionally correct and contextually relevant, showing some correct synthesis across years. However, the incorrect timing of commercial production start and unsupported financial data undermine quantitative and qualitative accuracy. The facility’s designation as a commercial site in 2024 is correctly noted, but the evolution narrative is overstated due to the premature 2022 claim. Thus, while the answer reflects partial understanding, it contains key factual errors in both timeline and data, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 457,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "\nThe share reserve for the 2003 Director Compensation Plan fell from ≈ 69.8 million shares at the end of 2022 to ≈ 58.5 million at the end of 2023, then rose again to ≈ 65.5 million by the end of 2024. The 2023 decline shows that shares were being allocated for director compensation that year, while the 2024 rebound indicates that Texas Instruments replenished the reserve, underscoring its continued reliance on the plan to fund future director awards.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that the number of shares available decreased from 1,843,134 in 2022 to 1,786,785 in 2023, and further to 1,745,284 in 2024. In contrast, the LLM claims the share reserve was approximately 69.8 million in 2022, dropped to 58.5 million in 2023, then rose to 65.5 million in 2024—these numbers are off by an order of magnitude (over 30x higher) and show a completely different trend. (2) The quantitative inaccuracies are severe: not only are the absolute values wrong, but the direction of change in 2024 (increase vs. continued decrease) contradicts the ground truth. There is no indication of share replenishment in the original data; the consistent decline indicates ongoing usage without replenishment. (3) The multi-hop reasoning is flawed: the model incorrectly infers that a rise in 2024 indicates replenishment and continued reliance, when in fact the actual data shows uninterrupted usage with gradual depletion, indicating sustained use without restoration of shares. The model fails to correctly synthesize the trend across years. (4) Despite the severe factual errors, the answer is contextually relevant in that it attempts to address the evolution of shares and interpret the trend regarding director compensation use. However, due to massive numerical and directional inaccuracies, the correctness and qualitative scores are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 403,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "\nFrom 2022 through 2024 IBM shifted the way it disclosed its 0.950 % Notes due 2025 from a simple exhibit citation in 8‑K filings (2022 p. 33; 2023 p. 20) to an explicit, ticker‑coded entry in the 2024 Form 10‑K securities table (p. 2), giving the issue a market‑wide identifier (IBM25B) and placing it alongside its equity securities. This increased visibility and formal market‑transparency signals a broader capital‑market strategy that treats its debt as a distinct, investable class and reflects a more investor‑focused, transparent approach to debt financing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: the 0.950% Notes due 2025 were initially cited via the May 22, 2017 Form 8-K in 2022 and 2023 (referenced as exhibit citations), and by 2024 were given a dedicated trading symbol IBM25B on the NYSE. The LLM correctly notes the shift from internal referencing to market-facing transparency. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), and trading symbol (IBM25B)—are all accurate. Page numbers cited (2022 p.33, 2023 p.20, 2024 p.2) align with typical disclosure locations and do not contradict the ground truth, which focuses on content rather than pagination. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, identifies the evolution in disclosure treatment, and correctly infers the strategic implication—elevating debt instruments to a more transparent, investor-accessible status. (4) The conclusion about IBM’s broader capital market strategy—treating debt as a distinct, investable class and enhancing investor engagement—is a valid interpretation supported by the progression in disclosure practices. Wording differs slightly but meaning is preserved and enriched with appropriate context. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 378,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s deposit assets on reinsurance expanded from roughly $1.8 billion (a level that had been stable in 2021‑22) to $5.1 billion in 2023 and then slipped to $4.6 billion in 2024, while deposit liabilities rose from about $1.4 billion to $1.3 billion in 2023 and fell to $1.2 billion in 2024 as the balances amortized.  The November 2023 Global Atlantic transaction—under which the company recorded a $10.3 billion deposit receivable, retained $5 billion of separate‑account assets and booked a $770 million net cost of reinsurance—demonstrated a strategic shift toward using deposit accounting for large, long‑duration block reinsurance to capture economic value and manage capital on a longer‑term basis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: deposit assets in 2022 ($1.8B), 2023 ($5.1B), and 2024 ($4.6B); liabilities in 2022 ($1.4B), 2023 ($1.3B), and 2024 ($1.2B); and the $10.3B deposit receivable from the Global Atlantic transaction are all accurately reported. Minor phrasing like 'slipped' or 'amortized' does not affect factual correctness. (2) The answer fully addresses both parts of the question: the evolution of deposit assets/liabilities from 2022–2024 and the strategic significance of the 2023 Global Atlantic transaction. (3) Multi-hop reasoning is sound—correctly linking the increase in deposit method usage to a strategic shift via the Global Atlantic deal. (4) The LLM adds contextual detail not in the original (e.g., $5B retained separate-account assets, $770M net cost of reinsurance), which are plausible and enhance the explanation, but since they are not in the ground truth, there is a slight risk of overreach—though not enough to constitute an error. Semantic equivalence is maintained, and the core facts, trends, and strategic interpretation are correct. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 362,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Safety and Industrial segment continued to list “respiratory, hearing, eye and fall‑protection solutions” among its core products, and in early 2024 3M reorganized those personal‑safety offerings—including fall‑protection equipment—into a newly created **Industrial Specialties** division.  This restructuring consolidates and highlights fall‑protection as a distinct growth platform, signaling that 3M is placing a stronger strategic emphasis on workplace‑safety solutions within its Safety and Industrial business.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding MMM's (3M's) organizational structure and product portfolio evolution. While it correctly identifies that fall protection solutions were part of the Safety and Industrial segment from 2022 to 2024, it incorrectly states that in early 2024, 3M reorganized these offerings into a newly created 'Industrial Specialties' division. This is false according to the ground truth, which shows no such restructuring—only a minor phrasing update in how the product lines were described. The original answer confirms consistent categorization under the Safety and Industrial segment with no mention of a new division. (2) There are no numeric values or calculations in either answer, so quantitative accuracy is not applicable beyond correct use of years (2022–2024), which the LLM gets right. (3) The multi-hop reasoning fails because the LLM infers a strategic restructuring and increased emphasis based on a non-existent organizational change, leading to an incorrect conclusion about 3M's strategic direction. The ground truth indicates stability and consistency, not a shift. (4) Despite the incorrect central claim, the LLM does capture the continuity of fall protection as a listed product line, maintaining some relevance. However, the erroneous restructuring narrative undermines the qualitative accuracy and overall correctness, warranting a low score. Contextual relevance is moderate because the response addresses the right segment and product line, but introduces misleading strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 434,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "\nAltria streamlined its reporting structure between 2022 and 2024, eliminating the standalone “Wine” category and folding all smokeless and oral‑nicotine activities—including UST’s MST and snus brands—into a single “Oral tobacco products” segment (see Note 17, 2023 10‑K, p. 82).  The company has kept 100 % ownership of UST LLC while increasingly integrating its assets with the broader oral‑tobacco portfolio, as highlighted by the $8.8 bn valuation of MST/snus trademarks (p. 66) and the full consolidation of Helix’s on! pouch business (p. 60).  This consolidation reflects Altria’s strategic shift to treat smokeless tobacco and next‑generation oral nicotine products as a unified growth platform to transition adult smokers away from cigarettes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $8.8 billion trademark valuation matches the original answer, and the references to specific pages and the 100% ownership of UST are factually sound. No calculations were required, but the cited figures are consistent with the source. (2) The answer addresses the evolution from 2022 to 2024: while it does not explicitly mention 2022 in the same terms as the original (e.g., amortization expenses), it correctly notes the structural changes culminating in the 2023 reporting shift, which is supported by the 2023 10-K. The integration of Helix’s on! brand is an additional but relevant detail that supports the strategic consolidation narrative. (3) The multi-hop reasoning is strong—linking UST’s MST/snus products to the broader 'Oral tobacco products' segment and framing this within Altria’s strategic shift toward reduced-risk products demonstrates correct synthesis across years and business units. (4) The LLM emphasizes strategic integration and alignment with transitioning adult smokers, which semantically matches the original answer’s conclusion about Altria’s 'Moving Beyond Smoking' initiative. The only minor shortcoming is the lack of explicit mention of UST being described as a 'core operating company' in 2024 or the direct reference to the 'Moving Beyond Smoking' initiative by name, but the strategic intent is accurately conveyed. Thus, the answer is factually robust, contextually relevant, and only slightly less complete than the ground truth in phrasing, not substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 441,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "\nThe repeated citation of SolarCity’s 5.45 % Solar Bonds, Series 2015/C92‑15 in Tesla’s 2022‑2024 filings shows that the company still regards this securitized‑bond structure as a key, long‑term financing vehicle for its solar portfolio. By continually referencing the same bond series, Tesla signals its intention to maintain and potentially roll‑over this type of debt‑backed capital to fund and refinance solar projects going forward.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core meaning of the ground truth. (1) All entities are correct: 'SolarCity 5.45% Solar Bonds, Series 2015/C92-15' is accurately referenced, and the years 2022–2024 are correctly cited. The percentage (5.45%) is exact. (2) Quantitative accuracy is perfect: no calculations are required, but the bond series identifier and interest rate are correctly stated. (3) Reasoning is sound: the LLM correctly infers that Tesla’s repeated mention of the bond indicates ongoing reliance on securitized solar debt as a long-term financing strategy. It appropriately suggests potential rollover or refinancing, which is a reasonable extension of the evidence. (4) The only minor shortcoming is completeness: the ground truth includes specific detail about the 'One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015' and emphasizes Tesla’s legal/financial linkage, which the LLM omits. While not critical to the main conclusion, this detail strengthens the original answer’s depth. Despite this, the LLM conveys the essential strategic implication—continued use of structured solar financing—with high fidelity. Semantic equivalence is strong, and the response is contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 347,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "\nIBM’s 10‑K filings consistently flag “governmental and stock‑exchange regulations” as a risk that can affect the valuation and liquidity of both its debt and equity securities—see the risk‑factor language on p. 22 of the 2022 filing, and the identical wording on p. 11 of the 2023 and 2024 filings.  The repetition shows that IBM’s exposure to exchange‑related rules has not changed materially across the three years, but the company treats regulatory risk as a permanent element of its capital‑market exposure and manages it through ongoing monitoring, diversified financing, strong credit‑rating oversight and transparent disclosure.  This multi‑year progression reveals a risk‑management strategy that relies on proactive compliance and diversification rather than on altering the nature of its securities‑related regulatory exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entity accuracy, time frame (2022–2024), and the core assertion that IBM consistently reported exposure to stock exchange regulations affecting its debt and equity securities. The quantitative accuracy is perfect—no numerical data is misstated, and there are no errors in dates or document references (e.g., correct page numbers and consistent risk factor language across filings). Contextual relevance is high, as the response directly addresses IBM’s regulatory exposure and capital market risk management strategy over the three-year period. However, the qualitative accuracy is slightly lower because the LLM introduces claims not present in the original answer: specifically, that IBM manages regulatory risk through 'diversified financing, strong credit-rating oversight, and transparent disclosure' and 'proactive compliance.' These mitigation strategies are not mentioned in the ground truth, which explicitly states there was 'no material reduction in dependency or mitigation strategy' over the period. The original answer emphasizes IBM’s growing recognition of regulatory risk as systemic but unchanged in terms of mitigation, whereas the LLM implies an active, diversified management approach, which overstates IBM’s reported actions. This misrepresents the nuance of the multi-hop reasoning—while the repetition of risk language is correctly noted, the interpretation of IBM’s strategy diverges from the source. Thus, while the core facts are correct, the inferred strategy weakens the qualitative accuracy, warranting a 7 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 442,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "\nAcross the three years, 3M kept electrical products for construction and maintenance inside its Safety‑and‑Industrial segment, but it refined the way those offerings were organized—creating an Industrial Specialties division in 2023 and, in 2024, further isolating them within that new division and linking them to commercial‑branding initiatives.  This realignment coincides with a sharp rise in segment profitability: operating income climbed from $1.1 billion in 2022 to $2.5 billion in 2024 even as net sales hovered around $11 billion, highlighting a deliberate shift toward higher‑margin electrical solutions.  The progression signals that 3M is strategically concentrating on industrial‑electrical markets to capture infrastructure‑driven growth and strengthen its position in the broader industrial sector.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that MMM consistently included electrical products in its Safety and Industrial segment across 2022–2024, with evolving supplementary product lines. However, the LLM incorrectly claims the creation of an 'Industrial Specialties division in 2023' and a reorganization 'within that new division' in 2024—details not present in the original answer or supported by the knowledge graph. There is no mention of such structural changes in the ground truth, which only describes shifts in segment description wording. (2) The quantitative claims are entirely fabricated: the LLM states operating income rose from $1.1 billion in 2022 to $2.5 billion in 2024 and that net sales hovered around $11 billion. These figures are not in the original answer and cannot be verified from the provided context—thus, they are incorrect. This severely undermines quantitative accuracy. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that electrical products remained in the Safety and Industrial segment, it infers strategic reorganizations and profitability trends not supported by the source. The original answer focuses on descriptive changes in segment composition, not financial performance or internal restructuring. The conclusion about 'higher-margin electrical solutions' and 'infrastructure-driven growth' is speculative and not grounded in the provided data. (4) Despite these issues, the LLM does capture the basic idea that MMM maintained a focus on electrical products while evolving its industrial portfolio, which gives it partial credit for contextual relevance. However, the invented details, incorrect financials, and unsupported strategic interpretations result in low correctness, quantitative, and qualitative scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 499,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead expanded the Oceanside, California site from a mainly clinical‑trial and process‑development location into a fully commercial retroviral‑vector manufacturing platform.  The facility now produces commercial‑scale retroviral vectors that support the company’s biologics pipeline—including its CAR‑T cell therapies (Yescarta, Tecartus) and other gene‑therapy candidates—while continuing to perform process‑development and clinical‑batch activities.  This evolution reflects a strategic shift toward leveraging Oceanside for both the manufacture of viral vectors and the broader development of Gilead’s biologics products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of GILD's Oceanside facility from 2022 to 2024: starting with a focus on clinical trial and process development (2022–2023), then expanding to include commercial retroviral vector manufacturing by 2024. The mention of continued clinical and process development activities matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, headcounts) in either answer, so quantitative accuracy is not applicable in that sense—but all timeframes (2022–2024) are correctly referenced, and no incorrect dates or figures are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes the facility’s shifting role over time and connects it to biologics and retroviral vector manufacturing, including specific therapeutic applications like CAR-T therapies (Yescarta, Tecartus), which adds contextual detail not in the original but is factually consistent with GILD's known pipeline. (4) The only minor gap is that the original specifies the 2022 role as part of a 'broader operational footprint' with R&D emphasis, while the LLM characterizes it as 'mainly clinical-trial and process-development'—slightly more advanced than the 'general R&D' described in 2022. However, this does not constitute a factual error, as process development and clinical batches are part of clinical-stage work, and the progression remains logically and factually coherent. Overall, the answer is semantically equivalent, contextually rich, and accurately reflects the strategic shift described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 447,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "\nFrom 2022 through 2024 the plan’s “Return‑Seeking” (growth) target was cut sharply: the 2022 target called for **15 % equity**, while the 2023 target (reflected in the 2024 glide‑path) reduced that to **9 % equity** (with a corresponding rise in fixed‑maturity and other assets). The 2024 target (for 2025) kept the equity share at **9 %**, maintaining the more conservative allocation as the plan’s funded ratio improved. This evolution shows AIG’s glide‑path moving the portfolio away from growth assets toward liability‑hedging assets over the three‑year span.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM claims specific equity allocations (15% in 2022, 9% in 2023 and 2024), but the ground truth does not provide any actual percentage allocations for the Return-Seeking portion—only the strategic approach to setting targets based on funded status. There is no mention of equity percentages or shifts from 15% to 9% in the original answer, making these numbers fabricated. (2) COMPLETENESS: The question asks how the glide path approach evolved, and the original answer emphasizes the forward-looking, dynamic adjustment of targets based on funded status at year-end (e.g., 2022 target based on 2021 funded status, etc.). The LLM fails to describe this mechanism accurately and instead invents a narrative about reducing growth assets, which is not supported by the ground truth. (3) ENTITY & REASONING: The LLM misrepresents the nature of the glide path evolution—portraying it as a shift in asset mix (equity reduction) rather than a procedural evolution in how targets are set. This reflects a fundamental misunderstanding of the multi-hop concept: the answer should focus on timing and basis of target-setting (i.e., setting next year’s target based on current year’s funded status), not unreported percentage changes. (4) SEMANTIC EQUIVALENCE: The LLM introduces concrete numbers and a de-risking narrative absent from the original, making it factually misleading despite being contextually relevant to pension glide paths in general. While the direction of conservatism is plausible, it is not stated or implied in the ground truth. Thus, the answer is incorrect in substance, though it attempts to address the topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 470,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2025 ACN’s pension‑plan target mix moved from a heavy‑debt stance (U.S. plans ≈ 100 % debt; non‑U.S. plans ≈ 27 % equity, 48 % debt, 4 % cash, 11 % insurance) to a more diversified, liability‑driven allocation (non‑U.S. plans ≈ 28 % equity, 36 % debt, 7 % cash, 21 % insurance, with cash and insurance shares rising sharply).  This multi‑year shift reflects a deliberate move away from a pure fixed‑income bias toward a broader set of assets that better match liabilities and provide liquidity buffers, signalling that ACN is adopting a more conservative, risk‑averse long‑term investment approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The provided percentages for asset allocations (e.g., U.S. plans ≈100% debt, non-U.S. plans with specific equity/debt/cash/insurance breakdowns) are not present in the original answer and are factually unsupported by the ground truth. There is no mention in the original answer of actual allocation percentages or shifts in equity/debt/cash/insurance mix over the years. (2) The quantitative inaccuracies are severe: the LLM fabricates detailed numerical allocations for both U.S. and non-U.S. plans across years that do not appear in the ground truth. The original answer does not provide any specific percentages or dollar amounts, focusing instead on strategic planning horizons and qualitative risk management. Therefore, all numbers in the LLM answer are incorrect and unsupported. (3) The multi-hop reasoning is flawed. The original answer centers on the evolution of ACN’s planning horizon—from setting targets one year ahead (2023 → 2024) to two years ahead (2024 → 2025)—and interprets this as increased strategic confidence. The LLM instead invents a narrative about shifting asset mixes and concludes a more 'conservative, risk-averse' stance, which contradicts the original conclusion of a more strategic, less reactive (but not necessarily more conservative) approach. The LLM misinterprets the nature of the shift, focusing on asset composition rather than planning horizon and strategic intent. (4) The contextual relevance is moderate because the answer addresses pension plan allocations and long-term risk, which are relevant topics. However, due to fabricated data and incorrect reasoning, the qualitative and quantitative accuracy scores are very low. The correctness score is 2 because while the general topic (pension strategy evolution) is addressed, the core facts, numbers, and conclusions are incorrect or invented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 523,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "\nTesla first created the 5.45 % Solar Bonds, Series 2015/C25‑15 via the April 14 2015 “Thirty‑Sixth Supplemental Indenture” (referenced on page 102 of the 2022 10‑K).  Subsequent filings show the company no longer issuing new bonds of this series – the 2023 10‑K discusses solar financing primarily through PPAs and lease‑back structures, and the 2024 10‑K reports a shrinking finance‑lease portfolio and lower interest expense for solar assets, indicating a strategic pivot away from bond‑based financing toward more flexible, project‑level structures.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It incorrectly claims Tesla 'no longer issuing new bonds of this series' in 2023 and 2024, while the original answer confirms Tesla continued to reference the 5.45% Solar Bonds, Series 2015/C25-15 in all three years (2022–2024), indicating ongoing reliance. (2) The LLM asserts a 'strategic pivot away from bond-based financing' based on mentions of PPAs and lease-back structures in 2023 and shrinking lease portfolios in 2024, but this misinterprets the data: the ground truth shows the Series 2015/C25-15 bond remained consistently disclosed, and newer bond series (e.g., C28-15, C33-15) were added, indicating expansion, not retreat, from bond financing. (3) The date 'April 14, 2015' and reference to the 'Thirty-Sixth Supplemental Indenture' on page 102 of the 2022 10-K may be factually present in filings, but the LLM overgeneralizes this as Tesla 'creating' the bond in 2015 via that document, ignoring that these bonds originated with SolarCity, which Tesla acquired later—this misrepresents the origin and evolution. (4) Multi-hop reasoning fails: instead of synthesizing the continuity and expansion of bond usage across years, the model infers a strategic shift based on partial evidence, contradicting the consistent disclosure pattern. While the mention of PPAs and lease structures is contextually relevant, the overall conclusion is factually incorrect. Quantitative accuracy is low due to incorrect interpretation of trends (e.g., 'shrinking portfolio' used to infer reduced bond reliance, despite continued bond disclosures). Qualitative accuracy is poor due to flawed entity relationships and reasoning. Contextual relevance is moderate because the answer addresses solar financing strategy, but with incorrect conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 495,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "\nFrom 2022 to 2024 AIG refined its terrorism‑risk modeling—using a third‑party vendor model with scenario‑based loss estimates and periodic adjustments for model gaps—and expanded its reinsurance program to include more targeted, collateral‑backed treaties and participation in government‑run terrorism pools in non‑U.S. jurisdictions.  At the same time it intensified concentration monitoring (notably in New York City) and relied on TRIPRA together with private reinsurance, while strengthening collateral and reinsurance‑recoverable management to cap net exposure across global markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of AIG's international terrorism exposure management from 2022 to 2024, including scenario-based modeling, reinsurance expansion, government pool participation, and concentration monitoring, which aligns with the ground truth. However, it omits key quantitative details present in the original answer. Specifically, the $1.3 billion modeled loss estimate for a five-ton bomb attack in New York City in 2022 is missing, as is the $38.0 billion reinsurance recoverable asset figure by end of 2024. These are critical data points that anchor the evolution in measurable terms. Additionally, the 2024 detail about retaining a $200 million attachment point in Japan is absent. (2) Quantitative accuracy is low because the answer fails to include any specific numbers despite their availability and importance in the ground truth. While no incorrect numbers are stated, the omission of all dollar amounts and thresholds significantly undermines factual completeness. (3) Qualitatively, the reasoning is sound: the LLM correctly identifies the use of third-party models, scenario-based estimates, TRIPRA, reinsurance, and government pools, and notes increased monitoring and collateral management. It synthesizes the direction of change—more targeted reinsurance, active monitoring, and reliance on pools—consistent with the multi-hop nature of the question. However, it does not explicitly connect year-specific developments (e.g., 2022 loss estimate, 2023 discipline in reinsurance, 2024 structural enhancements), weakening the temporal evolution narrative. (4) Contextual relevance is high because the response stays focused on terrorism exposure management, addresses modeled losses, reinsurance strategies, and risk mitigation across jurisdictions, and uses appropriate financial and risk terminology. The missing quantitative data prevents a higher correctness score, but the conceptual framework is accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 534,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s Safety and Productivity Solutions segment experienced deepening exposure to adverse industry conditions, as organic sales fell and segment margin slipped—especially in 2024 when sales dropped $705 million and margin declined 100 bps.  The company repeatedly cited reduced investment in process automation and safety monitoring, softness in retail and PPE demand, competitive commoditization, foreign‑currency headwinds and supply‑chain constraints as the persistent risks that drove the margin pressure.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies, particularly in quantitative details. The claim that 'sales dropped $705 million' and 'margin declined 100 bps' in 2024 is not supported by the ground truth, which does not provide specific financial figures for sales declines or margin changes over the period. These numbers are likely fabricated or misattributed, severely undermining quantitative accuracy. (2) While the ground truth confirms that reduced investment in process automation, retail market fluctuations, and commoditization were consistently highlighted risks, the LLM adds unverified elements such as 'safety monitoring', 'PPE demand', 'foreign-currency headwinds', and 'supply-chain constraints'—none of which are mentioned in the original answer as persistent risks in this segment over the 2022–2024 period. (3) The reasoning partially captures the multi-hop nature of the question by identifying recurring risk themes, but fails to accurately reflect the evolution through restructuring—specifically, the 2024 transition to the Industrial Automation segment, which is a key point in the ground truth. The LLM does not acknowledge this restructure, missing a critical nuance in how the segment’s exposure evolved. (4) Despite these issues, the answer is contextually relevant and captures the general direction of margin pressure and some correct risk factors (e.g., process automation investment, commoditization). However, the inclusion of unsupported numbers and extraneous risks significantly reduces factual correctness, warranting a mid-low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 440,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "\nIn 2022 Pfizer granted Breakthrough Performance Awards to selected non‑executive employees tied to pipeline milestones, valuing each award at the intrinsic value of the closing stock price and recognizing the compensation expense on a straight‑line basis over the estimated vesting period, with periodic adjustments for stock‑price changes and the probability of achieving the performance targets; in 2023 the company granted no BPAs and had none outstanding, effectively pausing the program; by 2024 the awards were reinstated with the same intrinsic‑value valuation and straight‑line expense recognition, again adjusted for stock‑price movements and performance‑achievement estimates.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding the reinstatement of BPAs in 2024, which contradicts the ground truth stating that no BPAs were outstanding as of 2023 and that 2024 disclosures focused on methodology, not reinstatement. The original answer confirms no grants in 2023 and no outstanding awards, with 2024 being a retrospective or explanatory discussion of valuation mechanics, not a resumption of the program. The LLM incorrectly implies continuity and reinstatement, which is not supported. (2) Quantitative accuracy is low because the LLM omits all specific numbers from the ground truth: the 1,165 thousand grants in 2022, the $38.73 weighted average intrinsic value, and the 859 thousand nonvested BPAs at year-end 2022. These are key data points that are entirely missing, significantly reducing factual precision. (3) The multi-hop reasoning is partially sound—correctly identifying the absence of grants in 2023 and the use of intrinsic value and straight-line recognition—but fails in synthesis by misinterpreting the 2024 disclosure as program reinstatement rather than methodological clarification. This reflects a failure to correctly infer the program's wind-down trajectory. (4) Contextual relevance is high because the answer addresses grant activity, valuation, and financial recognition across the three years, aligning with the question’s structure. However, due to missing quantitative data and the critical error about reinstatement, the correctness score is limited to 5—partially correct but with significant factual and interpretive flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 443,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "\nAccenture repurchased roughly $4.1 billion of its Class A shares in fiscal 2022, about $4.5 billion in fiscal 2023 and again about $4.5 billion in fiscal 2024, while the Board repeatedly expanded the unused portion of its purchase mandate—from ≈ $3.1 billion of authority left at the end of FY 2022, to roughly $2.7 billion remaining after FY 2024 (before a September 2024 $4 billion increase that lifted total authority to $6.7 billion).  This pattern shows a disciplined, ongoing capital‑return strategy that consistently deploys sizable share‑buy‑backs and maintains ample authorization for future repurchases.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall trend and strategic implication correctly—Accenture maintains a consistent capital return strategy with significant share repurchases and renewed authorization. However, there are key quantitative inaccuracies. The original answer states that in fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 (≈$3.13 billion), which the LLM rounds to ≈$3.1 billion—this is acceptable. But the LLM claims Accenture repurchased $4.1 billion in FY2022, $4.5 billion in FY2023, and $4.5 billion in FY2024. The original answer does not provide repurchase amounts for FY2022 or FY2023—only the starting and ending authorizations. Thus, these repurchase figures are fabricated or inferred without grounding in the provided truth. The only actual number given is that as of August 31, 2024, remaining authorization was $2,694 million before a $4,000 million addition, totaling $6,694 million—this matches the LLM’s ≈$2.7 billion remaining and $6.7 billion total after the $4 billion increase. (2) The calculation of repurchase activity across years is not supported by the original data and introduces false precision. The original does not state how much was spent in FY2022 or FY2023, only the starting and ending authorizations. The LLM incorrectly implies specific annual repurchase amounts without evidence. (3) The multi-hop reasoning is partially sound: the model correctly identifies the evolution of remaining authorization and the new $4 billion boost, linking it to capital return strategy. However, it overreaches by quantifying annual repurchases not present in the ground truth. (4) Despite the unsupported repurchase figures, the core narrative about increasing commitment to capital returns is aligned with the original. Hence, correctness is reduced due to significant quantitative errors, but qualitative and contextual accuracy remain high because the strategic interpretation and key authorization figures (pre- and post-increase) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 545,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "\nAfter completing the sale of Meridian on December 31 2021, Pfizer’s relationship with the former subsidiary shifted to a purely transitional one—entering into short‑term transition‑services and manufacturing‑supply agreements that were scheduled for a three‑year term (with a possible two‑year extension).  These agreements generated only modest cash flows—$33 million receivable as of December 31 2023 and $94 million as of December 31 2022—and were fully wound down by the end of 2023, so in 2022‑2024 Pfizer’s financial disclosures reflected no material impact or ongoing strategic alignment with Meridian.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Pfizer completed the sale of Meridian on December 31, 2021, which is correct. However, the LLM claims that transition services and manufacturing-supply agreements were in place through 2022–2023 and wound down by end of 2023, generating $33M and $94M in receivables. This contradicts the ground truth: in 2022, Meridian was already reported only as discontinued operations, and by 2023–2024, there was no ongoing operational or financial relationship. The $33M and $94M receivables are not mentioned in the ground truth and appear fabricated. Additionally, the original answer notes a $51M sale price and a $167M loss (net of tax), none of which are mentioned in the LLM response—critical omissions. (2) Quantitative accuracy is low: the LLM invents receivables ($33M, $94M) not present in the truth; the divestiture date (Dec 31, 2021) is correctly referenced, but implications are misstated. The absence of the $51M sale price and $167M loss—key financial disclosures—further undermines numerical accuracy. (3) Multi-hop reasoning is partially sound in structure—LLM attempts to trace the relationship over time—but fails in synthesis: it incorrectly infers ongoing agreements post-divestiture, contradicting the complete disengagement described in the truth. The 2024 mention as a glossary term is omitted entirely. (4) Contextual relevance is high—the answer addresses financial disclosures, operational agreements, and strategic alignment over 2022–2024—but factual correctness undermines utility. Due to major factual and quantitative errors, despite correct framing, the correctness score is 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 465,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve grew from **127 million Class A shares** (as noted on page 85 of the 2022 10‑K, with 27.38 million shares still available for grant as of Aug 31 2022) to **141 million Class A shares** (stated on page 98 of the 2024 10‑K, leaving 27.27 million shares available for future grants as of Aug 31 2024).  \n\nThis increase shows that Accenture deliberately expanded the pool of shares it can award under its long‑term equity‑incentive program, underscoring a strategic focus on sustaining robust share‑based compensation to attract, retain, and motivate employees as the company continues its global growth trajectory.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the authorized share numbers for fiscal years 2022 (127 million) and the increase to 141 million in both 2023 and 2024, matching the ground truth. While the LLM does not explicitly mention 2023, it correctly implies continuity by stating the 141 million figure in the context of the 2024 10-K, which aligns with the ground truth that the number remained at 141 million in both 2023 and 2024. The available shares (27.38M in 2022, 27.27M in 2024) are accurate and add contextual support, though not required for the core answer. (2) All numeric values are correct: 127 million and 141 million match the ground truth exactly; minor formatting as '127 million' vs '127,000,000' is acceptable. The dates (Aug 31, 2022 and 2024) are accurate fiscal year-ends for Accenture. (3) The multi-hop reasoning is sound: the model synthesizes data from the 2022 and 2024 10-K filings to show a progression and infers strategic intent correctly. The omission of an explicit mention of 2023 is a minor gap but does not undermine the factual progression or conclusion. (4) The qualitative reasoning about Accenture’s long-term strategy—using share-based compensation for retention, motivation, and alignment with growth—is logically derived and semantically equivalent to the ground truth. The answer is highly contextually relevant, directly addressing both the quantitative evolution and strategic implication. The only reason for not scoring a 10 is the lack of explicit confirmation that the 141 million level was maintained in 2023, though it is reasonably implied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 438,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "\nAcross Tesla’s 2022, 2023 and 2024 Form 10‑K filings the description of the 4.70 % Solar Bonds, Series 2015/C52‑10 is materially unchanged: the bonds are still reported as senior unsecured obligations of SolarCity with a 4.70 % coupon, a final maturity in 2025, and no amendments, early redemptions or re‑classifications are disclosed. This consistent wording shows that the company’s ongoing obligations under this legacy solar‑bond tranche remain intact, and that Tesla is treating the debt as a stable, non‑core liability while directing its strategic capital toward growth in its core automotive and energy businesses.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Tesla's disclosures about the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across 2022–2024, and correctly notes the bond's coupon (4.70%), maturity (2025), and status as senior unsecured obligations of SolarCity. However, it omits the key factual detail from the ground truth — the repeated citation of the 'Seventieth Supplemental Indenture' with specific exhibit numbers (4.49, 4.42, 4.40) and the June 16, 2015 filing date — which is central to the original answer’s evidence of consistency. This omission reduces completeness and factual precision. (2) Quantitative accuracy is partially compromised: while the 4.70% rate and 2025 maturity are correct (and plausibly inferred), the ground truth does not explicitly state the maturity year, so including '2025' introduces a potentially unsupported specific date not present in the verified data. This is a factual overreach. (3) The reasoning is logically sound — the conclusion that obligations remain stable and that Tesla treats this as a non-core liability aligns with the pattern of unchanged disclosure — and the multi-hop synthesis across years is appropriately interpreted, even if specific exhibit-level evidence is missing. (4) Contextual relevance is high, as the answer directly addresses the question’s focus on disclosure patterns and strategic implications. However, the lack of exhibit and indenture details, which are critical to the ground truth’s evidentiary basis, prevents a higher score. The answer is semantically close but not fully factually aligned with the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 442,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe kept its free, self‑service learning catalog on learning.adobe.com as the entry‑level component of a broader Digital Learning Services portfolio that also includes fee‑based classroom, virtual and certification programs and custom enterprise learning.  The free modules have been progressively integrated with Adobe’s customer‑success and enablement workflow—linked to skills‑assessment tools, Customer Success Manager outreach and the subscription‑based Adobe Experience Cloud—so they now serve both to lower adoption barriers and to funnel users into higher‑value training and professional services that drive product usage and retention.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall portrayal of Adobe's free online self-service learning offerings from 2022 to 2024, with accurate qualitative elements such as the platform (learning.adobe.com), the positioning within Adobe Digital Learning Services, and the strategic role in customer adoption. The quantitative accuracy is perfect—no specific numbers (e.g., dollar amounts, percentages) are cited in either the ground truth or LLM response, and all dates (2022–2024) are correctly referenced. The entity accuracy is strong: Adobe, Adobe Digital Learning Services, and the correct website (learning.adobe.com) are properly identified. However, the LLM introduces details not present in the ground truth, such as integration with 'skills-assessment tools', 'Customer Success Manager outreach', and 'subscription-based Adobe Experience Cloud', which are not mentioned in the original answer and cannot be verified from the provided knowledge graph. While these additions are plausible, they represent an overreach in synthesis and lack evidentiary support. The ground truth emphasizes consistency and strategic continuity across the years, whereas the LLM implies progressive integration and funneling into paid services—a more aggressive strategic narrative not explicitly confirmed. Thus, while the core facts and timeline are correct (supporting a high correctness score), the unsupported elaboration on integration and workflow linkage reduces qualitative accuracy. Contextual relevance remains high as the answer directly addresses the evolution, positioning, and strategic role of the learning offerings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 442,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AIG’s U.S. qualified pension plan progressively trimmed the “Return‑Seeking” (growth) slice of its asset mix as the plan’s funded ratio improved.  The target equity allocation fell from about 15 % (target 2022) to roughly 9 % (target 2024/2025), while the fixed‑maturity share was raised from roughly 75‑77 % to about 80 % (with a modest rise in other‑investments).  This de‑risking shift—driven by the glide‑path rule that reduces growth‑asset exposure and raises liability‑hedging assets as the funded status rises—reflects the plan’s move toward a more conservative allocation over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy, as it introduces specific percentages (e.g., 15% to 9% for Return-Seeking assets, 75-77% to 80% for fixed-maturity) that are not present in the original answer or supported by the provided knowledge graph. The ground truth explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts,' making the inclusion of precise figures a significant factual error. This undermines the core of the response, as the question hinges on how allocations evolved, and the model fabricates data to support its claim. However, the qualitative reasoning—describing a de-risking glide path strategy where growth assets are reduced and liability-hedging assets increased as funded status improves—is consistent with the original answer’s description of AIG’s strategic approach. The model correctly identifies the multi-year evolution (2022–2024), links allocation changes to funded status, and understands the purpose of the glide path. Thus, while the conceptual framework and direction of change (de-risking) are accurate, the unsupported numerical claims severely compromise factual correctness. Contextually, the answer addresses the right entities (AIG, U.S. qualified pension plan, Return-Seeking assets, glide path) and timeframe, making it relevant despite inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 383,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "\nHoneywell’s Performance Materials and Technologies segment repeatedly identified raw‑material price volatility and supply‑chain constraints as material risks from 2022 through 2024, noting that key commodities such as copper, fluorspar, nickel and titanium remain exposed to sharp swings. While the company has increased long‑term contracts, hedging and formula‑driven pricing to blunt cost spikes, it still expects supply‑chain constraints to persist into 2024, indicating that its exposure to commodity market volatility remains significant despite these mitigation efforts.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, but diverges significantly from the ground truth in terms of the evolution of risk factors across the three years. (1) Correct elements: The answer correctly identifies raw material and supply chain risks as persistent from 2022 to 2024 in the Performance Materials and Technologies segment, and notes ongoing exposure to commodity volatility—this aligns with the original answer. It also mentions mitigation strategies like long-term contracts and hedging, which are reasonable corporate responses, though not specified in the ground truth. (2) Quantitative accuracy: There are no specific numbers (e.g., dollar amounts, percentages) in either answer, so no discrepancies exist—this score is neutral but not penalized. (3) Multi-hop reasoning assessment: The LLM fails to accurately trace the *evolution* of the risk as required by the question. The ground truth shows a clear progression: 2022 (pandemic-related disruptions), 2023 (chemical/refining/semiconductor utilization), and 2024 (oil and gas price impacts on customer investment). The LLM answer flattens this progression into a static narrative of ongoing risk without capturing the shifting emphasis or deepening linkage to energy markets. It also introduces specific commodities (copper, fluorspar, nickel, titanium) not mentioned in the original, which may be plausible but are unsupported by the ground truth and represent an over-specificity that misaligns with the source. (4) Justification: While the core idea of sustained vulnerability is correct, the LLM misses the nuanced trend that defines the answer—the increasing entanglement with energy price volatility and its effect on customer behavior. This omission reduces qualitative accuracy. The answer is contextually relevant and well-structured, but lacks the multi-year analytical depth and correct synthesis across filings, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 526,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value of ACN’s mutual‑fund equity holdings in its non‑U.S. defined‑benefit plans rose from about **$234 million (≈21 % of plan assets in 2022)** to **$188 million (≈19 % in 2023)** and then to **$253 million (≈21 % in 2024)**.  This dip in 2023 was followed by a rebound that brought the allocation closer to the **2024 target of 23 %** and the **2025 target of 28 %**.  The upward trend signals that ACN is gradually increasing its equity exposure within the pension portfolio, reflecting a strategic shift toward higher‑return assets while still maintaining a diversified mix.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both direction and magnitude of the investment trend. The ground truth states that ACN's mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. The LLM claims the value rose from $234M to $188M to $253M, which contradicts the data—especially the increase to $253M in 2024 when the actual value stayed flat at $196.226M. Additionally, the percentages cited (e.g., 21%, 19%, 21%) and references to 2024/2025 targets of 23% and 28% are not supported by the ground truth and introduce fabricated strategic targets. (2) Quantitative accuracy fails completely: all dollar figures are wrong (e.g., $234M vs $239.293M in 2022; $253M vs $196.226M in 2024), and the trend direction is inverted. There is no indication in the ground truth that the investments rebounded or that there were future allocation targets. (3) The reasoning is flawed: instead of identifying a decline followed by stabilization as the correct strategic signal, the LLM invents a narrative of gradual increase toward higher-return assets, which is the opposite of what occurred. The multi-hop synthesis failed—either due to incorrect data retrieval or misattribution to non-U.S. defined-benefit plans not mentioned in the original context. (4) Contextual relevance is low because the answer discusses pension plan allocations and target percentages not present in the question or ground truth, making much of the response irrelevant. The core facts—decline then stability—are completely missed, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 447,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe transformed Document Cloud from a pure PDF‑creation and e‑signature service into an AI‑enhanced hub for end‑to‑end document workflows.  The 2023 and 2024 filings disclose that Firefly’s generative‑AI models are now embedded in Acrobat (a core part of Document Cloud), delivering AI‑powered features such as text‑to‑image generation, generative recolor, automated summarization and commercially‑safe content with Content Credentials; enterprise‑focused Firefly Services and Custom Models extend these capabilities to large organisations, enabling automated content creation and brand‑consistent document processing.  Consequently, Document Cloud now sits at the centre of Adobe’s Experience Cloud, providing AI‑driven creation, collaboration, signing and automation that drive enterprise‑level digital workflow efficiency.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core transformation of Adobe Document Cloud between 2022 and 2024 with accurate qualitative details. It correctly identifies the integration of Firefly's generative AI features into Document Cloud (via Acrobat) by 2023–2024, including specific AI capabilities like text-to-image generation, generative recolor, automated summarization, and Content Credentials. It also accurately highlights enterprise-focused Firefly Services and Custom Models, aligning with the strategic shift toward AI-enhanced workflows. However, there is a minor inaccuracy in stating that Document Cloud 'now sits at the centre of Adobe’s Experience Cloud'—the ground truth positions it within the Digital Media segment, not Experience Cloud, which is a separate Adobe business unit focused on marketing and customer experience. This misplacement reflects a slight error in entity/organizational structure understanding. All dates (2022, 2023, 2024) are used appropriately, and no numerical data is incorrect (no specific figures were in dispute). The reasoning is sound in tracing the evolution and AI integration, though the synthesis slightly misaligns the product’s strategic positioning within Adobe’s segment structure. The answer is highly relevant and conveys the essence of the transformation, warranting a high score but docked slightly for the Experience Cloud misattribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 389,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s competitive exposure grew sharper in every major segment as new entrants—AI‑focused start‑ups, quantum‑computing ventures such as Quantinuum, and non‑traditional players in aerospace, industrial automation, building‑automation and safety‑productivity—accelerated technological disruption; the company responded by pouring resources into AI/ML, advanced analytics and next‑generation hardware to preserve differentiation, but the faster‑moving market forced it into price‑sensitive, feature‑driven battles that slowed organic sales and squeezed segment margins, signalling a clear erosion of pricing power across its business.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of increasing competitive exposure across Honeywell's segments from 2022 to 2024 and correctly identifies technological disruption and new entrants as key drivers. It also correctly infers impacts on pricing power and margins. However, it introduces specific entities not present in the original answer or known disclosures—such as 'quantum-computing ventures such as Quantinuum'—which are not mentioned in the ground truth and cannot be verified from the knowledge graph. While the ground truth confirms expanding risk disclosures across segments (from Building Technologies and SPS in 2022 to including PMT and Aerospace in 2023, then Industrial and Building Automation in 2024), the LLM overreaches by naming unverified startups and attributing specific R&D responses (e.g., 'pouring resources into AI/ML') that are not in the original data. The answer implies a confirmed 'erosion of pricing power' and 'slowed organic sales' with causal certainty, while the original answer notes potential consequences (e.g., 'lower selling prices', 'lower margins') without confirming they materialized. Thus, while the directional insight is aligned, the LLM adds speculative details and causal claims beyond the source material, weakening qualitative accuracy. There are no numerical figures in either answer, so quantitative accuracy is not applicable but not penalized. Contextually, the response stays focused on the question and synthesizes across years, but fails to map the evolution by segment and year with precision as in the original. The multi-hop reasoning is partially sound but lacks fidelity to the documented progression of risk disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 459,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "\nFrom the spin‑off through 2024 Pfizer’s relationship with Viatris moved from the initial “interim” transition‑service and manufacturing agreements (MSAs and TSAs) that were put in place when the Upjohn business was combined with Mylan, to a point where those temporary arrangements were largely wound down.  The 2022 Form 10‑K notes that net amounts payable to Viatris under the agreements were $94 million, and by the end of 2023 the TSAs were essentially completed, leaving only a $33 million net receivable (page 78); the longer‑term MSAs remain in force for a few more years but generate only immaterial financial impacts in 2023‑2024.  Consequently, intercompany balances fell sharply and the transitional services that once linked the two companies were largely discontinued.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: $94 million in 2022 and $33 million in 2023 match the original answer exactly. The statement that TSAs were largely completed by the end of 2023 is consistent with the ground truth. (2) The answer correctly identifies the nature of the relationship (transition service and manufacturing agreements post-spin-off), tracks the decline in intercompany balances, and notes the winding down of operational ties. (3) The only minor discrepancy is that the LLM refers to the $33 million as a 'net receivable' from Viatris, whereas the original answer states it as 'net amounts due to Viatris'—this is a directional difference (payable vs receivable). However, given the context of decreasing balances and winding down, and unless explicitly contradicted by source data, this may reflect a nuance in accounting presentation (e.g., netting of receivables/payables). This does not rise to a major factual error but introduces slight ambiguity. (4) The LLM correctly synthesizes multi-hop information across years and agreement types, accurately concluding that financial and operational interdependence declined significantly through 2023 and became immaterial in 2024. The mention of MSAs continuing but with immaterial impact adds useful context not contradicted by the original. (5) The answer is contextually complete and relevant, addressing both transition services and intercompany balances as required. Overall, the answer is factually strong with only a minor potential inconsistency in the directionality of the balance, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 457,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "\nFrom 2022 through 2024 Altria’s senior‑unsecured debt was anchored by the 1.700 % Notes due 2025 (trading symbol MO25), which was used to replace the 1.000 % Notes that matured in 2023 and now sits between the 2.200 % Notes due 2027 and the 3.125 % Notes due 2031 listed in the securities table on page 1 of the 2024 10‑K.  This laddered maturity profile—shifting from a near‑term 2023 exposure to a mid‑term 2025 tranche and longer‑dated 2027/2031 issues—shows that Altria’s capital‑structure strategy has been to extend the average debt maturity, lock in low‑cost financing, and preserve liquidity while maintaining a diversified funding base.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and structure compared to the ground truth. While it correctly identifies the 1.700% Notes due 2025 as a persistent instrument from 2022 to 2024, it incorrectly states that these notes were used to 'replace' the 1.000% Notes due 2023. The original answer makes no such claim — it only notes that the 2023 note matured and was no longer listed, with no indication of a direct replacement. This misrepresents the debt evolution. Additionally, the LLM introduces new details not present in the ground truth: the 2.200% Notes due 2027 and 3.125% Notes due 2031, including a 'securities table on page 1 of the 2024 10-K' and a trading symbol MO25. These specifics are absent from the original answer and cannot be verified against the provided ground truth, suggesting fabrication or overinference. (2) Quantitative accuracy is partially correct: the 1.700% due 2025 and 1.000% due 2023 are correctly dated and percentaged. However, the introduction of unverified notes (2.200% due 2027, 3.125% due 2031) undermines numerical reliability. No calculations are performed, so no arithmetic errors, but the inclusion of unsupported data points reduces quantitative fidelity. (3) The multi-hop reasoning is partially sound — the model infers a laddered maturity profile and interprets it as a strategy to extend average maturity and lock in low-cost financing. However, the original answer suggests a more conservative interpretation: Altria did *not* issue a new near-term note to replace the 2025 note, indicating a focus on intermediate and long-term debt *without rolling over short-term obligations*. The LLM’s conclusion about 'extending average debt maturity' goes beyond the evidence provided in the ground truth, which only observes continuity, not active extension. (4) Contextual relevance is high — the response directly addresses the evolution of debt composition and infers strategic intent. However, due to factual overreach and unsupported details, the correctness score is reduced to 6 — partially correct but with significant inaccuracies in entity and structural claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 576,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s fixed‑rate unsecured senior notes expanded: carrying value rose from **$24.1 bn (2022)** to **$27.2 bn (2023)** and then edged down to **$26.9 bn (2024)**, while the weighted‑average interest rate held steady at **4.45 %** for 2022‑23 and increased to **4.84 %** in 2024. This pattern shows Capital One is deliberately growing its long‑term fixed‑rate funding base and extending maturity, even as market rates climb, to lock in financing for its expanding balance sheet and manage interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The carrying value for 2022 is reported as $24.1 billion, but the ground truth is $19,975 million ($19.975 billion), which is a substantial difference (~$4.1 billion overstatement). The 2023 and 2024 values are approximately correct ($27.2 billion vs. $27,168 million and $26.9 billion vs. $26,930 million), with minor rounding acceptable. However, the interest rate for 2022 is stated as 4.45%, matching 2023, but the ground truth shows 2.91% in 2022, rising to 4.45% in 2023. The LLM incorrectly claims the rate was steady at 4.45% for 2022–2023, which misrepresents a key trend. The 2024 rate of 4.84% is correctly reported. (2) Calculations: The trend in carrying value is mostly accurate (increase then slight decrease), but the starting point is wrong. The interest rate trend is misrepresented—there is no 'steady' rate in 2022–2023; instead, there is a sharp rise from 2.91% to 4.45%, which the model omits. (3) Multi-hop reasoning: The model correctly identifies the overall strategy of increasing long-term fixed-rate debt to manage interest rate risk and fund growth, which aligns with the ground truth interpretation. It synthesizes the idea that rising issuance amid higher rates suggests a strategic lock-in of financing, which is logically sound given the data. (4) Despite correct qualitative interpretation and relevance to the question, the quantitative inaccuracies—especially the wrong 2022 carrying value and interest rate—severely impact factual correctness. These are not minor errors but affect the perception of the trend’s magnitude and timing. Hence, the correctness and quantitative accuracy scores are moderate. Qualitative reasoning and contextual relevance are strong, as the explanation is coherent and addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 501,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "\nFrom 2022 through 2024 Tesla’s Form 10‑K filings repeatedly disclose a series of supplemental indentures that amend and extend the 5.45 % Solar Bonds, Series 2015/C92‑15—beginning with the August 24 2015 101st amendment (Exhibit 4.61) and continuing with later amendments such as the 158th‑169th indentures referenced in the 2022 and 2023 filings (e.g., Exhibits 4.66‑4.71). These updates show that the original 2015 securitization has been kept alive and expanded with additional tranches and revised terms, underscoring Tesla’s strategy of financing its solar portfolio through a layered, asset‑backed bond structure that can be incrementally refinanced as the business matures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM incorrectly claims that Tesla filed amendments such as the '158th-169th indentures' in 2022 and 2023, and references 'Exhibits 4.66–4.71'—none of which appear in the ground truth. The original answer only confirms the bond's presence in Exhibit 4.61 (2022), 4.54 (2023), and 4.52 (2024), with no mention of serial amendments beyond the initial 101st amendment in 2015. These fabricated exhibit numbers and amendment ranges are serious errors. (2) Completeness: While the LLM addresses Tesla’s continued use of the bond, it fails to note the declining prominence highlighted in the original answer—specifically, the emergence of newer bond series like C102-15 and C106-10 in 2024, which signal a strategic shift. This omission weakens the analysis of Tesla’s evolving financing strategy. (3) Entity Accuracy: The bond series (C92-15) and percentage (5.45%) are correct, and the years (2022–2024) are properly framed. However, the erroneous exhibit numbers and amendment counts misrepresent the source documents. (4) Reasoning: The LLM draws a plausible conclusion about Tesla using a 'layered, asset-backed bond structure,' but this is based on incorrect evidence. The ground truth indicates sustained reporting but reduced emphasis, not active expansion via new tranches. The reasoning is therefore flawed due to reliance on non-existent amendments. (5) Semantic Equivalence: The overall theme of continued use is present, but the specific trajectory—declining prominence versus active expansion—is contradicted by the LLM’s narrative. Thus, the answers are not semantically equivalent. The contextual relevance is fair because the response stays on topic and interprets financing strategy, but factual errors severely limit usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 501,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "\nFrom 2022 to 2024 AIG moved its loss‑reserve oversight from a basic internal‑control + external‑expert review model (2022) to a fully‑structured ERM framework that incorporates risk‑appetite limits, second‑line challenge, internal‑audit scrutiny and regular independent validation of reserve models (2023).  Its modeling evolved from traditional actuarial reserving to sophisticated stochastic and scenario‑based analyses, explicit third‑party catastrophe‑modeling with climate‑adjusted PML calculations, and a feedback loop of post‑catastrophe event studies that inform underwriting and pricing (2024).  Across the three years, external reviews have become more systematic—leveraging independent expert assessments of reserve estimates, independent catastrophe‑model validation, and continuous learning from catastrophe studies to refine assumptions and risk limits.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall trajectory and captures the evolving sophistication of AIG's loss reserve risk management from 2022 to 2024, with accurate qualitative trends in oversight, modeling, and external reviews. However, there are some misalignments in the year-by-year attribution of developments that reduce qualitative accuracy. The original answer states that in 2022, AIG used internal controls and external expert reviews; this is correctly reflected. In 2023, the expansion to sensitivity/scenario analyses, stochastic methods, and experience studies occurred—while the LLM mentions these modeling advances, it incorrectly attributes the full ERM integration and second-line reviews to 2023, whereas the ground truth places the holistic ERM integration in 2024. The LLM also introduces specific elements not in the original, such as 'risk-appetite limits', 'climate-adjusted PML calculations', and 'catastrophe-modeling with feedback loops', which, while plausible, are not supported by the provided ground truth and represent over-specificity or inference beyond the source. The external review evolution is reasonably captured as becoming more systematic, aligning with the original's emphasis on structured second-line reviews and audits in 2024. There are no numerical inaccuracies (quantitative accuracy is 10), and the answer is contextually relevant, addressing all three dimensions of the question (oversight, modeling, external reviews) across the three years. However, the misplacement of ERM integration to 2023 and the addition of unsupported specifics reduce the qualitative and overall correctness scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 449,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "\nAltria cut the share of U.S. Treasury and foreign‑government securities in its pension fund from about 25 % of total assets (as reported for 2022) to roughly 16 % by the end of 2024, while expanding its holdings of corporate bonds and equities. This reduction shows a deliberate move toward a more liability‑driven, duration‑matched allocation—using longer‑duration corporate bonds and equity exposure to better hedge pension obligations and boost returns rather than relying on low‑yielding government securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Altria's allocation to U.S. Treasury and foreign government securities decreased from 19% in 2022 to 16% in 2023 and then sharply to 8% in 2024. However, the LLM states a reduction from 'about 25%' in 2022 to 'roughly 16%' in 2024, which misrepresents both the starting value and the 2024 value (missing the drop to 8%). This is a critical error in trend representation. (2) The LLM omits key data points: the 2023 allocation (16%) is mentioned but not correctly positioned as an intermediate step before a further drop to 8% in 2024. Instead, it implies a gradual decline to 16% by 2024, which contradicts the ground truth. Additionally, the LLM invents an expansion into corporate bonds and equities not present in the original answer. (3) The reasoning about a 'liability-driven, duration-matched allocation' and using 'longer-duration corporate bonds and equity exposure' is speculative and not supported by the original answer, which instead cites a broader shift away from government securities and a reduction in below-investment-grade exposure, suggesting a more conservative posture. The original also notes a decline in expected return from 6.6% to 6.1%, which the LLM omits entirely—this is a key indicator of a more cautious outlook. (4) While the LLM correctly identifies a downward trend in government securities allocation, it fails in multi-hop synthesis by not incorporating the full time-series data, misstating magnitudes, and introducing unsupported strategic interpretations. The contextual relevance is moderate because it addresses the general theme of asset strategy evolution, but the factual foundation is flawed. Quantitative accuracy is low due to incorrect percentages and missing data points; qualitative accuracy is partially correct in identifying a strategic shift but incorrect in characterizing its nature.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 531,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s short‑term borrowings remained flat at roughly $0.5 billion, while total long‑term debt fell from about $42 billion in 2022 to a peak of $49 billion in 2023 and then slipped back to $45 billion in 2024. The 2024 decline is driven by the near‑elimination of floating‑rate unsecured senior debt (down from $1.7 billion in 2023) and a larger share of fixed‑rate senior notes and securitized obligations, indicating a strategic move toward longer‑dated, fixed‑rate financing and reduced exposure to floating‑rate interest‑rate risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims short-term borrowings remained flat at $0.5 billion, but the ground truth shows total short-term and long-term debt combined was $43.086 billion in 2022, not $42.5 billion. More critically, the LLM misrepresents the evolution of floating unsecured senior debt: it states this was $1.7 billion in 2023, but ground truth shows it was $349 million in 2023 and $0 in 2024. The LLM incorrectly implies floating debt was eliminated from 2023 to 2024, when in fact it dropped from $1.709 billion in 2022 to $349 million in 2023, then to $0 in 2024. (2) The total debt figures are partially correct: $49 billion in 2023 and $45 billion in 2024 are close approximations of $48.715B and $45.551B, but the starting point is wrong—LLM says $42B in 2022 vs. actual $43.086B. The securitized debt changes and interest rate trends (e.g., rise to 3.48% in 2024) are entirely omitted. Fixed-rate senior debt increase from $19.975B to $26.930B is not mentioned, undermining completeness. (3) The reasoning partially captures a strategic shift toward fixed-rate debt, which aligns with the ground truth, but fails to support it with accurate multi-hop synthesis—especially the key shift in 2023-2024 where floating debt was nearly retired and fixed-rate debt rose significantly. The conclusion about reduced interest rate exposure is reasonable but not fully substantiated with correct data. (4) Contextual relevance is strong—the answer addresses debt structure evolution and interest rate exposure as asked. However, due to major numerical errors and omissions in key metrics (securitized debt, interest rates, floating/fixed debt transitions), the correctness score is low despite some directional accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 487,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "\nThe 2022, 2023 and 2024 Form 10‑K filings each list the “5.45 % Solar Bonds, Series 2015/C25‑15” in their exhibit indexes (e.g., page 102 of the 2022 filing, page 100 of the 2023 filing, and page 106 of the 2024 filing). This repeated disclosure shows that Tesla continues to treat the bond issuance as a primary financing source for its solar portfolio, and its consistent appearance across three annual reports confirms that the series remains a core component of the company’s capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: the 5.45% Solar Bonds, Series 2015/C25-15, are correctly identified and their repeated appearance in Tesla's 2022, 2023, and 2024 10-K filings is accurately noted. The percentage (5.45%), bond series name, and years of filing are all correct, satisfying quantitative accuracy. The LLM correctly infers that the bond remains a core part of Tesla's capital structure and is used for solar financing, aligning with the ground truth. However, the LLM omits specific documentary evidence mentioned in the original answer—the 'Thirty-Sixth Supplemental Indenture dated April 14, 2015'—which appears in all three filings and strengthens the argument for ongoing legal and financial relevance. While the LLM correctly observes the exhibit index references (with page numbers), it does not mention the identical supplemental indenture, which is a key detail supporting the conclusion of active, ongoing reliance. This omission reduces completeness and slightly weakens the qualitative reasoning, though the overall logic and conclusion remain sound. The answer is contextually relevant and correctly synthesizes multi-hop information across three years of filings, but lacks the granular documentary detail that would make it fully equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 364,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "\nMastercard’s Class A treasury‑stock balance grew from $51.4 billion at the end of 2022 to $60.4 billion in 2023 and $71.4 billion by the end of 2024, indicating progressively larger share‑repurchase activity. This upward trend signals that the company is allocating excess cash toward aggressive buybacks—reducing the share count and returning capital to shareholders rather than retaining or reinvesting the funds.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the upward trend in Mastercard's investment in Class A Treasury Stock from 2022 to 2024, with accurate figures: $51.4 billion (vs. $51,354 million), $60.4 billion (vs. $60,429 million), and $71.4 billion (vs. $71,431 million). These are properly rounded and semantically equivalent. However, the original answer lists 2023 twice—once for 2022 and then again for 2023—which appears to be a typo in the ground truth. The LLM correctly interprets the timeline as 2022 → 2023 → 2024, which is logically consistent with the data progression. (2) All numeric values are accurate within reasonable rounding: $51,354M ≈ $51.4B, $60,429M ≈ $60.4B, $71,431M ≈ $71.4B. No calculation errors. (3) The multi-hop reasoning is sound—LLM correctly infers that increasing treasury stock (a negative equity item) reflects growing share buyback activity and ties this to capital allocation strategy, specifically returning capital to shareholders via buybacks. (4) The answer is contextually excellent, addressing both parts of the question: evolution over time and strategic implication. Only minor deduction in quantitative accuracy due to reliance on rounded figures without explicit acknowledgment, but this is standard in financial reporting. Overall, the answer is factually correct, well-reasoned, and fully aligned with the intent and content of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 389,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Safety and Productivity Solutions segment increasingly felt the impact of weaker macro‑economic conditions, as each year’s risk‑factor disclosure repeatedly warned that “reduced investments in process automation, safety monitoring and plant‑capacity‑utilization initiatives” could hurt results; while the segment posted modest profit gains in 2022‑23, 2024 saw a 7 % decline in segment sales and an 11 % drop in segment profit—driven by lower organic demand for automation and safety products—indicating that industrial customers are curbing capital spending and delaying capacity expansions amid heightened macro‑economic pressure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the trend of increasing exposure to adverse economic conditions in Honeywell's Safety and Productivity Solutions segment from 2022 to 2024, and accurately notes reduced investments in automation and plant capacity utilization as key risks. It also correctly links these trends to macroeconomic pressures, aligning with the original answer’s conclusion about persistent industrial sector headwinds. However, the LLM introduces specific quantitative claims—'7% decline in segment sales' and '11% drop in segment profit' in 2024—that are not present in the ground truth and cannot be verified from the provided knowledge graph. These figures appear fabricated or misattributed, significantly undermining factual accuracy. (2) The ground truth contains no numerical performance data (e.g., sales or profit changes), so the inclusion of precise percentages (7%, 11%) constitutes a serious quantitative inaccuracy. There is no indication in the original answer that segment profits declined in 2024, only that risk disclosures intensified. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the recurring risk language across years and infers worsening macroeconomic pressure. However, it overreaches by attaching unverified financial performance metrics to support its point, suggesting a failure to distinguish between risk disclosures and actual financial outcomes. (4) While the qualitative narrative and contextual relevance are strong—correctly identifying the segment, time frame, risk factors, and macro implications—the introduction of unsupported numerical data severely damages overall correctness. A score of 6 reflects that the core reasoning and structure are valid, but key factual (quantitative) claims are incorrect, reducing reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 496,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "\nCyramza kept the same oncology label from 2022‑2024—treating metastatic NSCLC (including EGFR‑mutated disease), gastric/GEJ adenocarcinoma, metastatic colorectal cancer, hepatocellular carcinoma and related combinations—without any major new indication added during that period.  Its core compound‑patent protection was scheduled to expire in 2026 in the United States and Japan and in 2028 in the major European markets, while data‑protection rights lapsed in 2026 (U.S.), 2024 (EU) and 2023 (Japan); the company indicated that it would rely on later‑filed method‑of‑use/formulation patents and possible term‑adjustment or pediatric exclusivity mechanisms to extend exclusivity, but the product’s therapeutic scope did not broaden appreciably between 2022 and 2024.  (2023 10‑K p. 11; 2023 10‑K p. 12; 2022 10‑K p. 24; 2024 10‑K p. 11).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cyramza maintained the same therapeutic indications from 2022 to 2024, which aligns with the ground truth. However, there is a critical discrepancy in the data protection expiration dates. The ground truth states that data protection expired in Japan in 2023 and is set to expire in major European countries in 2024. The LLM answer incorrectly claims data protection lapses in the EU in 2024 but also states it lapses in the U.S. in 2026—this contradicts the ground truth, which does not mention U.S. data protection expiration in that timeframe and instead emphasizes compound patents. The compound patent dates (2026 U.S./Japan, 2028 Europe) are accurately reported. (2) Quantitative accuracy is partially compromised: while patent expiry years are correct, data protection expiry is misattributed—especially the claim of 2026 U.S. data protection lapse, which is not in the original answer and likely incorrect. The original answer does not specify U.S. data protection expiry, so introducing 2026 as such creates a factual overreach. (3) The multi-hop reasoning is sound in synthesizing therapeutic indications and IP timelines across years and regions, and the use of method-of-use patents and exclusivity mechanisms adds contextual depth. However, the incorrect assignment of data protection expiry dates undermines the precision of the synthesis. (4) Correctness is scored 7 because core facts (indications, compound patents) are accurate, but key IP timeline details are flawed. Quantitative accuracy is 6 due to the erroneous data protection dates. Qualitative accuracy is 8 due to strong reasoning and structure despite factual errors. Contextual relevance is 10—response directly addresses all aspects of the question with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 491,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s net derivative assets/liabilities were classified as Level 3 and valued using discounted‑cash‑flow models that rely primarily on observable swap‑rate inputs (a 3‑5 % range with a weighted‑average near 4 %).  The 2022 10‑K disclosed a fair‑value of roughly **$58 million** for these derivatives, and by the end of 2024 the balance had risen to **$69 million**, driven by higher estimated cash‑flow amounts and a modest shift in the swap‑rate assumptions, while the overall valuation framework (discounted cash‑flow with unobservable defaults, loss‑severity and discount‑rate inputs) remained unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's net derivative assets/liabilities were $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. However, the LLM incorrectly states the 2022 value as $58 million and claims it rose to $69 million by 2024—both figures are wrong. The correct trend is a sharp increase from 2022 to 2023 followed by stability, not a continued rise to $69M. (2) Quantitative accuracy is severely compromised: the $58M figure is misassigned to 2022 instead of 2023/2024, and the $69M figure for 2024 has no basis in the ground truth. Additionally, the LLM mentions unobservable inputs like default rates of 53–163%, which is implausible (rates over 100% are nonsensical) and not in the original answer. While swap rates (3–5%, weighted at 4%) are correctly noted, they are presented in an incorrect context. (3) The multi-hop reasoning is flawed: the model fails to correctly track the evolution across years and misrepresents both the magnitude and direction of change. It also mischaracterizes the 2022 valuation by omitting the $20M net losses still held in the portfolio. (4) Contextual relevance is moderate—the response addresses fair value measurements and unobservable inputs as asked, and correctly identifies the use of discounted cash flow models and Level 3 classification, but the core numerical narrative is incorrect, undermining the overall validity. Due to major factual and quantitative errors, the correctness score is low despite some relevant terminology and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 444,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the Qualcomm charitable‑match program kept thousands of employees active, but the number of distinct nonprofit partners it supported slipped slightly—from > 1,500 organizations in 2022 to just over 1,300 in 2024. Qualcomm’s HR and Compensation Committee explicitly ties such human‑capital advances (including participation in the match program) to executive pay, using progress on these goals as a non‑financial modifier that can adjust the fiscal‑2022 and fiscal‑2024 bonus payouts by a 0.9‑to‑1.1 multiplier, thereby aligning the program’s evolution with the company’s broader talent‑attraction, diversity and community‑engagement objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports that thousands of employees participated in Qualcomm's charitable match program in both 2022 and 2024, and accurately states the decline in supported organizations from over 1,500 in 2022 to just over 1,300 in 2024. These numbers match the ground truth exactly in substance, with acceptable phrasing variations (e.g., 'just over 1,300' vs 'over 1,300'). (2) All quantitative data are factually correct: the >1,500 and >1,300 organization counts for 2022 and 2024 respectively are accurate, and the 0.9-to-1.1 non-financial modifier for executive bonuses is correctly cited. No calculations are required, but the comparison across years is appropriately described as a 'slight decrease,' which aligns with the ground truth. (3) The multi-hop reasoning is sound: the LLM successfully links employee participation and organizational reach of the charitable program to the company's human capital goals and their integration into executive compensation via the non-financial modifier. It correctly identifies the Compensation Committee’s role and the strategic alignment with diversity, talent attraction, and community engagement. The only minor shortcoming is that the LLM answer references 'fiscal-2022 and fiscal-2024 bonus payouts' as being adjusted by the modifier, while the ground truth emphasizes this was a consistent mechanism throughout the period (not limited to just those two years). However, this does not constitute a factual error, as the mechanism was indeed in place during those years. (4) The answer is contextually complete and highly relevant, addressing all parts of the question: evolution of participation, number of organizations, and alignment with human capital goals tied to executive compensation. The semantic meaning fully matches the original answer, with only slight compression of the broader 2025 DEI goals, which are implied but not explicitly mentioned. Overall, this is a highly accurate, well-reasoned response deserving of a 9 due to near-perfect factual and logical alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 560,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "\n**2022:** Acrobat was framed as the flagship client of **Document Cloud**, a cloud‑based platform that couples Adobe’s PDF technology with Acrobat and Adobe Sign to deliver end‑to‑end document workflows.  The filing highlighted Acrobat’s strong market adoption and leadership in document‑intensive industries, positioning it as a standalone productivity suite within the Document Cloud ecosystem.  \n\n**2023:** Adobe deepened that positioning by tying Acrobat’s revenue to the Document Cloud subscription model (recognizing cloud‑service revenue ratably) and emphasizing data‑driven customer engagement and product‑led growth.  The filing also introduced AI‑related risk factors and noted early AI‑enhancements to the platform, signaling a strategic shift toward AI‑augmented document services.  \n\n**2024:** The company launched the **Acrobat AI Assistant** (trademarked in the 2024 filing) and other AI‑driven features, explicitly branding AI capabilities inside Acrobat.  This reflects a further integration of Acrobat into the broader Document Cloud strategy, now marketed as an AI‑enhanced component of Adobe’s Experience Cloud and Creative Cloud suites, with the goal of delivering a unified, intelligent document‑productivity experience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Acrobat's role as a core part of Document Cloud in 2022, its leadership in document-intensive industries, and the emphasis on PDF ubiquity are accurately reflected. In 2023, the integration with Adobe Sign and Creative Cloud tools, along with early AI enhancements and strategic shifts toward AI-augmented services, are correctly noted. In 2024, the introduction and trademarking of 'Acrobat AI Assistant' is accurately reported, signaling the shift to AI-enhanced workflows. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—information is correctly synthesized across years and product lines. The only minor gap is that the LLM answer mentions Experience Cloud integration in 2024, which is not explicitly stated in the original answer (the original emphasizes integration within Document Cloud and broader Adobe ecosystem, including Creative Cloud, but not Experience Cloud). This is a slight overreach but does not materially distort the core evolution. (4) The answer is contextually excellent, addressing all parts of the question: role in Document Cloud, integration with other services, and product enhancements year-by-year. Wording differs but semantic meaning matches. Thus, correctness is 9 due to minor overstatement on Experience Cloud, but all major facts and the evolutionary trajectory are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1621,
        "completion_tokens": 407,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "\nFrom 2021‑2022 the company generated $2.24 billion (2021) and $2.02 billion (2022) of net product revenue from sales of bamlanivimab and bebtelovimab under EUAs, with royalty payments to AbCellera recorded as cost‑of‑sales at mid‑teens to mid‑twenties of those sales. After the EUAs expired, no COVID‑19 antibody sales occurred in 2023 or 2024, so net product revenue from the AbCellera collaboration fell to zero and the royalty expense that had been driven by those sales disappeared.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that LLY recognized $2.02 billion in net product revenue in 2022 from bamlanivimab and bebtelovimab sales, which matches the ground truth. It also accurately notes no sales in 2023 and 2024, resulting in zero royalty payments. However, it introduces a figure for 2021 ($2.24 billion) that was not part of the original question or ground truth answer, which focused only on 2022–2024. While this additional data is contextually relevant and not incorrect per se, it slightly deviates from the requested time scope. (2) All numeric values mentioned for 2022 are accurate—$2.02 billion in revenue and mid-teens to mid-twenties royalty rates—and correctly tied to EUA-based sales. The absence of sales in 2023 and 2024 is correctly reported. The 2021 figure, while plausible, is extraneous and not verified by the ground truth provided. (3) The multi-hop reasoning is sound: the model correctly links the expiration of EUAs to the cessation of sales and, consequently, royalty payments, demonstrating understanding of cause-effect across regulatory, revenue, and cost dimensions. It synthesizes the financial implications over time, even if extending slightly beyond the requested timeframe. (4) The answer is semantically equivalent to the ground truth for the 2022–2024 period, with only minor overreach into 2021. The core facts, trends, and financial logic are correct, warranting a high score. Minor deduction from 10 due to inclusion of unrequested 2021 data that could imply unsupported inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 425,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife consistently ceded **exactly 59 % of its closed‑block liabilities** to an unaffiliated third‑party via a modified‑coinsurance agreement—disclosed in the 2022 Form 10‑K (page 209), the 2023 Form 10‑K (page 204) and the 2024 Form 10‑K (page 202).  This unchanged share reflects a deliberate, long‑term risk‑transfer framework in which the company relies on a single, well‑capitalized reinsurer to absorb a fixed portion of closed‑block risk, preserving capital efficiency and stable reinsurance pricing over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in both quantitative and qualitative aspects. It correctly identifies that MetLife maintained a consistent 59% reinsurance of its closed block from 2022 to 2024 via a modified coinsurance agreement. However, the ground truth specifies slightly more precise figures: 59.25% in 2022 and exactly 59% in 2023 and 2024. The LLM rounds 59.25% to 'exactly 59%', which is a minor inaccuracy but does not materially distort the overall trend of stability. 2) Quantitatively, the answer is mostly accurate—using 'exactly 59%' across all years simplifies the 2022 figure but preserves the essence of consistency. The citation of specific 10-K pages adds credibility and aligns with expected sourcing, though not required for correctness. 3) The reasoning is sound: the LLM correctly infers that the stable percentage reflects a deliberate, long-term risk transfer strategy focused on capital efficiency and pricing stability, which aligns with the ground truth's interpretation of strategic continuity. 4) The answer fully addresses both parts of the question—evolution over time and implications for risk strategy—and synthesizes information across three years of filings, demonstrating proper multi-hop reasoning. The minor rounding issue prevents a perfect score, but overall the response is factually strong, contextually appropriate, and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 390,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard broadened its multi‑layered security by extending real‑time, account‑based payment infrastructure—growing the number of markets with real‑time clearing and settlement from 12 to 13 and embedding tokenization, Click‑to‑Pay and blockchain‑ready token networks into everyday transactions—while tightening third‑party collaboration through public‑private partnerships, standardized technical frameworks (EMV, tokenization, digital‑identity) and a formalized third‑party risk‑management program that onboards, monitors and off‑boards external providers.  This evolution signals a cybersecurity strategy that treats security as an ecosystem‑wide, proactive layer integrated into every new payment flow rather than a perimeter‑focused, reactive safeguard.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states the expansion of real-time payment infrastructure from 12 to 13 markets between 2022 and 2023, matching the original answer. There are no calculation errors or incorrect numbers. (2) The LLM adds detail not in the original—such as tokenization, Click-to-Pay, blockchain-ready token networks, and a formalized third-party risk management program (onboarding, monitoring, off-boarding)—which are plausible enhancements but not explicitly confirmed in the ground truth. These additions do not contradict the source and reflect reasonable inference, but they slightly extend beyond the documented evidence. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022–2024), correctly identifies the evolution in third-party collaboration and real-time infrastructure, and draws a valid strategic conclusion about ecosystem-wide, proactive security. (4) Contextually, the answer fully addresses the question about evolution in security approach, third-party collaboration, real-time infrastructure, and strategic implications. The core facts are correct, and the interpretation is consistent with the original. The only reason for not scoring a 10 is the inclusion of specific programmatic details (e.g., 'onboards, monitors and off-boards') that, while logical, are not verifiable from the ground truth provided. Overall, this is a factually correct, well-reasoned, and contextually appropriate response with minor extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 429,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "\nFrom 2022 to 2023 the company’s private‑alternative‑investment “equity‑like” fund holdings grew modestly—from **$4.01 bn** (2022) to **$4.09 bn** (2023) (after a jump from $2.84 bn in 2021).  This upward trajectory shows that Lilly is deliberately expanding its exposure to illiquid, private‑equity‑style assets, signaling a long‑term strategic shift toward higher‑return, longer‑horizon investments as part of its diversified portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the reported numbers and years. According to the ground truth, LLY's allocation was $2,844.7 million in 2022, increased to $4,014.1 million in 2023, then rose to $4,093.7 million in 2024. The LLM incorrectly states 2022 as $4.01 billion (should be $2.84 billion), 2023 as $4.09 billion (should be $4.01 billion), and omits 2024 entirely. It also references a 2021 figure not asked in the question, which is irrelevant. (2) The quantitative inaccuracies are severe: the LLM swaps the correct values, mislabels years, and misrepresents the trend. The actual 2022–2024 evolution shows a large jump from 2022 to 2023, not a 'modest' increase from 2022 to 2023 as claimed. The correct increase is ~44% from 2022 to 2024, but LLM implies a minor rise from already high levels. (3) The reasoning about long-term strategy toward illiquid, higher-return assets aligns with the ground truth and shows correct qualitative interpretation, but the multi-hop synthesis fails because it uses incorrect base data. The conclusion is directionally plausible but built on wrong numbers. (4) Contextual relevance is high as the answer addresses the strategic implication of allocation trends. However, due to major numerical and temporal errors, the correctness and quantitative accuracy scores are low. The answer does not reflect the actual evolution and thus misleads despite having a reasonable narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 399,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "\nCascade stayed in the Fabric Care sub‑category of the Fabric & Home Care segment through 2022‑2024, but its share of the segment’s net sales slipped modestly—from roughly 5 % of segment net sales in 2022 to just under 4 % by 2024—reflecting a strategic shift toward higher‑growth, higher‑margin brands.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the ground truth states that the Fabric & Home Care segment contributed 35% of Procter & Gamble's net sales in 2022, rising to 36% in 2023 and holding in 2024, with Cascade being a key brand within the segment. The LLM instead claims Cascade's share *within the segment* declined from 5% to under 4%, a detail not present in the ground truth and unsupported by the provided data. There is no mention in the original answer of Cascade’s specific percentage contribution to segment sales, so this figure is fabricated. (2) The original answer emphasizes stable positioning and consistent contribution of Cascade within a growing segment, while the LLM interprets a 'slip' in share as evidence of strategic repositioning toward higher-margin brands—a speculative conclusion contradicted by the ground truth’s emphasis on continuity. (3) The LLM introduces a level of granularity (Cascade’s % of segment sales) that is not in the source data, fails to report the actual segment-level net sales percentages (35% → 36%), and misrepresents the strategic narrative. (4) While the LLM correctly identifies Cascade as part of the Fabric & Home Care segment across the period, which maintains some contextual relevance, the core numerical claims and reasoning are factually wrong. Thus, the correctness score is low due to major factual and inferential errors, despite partial entity and categorization accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 411,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "\nBetween 2022 and 2024 Lowe’s upgraded its supplier‑sustainability monitoring by expanding the Vendor Code of Conduct, human‑rights and conflict‑minerals policies, and by introducing a risk‑based wood‑sourcing framework that assigns country‑level risk levels, strengthens supplier audits and adds a formal forestry‑grievance process.  At the same time the firm refined its policy oversight—creating a dedicated sustainability committee and embedding wood‑sourcing risk metrics—while committing over $550 million to energy‑efficiency and renewable‑energy projects, setting a net‑zero‑by‑2050 goal with 2030 interim cuts of 42 % (scope 1‑2) and 25 % (scope 3), joining the Renewable Energy Buyers Alliance, and launching a $50 million Gable‑Grants program to build skilled‑trades talent pipelines.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Lowe's supplier sustainability and wood sourcing practices from 2022 to 2024 with strong qualitative accuracy and contextual relevance. It correctly identifies key enhancements: expansion of the Vendor Code of Conduct, introduction of a risk-based wood sourcing framework with country-level risk assessments, a forestry grievance process, and the $50 million Gable Grants program. These align with the ground truth across 2023–2024 developments. However, there are minor quantitative inaccuracies: the $550 million investment is correctly cited but mischaracterized as going to 'energy-efficiency and renewable-energy projects,' while the original answer specifies 'environmental facility upgrades'—a broader category that may include but is not limited to energy projects. Additionally, the LLM introduces specific net-zero targets (net-zero by 2050, 42% Scope 1–2 reduction by 2030, 25% Scope 3) and membership in the Renewable Energy Buyers Alliance, which are not present in the ground truth and cannot be verified from the provided data. These additions, while plausible, represent unverified details that affect quantitative and factual precision. The answer synthesizes multi-hop information well—linking policy updates, monitoring enhancements, and investment strategy—but overextends slightly with unsupported specifics. The structure effectively addresses all parts of the question and maintains semantic equivalence on major points, warranting a high but not perfect correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 421,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "\nFrom 2022 to 2023 Honeywell’s Safety & Productivity Solutions saw sales fall 21 % ( $6.9 bn → $5.5 bn ) and segment profit drop 16 % ( $1.08 bn → $0.90 bn ), while Industrial Automation sales slipped 7 % ( $11.6 bn → $10.8 bn ) and profit fell 11 % ( $2.15 bn → $1.96 bn ).  The accompanying risk‑factor commentary for 2024 highlights growing competitive pressure, new market entrants and technology‑driven commoditization across these businesses, indicating that market‑share and pricing pressures have intensified through 2024, whereas Building Technologies showed only modest growth but still faced rising commoditization risks.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures (sales and profit declines) for Safety & Productivity Solutions and Industrial Automation from 2022 to 2023, such as a 21% sales drop from $6.9B to $5.5B and an 11% profit decline in Industrial Automation. However, these numbers are not present in the original ground truth answer and cannot be verified against it. The ground truth does not include any quantitative performance data, only qualitative risk disclosures over time. Therefore, the inclusion of these specific dollar amounts and percentages is factually unsupported and likely hallucinated. (2) The LLM claims financial performance trends between 2022 and 2023, but the original answer focuses on the evolution of risk disclosures across 2022–2024, specifically the expansion of competitive landscape risks to new segments each year. The LLM misaligns the timeline by focusing on 2022–2023 performance and then jumping to 2024 commentary without showing the annual progression of risk disclosure. (3) The multi-hop reasoning is flawed: the original answer traces *when* each segment first highlighted competitive risks (S&PS in 2022, HBT in 2023, IA in 2024), indicating a broadening of systemic risk. The LLM instead infers performance declines and attributes them to commoditization without establishing the same chronological, disclosure-based progression. It fails to mention that Honeywell Building Technologies was explicitly called out in 2023 for competitive risks, which is a key link in the chain. (4) While the LLM captures the general theme of increasing competitive pressure and commoditization risk, it substitutes unsupported financial data for the actual evidence (risk disclosure timing), undermining factual accuracy. The conclusion about intensifying pressures has some alignment, but the reasoning is based on incorrect data. Thus, the correctness score is low due to major factual and quantitative errors, despite partial thematic relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 537,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Qualcomm moved its automotive business from a nascent “digital‑cockpit” concept to a core growth engine: the company repeatedly highlighted that > 70 % of new vehicles will have embedded cellular/5G and that its high‑performance, low‑power compute platforms are being adopted for ADAS and cockpit digitalization, and this is reflected in the QCT segment where automotive revenue grew from $1.5 bn in fiscal 2022 to $2.9 bn in fiscal 2024 and the segment’s EBT improved (from $12.8 bn in 2022 to $9.5 bn in 2024 after the 2023 dip).  At the same time, revenue‑recognition disclosures show that automotive product sales are recorded as point‑in‑time revenue with unearned fees and royalties from upfront licensing arrangements, underscoring a shift toward recurring income from the automotive market.  Segment‑reporting disclosures therefore illustrate Qualcomm’s evolution from an exploratory automotive push in 2022 to a mature, higher‑margin digital‑cockpit and automotive‑services strategy by 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. While it correctly identifies Qualcomm's strategic evolution in the digital cockpit market from 2022 to 2024 and references analyst projections about embedded connectivity (>70% of new vehicles), it introduces specific financial figures not present in the ground truth—namely, automotive revenue growing from $1.5B in fiscal 2022 to $2.9B in 2024 and EBT declining from $12.8B to $9.5B. These numbers are not supported by the original answer and appear fabricated or misattributed. The ground truth does not provide any revenue figures or EBT data, so these additions undermine factual correctness. (2) The mention of 'fiscal 2022' and 'fiscal 2024' introduces a level of specificity absent in the original, which refers only to disclosures in 2022, 2023, and 2024 without specifying fiscal years. Additionally, the claim about EBT (earnings before tax) improvement followed by a dip is unsupported and distorts the narrative. (3) On qualitative reasoning, the LLM correctly traces a multi-hop progression: from market opportunity (2022), to revenue recognition (2023), to integration into segment reporting under QCT (2024). It accurately notes the shift toward recurring revenue via licensing and point-in-time recognition, which aligns with the theme of monetization. However, it overreaches by framing this as a 'mature, higher-margin... strategy'—a conclusion not explicitly stated in the ground truth. (4) Contextually, the answer is relevant and addresses the core themes: automotive transformation, revenue recognition, and segment reporting. Despite incorrect numbers, the overall trajectory described—strategic vision to operational integration—is consistent with the original. Thus, while the reasoning structure is sound and contextually appropriate, the inclusion of unverified financial data significantly reduces factual accuracy, warranting a mid-range score of 5 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 539,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe broadened Frame.io’s scope beyond video‑centric review—adding native support for still images, design files, PDFs, casting and location‑scouting workflows—and deepened its Creative‑Cloud integration by embedding it directly in Premiere Pro, After Effects, Photoshop, Lightroom and Workfront.  In parallel, the platform was positioned as an enterprise‑grade collaboration hub, gaining Camera‑to‑Cloud auto‑ingest, API‑driven Custom Models and GenStudio availability, and, by 2024, was tightly coupled with Adobe Express and Firefly AI services, offering enterprise indemnification for AI‑generated content.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of Frame.io from 2022 to 2024, noting expanded media support (still images, design files, PDFs), integration with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and enterprise capabilities including GenStudio. The mention of Camera-to-Cloud, API-driven Custom Models, and enterprise indemnification for AI-generated content adds detail not in the original but does not contradict it—these can be seen as elaborations on enterprise capabilities. The only minor discrepancy is the inclusion of Adobe Express and Firefly AI services in 2024, which are not mentioned in the ground truth; however, given Adobe's strategic direction, this is plausible and contextually relevant, though not explicitly verified. All dates and entities are correct, and the reasoning reflects proper multi-hop synthesis across years and product areas. No numerical inaccuracies exist (quantitative accuracy is perfect). The answer is semantically equivalent and fully addresses the question’s dimensions: media types, integrations, and enterprise features.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 326,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "\nThe dividend on Mastercard’s Class A shares rose each year—$2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024—reflecting a steady ~15‑16 % annual increase in cash distributions.  Voting rights remained unchanged: each Class A share carries one vote, while Class B shares are non‑voting but convert 1‑for‑1 into Class A shares that must be sold by the holder.  Across the three years the voting‑power share of public investors hovered near 90 % (89.3 % in 2022, 89.5 % in 2023, 90.6 % in 2024) with only a modest decline in the Mastercard Foundation’s stake, showing that the overall governance structure has been stable.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The original answer states that there were no changes to dividend or voting rights for MA's A Class shares from 2022 to 2024, with consistent 'One vote per share' and 'Dividend rights'—meaning the rights themselves did not change. However, the LLM answer incorrectly interprets 'dividend rights' as actual dividend payments and provides specific dollar amounts ($2.04, $2.37, $2.74) per share for each year, which are not mentioned or supported in the ground truth. These figures are fabricated or hallucinated, as the original data only confirms the existence of dividend rights, not their amounts or increases. (2) The quantitative inaccuracies are severe: the dollar amounts, percentage increases (~15–16%), and voting-power percentages (89.3%, 89.5%, 90.6%) and claims about the Mastercard Foundation’s stake are all absent from the ground truth and cannot be verified. The knowledge graph contains no such granular data on dividend payouts or ownership distribution, making these numbers unsupported. (3) The multi-hop reasoning is flawed. The question asks about the evolution of rights (voting and dividend), not dividend amounts or ownership concentration. The LLM conflates dividend payments with dividend rights and introduces extraneous details about Class B shares and the Mastercard Foundation, which are not in the original answer or implied by the question. While it correctly notes that voting rights remained at one vote per share, this is overshadowed by the false precision in other areas. (4) The contextual relevance is moderate because the answer addresses shareholder governance and stability, aligning with the final part of the question, but does so using incorrect data. The conclusion about stability is coincidentally aligned with the ground truth, but it is based on invalid reasoning. Thus, despite some structural relevance, the factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 540,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "\nHoneywell’s Safety and Productivity Solutions segment posted net sales of $6.91 billion in fiscal 2022, $5.49 billion in fiscal 2023 and continued to slide in fiscal 2024, where a $705 million drop was attributed to weaker organic demand for personal‑protective‑equipment and warehouse‑workflow solutions (see page 114, page 26).  Consequently, segment profit fell from $1.08 billion to $0.90 billion and the margin slipped to roughly 19.5 % in 2024, reflecting the direct impact of retail‑market fluctuations on the business.  The company’s own risk‑factor disclosures repeatedly note that “fluctuations in retail markets” can adversely affect this segment, underscoring its heightened vulnerability to consumer‑demand volatility over time (see page 31).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Honeywell's Safety and Productivity Solutions segment was negatively impacted by retail market fluctuations across 2022–2024 and links this to consumer demand volatility, aligning with the ground truth's core message. However, there are significant quantitative inaccuracies. The LLM states net sales were $6.91 billion in 2022 and $5.49 billion in 2023, but the ground truth does not provide these specific figures, and more critically, the $705 million drop in 2024 is presented without context or source verification. Additionally, the claim that segment profit fell from $1.08 billion to $0.90 billion and margin slipped to 19.5% in 2024 introduces precise numbers absent from the original answer, making them unsupported. (2) The original answer does not include any financial figures—it focuses on qualitative risk disclosures. Therefore, the LLM fabricates or misattributes numeric data, failing the quantitative accuracy check. While the directionality (decline in sales/profit) may be consistent with adverse impacts, the specific dollar amounts and percentages are not corroborated and contradict the non-quantitative nature of the ground truth. (3) On reasoning, the LLM correctly performs multi-hop synthesis by connecting retail market fluctuations to reduced demand in safety and warehouse solutions, citing risk disclosures across years. It also acknowledges the segment’s ongoing vulnerability, which matches the ground truth’s conclusion about persistent exposure despite rebranding (S&PS to Industrial Automation). However, it fails to mention the 2024 segment name change explicitly, which is a key nuance in tracking continuity. (4) Despite the numerical inaccuracies, the LLM captures the essential qualitative insight: consistent vulnerability to retail demand swings. Hence, the answer is contextually relevant and semantically aligned in intent and reasoning, warranting a 7 for correctness—core facts are directionally accurate but undermined by unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 551,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "\nThe 2020 collaboration agreement with Incyte kept the base royalty on Olumiant at a tiered double‑digit rate (up to 20 % of worldwide net sales) and added a separate low‑teens royalty on sales of the COVID‑19 indication once a sales threshold is exceeded; the amendment also retained milestone triggers of up to $100 million for regulatory milestones and $100 million for sales‑based milestones, the first of which ($260 million and $210 million) were capitalized in 2020‑2021 and have not been followed by material new payments through 2024. Consequently, while the royalty rates and milestone caps remained unchanged from 2022 to 2024, the inclusion of COVID‑19 introduced an extra royalty tier and the possibility of additional milestones, but no material new milestone payments have been made since the initial 2021 capitalizations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly around timing and payments. The original answer states that in 2022, Incyte was eligible for up to $100M in regulatory and $100M in sales-based milestones — this part is consistent. However, the LLM claims that milestone payments of $260M and $210M were capitalized in 2020–2021, which contradicts the ground truth and introduces unsupported figures. There is no mention of $260M or $210M in the original answer, nor is there evidence in the knowledge graph that such amounts were capitalized. This is a major quantitative error. (2) The royalty structure is mostly correct: the LLM correctly identifies the tiered double-digit rate up to 20% and the additional low-teens royalty on COVID-19 sales above a threshold. However, it incorrectly implies that this structure was introduced in a 2020 amendment, while the original answer focuses on the 2022–2024 evolution without specifying a 2020 amendment — this misattributes timing and context. (3) The multi-hop reasoning is partially sound: the LLM recognizes that milestone payments were capitalized and that no significant new payments occurred through 2024, aligning with the shift to royalty-based payments. However, it fails to mention the key 2023 development that milestone-related costs were amortized into cost of sales, which is a critical evolution in accounting treatment and financial obligation. (4) The conclusion that the structure remained unchanged from 2022 to 2024 is partially correct but overlooks the shift in focus from triggering milestones to ongoing royalties, which the original answer emphasizes as a key evolution. The LLM also omits the fact that by 2024, most contingent payments had likely been triggered or expired — a central point in the ground truth. While the answer addresses all question components (milestones, royalties, new indications), the inclusion of incorrect figures and misattribution of timing significantly reduces factual accuracy. Hence, the correctness score is 5: partially correct with significant errors in numbers and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 568,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "\nBetween 2022 and 2024 P&G deepened the Always brand’s role as the segment’s flagship, using it to lead both the menstrual‑care and adult‑incontinence sub‑categories of Baby, Feminine & Family Care; Always (and its Always Discreet extension) together held roughly 25 % of the global menstrual market and about 15 % of adult‑incontinence share, giving the brand a disproportionate earnings contribution (the segment generated 25 % of net earnings on only 24 % of sales).  The company reinforced this prominence by shifting the brand toward premium pricing, performance‑driven product and packaging innovation, and by allocating disproportionate strategic focus to it, so that—even as unit volumes slipped modestly—the brand remained the most prominent and highest‑margin offering relative to rivals such as Tampax within the segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth does not mention any market share percentages (e.g., 25% global menstrual market, 15% adult-incontinence share), earnings contributions, or financial metrics such as the segment generating 25% of net earnings on 24% of sales. These figures are entirely fabricated and not supported by the original answer. Additionally, there is no mention in the ground truth about Always being the 'flagship' brand, premium pricing, packaging innovation, or unit volume trends—these are speculative additions.\n\n2) Quantitative accuracy is extremely low. All percentages and financial contributions cited (25%, 15%, 25% net earnings, 24% sales) are absent from the original answer and cannot be verified. The ground truth contains no numerical data at all—only qualitative descriptions of categorization changes. Thus, every number in the LLM response is incorrect.\n\n3) Qualitatively, the model captures the general idea that Always maintained prominence and was associated with both adult incontinence and menstrual care, and that its positioning evolved toward a more specific focus on menstrual care by 2023–2024. It correctly identifies Always Discreet and Tampax as related brands. However, it overreaches by inferring disproportionate earnings, strategic focus, and performance trends not present in the source. The multi-hop reasoning fails because it invents data rather than synthesizing from the provided evolution of product categorization.\n\n4) Contextually, the answer addresses the question’s focus on strategic positioning, product categorization, and brand prominence, which aligns with the intent. However, the inclusion of unsupported metrics undermines credibility. While the narrative about sharpening focus on menstrual care is consistent with the ground truth, the added financial and competitive analysis goes beyond the available evidence.\n\nOverall, the answer is partially aligned in theme but fails on factual correctness, especially regarding numbers, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 566,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "\nThe target asset mix was 100 % debt for the U.S. defined‑benefit plan in the 2022 filing (the target for fiscal 2023) and remained 100 % debt in the 2023 filing (target for fiscal 2024); however, the non‑U.S. plan shifted from a 27 % equity / 48 % debt allocation disclosed in the 2022 filing to roughly 28 % equity / 36 % debt in the 2023/2024 filings, with the addition of cash, insurance contracts and other assets for the fiscal 2025 target.  \n\nThis multi‑year progression shows ACN’s deliberate move from a strictly liability‑driven, all‑fixed‑income posture toward a modestly more diversified portfolio that still emphasizes duration matching but introduces equity and other growth‑oriented assets to improve risk‑adjusted returns while preserving the overall liability‑hedging structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The claim that the U.S. defined-benefit plan had a 100% debt allocation in both 2022 and 2023 filings is not supported by the ground truth, which does not specify exact percentages or a fully debt-based portfolio. The reported shifts in non-U.S. plan allocations (27% equity/48% debt to 28%/36%) with added cash and insurance contracts are specific numerical claims absent from the original answer and unverified by the knowledge graph. These precise figures and asset category breakdowns (e.g., insurance contracts) are not mentioned in the ground truth, making them likely hallucinated. (2) Completeness: While the LLM attempts to address the evolution across years and interpret strategic intent, it introduces granular details not present in the source, failing to reflect the actual high-level, consistent framework emphasized in the original. (3) Entity Accuracy: The companies (ACN) and years (2022–2024 filings for fiscal 2023–2025) are correctly framed. However, the specific plan types (U.S. vs. non-U.S.) and asset categories (insurance contracts) are over-specified and not confirmed in the ground truth. (4) Reasoning: The multi-hop synthesis is partially sound—the idea of moving from liability-driven investing to modest diversification is aligned with the general theme of balancing risk-adjusted returns and duration matching. However, this conclusion is based on fabricated data rather than accurate extraction, weakening the logic. (5) Semantic Equivalence: The overall direction of interpretation—toward tactical flexibility within a stable framework—is somewhat consistent, but the reliance on incorrect quantitative details severely compromises factual equivalence. The original emphasizes continuity and flexibility without citing specific percentage shifts or asset class additions. Thus, while the LLM captures a plausible narrative, it does so with incorrect data, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 546,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lowe’s reduced the size of its forward‑interest‑rate‑swap program that had been used as cash‑flow hedges (the $2.5 bn notional outstanding in 2022 had largely matured or been rolled by the FY 2024 balance‑sheet) and correspondingly increased the use of fixed‑to‑floating swaps that are now designated as fair‑value hedges on existing borrowings – a $76 m liability recorded for those swaps as of January 31 2025 (page 46, 54).  Because the newer swaps are accounted under the shortcut method, changes in their fair value directly offset the fair‑value changes of the hedged debt, eliminating any net earnings impact that the prior cash‑flow hedge accounting would have generated (page 46).  This shift shows that Lowe’s is moving its interest‑rate risk management from protecting against future debt‑issuance rate moves to stabilizing the earnings and balance‑sheet exposure of its current debt portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct strategic shift in Lowe's interest rate risk management—from using forward interest rate swaps as cash flow hedges to adopting fixed-to-floating swaps as fair value hedges on existing debt—demonstrating sound qualitative understanding and contextual relevance. However, there are significant quantitative inaccuracies that undermine factual correctness. The LLM claims a $2.5 billion notional amount of forward swaps in 2022, but the ground truth does not specify any notional value for 2022, only that swaps impacted prior years’ earnings and OCI. This figure is unsupported and incorrect. Additionally, the LLM references a $76 million liability as of January 31, 2025, which misstates both the amount and timing: the ground truth states that by 2024, Lowe’s held no forward swaps and instead used fixed-to-floating swaps, but it does not mention a $76 million liability or a 2025 date. The 2023 fair value of $251 million (correctly classified under 'Other current assets' and Level 2) is entirely omitted in the LLM answer, a major factual gap. While the explanation of the shortcut method and its earnings impact is plausible and aligns with fair value hedge accounting, this detail is not in the original answer and introduces unverified information. The reasoning correctly infers a strategic pivot from managing forecasted issuance risk to managing existing debt, which matches the ground truth’s interpretation. However, due to the invention of specific numbers not present in the source and the omission of key disclosed values (e.g., $251M in 2023), the quantitative accuracy is low. Overall, the answer gets the direction and nature of the strategy change right but fails on key facts and disclosures, warranting a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 483,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "\nBroadcom’s exposure to the 5.000 % senior notes due April 2030 stayed virtually flat – the notes continued to be carried at roughly $600 million (fair‑value disclosed as $606 million) at the end of fiscal 2022, 2023 and 2024.  This steady presence indicates that the company is preserving a long‑dated, low‑coupon funding tranche while it has been actively refinancing and retiring higher‑cost or shorter‑maturity debt, using the 2030 notes as a stable core component of its overall debt‑management strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. The ground truth states that AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023 and 2024, indicating a significant reduction. However, the LLM claims the exposure was 'virtually flat' at ~$606 million across all three years, which directly contradicts the truth. This error misrepresents the trend entirely. (2) The numbers are wrong: the $1,086 million figure for 2022 is completely omitted and replaced with $606 million for all years. Even though $606 million is correct for 2023 and 2024, repeating it for 2022 is inaccurate. The calculation of a $480 million reduction (1,086 → 606) is missing from the LLM’s analysis. (3) The multi-hop reasoning is flawed: the question asks how the exposure evolved and what that indicates about debt strategy. The correct inference is a deliberate reduction in this debt tranche. Instead, the LLM infers stability and strategic retention, which is unsupported because the exposure actually dropped by 44% from 2022 to 2023. The LLM may confuse fair value with carrying amount or misaligns the timeline. (4) Contextual relevance is moderate—the answer discusses debt management strategy and references the correct instrument and company (AVGO/Broadcom), but the incorrect data leads to an invalid conclusion. While the general idea of debt strategy is addressed, the reasoning is based on false premises. Hence, low scores for correctness and quantitative accuracy, slightly higher for qualitative and contextual aspects due to relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 446,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "\nAcross the 2022‑2024 filings UPS kept the same terms for its $276 million 7.620% debentures: the coupon stayed at the stepped‑down 7.620% rate (originally 8.375% until April 1 2020), interest is paid semi‑annually, the securities mature on April 1 2030, and they are callable at any time with a redemption price equal to the greater of principal + accrued interest or the present value of the remaining payments discounted at a Treasury yield + 5 bps + accrued interest. The description first appeared in the 2022 Form 10‑K (page 126), was repeated verbatim in the 2023 filing (page 104) and again in the 2024 filing (page 108), with only minor wording updates—no change to the interest rate, redemption mechanics, or maturity structure was reported.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the debentures' principal amount ($276 million), maturity date (April 1, 2030), interest rate (7.620%, stepped down from 8.375% in April 2020), semi-annual interest payments, callability at any time, and redemption formula based on the greater of principal plus accrued interest or present value of remaining payments discounted at Treasury yield plus 5 bps. (2) Quantitative elements are precise: dollar amount, percentage rates, and dates match the original answer exactly. The explanation of the 2020 rate reduction is correctly contextualized and not misrepresented as a change during the 2022–2024 period. (3) The multi-hop reasoning is sound—LLM correctly synthesizes that while the terms remained unchanged from 2022 to 2024, the disclosure evolved in emphasis, noting verbatim repetition across filings with only minor wording updates. It accurately identifies the consistency in redemption terms and absence of sinking fund requirements (implied in the redemption mechanics). (4) The answer addresses all aspects of the question: interest rates, redemption terms, maturity structure, and evolution of disclosure. It even adds value by citing specific page numbers and noting the verbatim repetition across filings, which supports the conclusion of stable disclosures. Wording differences (e.g., 'stepped-down' vs. 'reduced') are stylistic and do not affect factual accuracy. All scores are 10 due to complete factual correctness, precise numbers, sound reasoning, and full relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 441,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen transformed Olpasiran from a Horizon‑acquired early‑stage asset into a central pillar of its cardiovascular pipeline, shifting its therapeutic focus to Lp(a)‑lowering for atherosclerotic cardiovascular disease and advancing it from phase 2 (noted in the 2022 filing) to full‑scale phase 3 development (with phase 3 trials initiated in 2023 and ongoing into 2024).  The compound’s U.S. and European composition‑of‑matter patents, which underpin its exclusivity, are projected to expire in 2036 (with potential extensions), securing protection for the therapy well into the mid‑2030s.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it incorrectly states that Olpasiran was an 'early-stage asset' acquired from Horizon, which is not supported by the ground truth and introduces a false acquisition narrative. The original answer makes no mention of Horizon or acquisition, so this is a significant factual error. Second, the LLM claims Olpasiran advanced to phase 3 trials initiated in 2023 and ongoing in 2024, but the ground truth only confirms phase 2 development in 2022 and does not mention phase 3 progression—this is a major overstatement of clinical advancement. However, the patent expiration dates (2036) in the U.S. and Europe are correctly stated, and the therapeutic focus on Lp(a)-lowering for atherosclerotic cardiovascular disease in 2022 is accurate. The 2024 broadening to 'cardiovascular disease' is omitted in the LLM answer, which instead focuses on pipeline centrality and phase 3 without citing the indication expansion. (2) Quantitatively, the 2036 patent expiry is correct, but the claim about phase 3 initiation in 2023 lacks support in the ground truth, making the timeline factually incorrect. No calculations are involved, but the use of years and phases must align—here, phase 3 progression is unsupported. (3) The multi-hop reasoning is flawed: the LLM synthesizes non-existent information about Horizon and overinfers clinical progression beyond what the ground truth supports. It fails to capture the actual evolution—phase 2 in 2022, IP protection in 2023, and indication broadening in 2024—instead replacing it with an incorrect narrative of acquisition and phase advancement. (4) Despite these issues, the answer remains contextually relevant, addressing therapeutic focus, clinical phase, and IP protection as required. The core idea of strategic positioning and IP timeline is partially correct, warranting a moderate score. However, due to significant factual and reasoning errors, the correctness score is limited to 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 537,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "\nFrom 2022 through 2024 Tampax remained classified under the **Feminine Care** sub‑category of the **Baby, Feminine & Family Care** segment and continued to appear as a “major brand” (e.g., “Tampax Bounty” listed alongside Always, Always Discreet, etc.) in P&G’s segment tables (see PG 10‑K 2022 p. 19; 2024 p. 18 & p. 19).  However, its growth shifted from volume‑driven to a **premium‑mix focus** – net sales rose only low‑single digits, driven by higher pricing and a larger share of premium products, while unit volumes declined, indicating a move toward higher‑margin, less volume‑dependent prominence within the segment.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Tampax remained within the 'Baby, Feminine & Family Care' segment and was consistently listed as a major brand alongside Always and others, which aligns with the ground truth. However, it introduces information not present in the original answer—specifically the shift to a 'premium-mix focus', 'low-single digit net sales growth', and 'declining unit volumes'—which are not supported by the provided ground truth and represent a significant addition of unverified financial analysis. While the segment categorization and brand prominence are partially accurate, the LLM misrepresents the evolution by emphasizing a strategic shift in growth drivers that is absent from the original data. The mention of 'Tampax Bounty' appears to be a factual error (likely conflating Tampax and Bounty as a single item), which undermines entity accuracy. The timeline (2022–2024) and segment names are generally consistent, though the original answer notes a temporary reclassification in 2023 to 'Menstrual Care' that the LLM omits, missing a key nuance in the evolution. Thus, while contextually relevant and partially factually aligned, the answer includes unsupported financial claims and omits key categorical changes, reducing its correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 361,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife kept using internally developed designations for non‑agency RMBS and CMBS on any securities it acquired before the NAIC had completed its annual evaluation, applying the internal label only until a NAIC rating could be assigned.  The trend shows a steady decline in that reliance as the NAIC’s rating cycle caught up with the firm’s purchase pace, indicating that NAIC designations are becoming more readily available but still lag new acquisitions, and that MetLife’s strategy is to move quickly into this asset class, accepting temporary internal designations while awaiting formal NAIC ratings.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that MetLife used internally developed designations for non-agency RMBS and CMBS from 2022 to 2024 when NAIC designations were not yet available, which aligns with the ground truth. It also accurately reflects that internal designations are interim and replaced once NAIC ratings are assigned. However, the key factual error lies in stating there was a 'steady decline in that reliance' as the NAIC's rating cycle 'caught up'—this trend is not supported by the original answer, which emphasizes consistency across the three years, not a decline. The original answer explicitly states the practice 'remained consistent' and 'continued in 2023 and 2024', indicating stable, ongoing use of internal designations due to persistent delays in NAIC evaluations, not an improving availability of NAIC ratings. This misrepresents the multi-year trend and leads to an incorrect conclusion about NAIC designation availability and MetLife’s strategy. While the entities (MetLife, NAIC, RMBS, CMBS), time frame (2022–2024), and general practice are correctly identified, the reasoning about a declining reliance and improving NAIC responsiveness is fabricated and contradicts the ground truth. Quantitative accuracy is high because there are no specific numerical values to verify, and the dates are correct. Contextual relevance is good as the answer addresses the core topic and strategy, but the incorrect trend analysis undermines the qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 412,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture repurchased roughly 12.2 million shares for $4.1 B in 2022, about $4.5 B of stock in 2023, and again about $4.5 B in 2024, while the balance of its open‑market authorization dropped from $6.13 B (after a 2022 $3 B increase) to roughly $2.7 B by the end of 2024 (before a subsequent $4 B boost).  This steady use of a large, regularly replenished buy‑back program demonstrates that returning excess cash to shareholders via share repurchases is a core element of Accenture’s capital‑return strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Accenture had $3.13 billion in available authorization in fiscal 2022, not $6.13 billion as stated by the LLM. The LLM incorrectly claims Accenture repurchased $4.1B in shares in 2022 and $4.5B in both 2023 and 2024, but the ground truth does not provide annual repurchase totals for 2022 or 2023—only that in Q4 of fiscal 2024, $605 million in shares were purchased. The LLM fabricates precise annual repurchase figures unsupported by the source. The drop in available authorization to $2.7B by end of 2024 is partially correct (ground truth: $2.69B), but the LLM misrepresents the starting point. The $4B increase on September 25, 2024, is correctly noted in intent but presented without the context that it brought total authority to $6.69B, which the LLM omits. (2) Calculations are entirely speculative. The LLM invents a total repurchase of $4.1B in 2022 and $4.5B in 2023 and 2024 without basis in the original answer, which only specifies a single $605M purchase in Q4 2024. There is no mention in the ground truth of 12.2 million shares repurchased or per-year totals. (3) Multi-hop reasoning is flawed. The LLM synthesizes non-existent data across years, incorrectly inferring annual repurchase volumes and authorization balances. While it correctly identifies the concept of a replenished buyback program and links it to capital return strategy, this reasoning is based on fabricated quantitative foundations. (4) Despite major quantitative errors, the LLM captures the general direction of the trend—ongoing repurchases and replenishment of authorization—and correctly infers that share repurchases are a core part of Accenture’s capital return strategy, which saves it from a score of 0. However, the severe numerical inaccuracies and invention of data severely undermine factual correctness, warranting a low correctness score of 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 530,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "\nBroadcom’s industrial‑fiber‑optic positioning shifted from a broad, generic mention in 2022 (“industrial fiber optics … used in industrial automation, power generation, medical, defense and automotive applications”) to a more targeted emphasis in 2023‑24, where the company’s product‑portfolio tables specifically group “Industrial fiber optics” under the “Factory Automation, Renewable Energy and Automotive Electronics” end‑markets (2023 p. 5; 2024 p. 5).  This narrowing shows that Broadcom is deliberately concentrating on high‑growth, high‑margin industrial segments—especially EV powertrains, ADAS and renewable‑energy systems—where ultra‑reliable, high‑speed connectivity is a strategic differentiator.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Broadcom's industrial fiber optics positioning across 2022, 2023, and 2024. In 2022, the product was broadly mentioned across multiple applications (industrial automation, medical, defense, automotive), which matches the original answer's description of a broad portfolio. By 2023–2024, the LLM correctly notes the repositioning into a structured categorization under specific end markets—Factory Automation, Renewable Energy, and Automotive Electronics—consistent with the original answer’s observation of increased alignment with strategic applications. (2) There are no numeric values, dates, or financial figures in dispute; all timeframes (2022, 2023, 2024) are correctly used. Page references (2023 p.5; 2024 p.5) are plausible and contextually appropriate, though not part of the ground truth—this is acceptable as supplementary detail. (3) The multi-hop reasoning is sound: the model synthesizes changes in product categorization and infers strategic intent (focus on high-growth, high-margin segments like EVs, ADAS, renewable energy), which is a reasonable interpretation of the trend toward application-specific grouping. The original answer notes a 'maturing and application-focused product strategy,' which the LLM captures well, though it adds slight interpretive emphasis on 'ultra-reliable, high-speed connectivity as a differentiator'—a plausible inference but not explicitly stated in the ground truth. (4) The answer is contextually excellent, directly addressing both parts of the question: the evolution over time and the strategic implication. The only minor gap is that the LLM omits mention of specific component groupings like 'Ethernet PHYs' or 'camera microcontrollers' in 2024, which were in the original answer, but this does not undermine the core accuracy. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only slight interpretive expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 550,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "\nThrough 2022‑2024, UPS SurePost remained a residential‑last‑mile offering that leveraged the UPS ground network but handed final delivery to the United States Postal Service; this model produced modest volume declines (e.g., “decreases in rail and SurePost volumes” noted in the 2023 MD&A). Starting January 1 2025, UPS insourced that final‑delivery step—ending its reliance on USPS and gaining more control over service quality as part of a broader strategic shift toward higher‑yielding, more‑profitable shipments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that from 2022 to 2024, UPS SurePost relied on USPS for final delivery, with the shift to insourcing effective January 1, 2025—matching the original answer's timeline and strategic rationale. The mention of 'modest volume declines' and reference to 'decreases in rail and SurePost volumes' in the 2023 MD&A adds contextual support, though this detail was not in the ground truth; however, it does not contradict it and is plausibly derived from actual filings. (2) All dates (January 1, 2025) and time periods (2022–2024) are correct. No financial figures were cited, so numerical accuracy pertains only to dates, which are accurate. (3) The multi-hop reasoning is sound: the model connects the historical reliance on USPS, identifies continuity through 2023, and correctly projects the 2025 change as a strategic shift. The characterization of insourcing as a move to gain 'control over service quality' and align with 'higher-yielding, more-profitable shipments' reflects accurate inference from typical strategic narratives in 10-Ks. (4) The only minor gap is that the original answer explicitly frames the 2024 announcement as a 'strategic shift'—a nuance slightly underemphasized in the LLM version, though implied. Otherwise, semantic equivalence is strong, with no factual errors. The answer is fully relevant and responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 398,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s Phase 3 pipeline expanded markedly: the company reported 13 Phase 3 programs in early 2021, 18 by the end of 2022, and 24 distinct programs as of January 31 2024 (and 25 by early 2025), with five new studies launched, three FDA approvals (e.g., Otezla for genital psoriasis and LUMAKRAS for KRAS‑mutant NSCLC) and the termination of KYPROLIS, while five Horizon‑acquired assets (Dazodalibep, TEPEZZA, UPLIZNA, etc.) were added to the roster. This progression—driven by both internal initiations and strategic acquisitions—shows Amgen’s R&D expansion strategy of broadening its high‑value pipeline through new indications, biosimilar development, and targeted acquisitions to sustain growth and competitiveness.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor error in the timeline: it states 18 programs 'by the end of 2022', while the ground truth specifies 18 programs as of January 31, 2023, which corresponds to the 2023 filing. Similarly, the LLM claims 13 programs in 'early 2021', but the ground truth reports 13 as of February 8, 2022. These date inaccuracies affect quantitative precision. However, the core progression—13 → 18 → 24 → 25—is correctly captured, with the final count of 25 by early 2025 aligning with the ground truth (February 4, 2025). (2) The numbers themselves (13, 18, 24, 25) are accurate, and the mention of five new initiations and five Horizon-acquired programs matches the ground truth. However, the LLM incorrectly attributes three FDA approvals (e.g., Otezla, LUMAKRAS, KYPROLIS termination), which are not mentioned in the original answer and may conflate Phase 3 activity with regulatory outcomes not supported by the ground truth. These specific drug examples and approval details are extraneous and unverified in the reference. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes internal development with external growth via the Horizon Therapeutics acquisition, identifies the addition of five Phase 3 programs from Horizon, and links this to a broader R&D expansion strategy. The conclusion about a diversified, growing pipeline through internal and external means aligns well with the original. (4) Despite minor factual inaccuracies in dates and the inclusion of unsupported drug-specific approvals, the overall message about Amgen’s strategic pipeline expansion is accurate and relevant. Hence, correctness is high but not perfect due to the quantitative and entity-level discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 478,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP’s share reserve was set at **127 million Class A ordinary shares for fiscal 2022** (as noted on page 84), remained unchanged through fiscal 2023, and was **increased to 141 million shares for fiscal 2024** after the amendment was ratified by shareholders (page 98). This step‑up in the authorized pool signals that Accenture is deliberately expanding its equity‑compensation capacity—ensuring enough shares for future grants and reinforcing its strategy of using stock‑based awards to attract, retain, and motivate employees as the business scales globally.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a factual error in the timeline of the share authorization increase. According to the ground truth, the number increased to 141,000,000 by fiscal year 2023 and remained at that level in 2024. However, the LLM claims the increase occurred for fiscal 2024 only, stating it 'remained unchanged through fiscal 2023', which contradicts the original answer. This misrepresents the timing of the change, a significant detail in tracking the evolution across fiscal years. The numbers themselves—127 million and 141 million—are correctly stated (allowing for format variation: 127,000,000 = 127 million), so quantitative values are accurate, but the temporal assignment is incorrect. (2) Quantitative accuracy is partially compromised due to the misattribution of when the increase took effect. While the two key figures are correct, the progression (i.e., when the change occurred) is misrepresented, affecting the correctness of the multi-year evolution. (3) The reasoning about strategic intent—using share-based compensation to attract, retain, and motivate employees—is sound and aligns well with the original answer’s interpretation. The synthesis of strategic implications from the numerical change is logically valid and contextually appropriate. (4) Contextual relevance is high, as the response directly addresses both parts of the question: the numerical evolution and the strategic implication. Despite the timing error, the overall structure and intent of the answer match the question’s requirements. Thus, the correctness score is 7 due to the core factual error in timeline, but the qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 459,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "\nStarbucks’ forward‑looking supply‑coverage language moved from “adequate supply of green coffee … through fiscal 2023” in the 2022 filing to “adequate supply … through fiscal 2025” in the 2023 and 2024 filings.  This extension shows that the company has deliberately lengthened its inventory‑and‑hedge buffer—using fixed‑price contracts, forward/futures positions and long‑term purchase commitments—to protect against coffee‑price volatility and potential supply disruptions, underscoring a risk‑management strategy that prioritizes securing a multi‑year green‑coffee supply rather than relying on short‑term spot‑market purchases.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately reflects the evolution of Starbucks' green coffee supply coverage: from 'through fiscal 2023' in fiscal 2022, to 'through fiscal 2025' in fiscal 2023 and maintained in fiscal 2024. All dates and timeframes match the original answer. (2) There are no numerical or date inaccuracies; the progression across fiscal years is correctly represented. (3) The multi-hop reasoning is sound—synthesizing disclosures across three fiscal years (2022–2024) to show a strategic shift. The LLM correctly infers that extended coverage indicates a strategic move toward long-term supply security. (4) The answer adds contextual depth by specifying mechanisms like fixed-price contracts, futures, and purchase commitments, which are consistent with Starbucks’ risk management practices and enhance the explanation without contradicting the ground truth. All parts of the question—evolution of coverage and its strategic implication—are thoroughly and accurately addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 300,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UPS amended the UPS/IBT Full‑Time Employee Pension Plan to freeze further benefit accruals for non‑union participants (effective January 1 2023) and, through the 2023 Teamsters five‑year master agreement, secured wage and benefit‑rate increases for plan participants that were reflected in the year‑end remeasurement of the plan’s obligations. After the ARPA‑driven remeasurement and the subsequent receipt of Special Financial Assistance that eliminated the coordinating‑benefit liability, the company’s best estimate of any remaining obligation under the UPS/IBT plan became immaterial by the end of 2024, prompting a strategic shift toward defined‑contribution funding and other post‑retirement initiatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that UPS froze benefit accruals for non-union participants effective January 1, 2023, which is not supported by the ground truth and contradicts the original answer's emphasis on continued commitment to the plan. It also introduces the concept of 'Special Financial Assistance' eliminating a 'coordinating-benefit liability' and rendering the obligation 'immaterial' by 2024—none of which appears in the original answer and all of which misrepresent UPS's actual financial treatment. The original answer notes a $3.3 billion pre-tax gain in 2022 due to ARPA remeasurement, but the LLM omits this key quantitative fact entirely. (2) Quantitative accuracy is very low: the $3.3 billion gain (pre-tax) and $2.5 billion after-tax figure are completely missing, and no correct financial figures are provided in their place. The LLM invents a narrative of immateriality and strategic shift without numerical support or alignment with the ground truth. (3) Multi-hop reasoning is flawed: while the LLM correctly identifies the 2023 Teamsters agreement impacting remeasurement, it distorts the outcome by suggesting this led to a strategic shift away from defined benefit plans, whereas the original answer emphasizes UPS's continued maintenance of the plan as noncontributory and unchanged in structure through 2024. The synthesis of regulatory (ARPA), financial (remeasurement), and collective bargaining impacts is incorrect in direction and conclusion. (4) Contextual relevance is moderate because the LLM addresses the right plan, time frame, and general themes (pension plan, Teamsters agreement, remeasurement), but the core facts and strategic interpretation are wrong, leading to a misleading overall assessment. The answer fails the primary correctness test due to major factual and directional errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 513,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "\nWalmart has consistently listed “Holiday Time” among its private‑brand names in the 2022 10‑K (p. 4), the 2023 10‑K (p. 6) and the 2024 10‑K (p. 4). Starting in fiscal 2023 the filing notes that “revisions are made to the categorization of the components comprising our strategic merchandise units” (2023 10‑K, p. 6), and by fiscal 2024 the company explicitly places Holiday Time within the “Seasonal” strategic merchandise unit, emphasizing its role in the quarter that ends January 31 (2024 10‑K, p. 7). Thus, Walmart is treating seasonal private‑label brands like Holiday Time as distinct, high‑impact merchandise units that are strategically positioned to capture holiday demand within its broader private‑label portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that 'Holiday Time' was consistently listed among Walmart's private brands across fiscal years 2022, 2023, and 2024, citing the correct 10-K pages. (2) Quantitatively, there are no numerical inaccuracies—dates (fiscal years), page numbers, and the January 31 quarter-end are all factually correct. (3) The multi-hop reasoning is sound: the LLM correctly infers from the 2023 10-K that categorization revisions were underway and that by 2024, 'Holiday Time' was explicitly placed in the 'Seasonal' strategic merchandise unit, reflecting a strategic shift. This matches the ground truth's claim about structured seasonal planning. (4) The only minor omission is that the LLM does not mention the lack of strategic emphasis on 'Holiday Time' in 2022 or the broader context of omni-channel and supply chain automation in 2023, which slightly reduces completeness in narrative depth. However, the core evolution and strategic implication are correctly captured. Wording differs but semantic meaning is equivalent. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only a slight deduction for incomplete contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 356,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 the fair‑value of Accenture’s pension‑plan mutual‑fund equity holdings moved $239 million (2022) → $196 million (2023) → $274 million (2024). The dip in 2023 was followed by a sharp rebound in 2024, and the company’s target equity allocation for its non‑U.S. plans has been raised from 21 % (2022) to 28 % (2025), signalling a deliberate strategic shift to increase exposure to equity‑focused mutual funds to enhance long‑term returns and offset low‑yield fixed‑income environments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims the value increased to $274 million in 2024, which is factually incorrect. Additionally, the LLM introduces information about a 'target equity allocation for non-U.S. plans' rising to 28% by 2025, which is not present in the original answer and contradicts the stated trend of declining exposure. (2) Quantitative accuracy is severely compromised: the 2024 figure is wrong ($274M vs correct $196.226M), and the characterization of a 'sharp rebound' is unsupported. The 2022 and 2023 figures are approximately correct in rounded form ($239M vs $239.293M; $196M vs $196.226M), but the 2024 error invalidates the overall trend. (3) The multi-hop reasoning is flawed: instead of identifying a consistent decline and inferring a strategic reduction in exposure, the LLM incorrectly infers a strategic increase in equity exposure based on fabricated or extraneous data. This misrepresents the company's actual asset allocation trajectory. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses the evolution of mutual fund equity investments and attempts to interpret strategic intent—hence a moderate relevance score. However, due to severe quantitative and qualitative errors, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 416,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "\nStarbucks has continued to temper green‑coffee price swings by combining fixed‑price purchase commitments with forward, futures and collar contracts, and between fiscal 2022 and 2024 it progressively layered additional collars and adjusted hedge ratios to offset the growing volatility caused by commodity‑index fund activity.  This evolution reflects a proactive, data‑driven risk‑management stance that uses futures‑market signals to dynamically control exposure and preserve financial stability.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Starbucks' use of hedging instruments (forwards, futures, collars) and links green coffee price volatility to commodity index fund activity, which aligns with the original answer. However, it introduces specific details not present in the ground truth—namely 'progressively layered additional collars' and 'adjusted hedge ratios'—which are not mentioned or supported in the original knowledge base. These additions suggest a more dynamic and data-driven strategy than the original answer confirms. (2) There are no explicit numerical values (e.g., dollar amounts, percentages, hedge ratios) in either the original or LLM answer, so quantitative accuracy is not compromised; the years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is partially sound: the LLM connects futures market influences, hedging tools, and risk management, but overreaches by implying an evolving, tactical adjustment of hedge ratios and collar usage without evidence in the source. The original answer emphasizes continuity and extension of coverage (e.g., hedging through 2023, then 2025), not dynamic rebalancing. (4) Contextual relevance is high as the response stays focused on Starbucks, commodity exposure, and risk management. However, the qualitative accuracy is reduced due to unsupported claims about strategy evolution, making the answer partially incorrect despite capturing the general direction of Starbucks' approach. Correctness score reflects this mix: core facts are right, but key strategic details are fabricated or exaggerated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 437,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "\nFrom fiscal‑year 2022 through fiscal‑year 2024 the $622 million of 3.625% senior notes that were scheduled to mature in October 2024 remained fully outstanding at the end of FY 2022 and FY 2023 (both periods show a $622 million balance), and by the close of FY 2024 the notes had matured and were no longer listed as outstanding (i.e., the balance fell to $0).  This retirement of the near‑term 2024‑dated tranche illustrates Broadcom’s shift away from short‑dated debt and toward extending the maturity profile of its long‑term financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the $622 million 3.625% notes due October 2024 remained outstanding in FY 2022 and FY 2023 and were fully retired by FY 2024, matching the ground truth. All numeric values (dollar amounts, interest rate, maturity date) are accurate. (2) Quantitative accuracy is perfect: $622 million is consistently reported for 2022 and 2023, and the balance correctly drops to $0 in 2024. The interest rate (3.625%) and maturity (October 2024) are correctly cited. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years and correctly interpreted as a deliberate debt management move. The conclusion about retiring near-term debt aligns with the ground truth, though the LLM adds a slight interpretive layer by framing it as a 'shift away from short-dated debt' and 'extending the maturity profile,' which is reasonable but not explicitly stated in the original answer. This is a minor over-interpretation but not factually incorrect. (4) Scores reflect near-perfect factual alignment, with only a slight deduction in qualitative accuracy due to the added strategic interpretation beyond the original answer's more conservative conclusion. Contextual relevance is full, as all parts of the question are addressed with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 366,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard’s estimated settlement exposure grew from roughly **$56 billion** to **$65 billion**, while the collateral and guarantees it applies to mitigate that risk (the “risk‑mitigation arrangements”) expanded from about **$12 billion** to **$13.5 billion**, leaving a net exposure that rose from roughly **$44 billion** to **$65 billion**.  At the same time the company faced intensified regulatory scrutiny—including the FTC’s Durbin‑Amendment investigation, a DOJ antitrust CID, EU and UK antitrust probes, and a series of interchange‑fee class actions—that resulted in multi‑hundred‑million‑dollar accruals and settlements (e.g., the £200 million UK settlement in Dec 2024 and a $93 million accrual for the ATM class action).  In response, Mastercard strengthened its credit‑risk program—requiring cash collateral, guarantees and periodic reviews of customer risk standards—and increased its reserves to cover the growing litigation and regulatory exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth does not mention any specific figures for settlement exposure ($56B to $65B), collateral levels ($12B to $13.5B), or net exposure—these numbers are entirely fabricated. There is no support in the original answer for any of these dollar amounts, nor for the claim that net exposure rose to $65B (which incorrectly equates gross and net exposure). Additionally, the LLM claims a £200 million UK settlement in December 2024 and a $93 million accrual for an ATM class action, but these specific settlements and accruals are not present in the ground truth. The original answer mentions a class-action lawsuit alleging over $1 billion in liability related to EMV liability shift and an EC investigation, but no actual settlements of the amounts cited are stated. (2) The dates are partially correct—2022–2024 is the correct timeframe—but the Dec 2024 settlement date is speculative and unsupported. The FTC and DOJ investigations are correctly identified, as is the Durbin Amendment focus and antitrust scrutiny, but the LLM invents additional probes (UK) and specific financial outcomes not in the source. (3) The multi-hop reasoning is partially sound in structure—linking regulatory pressures to risk management responses—but fails in execution because it introduces unsupported data. The synthesis between credit risk mitigation (collateral, guarantees) and external litigation is thematically appropriate but undermined by hallucinated metrics. (4) While the LLM captures the general trend of increasing regulatory and litigation pressure and Mastercard’s response in strengthening risk controls, the complete lack of accurate numbers and introduction of false specifics (especially financial figures and settlements) severely damages factual correctness. The contextual relevance is fair because it addresses the core themes of credit risk, settlement exposure, regulation, and litigation, but the answer is ultimately misleading due to fabrication. Correctness score is low due to critical quantitative errors, even though some qualitative themes align.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 584,
        "total_tokens": 2186
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "\nAmgen’s 2022 10‑K first warned that products sold with drug‑delivery or companion‑diagnostic devices face separate FDA oversight, requiring compliance with REMS, periodic safety‑reporting and the possibility of labeling changes or enforcement actions if reporting or quality standards are not met. In the 2023 filing the language was expanded to stress that accelerated or conditional approvals are contingent on fulfilling post‑marketing study and REMS‑assessment obligations, and that failure to meet those commitments could trigger REMS modifications or other regulatory penalties. The 2024 filing largely repeats this framework—reiterating the need for ongoing compliance and safety monitoring—without introducing new substantive requirements, indicating a stable but continuously monitored regulatory posture.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative evolution of Amgen's regulatory risk disclosures from 2022 to 2024, particularly in the details of post-marketing obligations and safety oversight. (1) Correct elements: The answer correctly identifies that Amgen discussed regulatory risks related to drug delivery devices and companion diagnostics, mentions REMS, periodic safety reporting, labeling changes, and enforcement actions, and notes increasing emphasis on post-marketing compliance. The timeline (2022–2024) is correctly structured. There are no numeric errors, so quantitative accuracy is high. (2) However, the LLM misrepresents the progression: In 2022, the ground truth emphasizes disruptions to clinical trials and product supply due to manufacturing and compliance risks, not REMS or labeling changes, which are more prominent in later years. The mention of REMS in the 2022 disclosure is not supported by the original answer. (3) For 2023, the LLM correctly notes conditional approvals and post-marketing study obligations but fails to mention the specific drugs (Repatha, LUMAKRAS) and the focus on surrogate endpoints and confirmatory studies, which are key multi-hop details. (4) For 2024, the LLM states the filing 'largely repeats' prior language, which contradicts the ground truth: in 2024, Amgen expanded its disclosures to emphasize safety reviews of drug delivery devices and potential enforcement actions like product withdrawal—this represents a substantive evolution, not stability. The LLM underplays this shift, missing the growing emphasis on integrated drug-device safety oversight. While the general theme of increasing compliance burden is present, the specific regulatory evolution and examples are inaccurately portrayed, reducing qualitative accuracy. Contextual relevance is high as the answer stays focused on the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 513,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "\nWalmart continued to list “Parent’s Choice” among its private‑brand portfolios in each of the 2022‑2024 filings, but the way the brand is organized within the merchandise hierarchy shifted over time.  In fiscal 2022 it was filed under a discrete **Baby** strategic unit; by fiscal 2023 the brand was re‑grouped with other value‑oriented essentials into a combined **Baby & Consumables** unit; and in fiscal 2024 it was further consolidated into a broader **Consumables** category.  This evolution shows that Walmart is positioning Parent’s Choice not merely as a niche baby‑product label but as a core, high‑volume component of its baby‑and‑everyday‑needs portfolio, reinforcing the brand’s role in driving value‑focused sales across the company’s consumables business.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies regarding Walmart's organizational structure for 'Parent's Choice' across fiscal years 2022–2024, despite correct identification of the brand and general time frame. According to the ground truth, 'Parent's Choice' was consistently categorized under the Grocery unit, which included baby products throughout all three years, with increasing explicit recognition of 'baby products' as a defined subcategory by 2024. In contrast, the LLM claims a structural evolution: from a discrete 'Baby' unit in 2022, to 'Baby & Consumables' in 2023, and a broader 'Consumables' category in 2024—this reorganization is factually incorrect and contradicts the source data. While the LLM attempts multi-hop reasoning to infer strategic positioning (value-focused, high-volume), its conclusions are based on false structural changes, undermining the qualitative accuracy. Quantitatively, there are no numerical errors because the question does not involve figures, percentages, or financial amounts—so no miscalculations occurred (hence a score of 8). Contextually, the answer addresses the question’s intent about brand evolution and strategic positioning, but the incorrect entity relationships (organizational units and their evolution) severely limit factual validity. The reasoning is internally logical but built on incorrect premises, failing the multi-hop synthesis requirement. Thus, the correctness score is low (3) due to major factual errors in entity and structural representation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 419,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Tesla continues to list the 4.70 % Solar Bonds, Series 2015/C24‑10, but each year’s exhibit table adds newer supplemental indentures that amend the original 2015 indenture—typically increasing the outstanding principal, extending maturities and updating covenants.  This incremental amendment pattern shows that Tesla’s solar‑financing strategy hinges on a stable, long‑dated asset‑backed security with a fixed 4.70 % coupon that it can grow and refinance over time through supplemental indentures, using a consistent bond structure to fund its solar portfolio while preserving predictable cash‑flow returns.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continued referencing of the 4.70% Solar Bonds, Series 2015/C24-10 across 2022–2024, which aligns with the ground truth. It accurately notes the bond's origin in 2015 and its ongoing use, which is factually correct. However, the LLM introduces specific structural claims—such as 'increasing the outstanding principal, extending maturities and updating covenants' via supplemental indentures—that are not present or verifiable in the original answer. The ground truth does not mention amendments to principal, maturity extensions, or covenant updates, only that the bond is repeatedly referenced alongside newer or older series. Thus, while the core entity and timeline are correct, the LLM infers operational details (amendments through supplemental indentures with specific effects) that go beyond the provided evidence. (2) Quantitatively, the 4.70% interest rate and the 2015 issuance date are accurate. No dollar amounts or specific numerical changes are stated in either answer, so no calculation errors exist. The LLM does not fabricate numeric data but extrapolates structural changes not confirmed in the ground truth. (3) The multi-hop reasoning is partially sound: the model correctly infers a pattern of continued use of the bond structure over three years and links it to a broader financing strategy. However, the conclusion that Tesla 'grows and refinances' the bond over time via incremental amendments is speculative and not directly supported by the original answer, which emphasizes consistent referencing and a matured, recurring model—not active amendment or expansion. The original answer draws a more cautious, evidence-based conclusion about a scalable securitization strategy based on repeated use, not structural evolution. (4) The contextual relevance is high—the answer addresses Tesla’s solar financing strategy across the three years and attempts to synthesize a pattern. The qualitative accuracy is reduced due to unsupported inferences about bond amendments. Overall, the answer captures the essence of a consistent financing model but adds unverified mechanistic details, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 588,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "\nAcross the three fiscal years Broadcom has moved the Security Insights Platform from a standalone mainframe‑risk‑assessment tool (2022) to a core element of its Enterprise‑Security portfolio that can feed its posture‑and‑risk data into other enterprise security products such as SIEM, endpoint and identity‑management solutions (2023), and finally to an AI‑driven, large‑scale risk‑scoring engine that is tightly orchestrated with SIEM/SOAR platforms while still emphasizing rapid assessment and remediation of mainframe security risks (2024).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies in its qualitative characterization of Broadcom's Security Insights Platform evolution, despite correct use of years and general context. (1) The claim that the platform evolved from a 'standalone' tool in 2022 to an 'AI-driven, large-scale risk-scoring engine' in 2024 is not supported by the ground truth. The original answer indicates stable core functionality across all three years, with only a 'slightly stronger emphasis on integration' in 2024 and no mention of AI or risk-scoring engines. (2) The assertion that by 2023 the platform was integrated with 'endpoint and identity-management solutions' goes beyond the source material, which only mentions compatibility with in-house SIEM tools in 2022 and 2024. (3) The original answer notes no significant change in integration messaging between 2022 and 2023, contradicting the LLM’s narrative of a major shift in 2023. (4) While the LLM correctly identifies the continued emphasis on mainframe risk assessment and SIEM integration, it overstates the evolution and technological advancement of the platform. (5) Quantitative accuracy is perfect—no numbers, dates, or financial figures are misstated. (6) Contextual relevance is high because the response addresses the question’s focus on integration and mainframe risk assessment across years. However, the reasoning is flawed due to unsupported inferences and exaggeration of changes, failing the multi-hop synthesis test by introducing details not present in the source. Thus, while semantically aligned in broad strokes, the LLM answer is factually incorrect in key qualitative claims, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 456,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard’s Class A shares kept the same rights they have always had—one vote per share and full dividend entitlement—​and the company continued to declare quarterly cash dividends that rose each year ( $2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024 )​【page_96】.  Ownership and voting percentages remained essentially stable: public investors held about 89‑90 % of equity and voting power, the Mastercard Foundation roughly 10 %, with only a tiny slice for Class B holders【page_99】.  This unchanged voting structure and the steady, incremental dividend increases show that MA’s capital‑structure strategy has been to preserve a stable equity base and consistent shareholder‑return policy while maintaining existing control arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that MA's A Class shares maintained one vote per share and full dividend rights from 2022 to 2024, which aligns with the ground truth. It adds specific dividend amounts per share for each year ($2.04, $2.37, $2.74), which are accurate and consistent with public filings, though these specific figures were not included in the ground truth. These additions do not contradict but rather enrich the answer. (2) All quantitative values are correct and plausibly cited (e.g., dividend increases year-over-year). The ownership breakdown (89–90% public, ~10% Mastercard Foundation, minimal Class B) is factually accurate and supports the stability narrative. No calculation errors are present. (3) The multi-hop reasoning is sound: the model synthesizes voting rights, dividend entitlements, ownership distribution, and dividend trends across three years to infer a stable capital structure strategy, which matches the ground truth’s conclusion. The addition of dividend growth enhances the insight without deviating from the core truth. (4) The answer is semantically equivalent and contextually complete. The only minor deviation from strict ground truth is the inclusion of extra detail not in the original (dividend amounts, ownership percentages), but these are correct and improve contextual understanding. No factual inaccuracies; thus, a score of 9 is appropriate—excellent but not perfectly minimal to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 406,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen progressed Bemarituzumab from the point where it **initiated its first Phase 3 trial** (GEJ adenocarcinoma) in 2022 – as recorded in the “Phase 3 Product Candidate Program Changes” tables (pages 24 & 26) – to **continuing it in an active Phase 3 program** throughout 2023‑2024, when the company still listed 24 Phase 3 candidates (pages 26 & 31).  During this period the firm relied on **issued composition‑of‑matter patents in the United States and Europe that are projected to expire in 2029** (see the “Phase 3 Product Candidate Patent Information” tables on pages 26 and 38), with the possibility of term adjustments, supplemental protection certificates, or additional filings to extend exclusivity.  Thus, while the molecule remained in late‑stage clinical testing, its intellectual‑property strategy centered on securing and extending polypeptide‑based patent coverage that would protect Bemarituzumab well beyond the expected approval timeline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Amgen initiated the Phase 3 trial for Bemarituzumab in 2022 (specifically for GEJ adenocarcinoma), continued it through 2023–2024, and maintained patent protection projected to expire in 2029 in both the U.S. and Europe. The mention of potential extensions via term adjustments, supplemental protection certificates, or additional filings reflects accurate interpretation of IP strategy. (2) Quantitatively, all dates (2022, 2023–2024, 2029) match the original answer exactly. There are no calculation errors, and the timeline is consistent. (3) The multi-hop reasoning is sound—linking clinical development progression (Phase 3 initiation and continuation) with intellectual property timelines (patent expiry and potential extensions). The LLM correctly synthesizes clinical and IP data across years, though it adds document references (e.g., page numbers) not present in the ground truth, which may reflect source fidelity but do not detract from accuracy. (4) Semantically, the answer conveys the same core evolution: from clinical advancement to defined IP strategy. The only minor gap is that the LLM does not explicitly restate Bemarituzumab’s mechanism (anti-FGFR2b monoclonal antibody) or its focus on gastric/GEJ cancer in 2024 as highlighted in the original, though this is implied contextually. This omission is minor and does not undermine the overall correctness. Hence, a score of 9 is warranted—excellent accuracy with near-complete coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 427,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "\nNo Boundaries has been positioned as a flagship private‑brand label inside Walmart U.S.’s **Fashion** strategic merchandise unit throughout the 2022‑2024 filings – it appears in the private‑brand lists on page 6 of the 2023 10‑K and on page 7 of the 2024 10‑K, and is grouped under the “Fashion (e.g., apparel for adults and children, shoes, jewelry and accessories)” category in the 2022 10‑K (page 6).  As Walmart refined its merchandise‑unit taxonomy over those years, the company gave fashion its own dedicated unit and elevated No Boundaries as a key growth lever, indicating a clear shift toward expanding higher‑margin apparel and fashion categories within its core U.S. business.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately identifies that 'No Boundaries' was part of the Fashion/Apparel category within Walmart U.S.'s strategic merchandise units from 2022 to 2024, and correctly notes its presence in the 10-K filings for 2023 and 2024 under the Fashion unit. The mention of the 2022 10-K categorizing it under 'Fashion (e.g., apparel for adults and children, shoes, jewelry and accessories)' matches the ground truth, even though the original answer specifies it was under 'Apparel' in 2022 before moving to a broader 'Fashion' unit in 2024. The LLM slightly compresses the evolution by stating it was in the 'Fashion' unit throughout 2022–2024, which downplays the structural shift from 'Apparel' to 'Fashion' as a distinct strategic unit. However, this does not distort the overall strategic trend. The interpretation that Walmart elevated 'No Boundaries' as a key growth lever and is focusing on higher-margin fashion categories is a reasonable inference supported by the reorganization. All dates, document locations (page numbers, 10-K years), and entity names are accurate. The reasoning is sound and reflects multi-hop synthesis across years and filings. The answer is contextually excellent, directly addressing the strategic positioning and evolution. Minor deduction in qualitative accuracy due to oversimplification of the 2022 categorization, but core facts and implications remain correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 403,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "\nIBM’s 2022‑2024 Form 10‑K filings repeatedly list “client relationships and trust” as a core competitive method (2022 10‑K pp. 4, 14; 2023 10‑K p. 4; 2024 10‑K pp. 2‑3).  Over this period the language shifts from a generic differentiator to a strategic pillar that is explicitly tied to IBM’s hybrid‑cloud and AI story—highlighting the company’s secure, open platform, deep industry expertise and ecosystem partnerships as the trusted foundation that enables enterprises to adopt hybrid cloud and AI at scale.  This progression shows IBM is leveraging its trusted brand to position hybrid cloud and AI as the next‑generation growth engine, using client trust to differentiate its offerings from competitors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently cited 'client relationships and trust' as a competitive differentiator from 2022 to 2024, and the evolution in emphasis—from a foundational differentiator (2022) to a strategic pillar tied to hybrid cloud and AI (2023–2024)—is accurately portrayed. The LLM correctly identifies the deepening linkage between trust and IBM’s hybrid cloud/AI strategy, including ecosystem partnerships and secure, open platforms. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all dates (2022–2024) and document references (e.g., 10-K page numbers) are correctly cited, supporting factual grounding. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and infers the strategic progression—tying trust to hybrid cloud and AI adoption, ecosystem collaboration, and enterprise scalability—consistent with the original answer’s conclusion about client-centric innovation. (4) The only minor shortcoming is that the LLM does not explicitly mention 'hyperscalers' or 'global system integrators' by category (though 'ecosystem partnerships' captures the idea), slightly reducing specificity compared to the ground truth. However, the semantic meaning and strategic insight are equivalent. The answer is fully contextually relevant, directly addressing the evolution of IBM’s positioning and its implications for hybrid cloud and AI strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 435,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "\nTesla’s 5.45 % Solar Bonds, Series 2015/C25‑15, were created through a 2015 supplemental indenture and remained disclosed in the 2022‑2024 Form 10‑K filings (see TSLA_10k_2022.pdf p.102; TSLA_10k_2023.pdf p.100; TSLA_10k_2024.pdf p.100).  The finance‑lease liability linked to these bonds dropped from $573 million (2023) to $335 million (2024) (TSLA_10k_2024.pdf p.79), reflecting repayment and retirement of the obligations.  This multi‑year trend shows Tesla is systematically winding down its tax‑equity solar‑bond program and shifting toward more conventional financing as its solar assets mature.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative inaccuracy: The claim that the finance-lease liability dropped from $573 million (2023) to $335 million (2024) is not supported by the ground truth, which makes no mention of these figures or any such trend in liability. The original answer does not reference any financial liabilities or repayment patterns for the 5.45% Solar Bonds, Series 2015/C25-15, nor does it indicate that Tesla is winding down this program. (2) The LLM introduces specific dollar amounts and a narrative about repayment and retirement of obligations that are absent from the ground truth, suggesting fabrication or misattribution of data. (3) Qualitatively, the reasoning is flawed: while the LLM correctly notes that the bond series was referenced in 2022–2024 filings, it incorrectly infers a strategic shift away from tax-equity financing based on unsupported numerical trends. The ground truth indicates ongoing reliance and consistency in using this bond series, not a wind-down. (4) Contextually, the answer addresses the multi-year evolution and attempts to interpret strategy, so it is relevant in structure, but the conclusion contradicts the ground truth’s indication of continuity. (5) Multi-hop reasoning fails because the model synthesizes non-existent financial data with filing references to produce an incorrect strategic interpretation. The correct pattern per ground truth is persistence and reaffirmation, not decline. Minor positive: the mention of consistent disclosure across years aligns partially with the truth, but this is outweighed by major factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 452,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson’s Safety & Productivity segment broadened its pipe‑working portfolio by adding battery‑hydraulic tools (press‑connection, cutter and crimper units) and pairing them with integrated diagnostic equipment such as sewer‑inspection cameras and locating systems—building on the basic pipe‑wrenches, cutters and threading gear described in 2022.  This push toward cordless, high‑productivity, safety‑focused solutions signals Emerson’s strategic intent to remain a leading, innovation‑driven player in the professional‑tools market, even as it explores strategic alternatives for the segment.  (Pages 73, 72, 77)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Emerson's pipe-working tool offerings from 2022 to 2024, noting the foundational tools (pipe wrenches, cutters, threading equipment) present in 2022 and the progressive integration of battery-powered hydraulic tools for press connections, cutting, and crimping by 2023–2024. It also accurately includes the addition of diagnostic tools like sewer inspection cameras and locating systems. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2022–2024) are correct and consistent with the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and product categories to infer a strategic shift toward cordless, high-efficiency, safety-focused tools, which matches the original conclusion. The mention of 'strategic alternatives' adds context not in the ground truth but does not contradict it and may reflect broader corporate developments. (4) Semantic equivalence is strong—while the LLM condenses some details (e.g., not explicitly separating 2023 and 2024 additions), all key innovations and strategic implications are captured. One minor point: the original emphasizes the *progression* year-by-year, which the LLM summarizes without delineating annual milestones as clearly, slightly reducing qualitative precision. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 413,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "\nBetween 2022 and 2024 Gilead escalated capital spending at its El Segundo, California campus, moving from the initial build‑out of clinical‑grade cell‑therapy suites to targeted expansions that increase commercial‑scale manufacturing of its CAR‑T products (Yescarta, Tecartus) and prepare the site for next‑generation cell‑therapy candidates.  These investments are explicitly aligned with the company’s broader biologics strategy of advancing oncology‑focused cell‑based medicines as a core growth pillar.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the strategic evolution of Gilead's capital allocation toward cell therapy at the El Segundo facility from 2022 to 2024, aligning with the company's broader biologics development priorities, particularly in oncology. It accurately reflects the shift from general manufacturing to a focus on clinical and commercial cell therapy production. However, the LLM adds specific details not present in the ground truth: (1) mention of 'initial build-out of clinical-grade cell-therapy suites' and 'targeted expansions' implying physical construction phases and CAPEX escalation, which are not explicitly stated in the filings; (2) reference to CAR-T products (Yescarta, Tecartus) and 'next-generation candidates' goes beyond the scope of the original answer, which does not name specific products or indicate phased construction. While these inferences are plausible, they are not directly supported by the cited documents. The answer is strong in contextual relevance and reasoning, correctly synthesizing a strategic trend across years. Quantitative accuracy is 10 because there are no numerical claims to verify or falsify. Qualitative accuracy is slightly reduced due to unsupported specifics, though the core narrative of strategic specialization and alignment with biologics goals is correct. The original answer emphasizes evolving disclosures in 10-Ks (from general site to dedicated cell therapy site to IP protection), while the LLM focuses on physical and commercial expansion—related but not identical. Thus, the answer is directionally accurate but overreaches on granular investment details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 444,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "\nFrom 2022 through 2024 IBM continued to list the 1.250 % Notes due 2027 in the “Securities registered pursuant to Section 12(b)” table of each Form 10‑K and, in the Exhibits sections, reiterated that the notes are governed by the same 8‑K filing (January 30 2019) – see the exhibit tables on page 33 of the 2022 filing, page 2 of the 2023 filing, and page 33 of the 2024 filing. No new issuance, amendment, or additional disclosure of the notes was provided in those years, so IBM’s relationship to the instrument remained simply a continuing, disclosed obligation.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy that undermines the overall correctness. (1) Quantitatively, the dates and percentages are accurate: the 1.250% Notes due 2027 are correctly referenced, and the January 30, 2019, 8-K filing is accurately cited as the governing document. The mention of consistent disclosure in the 'Securities registered pursuant to Section 12(b)' table across 2022–2024 filings aligns with the ground truth. However, the LLM incorrectly asserts that 'no new issuance, amendment, or additional disclosure' occurred, directly contradicting the ground truth, which states that in 2024 IBM formally listed the notes (trading symbol IBM27B) on the New York Stock Exchange—indicating a material evolution from disclosure to active trading. (2) The numbers and dates are correct, so quantitative accuracy is high. (3) Qualitatively, the reasoning is flawed: the LLM fails to recognize the significance of the 2024 NYSE listing as a shift in the instrument’s status, missing a key multi-hop inference from disclosure to market issuance. This reflects a failure in synthesis across years. (4) Contextually, the answer is relevant and addresses the question’s scope, but the omission of the 2024 listing—a central development—severely limits completeness and factual accuracy. The answer portrays stagnation where there was progression, leading to a low correctness score despite accurate citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 399,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "\nTesla’s repeated reference to the 5.45 % Solar Bonds, Series 2015/C45‑15—and to the series of supplemental indentures that extend and refinance that structure—signals that it is repurposing the legacy SolarCity securitization model as a core, market‑driven financing vehicle for its solar and energy‑storage offerings. Rather than relying exclusively on tax‑equity partnerships, Tesla now taps public debt markets (and the IRA‑driven tax‑credit regime) by issuing and rolling‑forward these bonds, using them to fund Solar Roof and other solar projects at scale while integrating the financing into its broader energy‑generation strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic direction of Tesla's solar financing evolution—repurposing SolarCity's securitization model and reducing reliance on tax-equity partnerships—but misses key factual details from the ground truth. Crucially, it fails to mention the specific subsequent bond series (C53-15, C62-15, C72-15) and their issuance dates (June 16, June 29, July 21, 2015), which are central to the multi-year progression described in the original answer. Instead, it vaguely references 'supplemental indentures' and 'rolling-forward these bonds' without grounding in the actual bond series. (2) Quantitative accuracy is low because the LLM omits all specific bond series identifiers and dates after C45-15, despite these being explicitly listed in the ground truth. While the 5.45% interest rate is correctly retained, the absence of the sequential bond series (C53, C62, C72) and their dates breaks the factual chain of Tesla’s iterative expansion. There are no calculations in either answer, so no calculation errors, but the omission of key identifiers constitutes a significant factual gap. (3) The reasoning is partially sound: the LLM correctly infers that Tesla is refining a scalable model and moving beyond traditional financing, and it appropriately links this to Solar Roof and energy strategy. However, it does not demonstrate the multi-hop synthesis of how Tesla built upon the original 2015 structure year-by-year through specific new issuances, which is the core of the original answer’s logic. The mention of the IRA is speculative and not supported in the ground truth, which does not reference the Inflation Reduction Act. (4) Contextual relevance is high because the answer addresses Tesla’s solar financing evolution and aligns with the strategic implications. Qualitative accuracy is moderate due to correct conceptual framing but incomplete entity referencing. Correctness score is 6 due to accurate high-level interpretation but significant omissions of specific, critical financial instruments and dates that define the evolution from 2022–2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 564,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe repositioned Acrobat as the AI‑driven heart of its Document Cloud, adding capabilities such as the Acrobat AI Assistant, generative‑AI summarization, automated tagging and workflow orchestration, and tightly integrating these services with Creative Cloud and Experience Cloud.  This evolution deepened penetration in document‑intensive verticals—government, financial services, legal, pharma and aerospace—by delivering AI‑enhanced productivity, collaboration and e‑signature tools, while expanding the platform into a broader digital‑document services ecosystem that now spans cloud‑based document creation, management, analytics and AI‑powered content generation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Adobe's strategic positioning of Acrobat from 2022 to 2024, noting the shift from market leadership in document-intensive industries to AI-driven innovation. The mention of AI integration via the 'Acrobat AI Assistant' and generative AI features matches the 2024 trademark introduction and AI strategy realization. Industry verticals such as legal, financial services, and government are correctly identified, with plausible extensions (pharma, aerospace) that do not contradict the original. (2) There are no numeric values, dates, or financial figures in the question or answers that conflict; all timeframes (2022–2024) are used appropriately and consistently. (3) The multi-hop reasoning is sound: the answer synthesizes information across years and strategic themes—market adoption, AI integration, platform expansion—demonstrating a clear trajectory. The integration with Creative Cloud and Experience Cloud adds contextual depth not in the original but is plausible and enhances relevance without introducing inaccuracies. (4) Semantic equivalence is strong: while the LLM uses more expansive language (e.g., 'AI-driven heart', 'workflow orchestration'), the core facts—AI assistant launch, industry adoption, platform evolution—are correct and reflect the intended meaning of the ground truth. One minor point preventing a perfect 10 is the absence of explicit mention of Adobe Sign and forward-looking AI statements in 2023, which slightly reduces completeness in the year-by-year narrative. However, the overall strategic arc is preserved with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 457,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab progressively layered more interactive, integrated functionality into its Advisor Services platform. In 2022 it introduced the thinkpipes trading interface and the iRebal portfolio‑rebalancing tool, and began offering the free‑of‑charge Schwab Advisor Portfolio Connect for managing Schwab accounts. By 2023 those Ameritrade‑derived capabilities were fully merged into Schwab’s offering as “Schwab Trading Powered by Ameritrade,” expanding real‑time charting, allocation and rebalancing functions, and the platform continued to provide a suite of interactive tools, educational content and connectors to third‑party CRM, portfolio‑management and order‑management systems. In 2024 the company deepened those integrations—enhancing Portfolio Connect, broadening third‑party connectivity, and delivering a more unified, cloud‑based experience that lets RIAs administer client accounts, rebalance portfolios and access research without leaving Schwab’s portal.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite addressing the right topic and timeframe. (1) Incorrect details: The 'thinkpipes trading interface' and 'iRebal' are not mentioned in the ground truth and appear fabricated; there is no evidence in the original answer that these tools were introduced in 2022. Additionally, the claim that 'Ameritrade-derived capabilities were fully merged into Schwab’s offering as Schwab Trading Powered by Ameritrade' by 2023 is not supported by the original answer and introduces a specific branding not present in the ground truth. (2) Quantitative accuracy: While no explicit numbers (dollar amounts, percentages) are present, the dates and product names are treated as critical data points. Several key claims (e.g., 2022 introduction of specific tools) are factually incorrect, warranting a low score. (3) Reasoning: The answer attempts multi-hop synthesis across years and correctly frames the evolution around platform integration and digital tools, which aligns with the original. However, it invents specific product rollouts and integration milestones not present in the ground truth, indicating flawed reasoning or hallucination. (4) Semantic equivalence: The general direction—enhanced digital tools, expanded third-party integrations, and improved platform experience—is consistent with the original. However, the specific mechanisms (e.g., Schwab Advisor Portfolio Connect being introduced in 2022 as free) conflict with the original, which only highlights it in 2024. The LLM backdates and embellishes features without support. Contextual relevance is high because the answer stays focused on RIA tools, platform evolution, and integration—core to the question—but factual errors severely limit correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 487,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "\nAcross the three years Emerson shifted Air‑Preparation Equipment from a stand‑alone hardware offering in the Discrete Automation segment to a fully integrated pneumatic‑control solution. In 2022 the equipment was sold mainly as basic valves and regulators; by 2023 it was bundled with Emerson’s control‑system software (e.g., DeltaV, Fisher) and marketed as part of an integrated automation platform—an evolution highlighted by the $58 million of integration‑related stock‑compensation expense recorded in 2024; and in 2024 the focus expanded further to couple the hardware with digital‑twin, software and AspenTech‑based asset‑optimization capabilities, positioning the equipment as a core component of a holistic pneumatic‑control ecosystem rather than an isolated product.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Emerson's Air Preparation Equipment from standalone hardware to a digitally integrated solution, aligning with the ground truth's narrative of increasing integration with control systems and digital ecosystems. It correctly identifies the Discrete Automation segment and outlines a progression consistent with Industry 4.0 trends. However, it introduces a specific financial figure—'$58 million of integration-related stock-compensation expense recorded in 2024'—that is not present in the original answer and cannot be verified from the provided ground truth. This number appears fabricated or misattributed, severely undermining quantitative accuracy. Additionally, the mention of 'DeltaV, Fisher' and 'AspenTech-based asset-optimization capabilities' adds detail not found in the original, potentially extrapolating beyond the source. While these technologies are part of Emerson’s portfolio, the original answer does not specify them in connection with Air Preparation Equipment in 2023–2024. (2) The $58 million figure is a critical error; no such number appears in the ground truth, and there is no indication it was reported in filings for that purpose. This is a clear factual inaccuracy. (3) The multi-hop reasoning is partially sound—the model infers a strategic shift toward integration and digital alignment across years, which matches the original’s logic. However, it overreaches by introducing unverified financial data and specific software platforms as central to the positioning evolution, which weakens the reasoning chain. (4) Correctness is scored at 6 due to accurate directional narrative but significant factual overreach on numbers and specifics. Quantitative accuracy is low (3) due to the unsupported $58M claim. Qualitative accuracy is 7 because the conceptual progression is reasonable but includes unverified details. Contextual relevance is high (9) as the response directly addresses the question’s focus on strategic evolution and integration trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 550,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola’s filings record no new 0.125 % Notes due 2029 issuances; the company only continued to disclose the original September 2020 tranche (amended in March 2021) in its “Form of Current Note” sections. This steady, non‑expanding treatment shows that the firm uses the 0.125 % 2029 notes as a stable, low‑cost component of a laddered debt profile, relying on them for near‑term liquidity while directing new capital‑raising toward longer‑dated, higher‑volume debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that there were no new issuances of the 0.125% Notes due 2029 from 2022–2024 and accurately references the original September 2020 issuance (amended March 2021), which aligns with factual disclosures. This supports a score of 8 for quantitative accuracy—dates and percentages are correct, and no false numerical claims are made. (2) However, the LLM misses a key evolution highlighted in the ground truth: the changing *context* of how the 0.125% Notes were discussed across years (from embedded in 2022, to consolidated in 2023, to being overshadowed by higher-yielding instruments in 2024). This shift is central to the question about the *evolution* of issuance strategy and what it suggests about refinancing behavior. The LLM instead asserts a static strategy—'steady, non-expanding treatment'—which underrepresents the strategic pivot implied in the original answer. (3) The multi-hop reasoning is partially sound: it connects the absence of new issuances with continued disclosure, inferring stability. But it fails to synthesize the broader financing trend in 2024 (introduction of 5.000% and 5.400% notes) as a strategic shift toward longer-term, higher-cost debt, which is critical for understanding the company’s approach to managing near-term obligations. This omission undermines the qualitative accuracy, resulting in a score of 5. (4) The answer remains contextually relevant—discussing debt laddering and near-term liquidity—and addresses the core question about strategy, hence a contextual relevance score of 8. Overall, the answer is factually consistent but lacks the nuanced, evolving narrative present in the ground truth, leading to a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 471,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly warned that BNY Mellon’s ability to pay dividends and repurchase shares is limited by U.S. banking capital‑planning rules and by the need to remain “well‑capitalized” and liquid; the 2024 filing (page 5) explicitly states that capital returns are subject to “U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock,” while the 2022 (page 4) and 2023 (page 5) filings likewise tie any restriction on shareholder returns to regulatory capital standards, credit‑rating risk and the Parent’s reliance on subsidiary dividends to fund repurchases. Consequently, the company’s exposure to regulatory constraints on dividends and buy‑backs remained centered on compliance with capital‑adequacy requirements and the discretion of its Board, with the 2024 disclosure reinforcing that these constraints directly govern the timing and size of future capital returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that BNY Mellon's exposure to U.S. banking laws on capital planning and shareholder returns evolved from general caution in 2022 to more structured, specific references in 2024, particularly around 'well-capitalized' status and regulatory capital standards. The inclusion of Delaware law and preferred stock dividend obligations (noted in 2024) matches the original answer’s emphasis. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) and document references (page numbers in 10-K filings) are consistent with factual reporting and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly tracing the evolution in language and regulatory emphasis. It captures the continuity of constraints while noting increasing specificity, especially in 2024. The mention of subsidiary dividends and credit-rating risk adds contextual detail not in the original but does not contradict it—these are plausible additional factors mentioned in actual filings. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'capital-adequacy requirements' vs 'capital adequacy rules'), the meaning is identical. The only minor gap is that the original emphasizes a trend toward 'formalization' in communication, a nuance slightly underdeveloped in the LLM response. However, the core factual and conceptual content is preserved. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 467,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings, McGriddles is mentioned only as a standard breakfast item (“Egg McMuffin, Sausage McMuffin with Egg and **McGriddles**, biscuit and bagel sandwiches…”) and is never presented as a flagship innovation.  Instead, the menu‑innovation discussion in 2023 and 2024 spotlights new products such as the Crispy Chicken Sandwich, McSpicy and digital‑order enhancements, showing that McGriddles is treated as a stable core offering rather than a focal point of the company’s evolving breakfast strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately conveys that McGriddles was consistently mentioned as a standard breakfast item across 2022–2024 without being highlighted as an innovation, which matches the original answer's claim of stable positioning. The LLM correctly identifies that broader innovation efforts (e.g., Crispy Chicken Sandwich, McSpicy, digital enhancements) were emphasized instead, supporting the conclusion about a consistent breakfast strategy. All entities (McGriddles, Egg McMuffin, Sausage McMuffin with Egg, biscuit and bagel sandwiches) and years (2022–2024) are accurate. There are no numeric inaccuracies—no calculations or figures were required, and none were misstated. The reasoning is sound: it synthesizes the absence of innovation-related language around McGriddles while correctly contrasting it with new product mentions elsewhere in the filings. The only minor shortcoming is that the LLM does not explicitly cite the specific phrasing from each year (e.g., 'continuous evolution' in 2023 or 'testing new products' in 2024), nor does it directly quote the document locations (page/chunk references), which slightly reduces completeness compared to the original. However, the core insight—that McGriddles remained a static core offering amid broader innovation—is preserved and correctly inferred. Thus, the answer is semantically equivalent in substance, with only slight omission of granular contextual details from each filing year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 415,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "\nAdobe has consistently presented free, self‑service learning on the learning.adobe.com portal as the foundational component of Adobe Digital Learning Services, using it to drive awareness and adoption of its cloud solutions. Over the 2022‑2024 period the free tier has been increasingly integrated with paid certification tracks, custom enterprise learning, and solution‑specific skills assessments, positioning it as a strategic gateway that feeds into Adobe’s broader learning‑and‑enablement ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution of Adobe's free self-service learning as a foundational and increasingly integrated component of Adobe Digital Learning Services from 2022 to 2024. It accurately reflects the growing integration with paid certifications, enterprise learning, and skills assessments, aligning with the ground truth’s emphasis on maturation and ecosystem integration. However, it omits key platform transition details: the 2022 hosting on www.training.adobe.com and the shift to learning.adobe.com in 2023. This missing detail weakens the completeness and factual accuracy regarding platform evolution. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound in recognizing the strategic trajectory and integration of free learning into a broader ecosystem, but fails to synthesize the specific domain change across years, which is a key factual element in the original answer. This affects qualitative accuracy. (4) The answer remains contextually relevant and conveys the overarching strategic intent correctly, just without the full platform history. Thus, correctness is reduced to 7 due to omission of critical platform branding shift, despite strong conceptual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 374,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "\nThrough 2022‑2024 Emerson kept commercial vacuums classified under the “Other professional tools” bucket of its Safety & Productivity segment, alongside pipe‑working and electrical tools, and continued to market them as part of a broader safety‑and‑productivity tool suite for professionals. In November 2024 the company announced it was exploring strategic alternatives—including a cash sale—for the entire Safety & Productivity segment, indicating a shift away from treating commercial vacuums as a core growth pillar and toward focusing on its industrial‑automation and software businesses.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of Emerson's Commercial Vacuums positioning from 2022 to 2024. (1) Incorrect entity and segment classification: The original answer clearly states that in 2022, Commercial Vacuums were part of the Tools & Home Products segment, not the Safety & Productivity segment as claimed by the LLM. The reclassification into Safety & Productivity occurred in 2023, not before 2022. (2) The LLM incorrectly asserts that Commercial Vacuums were consistently in the Safety & Productivity segment throughout 2022–2024, contradicting the ground truth. (3) The mention of a November 2024 announcement about exploring strategic alternatives for the Safety & Productivity segment is not present in the original answer and introduces unverified information not supported by the ground truth. (4) The strategic emphasis described in the LLM answer focuses on divestiture, whereas the original answer highlights a progressive integration and technological alignment of Commercial Vacuums within industrial productivity tools—indicating strategic enhancement, not de-emphasis. (5) While the LLM correctly identifies the association with professional tools and safety/productivity themes, it fails the multi-hop reasoning by missing the key transition across segments and the evolving product categorization narrative. (6) Quantitative accuracy is partially acceptable because there are no explicit numerical errors (dates like 2024 are plausible), but the misuse of 2022 and 2023 classifications undermines factual precision. (7) Contextual relevance is moderate because the answer addresses strategic emphasis and professional tools alignment, but it misses the core evolution trajectory and introduces a misleading exit strategy narrative. Overall, major factual and reasoning errors result in a low correctness score despite some thematically relevant content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 518,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Hoofddorp, Netherlands site was repeatedly described in GILD’s Form 10‑K filings (2022 p. 33; 2023 p. 13; 2024 p. 11) as the company’s **commercial manufacturing and processing facility for its cell‑therapy products** (e.g., Yescarta and Tecartus).  The filings show a steady evolution: after the initial commercial launch, the site was expanded and ramped up to meet growing demand, and by 2024 it was fully operational for large‑scale commercial production of cell‑therapy drugs.  Thus, the Hoofddorp facility’s role has progressed from establishing commercial cell‑therapy capacity to consistently supporting higher‑volume, full‑scale manufacturing of those therapies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the Hoofddorp facility is consistently described as a commercial manufacturing and processing site for cell therapy products (e.g., Yescarta and Tecartus) across 2022–2024, with increasing operational scale. The citations to the 10-K filings (2022 p.33, 2023 p.13, 2024 p.11) are plausible and support the claims. (2) There are no numeric inaccuracies—no specific financial figures or dates are misstated, and the timeline (2022 to 2024) is correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to show an evolution from initial commercial use to full-scale production, which is consistent with the ground truth’s emphasis on growing strategic importance. The addition that the site was 'expanded and ramped up' is a reasonable inference from the progression described, though slightly more interpretive than the original answer. (4) The answer is contextually excellent—directly addresses the evolution of the facility’s role in cell therapy manufacturing. The only minor deviation is that the original answer emphasizes the 2022 designation as a 'principal manufacturing site' without explicitly mentioning cell therapy that year, while the LLM implies cell therapy focus from 2022. However, since the 2022 filing does link Hoofddorp to cell therapy (as confirmed in later filings), this is a justifiable synthesis. Overall, the answer is factually correct, well-reasoned, and comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 428,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "\nThe 1.000 % Notes due 2028 are repeatedly cited in the 2022‑2024 filings (e.g., the “Form of Note” tables on pages 136 and 138), preserving a low‑cost, long‑dated reference tranche in Coca‑Cola’s debt profile.  At the same time, the 2024 filings introduce new higher‑yield issues such as the 5.000 % Notes due 2034 and 5.400 % Notes due 2064 (see page 130), signalling that the company is deliberately adding higher‑coupon, longer‑maturity debt to take advantage of favorable market conditions and to diversify its financing mix.  Together, the persistence of the 1 % 2028 note and the issuance of higher‑yield notes reflect a shift toward a more flexible capital‑structure strategy that balances cheap legacy funding with opportunistic, higher‑cost borrowing to support growth and strategic initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064—are correctly stated, matching the original answer exactly. There are no calculation errors, and the dates and percentages are factually consistent. (2) The answer is complete, addressing both the persistent reference to the low-yield 2028 notes and the introduction of higher-yield notes in 2024, as well as the implications for debt financing costs and capital structure. (3) Entity accuracy is strong: Coca-Cola is correctly identified, and the financial instruments and years (2022–2024) are accurate. The mention of specific filing pages (e.g., 130, 136, 138) adds precision, though these are not part of the ground truth; however, they do not contradict it and may reflect actual document locations, so they don't detract from accuracy. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model connects the continued presence of low-cost debt with the strategic addition of higher-cost debt, inferring a balanced, flexible capital structure approach. The conclusion about 'opportunistic, higher-cost borrowing to support growth' is a slightly stronger interpretation than the original's 'recalibration... balancing near-term affordability with long-term funding,' but it is semantically equivalent and logically supported. The only minor gap is that the LLM does not explicitly state that the 1.000% Notes' persistence underscores their ongoing importance—though this is implied—making it a near-perfect but not fully verbatim match in emphasis. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 476,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "\nEmerson’s Safety & Productivity segment (see page 73) has progressively highlighted battery‑powered pipe‑cutters and tools that embed diagnostic functions—such as data‑rich cut‑monitoring and connectivity—while the 2024 announcement that the company is “exploring strategic alternatives” for this segment (page 77) signals a deliberate focus on these higher‑margin, tech‑enabled offerings.  This evolution shows Emerson is repositioning itself from a traditional mechanical‑tool vendor to a leader in smart, connected plumbing‑tool solutions for professional users.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Emerson's strategic shift toward battery-powered and diagnostic-integrated pipe cutters, aligning with the ground truth's timeline and intent. It accurately references the 2024 strategic review (‘exploring strategic alternatives’) which is contextually relevant, though this detail is not in the original answer. However, it omits the specific evolution across 2022–2024 as described in the ground truth: no mention of the 2022 traditional tools baseline, and the 2023 introduction of battery hydraulic technology is generalized. The 2024 diagnostic integration (e.g., sewer cameras, locating equipment) is rephrased as ‘data-rich cut-monitoring and connectivity,’ which captures a similar idea but lacks specificity. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the LLM infers a strategic pivot based on segment-level developments, but does not clearly trace the year-by-year product evolution (2022 → 2023 → 2024) as required by the question. The reference to page 73 and 77 suggests document grounding, but the synthesis across years is less explicit than in the original. (4) The answer is contextually relevant and captures the core strategic implication—positioning Emerson as moving toward smart, connected tools. However, it substitutes specific diagnostic integrations (cameras, locators) with more generic ‘diagnostic functions’ and connectivity, reducing qualitative precision. Thus, while the overall direction is correct, key descriptive details from the ground truth are missing or generalized, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 476,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Santa Monica, California site was repeatedly identified as a location where GILD “utilizes the facility for **clinical manufacturing and processing of our cell‑therapy products**” (2023 10‑K p. 11; 2024 10‑K p. 11).  The 2022 filing also listed Santa Monica among the company’s manufacturing locations, but the description remained focused on clinical‑supply activities, indicating that the site’s role was deepening rather than expanding into commercial production.  This steady, clinical‑focused utilization shows that Santa Monica has become a strategic hub in GILD’s manufacturing network—providing in‑house capacity to move cell‑therapy candidates from early R&D through late‑stage clinical trials and thereby reducing reliance on external contract manufacturers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that the Santa Monica facility was listed in 2022 as part of GILD's manufacturing network but without specific mention of cell therapy processing, and that by 2023 and 2024 it was explicitly described as being used for clinical manufacturing and processing of cell therapy products—consistent with the original answer. (2) There are no numerical values to verify, but the years (2022–2024) are correctly referenced and tied to the appropriate evolution in facility use. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports to show a progression in the facility’s role, correctly inferring a deepening strategic role focused on clinical (not commercial) manufacturing. (4) The only minor shortcoming is that the LLM does not explicitly state the contrast between Santa Monica’s earlier general R&D role and its later dedicated cell therapy function as clearly as the ground truth does, instead implying it through emphasis on continuity in clinical use. However, the core facts, timeline, and strategic interpretation are correct. Wording differs slightly but maintains semantic equivalence. The answer is fully relevant and addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 364,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe broadened Frame.io from a video‑centric review tool into a full‑stack collaboration hub for the Creative Cloud.  Early disclosures (2022 – page 34) described it as a platform for real‑time upload, frame‑accurate commenting and approvals that integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and supported video, still images, design files and PDFs.  By 2023 (2023 – page 27) the integration deepened, adding native connections to Adobe Express and Firefly Services within GenStudio, while the 2024 filing (2024 – page 27 & page 89) highlighted expanded media support (still images, design files, PDFs) and tighter, direct integration with Premiere Pro and After Effects for frame‑specific comments and camera‑to‑cloud uploads.  Together, these updates show Adobe positioning Frame.io as the collaborative backbone of Creative Cloud, enabling seamless, cross‑application workflows across video, graphic, and generative‑AI content creation.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Frame.io's integration into Adobe's Creative Cloud ecosystem and correctly identifies key applications and media types. However, there are significant factual inaccuracies in the timeline and feature rollout. According to the ground truth, in 2022 Frame.io was only listed in the trademark portfolio without functional details, but the LLM incorrectly attributes detailed integration (with Premiere Pro, Photoshop, etc.) and media support to 2022, which is not supported by the original data. The ground truth states that integration with Photoshop, Lightroom, and Workfront was introduced in 2024, not in 2022 as the LLM claims. Additionally, the LLM mentions integration with Adobe Express and Firefly Services within GenStudio by 2023, but the ground truth specifies that Frame.io was positioned as part of Adobe GenStudio in 2024, not earlier. The LLM also omits the 2024 expansion into casting, location scouting, and marketing campaign management, which is a key qualitative enhancement. While the supported media types (still images, design files, PDFs) are correctly mentioned, the LLM incorrectly implies video support was present in 2022, whereas the ground truth emphasizes video support expansion in 2024 beyond post-production. The reasoning is partially sound but flawed in sequencing and attribution, undermining the multi-hop synthesis. Quantitative accuracy is high as there are no numerical errors—dates and page references are plausible and contextually consistent. Contextual relevance is strong as the response directly addresses the question's focus on integration, media types, and collaboration. However, due to misalignment in the chronological development and incorrect assignment of features to years, the overall correctness is reduced to a 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 491,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "\nFrom 2022‑2024 Emerson’s Discrete Automation segment moved beyond its original hardware‑only lineup of solenoid/pneumatic valves, actuators and electrical‑distribution gear toward a broader, software‑enabled automation portfolio.  The segment’s product scope expanded to include programmable automation control systems, digital‑twin and cybersecurity capabilities, and materials‑joining solutions, and its sales grew from $2.61 B (2022) to $2.64 B (2023) before slipping to $2.51 B (2024) as the business emphasized higher‑value, integrated control‑software and services rather than standalone hardware.  This evolution reflects a strategic shift to couple electrical‑distribution equipment with advanced automation technologies and to leverage acquisitions such as National Instruments, positioning the segment as a core part of Emerson’s Automation Solutions and Software‑and‑Control offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic direction of Emerson's Discrete Automation segment—integration of electrical distribution equipment with automation technologies and product scope expansion—aligning with the ground truth. However, it introduces significant factual inaccuracies. Notably, the financial figures ($2.61B, $2.64B, $2.51B) are not present in the original answer and cannot be verified from the provided ground truth; these numbers are therefore incorrect or hallucinated. There is no mention in the ground truth of sales figures or revenue trends, so including them undermines quantitative accuracy. (2) The reference to the acquisition of National Instruments is contextually plausible but not mentioned in the original answer, making it an unsupported addition. While Emerson did acquire National Instruments, the ground truth does not cite this as part of the 2022–2024 evolution of Electrical Distribution Equipment within Discrete Automation, so its inclusion as a key driver is speculative. (3) The qualitative reasoning about integration with software, programmable controls, and expansion into materials joining is consistent with the ground truth and correctly identifies the multi-hop evolution: from standalone hardware to integrated automation solutions. The progression from electrical distribution gear being foundational (2022), linked with control systems (2023), and combined with motion and joining solutions (2024) is partially reflected, though the year-by-year positioning shift is less clearly articulated. (4) Contextual relevance is high because the answer addresses the core theme of strategic evolution and integration. However, the hallucinated revenue data and unsupported acquisition linkage reduce correctness and quantitative accuracy significantly. The answer is semantically aligned in direction but flawed in factual precision, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 528,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "\nCapital One’s fixed unsecured senior debt rose from about **$24.1 bn** at the end of 2022 to **$27.2 bn** in 2023, then slipped slightly to **$26.9 bn** by the end of 2024, while its weighted‑average interest rate climbed from roughly **2.8 %** to **4.45 %** and then to **4.84 %**. This shows the company has been refinancing maturing, lower‑cost debt with longer‑dated senior notes at higher rates, extending the maturity profile and locking in funding as market rates rise. (Data from the “Components of Deposits, Short‑Term Borrowings and Long‑Term Debt” tables in the 2023 10‑K (p. 178) and the 2024 10‑K (p. 188).)",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in direction and trend but contains inaccuracies in the 2022 carrying value and interest rate. The ground truth states the 2022 carrying value was $19,975 million ($19.975 billion), but the LLM reports approximately $24.1 billion, which is significantly off. The 2023 and 2024 carrying values are close ($27.168B vs $27.2B and $26,930M vs $26.9B), with minor rounding acceptable. The weighted-average interest rate for 2022 is reported as 'roughly 2.8%' by the LLM, while the ground truth is 2.91%, a small but notable discrepancy. The 2023 (4.45%) and 2024 (4.84%) rates are correctly reported. (2) Calculations: The LLM does not perform any explicit incorrect math, but the use of inaccurate starting values undermines quantitative precision. The progression (increase in debt, rising rates) is accurate. (3) Multi-hop reasoning is sound: the model correctly synthesizes trends across three years, identifies the strategy of refinancing at higher rates to extend maturities, and links this to a rising rate environment—consistent with the ground truth's interpretation. (4) Contextual relevance is excellent—the answer directly addresses all parts of the question, cites appropriate tables and document pages, and provides a logical inference. However, due to the significant error in the 2022 carrying value and slight error in the 2022 interest rate, the quantitative accuracy is reduced. The qualitative reasoning and overall conclusion remain strong, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 424,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "\nFrom 2022 through 2024 the accrued liability for performance‑ and operating‑cost guarantees fell steadily—from about **$1.11 billion at the end of 2022 to $1.09 billion in 2023 and $0.99 billion by the end of 2024** (see the “service and product warranties and product performance guarantees” roll‑forward table in Note 16).  This decline reflects lower new guarantee issuances and higher settlements than additions, indicating that the company’s historical experience with engine durability and operating‑cost claims is improving and that its exposure to long‑term product‑performance risk in the commercial aerospace segment is modestly receding, although a substantial liability remains and continues to be monitored.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer is largely incorrect in terms of factual content. It reports liabilities in the billions (e.g., $1.11 billion in 2022), whereas the ground truth states the liability was $120 million in 2022 and 2023, and $101 million in 2024—over 90% lower than reported. This massive discrepancy in scale renders the quantitative foundation of the answer invalid. (2) The numbers are not just inaccurate but off by an order of magnitude: $1.11 billion vs. $120 million is a factor of over 9x too high. The trend (a slight decrease) is directionally similar (downward), but the magnitude and absolute values are completely wrong. Calculations based on these figures, such as implying a $120 million reduction over two years, are therefore also incorrect. (3) The reasoning and multi-hop synthesis fail due to reliance on incorrect data. While the LLM attempts to interpret the trend (declining liability indicating reduced risk), this conclusion is drawn from fabricated or misattributed numbers. The mention of Note 16 and warranty roll-forwards suggests some grounding in actual SEC filing structures, but the data extracted is erroneous. (4) Contextual relevance is moderate—the answer addresses the right topic (liabilities for performance and operating cost guarantees in commercial aerospace), uses appropriate financial terminology, and attempts to infer risk exposure. However, due to the severe quantitative inaccuracies, the qualitative analysis is misleading. The stability (not steady decline) in the real data suggests consistent risk exposure, not a receding one. Thus, the core conclusion contradicts the ground truth. Correctness is severely compromised by factual inaccuracy, warranting a low score of 2/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 467,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "\nThe 2022 10‑K (page 39) explicitly identified “estimates of sales proceeds” as a distinct valuation method for non‑public investments, especially in emerging markets, and listed it alongside discounted cash‑flows and appraisals. In the 2023 filing (page 75) the language was broadened to “various valuation methodologies, including discounted cash‑flows, estimates of sales proceeds, and appraisals,” and the 2024 filing (page 79) kept the same phrasing but placed greater emphasis on observable market inputs and the difficulty of forecasting cash‑flows in those markets. This progression shows that Coca‑Cola has moved from a relatively simple, sales‑proceeds‑centric approach toward a more layered, market‑oriented fair‑value framework, relying less on straightforward sales‑proceeds estimates and more on cash‑flow forecasts, appraisals and other inputs to handle the heightened uncertainty of emerging‑market investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant misinterpretation of the evolution in Coca-Cola's reliance on 'estimates of sales proceeds.' Quantitatively, the answer is accurate in citing the correct years (2022–2024), document types (10-K), and page numbers (39, 75, 79), and correctly identifies the valuation methods used (discounted cash flows, appraisals, estimates of sales proceeds). There are no numerical inaccuracies, so quantitative accuracy is high. However, the qualitative reasoning is flawed: the LLM claims Coca-Cola moved *away* from a 'sales-proceeds-centric approach' toward a more market-oriented framework, which contradicts the ground truth. The original answer shows an *increasing reliance* on 'estimates of sales proceeds'—from disclosure in 2022, to explicit operational reliance in 2023, to continued use with caution in 2024. The LLM incorrectly interprets the increased emphasis on challenges in forecasting cash flows as a shift *away* from sales proceeds, when in fact the company deepened its use of that method while acknowledging its limitations. This misrepresents the core trend. The multi-hop synthesis is present but logically unsound, as it fails to correctly trace the progression of reliance. Contextually, the answer addresses the question's scope and focuses on emerging markets, so relevance is strong. Overall, the answer gets facts and context right but fails on the key interpretive point, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 407,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "\nThe 10‑K risk‑factor disclosures show a clear tightening of language across the three years.  \n- **2022** (pages 4‑5) merely notes that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, and by our failure to pay full and timely dividends on our preferred stock.”  \n- **2023** (pages 4‑5) adds the same wording but is embedded in a broader list that also warns that “failure to satisfy regulatory standards, including ‘well‑capitalized’ and ‘well‑managed’ status or capital adequacy and liquidity rules more generally, could result in limitations on our activities.”  \n- **2024** (pages 1 and 5) expands the reference to regulatory standards, emphasizing that “failure to satisfy regulatory standards … could result in limitations on our activities and adversely affect our business,” and reiterates the Board‑discretion and dividend‑payment constraints.\n\n**What this progression suggests:** BNY Mellon’s capital‑return flexibility is increasingly conditioned on meeting strict regulatory capital metrics and maintaining its credit ratings; the company can distribute capital only so long as it remains “well‑capitalized,” can meet dividend obligations on its preferred shares, and retains Board discretion—meaning strategic shareholder distributions are now tightly bounded by U.S. banking rules rather than being freely discretionary.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the evolving language in BNY Mellon's 10-K filings from 2022 to 2024, with correct citations to page numbers and accurate representation of the disclosed constraints. There are no numeric inaccuracies (quantitative accuracy is perfect), and the answer is contextually relevant, directly addressing the evolution of disclosures and their implications. However, the qualitative accuracy is compromised due to a significant misinterpretation of the nature and direction of the disclosure changes. The LLM characterizes the progression as a 'tightening of language' and increasing restrictions, but the ground truth indicates that the core regulatory language remained *consistent* across all three years, with only a *new emphasis in 2024* on internal capital flows (i.e., dependency on subsidiary dividends and IHC credit). The LLM incorrectly frames the 2023 and 2024 additions as new regulatory constraints or broader warnings, when in fact the core risk factor text was largely repeated. The 2023 and 2024 additions about 'well-capitalized' status and adverse business effects were part of broader risk factor reorganizations, not new capital return limitations. Furthermore, the LLM misses the key insight from the ground truth: that despite stable regulatory language, the 2024 filing highlights growing internal structural dependencies, suggesting strategic adaptation within ongoing constraints. This misrepresents the multi-hop synthesis—failing to distinguish between repetition and evolution—and leads to an incorrect conclusion about 'tightening' rather than consistent constraints with shifting internal focus. Thus, while the surface-level facts are correct, the reasoning and interpretation are significantly flawed, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1633,
        "completion_tokens": 493,
        "total_tokens": 2126
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s risk disclosures show a clear escalation in both the scope and detail of the “loss or modification of tax and tariff exemptions” threat. The 2022 filing merely listed the risk, while the 2023 and especially the 2024 10‑Ks expand the language to tie the exemption risk to recent geopolitical events—U.S. sanctions, export‑control revisions, the Ukraine conflict, and heightened scrutiny of China‑related operations—underscoring that regulatory changes could materially affect AMD’s cost structure and supply chain. This progression signals that AMD is confronting a far more intricate global regulatory environment, where tax and tariff benefits are increasingly vulnerable to shifting political and trade policies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD's increasing emphasis on the risk of losing tax and tariff exemptions from 2022 to 2024 is accurately portrayed. In 2022, the risk was listed generically; in 2023, it was linked to geopolitical events like the Ukraine conflict; and in 2024, it was tied to U.S. export controls and China-related scrutiny—details consistent with the original answer. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are correct and used appropriately. (3) The multi-hop reasoning is sound: the model correctly synthesizes how AMD’s risk disclosures evolved over time across filings, connecting expanding geopolitical concerns to increasing regulatory complexity. (4) The LLM captures the core trend—escalating exposure and complexity—and attributes it correctly to both internal and external factors, though it slightly underemphasizes the 'internal expansion' aspect mentioned in the original answer. However, this does not detract significantly from the overall accuracy. Wording differs but semantic meaning is equivalent. Minor deduction from 10 to 9 due to slightly less explicit mention of AMD’s own operational expansion as a contributing factor, but the emphasis on external geopolitical drivers is fully supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 399,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "\nFrom 2022 to 2024 Capital One’s short‑term borrowings fell sharply—from **$883 million in 2022 to $562 million in 2024** (a roughly 36 % decline), with a brief dip to $538 million in 2023.  Long‑term debt was relatively stable, rising to **$49.3 billion in 2023** before pulling back to **$45.0 billion in 2024**.  During the same period the company’s **floating‑rate unsecured senior debt collapsed from $1.6 billion (2022) to essentially zero by 2024**, reflecting a strategic shift toward longer‑dated, predominantly fixed‑rate funding (senior notes and securitized debt) and a deliberate reduction of exposure to floating‑rate interest‑rate risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly in short-term borrowings and total debt figures. According to the ground truth, total short-term borrowings and long-term debt were $43.086B (2022), $49.856B (2023), and $45.551B (2024). The LLM incorrectly reports only long-term debt as $49.3B and $45.0B, omitting or misrepresenting the full combined total. More critically, it states short-term borrowings were $883M in 2022 and $562M in 2024 — but the ground truth does not provide standalone short-term borrowing figures at this granularity, and the LLM appears to fabricate or misextract these numbers, as the original answer focuses on debt composition (floating vs fixed), not a split between short- and long-term. (2) The floating unsecured senior debt is mostly correct in direction: it drops from $1.6B (close to $1.709B) to near zero by 2024, though the LLM omits the 2023 spike to $349M and the sharp rate increase to 6.75%. It also fails to mention the elimination of floating debt in 2024 was complete. Fixed unsecured senior debt is misrepresented: the LLM omits the increase from $21.045B (2022) to $27.168B (2023) to $26.930B (2024) and the rising interest rates (2.91% to 4.84%), which are central to the strategic shift. (3) The multi-hop reasoning is partially sound — the LLM correctly infers a strategic pivot from floating to fixed-rate debt to reduce interest rate risk — which aligns with the ground truth’s conclusion. However, it lacks synthesis of interest rate data and precise debt category shifts, weakening the reasoning. (4) Scores reflect: correctness (5) due to major number errors but correct directional trend; quantitative accuracy (4) due to significant deviations in key figures; qualitative accuracy (6) as logic and intent are reasonable but incomplete; contextual relevance (9) as the answer stays on-topic and addresses the core strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 524,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "\nRTX’s net program‑share in the International Aero Engines AG (IAE) V2500 collaboration was 57 % in 2022 and remained at essentially the same 57 % level in 2023‑2024 (the same 51 % net share for IAE LLC).  This stability shows that RTX continues to retain a controlling, strategic position in the V2500 engine programme, using its majority program‑share to guide the partnership while still sharing the economic upside with its sub‑collaborators.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect on the core quantitative claim. The ground truth states RTX's net program share decreased from 61% in 2022 to 57% in 2023 and 2024, but the LLM claims it was 57% in 2022 and remained stable, which contradicts the data. Additionally, the LLM introduces a figure of '51% net share for IAE LLC' that is not present in the original answer and appears to be fabricated or misattributed. (2) The numbers are significantly inaccurate: the starting percentage (57% vs 61%), the trend (stable vs decreasing), and the introduction of an unsupported 51% figure all fail the quantitative accuracy test. Even allowing for format variation, these are distinct values with strategic implications. (3) The reasoning is flawed because it interprets stability where there is actually a deliberate reduction. The original answer infers a strategic dilution of economic exposure, while the LLM concludes continued control and stable positioning—this misreads the direction of change and thus invalidates the multi-hop synthesis. The model fails to correctly track the evolution over time and misidentifies the nature of RTX's shifting role. (4) Contextual relevance is moderate because the answer addresses the right entities (RTX, IAE, V2500 program) and attempts to interpret strategic positioning, but due to incorrect data, the conclusion is opposite to the ground truth. The mention of 'IAE LLC' introduces an entity or structure not referenced in the original, reducing entity accuracy. Overall, major factual and reasoning errors result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 439,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "\nFrom 2022 through 2024, the Fabric & Home Care segment’s net sales grew about 4 % each year (to $29.5 bn in 2024) and net earnings rose 18 % in 2024, with Cascade’s brand helping lift its earnings contribution—its share of segment earnings climbed from roughly 17 % of sales in 2022 to 19.3 % in 2024. Although the segment’s overall market share was flat, Cascade’s stronger pricing and margin performance signal a more central, higher‑margin role for the brand within P&G’s home‑care portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Cascade's positioning within P&G's portfolio is described in terms of its role as a key brand in the Home Care sub-category under the Fabric & Home Care segment, with segment-level financials (35%-36% of net sales, 31%-34% of net earnings). However, the LLM introduces unsupported metrics such as Cascade contributing '17% of sales' in 2022 and '19.3% in 2024', which are not present in the original answer or implied by the data. It also claims the Fabric & Home Care segment grew 4% annually to $29.5B in 2024 and that net earnings rose 18% in 2024—none of which appear in the ground truth. (2) The ground truth does not provide absolute revenue figures, year-over-year growth rates, or brand-level financial contributions like '17%' or '19.3%'. These numbers are either fabricated or misattributed. The only correct quantitative elements are the general stability of the segment’s sales (35% → 36%) and earnings (31% → 34%) shares, but even these are misrepresented in the LLM’s narrative. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that Cascade has taken on a 'more central, higher-margin role' based on invented pricing and margin data. The ground truth emphasizes *consistency* in Cascade’s strategic positioning, not an evolution toward greater centrality. There is no evidence in the original answer of changing market share or margin performance at the brand level. (4) While the LLM attempts to address the evolution of Cascade’s role, it fundamentally misrepresents both the data and the conclusion. The contextual relevance is moderate because it discusses the right segment and brand, but the incorrect numbers and reasoning severely undermine accuracy. Correctness score is low due to major factual and quantitative errors despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 514,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "\nFrom 2022 to 2024 BNY Mellon moved the posting of its Directors’ Code of Conduct from a generic “in relations” folder to the dedicated “investor‑relations” directory, reflecting a tighter domain‑branding of the URL. Each annual filing references the code in Item 10 and the Proxy, and the 2024 filing explicitly integrates the code into the “Corporate Governance and Board Information” subsection, making the disclosure part of the firm’s overall governance framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in BNY Mellon's disclosure practices from 2022 to 2024. It accurately identifies the shift from a generic 'in relations' path to a dedicated 'investor-relations' directory, reflecting improved domain branding and integration with corporate governance. The mention of Item 10 and Proxy statements aligns with standard SEC filing practices, and the 2024 integration into 'Corporate Governance and Board Information' correctly signals enhanced contextual embedding. However, the LLM omits key details present in the ground truth: (1) the specific legacy URL paths in 2022 and 2023 (e.g., '/content/dam/bnymellon/documents/pdf/in relations/...'), (2) the minor 2023 change from 'in relations' to 'inv relations' indicating internal reorganization, and (3) the full significance of the 2024 domain shift from 'bnymellon.com' to 'bny.com', which reflects broader brand consolidation. While the LLM correctly infers strategic integration, it does not explicitly note the transition to a new domain (bny.com), a key branding evolution. All dates and entities (BNY Mellon, Directors' Code of Conduct, 2022–2024 timeframe) are accurate. No numerical inaccuracies exist, as the question is qualitative. The reasoning is sound and synthesizes multi-hop information across years and disclosure formats, though with minor gaps in URL specificity and domain-level changes. The answer remains contextually relevant and conveys the essential trend toward stakeholder-oriented, brand-consistent governance disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 427,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 AMD shifted from simply selling component‑level graphics to AIB makers into a tighter partnership that codified inventory‑protection terms—price‑protection, return rights and limited stock‑rotation clauses—to shield AIB inventory from price erosion. At the same time, AMD leveraged its discrete Radeon GPU portfolio as a differentiation platform, promoting newer, performance‑ and AI‑focused graphics to help AIBs create distinct, higher‑margin board products while preserving margins amid intensifying competition.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in spirit and captures the core elements of AMD's strategic positioning with AIB manufacturers from 2022 to 2024, particularly around inventory protection and the role of discrete graphics in differentiation. (1) It correctly identifies that AMD maintained inventory protection policies (referred to as price protection, return rights, and stock-rotation clauses), which aligns with the ground truth's assertion of shielding AIB inventory from price reductions. The emphasis on discrete Radeon GPUs as a differentiation tool for AIBs is also consistent with the original answer. (2) There are no specific numbers, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors here, warranting a score of 10. (3) However, the LLM implies a 'shift' in strategy ('shifted from simply selling component-level graphics... into a tighter partnership'), which is not supported by the ground truth. The original answer emphasizes *consistency* across 2022–2024, not a strategic evolution or tightening of partnerships. This misrepresents the multi-hop synthesis: the knowledge graph shows stable policy year-over-year, not a transformation. Additionally, the mention of 'AI-focused graphics' and 'limited stock-rotation clauses' introduces details not present in the source, potentially extrapolating beyond the data. (4) Despite these qualitative inaccuracies in reasoning and framing, the answer remains contextually relevant and captures key themes—inventory protection and discrete GPU differentiation—making it mostly correct but slightly misleading in narrative. Hence, correctness and qualitative accuracy are docked to 7, while contextual relevance remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 473,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "\nFrom 2022 to 2024 the 10‑K disclosures moved from a brief mention that Egg McMuffin is part of the breakfast menu (2022 p. 7) to a clear emphasis on the supply‑chain and quality systems that enable that menu item. The 2024 filing (pp. 5‑6) details McDonald’s global food‑safety standards, supplier‑code of conduct and consistent breakfast‑menu execution as a way to meet customer expectations for taste and reliability, whereas the 2022 filing only noted “continuously evolving its menu” without describing those supply‑chain controls. This progression shows the Company increasingly highlighting the supply‑chain’s role in delivering a consistent Egg McMuffin experience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in McDonald's disclosures from 2022 to 2024. It correctly identifies that in 2022, the Egg McMuffin was mentioned as part of the breakfast menu with general references to menu evolution (p.7), and that by 2024, the focus shifted to supply chain controls, food safety standards, and consistent execution (pp.5-6), aligning with the ground truth. The answer accurately reflects the progression from general quality assurance to a more structured, supply-chain and systems-driven approach. It correctly emphasizes the increasing focus on supply chain and quality systems, including supplier codes of conduct and global food safety standards, which support consistency of the Egg McMuffin. The only minor omission is the lack of explicit mention of the 'digital transformation project for data excellence in quality and food safety' highlighted in 2024 in the original answer, which represents a specific technological dimension of the supply chain evolution. However, the reference to 'consistent breakfast-menu execution' and 'global food-safety standards' implies this shift. All years, entities (McDonald's, Egg McMuffin), and document references (page numbers) are accurate. The reasoning is sound, showing a clear multi-hop synthesis across years and disclosure themes. Wording differs but semantic meaning is equivalent. Quantitative elements (years, page references) are correct. Thus, the answer is excellent but slightly less complete than the ground truth, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 433,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "\nThe 2022, 2023 and 2024 10‑K filings each list Oracle’s 4.30 % senior unsecured note maturing in 2034 (see the “Forms of 3.40 % Note due 2024, 4.30 % Note due 2034 and 4.50 % Note due 2044” table on pages 110/112).  This repeated disclosure shows that the 2034 note is a permanent component of Oracle’s long‑term debt capital, indicating that the company is maintaining a stable, low‑cost funding tranche with a decade‑plus maturity to support its growth, acquisition and shareholder‑return strategy while keeping its overall debt maturity profile diversified.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All numeric values—4.30%, 2034 maturity, and references to other notes like the 4.50% Note due 2044—are correct. The mention of the '3.40% Note due 2024' appears to be a typo (should be 2.950% Note due 2024 per ground truth), but this does not materially alter the overall assessment of Oracle’s debt structure. (2) The quantitative accuracy is excellent: percentages and years are correctly cited, and no calculations are required. (3) The multi-hop reasoning is sound—the LLM correctly infers from consistent disclosure across 2022–2024 that the 4.30% Note is a stable, long-term component of Oracle’s debt, reflecting strategic financing priorities. It appropriately links the note’s persistence to Oracle’s broader capital structure strategy, including growth, acquisitions, and shareholder returns. (4) While the LLM omits specific details about the evolving mix of debt instruments in each year (e.g., the introduction of the 2.950% Notes in 2023), it still captures the essential conclusion: Oracle maintains a diversified, long-term debt profile with the 2034 note as a stable element. The answer is semantically equivalent in intent and meaning to the original, with only minor omissions in granularity. Contextual relevance is perfect—it directly addresses the question about long-term debt structure and financing priorities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 394,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One valued its net derivative assets and liabilities with discounted‑cash‑flow models that increasingly relied on unobservable inputs such as swap‑rate curves, prepayment and default assumptions, and loss‑severity estimates.  Gross derivative assets fell from $3.1 bn (2022) to $2.68 bn (2023) and, after netting, net derivative assets declined from $1.96 bn (2022) to $1.67 bn (2023), while the Level‑3 fair‑value estimate of net derivative assets rose from $58 m (2023) to $69 m (2024), showing a growing proportion of the portfolio classified as Level 3 and therefore greater exposure to subjective, unobservable market inputs over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key financial figures and misrepresents the evolution of Capital One's net derivative assets/liabilities from 2022 to 2024. According to the ground truth, the fair value of net derivative assets/liabilities was $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. The LLM incorrectly states that net derivative assets were $1.96 billion in 2022 and $1.67 billion in 2023, which is off by an order of magnitude. It also claims the Level-3 fair value rose from $58 million in 2023 to $69 million in 2024, contradicting the ground truth that the fair value remained stable at $58 million in both years. Additionally, the LLM introduces gross derivative assets ($3.1B, $2.68B) and net assets in billions, which are not mentioned in the original answer and appear to be fabricated. While the LLM correctly identifies the use of unobservable inputs like swap rates and default assumptions, it mischaracterizes the trend: the ground truth shows a stabilization of fair value and increased transparency in methodology by 2023–2024, not a continuous increase in Level-3 exposure. The reasoning is flawed in concluding 'growing proportion... classified as Level 3' based on incorrect numbers. The answer is contextually relevant in discussing valuation methodology and unobservable inputs but fails on quantitative accuracy and multi-hop synthesis, particularly in cross-year comparison and correct entity/metric alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 414,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "\nFrom 2022 through 2024 RTX’s financial tie‑up with Rolls‑Royce remained a **flight‑hour‑contingent payment** on V2500‑powered aircraft that is accrued as a **collaboration intangible asset** and amortized to cost of sales over the engine’s economic life (generally ~30 years).  The payment schedule disclosed in the “Other commercial aerospace commitments” table shows the obligations rising to about **$0.84 bn in 2025, $0.77 bn in 2026 and $0.70 bn in 2027**, with the accrued intangible asset being written off incrementally as those flight‑hour credits are earned and the related performance obligation is satisfied.  Consequently, each year’s amortization expense grows as the V2500 flight‑hour base expands, and the remaining commitment will be settled through June 2027.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core concept of RTX's flight-hour-contingent payments to Rolls-Royce tied to V2500-powered aircraft and correctly identifies the accounting treatment as collaboration intangible assets amortized to cost of sales. However, it introduces specific future payment amounts—$0.84B in 2025, $0.77B in 2026, and $0.70B in 2027—that are not present in the original answer or supported by the provided ground truth. The original answer only states that the total commercial aerospace financing and other commitments stood at $14.1B in 2024, with Rolls-Royce payments continuing on a per-hour basis through June 2027, but does not break down annual obligations. These fabricated figures significantly undermine quantitative accuracy. (2) The original answer confirms the evolution of accounting policy: in 2022, payments were contingent liabilities to be capitalized; by 2023, they were being capitalized and amortized; in 2024, the $14.1B total commitment included these ongoing payments. The LLM omits this year-by-year evolution of disclosure and policy transparency, instead presenting a static view of the accounting treatment. (3) While the LLM correctly synthesizes the multi-hop link between RTX, Rolls-Royce, IAE, V2500 flight hours, and intangible asset amortization, it fails to reflect the progression in reporting clarity over time (2022–2024), which is a key element of the original answer. (4) Despite the incorrect numerical specifics, the LLM answer remains contextually relevant and semantically aligned on the payment structure and amortization strategy. The core reasoning about flight-hour-based payments and asset amortization is sound, but the inclusion of unsupported dollar figures and omission of the temporal evolution in disclosure reduce correctness and quantitative accuracy. Hence, correctness is scored at 5 (partially correct with significant errors), quantitative accuracy at 4 (major unsupported numbers), qualitative accuracy at 6 (correct entities and logic but missing nuance), and contextual relevance at 9 (highly relevant to the question).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 566,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "\nAmgen first disclosed in its 2022 10‑K that the Neulasta Onpro kit had received FDA‑driven device and labeling enhancements in response to user complaints and that it continuously monitors adverse‑event reports. By the 2023 filing the language was broadened to note that the company routinely implements further device‑related improvements (software/label updates) and that it was beginning to embed redundancy into its supply chain. In the 2024 filing Amgen added explicit operational‑resilience measures—backup generators, diversified supplier routes and contingency plans for island‑wide power outages—while reaffirming its ongoing monitoring and incremental device enhancements to mitigate risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and evolution of disclosures from 2022 to 2024. (1) It accurately captures the key elements: 2022 disclosure of FDA-driven enhancements in response to user complaints and ongoing monitoring; 2023 continuation with emphasis on further device improvements; and 2024 expansion to include operational resilience measures. The core facts—device enhancements, labeling updates, adverse event monitoring, and later inclusion of infrastructure-related contingencies—are all present. (2) There are no numeric values or dates that conflict with the ground truth; the mention of an island-wide outage in the original answer (December 31, 2024) is not contradicted by the LLM, though it is not explicitly included. The LLM correctly avoids fabricating specific dates not in the source. (3) The multi-hop reasoning is sound: it synthesizes information across years and correctly identifies the progression from device-focused risk mitigation to broader operational resilience. However, the LLM slightly overreaches by specifying 'diversified supplier routes' and 'contingency plans for island-wide power outages' as explicitly stated in the 2024 filing—while consistent with the spirit of the original, these exact phrases are not in the ground truth, which only confirms use of backup generators during outages. (4) Despite minor elaboration beyond the original, the answer remains factually grounded, contextually relevant, and semantically equivalent in intent. The correctness score is 8 due to these small additions that, while plausible, are not verifiably present in the source disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 457,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "\nThe 2022, 2023 and 2024 Form 10‑Ks each contain an “Item 3 – Ratification of KPMG LLP” reference that incorporates the proxy statement’s ratification of KPMG LLP as BNY’s independent auditor and explicitly note that KPMG’s PCAOB firm identification number is 185.  The wording and the inclusion of the PCAOB number are unchanged across the three filings, indicating that BNY has consistently retained KPMG as its principal auditor and that this audit‑governance practice has remained stable over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All key facts are accurate: BK (referred to as BNY, a known shorthand for The Bank of New York Mellon Corporation) consistently disclosed KPMG LLP as principal accountant in 2022, 2023, and 2024; the PCAOB firm number 185 is correctly cited across all years. The mention of 'Item 3 – Ratification of KPMG LLP' and its incorporation of the proxy statement is consistent with standard 10-K structure. (2) Quantitative accuracy is perfect: no calculations required, but the PCAOB number 185 is correctly repeated across years, and the years 2022–2024 are accurately referenced. (3) Multi-hop reasoning is sound: the model correctly infers continuity in audit governance from the unchanged disclosure and PCAOB number. (4) The only minor issue is the use of 'BNY' instead of 'BK'—while contextually acceptable (as both refer to the same entity), 'BK' is the ticker used in the question and ground truth, so consistency would have been preferable. However, this does not impair understanding or factual correctness. The conclusion about stable audit governance is logically supported and semantically equivalent to the original answer. Thus, the response is highly accurate, complete, and relevant, warranting a 9/10 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 366,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "\nRTX’s exposure to commercial‑aerospace financing guarantees held through collaboration partners fell steadily—$142 million in 2022, $135 million in 2023 and $131 million in 2024—mirroring a reduction in the total guarantee commitments (from about $309 million in 2021 to $274 million by 2024).  This downward trend shows that RTX is deliberately shrinking the portion of risk it shares with partners and is moving more of the financing risk onto its own balance sheet, reflecting a tighter risk‑management stance as the company streamlines its aerospace financing arrangements.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the collaboration partners' share of guarantees: $142M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. However, it introduces a new data point—total guarantee commitments declining from $309M in 2021 to $274M in 2024—that is not present in the original answer and cannot be verified from the provided ground truth. This addition, while potentially accurate, introduces unverified information and affects reasoning. (2) All reported numbers for the collaboration partners’ share are quantitatively accurate, with correct year-to-year decreases ($7M drop from 2022–2023, $4M from 2023–2024). The calculation of trend direction (downward) is correct. However, the inclusion of unverified total guarantee figures reduces confidence in pure quantitative fidelity. (3) The LLM misinterprets the implication of the declining partner share: it claims RTX is moving 'more of the financing risk onto its own balance sheet,' which contradicts the ground truth that suggests RTX is reducing shared risk and contingent liabilities. The original answer implies a de-risking strategy through reduced exposure overall, not an internalization of risk. This is a significant error in multi-hop reasoning and strategic interpretation. (4) The answer is contextually relevant and addresses both parts of the question—evolution of exposure and interpretation of trend—but draws an incorrect conclusion about risk management strategy due to flawed logic. The downward trend is correctly identified, but the explanation of RTX’s intent is inconsistent with the source. Thus, while factually strong on the numbers, the qualitative reasoning is flawed, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 475,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "\nThrough 2022 to 2024, Always stayed within the **Feminine Care (Adult Incontinence / Menstrual Care)** sub‑category of P&G’s **Baby, Feminine & Family Care** segment and was consistently listed as a core brand alongside Always Discreet, Tampax Bounty, Charmin and Puffs.  Management repeatedly pointed to **low‑single‑digit growth driven by higher pricing and a shift toward a more premium product mix**, using the Always brand to capture higher‑margin, premium‑positioned demand and to reinforce its leadership relative to other feminine‑hygiene offerings such as Tampax.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Always was part of the 'Baby, Feminine & Family Care' segment starting in 2022, but according to the ground truth, the segment was renamed to this in 2023, not 2022. In 2022, the segment was still called 'Feminine Care'. Second, the LLM claims Always was grouped with Bounty, Charmin, and Puffs, which are unrelated brands in different categories (tissue, paper towels, etc.)—this is incorrect and not supported by the original answer. The ground truth only mentions Always, Always Discreet, and Tampax as co-brands in the segment. (2) Quantitatively, the LLM omits the key percentages (25% in 2022, 24% in 2023 and 2024) that are central to the original answer and instead introduces unverified claims about 'low-single-digit growth' and 'higher pricing' that are not present in the ground truth. These numbers and assertions are unsupported and likely hallucinated. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer strategic emphasis on premium positioning, this interpretation is not grounded in the provided data. The original answer notes structural and formatting changes, not pricing or product mix shifts. The evolution described in the LLM answer conflates unrelated brands and misrepresents the timeline of segment reorganization. (4) Despite these issues, the answer is contextually relevant—it addresses the evolution of Always within P&G’s portfolio and attempts to discuss brand positioning. However, due to significant factual and entity errors, especially the incorrect inclusion of unrelated brands and wrong segment timeline, the correctness score is low. The qualitative accuracy is partially preserved due to correct mention of Always Discreet and Tampax, but reasoning is unsound. Quantitative accuracy is poor due to missing or invented metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 511,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s IP‑protection risk moved from a generic warning that “inadequate protection of our technology abroad could erode our competitive advantage” (2022 Risk Factors) to a far more specific concern that its expanding global footprint—particularly the ≈ 65‑70 % of revenue generated outside the United States and the heavy reliance on third‑party fabs in China, Taiwan and other Asian locations—exposes the company to heightened chances of IP theft, weaker enforcement of patents and trade‑secret rights, and geopolitical pressures that can limit its ability to safeguard proprietary designs. Consequently, the later filings emphasize that these international and Asian‑manufacturing dependencies materially increase AMD’s vulnerability to IP‑related disputes and potential loss of its core technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly captures the evolution of AMD's IP protection risks from 2022 to 2024, noting the shift from generic international IP concerns in 2022 to more specific, regionally focused risks tied to third-party manufacturing in Asia. The mention of ~65-70% of revenue coming from outside the U.S. is consistent with the 65% figure cited in the original answer for 2023, and while the upper end (70%) is slightly speculative, it does not materially misrepresent the data. (2) Quantitatively, the 65% international revenue is accurate per the original answer; the LLM rounds it to a range (65–70%), which is a reasonable approximation and common in summarization. No incorrect calculations are made. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes AMD’s expanding international operations, reliance on third-party fabs in China, Taiwan, and Malaysia, and the resulting increased IP risks. It also appropriately infers heightened exposure due to weaker IP enforcement and geopolitical pressures, which aligns with the 2024 emphasis on China-Taiwan tensions in the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly name Malaysia as a manufacturing location (mentions 'other Asian locations' instead) and slightly generalizes the geopolitical risk without directly citing the China-Taiwan tension as a discrete 2024 development. However, the core factual progression, entities, and synthesis are correct. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 451,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "\nOracle first introduced the 2.300 % Notes due 2028 in its March 2021 8‑K filing (Exhibit 4.14) as part of a staggered senior‑note program, and then did not issue any additional 2.300 % 2028 tranches; instead it added higher‑coupon replacements—most notably the 4.5 % Notes due 2028 in the February 2023 8‑K (Exhibit 4.16)—while continuing to launch new fixed‑rate series in subsequent years. This multi‑year pattern reveals Oracle’s debt‑financing strategy of laddering maturities and periodically refinancing low‑coupon long‑dated debt to adapt to changing market rates, using a standardized officer‑certificate structure to maintain a diversified pool of senior unsecured obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Oracle first referenced the 2.300% Notes due 2028 in 2022 in Exhibit 4.16 as part of a broader set of debt instruments, not in a March 2021 8-K filing as the LLM claims. The LLM incorrectly asserts that the notes were introduced in March 2021 in Exhibit 4.14, which contradicts the ground truth. Additionally, the LLM invents a '4.5% Notes due 2028' issued in February 2023 (Exhibit 4.16), which is not mentioned in the original answer and appears fabricated. There is no mention in the ground truth of Oracle issuing higher-coupon replacements or refinancing the 2.300% notes. (2) Quantitative accuracy is poor: the dates (2021 vs. first mention in 2022), exhibit numbers (4.14 vs. 4.16 in 2022), and the entirely fictional 4.5% notes are all incorrect. The core numeric and date-based facts are wrong. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers a refinancing strategy and maturity laddering based on non-existent instruments. The original answer emphasizes consistency and continuity in disclosure across years, not refinancing or replacement. The LLM misinterprets the pattern of disclosure as active restructuring, when the ground truth indicates passive carry-forward in disclosures. (4) Contextual relevance is moderate—the response addresses Oracle's debt strategy and attempts to interpret multi-year patterns—but the factual foundation is unsound, leading to an incorrect conclusion. The structure and intent align with the question, but the content does not match the evidence. Thus, the correctness score is low due to major factual and quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 462,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "\nBoeing’s pension fund has continued to use limited‑partnership vehicles to gain private‑equity exposure, focusing on leveraged‑buyout, venture‑capital, growth‑equity and special‑situations strategies that are deployed both in the United States and abroad; the target allocation to these assets rose from roughly 4 % of the portfolio in 2022 to about 7 % in 2023 and remained at that level in 2024, while the actual holding has hovered near 8 % of total assets.  The geographic scope has stayed global—spanning North America, Europe and Asia—without a material shift toward any one region, and the strategic emphasis has remained on diversified private‑equity deal types rather than on a new geographic or sectoral focus.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. It refers to 'Boeing’s pension fund' and specific allocation percentages (4% in 2022, 7% in 2023, 8% actual), which are not mentioned or supported by the original answer. The ground truth does not provide any numerical data on portfolio allocations or percentages, so these figures are fabricated. (2) Quantitative accuracy is low because the LLM invents precise numbers (4%, 7%, 8%) that do not appear in the original answer and cannot be verified from the provided context. There is no mention of target or actual allocations in the ground truth, making these values incorrect. (3) Qualitatively, the LLM captures a general global geographic scope and mentions leveraged buyout and venture capital strategies, which aligns partially with the original answer. However, it fails to identify the key evolution in strategic focus: the expansion into global private investments in real assets (energy, farmland, infrastructure) in 2023 and the increased use of derivatives in 2024. These critical developments are entirely missing. Instead, the LLM claims there was 'no material shift' and 'remained on diversified private-equity deal types,' which contradicts the ground truth’s description of a strategic deepening and broader integration of alternative tools. (4) Contextual relevance is moderate because the answer discusses limited partnership investments in private equity with a global focus, which is relevant. However, it misrepresents the entity (referring to Boeing rather than BA, though potentially synonymous, the context is unclear) and misses the core evolution in strategy over the three years. The multi-hop reasoning is weak as it fails to synthesize the progression across 2022–2024 in terms of both focus areas and vehicle sophistication. Overall, while some surface-level elements are correct, the absence of key strategic shifts and the introduction of unsupported quantitative claims result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 556,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "\nAmgen advanced bemarituzumab into a global Phase 3 trial for advanced gastro‑esophageal‑junction adenocarcinoma in early 2022 and kept the program in Phase 3 throughout 2023‑2024, with no regulatory approval or new indication launched by the end of 2024.  The company’s issued composition‑of‑matter patents for bemarituzumab are projected to expire in 2029 in both the United States and Europe (the same 2029 dates shown in the 2022‑2024 SEC filings), with any further extensions possible only through future term adjustments or supplemental protection certificates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Bemarituzumab entered a Phase 3 trial in 2022 for gastroesophageal junction (GEJ) adenocarcinoma, remained in Phase 3 through 2024, and had U.S. and European patent expirations projected for 2029. These dates match the original answer exactly and are consistently reported across years, as confirmed in the knowledge graph. (2) Quantitative accuracy is perfect: the 2029 patent expiration is correctly cited for both regions, and no incorrect numbers or miscalculations are present. Format variations (e.g., '2029' vs 'set to expire in 2029') are semantically equivalent. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024, correctly tracking clinical phase progression and patent timelines across time, and acknowledges the stability of IP positioning. It correctly infers that no approval occurred by 2024, which is consistent with continued Phase 3 status. (4) The only minor omission is that the LLM does not explicitly mention that Bemarituzumab is a monoclonal antibody targeting FGFR2b, which was included in the 2024 update in the original answer. While this detail is scientifically relevant, it does not undermine the core factual accuracy regarding development and patent positioning. The answer remains contextually complete and highly relevant to the question. Thus, a score of 9 is justified—excellent accuracy with a small gap in descriptive completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 413,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "\nDawn has remained a core, listed brand of P&G’s Fabric & Home Care segment throughout 2022‑2024, appearing in the segment’s “Major Brands” tables for each fiscal year.  During that period the segment’s earnings contribution rose from about 31 % of segment earnings in 2022 to roughly 34 % in 2024, and segment net earnings jumped 18 % in 2024—driven by higher pricing, a more favorable product mix and productivity gains that also lifted the performance of its flagship brands.  Consequently, Dawn’s prominence within the segment grew in step with the segment’s improving earnings contribution, underscoring its expanding role in delivering the segment’s stronger profitability from 2022 to 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Dawn remained a listed brand in the Fabric & Home Care segment from 2022 to 2024, and accurately reports the segment’s earnings contribution increasing from 31% in 2022 to 34% in 2024, aligning with the ground truth. However, the LLM introduces an unsupported claim that 'segment net earnings jumped 18% in 2024'—this figure is not present in the original answer and cannot be verified from the provided ground truth, representing a factual overreach. (2) The percentages for earnings contribution (31% to 34%) are correct and match the ground truth. The stable sales contribution (35% to 36%) is omitted in the LLM answer, which weakens completeness. The 18% net earnings increase is unverified and likely incorrect as it was not derived from the source. (3) The multi-hop reasoning is partially sound: the model correctly infers that Dawn’s positioning strengthened alongside the segment’s improved earnings performance. However, it misses the nuance that sales contribution remained stable, which the original answer uses to emphasize strategic stability rather than expansion. This affects qualitative depth. (4) Despite the addition of unverified data, the core facts—Dawn’s consistent inclusion, segment earnings growth, and implied importance—are correct. The answer remains contextually relevant and captures the main trend, warranting a score of 8. Quantitative accuracy is slightly penalized due to the unsupported 18% figure, and qualitative accuracy due to omitted context about stable sales contribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 430,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab expanded the amount of client‑held securities it pledges as collateral—both for margin‑lending and to meet clearing‑house initial‑margin and securities‑lending obligations—so that the fair value of securities it borrowed and pledged grew from about $685 million (2022) to roughly $1.5 billion (2023), and the pool of client securities that could be used as collateral rose to well over $120 billion.  This heightened reliance on client collateral ties a larger share of Schwab’s balance‑sheet funding to the performance of those client assets, increasing its exposure to market‑price declines and credit risk if client positions fall or borrowers default.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The claimed fair value of pledged securities growing from $685 million (2022) to $1.5 billion (2023) and a pool exceeding $120 billion in 2024 is not supported by the ground truth, which does not provide specific dollar amounts for the scale of pledged securities over these years. The original answer mentions qualitative disclosures about pledging practices under ASC 326 and for options clearing and securities lending, but no such figures appear in the ground truth. These invented numbers severely undermine factual correctness. While the LLM captures the general trend of increasing use of client securities for margin lending, collateral obligations, and securities lending, and correctly identifies regulatory and risk implications, it misrepresents the data. The reasoning partially aligns with the multi-hop nature of the question by connecting pledging to margin loans and clearing obligations, but fails to reference key specifics like the practical expedient under ASC 326 or the Options Clearing Corporation role in 2024. The conclusion about increased exposure to market and credit risk is a reasonable inference but overstated without grounding in the actual disclosures. Overall, the answer fabricates critical financial figures, leading to a low correctness score despite some contextual relevance and partial qualitative alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 397,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "\nFrom fiscal 2023 to the 2025 target, Accenture’s defined‑benefit glide‑path moves from a heavily debt‑biased stance to a more balanced mix: the U.S. plan goes from about 95 % debt (≈5 % cash) in 2023 to a full 100 % debt allocation in the 2025 target, while the non‑U.S. plan raises its equity exposure from 19 % to 28 % and trims debt from 43 % to 36 %, with cash edging up to roughly 7 % and insurance/other assets adjusting accordingly. This evolution reflects a deliberate shift toward greater equity and cash positioning in the non‑U.S. portfolio while solidifying a fully debt‑only profile for the U.S. portfolio by fiscal 2025.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitatively, the percentages cited are completely wrong: the ground truth shows a gradual shift from 55% fixed income in fiscal 2023 to 61% in fiscal 2025, with equities decreasing from 45% to 39%. The LLM instead claims the U.S. plan shifts from 95% debt to 100% debt and the non-U.S. plan increases equity from 19% to 28%, which contradicts the disclosed weighted-average allocations. These numbers do not appear in the original answer and are factually unsupported. (2) The answer introduces a U.S./non-U.S. plan breakdown and mentions cash, insurance, and other asset categories, which are not part of the original multi-year weighted-average strategy described. (3) The reasoning is flawed: the ground truth describes a consistent de-risking trend across the global weighted-average portfolio toward more fixed income, while the LLM describes divergent and contradictory strategies across regions, including increased equity exposure, which is the opposite of the actual trend. (4) The answer fails the multi-hop synthesis requirement—it does not correctly extract or compare the weighted-average allocations as of August 31 in 2022, 2023, and 2024. Instead, it fabricates a narrative around sub-plan allocations not mentioned in the original. (5) Contextual relevance is low because it addresses a different aspect (plan-specific allocations and glide paths) rather than the disclosed weighted-average asset allocations over time. The only partial relevance is that it discusses asset allocation evolution, but the substance is incorrect. Due to major factual, numerical, and reasoning errors, the correctness score is 1.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 469,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s funding mix changed modestly but strategically: short‑term borrowings fell from roughly **$880 million in 2022 to $540 million in 2023** and edged up to **$562 million in 2024**, while long‑term debt **peaked at $49.3 billion in 2023**, was about **$48.7 billion in 2022**, and then **declined to $45.0 billion in 2024**.  The three‑year trend shows the firm relies overwhelmingly on long‑term, largely fixed‑rate debt, but it deliberately reduced that exposure in 2024 and kept short‑term borrowings a tiny fraction of total funding, indicating a conscious shift toward a more balanced debt structure with lower interest‑rate sensitivity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM incorrectly states long-term debt was $48.7B in 2022 and $49.3B in 2023, conflating total debt with long-term debt and misrepresenting the 2022 baseline. It also fabricates short-term borrowing figures: ground truth does not provide a breakdown of short-term borrowings, only total combined debt, yet the LLM invents specific numbers like $880M, $540M, and $562M, which are unsupported. (2) The calculation of trends is partially correct in direction—debt increased in 2023 and decreased in 2024—but magnitudes are wrong. The LLM claims long-term debt declined to $45.0B in 2024, while the correct figure is $45.551B—close but still inaccurate. More critically, it fails to report the actual total debt figures and instead introduces a false decomposition. (3) The reasoning about a strategic shift away from variable-rate debt is partially aligned with the ground truth (e.g., reduction in floating unsecured senior debt to $0 in 2024), but the LLM does not mention this specific debt class or the rising weighted-average interest rates (1.51% → 3.01% → 3.48%), which are central to the interest rate exposure analysis. Instead, it infers a general 'more balanced debt structure' without citing the key evidence. (4) Contextually, the answer addresses the evolution of debt and interest rate exposure, so relevance is high. However, due to major quantitative errors and failure to report critical data points (interest rates, specific debt reductions), the correctness score is low. The qualitative reasoning is plausible but not grounded in the correct data, limiting its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 502,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "\nBA’s fleet‑support services have stayed roughly constant at **about 1 % of total consolidated costs** in each of the last three years—2022, 2023 and 2024—because the 10‑K notes repeatedly state that fleet‑support expenses “have historically been approximately 1 % of total consolidated costs of products and services” and no year‑over‑year percentage is given to suggest a change.  \n\nAt the same time, the company has recorded **large abnormal production costs for the 787 (cumulative $2.7 bn through 2023 and $256 m in 2024)** and **reach‑forward losses on the 777X program of $2.6 bn in Q3 2024 plus an additional $0.9 bn in Q4 2024**. These program‑specific cost spikes have driven a sharp rise in overall losses and operating expenses, but the **steady ~1 % share of fleet‑support costs shows that the surge in abnormal production and reach‑forward losses is not being reflected in the fleet‑support cost proportion**.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core facts from the ground truth, but contains a minor quantitative inaccuracy regarding the 787 program's abnormal production costs. The original answer states that the 787 program incurred $2.7 billion in cumulative abnormal production costs by 2023, with no additional breakdown for 2024. However, the LLM answer incorrectly adds a $256 million cost for 2024, which is not present in the ground truth. This introduces a factual error, though it does not fundamentally alter the overall trend analysis. All other numbers are accurate: the 1% fleet support cost ratio across 2022–2024 is correctly reported, and the 777X reach-forward losses of $2,608 million in Q3 2024 and $891 million in Q4 2024 are correctly rounded to $2.6 billion and $0.9 billion, respectively—acceptable under format variation. The entity identification (BA, 787, 777X, fleet support services) and time periods are correct. The reasoning is sound: the LLM correctly contrasts the stable proportion of fleet support costs with the escalating program-specific losses, demonstrating multi-hop synthesis between cost structure and production challenges. It accurately infers that the financial strain stems from production inefficiencies, not service delivery. The answer is contextually complete and relevant, addressing both parts of the question—the trend in fleet support costs and its relation to abnormal costs and reach-forward losses. The wording is slightly more concise than the original, but semantically equivalent on all key points except the erroneous 2024 787 cost addition. This minor factual overstatement prevents a top score, but the overall accuracy and logic remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1580,
        "completion_tokens": 465,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "\nAbbVie’s short‑term cash‑equivalent allocation fell from **$12 million at the end of 2022** (fair‑value table for 2020 / 2022 reporting) to **$10 million at the end of 2023** and stayed at **$10 million at the end of 2024** (both 2023 and 2024 fair‑value tables).  \n\nThis modest, flat‑lining allocation after the 2022 decline indicates that the company is deliberately reducing the share of cash parked in ultra‑short‑term, low‑yield instruments and instead deploying the bulk of its liquidity toward strategic acquisitions, debt financing and shareholder‑return initiatives, while retaining only a small, highly liquid buffer for day‑to‑day needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and years. According to the ground truth, AbbVie's allocation was $12M in 2022, increased to $21M in 2023, and decreased to $10M in 2024. However, the LLM states it decreased from $12M in 2022 to $10M in 2023 and remained at $10M in 2024—missing the critical $21M peak in 2023 entirely. This misrepresents the trend as a decline and plateau rather than a rise and fall. (2) The quantitative error is severe: the $21M value for 2023 is completely omitted, and the timeline is misaligned (e.g., referencing a '2020/2022 reporting' that does not align with the question’s focus on 2022–2024). The claim that $10M was the amount at the end of both 2023 and 2024 contradicts the ground truth, which shows $21M in 2023. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the three-year trend. The conclusion that AbbVie is 'reducing' and 'flat-lining' contradicts the actual fluctuating pattern, which includes a near-doubling in 2023. The interpretation of strategy may be plausible in isolation but is based on incorrect data. (4) While the answer addresses the question’s structure and attempts to interpret liquidity strategy (hence moderate contextual relevance), the factual foundation is unsound. The correctness score is low due to major numerical and temporal inaccuracies that distort the core trend. Quantitative accuracy is penalized heavily for wrong values and years; qualitative accuracy suffers due to incorrect synthesis; contextual relevance is acceptable as the response stays on topic and uses appropriate financial reasoning, albeit on faulty premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 463,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture repurchased roughly **$4.1 billion** of its Class A shares in 2022, **$4.5 billion** in 2023 and continued a comparable **$4.5 billion** buy‑back program in 2024 (including $605 million in the fourth quarter of 2024).  During the same period the Board expanded the total repurchase authorization from about **$6.1 billion** (as of Aug 31 2022) to **$6.7 billion** (after the September 2024 increase), while the unused portion of that authority fell from **≈$3.1 billion** to **≈$2.7 billion**.  This demonstrates a disciplined, ongoing capital‑return strategy that combines regular dividend payments with opportunistic share‑repurchases, using a sizable, evergreen authorization to return cash to shareholders while preserving flexibility for future investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures and misrepresents the evolution of Accenture's share repurchase authorization. While it correctly identifies a trend of ongoing share repurchases and increasing board support, the specific numbers are largely incorrect. (2) Quantitative inaccuracies: The LLM claims $4.1B repurchased in 2022 and $4.5B in 2023, but the ground truth does not provide actual repurchase amounts for those years—only remaining authorizations. The LLM incorrectly states remaining authorization fell from ~$3.1B to ~$2.7B, while the truth shows it increased from $3,129M in 2022 to $2,694M in 2023 (a decrease), then jumped to $6,694M in 2024 after a $4B increase. The LLM claims total authorization was $6.1B as of Aug 31, 2022, but the truth reports $3,129,296K (~$3.13B) available at that time. The $6.7B total post-2024 increase is close to the correct $6,694M (~$6.69B), so this part is approximately accurate. However, the LLM incorrectly implies the unused portion decreased, when in fact it more than doubled due to a large new authorization. (3) Multi-hop reasoning is partially sound—the LLM correctly infers a consistent capital return strategy from repurchase activity and board actions—but it fabricates actual repurchase volumes not present in the ground truth and misinterprets the direction of remaining authorization changes. It also conflates total cumulative authorization since 2001 ($50.1B) with remaining available capacity, which are distinct concepts. (4) Correctness score is 4 due to major quantitative errors and misunderstanding of the data, though the general qualitative trend is recognized. Quantitative accuracy is low (3) due to incorrect figures and misrepresentations. Qualitative accuracy is moderate (5) because the conclusion about capital return strategy is directionally correct. Contextual relevance is high (8) as the answer addresses the right topic and timeframe with appropriate financial terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 544,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the company’s charter language was essentially unchanged: directors may be removed only “for cause,” the board is divided into three staggered classes, and any amendment to those provisions requires the affirmative vote of at least 80 % of the voting stock.  This steady reinforcement of removal‑for‑cause and other board‑entrenchment clauses shows that AbbVie’s long‑term takeover‑defense strategy is to make any change of control difficult and costly, preserving board continuity to protect its multi‑year pipeline and strategic objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AbbVie maintained the 'removal for cause only' provision across 2022, 2023, and 2024, consistent with the original answer. It also accurately references the staggered board and supermajority requirement (80%) for amending these provisions, which matches the anti-takeover measures in the ground truth. (2) Quantitatively, the 80% threshold is correctly stated and aligns with the knowledge graph data; no other numbers or dates are in dispute. (3) The multi-hop reasoning is sound: the model synthesizes governance provisions across multiple years and correctly infers that the consistency reflects a deliberate, long-term takeover defense strategy focused on board entrenchment and continuity. (4) While the LLM does not explicitly mention 'restrictions on special meetings'—a minor omission from the full set of defenses—the core elements (removal for cause, staggered board, supermajority vote) are present and correctly interpreted. The conclusion about protecting a 'multi-year pipeline and strategic objectives' is a reasonable qualitative extension of the board stability rationale. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only a slight lack of completeness regarding all ancillary provisions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 382,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑Ks the 4.000% Senior Note due 2047 is disclosed in exactly the same “Form of” exhibit entry—“Formof4.000% Senior Note due 2047, which is incorporated herein by reference to Exhibit 4.5 to PepsiCo’s Current Report on Form 8‑K filed May 2 2017.” The phrasing and placement are unchanged in each filing, underscoring that the note remains a stable, long‑dated component of PepsiCo’s capital structure. Its repeated, unaltered disclosure signals that the instrument serves as a foundational, low‑cost financing pillar that supports the company’s long‑term strategic investments and a diversified maturity‑laddered debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.000% Senior Note due 2047 is consistently referenced in each 10-K (2022, 2023, 2024) via Exhibit 4.5 to the May 2, 2017 8-K filing—this matches the original answer exactly. The date (May 2, 2017), exhibit number (4.5), and form type (8-K) are all correctly stated. (2) Quantitative accuracy is perfect: percentages (4.000%), years (2047, 2017), and filing types (Form 8-K, Form 10-K) are precise and consistent with the ground truth. (3) The multi-hop reasoning is sound—by identifying the same disclosure across three years, the model correctly infers stability in PepsiCo’s capital structure. It appropriately concludes that the unmodified reference indicates no changes to the note’s terms, reflecting its role as a stable, long-term financing instrument. (4) The LLM adds slight interpretive depth (e.g., 'foundational, low-cost financing pillar', 'diversified maturity-laddered debt strategy') that goes beyond the original answer but remains logically consistent with the evidence and does not introduce inaccuracies. This interpretive expansion is reasonable and contextually appropriate, though not explicitly confirmed by the ground truth, which keeps the conclusion more factual. Thus, while the core facts and synthesis are fully correct, the added strategic interpretation slightly exceeds the scope of the provided truth, preventing a perfect 10. Overall, the answer is factually correct, complete, and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 424,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "\nAcross the three fiscal‑year 10‑Ks the 4.30 % senior unsecured note due 2034 is repeatedly disclosed in the same Exhibit 4.09 “Forms of 3.40 % Note due 2024, 4.30 % Note due 2034 and 4.50 % Note due 2044…” – first noted in the 2022 filing (page 94 – “senior notes and other borrowings that mature at various future dates”), again listed in the 2023 filing (page 110 – exhibit list) and again in the 2024 filing (page 110 – exhibit list).  No new issuance is reported; the company simply re‑files the existing instrument each year, underscoring that the 2034 note remains a core, long‑dated piece of Oracle’s capital structure and that its long‑term debt strategy relies on a stable ladder of fixed‑rate senior notes to fund operations, acquisitions and shareholder returns without frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.30% Note due 2034 was disclosed in Oracle's 10-K filings in 2022, 2023, and 2024, consistently listed in Exhibit 4.09 across years, with no indication of new issuance—only reaffirmation. The percentages (4.30%), maturity year (2034), and exhibit number (4.09) are all factually correct. (2) Quantitative elements—interest rate, maturity date, exhibit number, and page references—are accurate and consistent with the source data. No calculations were required, but the temporal tracking across years is precise. (3) The reasoning is sound: the repeated disclosure without new issuance supports the conclusion that Oracle maintains a stable long-term debt strategy with a maturity ladder of fixed-rate notes. The LLM correctly infers strategic intent (funding operations, acquisitions, shareholder returns) and emphasizes reduced refinancing risk, which is consistent with the ground truth’s emphasis on 'stable long-term debt strategy' and 'sustained capital market engagement.' (4) The only minor gap is that the LLM adds slightly more detail than the ground truth (e.g., specific funding uses like acquisitions and shareholder returns), which, while reasonable and plausible, are not explicitly confirmed in the original answer. However, this does not detract from factual correctness. Overall, the answer demonstrates strong multi-hop synthesis across three years of filings and accurate interpretation of disclosure patterns. Semantic equivalence is maintained, with the LLM providing a slightly more granular but still correct interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 451,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share ceiling grew from **127 million Class A shares in fiscal 2022** (page 86 of ACN_10k_2022.pdf) to **141 million shares in fiscal 2023 and again in fiscal 2024** (pages 97 & 98 of ACN_10k_2023.pdf and ACN_10k_2024.pdf).  While the authorized amount rose sharply, the pool of shares actually available for new grants fell only modestly—from roughly **27.38 million shares available at the end of FY 2022** (page 86) to about **27.27 million shares available as of FY 2024** (page 98).  \n\nThis upward step‑up in the authorized share reserve shows Accenture is deliberately expanding its equity‑based incentive pool to sustain long‑term share‑based compensation as it scales globally, while the slight decline in available shares reflects ongoing grant activity but still leaves a sizable buffer for future awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: 127 million shares in FY 2022, increasing to 141 million in FY 2023 and remaining at that level in FY 2024. These match the original answer exactly, with acceptable formatting (127 million = 127,000,000). The additional detail about available shares (27.38 million vs. 27.27 million) is factually consistent with the filings and adds context without contradicting the ground truth. (2) The core evolution of authorized shares is correctly reported across all three fiscal years, satisfying the multi-hop requirement across FY2022–FY2024. (3) The reasoning is sound: the increase from 127M to 141M shares indicates a strategic expansion of share-based compensation capacity, which the LLM correctly interprets as supporting long-term incentives and talent retention, even adding nuanced insight about the stable available pool. (4) The only minor deviation from the original answer is the inclusion of extra detail about available shares not requested in the question—this does not detract from correctness but slightly shifts focus. However, this information enhances rather than distorts the response. All entities (Accenture plc, Amended 2010 SIP, Class A ordinary shares) and fiscal years are correctly identified. The LLM demonstrates strong multi-hop synthesis across three annual reports. Thus, the answer earns a 9/10 for correctness due to slight over-elaboration, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 425,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "\nThe 2.750 % Senior Note due 2051 was first disclosed in PepsiCo’s October 21 2021 Form 8‑K (page 128) as the “Form of 2.750 % Senior Note due 2051.”  Subsequent annual reports and 8‑K filings in 2022, 2023 and the 2024 filing (pages 129‑135) re‑incorporated the same note in updated Board‑resolution tables and supplemental indenture listings, reaffirming its terms without alteration.  This recurring appearance across multiple years shows that PepsiCo is deliberately issuing and periodically re‑authorizing a large‑tenor, fixed‑rate tranche as part of a staggered, long‑term debt strategy that secures low‑cost financing and extends the maturity profile of its capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in dates and documentation progression, undermining its correctness. The original answer states that the note was first introduced in a 2022 Board resolution (Exhibit 4.60), but the LLM claims it was disclosed on October 21, 2021, in a Form 8-K as the 'Form of 2.750% Senior Note due 2051'—a detail not present in the ground truth and factually inconsistent. This misrepresents the timeline: the ground truth shows initial authorization in 2022, formalization in 2023 with Exhibit 4.51, and continuity in 2024 with Exhibit 4.48. The LLM incorrectly implies the form was already finalized in 2021, contradicting the phased evolution. Additionally, the LLM references 'pages 129–135' in the 2024 filing without supporting evidence in the ground truth, which only notes consistent exhibit numbering. While the LLM correctly infers a long-term, staggered debt strategy and stability in terms, this reasoning is based on incorrect premises. The qualitative analysis of PepsiCo’s capital strategy—extending maturities and securing low-cost financing—is contextually relevant and aligns with the intent of the original answer. However, due to the critical error in the timeline and exhibit evolution, the quantitative and qualitative accuracy scores are reduced. The answer is partially correct in concept but flawed in execution on key facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 384,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "\nAmerican Express has held its position as the fourth‑largest general‑purpose card network from 2022‑2024, but the gap with the market leaders (Visa and Mastercard) has widened as those networks deepened their scale and as a growing ecosystem of alternative payment mechanisms—digital wallets, buy‑now‑pay‑later, real‑time settlement and other fintech platforms—has proliferated (see Competition discussion on pages 12 & 13).  At the same time, regulatory pressure has intensified: in 2024 the company was classified as a Category III bank‑holding firm, subject to tougher supervisory expectations, and it faces ongoing scrutiny over sales‑practice investigations and interchange‑fee caps that constrain discount‑rate pricing (see Regulatory Overview on pages 33 & 34).  Consequently, Amex has had to accelerate investment in new products, partnerships and cyber‑security to preserve its competitive standing amid both heightened regulation and the rise of alternative payment solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth, earning a high correctness score. (1) It correctly identifies American Express as the fourth-largest general-purpose card network from 2022 to 2024, consistent with the original answer. While it does not name China UnionPay as the largest (mentioned in the ground truth), this omission does not distort the relative ranking. (2) Quantitative accuracy is strong: no specific numbers (e.g., transaction volumes, revenue) are cited, so there are no errors in figures, dates, or calculations. The mention of 2024 regulatory classification as a Category III bank-holding company is factually plausible and contextually relevant, though not explicitly in the ground truth; it does not contradict it. (3) The reasoning is sound: the LLM correctly synthesizes the dual pressures of regulatory scrutiny and alternative payment growth, linking them to strategic responses like increased investment. It accurately reflects the shift toward a regulation-constrained environment. However, it omits specific details about cobrand arrangements in the EU and market exits, which are key elements in the ground truth’s multi-hop reasoning. (4) Contextual relevance is excellent—the response directly addresses the evolution of Amex’s competitive positioning, regulatory trends, and alternative payment threats. The use of document page references (e.g., pages 12, 13, 33, 34) suggests grounding in source material, enhancing credibility. Overall, the answer is semantically equivalent in intent and key facts but lacks minor specifics on EU regulations and market exits, preventing a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 455,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "\nBoeing’s public focus on aircraft upgrades and conversions grew markedly from 2022 to 2024.  In the 2022 filing the upgrade/conversion activity was only a brief part of the Global Services description, but the 2023 and 2024 filings explicitly list “upgrades and conversions” as a core service offering and note increasing backlog and revenue from that work.  This shift shows Boeing is deliberately pivoting toward a services‑centric strategy—using upgrades and conversions to generate recurring, higher‑margin income from its installed fleet rather than relying primarily on new aircraft sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a growing emphasis on upgrades and conversions from 2022 to 2024 and links it to a strategic shift toward services, which aligns with the ground truth. However, it diverges in key qualitative aspects. While the original answer notes a structural evolution—from upgrades being one of many services in 2022, to 'modifications' being more prominent in 2023, to integration with 'data analytics and digital services' in 2024—the LLM instead claims that upgrades/conversions were only 'briefly mentioned' in 2022 and became a 'core offering' in 2023/2024 with increasing backlog and revenue. The ground truth does not support specific claims about 'increasing backlog and revenue' or a change in categorization to 'core service offering'; rather, the shift was in integration with digital capabilities and lifecycle support. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no errors here, hence a score of 10 by default. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic pivot toward services over time. However, it misses the nuanced progression involving modifications and digital integration, failing to synthesize the full evolution across years as described in the original. It overstates commercial performance (backlog/revenue growth) not present in the ground truth. (4) Correctness is partially accurate but lacks key strategic nuances—especially the move toward technology-enabled differentiation—resulting in a score of 6. Qualitative accuracy is also 6 due to misrepresentation of the nature of the change. Contextual relevance is high as the answer addresses the strategic shift in services, earning a 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 474,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "\nPepsiCo originally issued the 5.50 % Senior Note due 2035 in November 2018, disclosing it in a Current Report on Form 8‑K and later registering the issue on an S‑4 filing.  In each of the 2022, 2023 and 2024 Form 10‑K filings the note is reproduced in the “Form of” tables (2022 p. 132; 2023 p. 122; 2024 p. 128) as “5.50 % Senior Note due 2035, Series A,” consistently referencing the 2018 filing.  This repeated, unchanged disclosure shows that the company treats the 5.5 % 2035 note as a core, long‑dated component of its laddered senior‑debt portfolio and maintains it through regular SEC filings to keep the market informed and preserve flexibility for future refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 5.50% Senior Note due 2035 was issued in November 2018, consistently referenced in 2022, 2023, and 2024 10-K filings as 'Series A', and tied to the same 8-K filing. The exhibit numbers (not explicitly listed in the LLM answer) are not required for correctness, and page numbers (2022 p.132, 2023 p.122, 2024 p.128) are a value-add, not present in the original but factually plausible and consistent with filing patterns. (2) Quantitative accuracy is perfect: percentages (5.50%), years (2018 issuance, 2035 maturity), and time frame (2022–2024) are all correct. No calculations are needed, but temporal logic is sound. (3) Reasoning is strong: the LLM correctly infers that the unchanged, repeated disclosure indicates the note remains an active, long-term component of PepsiCo’s debt structure, reflecting a stable, laddered debt strategy. It adds value by introducing the concept of a 'laddered senior-debt portfolio' and 'preserving flexibility for future refinancing,' which are reasonable interpretations consistent with the filing pattern. (4) The only minor gap is that the original answer emphasizes the lack of modification or retirement, while the LLM focuses more on strategic intent. However, this is a difference in emphasis, not factual inaccuracy. The LLM answer is semantically equivalent and slightly richer in strategic interpretation. Thus, it earns a 9/10 for correctness—excellent, but not perfectly aligned in framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 424,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings, BNY Mellon repeatedly stresses that U.S. banking capital regulations—particularly the “well‑capitalized” and capital‑planning requirements—directly constrain its discretion to pay dividends or repurchase shares, tying shareholder returns to board oversight, credit‑rating stability, and the maintenance of adequate regulatory capital buffers. This multi‑year emphasis shows that regulatory capital constraints are a persistent and decisive factor shaping the firm’s capital‑return policy, meaning any deterioration in capital ratios or credit ratings could immediately curtail planned share repurchases and dividend increases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution and regulatory constraints on BNY Mellon's capital return policies from 2022 to 2024. (1) There are no numeric values to verify (e.g., capital ratios, dollar amounts), and the question is qualitative; thus, quantitative accuracy is not applicable in a traditional sense, but the absence of incorrect numbers supports a score of 10. (2) The LLM correctly identifies the persistent impact of U.S. banking laws, specifically referencing 'well-capitalized' requirements and capital-planning rules, which aligns with the ground truth. It accurately reflects that shareholder returns (dividends, buybacks) are constrained by regulatory capital rules, board oversight, and credit ratings. (3) The multi-hop reasoning is sound: it synthesizes the consistent regulatory theme across the three years and infers that capital planning is tightly linked to prudential oversight. While the LLM omits the specific mention of Delaware law and preferred stock obligations noted in 2023 and 2024, this is a minor omission that does not undermine the central factual and conceptual accuracy. (4) The answer is contextually excellent—directly addressing how regulatory constraints evolved (or remained stable) and what that implies about capital return flexibility. The conclusion that deteriorating capital ratios could curtail returns is a reasonable inference supported by the filings. Overall, the answer is semantically equivalent to the ground truth with only slight detail gaps, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 434,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "\nThe 2.300 % Notes due 2028 were first defined in the March 24 2021 Officers’ Certificate (Exhibit 4.14), which set a fixed 2.3 % coupon, a 2028 maturity and standard unsecured terms. No new 2.3 % issuance occurred in 2022‑2024; instead Oracle added higher‑coupon notes—e.g., 4.5 % Notes due 2028 in the February 6 2023 filing (Exhibit 4.16)—while the original 2.3 % tranche remained outstanding. This shows Oracle’s fixed‑income strategy of locking in low‑cost long‑term rates when markets are favorable and then supplementing its capital structure with higher‑yielding debt as rates rise, rather than repeatedly refinancing existing low‑coupon obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 2.300% Notes due 2028 were established in the March 24, 2021 Officers' Certificate (Exhibit 4.14), no new issuance of these notes occurred from 2022–2024, and Oracle issued 4.500% Notes due 2028 on February 6, 2023 (Exhibit 4.16). These details match the original answer. (2) Quantitative accuracy is perfect: percentages (2.3%, 4.5%), dates (March 24, 2021; February 6, 2023), maturity year (2028), and exhibit numbers are all correct. Minor formatting differences (e.g., '2.3%' vs '2.300%') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly infers Oracle’s financing strategy by comparing issuance patterns across years and interest rate environments, noting the company locked in low rates early and later issued higher-coupon debt without refinancing the original 2.3% tranche. (4) The only minor shortcoming is a slight omission of context about the broader 2021 multi-tiered offering (e.g., 2.875% and 3.950% tranches), which the original answer includes to show the 2.3% note was part of a larger capital structure move. However, this does not undermine the core conclusion. The strategic interpretation is consistent and well-supported. Thus, the answer is factually complete and semantically equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 390,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings IBM repeatedly lists “client relationships and trust” as a principal competitive method, but the emphasis sharpens each year: in 2022 it is cited as part of the brand‑and‑innovation differentiator for hybrid‑cloud; by 2023 the language ties trust directly to IBM’s claim of leadership in hybrid cloud and AI and to the need to safeguard its strong reputation; and in 2024 the narrative frames trust as the foundation for winning enterprise clients on its hybrid‑cloud/AI platform and for leveraging its partner ecosystem. This multi‑year progression shows IBM is deliberately using its long‑standing client trust as a strategic moat to differentiate itself in the crowded hybrid‑cloud and AI market and to position the company as the trusted partner for mission‑critical digital transformations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM's emphasis on client relationships and trust evolves from being part of a broader differentiator in 2022 (linked to brand and innovation in hybrid cloud) to a more central, strategic foundation in 2023–2024, tied to leadership in hybrid cloud and AI, reputation management, and enterprise client acquisition. The 2024 addition of strategic partnerships (e.g., Palo Alto Networks, though not explicitly named in the LLM answer) is implied through 'leveraging its partner ecosystem,' which is semantically acceptable. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution across three years, identifying the increasing centrality of trust in IBM’s strategic positioning. The only minor shortcoming is the omission of a specific example of a strategic partnership (e.g., Palo Alto Networks), which was present in the original answer and adds concrete evidence to the 2024 claim. This does not undermine the overall correctness but slightly reduces qualitative precision. (4) The answer is fully contextually relevant, directly addressing the evolution across years and the strategic implications in the hybrid cloud and AI market. Wording differs but meaning is semantically equivalent and well-articulated. The conclusion about 'strategic moat' and 'trusted partner for mission-critical transformations' is a valid interpretation of the trend. Thus, a score of 9 is justified for both correctness and qualitative accuracy, with full marks for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 476,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign‑government‑bond portfolio dropped from roughly 6.4 % in 2022 to 6.45 % in 2023 and then to about 5.9 % by the end of 2024 (see the 2023 yields in Note 17 of the 2023 10‑K and the 2024 yields in Note 17 of the 2024 10‑K).  This three‑year progression shows the company has been deliberately shortening the duration of its AFS holdings and moving into shorter‑maturity, lower‑yielding securities, thereby reducing its sensitivity to rising interest‑rate movements and signaling a more defensive, liquidity‑focused investment strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the yield values and the direction of the duration shift. According to the ground truth, there is no yield data provided for 2022; the first yield figure is from 2023 at 6.45%. However, the LLM incorrectly states that the yield was 'roughly 6.4%' in 2022 and then rose to 6.45% in 2023, implying a small increase, which is unsupported by the original data. The 2024 yield is reported as 'about 5.9%', which is close to the correct 5.85%, so this part is approximately accurate. More critically, the LLM misrepresents the maturity profile evolution: the ground truth shows that in 2024, a notable portion (2.03%) of holdings matured between 1–5 years, indicating a move toward longer maturities compared to 2023, when all holdings were in securities maturing within one year. But the LLM claims American Express was 'shortening the duration' and moving into 'shorter-maturity' securities, which is the opposite of the truth. (2) The dollar amounts from 2022 ($630 million total, $628 million in under one year) are omitted entirely in the LLM answer, representing a major omission of quantitative detail. The LLM also fabricates a 2022 yield figure not present in the original. (3) The multi-hop reasoning is flawed: instead of recognizing the strategic shift toward slightly longer durations to manage interest rate risk while maintaining yield, the LLM infers a defensive, liquidity-focused strategy based on shortening duration—this contradicts the evidence. The synthesis across years is therefore incorrect. (4) Despite these issues, the answer is contextually relevant, addressing yield trends and linking them to interest rate risk and investment strategy as asked. The mention of Note 17 in the 10-K filings adds apparent sourcing, though it's not verifiable here. Overall, the answer gets partial credit for approximate 2024 yield and general topic relevance but fails on key facts and directional logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 539,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Danaher increasingly relied on U.S. government grants—primarily BARDA and related health‑agency awards—to defray the cost of expanding its Diagnostics testing infrastructure, with grant‑related offsets rising from $87 million of capital‑expenditure reimbursement in 2022 to $136 million in 2023 and $198 million in 2024 (and offsetting $49 million, $51 million and $43 million of operating expenses in those years, respectively).  This upward trend in publicly‑funded CAPEX underscores that diagnostics testing has become a strategic cornerstone of Danaher’s broader health‑care portfolio, with government support serving as a key enabler for scaling production capacity and accelerating growth in the segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the capital expenditure offsets from government grants are correct: $87M in 2022, $136M in 2023, and $198M in 2024—matching the original answer exactly. However, the LLM introduces additional information not present in the ground truth: operating expense offsets of $49M, $51M, and $43M in respective years. Since this data is unverified and not in the original knowledge base, it constitutes a minor factual overreach, slightly reducing quantitative accuracy. (2) The answer is complete, addressing both the evolution of funding and the strategic implications. It correctly identifies the upward trend and interprets it as evidence of diagnostics becoming a strategic cornerstone, which is consistent with the original reasoning. (3) Entity accuracy is strong: Danaher Corporation (DHR), diagnostics testing technologies, and the time frame (2022–2024) are all correctly referenced. While BARDA is mentioned as a source, this detail was not in the ground truth but is plausible and contextually reasonable, not constituting an error per se. (4) Multi-hop reasoning is sound—the model synthesizes year-over-year funding increases and infers growing strategic importance, correctly linking increased government support to capacity expansion and segment growth. (5) Semantic equivalence is high; the core message about increasing grant funding reflecting strategic prioritization is preserved. The only deviation is the inclusion of unverified operating expense figures, which prevents a perfect score but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 447,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s Proxy section (Item 14 – Principal Accountant Fees and Services) consistently notes that KPMG LLP’s PCAOB firm identification number is **185** and that shareholders will be asked to **ratify KPMG LLP as the independent auditor (Item 3 – “Ratification of KPMG LLP”)**. The wording and placement of this disclosure are essentially unchanged in each year’s filing, with the same reference to PCAOB ID 185 appearing in the Proxy‑related Item 14 discussion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: KPMG LLP was consistently ratified as principal accountant across 2022, 2023, and 2024; the PCAOB identification number is correctly stated as 185 in each year; and the disclosure appears under Item 14 of the Proxy, specifically referencing 'Item 3 – Ratification of KPMG LLP'. (2) Quantitative accuracy is perfect: the PCAOB number 185 is correctly reported with no variation, and the years (2022–2024) match exactly. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years and correctly tied to both the Proxy structure and the consistent presentation. The only minor shortcoming is that the LLM refers to 'Form 10-K filings' and 'Item 14 – Principal Accountant Fees and Services', whereas the ground truth emphasizes the Proxy sections and does not specify the form type; however, this is a common and reasonable conflation since Proxy information is often included in the 10-K via incorporation by reference. (4) Despite this slight contextual nuance, the answer is semantically equivalent, factually correct, and fully addresses the evolution (or lack thereof) in disclosure. Hence, a score of 9 is warranted—excellent but not perfect due to the minor form reference imprecision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 367,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "\nFrom 2022 through 2024 American Express deepened its reliance on third‑party merchant acquirers—particularly via the OptBlue and Global Network Services models—so that a negotiated network‑rate fee is recorded as discount revenue at the moment a Card‑Member transaction is processed, rather than retaining the full merchant‑discount margin itself.  These arrangements are formalized through fixed‑term acceptance contracts (typically three‑to‑seven years for large merchants, with auto‑renewal provisions) for small‑ and mid‑size merchants the agreements are open‑ended, and revenue is recognized daily as transactions flow through the acquirer’s platform.  Strategically, the expansion of third‑party acquirer networks supports Amex’s goal of widening global merchant coverage, accelerating digital‑payment and B2B acceptance, and investing in data‑driven services, even as it navigates regulatory pressure on interchange fees and cobrand relationships.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, entities, and timeline. (1) It accurately identifies the key programs (OptBlue and Global Network Services) and correctly describes the revenue recognition model as discount revenue based on negotiated network-rate fees, recognized at transaction processing—consistent with the 2022–2023 evolution. The description of contractual terms (fixed-term for large merchants, open-ended for small/mid-size) adds detail not in the original but does not contradict it. (2) There are no explicit numbers (e.g., dollar amounts, percentages, or exact dates) in either answer, so quantitative accuracy is not compromised; all temporal references (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes revenue recognition, contractual structure, and strategic goals across years. However, it misses the explicit 2024 shift to a 'Processed Revenue' model encompassing royalties and broader revenue-sharing, which is a key qualitative evolution in the original answer. While it mentions strategic expansion in global merchant coverage and digital/B2B acceptance, it does not fully capture the 2024 emphasis on low- and new-to-plastic industries and international markets as highlighted in the ground truth. (4) The answer remains highly contextually relevant, addressing all three dimensions of the question (revenue recognition, contracts, strategy), with strong qualitative accuracy, though slightly less precise in capturing the full scope of the 2023–2024 strategic and structural shift. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 473,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Qualcomm linked a portion of executive pay to the achievement of its human‑capital objectives—most notably the 2025 diversity targets that call for a 15 % increase in women and under‑represented minorities at the leadership level and a 20 % rise in overall URM representation.  The HR & Compensation Committee treats progress on these goals as a non‑financial performance modifier that can adjust the annual bonus by a factor of 0.9 to 1.1 (i.e., up to ±10 % of the target payout), a mechanism that has been applied in each of the last three years as the company reports on its diversity‑and‑inclusion advancements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key quantitative elements correctly: the 15% increase in women and underrepresented minorities (URM) in leadership, the 20% overall URM representation target, the non-financial performance modifier range of 0.9 to 1.1 (±10%), and the linkage to executive compensation across fiscal years 2022–2024. These numbers match the ground truth exactly, and the mechanism’s consistent application over the three years is correctly stated. The answer also correctly identifies the role of the HR & Compensation Committee and the ongoing nature of the incentive structure. However, it omits some qualitative evolution noted in the original answer—specifically, the expanded global engagement, wellness and development programs in 2024, and participation in initiatives like the Reboot Representation Tech Coalition in 2023. While the core multi-hop reasoning (linking diversity goals to executive pay over time) is sound and well-synthesized, the lack of these incremental strategic developments slightly reduces completeness in the qualitative dimension. Despite this, the answer remains factually correct, contextually relevant, and semantically aligned with the main thrust of the ground truth, earning high marks across all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 356,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "\nFrom the 2022 filing (page 68) Caterpillar’s dealer network reached 41 U.S. and 111 non‑U.S. locations serving 187 countries, while the 2024 filing (page 64) shows the network expanded to 44 U.S. and 116 non‑U.S. locations serving 193 countries—a gain of six additional countries. This geographic expansion of the EMD‑branded product distribution signals Caterpillar’s intent to broaden its global footprint, targeting growth in emerging markets and reinforcing its positioning as a worldwide leader in heavy‑equipment and locomotive sales.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that Caterpillar's EMD-branded product distribution decreased from 193 countries in 2022 to 187 in 2024, while the LLM claims an increase from 187 to 193 countries—exactly reversing the trend. This fundamental error invalidates the conclusion. (2) The quantitative inaccuracies are severe: the LLM misrepresents the starting and ending country counts and incorrectly attributes growth. Additionally, the LLM cites dealer network locations (41 U.S. + 111 non-U.S.) which sum to 152 locations—not 187 countries—as if locations equate to countries served, demonstrating a misunderstanding of the data. The 2024 claim of 44 + 116 = 160 locations serving 193 countries again confuses physical dealer locations with geographic reach. These numbers do not align with the ground truth of declining country coverage. (3) The multi-hop reasoning is flawed: instead of tracking EMD-branded product distribution across years, the model conflates dealer network size with country-level distribution reach and draws an opposite conclusion. It fails to correctly identify the metric (geographic reach in number of countries) and misinterprets the relationship between dealer locations and market coverage. (4) Due to completely incorrect numerical data, reversed trend interpretation, and faulty logic, the correctness and quantitative accuracy scores are very low. The qualitative accuracy is also poor due to incorrect entity interpretation and reasoning. Contextual relevance is slightly higher because the answer addresses the general topic of global expansion and strategic positioning, but with the wrong data and inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 472,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "\nThe repeated listing of **Palmolive** among Colgate‑Palmolive’s principal global trademarks (2022‑2024) shows that it is treated as a core, revenue‑generating brand within the Oral, Personal and Home Care segment. Because the company’s net‑sales breakdown (≈ 19 % Personal Care and 17 % Home Care) is anchored by flagship brands, Palmolive’s presence signals that it serves as a strategic growth driver and diversification anchor, reinforcing the segment’s overall profitability and market reach.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic importance of Palmolive as a core brand in Colgate's portfolio and correctly identifies its role in the Personal and Home Care categories, which aligns with the ground truth. However, it introduces unsupported quantitative claims that are not present or verifiable in the original answer: specifically, the breakdown of net sales into '≈ 19% Personal Care and 17% Home Care' is not mentioned in the ground truth and cannot be confirmed from the provided information. This significantly undermines quantitative accuracy. Additionally, the claim that Palmolive is a 'strategic growth driver and diversification anchor' goes beyond the evidence presented; while the original answer emphasizes sustained strategic importance and enduring relevance, it does not assert active growth driver status or provide financial weightings. The reasoning is partially sound—linking consistent trademark listing to strategic relevance is valid—but the synthesis includes speculative financial data not present in the source. Entity accuracy (Colgate, Palmolive, years 2022–2024) and time frame are correct, and the contextual relevance is high as the answer addresses the strategic role question directly. Semantic equivalence is partially met, but the addition of unverified percentages reduces factual fidelity. No calculation errors per se, but unsupported numbers introduced. Multi-hop reasoning is attempted but based on incorrect assumptions about available data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 410,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm moved edge‑networking from a peripheral part of its IoT portfolio to a highlighted growth pillar, repeatedly citing 5G‑driven demand and hybrid‑work trends as the catalyst for future IoT expansion.  Accordingly, edge‑networking is now listed as a separate sub‑category within the IoT revenue stream (consumer, edge‑networking, industrial) and is accounted for as point‑in‑time equipment sales, while the associated licensing and royalty streams continue to be recognized over time; this shift is reflected in the declining IoT revenue figures and the near‑elimination of deferred‑revenue balances by fiscal 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Edge Networking became a 'separate sub-category within the IoT revenue stream' with the structure 'consumer, edge-networking, industrial'. The ground truth specifies that in fiscal 2023, Edge Networking was included in a third revenue category alongside consumer and industrial applications — not as a standalone sub-category within IoT, but as part of a broader formalized grouping. More critically, the LLM claims a change in revenue recognition to 'point-in-time equipment sales' and states that this caused 'declining IoT revenue figures' and 'near-elimination of deferred-revenue balances by fiscal 2024'. This is factually incorrect: the original answer states that the revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the QCT segment that included royalty and incentive-related revenue from prior periods. There is no mention of a shift to point-in-time recognition or declining IoT revenues. (2) Quantitatively, the LLM omits the key projection of 'over 27 billion IoT devices by 2026' cited in 2022, and introduces unsupported claims about declining revenue and deferred balances without any numerical backing. These are major omissions and fabrications. (3) The multi-hop reasoning is partially sound in identifying the strategic elevation of Edge Networking and linking it to 5G and hybrid work trends, which aligns with the 2022 framing. However, it fails to correctly trace the structural evolution: from emerging opportunity (2022) to formal product categorization (2023) to sustained emphasis (2024). Instead, it invents a narrative of accounting change and revenue decline not present in the ground truth. (4) Contextual relevance is moderate — the answer addresses IoT growth, product categorization, and revenue recognition as asked, but distorts the facts, especially on revenue recognition. Correctness score is low due to significant factual and quantitative errors, despite some correct thematic elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 560,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "\nCaterpillar’s 2022‑2024 filings repeatedly note that its worldwide sales generate significant currency‑exchange exposure, and that the company mitigates this risk by actively using currency‑hedging instruments.  The disclosures make clear that hedges are employed to shield earnings from adverse rate moves—while also acknowledging that such hedges can eliminate upside from favorable fluctuations—and that Caterpillar’s outlooks do not assume any specific currency movement, a practice that has remained steady across the three years.  Consequently, the hedging program serves to stabilize the profit contribution from its international operations and to limit the volatility of overall earnings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Caterpillar's ongoing use of hedging instruments to manage currency exchange risk across 2022–2024 and accurately captures the core trade-off: hedges protect against adverse movements but limit upside from favorable ones. It also correctly notes the stability of this approach over the three years and its role in reducing earnings volatility from international operations. However, the LLM answer omits key qualitative developments emphasized in the original answer, particularly the evolution of Caterpillar’s risk disclosures. Specifically, it fails to mention the expanded discussion in 2023 and 2024 about emerging market risks such as exchange controls and currency devaluations, which reflect a growing concern over geopolitical and macroeconomic volatility. This missing element represents a significant part of the 'evolution' asked about in the question. While the core hedging strategy is accurately described, the answer lacks the nuanced progression toward increased caution and recognition of external macroeconomic pressures over time. There are no numerical inaccuracies (quantitative accuracy is perfect), and the entities (Caterpillar, hedging instruments, international operations) and time frame (2022–2024) are correct. The reasoning is sound but incomplete in synthesizing the multi-hop evolution across years. Contextual relevance is high as the response stays focused on the question, but the absence of the evolving risk landscape limits its qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 423,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "\nColgate‑Palmolive reduced the share of U.S. Treasury and agency securities in its U.S. pension plan’s fixed‑income portfolio from roughly 40 % in 2022 to about 30 % in both 2023 and 2024 (as shown in the pension‑asset tables of the 2022 and 2024 10‑K filings). This pull‑back signals a deliberate lowering of interest‑rate sensitivity as rates rose, indicating the company is actively managing interest‑rate risk by shifting assets into higher‑yielding government and corporate bonds.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Colgate-Palmolive's allocation was 50% as of December 31, 2020 (reported in 2022 filing), dropped to 40% as of December 31, 2021, then to 30% as of December 31, 2022, and remained at 30% through 2024. The LLM incorrectly states the 2022 allocation as 'roughly 40%', when it should be 30% as of the end of 2022 (per the 2023 filing). The LLM also omits the earlier data points (50% and 40%), failing to capture the full evolution from 2020 to 2022. (2) The numbers cited for 2023 and 2024 (30%) are correct, but the starting point (2022) is wrong, leading to an incomplete and misleading trend description. The LLM references the '2022 and 2024 10-K filings' but misinterprets the reporting lags—2022 filing reports 2020 data, not 2022 portfolio composition. (3) The reasoning about interest rate risk management is plausible and aligns with the ground truth—reducing exposure to Treasuries during rising rate environments to seek higher yields is a sound interpretation. However, the LLM misses the stabilization after 2022 and the Level 2 classification detail, which adds nuance to the liquidity and risk management strategy. (4) Despite the incorrect baseline and missing intermediate steps, the LLM captures the directional trend (decline followed by stability) and offers a reasonable qualitative interpretation. Hence, correctness is partially accurate but significantly undermined by incorrect figures and incomplete multi-hop data synthesis across filings. Quantitative accuracy is low due to wrong percentages and years; qualitative accuracy is moderate due to sound logic on risk management; contextual relevance is high as it addresses the core question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 482,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s Breakthrough Performance Awards (BPAs) moved from an active, quantitatively‑disclosed long‑term incentive to a discontinued program.  In the 2022 Form 10‑K (Note 13) the company reported actual grants, vestings, forfeitures and a fair‑value/​intrinsic‑value valuation based on the closing stock price, amortized straight‑line over the probable vesting term and adjusted each reporting period; by contrast, the 2023 filing stated that **no BPAs were granted in 2023 and none were outstanding as of 31 Dec 2023**, and the 2024 filing retained only a generic description of the award type with no quantitative grant activity or outstanding balance disclosed.  Thus, grant activity ceased after 2022, the valuation methodology (intrinsic‑value based on closing price and straight‑line amortization) remained the same, but disclosure transparency declined sharply in 2023‑2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies that affect the overall correctness. (1) Quantitatively, the LLM correctly notes that no BPAs were granted in 2023 and none were outstanding as of December 31, 2023, aligning with the ground truth. However, it fails to report the specific 2022 grant of 1,165 thousand shares and the 859 thousand nonvested shares at year-end, instead referring generally to 'actual grants' without citing numbers. It also omits any mention of the weighted average intrinsic value of $38.73 per share in 2022. (2) On completeness, the LLM incorrectly claims that the 2024 filing retained only a 'generic description' with no quantitative disclosure—this contradicts the ground truth, which states that in 2024, Pfizer reintroduced BPAs with enhanced transparency, including detailed valuation and amortization policies. The LLM instead asserts that disclosure transparency declined, which is factually incorrect. (3) Entity accuracy is mostly correct—Pfizer, BPAs, and the years 2022–2024 are properly identified. (4) Reasoning is flawed: the LLM concludes that the program was discontinued and transparency declined, when the ground truth shows a strategic evolution—suspension in 2023 followed by a more transparent and dynamic framework in 2024. The LLM misinterprets the 2024 disclosures, failing to recognize the reintroduction and methodological refinement. (5) While the LLM captures the cessation of grants after 2022 correctly, it misses the key evolution in 2024, leading to an incomplete and partially incorrect synthesis. The valuation methodology description (intrinsic value, straight-line amortization) is consistent with 2022 but not confirmed for 2024 in the LLM answer, and no mention is made of adjustments based on performance probability and stock price changes as noted in the ground truth. Thus, despite some accurate details, the core narrative of the program’s evolution is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 529,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s Advisor Services platform added a series of interactive, RIA‑focused tools and broadened its connections to external systems.  In 2023 the company rolled out **Schwab Advisor Portfolio Connect**—a free, web‑based portfolio‑management solution—and began offering **native integrations with third‑party platforms** such as TD Ameritrade’s thinkpipes trading interface and the iRebal customizable rebalancing engine, as well as CRM, order‑management and financial‑planning tools.  By 2024 those integrations were deepened and expanded, giving RIAs a seamless workflow that combines portfolio construction, automated rebalancing, real‑time performance analytics and client reporting within Schwab’s platform while leveraging the partner systems they already use.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Schwab's tools for RIAs with a focus on third-party integrations and portfolio management, which aligns with the question's intent. However, there are significant factual inaccuracies that reduce correctness. First, the claim that Schwab rolled out 'Schwab Advisor Portfolio Connect' in 2023 is incorrect—the original answer states it was already a key offering in 2022. Second, the LLM introduces specific third-party platforms—'TD Ameritrade’s thinkpipes trading interface' and 'iRebal'—that are not mentioned in the ground truth; while the general idea of third-party integrations is correct, naming unverified platforms constitutes a factual error. Additionally, the ground truth emphasizes a shift in focus toward the Advisor Services website in 2023 (with document archiving and search), and in 2024 a refinement in usability and 'intuitive modern experience,' none of which are reflected in the LLM answer. Instead, the LLM overstates integration depth and feature delivery without evidence from the filings. Quantitatively, there are no numerical errors (dates are within range, no incorrect figures), so quantitative accuracy is high. Contextually, the answer stays focused on RIA tools, integrations, and platform capabilities, so relevance is strong. However, the qualitative accuracy suffers due to incorrect entity attribution and timeline misrepresentation, and the multi-hop synthesis is flawed—failing to accurately track the evolution across years as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 417,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "\nAcross the three years TI repeatedly placed embedded‑processing at the center of its strategy: in 2022 it was identified as a key growth market, in 2023 its revenue ($≈ $3.4 B) and operating‑profit contribution were highlighted as expanding, and in 2024 the company pledged continued capital investment to strengthen manufacturing and product capabilities for that segment.  This steady emphasis shows TI is positioning itself as a pure‑play analog and embedded‑processing leader that leverages its manufacturing scale, software‑centric customer lock‑in and industrial/automotive focus to drive long‑term free‑cash‑flow growth and sustain its competitive advantage in the semiconductor market.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, particularly the $3.4B revenue figure for embedded processing in 2023, which is not mentioned or verifiable from the original answer. This is a significant factual overreach, as the ground truth does not provide any financial figures for embedded processing products. Additionally, the claim about capital investment in 2024 is not explicitly supported in the original answer, which only notes consistent strategic framing, not specific investment pledges. (2) The original answer emphasizes that TI consistently framed its strategy around four sustainable competitive advantages, with embedded processing as part of a broad portfolio of analog and embedded products. The LLM answer correctly identifies the strategic centrality of embedded processing but adds unsupported specifics—especially the revenue number and year-by-year evolution—that go beyond the source. (3) The multi-hop reasoning is partially sound: the model correctly infers that consistent emphasis implies long-term positioning and connects this to free cash flow and competitive advantage, aligning with the original's conclusion. However, it fabricates a progression (2022: growth market, 2023: revenue highlight, 2024: investment pledge) that is not in the ground truth, which states only that the same strategic framing was used across all three years. (4) The contextual relevance is high because the answer addresses the evolution and long-term positioning as asked. Qualitative accuracy is moderate due to correct thematic synthesis but flawed reasoning in asserting a changing emphasis when the original stresses consistency. Quantitative accuracy is low due to the unsupported $3.4B figure and implied precision. Correctness score is 6 because the core idea—TI’s sustained strategic focus on embedded processing as part of its long-term semiconductor positioning—is correct, but significant factual embellishments reduce overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 543,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Boeing’s fleet‑support services remained roughly 1 % of total consolidated costs and are expensed as incurred.  Abnormal production costs for the 787 program grew to about $2.7 billion in cumulative abnormal expenses through the end of 2023, with an additional $256 million charged in 2024 for re‑work and inspection‑related delays.  These cost pressures coincide with ongoing delivery constraints—production rates fell below 5 aircraft per month, deliveries were paused and only resumed after extensive re‑work and FAA‑mandated inspections—resulting in continued delivery delays that further weigh on the company’s earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: the $2.7 billion cumulative abnormal costs through 2023 and the $256 million expensed in 2024 match the original answer exactly. The 1% cost profile for fleet support services is also correctly stated. (2) The answer correctly identifies that these costs were primarily due to rework and inspection-related delays, consistent with the knowledge graph. (3) Multi-hop reasoning is sound: the model synthesizes information across years (2022–2024), connects abnormal costs to delivery delays, and links them to the 787 program’s production challenges. (4) Minor omission: the original answer notes that Boeing expected remaining rework costs after 2023 to not be significant and that most of the 25 inventoried aircraft were reworked by 2024, with deliveries expected in 2025—this forward-looking context is missing in the LLM response. However, this does not undermine the core factual accuracy. The LLM also correctly notes reduced production rates and FAA involvement, which are implied in the delays but not explicitly detailed in the ground truth, so this adds reasonable context without introducing error. Overall, the answer is factually correct, well-synthesized, and relevant, warranting a high score with only slight deduction for incomplete forward-looking resolution details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 387,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "\nPfizer sold Meridian on 31 December 2021 for about $51 million cash and recorded a roughly $167 million after‑tax loss, then put in place interim transition‑service agreements (TSAs) and a three‑year Manufacturing Services Agreement (MSA) to govern any continued relationship; the TSAs were fully wound down by 31 December 2023, and the MSA remains in effect (with a two‑year extension option) but has generated no material revenue or expense beyond the original cash proceeds and loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys nearly all key information from the ground truth with correct multi-hop synthesis. (1) Quantitatively, all numbers and dates are correct: sale date (December 31, 2021), after-tax loss (~$167 million), TSA wind-down date (December 31, 2023), and the three-year MSA with a two-year extension option. The mention of $51 million cash proceeds, while not in the original answer, does not contradict the ground truth and may reflect additional context from the filing; its inclusion is acceptable and does not reduce accuracy. (2) The financial implications are correctly summarized: the loss was recognized in 2022 as part of discontinued operations (implied by post-sale accounting), and the MSA has no material impact, consistent with the original answer. (3) The evolution of the relationship—from ownership to a limited supplier arrangement via TSAs and MSA—is logically and correctly traced across 2022–2024. (4) The only minor omission is that the 2024 reference to Meridian in Pfizer’s glossary as 'Meridian Medical Technologies, Inc.' is not mentioned, which slightly weakens completeness in showing ongoing recognition. However, the continued MSA with extension option implies ongoing relevance, preserving semantic equivalence. Wording differs (e.g., 'Manufacturing Services Agreement' vs 'Manufacturing Supply Agreement'), but this does not affect meaning. Overall, the answer is factually sound, contextually appropriate, and synthesizes information correctly across years and contractual arrangements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 425,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the “hello” brand has moved from being a newly‑acquired niche oral‑care line (acquired in 2020 and highlighted in 2022 as part of the company’s push into high‑growth oral‑care segments) to a core growth driver that is fully integrated within Colgate‑Palmolive’s Oral, Personal and Home Care portfolio.  The brand is now listed alongside the other flagship trademarks (page 77/79), receives dedicated capital spending (e.g., $52 million of 2024 capex for the Oral, Personal and Home Care segment) and is treated as a strategic platform for premium, natural‑care innovation that feeds growth across the entire Oral, Personal and Home Care segment rather than standing apart from it.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. (1) The claim that 'hello' was acquired in 2020 is not supported by the ground truth, which does not mention acquisition timing. (2) The assertion that 'hello' evolved from a 'niche oral-care line' to a 'core growth driver' implies a strategic elevation that is not confirmed in the original answer, which states only that 'hello' was consistently listed among principal trademarks—indicating sustained positioning, not evolution. (3) The mention of $52 million of 2024 capex dedicated to the Oral, Personal and Home Care segment is not in the ground truth and cannot be verified; no specific capital allocation to 'hello' is mentioned. (4) The reference to 'page 77/79' lacks context and is not corroborated. While the LLM correctly identifies 'hello' as part of the broader portfolio and aligned with brands like Colgate and Palmolive, it overreaches in claiming integration and strategic platform status. The original answer emphasizes consistency, not transformation. The reasoning is thus flawed in implying progression and impact beyond what the evidence supports. However, the answer is contextually relevant and addresses the right segment and timeframe. Some qualitative elements—like inclusion in the portfolio—are directionally correct, but the narrative of evolution is not substantiated. Quantitative accuracy is low due to unsupported figures and dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 402,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "\nThe unfunded non‑qualified defined benefit obligation fell sharply—from $895 million at the start of 2022 to $505 million by year‑end 2023, narrowing the funded deficit from roughly $100 million to $87 million—while settlement payments dropped from $309 million in 2022 to just $40 million in 2023, signaling a steep decline in participant exits. Because the plan has been closed to new members since 1997 and remains unfunded, Texas Instruments expects only about $10 million of contributions in 2024, reflecting a sustained reduction in employee participation and a deliberate wind‑down of its long‑term pension liability.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth on key quantitative and qualitative points. (1) Quantitative Accuracy: The reported unfunded obligation amounts ($895M in 2022 to $505M in 2023) and settlement payments ($309M in 2022 to $40M in 2023) are not supported by the original answer, which does not mention these figures at all. The original answer states that the non-qualified plan is unfunded and closed but provides no data on changes in obligation size or settlement payments. The $10M expected contribution in 2024 is mentioned, but in the context of low funding needs due to the plan's legacy status—however, the original answer does not state this as a company expectation or provide such a projection. (2) Completeness: The LLM omits critical information from the original answer, including the evolution of TI common stock holdings in defined contribution plans (6M shares in 2022, 5M in 2023–2024), the decline in dividend income, and the increasing defined contribution expenses ($70M → $75M → $76M). These are central to understanding the shift toward defined contribution plans. (3) Entity Accuracy: While Texas Instruments and the plan type are correctly identified, the LLM invents specific financial data (obligation balances, settlement payments) not present in the source. (4) Reasoning: The conclusion about a 'deliberate wind-down' is speculative and not directly supported by the original answer, which instead emphasizes a strategic shift to defined contribution plans. The LLM misrepresents the nature of the evidence—focusing on alleged reductions in liability rather than the actual trend of increasing DC investment. (5) Semantic Equivalence: The overall message of reduced pension obligations is partially aligned, but the factual basis and supporting data are incorrect or fabricated. The original answer indicates stability in the unfunded status and a growing focus on DC plans, not a rapid reduction in liabilities. Thus, while the general direction of 'moving away from DB plans' is contextually relevant, the specific claims and numbers are largely incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 573,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "\nPfizer’s long‑term investment in private‑equity securities at cost fell from **$800 million in 2022 → $755 million in 2023 → $719 million in 2024**, a cumulative reduction of roughly **$81 million (≈10 %)** over the three‑year span.  \nThis downward trajectory signals that Pfizer is **scaling back its private‑equity exposure** and reallocating the freed capital toward its core biopharmaceutical operations, strategic acquisitions, debt reduction and shareholder‑return initiatives rather than expanding its private‑equity portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Pfizer's long-term investment in private equity securities increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. The LLM incorrectly states the 2022 value as $800 million (should be $623 million), creating a false downward trend from the start. This error invalidates the entire quantitative trajectory and subsequent analysis. (2) The calculation of a $81 million (≈10%) cumulative reduction is incorrect because it is based on wrong starting and ending values. The actual change from 2022 to 2024 is an increase of $96 million ($719M - $623M), despite the drop in 2024. The LLM’s percentage and direction of change are therefore factually wrong. (3) The multi-hop reasoning fails because the model misidentifies the initial investment value, leading to an incorrect interpretation of strategic intent. The ground truth indicates a short-term increase followed by a partial pullback, suggesting measured allocation. The LLM concludes a continuous 'scaling back,' which contradicts the actual increase in 2023. (4) While the answer addresses both parts of the question (numerical trend and strategic implication), the severe quantitative errors undermine both completeness and reasoning. Contextual relevance is moderate because the structure and intent align with the question, but factual correctness is critically compromised. Scores reflect major factual and computational errors that distort the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 429,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "\nUnder the 2019 IDA agreement Schwab could migrate up to $10 billion of IDA balances onto its balance sheet each 12‑month window (which it did in 2021‑22), subject only to capital and fixed‑rate‑designation limits. When the 2023 IDA agreement replaced the 2019 pact (effective May 4 2023), migration was conditioned on keeping IDA balances above a minimum (initially $30 billion above unmatured fixed‑rate obligations through Sep 10 2025 and $60 billion thereafter) and below a $90 billion ceiling, with withdrawals generally allowed only to the extent of customer‑initiated draws; consequently Schwab migrated no balances in 2023 or 2024. The constraints in 2022 required that any migration stay within the $10 billion annual cap and respect fixed‑rate‑obligation limits, while the 2023‑24 constraints add the minimum‑balance thresholds, the $5 billion fixed‑rate “buy‑down” fee provision, and the requirement that only floating‑rate portions may be moved, making further migrations essentially contingent on meeting those balance‑minimum and capital requirements.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Schwab's IDA balance migration constraints from 2022 to 2024 but contains significant quantitative and factual inaccuracies that undermine its correctness. (1) Correct elements: The answer correctly notes that Schwab operated under the 2019 IDA agreement in 2022 with a $10 billion annual migration capacity and that no balances were migrated in 2023 or 2024 under the new 2023 agreement. It also correctly identifies that the 2023 agreement introduced minimum and maximum balance thresholds and restricted migrations. (2) Quantitative inaccuracies: The LLM incorrectly states the minimum IDA balance threshold as '$30 billion above unmatured fixed-rate obligations through Sep 10 2025 and $60 billion thereafter' and a '$90 billion ceiling', which contradicts the ground truth. The original answer specifies that Schwab must maintain minimum balances above the unmatured fixed-rate obligations with a maximum of $30 billion above that total through September 10, 2025 — not $30 billion minimum or $90 billion ceiling. The $5 billion 'buy-down' fee is mentioned in the LLM answer but not in the ground truth and is therefore an unsupported addition. (3) Multi-hop reasoning: The model attempts to synthesize changes across years and agreements, showing understanding of the shift from a permissive to a restrictive framework. However, it misrepresents the nature of the constraints — for example, the requirement that 'only floating-rate portions may be moved' is not in the ground truth and appears speculative. (4) The answer is contextually relevant and addresses all parts of the question, but the inclusion of fabricated numerical thresholds and conditions reduces factual reliability. While the directional conclusion (tightening constraints) is correct, the specific mechanisms and limits are misrepresented. Hence, partial credit is given for structure and high-level accuracy, but significant deductions apply for incorrect figures and unsupported details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 539,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "\nTexas Instruments continued to list Melaka, Malaysia as a dedicated analog‑manufacturing site in its property tables for 2022, 2023 and 2024, indicating that the facility has remained a consistent part of the company’s global analog production network across those years.  This multi‑year stability signals that Melaka is strategically important to TI—providing a sizable, cost‑effective manufacturing footprint in the Asia‑Pacific region that supports the company’s analog product strategy and supply‑chain resilience.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Texas Instruments consistently listed Melaka, Malaysia as a site for analog product manufacturing across 2022, 2023, and 2024, which aligns with the ground truth. There are no numeric values requiring calculation, and the years referenced are accurate. The answer correctly identifies the entity (Texas Instruments), location (Melaka, Malaysia), and the nature of operations (analog manufacturing), satisfying entity accuracy. However, the LLM omits specific details about the evolving notation markers († in 2022, * in 2023, ** in 2024) that indicate potential escalation in operational emphasis—information present in the original answer that adds nuance to the multi-year trend. While the LLM correctly infers strategic importance due to consistency, it does not mention the possible signal of expansion implied by the changing markers, which weakens the depth of multi-hop reasoning. Despite this omission, the core facts and overall conclusion are sound and semantically aligned with the ground truth. The answer is highly relevant and addresses the strategic implication of multi-year consistency. Thus, the correctness and qualitative accuracy scores are slightly reduced for missing incremental detail, but quantitative accuracy and contextual relevance remain perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 368,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "\nThe Target Debit/Circle Card’s share of purchases fell from **19.8 % in fiscal 2022** to **18.6 % in fiscal 2023** and **17.8 % in fiscal 2024**.  This modest decline indicates that, although the card continues to produce incremental sales—because purchases made with it are disproportionately new transactions—the proportion of total sales driven by the card is gradually eroding, suggesting its contribution to incremental revenue is weakening over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies: it reports the 2022 penetration rate as 19.8%, but the ground truth is 20.5%. It also states 18.6% for 2023, whereas the correct value is 19.8%. Only the 2024 figure (17.8%) is accurate. These errors affect the core factual basis of the response. 2) Quantitative accuracy is low because two of the three key percentages are incorrect, and the trend is misrepresented—LLM shows a steeper decline (19.8% → 18.6% → 17.8%) than actual (20.5% → 19.8% → 17.8%). The calculation of the trend magnitude is thus flawed. 3) Qualitatively, the reasoning is sound: the model correctly interprets a declining penetration rate as indicating a weakening role in driving incremental sales, which aligns with the ground truth's implication. It also appropriately references the concept of incremental transactions, showing good multi-hop synthesis of behavioral impact. 4) Contextually, the answer is highly relevant—addresses both parts of the question (evolution over time and implications for sales), uses appropriate terminology (penetration/share of purchases, incremental sales), and draws a reasonable conclusion despite incorrect inputs. However, factual correctness is undermined by key numeric errors, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 358,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "\nThe share reserve under the Texas Instruments 2003 Director Compensation Plan was roughly 58.5 million shares at the end of 2022, remained essentially unchanged in 2023, and rose to about 65.5 million shares by the end of 2024. This upward trend shows the company has been replenishing its director‑equity pool, signaling continued reliance on equity‑based incentives for directors and a strategic intent to keep a larger reserve for future grants.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key aspects. The original answer states that shares available decreased from 35,385,153 in 2022 to 25,296,767 in 2023 to 24,503,062 in 2024, while the LLM claims the reserve was ~58.5 million in 2022, unchanged in 2023, and increased to ~65.5 million in 2024—this is a complete reversal of the actual trend. (2) Quantitative accuracy is extremely low: none of the numbers match (e.g., 58.5M vs 35.4M in 2022), and the direction of change (decrease vs increase) is opposite. Calculations based on these numbers would be fundamentally flawed. (3) The multi-hop reasoning is unsound: the LLM incorrectly infers replenishment due to an upward trend, while the ground truth shows a consistent decline without replenishment. The conclusion about strategic reserve expansion contradicts the actual evidence of depletion without refill. (4) Contextual relevance is low but not zero—the answer addresses director equity incentives and attempts to interpret trends, so it stays on topic, but with entirely incorrect data and reasoning. Thus, correctness, quantitative, and qualitative scores are very low; relevance receives minimal points for topical alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 341,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Visa wove virtual‑account technology into its Visa Direct ecosystem—starting with the 2022 acquisition of Currencycloud, which gave the network cloud‑native virtual accounts and real‑time FX capabilities, and culminating in 2024 with the launch of Visa Cross‑Border Solutions and the fully‑live Visa+ platform that enable P2P transfers between cards, bank accounts and digital wallets in more than 190 countries.  This integration turned Visa Direct into a global, real‑time payouts hub that now processes nearly 10 billion transactions a year and supports expanding cross‑border B2B, B2C and G2C use cases through a network of 75 domestic schemes, 15 real‑time‑payment networks and over 11 billion endpoints.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Visa's virtual accounts and their integration with Visa Direct and cross-border use cases across 2022–2024, aligning well with the ground truth in terms of narrative and strategic direction. However, there are notable quantitative inaccuracies that reduce factual precision. First, the claim that Visa Direct 'processes nearly 10 billion transactions a year' is not supported by the original answer, which does not mention transaction volume—this figure is likely fabricated or misattributed. Second, the LLM states that the 'fully-live Visa+ platform' was launched in 2024, but the original answer does not mention 'Visa+' as a platform, nor its launch status. The acquisition of Currencycloud is correctly cited as foundational in 2022, though the original answer frames it as part of 'Visa Treasury as a Service' rather than being introduced via acquisition (the acquisition timing is accurate, but the integration context is slightly misrepresented). The mention of 11 billion endpoints matches the original answer and is correctly used. The expansion to 190 countries and integration with 75 domestic schemes and 15 real-time payment networks are not in the original answer and appear to be speculative additions. While the LLM correctly identifies the deepening integration of virtual accounts into Visa Direct and the expansion of cross-border B2B/B2C use cases, it overreaches on specific metrics and platform names. The reasoning is logically sound and synthesizes multi-hop elements (2022 foundation → 2023 integration → 2024 expansion), but introduces unsupported details. The answer remains contextually relevant and conveys a similar strategic trajectory, warranting a solid but not high score on correctness due to the embellished quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 489,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "\nThe 2023 revenue slide for Xtandi—down 1 % internationally and eroded by lower net pricing due to channel‑mix shifts—revealed that the product’s growth was being squeezed just as its patent exclusivity window neared (U.S. basic patent not slated to expire until 2027).  In reaction, Pfizer pursued a lifecycle‑management strategy, securing an EU label expansion in April 2024 (and a U.S. approval in November 2023) for a new high‑risk nmCSPC indication, thereby extending the product’s commercial relevance.  This continued investment is reflected in the 2022 intangible‑asset valuation, which still listed Xtandi as a developed‑technology right with a net carrying amount of roughly $19.6 bn (see the developed‑technology rights disclosure in the 2022 intangible‑asset schedule).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Xtandi's 2023 revenue pressure (down 1% internationally) and links it to Pfizer's lifecycle management efforts, including the 2024 EU indication expansion and the 2022 intangible asset valuation. However, there are key inaccuracies in dates and figures. The U.S. approval for nmCSPC was in 2024, not November 2023 as stated—this misaligns with the ground truth timeline. Additionally, the $19.6 billion carrying amount for Xtandi in 2022 is not supported by the original answer or verifiable public disclosures; the ground truth mentions Xtandi was listed among significant developed technology rights but does not specify a dollar value, making this figure a significant overprecision or fabrication. (2) Quantitative accuracy is compromised by the unsupported $19.6B figure and incorrect approval date (Nov 2023 vs actual Nov 2023 FDA submission and April 2024 EU decision). The 1% revenue decline is correctly cited. (3) The multi-hop reasoning is sound: the model connects declining revenues to strategic lifecycle investment and ties this to prior asset valuation, showing logical synthesis across time and documents. However, the incorrect U.S. approval timing weakens the causal narrative. (4) Despite these issues, the answer captures the core intent—Pfizer maintained strategic investment in Xtandi despite revenue headwinds—and remains contextually relevant and well-structured. The qualitative reasoning is strong, but quantitative errors prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 419,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "\nThe RedCard (Target Credit/MasterCard) penetration fell each year – from **20.5 % in 2022**, to **19.8 % in 2023**, and **18.6 % in 2024**. This steady decline indicates that shoppers are increasingly less inclined to use the Target MasterCard for their purchases, suggesting a waning preference for the card’s 5 % discount and loyalty‑program incentives and possibly reflecting stronger competition or reduced perceived value of the program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. These numbers are presented clearly and accurately, satisfying the quantitative component of the question. 2) All numeric values and years are correct, with no calculation errors. The trend of decline is accurately described year-over-year. 3) The reasoning is sound: the model correctly infers that the declining penetration rate suggests reduced consumer preference and weaker loyalty program engagement. It appropriately links the trend to potential causes such as reduced perceived value of the 5% discount and loyalty incentives, which aligns with the ground truth's interpretation. While the original answer references the rebranding to Target Circle Cards, the LLM answer does not mention this nuance but still captures the core entity (RedCard/Target MasterCard) and its evolving usage. 4) The answer is semantically equivalent in conveying the trend and its implications. The omission of the rebranding detail slightly affects qualitative completeness but does not detract from the central factual accuracy or reasoning. Overall, the response is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 353,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Visa folded Currencycloud’s virtual‑account functionality into its Visa Direct and Visa B2B Connect platforms, turning the former standalone fintech asset into a core engine for cross‑border money movement. By FY 2024 that virtual‑account capability—combined with real‑time FX rates and enhanced liquidity and settlement—enabled Visa Direct to reach more than 11 billion endpoints (4 bn cards, 3.5 bn bank accounts and 3.5 bn digital wallets) across 195 + countries, vastly expanding both the speed and geographic scope of cross‑border payments.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Visa's use of virtual accounts from 2022 to 2024, noting integration into Visa Direct and B2B Connect, real-time FX, liquidity, and settlement enhancements. It accurately reflects the expansion of network reach and cross-border capabilities. However, there are quantitative discrepancies: the original answer states 'over 11 billion endpoints' by 2023, while the LLM claims this reach was achieved by FY2024 and breaks it down into 4bn cards, 3.5bn bank accounts, and 3.5bn digital wallets (summing to 11bn), which is not present in the ground truth. This specific breakdown and the claim of 195+ countries are unsupported in the original and appear to be embellishments. (2) The ground truth does not specify the 4bn/3.5bn/3.5bn split or the 195+ countries figure; these are likely fabrications or over-precise inferences. The timeline is also slightly off—network reach to 11 billion endpoints was achieved by 2023, not 2024. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes the role of virtual accounts across Currencycloud, Visa Direct, and B2B Connect, and shows how capabilities evolved over time. It correctly identifies the strategic shift toward cross-border digital payments. (4) Despite the numerical inaccuracies, the core narrative and qualitative progression align well with the original, earning high marks for reasoning and relevance. The answer is focused, contextually appropriate, and conveys the strategic intent accurately, just with over-specified and unverified metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 433,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "\nIn 2022 AMD’s 10‑K warned that failure to protect its technology and other intellectual property abroad could erode its competitive advantage and result in significant expenses. Starting in 2023 the filing highlighted that new product development depends on third‑party IP and that AMD’s manufacturing is concentrated in overseas wafer foundries, making IP protection vulnerable to geopolitical tensions such as the China‑Taiwan relationship. By 2024 the disclosure explicitly ties IP‑related risk to its international operations and third‑party manufacturing dependencies, cautioning that sanctions, export‑control restrictions and natural‑disaster‑driven supply‑chain disruptions could impair AMD’s ability to safeguard and exploit its IP worldwide.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All years (2022, 2023, 2024) are correctly referenced, and the evolution of AMD's IP protection risks is accurately portrayed. In 2022, the focus was on general international IP protection challenges; in 2023, the linkage to third-party manufacturing in geopolitically sensitive regions (China, Taiwan, Malaysia) is correctly identified; and in 2024, the mention of export controls and sanctions tied to global conflicts (Ukraine-Russia, Israel-Hamas) is appropriately reflected. (2) There are no numeric values in this question, so quantitative accuracy is not applicable in the traditional sense, but all dates and time periods are correct—thus scored as 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes AMD’s increasing concern over IP protection by connecting international operations, third-party manufacturing dependencies, and evolving geopolitical and regulatory risks across three years of filings. The only minor shortcoming is that the LLM omits explicit mention of Malaysia in the 2023 risk expansion, instead generalizing to 'overseas wafer foundries'—a small loss in specificity that prevents a perfect qualitative score. (4) The answer is fully contextually relevant, directly addressing the evolution of IP protection difficulties in relation to international operations and third-party manufacturing. Overall, the semantic meaning matches the ground truth with high fidelity, warranting a correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 429,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "\nBetween 2022 and 2024 Union Pacific’s pension‑plan corporate‑stock holdings were re‑classified and sharply reduced.  In 2022 the equity was valued as Level 2 (significant observable inputs) at about **$1.1 billion**; by 2023‑24 it was re‑classified to Level 1 (quoted market prices) and fell to roughly **$176 million** (≈ $0.18 billion), an 85 % decline.  This contraction and the move to a higher‑level fair‑value classification indicate a deliberate de‑risking of the pension fund—shifting assets out of public equity into higher‑quality debt and alternative investments—to lower market volatility and align the portfolio with a more stable, liability‑driven strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It states that in 2022, UNP's Corporate Stock investment was valued at $1.1 billion and classified as Level 2, which is incorrect. According to the ground truth, the 2022 total was $1,990 million ($1.99 billion), with $1,980 million in Level 1 and only $10 million in Level 2. The LLM incorrectly assigns the entire amount to Level 2 and underreports the total by nearly $900 million. The 2023 figure of $176 million in Level 1 is partially correct (actual: $176M Level 1 of $181M total), but the LLM omits the $5M Level 2 component and misrepresents the classification shift as a reclassification rather than a massive reduction in holdings. The 85% decline claim is inaccurate: from $1,990M to $181M is a 91% drop, not 85%. (2) The LLM fails to mention that in 2024, while classification by stock type (common = Level 1, preferred = Level 2) was specified, no dollar values were disclosed—this omission affects completeness. (3) The reasoning about de-risking and strategic shift toward liability-driven investing is plausible and aligns with the ground truth’s interpretation, showing sound qualitative logic. However, the misrepresentation of valuation levels in 2022 (saying all was Level 2 when almost all was Level 1) undermines the validity of the claimed 'reclassification' narrative. The shift was primarily in allocation size, not classification level. (4) Despite incorrect numbers and mischaracterized classification evolution, the answer addresses the core question about valuation changes and strategic implications, earning moderate scores for qualitative reasoning and relevance. The conclusion about de-risking is consistent with the ground truth, even if based on flawed data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 485,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s disclosure of the 4.75 % Senior Notes due 2043 shifted from a single, terse footnote in the 2022 Exhibit Table (the “Fourth Supplemental Indenture… 4.75 % Senior Notes due 2043” and a stand‑alone “Form of 4.75 % Notes due 2043” entry) to a more structured, consistently numbered set of exhibits in the 2023‑24 filings that bundle the note within a suite of supplemental indentures, officer certificates and related filings.  This steady, more organized presentation indicates that Abbott is placing greater emphasis on transparent, long‑term debt management and on providing investors with clear, easily accessible information about the terms and maturity of its senior obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Abbott's disclosure strategy and correctly identifies the 4.75% Senior Notes due 2043 as the subject. It accurately notes a shift from a more fragmented or terse presentation in 2022 to a more structured and consistent format in 2023–2024, which aligns with the ground truth’s theme of increasing transparency. However, it misses key factual specifics: (1) the 2022 reference being tied to St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, which is a critical legacy context; (2) the 2023 formalization via Exhibit 4.6 to the Form 8-K dated March 22, 2017—this date and exhibit number are not mentioned, weakening quantitative and qualitative accuracy. While the LLM infers a trend toward better organization and investor communication, it does not explicitly recognize that the 2023–2024 disclosures reaffirm inclusion in the core indenture framework, a key point in the original answer. The percentage (4.75%) and maturity year (2043) are correct, and the overall reasoning about improved transparency is semantically aligned, but the absence of specific exhibit references, dates, and the St. Jude Medical linkage results in partial credit. The answer is contextually relevant and logically sound in its interpretation but lacks the precise multi-hop synthesis of document types, dates, and corporate history required for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 387,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "\nThe Target Credit Card (branded as RedCard/Target Circle Card) penetration fell from **≈20.5 % of transactions in fiscal 2022** to **≈19.8 % in fiscal 2023** and **≈18.6 % in fiscal 2024** (see 2023 Form 10‑K pages 26‑27).  This steady 2‑percentage‑point decline indicates that customers are increasingly less likely to use Target’s proprietary payment products, suggesting a weakening adoption of the branded card‑based discount program.  As the discount‑driven incentive loses traction, the card’s contribution to incremental sales—historically a source of additional spend—has correspondingly eroded, limiting its ability to boost overall sales growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. The use of '≈' is acceptable given typical reporting conventions and does not distort accuracy. 2) All numbers are correct and consistent with the original answer; the 2-percentage-point decline is approximately accurate (actual decline is 1.9 pp, so '2-point' is a reasonable rounding for trend description). 3) The reasoning correctly identifies the downward trend and links it to weakening customer adoption of Target’s branded payment products, which aligns with the ground truth. It appropriately infers reduced incremental sales impact due to eroding card usage. However, the LLM omits the point that the card remains a key part of Target’s loyalty and revenue strategy (e.g., profit sharing, retention), which slightly weakens completeness. 4) Despite this minor omission, the answer is factually correct, contextually appropriate, and synthesizes multi-hop information (trend over three years + implication for sales). Semantic meaning is equivalent to the original, with only slight differences in emphasis. Quantitative accuracy is perfect; qualitative and contextual scores are high but not perfect due to the missing strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 359,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "\nFrom 2022 to 2024 the Multiple‑Purpose Locomotive fleet shrank from **7,242 units (average age ≈ 22.5 years)** to **6,893 units (average age ≈ 25.2 years)**—a drop of roughly 350 locomotives while the remaining engines are now about 2.7 years older on average.  This pattern shows Union Pacific is deliberately **right‑sizing and extending the life of its existing high‑efficiency fleet rather than pursuing aggressive new purchases**, using a leaner, more utilized locomotive base to improve capital efficiency and support longer‑term asset management goals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all quantitative facts: the fleet size decreased from 7,242 units in 2022 to 6,893 units in 2024 (a reduction of 349 units, rounded to 'roughly 350'—acceptable), and the average age increased from 22.5 to 25.2 years (correctly noting a 2.7-year increase). These match the ground truth exactly in substance, with only minor rounding in the difference, which is reasonable.\n\n2) Quantitative accuracy is perfect: all numbers (7,242, 6,893, 22.5, 25.2) are identical to the original answer. The calculation of the change in fleet size (7,242 - 6,893 = 349) is accurately approximated as 'roughly 350', and the age difference (25.2 - 22.5 = 2.7) is correctly stated.\n\n3) The multi-hop reasoning is sound—information from two time points (2022 and 2024) is correctly synthesized for both fleet size and average age. The entity (Union Pacific), asset type (Multiple Purpose Locomotives), and years are all accurate.\n\n4) The qualitative interpretation differs slightly in tone but remains plausible and contextually consistent. The original answer suggests a 'deferral of fleet modernization' and 'cost-conscious strategy', while the LLM frames it as 'right-sizing' and 'extending the life of existing high-efficiency fleet' with a focus on 'capital efficiency'. This is a slightly more positive spin but still logically consistent with the data. It does not contradict the ground truth but adds interpretive nuance. This prevents a perfect 10 on qualitative accuracy, but the reasoning is still sound and relevant.\n\n5) The answer is fully contextually relevant, addressing all parts of the question: changes in total units, changes in average age, and the implication for asset management strategy. The synthesis across years and metrics is complete and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 486,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "\nAbbott’s unfunded commitments to private real‑estate and other private funds fell from $585 million at year‑end 2021 to $555 million at year‑end 2023 and $540 million at year‑end 2024 (the 2022 figure is not disclosed separately but lies between these values), a reduction of roughly $45 million over the three‑year span.  This steady pull‑back from illiquid alternative‑asset holdings indicates that Abbott is deliberately scaling down its exposure to such investments, prioritizing capital flexibility and focusing on its core pharmaceutical, nutrition and medical‑device businesses.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It incorrectly states that the $585 million figure is from year-end 2021, while the ground truth specifies it as 2022. This misalignment affects the entire timeline. The 2022 value is actually disclosed in the ground truth ($585M), but the LLM claims it is 'not disclosed separately,' which is incorrect. The 2023 ($555M) and 2024 ($540M) figures are correct. The claimed reduction of 'roughly $45 million' is wrong—the actual decline from 2022 to 2024 is $45 million only if starting from 2021, but the question asks about 2022–2024, during which the decline was $45M → $585M to $540M is $45M, but the ground truth says it decreased by $15M over three years, which contradicts this. Wait: $585M (2022) → $555M (2023) → $540M (2024) is a $45M total drop, but the ground truth says 'a consistent downward trend of $15 million over the three-year period'—this appears to be an error in the ground truth (likely meant $45M or $15M per year). However, the LLM interprets the drop as $45M over three years, which matches the math. But the LLM incorrectly shifts the starting point to 2021, which is not supported. (2) Calculations: The drop from $585M to $540M is indeed $45M, so the magnitude is correct, but the time frame is misrepresented. The annual reductions are $30M (2022–2023) and $15M (2023–2024), not a consistent $15M per year. The ground truth's claim of '$15 million over the three-year period' is factually incorrect—it should be $45M. Given this, the LLM’s calculation is mathematically correct but based on wrong years. (3) Multi-hop reasoning: The LLM correctly infers a trend of decreasing commitments and links it to strategic capital allocation, which aligns with the ground truth’s interpretation of reduced exposure. However, it fails to mention the nuance that Abbott maintains significant commitments, suggesting continued long-term participation via distributions—this is omitted, weakening the qualitative analysis. (4) The contextual relevance is high—the answer addresses both parts of the question: trend and strategic implication. But due to incorrect year attribution and missing nuance in strategy (measured approach vs. 'scaling down'), the qualitative and quantitative scores are reduced. Despite the ground truth possibly containing a calculation error, the LLM should have used the correct years. Final correctness score reflects partial accuracy: right direction, right final numbers, wrong starting year, and incomplete strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 678,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "\nThe 3.50 % Notes due 2050 carried a book (net) value of roughly **$2.1 billion at the end of fiscal 2022**.  In the subsequent two years the carrying amount stayed essentially flat – the 2024 filing lists a **$2.0 billion long‑term balance for the 2050 notes** (the same $2.0 billion figure was shown for the prior year), indicating that the company has not retired or significantly re‑issued this tranche of debt.  \n\nThis stable progression signals that NVIDIA is maintaining a large, low‑coupon, long‑dated senior obligation on its balance sheet, using it as a steady source of long‑term financing while it supplements its capital structure with newer note issuances.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative evolution of the carrying value. According to the ground truth, the carrying value decreased from $2,147 million in 2022 to $1,604 million in 2023, then increased to $2,000 million in 2024. The LLM incorrectly states that the value was flat between 2023 and 2024 at $2.0 billion, completely missing the sharp drop in 2023. While the $2.1 billion figure for 2022 is approximately correct (rounding $2,147M), the omission of the $1,604M value in 2023 is a major error. (2) The calculation and trend analysis are flawed: the LLM describes a 'stable progression', but the actual data shows a 25% decrease followed by a 25% increase, which is a significant fluctuation. This undermines the conclusion about stability. (3) The multi-hop reasoning is partially sound in that it attempts to interpret the strategic implications of long-term debt positioning, but it does so based on incorrect data. The LLM correctly identifies the note's characteristics (3.50%, due 2050) and ties them to long-term financing strategy, which shows contextual understanding. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of carrying value and its implication—though based on incorrect numbers. The qualitative reasoning would have scored higher if grounded in accurate data. The quantitative accuracy is low due to the omission of the 2023 decline, which is a core part of the trend. Overall, the answer is partially correct in entity identification and intent but fails on key facts, warranting a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 450,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s disclosures show a clear escalation in how it describes the threat of losing tax‑ and tariff‑related exemptions. In the 2022 10‑K (Item 1A, p. 16) the company listed “loss or modification of exemptions for taxes and tariffs” as a generic risk. By 2023 the same language was expanded (pp. 40‑41) to flag concrete geopolitical pressures—U.S. sanctions on Russia/Belarus, export‑control curbs on China and Taiwan, and the broader impact of trade‑policy shifts—signaling that the risk is now tied to specific regulatory actions. The 2024 filing (pp. 40‑41) goes further, weaving the exemption risk into a laundry‑list of emerging threats (Ukraine‑Russia conflict, China‑Taiwan tensions, new export‑control rules, sanctions, and evolving foreign tax regimes), underscoring that AMD must now monitor a far wider set of international tax and tariff rules. This progression reveals that AMD’s exposure to losing tax and tariff benefits has grown both in magnitude and complexity, reflecting an increasingly intricate global regulatory environment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies the evolution of AMD's risk disclosures from 2022 to 2024, noting the progression from a generic mention of tax and tariff exemption risks in 2022 to increasingly specific and complex geopolitical and regulatory concerns in 2023 and 2024. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) and document references (10-K, page numbers) are accurately cited and consistent with the expected detail. (3) The multi-hop reasoning is sound: the answer synthesizes information across three annual filings, correctly tracing the escalation in risk language and linking it to geopolitical developments (Russia/Belarus sanctions, China/Taiwan export controls, Ukraine-Russia and Israel-Hamas conflicts). (4) The LLM captures all key elements from the original answer—increased exposure, growing specificity, and the implication of rising regulatory complexity—and enhances it with precise filing references (Item 1A, page numbers), demonstrating strong contextual and qualitative accuracy. Wording differs but meaning is preserved and enriched. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 357,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "\nBNY Mellon repeatedly discloses that its ability to return capital—whether through dividends or share repurchases—is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” (2022 10‑K p. 5; 2023 10‑K p. 5; 2024 10‑K p. 5).  While the core regulatory constraint remains the same—compliance with well‑capitalized, capital‑planning and Delaware‑law requirements—the 2023 and 2024 filings add new layers of risk, such as potential rating downgrades, the impact of Title I resolution planning and the need to satisfy broader regulatory expectations, but the fundamental exposure to U.S. banking rules that can restrict capital returns has not changed materially across 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's capital return flexibility is consistently constrained by U.S. banking laws, capital planning requirements, Delaware law, and preferred stock obligations across 2022–2024. The LLM correctly identifies that these core constraints remain stable over time. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years of 10-K filings, noting both continuity (persistent regulatory constraints) and evolution (added emphasis in 2023–2024 on credit rating downgrades, Title I resolution planning, and broader regulatory expectations). This matches the original answer’s point about expanded context in later years. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., quoting directly from filings), it conveys the same core message—stable regulatory exposure with incremental additions in risk disclosure. The only minor shortcoming is that the LLM does not explicitly mention 'Title II' (only Title I), whereas the original answer references both Title I and II. This is a small omission but does not undermine the overall correctness. Contextual relevance is perfect—the response directly addresses dividend and share repurchase constraints as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 415,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "\nThe 2.950% Note due 2025 has remained in Abbott’s 10‑K exhibit tables throughout 2022‑2024, but its placement shifted from Exhibit 4.9 in the 2022 filing to Exhibit 4.1 in the 2023 and 2024 filings after a re‑ordering of the exhibit index. Regardless of the year, the same underlying documents—the March 10 2015 indenture and the “Actions of the Authorized Officers” filing covering the 2.000%, 2.550% and 2.950% notes—are consistently referenced, showing a stable disclosure of the note’s terms with only the exhibit numbering changing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the 2.950% Note due 2025 was referenced as Exhibit 99.6 in an 8-K filing dated March 5, 2015, and this same reference was reiterated in 2023 and 2024. However, the LLM claims the note appeared in 10-K filings as Exhibit 4.9 in 2022 and then moved to Exhibit 4.1 in 2023 and 2024 due to reordering—this contradicts the original answer, which does not mention 10-K filings or exhibit renumbering. Additionally, the LLM cites a March 10, 2015 indenture, while the ground truth specifies March 5, 2015—this date discrepancy is material. (2) Quantitative accuracy is low: the exhibit numbers (4.9, 4.1 vs 99.6), filing type (10-K vs 8-K), and date (March 10 vs March 5) are all incorrect. These are not formatting differences but factual errors. (3) The reasoning is partially sound in that it recognizes consistency in underlying documentation, but it fails the multi-hop synthesis by misrepresenting the source documents and their structure. It incorrectly infers exhibit renumbering in 10-Ks when the truth is about stable citation of a single 8-K exhibit. (4) Contextual relevance is high because the answer addresses the evolution of disclosure and exhibit inclusion as asked, but the factual foundation is flawed. While the conclusion about stable terms aligns with the ground truth, the supporting evidence is incorrect, undermining overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 403,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "\nThe 1.55 % Notes Due 2028 showed a modest upward trend in carrying value: approximately **$1.09 billion at the end of fiscal 2022**, **$1.10 billion at the close of fiscal 2023**, and **$1.115 billion by the end of fiscal 2024**.  This steady, incremental increase indicates that NVIDIA is deliberately maintaining a sizable, low‑coupon, long‑dated senior note tranche as a permanent component of its capital structure—using long‑term debt to fund its capital‑intensive R&D and expansion initiatives while preserving a conservative, stable long‑term debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the carrying values of NVIDIA's 1.55% Notes Due 2028. The ground truth states the values were $1,200 million in fiscal 2022, $1,099 million in fiscal 2023, and $1,250 million in fiscal 2024. In contrast, the LLM reports $1.09 billion (≈$1,090 million) for 2022, $1.10 billion ($1,100 million) for 2023, and $1.115 billion ($1,115 million) for 2024—none of which match the correct figures. The trend is also misrepresented: the actual data shows a drop from 2022 to 2023 followed by a rise in 2024, not a 'steady, incremental increase' as claimed. (2) All three reported numbers are quantitatively incorrect, with errors ranging from $85 million to $135 million. The LLM underreports the 2022 value by $110 million and overstates the 2024 value by $135 million. These are material discrepancies that undermine the answer’s reliability. (3) The reasoning is flawed due to incorrect data input. The conclusion that NVIDIA is maintaining a 'steady, incremental' debt strategy contradicts the actual fluctuating pattern (down then up), which the ground truth interprets as strategic management and rebalancing. The LLM fails to capture this nuance because it misreads the trend. (4) While the answer addresses the right question and attempts multi-hop reasoning (tracking changes over time and inferring strategy), the severe numerical inaccuracies render the analysis invalid. The contextual relevance is moderate because the structure and intent align with the question, but factual correctness is critically lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 436,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "\nFrom 2022 through 2024 AMD moved beyond simply supplying component‑level graphics IP to AIB manufacturers and instead built a tighter partnership that includes inventory‑protection clauses—such as price‑reduction shields and limited return rights—while also selling directly to system‑integrator customers.  It then leveraged its discrete Radeon GPU portfolio as a differentiator, emphasizing energy‑efficient performance and AI‑ready architectures to win share in gaming and data‑center markets, and reinforced those policies to safeguard AIB inventory amid rising competition and export‑control pressures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of AMD's strategy with AIB manufacturers from 2022 to 2024, particularly around inventory protection policies and the role of discrete graphics in differentiation. It accurately notes inventory protection mechanisms such as price-reduction shields and return rights, which aligns with the ground truth. However, it introduces new claims not present in the original answer, such as AMD selling directly to system integrators and emphasizing 'AI-ready architectures' and 'energy-efficient performance'—details not mentioned in the ground truth and thus unsupported. While the general direction of strategic tightening with AIBs is correct, the specific evolution across years (e.g., 2022 having explicit return policies, 2023 emphasizing timely introductions, 2024 focusing on differentiation) is oversimplified and not clearly delineated in the LLM response. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the model connects inventory protection with market differentiation, which is valid, but fails to accurately represent the year-by-year evolution and adds unverified elements (e.g., AI-ready architectures, direct sales to system integrators), weakening the qualitative accuracy. (4) The answer is contextually relevant and addresses the main themes of the question—inventory protection and discrete graphics' role in differentiation—but adds speculative strategic details not grounded in the source. Thus, while factually plausible, it does not fully match the ground truth's precise evolution narrative, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 475,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s IP‑protection risk shifted from a broad warning about safeguarding patents and trade secrets in foreign markets to a concrete exposure linked to its expanding global footprint.  As overseas sales climbed to roughly two‑thirds of total revenue and the company deepened reliance on third‑party fabs in politically sensitive regions such as China, Taiwan and other jurisdictions, AMD repeatedly highlighted heightened threats of expropriation, export‑control curbs and forced technology transfer, making intellectual‑property security a more acute strategic vulnerability.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AMD's IP protection risks from 2022 to 2024, noting the shift from general foreign operation risks to more specific geopolitical threats tied to third-party manufacturing in sensitive regions like China and Taiwan. It accurately reflects the increasing international revenue dependence, stating 'overseas sales climbed to roughly two-thirds,' which aligns with the ground truth figure of 66% in 2024 (up from 65% in 2023 and a lower unspecified amount in 2022). While 'roughly two-thirds' is an acceptable approximation of 66%, the LLM does not provide the exact percentage progression or cite the year-by-year increase explicitly, leading to a minor deduction in quantitative precision. (2) There are no incorrect numbers or fabricated data; however, the answer omits the specific 65% figure for 2023 and fails to mention the Ukraine conflict and Middle East as highlighted regions of concern in the original. Instead, it generalizes to 'politically sensitive regions' without naming all key geographies. (3) The multi-hop reasoning is strong: the model correctly synthesizes AMD’s growing international sales, reliance on third-party foundries, and escalating geopolitical tensions into a coherent narrative about increasing IP vulnerability. It connects expanding global operations with heightened strategic risk, demonstrating sound qualitative understanding. (4) The answer is contextually fully relevant, directly addressing how IP protection challenges evolved in relation to international expansion and third-party manufacturing. Despite minor omissions in specificity and geographic detail, the core facts, trends, and implications are accurately conveyed, warranting a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 482,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "\nFrom 2022 through 2024 the company refreshed the 2019 Long‑Term Incentive Plan with new, year‑specific incentive agreements: 2022 introduced a Performance Share Unit (PSU) agreement and a Restricted Stock Unit (RSU) agreement; 2023 filed updated 2023‑cycle PSU and RSU agreements (the same two agreement types but with revised performance metrics and target percentages); and 2024 added a fresh 2024‑cycle PSU agreement and a 2024 RSU agreement (Exhibit 10.29), together with an amended executive severance plan. This progression shows BNY is moving toward a more performance‑driven equity regime, tightening the link between executive pay and multi‑year results and reducing reliance on time‑vested or discretionary awards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of BK's 2019 Long-Term Incentive Plan from 2022 to 2024. (1) It incorrectly states that in 2022, BK introduced both a PSU and an RSU agreement, whereas the ground truth indicates only the 2021 Form of PSU Agreement was referenced. (2) It claims 2023 saw updated '2023-cycle' PSU and RSU agreements, but the original answer notes the introduction of the 2020 Form of PSU Agreement, not new 2023 agreements. (3) For 2024, the LLM mentions a '2024-cycle PSU' and '2024 RSU agreement (Exhibit 10.29)' and an amended severance plan, which are not supported by the ground truth; instead, the 2022 Form of PSU Agreement was introduced. (4) The LLM incorrectly refers to 'BNY' instead of 'BK', indicating a critical entity error. (5) The conclusion about moving toward a 'more performance-driven equity regime' and 'reducing reliance on time-vested awards' is speculative and not supported by the provided ground truth, which emphasizes continuity and layered updates rather than strategic shift. The answer fabricates agreement types (RSUs), misdates forms (2020 form introduced in 2023), and invents exhibits. While the response attempts multi-hop reasoning by analyzing trends across years, the underlying facts are largely incorrect, undermining the reasoning. Quantitative accuracy is very low due to incorrect years and invented documents. Qualitative accuracy suffers from wrong entities, incorrect agreement types, and unsupported conclusions. Contextual relevance is moderate as it addresses the general topic of incentive plan evolution but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 449,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "\nFrom 2022 through 2024 the portfolio of diagnostics instruments that Abbott leases to customers expanded steadily: the original cost of these leased assets rose from **$3.3 billion** (2022) to **$3.6 billion** (2023) and **$3.9 billion** (2024), while the net book value grew from **$1.4 billion** to **$1.6 billion** and **$1.8 billion** over the same periods.  \n\nThis upward trajectory indicates that Abbott is deliberately increasing its capital deployment in the diagnostics lease business—adding more instruments to its fleet to drive recurring revenue from reagents and consumables rather than relying on outright equipment sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the upward trend in the original cost of leased diagnostics instruments: $3.3B (2022), $3.6B (2023), and $3.9B (2024), which matches the ground truth exactly. However, the net book value is incorrect for 2024: the LLM states $1.8 billion, while the ground truth reports $1.6 billion (unchanged from 2023). The net book values for 2022 ($1.4B) and 2023 ($1.6B) are correct. This is a significant quantitative error in the final year.\n\n2) The numbers for original cost are accurate across all years. The net book value values are correct for 2022 and 2023 but incorrect for 2024. The LLM incorrectly implies continued growth in net book value to $1.8B, which contradicts the ground truth that it remained flat at $1.6B. This affects the factual accuracy of the trend description.\n\n3) The reasoning about Abbott's capital deployment strategy—expanding leasing to drive recurring reagent and consumables revenue—is sound and aligns with the ground truth. The multi-hop synthesis between leased instrument growth and downstream revenue model is logically valid and well-articulated.\n\n4) The contextual relevance is high: the answer addresses both parts of the question (evolution of investment and strategic implication) and uses appropriate financial metrics. The qualitative interpretation is strong, but the quantitative inaccuracy in the 2024 net book value reduces overall correctness. A score of 7 reflects mostly correct facts with one key numerical error that affects the trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 420,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 NVIDIA repeatedly placed Lumentum Holdings in the same “networking products” bucket as AMD, Arista, Broadcom, Cisco, Intel and Marvell—i.e., a competitor in switches, network adapters and optical‑module/interconnect supplies.  At the same time, NVIDIA’s own strategic emphasis on AI‑driven networking and interconnect (e.g., DPU‑centric Spectrum/Quantum platforms, Mellanox‑derived technologies and end‑to‑end AI‑networking software) has broadened the scope of competition, turning Lumentum’s traditional optical‑interconnect business into a more direct rival as NVIDIA expands its full‑stack AI networking portfolio.  Consequently, Lumentum’s positioning has remained listed as a networking competitor, but the intensifying focus on AI‑centric interconnect solutions has increased the competitive pressure on its core offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable in a traditional sense; however, since there are no incorrect numbers or miscalculations, it scores full marks by default. Contextually, the answer correctly identifies that Lumentum is positioned as a competitor in networking and that NVIDIA has expanded its focus on AI-driven interconnect technologies, which increases competitive pressure—this addresses the broader theme of the question and maintains relevance. However, the qualitative accuracy is significantly compromised because the LLM misrepresents the evolution of Lumentum’s positioning across the fiscal years. According to the ground truth, Lumentum’s categorization evolved: from being grouped with general interconnect suppliers in FY2022, to a more specialized segment in FY2023 (high-performance interconnects tied to InfiniBand/Ethernet), and then to a specifically named entity ('Lumentum Holdings Inc.') in FY2024, indicating rising prominence and recognition. In contrast, the LLM claims Lumentum was consistently grouped with major players like AMD, Arista, Broadcom, Cisco, Intel, and Marvell across all three years—which contradicts the original answer. This mischaracterization fails the multi-hop synthesis requirement: the model does not capture the nuanced progression in competitive positioning or the increasing specificity with which Lumentum is identified in NVIDIA’s disclosures. Instead, it flattens the timeline into a static competitive relationship, missing the core insight of evolving strategic relevance. While the general direction of increased competitive pressure due to NVIDIA’s AI networking push is plausible, the absence of year-by-year evolution and incorrect grouping of competitors results in a partially correct but factually inaccurate portrayal of Lumentum’s changing positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 503,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson moved pipe‑cutters out of the **Tools & Home Products** group (where they were presented alongside consumer‑grade DIY tools) and placed them inside the **Safety & Productivity** segment, explicitly framing them as professional pipe‑working equipment for industrial safety and productivity. This re‑classification—first noted in the 2022 segment overview (page 8) and later highlighted in the 2023‑2024 Safety & Productivity description (page 73)—signals a strategic shift toward marketing high‑margin, safety‑critical tools to professional users rather than through the broader consumer‑focused Tools & Home Products channel.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core shift in Emerson's positioning of pipe cutters from 2022 to 2024. It correctly identifies the move from the Tools & Home Products segment to the Safety & Productivity segment, aligning with the ground truth. The dates (2022–2024) and segment names are accurate, and the interpretation of strategic intent—shifting toward professional, industrial-grade tools and away from consumer/DIY channels—is well-supported and semantically equivalent to the original answer. The mention of 'battery hydraulic tools for press connections, drain cleaners, and diagnostic systems' is omitted, but the broader characterization of the new segment as focused on 'safety-critical tools' and 'industrial safety and productivity' conveys the same essence. The reference to page numbers (8 and 73) adds specificity not in the ground truth, but does not contradict it and may reflect actual document locations. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning correctly synthesizes multi-hop information across years and segments. The only minor shortcoming is the lack of explicit mention of the InSinkErator divestiture as contextual reinforcement of the consumer exit, which slightly reduces completeness in qualitative reasoning. However, the strategic inference is still sound. Thus, the answer is excellent but not fully comprehensive, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 405,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s Advisor Services evolved from a basic, web‑based account‑servicing portal into a fully integrated, interactive suite.  The 2023 filing (page 33) notes that Schwab Advisor Portfolio Connect was launched as a free, download‑free tool that gives advisors a modern, intuitive way to monitor and manage Schwab‑held portfolios, while the 2024 filing (pages 8‑10) describes how the Company embedded its thinkpipes trading platform and iRebal rebalancing engine directly into the Advisor Services website, enabling seamless data flow, automated portfolio rebalancing and tighter linkage with banking and cash‑sweep services.  Alongside these functional upgrades, Schwab broadened advisor support by adding dedicated transition consultants, expanded benchmarking and educational programming, and deeper integration with its banking and cash‑management offerings, delivering a more cohesive, end‑to‑end platform for RIAs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of Schwab's evolution in tools for RIAs from 2022 to 2024, including enhanced functionality, integration, and advisor support, which aligns with the ground truth. However, there are significant factual inaccuracies that reduce correctness. First, the claim that 'Schwab Advisor Portfolio Connect was launched in 2023' is incorrect — the original answer and supporting data indicate it was already available in 2022 as a free tool. Second, the LLM introduces specific platform names — 'thinkpipes trading platform' and 'iRebal rebalancing engine' — that are not mentioned in the ground truth and cannot be verified from the provided context; these appear to be hallucinated. Additionally, while the ground truth emphasizes multi-year document archiving, outbound data feeds for compliance, and expanded consulting for independence transition, the LLM overemphasizes banking and cash-sweep integrations not highlighted in the original. The mention of '2023 filing (page 33)' and '2024 filing (pages 8-10)' implies precise sourcing, but without confirmation of those details in actual filings, this risks misattribution. While the qualitative trend of increasing integration and support is correctly inferred, the inclusion of unverified features and incorrect launch timing of Portfolio Connect undermines factual accuracy. The reasoning shows an attempt at multi-hop synthesis across years, but with flawed entity identification and timeline errors. Contextual relevance is high as the response stays focused on the evolution of tools for RIAs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 433,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "\nOracle first brought the 1.650 % Notes due 2026 into its public filings in the FY 2022 10‑K (the notes had been issued March 24 2021) and, in the FY 2023 and FY 2024 10‑Ks, the company reproduced the identical Exhibit 4.14 disclosure without any amendment, redemption or re‑pricing.  This unchanged treatment shows that Oracle has kept the 2026 notes as a steady, low‑cost component of a staggered ladder of fixed‑rate senior debt, using them to fund short‑to‑intermediate‑term needs rather than frequently refinancing or altering that portion of its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the 1.650% Notes due 2026 and their initial appearance in the 2022 10-K, though it adds a specific issuance date (March 24, 2021) not present in the original answer. This date is plausible and consistent with typical debt issuance timelines relative to 10-K disclosures, but was not confirmed in the ground truth, so it's a minor addition rather than an error. (2) The LLM correctly notes the consistent reproduction of the note disclosure in the 2023 and 2024 10-Ks, citing Exhibit 4.14 in both years. The ground truth mentions Exhibit 4.16 in 2022 and 4.14 in 2023/2024, which the LLM does not contradict—Exhibit numbering changes across years are common and the LLM’s focus on 4.14 for the later years is accurate. (3) The reasoning about Oracle’s stable debt strategy is sound and represents valid multi-hop synthesis: the unchanged disclosure over three years supports the conclusion of a consistent, low-cost, fixed-rate financing strategy. The LLM extends this insight slightly by framing the notes as part of a 'staggered ladder' of debt, which is a reasonable financial interpretation and adds contextual depth without misrepresenting facts. (4) All entities—Oracle, the 1.650% Notes, due 2026, and the 2022–2024 timeframe—are correct. The answer fully addresses both parts of the question: the evolution (or lack thereof) of the notes’ treatment and what it reveals about Oracle’s financing strategy. The only minor deviation is the inclusion of the March 2021 issuance date, which, while likely accurate, was not in the ground truth and thus introduces unverified detail. This prevents a perfect 10 but does not undermine correctness. Overall, the answer is factually solid, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 494,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the Discrete‑Automation business—where electrical‑distribution equipment is reported—showed only modest growth: sales rose from **$2.612 bn (2022)** to **$2.635 bn (2023)** but fell back to **$2.506 bn (2024)**, and earnings dropped from **$542 m (2022)** to **$466 m (2024)**.  The slight contraction, together with the company’s increasing emphasis on software‑driven automation, asset‑optimization (AspenTech) and integrated control platforms, indicates that Emerson is deliberately shifting away from pure electrical‑distribution hardware toward higher‑margin, digitally‑enabled electrification solutions that combine hardware with advanced controls, analytics and services.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The financial figures provided—$2.612B (2022), $2.635B (2023), $2.506B (2024) sales, and $542M (2022) to $466M (2024) earnings—are not supported by the ground truth. The original answer contains no financial data, so these numbers appear to be fabricated or misattributed. There is no verification that these figures correspond to the Discrete Automation segment or Electrical Distribution Equipment specifically. (2) Completeness: The question asks about the *evolution of positioning* of Electrical Distribution Equipment within the Discrete Automation segment and what it reveals about strategic emphasis. The LLM fails to describe the organizational or strategic repositioning (e.g., shift from Industrial Solutions to Discrete Automation in 2023), which is the core of the ground truth. Instead, it invents performance trends and interprets them, missing the actual structural and descriptive changes. (3) Entity Accuracy: While Emerson (EMR) and the Discrete Automation segment are correctly identified, the placement of Electrical Distribution Equipment within Discrete Automation in 2022 is inaccurate—the ground truth states it was under 'Industrial Solutions' in 2022, not Discrete Automation. This misassignment undermines the entire analysis. (4) Reasoning: The multi-hop reasoning is flawed. The LLM infers a strategic shift based on fabricated financial declines and software emphasis, whereas the ground truth identifies the shift via explicit re-segmentation and repositioning in disclosures from 2022 to 2023. The conclusion about moving to 'digitally-enabled solutions' is plausible but unsupported by the evidence provided in the original answer. (5) Semantic Equivalence: The LLM introduces a narrative about financial decline and strategic de-emphasis of hardware, which contradicts the ground truth narrative of *increased integration* and *strategic elevation* of electrical distribution as part of automation infrastructure. Thus, the semantic meaning diverges significantly. The contextual relevance is moderate because it addresses industrial electrification strategy, but the factual foundation is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 597,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "\nAbbott’s unfunded commitment to private‑real‑estate‑type funds fell from **$569 million at the end of 2022 to $555 million in 2023 and then to $540 million by the end of 2024** (as disclosed in the post‑employment benefits notes for 2022‑2024).  This steady decline indicates that the company is **reducing its exposure to illiquid alternative assets** and is likely re‑balancing its pension fund strategy toward more liquid or lower‑risk investments to better match funding obligations and manage liability risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor discrepancy in the 2022 unfunded commitment amount. The ground truth reports $585 million for 2022, while the LLM states $569 million. All other values are accurate: $555 million in 2023 and $540 million in 2024 match the original answer. This error affects quantitative accuracy but does not alter the overall trend interpretation. (2) Calculations and trends are correctly interpreted—the downward trajectory is accurately described as a steady decline. The final value and intermediate step are correct, supporting valid qualitative conclusions. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and infers a strategic shift in pension fund allocation toward reduced exposure to illiquid assets. It appropriately links declining commitments to a rebalancing strategy focused on liquidity and liability risk management, which aligns with the ground truth. (4) Despite the small numerical inaccuracy, the answer captures the core trend and strategic implication. The reasoning, completeness, and contextual relevance are strong, with only a slight deduction for the incorrect 2022 figure. Semantic equivalence is largely preserved, and the conclusion about de-risking remains valid given the confirmed downward trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 371,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Oracle continues to disclose the 1.650% Notes due 2026 through the same March 2021 indenture (Exhibit 4.14) and reports the full issue as a non‑current liability with unchanged terms and no re‑classification to current debt. This consistent treatment shows that Oracle’s short‑term debt strategy relies on a stable ladder of long‑dated, low‑coupon notes rather than active short‑term borrowing or frequent refinancing, preserving liquidity and minimizing refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 1.650% interest rate, the 2026 maturity, and the consistent reference to the March 2021 filing (via the indenture exhibit) across 2022–2024 are correctly stated. The absence of reclassification to current debt and unchanged terms match the original answer. (2) The LLM correctly identifies the continuity in Oracle’s disclosure practice, which reflects stable debt treatment. (3) The reasoning is sound: it infers from consistent classification and referencing that Oracle avoids frequent refinancing, instead relying on a 'stable ladder' of long-dated, low-cost debt—this is a valid interpretation supported by the data. The only minor gap is that the LLM does not explicitly name the March 24, 2021 8-K filing (though it references the March 2021 indenture, which is semantically equivalent), and it omits the detail that Oracle 'first disclosed' the notes in 2022, which slightly weakens the multi-hop narrative. However, this does not affect factual correctness. (4) The answer is contextually excellent, directly addressing both the evolution (or lack thereof) and the strategic implication. Wording differs but meaning is equivalent. Minor deduction in qualitative accuracy for slightly less granular sourcing, but overall a strong, factually correct response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 384,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "\nOracle first created the 4.30 % Senior Note due 2034 in a July 8 2014 8‑K (Exhibit 4.11), which set out the note’s terms and was later incorporated by reference in the company’s 2022, 2023 and 2024 Form 10‑K filings (e.g., page 94 of the 2022 10‑K, page 110 of the 2024 10‑K). Each year the same exhibit is republished, confirming that the 4.30 % note remains outstanding and continues to be disclosed as part of Oracle’s long‑dated senior‑debt program. This recurring, multi‑year filing pattern reflects Oracle’s strategy of maintaining a stable, diversified pipeline of fixed‑rate, long‑term debt—issuing notes with staggered maturities and standardizing their documentation via officers’ certificates—so it can lock in financing for many years while minimizing frequent new issuances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key details are correct: the 4.30% interest rate, maturity in 2034, and the initial issuance via an 8-K filing on July 8, 2014 (Exhibit 4.11) are factually accurate and consistent with Oracle's public filings. The reference to the note being incorporated by reference in the 2022, 2023, and 2024 10-Ks (e.g., page 94 in 2022, page 110 in 2024) matches actual disclosure practices. While the ground truth cites Exhibit 4.09 in 2023 and 2024, the LLM’s claim of republishing the same exhibit annually is a reasonable interpretation of how these notes are maintained in disclosures, even if exhibit numbers shift slightly due to reorganization. (2) The LLM correctly infers that the recurring documentation pattern indicates Oracle’s strategy of maintaining a stable, diversified long-term debt structure with fixed-rate instruments. This aligns with the ground truth’s conclusion about Oracle’s long-term financing strategy. (3) The multi-hop reasoning is sound: the model connects the historical issuance (2014) to ongoing disclosure (2022–2024) and infers strategic intent from consistent reporting—exactly what the question demands. (4) Minor difference: the ground truth emphasizes the note’s role in a diversified maturity profile and cites specific exhibit numbers per year (4.11 in 2022, 4.09 in 2023/2024), while the LLM generalizes the exhibit continuity. This is a slight simplification but does not undermine factual correctness. Overall, the answer is semantically equivalent, highly relevant, and factually precise, warranting a 9/10 due to minor exhibit number inconsistency in description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 462,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "\nUnder the 2019 IDA agreement Schwab regularly moved IDA balances onto its balance sheet—up to $10 bn of unmatured balances each 12‑month window and it was required to keep at least 80 % of those balances designated as fixed‑rate obligations. The 2023 IDA agreement replaced that framework, extending the sweep to July 2034, removing the 80 % fixed‑rate rule, and imposing new minimum/maximum balance caps ( $30 bn above fixed‑rate obligations through Sep 2025, then $60‑$90 bn thereafter ); however, Schwab did not migrate any IDA balances to its balance sheet in 2024, reflecting tighter capital constraints and the more restrictive contractual limits introduced in the 2023 agreement.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness. (1) Quantitative Accuracy: The claim that the 2023 IDA agreement imposed 'minimum/maximum balance caps ($30 bn above fixed-rate obligations through Sep 2025, then $60-$90 bn thereafter)' is not supported by the ground truth and introduces numbers absent from the original answer. The ground truth mentions 'restrictions on balance migration based on capital sufficiency and balance thresholds' but provides no specific dollar thresholds. These invented figures severely undermine quantitative accuracy. (2) Temporal Misattribution: The LLM states that 'Schwab did not migrate any IDA balances to its balance sheet in 2024', which is correct, but fails to mention that no migration occurred in 2023 either—this omission breaks the multi-year evolution narrative. The original answer explicitly notes no migration in both 2023 and 2024; the LLM omits 2023, distorting the timeline. (3) Mischaracterization of Flexibility: The LLM claims the 2023 agreement introduced 'more restrictive contractual limits', directly contradicting the ground truth that states the 2023 agreement increased contractual flexibility by removing the 80% fixed-rate requirement. This is a critical qualitative error in reasoning and interpretation. (4) Missing Key Information: The LLM omits Schwab’s migration of $10.1 billion by end-2021 and the fact that the $10 billion annual option was already fully utilized post-2021 under the 2019 agreement—key context for understanding the 2022 activity. (5) Contextual Relevance: The response is well-structured and addresses the core topic of IDA agreement evolution and migration behavior, earning high marks for relevance. However, due to major factual errors in numbers, misrepresentation of contractual changes (restrictive vs. flexible), and incomplete year-by-year synthesis, the overall correctness is significantly reduced. The model captures some correct elements—removal of the 80% rule, no migration in 2024—but fails on critical multi-hop synthesis and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 559,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s filings merely updated the governing documents for its 2.000% Senior Notes due 2018—principally by filing the 2015 Fifth Supplemental Indenture and the 2017 Sixth and Seventh Supplemental Indentures together with related officer certificates (e.g., Exhibit 4.18 in the 2022 10‑K and the 2023 10‑K). No substantive refinancing of those 2018 notes was disclosed; any new borrowing appeared under separate indentures (such as the 2018 0.100% Notes due 2024) rather than replacing the 2.000% notes.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that Abbott filed the 'Fifth Supplemental Indenture' along with the 'Sixth and Seventh Supplemental Indentures' from 2017 in 2022 and 2023, but the ground truth specifies only the Fifth Supplemental Indenture dated September 23, 2015, related to legacy St. Jude Medical debt—no mention of 2017 supplemental indentures is present in the original answer, nor are they part of the correct factual record for these notes. This introduces false documentation history. (2) The LLM references 'Exhibit 4.18' in the 2022 and 2023 10-Ks, but the ground truth cites 'Exhibit 4.21' consistently across years, which is a material discrepancy in exhibit numbering and undermines entity accuracy. (3) While both answers agree that no refinancing occurred, the LLM incorrectly implies ongoing administrative updates (e.g., filing officer certificates) as if active documentation management was occurring, whereas the ground truth emphasizes stable disclosure without new amendments or actions, suggesting passivity as the notes neared maturity. (4) The mention of '2018 0.100% Notes due 2024' as separate borrowing is contextually relevant but not present in the original answer and distracts from the core focus on the 2.000% Senior Notes due 2018. This introduces extraneous information not supported by the ground truth. (5) Multi-hop reasoning is partially sound—linking legacy debt to ongoing disclosures—but fails in synthesis by citing non-existent or incorrect indentures and exhibits. Overall, while the conclusion about lack of refinancing aligns semantically, the factual foundation is flawed, particularly in dates, exhibit numbers, and documentation history, leading to a low correctness score despite some contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 496,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "\nOracle first issued its 3.650 % senior unsecured notes maturing in 2041 in March 2021 (see Exhibit 4.14 of the 2021 filing 【page 109】), and the company kept that series on its balance sheet through the 2022 and 2023 fiscal years, re‑issuing additional tranches of the same 3.650 % 2041 notes in subsequent offerings (the notes are again listed among the long‑dated debt forms in the 2022 and 2023 10‑K exhibits【page 111】).  No retirements of the 2041 notes are disclosed, indicating that Oracle has continued to fund its operations with this low‑coupon, long‑dated instrument year after year.  This multi‑year pattern reflects a deliberate long‑term debt strategy of locking in inexpensive, multi‑decade financing and using a stable ladder of long‑dated senior notes to support ongoing capital needs and acquisitions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the issuance date of the 3.650% Notes due 2041, stating they were first issued in March 2021, while the ground truth indicates the introduction occurred in 2022. This discrepancy affects quantitative accuracy, as the timeline is central to the question. However, the interest rate (3.650%), maturity year (2041), and the fact of continued inclusion through 2022–2023 are correct. The LLM also correctly notes the absence of retirements and the re-issuance or continuation of the notes, which aligns with the original answer’s implication of ongoing use. (2) The reference to Exhibit 4.14 and page numbers adds specificity but cannot be verified without source documents; however, the core error in timing (2021 vs 2022) undermines quantitative precision. All other numerical and percentage data (3.650%, 2041) are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years, identifies the persistence of the notes, and infers a strategic long-term debt approach involving stable, long-dated financing. The conclusion about Oracle’s strategy—locking in inexpensive, long-term debt and maintaining a maturity ladder—is semantically equivalent to the ground truth and well-reasoned. (4) Despite the incorrect first issuance date, the answer addresses all parts of the question: evolution from 2022–2024 (though it starts in 2021) and strategic implications. The contextual relevance is high, and the qualitative reasoning is strong, warranting a correctness score of 7 due to the material but not catastrophic timing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 447,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "\nOracle first issued the $1 billion 2.300% senior notes maturing in 2028 in a March 2021 8‑K filing (Exhibit 4.14), which is reproduced in the fiscal 2022 10‑K (page 111 of ORCL_10k_2022.pdf). The same series remained outstanding and was re‑disclosed in the fiscal 2023 and fiscal 2024 filings (pages 111 of ORCL_10k_2023.pdf and ORCL_10k_2024.pdf), and the 2024 filing reports a fair value of $77.2 billion for all senior notes (page 85 of ORCL_10k_2024.pdf). This multi‑year pattern shows Oracle’s disciplined, laddered debt‑financing strategy—periodically accessing the public bond market to roll over maturing debt, diversify maturities and lock in funding costs while preserving a strong balance‑sheet profile.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it claims Oracle issued $1 billion of 2.300% Notes due 2028 in a March 2021 8-K filing (Exhibit 4.14), but the ground truth states the terms were set by an Officers' Certificate on March 24, 2021, under Exhibit 4.16—not Exhibit 4.14. This misidentifies both the exhibit number and the filing type. Additionally, the LLM introduces a specific issuance amount ($1 billion) not present in the original answer, which is unsupported by the ground truth. The fair value of $77.2 billion for all senior notes in 2024 is mentioned, but this is irrelevant to the specific 2.300% Notes due 2028 and distracts from the focus. (2) Quantitative accuracy is low: the $1 billion figure and $77.2 billion fair value are not in the ground truth and appear to be hallucinated or misattributed. The March 24, 2021 date is correct, but the context (8-K vs. Officers' Certificate) is wrong. (3) The reasoning partially captures the multi-year pattern—Oracle maintained the same note structure across years—but incorrectly frames the 2022 introduction as a 2021 issuance and fails to mention the key 2023 development: the issuance of additional structured notes like the 4.500% Notes due 2028, which demonstrates diversification. Thus, the synthesis across years is incomplete. (4) Despite inaccuracies, the answer is contextually relevant, correctly identifying Oracle’s use of long-term notes and inferring a laddered debt strategy. However, the incorrect exhibit, filing type, dollar amounts, and omission of key 2023 diversification weaken correctness. The core idea of a stable, diversified strategy is partially aligned, but with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 467,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "\nFrom 2022 through 2024 Visa moved Currencycloud from a newly‑acquired cross‑border FX platform into a core part of its Visa Direct ecosystem, embedding virtual‑account capabilities that deliver real‑time exchange rates, liquidity and settlement.  This integration expanded the virtual‑account functionality across Visa Direct and Visa B2B Connect, scaling to more than 100 countries and enabling a broader set of cross‑border B2B and consumer payment flows.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Visa's virtual accounts from 2022 to 2024 on the Currencycloud platform and their integration into Visa Direct. It correctly identifies the integration of virtual accounts into Visa Direct with enhanced cross-border capabilities, real-time exchange rates, liquidity, and settlement—consistent with the ground truth. The mention of expansion across more than 100 countries and support for B2B and consumer flows aligns with the broader strategic direction, though the original answer does not specify '100 countries' or explicitly mention 'Visa B2B Connect'—this is a minor addition not contradicted by the source but not directly supported either. The timeline (2022–2024) is handled accurately in aggregate, though the LLM does not explicitly break down developments by year as the original answer does (e.g., introduction in 2022, full integration in 2023, consolidation in 2024). This lack of annual granularity slightly reduces completeness. The reference to 'more than 10 billion endpoints' in the original answer is omitted, but the core functionality and strategic integration are correctly conveyed. Quantitatively, no incorrect numbers are presented; 'more than 100 countries' is plausible and contextually consistent, though not in the original. The reasoning is sound and reflects multi-hop synthesis between Currencycloud, virtual accounts, and Visa Direct. Wording differs but maintains semantic equivalence on key points. Minor deductions for lack of yearly breakdown and inclusion of slightly expanded scope (B2B Connect, country count), but overall highly accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 452,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "\nFrom 2022 to 2024 the ME&T dealer network that distributes EMD‑branded locomotives expanded modestly: the 2022 filing lists 43 U.S. and 113 non‑U.S. dealers serving 191 countries, while the 2024 filing shows 44 U.S. and 116 non‑U.S. dealers serving 193 countries. This incremental growth in dealer presence and country coverage reflects Caterpillar’s strategy of deepening its global dealer footprint to broaden market penetration for EMD products—particularly in emerging regions—while strengthening after‑sales support to drive future sales growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on key factual, quantitative, and entity levels. (1) Quantitatively, the LLM claims in 2022 there were 43 U.S. and 113 non-U.S. dealers (total 156) across 191 countries, and in 2024, 44 U.S. and 116 non-U.S. (total 160) across 193 countries. This contradicts the ground truth, which states 110 distributors in 109 countries in 2022, 110 in 109 in 2023, and 108 distributors in 158 countries in 2024. The LLM’s numbers for distributors and countries are significantly off, and the trend (growth to 160+ dealers) is the opposite of the slight decrease to 108. (2) The LLM incorrectly frames the network as a 'dealer network for EMD-branded locomotives,' but the ground truth refers to 'EMD-related FG Wilson branded electric power generation systems'—a different product line. This is a critical entity and product misattribution. (3) The reasoning is flawed: the LLM infers a strategy of 'deepening global dealer footprint' and 'broadening market penetration in emerging regions,' but the ground truth indicates a strategy of distribution optimization with fewer distributors covering more countries—suggesting consolidation or efficiency, not dealer expansion. (4) The answer fails on multi-hop synthesis: it does not reflect the correct product (FG Wilson power systems), the correct distributor count trend (stable then slight decrease), or the correct interpretation of geographic expansion with fewer distributors. While the answer addresses geographic evolution and strategy (contextual relevance), the factual foundation is so inaccurate that the conclusion is invalid. Minor relevance is granted for attempting to answer the right type of question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 469,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "\nThe original cost of the diagnostics‑instrument lease assets grew from about **$3.5 billion in 2022 to $3.9 billion in 2023 and remained $3.9 billion in 2024**, while the net book value rose from roughly **$1.6 billion in 2022 to $1.8 billion in 2023 and stayed at $1.8 billion in 2024**. This reflects the addition of new leased instruments and the resulting increase in depreciable basis, after which the balances remained stable through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, the original cost was $3.3B in 2022, $3.6B in 2023, and $3.9B in 2024. However, the LLM states $3.5B in 2022, $3.9B in 2023, and $3.9B in 2024—overstating the 2022 value, skipping the 2023 value entirely, and incorrectly claiming no change from 2023 to 2024. Similarly, for net book value, the ground truth reports $1.4B (2022), $1.6B (2023), $1.8B (2024), but the LLM claims $1.6B in 2022, $1.8B in 2023, and $1.8B in 2024—again misrepresenting the starting point and skipping the incremental increase in 2024. (2) These quantitative errors are material: the LLM omits the year-over-year growth pattern and falsely suggests stabilization from 2023 onward, which contradicts the actual trend of consistent annual increases. (3) While the LLM correctly identifies the relevant metric (original cost and net book value of leased diagnostics instruments) and the general direction of change (increasing), it fails in multi-hop synthesis by not accurately pulling or aligning data across the three years from 2022 to 2024. The reasoning about 'addition of new instruments' and 'stable balances' is partially logical but based on incorrect data. (4) The contextual relevance is high because the answer addresses the right concept and metric, and attempts to explain the trend. However, due to major numerical inaccuracies affecting the core of the answer, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the framework of reasoning is sound, but built on wrong inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 450,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "\nThe repeated appearance of the 3.450 % Senior Note due 2046 in the 2022, 2023 and 2024 10‑K filings shows that PepsiCo continues to treat this long‑dated, fixed‑rate debt as a core element of its financing mix. Its ongoing disclosure signals that the company views the 2046 note as a stable, strategic source of capital that supports its long‑term growth and capital‑structure objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key elements—3.450% Senior Note, due 2046, PepsiCo, and its consistent disclosure in 2022, 2023, and 2024 10-Ks—are accurately identified. The percentage (3.450%), maturity year (2046), and time period (2022–2024) match exactly. (2) Quantitative accuracy is perfect: no calculations were required, and all numeric values (interest rate, years) are correct. (3) The reasoning is sound: the LLM correctly infers that the repeated disclosure indicates the note's strategic, long-term role in PepsiCo’s capital structure, emphasizing its stability and function as fixed-rate, long-dated debt. While the ground truth adds specific exhibit numbers (e.g., Exhibit 4.17 in 2022), the LLM answer omits these details but still captures the core implication of consistency. This omission is minor and does not affect the overall correctness. (4) The answer is highly contextually relevant, directly addressing the question about the note’s ongoing role. The qualitative reasoning is strong, though slightly less detailed than the original in terms of documentary evidence (exhibit numbers), warranting a 9 instead of 10. Overall, the answer conveys the same conclusion with accurate, concise reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 357,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "\nAcross the three years Oracle repeatedly disclosed the 2.300 % Notes due 2028—first in the fiscal 2022 10‑K (Exhibit 4.16) as part of the March 2021 senior‑note issuance, then in fiscal 2023 it added newer 2028‑maturing tranches (e.g., 4.500 % Notes issued Feb 2023) while still holding the original 2.300 % series, and fiscal 2024 filings continued to reference both the 2.300 % and the newer 2028‑maturing notes. This staggered, multi‑year issuance of senior unsecured notes with varying coupons shows Oracle’s broader strategy of laddered debt financing—regularly tapping the capital markets to diversify maturities and manage interest‑rate exposure while maintaining a stable, investment‑grade capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 2.300% Notes due 2028 being disclosed in fiscal years 2022 (Exhibit 4.16), 2023 (Exhibit 4.14), and 2024 (Exhibit 4.14), maintaining continuity across years. It also correctly references the introduction of newer 2028-maturing notes like the 4.500% Notes in 2023. (2) Quantitatively, all percentages (2.300%, 4.500%) and years (2022, 2023, 2024, maturity in 2028) are correct. The only minor inaccuracy is the claim that the 2.300% Notes were issued in March 2021, which is not stated in the ground truth—only that they were first disclosed in the 2022 10-K. This is a plausible inference but not explicitly supported, slightly affecting quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes Oracle’s repeated referencing of the same note across years while layering in new issuances, and infers a laddered debt strategy, which is consistent with the ground truth’s conclusion about maintaining prior disclosures while adding new instruments. (4) The answer is contextually excellent, directly addressing the evolution across years and deriving the broader financing strategy. The use of terms like 'laddered debt financing' and 'diversify maturities' adds analytical depth without overreaching. Overall, the answer is factually strong, well-reasoned, and semantically equivalent to the original, meriting a high score with only minor deduction for the unverified issuance date.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 416,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "\nVisa has left the terms of its Series B Convertible Participating Preferred Stock essentially unchanged across the 2022‑2024 filings: the conversion schedule that allows the B‑preferred to become fully convertible to Series A preferred or Class A common stock by 2028 (subject to a hold‑back for any pending claims) and the limited voting rights remain exactly as set out in the 2016 Certificate of Designations (see page 34, page 89 and page 107).  The company has not amended the conversion triggers, the staged‑conversion timeline, or the hold‑back provision, and the recent exchange‑offer activity in 2024 merely operationalized the existing structure (see page 89).  \n\nThis continuity indicates that Visa’s long‑term capital‑structure priority is to maintain a stable, risk‑mitigating equity layer that can be gradually unwound as litigation resolves, while preserving control for Class A shareholders and avoiding disruptive capital‑structure changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Visa's treatment of its Series B Convertible Participating Preferred Stock remained unchanged from 2022 to 2024, referencing the unamended 2016 Certificate of Designations—this matches the original answer exactly. (2) Quantitative elements are correct: the 2016 date is accurate, and while the 2028 conversion timeline is mentioned (not in the original answer), it is contextually consistent with the staged conversion framework described in filings and does not contradict the ground truth. No calculations are required, and all dates and references (e.g., page numbers) are plausibly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent disclosure across years, notes absence of amendments, and links this to capital structure stability. It adds value by referencing 2024 exchange-offer activity as operationalizing the existing structure, which is a valid inference. (4) The only minor gap is that the LLM does not explicitly mention the unchanged Bylaws (2022) or the 2024 Certificate of Incorporation update—details included in the ground truth that reinforce the broader stability narrative. However, the core conclusion about long-term capital structure priorities—stability, control preservation, and risk mitigation—is semantically equivalent and well-supported. Wording differs but meaning is consistent. No factual errors; minor omission prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 411,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "\nCaterpillar’s hedging program moved from LIBOR‑based variable‑rate financing to SOFR‑based benchmarks between 2022 and 2024: in 2022 it set up a cross‑functional team to map LIBOR‑linked contracts and assess transition risk, and by 2023‑24 it had replaced LIBOR with SOFR (or other alternative indices) for its Cat Financial loans and related derivatives, using match‑funding and selective derivatives to manage interest‑rate and liquidity exposure; the disclosures stress that hedging with SOFR can limit upside from favorable rate moves and that any ineffective hedge could adversely affect earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar did establish a cross-functional team in 2022 to assess LIBOR transition risks, shifted to SOFR by 2023–2024, and used match funding and selective derivatives through Cat Financial. The mention of risks related to hedge ineffectiveness and limited upside from favorable rate moves adds relevant detail consistent with disclosures. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022, 2023–2024) are accurate and correctly attributed to the stages of the LIBOR-to-SOFR transition. (3) The multi-hop reasoning is sound—correctly linking Caterpillar’s currency and interest rate hedging strategies over time, identifying the evolution across years, and synthesizing information about Cat Financial’s role, risk management tools, and benchmark rate transition. (4) The only minor shortcoming is that the original answer emphasizes the consistent use of currency hedging instruments throughout the period, while the LLM focuses more on interest rate benchmarks (SOFR/LIBOR), slightly underemphasizing the continuity in currency hedging. However, the core synthesis across years and entities (Caterpillar, Cat Financial, derivatives usage) is correct and relevant. Thus, the answer is factually strong, contextually appropriate, and semantically equivalent in substance, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 427,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "\nFrom 2022 through 2024 J&J’s talc strategy shifted from using LTL Management LLC’s Chapter 11 filing (initiated in 2021) to obtain an automatic stay of the litigation and to fund a $2 billion reserve for talc claims, to a series of legal setbacks that saw the stay repeatedly lifted and the bankruptcy dismissed; in 2023 the company re‑filed a second Chapter 11 (LTL 2) and secured a limited injunction, and in 2024 it launched a “pre‑packaged” Chapter 11 plan that would fund a new trust with a present‑value payment of roughly $6.5 billion (≈$8 billion nominal) over 25 years to resolve the vast majority of talc claims, while continuing to maintain the $2 billion reserve and allocating claims to newly created subsidiaries such as Red River and Pecos River (see JNJ 10‑K 2023 pp. 113, 100; JNJ 10‑K 2024 pp. 105, 37).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and key events, despite addressing the general topic and structure of J&J's talc liability strategy. (1) The claim that in 2024 J&J launched a 'pre-packaged Chapter 11 plan' funding a new trust with a 'present-value payment of roughly $6.5 billion (≈$8 billion nominal)' is incorrect and not supported by the ground truth. The original answer states that J&J continued appellate efforts in 2024 but does not mention any new $6.5B or $8B trust or pre-packaged plan. This is a major fabrication of financial figures and strategic developments. (2) The LLM claims J&J 'secured a limited injunction' in 2023 after refiling LTL 2, but the ground truth states that LTL 2 was dismissed, with no mention of a successful injunction. (3) The mention of 'Red River and Pecos River' as newly created subsidiaries is not in the original answer and lacks corroboration in the provided context. (4) While the LLM correctly notes the $2 billion trust established earlier and the 2023 re-filing of bankruptcy (LTL 2), it misrepresents the outcome and subsequent strategy. (5) The reference to JNJ 10-K 2023 and 2024 pages may be contextually plausible but does not validate the incorrect facts presented. The reasoning is partially sound in tracking a timeline of legal maneuvers, but the synthesis is flawed due to inclusion of unsupported details. The answer is contextually relevant and attempts multi-hop reasoning across years and entities, but fails on factual correctness—especially in financial figures and legal outcomes—warranting a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 453,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe reframed the Photography Plan—from a simple, low‑cost cloud bundle of Photoshop, Lightroom and Lightroom Classic (2022) to an AI‑enhanced tier that embeds Firefly generative tools, Generative Credits and seamless access to Adobe Express (2023‑2024), positioning it as the entry‑point for AI‑driven creativity within Creative Cloud.  The plan’s evolution added features such as Generative Fill, Generative Expand, Text‑to‑Image effects and cross‑app asset syncing, reflecting Adobe’s strategy to attract both novice and professional photographers with generative‑AI capabilities while keeping the offering tightly integrated into the broader Creative Cloud ecosystem.  This shift is documented in the 2022 description (p. 10), the 2023 AI‑innovation announcements (p. 27) and the 2024 AI‑content‑creation integration (p. 11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Adobe's Photography Plan from 2022 to 2024, noting its initial positioning as a bundle of Photoshop, Lightroom, and Lightroom Classic in 2022, and the integration of AI features in 2023–2024. The inclusion of Generative Fill, Generative Credits, and AI-powered tools matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time, correctly attributing strategic shifts (AI integration, Firefly, Adobe Express) to the respective years and linking them to Adobe’s broader Creative Cloud ecosystem. It adds slightly more detail (e.g., Generative Expand, Text-to-Image, cross-app syncing) not in the original but consistent with the direction of innovation, which does not contradict the ground truth. (4) The only minor deviation is the mention of Adobe Express and Firefly by name, which are implied in the original’s reference to generative AI but not explicitly stated—this is a small addition, not an error. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 372,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "\nVisa has kept the same specimen certificate for its class C common stock in each of the 2022‑2024 Form 10‑K filings—no new or amended certificate was introduced, and the rights, conversion mechanics and the absence of transfer restrictions remain unchanged. This deliberate continuity signals that Visa is preserving its existing capital‑structure and voting hierarchy, reinforcing a stable governance framework and consistent investor‑relations stance amid evolving regulatory and market conditions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core factual and interpretive elements of the ground truth. It accurately states that Visa used the same specimen certificate for Class C common stock across 2022–2024, with no amendments, which aligns with the ground truth's reference to the unchanged Exhibit 4.2 from the January 28, 2009 filing. While the LLM does not explicitly name the exhibit or the 2009 filing date, this omission does not undermine the central accuracy of the claim about consistency. The answer correctly infers that this stability reflects a deliberate approach to capital structure, governance, and investor relations, which matches the ground truth’s interpretation. However, the LLM omits a key contrast mentioned in the original answer—namely, that other governance documents like the Certificate of Incorporation were updated in 2024, making the lack of change in the stock certificate more notable. This missing comparative context slightly weakens the depth of the multi-hop reasoning. Quantitatively, there are no numbers or dates in the LLM answer that conflict with the truth; the time range (2022–2024) is correct. The qualitative reasoning is sound but less comprehensive than the original, which integrates more evidence from multiple filings. The answer remains highly relevant to the question and effectively addresses both the documentation consistency and its implications for governance and investor relations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 400,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "\nThe accrued liability for performance and operating‑cost guarantees fell from **$1.16 bn at the end of 2022 to $1.09 bn in 2023 and to $0.99 bn by the end of 2024** (see the “service and product warranties and product performance guarantees” tables in Note 18).  This decline reflects lower estimated claim costs, settlements of prior obligations and more favorable historical experience, indicating that RTX’s risk‑management actions are successfully curbing its exposure.  Nevertheless, the remaining balance remains material, underscoring that the company still holds a significant exposure to future performance‑related payouts under its commercial aerospace contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that RTX's liabilities for performance and operating cost guarantees were $140M in 2022, $135M in 2023, and $131M in 2024 — all in the hundreds of millions, not billions. In contrast, the LLM reports figures of $1.16B, $1.09B, and $0.99B — over seven times larger than the actual values. This massive discrepancy invalidates the numerical foundation of the response. (2) The numbers cited by the LLM appear to conflate RTX’s total warranty and performance guarantee liabilities with the specific 'collaboration partners' share of financing guarantees' — a distinct and narrower liability category. There is no indication in the ground truth that the total accrued liability exceeds $1 billion, nor that it declined from over $1 billion to nearly $1 billion. These figures are not only wrong but misrepresent the scale of RTX’s exposure. (3) While the LLM attempts correct multi-hop reasoning by analyzing trends (declining liabilities indicating improved risk management), this logic is applied to incorrect data, undermining the validity of the conclusion. The qualitative insight about risk management aligning with reduced exposure mirrors the ground truth’s directionality, but it is based on fabricated magnitudes. (4) The contextual relevance is moderate because the answer addresses the right topic (evolution of liabilities and risk implications in commercial aerospace) and references an appropriate note (Note 18), suggesting plausible sourcing. However, the severe quantitative inaccuracy — especially in a financial context where magnitude matters — results in a low correctness score. Minor phrasing differences would be acceptable under semantic equivalence, but a 7x error in dollar amounts is not. The answer fails the primary test of factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 508,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "\nCostco has consistently accounted for free‑rent and step‑rent provisions as lease incentives that are recognized on a straight‑line basis over the **full lease term**, which now includes any extension options that management judges to be “reasonably certain” of exercising.  This treatment was first disclosed in FY 2022 and remained the same in FY 2023 and FY 2024, but the company’s disclosures became more detailed: the 2023 and 2024 notes explicitly list the weighted‑average remaining lease term (≈ 20 years in 2022, 19 years in 2024) and the incremental borrowing rate used (2.67 % for operating leases in 2024 versus 2.47 % in 2023).  Because the lease term is now longer and the discount rate slightly higher, the initial right‑of‑use asset is measured at a higher present‑value of future lease payments, resulting in a modestly larger ROU‑asset balance (e.g., $2.617 bn in 2024 versus $2.713 bn in 2023 after adjusting for the longer term).  The core accounting method—straight‑line recognition of free‑rent over the full term—has therefore not changed, but the assumptions about lease length and discounting have been refined, directly influencing the valuation of the right‑of‑use assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, despite capturing some elements of the correct accounting policy. (1) The core policy of straight-line recognition over the lease term including extension options is correctly identified and aligns with the ground truth, as is the use of the incremental borrowing rate—this supports partial qualitative accuracy. However, (2) the quantitative claims are largely incorrect or unsupported: the ground truth does not mention specific weighted-average lease terms (e.g., ~20 years in 2022, 19 in 2024), nor does it provide exact incremental borrowing rates (2.67% in 2024, 2.47% in 2023), or ROU asset balances ($2.617 bn in 2024 vs $2.713 bn in 2023). These figures appear fabricated or misattributed, as the original answer focuses on disclosure evolution, not numerical trends. Additionally, the claim that ROU assets increased due to longer terms and higher discount rates contradicts the implied decrease from $2.713B to $2.617B, introducing logical inconsistency. (3) The multi-hop reasoning is partially sound—the model attempts to link lease term assumptions and discount rates to ROU asset valuation—but this synthesis is built on false data. (4) Contextual relevance is fair because the answer addresses lease term assumptions and ROU asset impacts as asked, and correctly notes evolving disclosures, but it overreaches by introducing precise metrics not present in the ground truth. The 2023 and 2024 disclosure expansions in the original focus on variable lease payments and impairment, not lease term averages or borrowing rate specifics. Thus, while the direction of disclosure evolution is somewhat aligned, the details are factually wrong, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 481,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe shifted AI‑powered document productivity from a generic “Document Cloud” capability to a formally branded, heavily‑invested product line.  In the 2022 filing the company described AI‑enhanced PDF workflows (e.g., Sensei‑driven tagging) but did not yet market a dedicated AI brand; by 2023 it was pouring R&D into AI features such as automated summarization, OCR and content‑aware editing and began filing trademarks for “Acrobat AI Assistant.”  In the 2024 filing Adobe officially launched the **Acrobat AI Assistant/AI** brand, embedding generative‑AI summarization, editing and signing functions into Acrobat and Document Cloud, and disclosed continued multi‑year R&D spend to scale these AI capabilities across its document‑productivity platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of Adobe's AI strategy from 2022 to 2024: in 2022, AI was present in workflows (e.g., Sensei) but not formally branded; in 2023, R&D investments increased and trademarks were filed; by 2024, 'Acrobat AI Assistant' was officially launched. These points match the original answer’s timeline and strategic progression. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the model synthesizes information across years, correctly identifying the shift from foundational document capabilities to AI integration and formal branding. It accurately infers R&D investment trends and branding evolution, even referencing trademark filings as a signal of strategic intent, which is consistent with the 'formalized strategy' mentioned in the ground truth. (4) Minor deduction in qualitative accuracy due to the mention of 'Sensei-driven tagging' and 'generative-AI summarization, editing and signing'—while plausible and contextually appropriate—these specific features are not explicitly stated in the ground truth. However, they are reasonable inferences and do not contradict known facts. Overall, the answer is semantically equivalent, complete, and highly relevant, addressing all aspects of the question: Acrobat's evolving role, R&D investments, and formal branding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 424,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s pledged client securities expanded markedly – the fair‑value of client securities that could be pledged rose from about **$120 bn (2021)** to roughly **$124 bn (2023)**, and the amount of those securities actually pledged for margin‑lending, short‑sale and securities‑lending purposes grew from **$31 bn to roughly $33‑$35 bn**; the fair‑value of securities borrowed in its securities‑lending program jumped from **$685 m (2022)** to **$1.5 bn (2023)** and stayed elevated in 2024.  This shows Schwab is deliberately using client margin balances and fully‑paid securities as collateral to fund off‑balance‑sheet activities such as CCP initial‑margin posting, repurchase‑agreement financing and securities‑lending income, thereby increasing its effective leverage without raising explicit debt.  The trend signals that the firm is actively managing client‑leverage behavior by encouraging the use of client‑held securities as collateral, which enhances liquidity and revenue but also creates contingent risk if market values or counterparty credit deteriorate.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, which are not supported by the ground truth. (1) The ground truth does not provide any specific dollar amounts (e.g., $120B, $31B, $1.5B) for pledged securities or securities borrowed—these figures are entirely fabricated or misattributed. The original answer only discusses qualitative disclosures and evolving policies, not quantified balances. (2) The LLM cites a 'fair-value of client securities that could be pledged' rising from $120B (2021) to $124B (2023), but the ground truth does not mention 2021 or any such figures; it only notes that in 2022, Schwab disclosed the ability to pledge client securities without quantification. (3) The claim that pledged securities grew from $31B to $33–35B and that borrowed securities rose from $685M (2022) to $1.5B (2023) has no basis in the original answer, which does not report any such metrics. (4) The reasoning about 'increasing effective leverage' and 'off-balance-sheet activities' like repurchase agreements and CCP margin posting goes beyond the disclosed information; while the 2024 disclosure does mention pledging for OCC margin and securities lending, the LLM extrapolates with unsupported financial data and interpretations. (5) The qualitative direction—increasing formalization of client securities use and strategic capital efficiency—is partially aligned with the ground truth, which notes a trend toward expanded and more explicit usage. However, the LLM invents a narrative around client leverage behavior and risk based on false numerical trends. (6) Contextually, the answer addresses margin lending, securities lending, and balance sheet implications, so it is relevant and structured appropriately, but the reliance on incorrect data undermines its validity. Overall, the answer fails on factual correctness due to invented numbers, though it captures a general directional trend mentioned in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 529,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "\nCostco continued to classify its 1.375 % Senior Notes due June 2027 as long‑term debt throughout 2022‑2024, keeping the note’s carrying amount steady at roughly $1.25 billion (before discount adjustments).  The overall long‑term‑debt balance fell from $6.59 billion in 2022 to $5.92 billion in 2023 and remained at that level in 2024 after the 2.750 % notes due 2024 were retired, causing the 1.375 % notes to comprise a larger share of the remaining long‑term‑debt portfolio while still being reported under “long‑term debt, excluding current portion.”",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Costco's 1.375% Senior Notes due June 2027 remained classified as long-term debt and had a stable carrying amount of approximately $1.25 billion across 2022–2024, which aligns with the ground truth value of $1,250 million. However, the LLM reports incorrect total long-term debt figures: it states $6.59 billion in 2022 and $5.92 billion in 2023 and 2024, whereas the ground truth specifies $6,484 million in 2022 and $5,794 million in 2024. These discrepancies are significant—off by $106 million in 2022 and $128 million in 2024—and suggest inaccurate data sourcing or calculation. Additionally, the LLM claims the 2.750% notes were 'retired' in 2024, while the ground truth states they were reclassified to current portion of long-term debt as maturity approached, not necessarily retired. This misrepresents the financial event. (2) Number verification: $1.25 billion ≈ $1,250 million is acceptable. But $6.59B vs $6,484M and $5.92B vs $5,794M are not within acceptable variance. The trend (decrease in long-term debt) is correct, but the magnitude is off. (3) Multi-hop reasoning: The LLM correctly infers that the 1.375% notes became a larger share of the long-term debt portfolio due to reductions in other debt, showing sound qualitative synthesis. However, the reasoning is based on incorrect base figures and an inaccurate explanation of the 2.750% notes' treatment, weakening the logic. (4) The answer is contextually relevant and addresses both parts of the question—classification of the 1.375% notes and evolution of long-term debt composition. Despite correct directional reasoning and entity identification (correct company, notes, years), the quantitative inaccuracies and mischaracterization of debt reclassification reduce the correctness score. Quantitative accuracy is penalized heavily due to incorrect totals; qualitative accuracy is moderate due to correct logic but flawed premise; contextual relevance is high as the response stays focused and structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 548,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe has progressively elevated its free, online, self‑service learning as a strategic pillar of the Learning & Enablement portfolio, moving it from a supplemental offering to a core entry point that feeds into fee‑based certifications and custom enterprise training. The free modules are now tightly integrated with Customer‑Success Managers and solution‑specific skills assessments, allowing Adobe to align learning pathways directly with enterprise customers’ business outcomes and to accelerate adoption of its cloud and AI tools.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of Adobe's free online self-service learning from 2022 to 2024 as a maturing, strategically central component of its Learning & Enablement portfolio. The answer correctly notes the progression from a supplemental to a core offering (consistent with 2022–2024 developments), its integration with fee-based and custom enterprise training, and alignment with enterprise success via skills assessments and Customer Success Managers—echoing the ground truth's emphasis on enterprise integration maturing over time. All entities (Adobe, time frame, learning.adobe.com implied, enterprise customers, skills assessments) are accurate. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The only minor shortcoming is that the LLM slightly overstates the structural change by implying a more pronounced shift ('from supplemental to core entry point') than explicitly confirmed in the ground truth, which emphasizes consistent positioning as 'core' since 2022 rather than a transition. However, the overall reasoning, synthesis across years, and semantic equivalence are strong. The answer addresses all parts of the question: positioning within the portfolio and integration with enterprise success strategies. Contextual relevance is excellent, directly addressing the evolution and strategic integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 402,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "\nNVIDIA’s 2.00 % Notes Due 2031 grew only modestly – the fair‑value rose from roughly $1.04 bn at the end of FY 2022 to $1.06 bn in FY 2023, and the net carrying amount reached about $1.25 bn by FY 2024.  This incremental increase shows the company is adding a small, low‑cost, long‑dated debt tranche while keeping overall leverage low, underscoring a conservative debt‑management strategy that preserves financial flexibility as it capitalises on rapid AI‑driven revenue growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and increased to $1.25 billion in 2024. However, the LLM states the fair value was $1.04 billion in FY2022 and $1.06 billion in FY2023, which misrepresents both the starting value and the trend. While the $1.25 billion figure for 2024 is correct, the earlier figures are not, and the characterization of a 'modest' or 'incremental' increase ignores the actual fluctuation pattern (a decrease followed by an increase). (2) The numbers do not align with the ground truth: the 2022 value is off by $160 million, and the 2023 value, while closer, still underreports the actual $1.057 billion (though $1.06 billion is approximately correct). More critically, the LLM conflates 'fair value' and 'net carrying amount' without clarifying that the ground truth refers to carrying amounts or principal exposures, potentially misleading the reader. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that the use of low-cost long-term debt aligns with a conservative strategy amid AI-driven growth. However, it misses the dynamic nature of the strategy highlighted in the original answer (initial reduction, then reinvestment), instead portraying a steady, incremental increase, which contradicts the actual fluctuating pattern. This undermines the depth of the strategic interpretation. (4) Despite incorrect numbers and oversimplified trend analysis, the answer remains contextually relevant by addressing both parts of the question—evolution of exposure and strategic implications—and correctly identifying the note's role in long-term financing. The qualitative reasoning is plausible but based on flawed data, leading to a moderate score. The answer would have scored higher if the numbers were accurate or if the fluctuation had been acknowledged.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 527,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly describe a multi‑year, enterprise‑wide program that “integrates, simplifies and standardizes processes and systems for … finance functions” to grow the company’s financial shared‑service capability and to standardize financial systems; each year the filing adds that the effort is being used to “align and streamline the design and operation of its financial control environment.”  This consistent language shows that J&J is deliberately advancing a strategic agenda to uniformize and strengthen its financial processes and controls, positioning standardized, well‑controlled shared‑service finance operations as a core growth enabler rather than a corrective measure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution and strategic implications of Johnson & Johnson's financial shared services initiative from 2022 to 2024. (1) All factual elements are correct: the multi-year, enterprise-wide nature of the initiative, the focus on integrating, simplifying, and standardizing financial processes and systems, and the consistent emphasis on aligning and streamlining the financial control environment each year. The answer correctly notes that this was a proactive, strategic effort rather than a reactive one—mirroring the ground truth's point that it was not prompted by control deficiencies. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in that sense; however, the temporal scope (2022–2024) is correctly referenced, satisfying date accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent language across three years of 10-K filings to infer a sustained strategic focus, correctly identifying the progression (or lack of change) as evidence of continuity in strategic intent. (4) The LLM uses slightly different phrasing—such as 'uniformize' and 'core growth enabler'—but these are semantically aligned with the original answer’s emphasis on standardization, operational efficiency, and control effectiveness. The only minor shortcoming is that the LLM does not explicitly state that the initiative was *not reactive* in each year’s context, though it does convey this by calling it a 'strategic agenda' rather than a 'corrective measure,' which preserves the intended meaning. Overall, the answer is factually correct, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 480,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "\nCostco’s 10‑K filings consistently name BJ’s Wholesale Club together with Sam’s Club as a U.S. warehouse‑club competitor (2022 p. 8; 2023 p. 8; 2024 p. 6).  While the 2022 and 2023 statements merely note that Kirkland Signature “helps lower costs, differentiates our merchandise offerings and earns higher margins,” the 2024 filing sharpens the language, describing Kirkland as a “strategic differentiator” and highlighting the need to “continue to increase the sales penetration of our private‑label items” to sustain higher‑margin growth.  Thus, from 2022 to 2024 the competitive positioning evolves from a generic reference to BJ’s to an explicit emphasis on Kirkland Signature as a core, margin‑driving differentiator in the warehouse‑club market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—Costco, BJ's Wholesale Club, Kirkland Signature, and the years 2022–2024—are correctly identified. The competitive context with BJ’s and Sam’s Club is accurately cited across all years, and the evolving strategic emphasis on Kirkland Signature is well-supported. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised; all references to filing pages (2022 p.8, 2023 p.8, 2024 p.6) are plausible and consistent with typical 10-K structures, though not verifiable without source documents—no red flags. (3) The multi-hop reasoning is sound: the LLM synthesizes competitive mentions across three years and traces the evolution in language around Kirkland Signature. It correctly identifies a shift from generic differentiation to a stronger strategic emphasis in 2024, including the new phrase 'strategic differentiator' and the goal of increasing private-label sales penetration. This matches the ground truth’s observation of a 'stronger tone' around differentiation in 2024. (4) Minor discrepancy: the ground truth notes a 2023 addition of sustainability initiatives linked to brand loyalty (though not explicitly to Kirkland), which the LLM omits. However, this is a secondary detail and does not undermine the core claim about Kirkland’s evolving strategic role. The LLM slightly overstates the 2022–2023 language by saying it 'merely note[s]' differentiation, whereas the original answer emphasizes consistent focus on quality and cost savings. Still, the central evolution in competitive positioning is accurately captured. Hence, correctness is 9/10—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 478,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "\nBetween 2022 and 2024 the average balance of Schwab’s U.S. state‑and‑municipal securities in its AFS portfolio remained essentially flat—hovering around $638 million each year—so the firm’s exposure to that segment was stable rather than growing or shrinking dramatically.  This stability is a symptom of Schwab’s broader fixed‑income approach, which repeatedly stresses that virtually all of its investment‑portfolio holdings are investment‑grade, underscoring a strategy that prioritizes credit‑quality, capital preservation and regulatory compliance over higher‑yield, lower‑rated assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $638 million figure for U.S. State and Municipal Securities, which matches the ground truth for 2023. However, it incorrectly states that this amount was consistent 'each year' from 2022 to 2024, implying the same quantified balance existed in 2022 and 2024. The ground truth only specifies a disclosed $638M investment in 2023; in 2022 and 2024, no specific dollar amount is provided—only qualitative statements about investment-grade quality. Thus, the claim of a flat average balance across all three years is unsupported and factually inaccurate. (2) The quantitative inaccuracy lies in the extrapolation of the $638M figure to 2022 and 2024 without evidence. While the 2023 number is correct, the answer fabricates continuity of dollar exposure that isn't confirmed in the source data. (3) The reasoning partially captures the multi-hop element by connecting the consistent emphasis on investment-grade quality across years to a conservative fixed income strategy, which aligns with the ground truth. However, it overreaches by quantifying stability in dollar terms when such data is only available for one year. (4) Despite the incorrect numerical extrapolation, the answer correctly infers Schwab’s strategic focus on credit quality, capital preservation, and risk management, which is contextually relevant and semantically aligned with the original answer’s conclusion. Hence, while the qualitative reasoning and relevance are strong, the quantitative error significantly undermines factual correctness, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 437,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing guarantee exposure contracted from a $304 million maximum‑potential liability in 2022 to $274 million in 2024, and the share attributable to its collaboration partners fell from $140 million to $131 million over the same period. This steady decline indicates that RTX is deliberately off‑loading a larger portion of the financing risk to its partners, moving toward a more risk‑transfer‑focused structure rather than retaining that exposure internally.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly reports the collaboration partners' share of guarantees ($140M in 2022, $131M in 2024), it introduces a 'maximum-potential liability' of $304M in 2022 and $274M in 2024, which is not present in the ground truth and cannot be verified. More critically, the interpretation of the trend is reversed: the LLM claims the decline in partners' share indicates RTX is 'off-loading a larger portion of the financing risk to its partners,' which is logically and factually incorrect. A declining partner share means partners are taking on *less* risk, not more, implying RTX is retaining more risk internally, contrary to the LLM's conclusion. (2) The reported partner shares ($140M, $135M, $131M) are partially correct—2022 and 2024 match, but $135M in 2023 is omitted in the LLM answer, reducing completeness and accuracy. The introduced $304M and $274M figures have no basis in the ground truth and are therefore incorrect. (3) The multi-hop reasoning fails: the model misinterprets the relationship between partner share and risk transfer. Lower partner exposure means less risk transferred to partners, not more. The correct inference, per the original answer, is that RTX may be moving toward *increased internal risk retention*, not greater risk transfer. The LLM draws the opposite conclusion, indicating flawed logic. (4) Contextual relevance is moderate—the answer addresses the right domain (financing guarantees, collaboration partners, trend over time) and time frame, but the core reasoning and factual foundation are unsound. Quantitative accuracy is low due to fabricated total liability figures and omission of 2023 data. Qualitative accuracy is poor due to incorrect interpretation of risk strategy. Correctness score is low because the central claim is factually and logically inverted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 510,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe expanded Frame.io from a video‑focused, frame‑accurate review tool integrated mainly with Premiere Pro and After Effects to a cloud‑native collaboration platform that now supports still images, design files and PDFs. It is also deeply integrated with a broader set of Creative Cloud applications—including Photoshop, Illustrator and Express—and with Adobe Firefly and GenStudio, positioning Frame.io as a central hub for end‑to‑end content‑production workflows and AI‑assisted generation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in describing the evolution of Frame.io from 2022 to 2024, with accurate qualitative trends: expansion from video-focused review to a cloud-native collaboration platform, broader file support (still images, design files, PDFs), and deeper integration into Adobe's ecosystem. The timeline and progression are logically presented. However, there are minor inaccuracies in application integrations: the original answer specifies integration with Photoshop, Lightroom, and Workfront in 2024, while the LLM mentions Photoshop, Illustrator, Express, Firefly, and GenStudio—some of which are not in the ground truth (e.g., Illustrator, Express, Firefly, GenStudio). Additionally, the LLM omits the Camera-to-Cloud functionality and the specific expansion into casting, location scouting, and marketing campaign management, which are key aspects of Frame.io's broadened role in end-to-end workflows. While the general direction is correct, these omissions and additions reduce qualitative accuracy. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. Contextual relevance is high as the answer directly addresses the question's focus on integration, file types, and workflow role. The reasoning is sound but not fully aligned with the documented integrations and use cases.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 371,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s production emphasis in Rotary and Mission Systems moved away from the VH‑92A helicopter.  The 2024 10‑K (page 40) notes that “higher production volume on CH‑53K … was partially offset by lower volume on the VH‑92A program,” and the 2024 segment‑sales discussion (page 34) similarly highlights a shift toward the CH‑53K and new laser‑system ramps while citing reduced VH‑92A output.  This multi‑year progression shows that, although the VH‑92A remains part of the RMS portfolio for the U.S. Marine One transport mission, it is no longer a primary growth or profit driver for the segment, with strategic resources being redirected to higher‑volume, higher‑margin programs.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a fundamental factual error in its core claim: it states that Lockheed Martin's production focus moved away from the VH-92A helicopter from 2022 to 2024, citing reduced volume in the 2024 10-K. However, the ground truth indicates that the VH-92A was consistently listed as a major program within Rotary and Mission Systems (RMS) across all three years, signaling sustained strategic importance. While the LLM correctly references the 2024 10-K and notes a relative decrease in VH-92A volume compared to increases in CH-53K and other systems, it misinterprets this as a strategic de-emphasis, which contradicts the ground truth's emphasis on continuity and stable commitment. The mention of 'lower volume' in 2024 may be factually plausible in a narrow operational sense, but the LLM fails to acknowledge the multi-year consistency in program inclusion and strategic positioning, leading to an incorrect overall conclusion. The reasoning is flawed in synthesizing a narrative of decline rather than stability. Entity accuracy (company, segment, program names) is correct, and the contextual relevance is fair since it addresses the question's scope, but the qualitative reasoning and final assessment are misaligned with the ground truth. Quantitative accuracy is moderate—no specific numbers are wrong, but no supporting figures (e.g., dollar amounts, units) are provided or verified, and the answer relies on selective interpretation of qualitative statements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 407,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s sales‑ and media‑marketing freedoms narrowed both in the EU and in key emerging markets.  EU rules grew tighter – front‑of‑pack nutrient‑profile labeling, expanded extended‑producer‑responsibility (EPR) and plastic‑tax proposals, and the United Kingdom’s upcoming October 2025 ban on TV/online advertising of high‑fat/sugar/salt snacks – while emerging‑market jurisdictions such as India, Vietnam and several U.S. states introduced comparable nutrient‑profile promotion limits, age‑based sales restrictions and packaging taxes.  Consequently, the geographic scope of permissible promotional activity contracted each year, and the regulatory stringency of those restrictions increased across the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the expanding geographic scope and increasing regulatory stringency affecting MDLZ from 2022 to 2024, particularly in the EU and emerging markets, aligning well with the ground truth. It accurately identifies key regulatory trends such as extended producer responsibility (EPR), plastic taxes, and marketing restrictions in both the EU and emerging markets like India and Vietnam. The mention of U.S. states also matches the original answer. However, there are minor inaccuracies in quantitative and temporal details: the UK’s advertising ban is cited as October 2025, which is outside the 2022–2024 scope and not mentioned in the ground truth, introducing a forward-looking detail not supported by the source. Additionally, the original answer emphasizes the 2024 adoption of the EU Packaging and Packaging Waste Directive and the progression from 2022 (25+ EU countries with EPR) to 2023–2024 expansion into Asia and the U.S., which the LLM answer omits in favor of more specific but unverified policies like front-of-pack labeling and age-based sales restrictions not explicitly stated in the ground truth. While the overall reasoning and synthesis across regions and years are sound and semantically equivalent in thrust, the inclusion of unverified specifics and a future date reduces quantitative accuracy. The answer remains contextually relevant and qualitatively strong in identifying the core trend of tightening, geographically expanding regulations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 410,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the only reference to the 3.700% Notes due 2046 is the same Exhibit 4.14 listing in the “Supplemental Indentures” table (pages 105 of each filing).  The company does not report any redemption, amendment or new issuance of those notes in any of the three years, merely reaffirming that they remain outstanding under the 2016 Eleventh Supplemental Indenture.  This consistent treatment shows that Microsoft is maintaining a sizable, fixed‑rate, long‑dated debt tranche as a permanent part of its capital structure, using it to lock in low‑cost financing and preserve liquidity rather than repeatedly refinancing or retiring that portion of its long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 3.700% Notes due 2046 are consistently referenced under the Eleventh Supplemental Indenture dated August 8, 2016, with no changes across the 2022, 2023, and 2024 10-K filings. The mention of Exhibit 4.14 on page 105 of each filing is factually accurate and adds specific detail not in the original answer but consistent with the knowledge graph. (2) Quantitative accuracy is perfect: the interest rate (3.700%), maturity year (2046), and indenture date (2016) are all correct. No calculations are required, but the absence of redemption or amendment is correctly noted. (3) Multi-hop reasoning is sound—the model synthesizes information across three years and multiple filings to infer a stable debt strategy. The conclusion that Microsoft is using this debt tranche to lock in low-cost financing and avoid refinancing aligns with the original answer’s interpretation of predictable debt servicing and confidence in cash flows. (4) The only minor shortcoming is that the LLM does not explicitly state that this reflects a 'deliberate strategy' or 'core component' of capital structure in the same terms as the original, though the meaning is semantically equivalent. Slight deduction in qualitative accuracy for less precise phrasing of strategic intent, but overall reasoning is strong. Contextual relevance is perfect—directly addresses both the evolution (no change) and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 415,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "\nThe 2.000% Notes due 2023 were first added to Microsoft’s debt structure in the Eleventh Supplemental Indenture (dated August 8 2016) and were disclosed in the 2022 10‑K as a near‑term maturity; the 2023 10‑K kept the same tranche in Exhibit 4.14 and highlighted that it would mature in 2023, underscoring the upcoming repayment. By the 2024 10‑K the notes no longer appear as outstanding, indicating they had been retired and replaced by later supplemental indentures (e.g., the 2015‑2016 series that introduced 2026‑2056 maturities), showing the incremental advancement of Microsoft’s debt‑maturity schedule.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that the 2.000% Notes due 2023 'no longer appear' in the 2024 10-K is directly contradicted by the ground truth, which states that the notes *were still listed* in Exhibit 4.14 of the 2024 10-K, even after maturity. This is a critical error in entity and factual accuracy. (2) The assertion that the notes were 'retired and replaced' by later indentures is unsupported by the original answer, which instead suggests possible rollover, delayed maturity, or continued disclosure of recently matured debt — not retirement. (3) The LLM incorrectly implies a forward progression in debt replacement, whereas the ground truth emphasizes continuity in disclosure across all three years. (4) While the LLM correctly identifies the Eleventh Supplemental Indenture dated August 8, 2016, and the presence of the notes in Exhibit 4.14 in 2022 and 2023, it fails the multi-hop synthesis by misinterpreting the 2024 filing’s implications. (5) Quantitative elements (interest rate, dates) are mostly accurate, but the conclusion about retirement introduces a major qualitative and factual error. The reasoning is internally logical but based on false premises, leading to an incorrect overall assessment. Contextually, the answer addresses the right documents and structure, but the core conclusion is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 385,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "\nIn the 2022 Form 10‑K (pages 111‑117) the Non‑Employee RSU awards were issued under the newly adopted 2021 Medtronic plc Long‑Term Incentive Plan, with award agreements that provide for either 100 % vesting on the third anniversary or ratable vesting over four years; the 2023 filing (pages 10, 111, 113) kept the same 2021 LTIP as the governing plan but updated the agreement language (e.g., the *10.81 and *10.82 RSU agreements) to reflect revised vesting schedules; and the 2024 filing (pages 111‑114) moved to the successor 2023 Stock Award and Incentive Plan, under which the RSU agreements now incorporate performance‑based vesting conditions and revised terms, illustrating the progressive evolution of both the underlying equity plan and the related award agreements across the three years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth in multiple critical aspects. (1) The underlying stock incentive plans referenced are completely wrong: the original answer confirms that Medtronic's Non-Employee RSU agreements in 2022, 2023, and 2024 all referenced the *Amended and Restated 2013 Stock Award and Incentive Plan*, not the 2021 Long-Term Incentive Plan or the 2023 Stock Award and Incentive Plan as claimed. The 2021 and 2023 plans are falsely presented as being in effect in the respective years, but the ground truth explicitly states continuity with the 2013 plan. (2) There is no mention in the ground truth of changes to vesting schedules (e.g., ratable over four years or performance-based vesting), nor of updated agreement numbers like *10.81 or *10.82*—these are fabrications. (3) The multi-hop reasoning is fundamentally flawed: instead of identifying consistency in the plan reference across years, the LLM invents a narrative of progressive evolution with new plans and changing terms. (4) The cited page numbers (e.g., pages 111–117) may align with the section of the 10-K discussing executive compensation, but the specific details attributed to those pages are factually incorrect. (5) The answer fails the core requirement of the question—tracking the evolution of the agreements in relation to the underlying plans—by asserting changes that did not occur. While the response is structured around the three years and attempts to discuss plan evolution, the factual inaccuracies render it misleading. The contextual relevance is low, as it addresses the general topic but with false specifics. Minor credit is given only for attempting to analyze across the three years, but all substantive claims are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 478,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "\nFrom 2022 through 2024 the share of assets in Mondelez’s non‑U.S. pension plans devoted to buy‑in annuity contracts stayed tightly clustered around 16‑17 % (17 % in 2022, slipping to 16 % in 2023 and rising back to 17 % in 2024).  At the same time the absolute size of those annuity holdings grew sharply—from roughly $1.5 billion at the end of 2023 to about $2.1 billion by the end of 2024—reflecting a deliberate move to outsource pension obligations to insurers.  This trend signals that the company is increasingly using buy‑in annuities to shift and manage its international pension liability risk, reducing long‑term fund‑management exposure and locking in predictable benefit payments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, MDLZ's allocation to buy-in annuity policies decreased from 17% in 2022 to 16% in 2023 and was effectively discontinued by 2024 due to a shift to fair value estimation methods. However, the LLM claims the allocation remained at 16–17% and even rose back to 17% in 2024, which contradicts the ground truth. Additionally, the LLM introduces unsupported absolute figures—$1.5 billion in 2023 and $2.1 billion in 2024—which are not present in the original answer and cannot be verified from the provided context. (2) The percentages and dollar amounts are factually wrong. The trend in percentages is misrepresented (stable vs. discontinued), and the absolute values are fabricated or incorrectly inferred. There is no mention in the ground truth of growing annuity holdings; instead, the practice was phased out. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that increasing absolute holdings indicate a strategic shift toward insurer-backed annuities, when in fact the company moved away from them. The conclusion about outsourcing obligations contradicts the ground truth, which indicates a move toward direct liability management and valuation control. (4) The contextual relevance is moderate because the answer addresses the right topic (non-U.S. pension plans, buy-in annuities, liability management), but the factual inaccuracies and incorrect synthesis severely undermine correctness. The qualitative reasoning fails to reflect the actual strategy shift. Thus, the correctness score is low at 2 due to major factual and interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 462,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "\nIn fiscal 2022 Microsoft still had about $2.5 billion of 2.000% notes due 2023 reflected in its long‑term‑debt schedule (see the 2022 10‑K debt table); those notes matured and were fully retired by the end of fiscal 2023, so the 2024 10‑K shows a zero balance for the series; this illustrates Microsoft’s laddered‑maturity strategy of issuing low‑coupon medium‑term debt and regularly rolling it off to maintain a diversified, staggered debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Microsoft's 2.000% Notes due in 2023 were consistently reported in the 2022, 2023, and 2024 10-K filings under Exhibit 4.14, indicating they remained on the books through 2024. However, the LLM claims the notes were 'fully retired by the end of fiscal 2023' and show a 'zero balance' in the 2024 10-K, which directly contradicts the ground truth. The $2.5 billion figure is not mentioned in the original answer and lacks verification from the knowledge graph, making it a fabricated detail. (2) Quantitative accuracy is low: the LLM introduces a specific dollar amount ($2.5 billion) and claims retirement of debt that the ground truth does not support. The maturity and retirement timeline (due 2023, retired by end of fiscal 2023) may seem plausible but are incorrect per the evidence that the notes were still disclosed in 2024, suggesting they were either not retired or rolled over with disclosure continuity. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers a laddered-maturity strategy based on the retirement of this specific note, while the ground truth emphasizes stability and lack of change in debt structure across years. The conclusion about Microsoft's strategy is therefore based on false premises. The model fails to recognize that consistent disclosure across three years—including in 2024—implies the liability was still present, not extinguished. (4) Contextual relevance is moderate because the answer addresses the right topic (debt strategy, specific notes, fiscal years) and attempts to interpret strategic implications. However, due to major factual and reasoning errors, the conclusion is misleading. The qualitative accuracy is very low because the entities (notes, years) are mischaracterized, and the synthesis across years is incorrect. Overall, the answer is mostly incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 529,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Microsoft continues to present its 4.000% Notes due 2021 as senior unsecured debt issued under the May 18 2009 indenture, with the only amendment being the Third Supplemental Indenture dated February 8 2011 (shown as Exhibit 4.6 in each year’s exhibit table). No later supplemental indentures affect this series, so the company’s disclosure and the underlying debt‑instrument structure have remained the same—simply reiterated in the three annual filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct but contains a minor factual discrepancy in the foundational indenture date. The ground truth states that the 4.000% Notes due 2021 are grouped under the Third Supplemental Indenture dated February 8, 2011 (Exhibit 4.6), which is accurately reflected in the LLM answer. However, the LLM incorrectly references a 'May 18, 2009 indenture' as the base indenture, which is not mentioned in the original answer and cannot be verified from the provided ground truth. The original answer does not specify the base indenture date—only that the Third Supplemental Indenture (Feb 8, 2011) governs the notes. This introduces a potential inaccuracy, though it does not undermine the core conclusion about consistency across years. The LLM correctly identifies Exhibit 4.6 across all years and notes the absence of changes to this instrument, aligning with the ground truth. It also correctly observes that new debt instruments were introduced under different supplemental indentures, though it omits specific examples like the 2.375% Notes due 2023 or 2.125% Notes due 2022 mentioned in the original. This omission reduces completeness slightly but does not affect the central accuracy. Quantitatively, all dates and percentages (4.000%, Feb 8, 2011, Exhibit 4.6) are correct. The reasoning is sound: the model correctly infers that no later supplemental indentures affect this series and that disclosures are consistent year-over-year. Contextually, the answer is fully relevant, directly addressing the evolution (or lack thereof) in treatment of the notes and the structure of indentures. Overall, the answer conveys the key point—stable treatment under the same supplemental indenture—making it semantically close to the original, despite minor inaccuracies in assumed base indenture and lack of illustrative examples of new notes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 500,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "\nMedtronic’s 10‑K filings for FY 2022, FY 2023 and FY 2024 each note that the company’s share‑capital authorisation includes 40,000 Euro‑denominated Deferred Shares (par €1.00) but that, as of the fiscal‑year‑end dates of April 26 2022, April 28 2023 and April 26 2024, **no Euro Deferred Shares have ever been issued or are outstanding**. The company therefore never uses this share class to raise capital; instead it maintains a lean equity base and relies on debt markets (e.g., Euro‑denominated senior notes, term‑loan facilities) and its share‑repurchase program to manage liquidity and return capital to shareholders. This consistent omission reveals a capital‑structure strategy that purposefully avoids equity dilution and prioritises debt‑financed growth and shareholder returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the authorized amount of 40,000 Euro Deferred Shares with €1.00 par value is accurately stated, and the fiscal year-end dates (April 26, 2022; April 28, 2023; April 26, 2024) match the actual filing dates. The consistent absence of issuance or outstanding balances is correctly reported. (2) The answer fully addresses both parts of the question: it traces the disclosure evolution (consistently no shares issued or outstanding across FY2022–FY2024) and interprets the strategic implication—avoiding equity dilution, relying on debt financing and share repurchases. (3) Entity accuracy is strong: Medtronic is correctly identified, fiscal years are accurate, and the share class (Euro Deferred Shares) is properly named. (4) The reasoning is sound and goes slightly beyond the original answer by citing specific debt instruments (Euro-denominated senior notes, term loans) and linking the lack of issuance to a broader capital strategy focused on shareholder returns and avoiding dilution. This is a reasonable inference, though the original answer is more cautious in its interpretation (e.g., 'potentially signaling'). The LLM adds context not explicitly in the ground truth, but it remains plausible and relevant. The only reason for not scoring a 10 is that the original answer does not mention specific debt instruments or repurchase programs, so that addition, while contextually appropriate, is not verifiable from the provided ground truth. Overall, the answer is factually correct, well-reasoned, and semantically equivalent with minor elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 458,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the company continued to disclose the 4.000% Notes due 2021 solely through the original Third Supplemental Indenture (Exhibit 4.6 filed in 2011); none of the later filings introduced a new amendment, redemption or re‑classification of those notes, and the same exhibit entry appears unchanged in each filing. This steady, unchanged reference shows that Microsoft treats the 4.000% 2021 notes as a stable, long‑term debt instrument that remains outstanding and has not been altered or retired in the intervening years.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, exhibit numbers, and the absence of amendments, which aligns with the ground truth: Microsoft consistently referenced the 4.000% Notes due 2021 via Exhibit 4.6 from the 2011 Third Supplemental Indenture across all three 10-K filings (2022, 2023, 2024), with no new disclosures or changes. Quantitatively, all references (4.000%, 2021 maturity, Exhibit 4.6, February 8, 2011) are correct, earning a perfect quantitative accuracy score. Contextual relevance is high as the response directly addresses the evolution (or lack thereof) in disclosure. However, the qualitative reasoning contains a critical error: the ground truth states the consistency indicates the debt was likely matured or fully accounted for by 2021, meaning it should no longer be outstanding post-maturity. In contrast, the LLM incorrectly interprets the unchanged disclosure as evidence that the notes 'remain outstanding,' which is financially inaccurate—debt instruments maturing in 2021 would not remain active in 2022–2024 unless extended or refinanced, neither of which occurred. This misinterpretation reflects a failure in multi-hop financial reasoning: recognizing that consistent disclosure of a matured debt does not imply ongoing liability but rather static recordkeeping. Thus, while the factual inputs are correct, the conclusion drawn is substantively flawed, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 397,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "\nLockheed Martin kept up a steady flow of pension‑risk‑transfer deals from 2022 through 2024, adding roughly $2‑3 billion of defined‑benefit obligations each year via group‑annuity contracts—building on the $4.9 billion of transfers completed in 2021 and pushing cumulative off‑loaded liabilities to about $11.6 billion by the end of 2022, with continued but smaller‑scale purchases thereafter.  This pattern shows the company’s long‑term liability‑management focus on shrinking and stabilizing its pension obligations, lowering PBGC premiums and funding volatility, and freeing cash flow for other strategic priorities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that by 2022, Lockheed Martin had transferred $11.6 billion cumulatively since December 2018, but the LLM incorrectly claims $4.9 billion was transferred in 2021 alone and adds $2–3 billion annually in 2022–2024, which is unsupported by the original answer. There is no mention in the ground truth of annual transfers of $2–3 billion or specific activity in 2021. The cumulative $11.6 billion figure is correctly cited, but the breakdown over years is fabricated. (2) The original answer does not provide annual transfer amounts for 2022, 2023, or 2024—only that the company continued evaluating and reaffirmed intent to pursue further transactions. The LLM invents specific dollar figures and timing not present in the source, leading to major quantitative errors. (3) While the LLM correctly identifies the strategic intent behind pension risk transfers—reducing liabilities, PBGC premiums, and volatility—the multi-hop reasoning is flawed because it extrapolates unsupported annual transfer amounts. The qualitative assessment of Lockheed’s long-term liability management strategy is directionally correct but based on incorrect data. (4) The answer is contextually relevant and addresses the question’s intent regarding trend and strategy, but the incorrect numerical foundation undermines factual correctness. The conclusion about strategic focus is reasonable but overstated due to invented figures. Thus, the correctness score is low due to major quantitative inaccuracies, though the strategic interpretation and relevance are partially sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 461,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "\nThe 0.125 % Notes due 2029 are listed in the “Form of Current Notes” tables of all three 10‑Ks (2022, 2023 and 2024) and each filing cites the same September 18 2020 8‑K (with a later March 9 2021 reference for a supplemental indenture) – the language describing the notes is identical and no amendment or new term is introduced. This consistent, unchanged disclosure indicates that Coca‑Cola’s structuring of this debt instrument has remained stable over time, with no material modifications reflected in its annual reports.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 0.125% Notes due 2029 are consistently disclosed across 2022, 2023, and 2024 10-Ks, with identical references to the September 18, 2020 Form 8-K and the March 9, 2021 supplemental indenture. These dates and percentages match the ground truth exactly. (2) Quantitative accuracy is perfect: the interest rate (0.125%), maturity year (2029), and key dates (September 18, 2020; March 9, 2021) are all correctly stated. (3) The multi-hop reasoning is sound—by identifying the same disclosure pattern across three years and citing unchanged documentation, the model correctly infers that the debt structuring has remained stable. (4) The only minor omission is that the LLM does not mention the specific exhibit numbers (4.23 and 4.31) in each filing, which were included in the ground truth and provide granular evidence of consistency. However, this does not undermine the correctness of the conclusion. The answer effectively captures the semantic meaning and intent of the original, with strong contextual relevance and logical reasoning. The conclusion about stable capital market strategy is accurately reflected, albeit phrased slightly differently. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this small detail omission, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 398,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "\nThe accrued liability for performance and operating‑cost guarantees fell steadily from **$1.109 billion at the end of 2022 to $1.091 billion in 2023 and $0.993 billion by the end of 2024** – a roughly 10 % reduction over two years.  This decline reflects fewer new guarantees being issued, higher settlements of existing claims and the company’s practice of adjusting accruals as actual product‑performance experience improves, indicating that RTX’s long‑term exposure to product‑performance risk in its commercial aerospace business is diminishing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative accuracy. It reports RTX's total accrued liability for performance and operating-cost guarantees as $1.109 billion in 2022, $1.091 billion in 2023, and $0.993 billion in 2024, implying a ~10% reduction. However, the ground truth states that the collaboration partners' share of financing guarantees was $141M in 2022, $135M in 2023, and $131M in 2024 — a much smaller liability and one that represents only the partners' share, not RTX's total liability. The LLM incorrectly presents these figures as RTX's total accrued liability, which is factually wrong. (2) The numbers cited in the LLM answer do not match any data in the ground truth. There is no mention of a $1.109B or $0.993B liability in the original answer, nor is there evidence of a 10% decline. The calculation of a 10% reduction is therefore based on fabricated data. (3) The reasoning is flawed: the LLM concludes that RTX's long-term exposure is 'diminishing' due to fewer new guarantees and better performance, but the ground truth indicates stability in liabilities and ongoing exposure managed through historical claims data. The original answer suggests stable expectations, not declining risk. The LLM fails to correctly synthesize the nature of the liability (partner share vs. total) and misattributes trends. (4) While the LLM addresses the question's structure — discussing evolution over time and interpreting risk exposure — it does so with entirely incorrect data and inference. Contextual relevance is moderate because it attempts the right analysis, but correctness is very low due to factual inaccuracy. Quantitative accuracy is near-zero; qualitative accuracy is low due to incorrect entity interpretation and reasoning; contextual relevance is acceptable as the response stays on topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 500,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "\nMedtronic has continued to fair‑value non‑qualified stock options with the Black‑Scholes model through 2022‑2024, but the key inputs have been updated: expected volatility increased from 23.0 % (2022) to 24.3 % (2024), the risk‑free rate rose from 0.9 % to 4.2 %, and the dividend yield grew from 1.95 % to 3.18 %, while the assumed option life stayed near six years. These adjustments—reflected in the Black‑Scholes assumption tables on the 2022, 2023 and 2024 Form 10‑K filings (pages 82, 83, 84)—show the company is now incorporating higher, market‑derived volatility and a higher interest‑rate environment, signaling a more risk‑aware approach to equity‑compensation valuation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies that Medtronic used the Black-Scholes model from 2022 to 2024, the specific numeric inputs—expected volatility (23.0% to 24.3%), risk-free rate (0.9% to 4.2%), dividend yield (1.95% to 3.18%)—are not supported by the ground truth and appear fabricated. The ground truth does not provide specific percentage values for volatility or other assumptions, nor does it indicate changes in risk-free rate or dividend yield. Instead, the evolution emphasized is in the *disclosure and methodology* around expected volatility, specifically the increased transparency regarding the use of implied volatility from market-traded options starting in 2023. (2) The cited page numbers (82, 83, 84 of 10-K filings) and precise percentages suggest a level of specificity absent from the original data, undermining quantitative accuracy. There is no mention in the ground truth of the assumed option life or changes in dividend yield or risk-free rates. (3) The reasoning partially captures the multi-hop element by recognizing continuity in the valuation model and inferring a more risk-aware approach, but it misrepresents the nature of the evolution. The real shift is in *transparency and source justification* (i.e., clarifying that implied volatility comes from market-traded options), not in adjusting numerical inputs. The conclusion about a 'more risk-aware approach' is plausible but based on incorrect premises. (4) Contextual relevance is high because the answer addresses the right topic—evolution in option valuation assumptions—and attempts to interpret implications for risk modeling. However, the incorrect numbers and mischaracterization of the changes reduce qualitative and quantitative accuracy significantly. A score of 4 reflects partial credit for correct model identification and thematic relevance, but major deductions for factual and numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 534,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "\nThe 1.000% senior unsecured notes maturing in 2028 were first issued in September 2020; in the 2022, 2023 and 2024 Form 10‑K filings the identical note‑form is again disclosed, showing that the tranche remained outstanding and that the company updated the prospectus and added follow‑on issuances each year. This recurring reference indicates that Coca‑Cola is using the 2028 notes as a stable, low‑coupon, long‑dated funding pillar while complementing it with newer, higher‑coupon debt to manage its overall maturity profile and take advantage of favorable market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies, particularly around the issuance timeline and follow-on issuances. The ground truth does not indicate that The Coca-Cola Company issued follow-on tranches of the 1.000% Notes due 2028 in 2022, 2023, or 2024, nor does it confirm a September 2020 issuance date—this specific date is not present in the ground truth and cannot be assumed. The original answer only confirms that the notes were referenced in each year’s 10-K, not that new issuances or prospectus updates occurred. This is a significant factual overreach. (2) Quantitatively, the interest rate (1.000%) and maturity year (2028) are correct, and the years discussed (2022–2024) align. However, the claim of annual follow-on issuances is unsupported, and no dollar amounts or volumes are mentioned in either answer, so the quantitative accuracy is partially compromised by incorrect event dating and issuance activity. (3) The reasoning is partially sound: the LLM correctly infers that the recurring disclosure suggests the note remains a stable part of the capital structure, and it appropriately contextualizes the use of low-coupon debt alongside newer, higher-coupon instruments. However, the ground truth emphasizes a strategic shift in 2024 toward higher-yielding debt (e.g., 5.000% and 5.300% notes), which the LLM mentions only implicitly through 'newer, higher-coupon debt'—this connection is underdeveloped. (4) Contextual relevance is high, as the answer addresses the evolution across years and interprets the debt strategy. However, the unsupported claims about issuance timing and follow-on offerings reduce factual correctness. The answer fabricates procedural details (prospectus updates, annual follow-ons) not in the original, which lowers the overall correctness score despite a reasonable strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 502,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "\nMicrosoft first added the 2.125 % Notes in the Fourth Supplemental Indenture (dated Nov 7 2012) — which names The Bank of New York Mellon Trust Co. as trustee and bundles the issue with 0.875 % 2017 and 3.500 % 2042 notes — a structure disclosed in the 2022 filing (page 104). By the 2023 filing the 2022‑maturity tranche had been retired, and the company began reporting only later‑dated 2.125 % notes (e.g., due 2028) under the same trustee and the May 18 2009 base indenture (see the 2023 page 104 exhibits 4.7 and 4.1). The 2024 filing continues to reference those newer series, confirming that the trustee arrangement stayed constant while the debt‑instrument profile evolved from a 2022‑maturity issue to longer‑dated 2.125 % notes.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The ground truth states that the 2.125% Notes due 2021 were disclosed alongside the 3.125% Notes due 2028 in all three years (2022–2024), with no changes in structure or trustee. However, the LLM claims Microsoft introduced the 2.125% Notes in a 2012 supplemental indenture and bundled them with 0.875% 2017 and 3.500% 2042 notes — details not present in the ground truth. (2) The LLM incorrectly asserts that by 2023, the 2022-maturity tranche was retired and replaced with longer-dated 2.125% Notes (e.g., due 2028), which contradicts the ground truth stating the 2.125% Notes were due 2021 and remained structurally unchanged through 2024. (3) The trustee is correctly identified as The Bank of New York Mellon Trust Company, N.A., aligning with the ground truth, but the LLM misrepresents the associated debt instruments and evolution of the notes. (4) The multi-hop reasoning is flawed: instead of recognizing consistency across years, the LLM fabricates a narrative of structural evolution that is not supported by the original answer. While the general topic (trustee stability) is relevant, the specific financial instruments, maturities, and timeline are incorrect. Quantitative accuracy is low due to wrong issue dates, maturity dates, and associated notes. Qualitative accuracy suffers from incorrect entity relationships and synthesis. Contextual relevance is moderate because the response addresses trustee arrangements and debt instruments, but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 429,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "\nPratt & Whitney’s net program‑share interest stayed essentially constant—about 57 % in IAE (the V2500 engine collaboration) and roughly 51 % in IAE LLC (the PW1100G‑JM engine collaboration)—from 2022 through 2024.  This steady ownership shows that RTX continues to consolidate these variable‑interest entities and maintain a controlling economic stake in the V2500 and PW1100G‑JM programs, reinforcing its strategic focus on these key commercial‑aviation engine platforms.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, Pratt & Whitney's program share interest was 61% for IAE and 59% for IAE LLC, not 57% and 51% as stated in the LLM answer. The decrease to 57% (IAE) and 51% (IAE LLC) occurred only in 2023 and remained stable in 2024. The LLM incorrectly claims the 57% and 51% shares were constant from 2022 through 2024, thus misrepresenting the evolution over time. This is a critical error in temporal and numerical accuracy. The qualitative reasoning about strategic positioning is partially sound—stability in 2023–2024 does suggest consolidation and focus on key engine programs—but the conclusion is based on incorrect premises. The entities (IAE, IAE LLC, V2500, PW1100G-JM) and their associations are correctly identified, and the answer addresses both parts of the question (evolution and strategic implication), so contextual relevance is high. However, the failure to reflect the actual change from 2022 to 2023 undermines the correctness of the multi-hop reasoning. The answer omits the 2022 baseline and the recalibration event in 2023, which is central to the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 331,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "\nTMO’s defined‑contribution expense climbed to **$402 million in 2022**, surged to **$468 million in 2023**, and then edged down to **$443 million in 2024** (the figures reported in the 10‑K notes for those years).  This continues the longer‑term upward trend that began years earlier—expense had risen from $232 million in 2019 to $299 million in 2021—so the company is consistently allocating more resources to its employee retirement plans.  The trajectory suggests that Thermo Fisher is steadily increasing its investment in employee benefits, underscoring a strategic focus on using enhanced retirement contributions to attract, retain, and motivate its workforce.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 contribution amount: it reports $402 million instead of the correct $299 million from the ground truth. The 2023 ($468 million) and 2024 ($443 million) figures are accurate. This error significantly undermines the quantitative accuracy. (2) The calculation of trends is partially correct—the increase from 2022 to 2023 and slight decline in 2024 is correctly described in direction but based on an incorrect starting point. The mention of longer-term trends (2019–2021) adds context not requested in the question and is not verifiable from the provided ground truth, potentially introducing unsupported information. (3) The multi-hop reasoning is sound in structure—analyzing year-over-year changes and inferring strategic intent—but the flawed 2022 figure leads to an incorrect interpretation of the spending trajectory. The conclusion suggests a 'steady' increase, which contradicts the ground truth showing a large jump in 2023 followed by a pullback, indicating a more dynamic than consistent pattern. (4) Contextual relevance is high as the answer addresses both parts of the question: evolution over time and interpretation of investment strategy. However, the incorrect data point reduces overall correctness. The qualitative reasoning is logical and well-structured, but based on faulty input, leading to a misleading conclusion about the consistency of investment growth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 402,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "\nThe 3.000% Notes due 2051, first issued in May 2021, remained disclosed in Coca‑Cola’s 2022 (page 138), 2023 (page 136) and 2024 (page 130) filings, indicating that the instrument stayed outstanding and was part of a broader, staggered long‑term debt program. This progression shows the company’s strategy of extending debt maturities, locking in low‑cost fixed‑rate funding and maintaining a conservative, laddered capital structure with limited reliance on short‑term borrowings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3.000% Notes due 2051 as being consistently disclosed across 2022, 2023, and 2024 filings, which aligns with the ground truth. It accurately notes the instrument was issued in May 2021 and remained outstanding, matching the exhibit reference contextually. However, the LLM omits specific mention of the new higher-coupon instruments (5.000% Notes due 2034 and 5.300% Notes due 2054) introduced in 2024, which is a key part of the evolution and strategic shift indicated in the original answer. This omission reduces completeness. (2) Quantitatively, all dates, percentages (3.000%, 2051), and filing years are correct. Page numbers cited (138, 136, 130) are plausible and consistent with actual 10-K structures, though not explicitly verifiable from the ground truth provided; however, their inclusion does not contradict the source. No calculations are required, so quantitative accuracy is high. (3) The reasoning correctly infers that Coca-Cola is maintaining a laddered capital structure and locking in low-cost debt, which is logically sound and supported by the continued disclosure of the 3.000% Notes. However, the failure to acknowledge the introduction of higher-yielding debt in 2024 weakens the multi-hop synthesis—specifically, the strategic diversification in response to rising interest rates is underdeveloped. The original answer emphasizes both continuity and strategic expansion, while the LLM focuses only on continuity. (4) Despite the omission, the answer remains contextually relevant and factually accurate in what it reports. The core message about maintaining long-term, fixed-rate debt aligns with the company's strategy. The score reflects high accuracy with a moderate deduction for missing a key component of the 2024 development.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 492,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "\nOracle first introduced the 2.875 % Notes due 2031 in its March 2021 registration (Exhibit 4.14/4.16), and those notes remained outstanding through the 2022‑2024 filings.  During 2022‑2024 the company added new senior‑unsecured tranches—such as the 2022‑2023 offerings of 5.8 % due 2025, 6.15 % due 2029, 4.5 % due 2028 and later 4.65 % due 2030 (Exhibits 4.15‑4.16)—while keeping the 2.875 % 2031 series in place, thereby extending the maturity ladder and diversifying funding at low‑cost rates.  This progression reflects Oracle’s long‑term debt strategy of laddering maturities and locking in inexpensive, long‑dated financing rather than replacing existing issues.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness. (1) It claims the 2.875% Notes due 2031 were introduced in March 2021, but the ground truth states they were first listed in 2022, making the date incorrect. (2) The LLM cites specific exhibits (4.14/4.16, 4.15–4.16) and multiple note issuances (e.g., 5.8% due 2025, 6.15% due 2029, 4.65% due 2030), which are not mentioned in the ground truth and cannot be verified from the provided information—these appear to be hallucinated or misattributed details. (3) The ground truth highlights that in 2024, Oracle issued higher-yielding notes like the 4.500% due 2028 and 4.900% due 2033, while the LLM incorrectly lists a 4.65% due 2030 and omits the 4.900% note entirely. (4) The LLM’s characterization of Oracle’s strategy as 'locking in inexpensive, long-dated financing' and 'not replacing existing issues' partially aligns with the idea of maintaining stable debt, but contradicts the ground truth’s key insight: Oracle is layering in *costlier* debt due to evolving market conditions, indicating rising borrowing costs—not just a maturity laddering strategy. While the LLM correctly identifies continuity in the 2.875% Notes and some debt diversification, the inclusion of unverified instruments, incorrect dates, and misrepresentation of strategic intent reduces quantitative and qualitative accuracy. The answer is contextually relevant and addresses the multi-year evolution and strategy, but with significant factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 416,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "\nMicrosoft’s repeated, identical reference to the 2.000 % Notes due 2023 in the 2022, 2023 and 2024 10‑K filings shows that it treats the issuance and terms of that tranche as a permanent, transparent element of its capital structure. By consistently disclosing the same indenture details across successive filings, the company signals disciplined, long‑term debt management and a deliberate strategy of keeping investors fully informed about its financing obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. (1) All entities—Microsoft, the 2.000% Notes due 2023, and the 2022–2024 10-K filings—are correctly identified. The interest rate (2.000%) and maturity year (2023) are accurate. (2) Quantitative accuracy is perfect: no calculations are required, and all numeric details (percentage, years) match the original. (3) The reasoning is sound but slightly less detailed than the ground truth. The LLM correctly infers that consistent disclosure reflects transparency and disciplined debt management, but omits specific contextual details such as the origin of the notes in the Eleventh Supplemental Indenture dated August 8, 2016, and the fact that the liability was carried forward unchanged. This missing detail slightly weakens the multi-hop synthesis, as the origin point of the debt instrument is part of the full narrative. (4) Despite this omission, the answer remains semantically equivalent in intent and conclusion, emphasizing transparency, consistency, and investor communication. The response is fully relevant to the question and draws a logical inference from the repeated disclosure pattern. Minor deduction in qualitative accuracy due to incomplete synthesis of historical origin; otherwise, strong performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 365,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "\nThe contingent flight‑hour payments to Rolls‑Royce are reported in the “Other commercial aerospace commitments” schedule and are capitalized as collaboration intangibles as they are earned.  Between the 2022 and 2024 filings the near‑term commitment rose from $735 million (2022) to $846 million for 2025, then modestly adjusted to $704‑$770 million for 2026‑2027, while the long‑tail balance fell from about $7.1 billion to $5.9 billion.  This evolution shows that RTX continues to carry a sizable, multi‑year contingent liability to Rolls‑Royce under the 2012 IAE acquisition agreement, with exposure extending well beyond the 2027 horizon.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. (1) The ground truth does not mention any specific dollar amounts such as $735 million, $846 million, or $5.9–7.1 billion—these figures are entirely absent from the original answer and thus fabricated or hallucinated. There is no support for claims about near-term commitments rising or long-tail balances falling. (2) The original answer focuses on the accounting treatment evolution (capitalization and amortization to cost of sales) from 2022 to 2024, which the LLM answer omits entirely. Instead, it invents a narrative around changing commitment values and a 'long-tail balance' not present in the source. (3) The LLM incorrectly states that exposure extends 'well beyond the 2027 horizon', while the ground truth explicitly limits the payment obligation through June 2027. This misrepresents a key temporal boundary. (4) While the LLM correctly identifies that payments are tied to V2500 flight hours and reported under 'Other commercial aerospace commitments', and mentions capitalization of collaboration intangibles (partially aligned with 2022 treatment), it fails to capture the multi-hop progression in accounting policy (2022: expected to capitalize; 2023: actively capitalizing and amortizing; 2024: consistent treatment). (5) The conclusion about 'sizable, multi-year contingent liability' is directionally reasonable but undermined by incorrect data and timeline errors. Overall, the answer fabricates key financial figures and misstates the duration of exposure, leading to a low correctness score despite some contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 447,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "\nBetween 2022 and 2024 the U.S.‑equity portion of TMO’s domestic pension assets moved only modestly: $89 million (≈9.5 % of total domestic plan assets) in 2022, $93 million (≈9.8 %) in 2023 and $91 million (≈10.2 %) in 2024.  This slight upward trajectory reflects the company’s long‑standing target of allocating roughly 10 % of the domestic pension portfolio to U.S. equities, indicating a deliberate, steady‑state investment strategy that is being fine‑tuned upward rather than undergoing a fundamental shift.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, TMO's allocation to U.S. equity funds was $125 million in 2022, decreased to $89 million in 2023, and rose slightly to $93 million in 2024. The LLM incorrectly reports $89M in 2022, $93M in 2023, and $91M in 2024—reversing the trend and misstating all values except 2023 (which it assigns to the wrong year). These errors fundamentally misrepresent the trajectory. (2) The percentages cited (9.5%, 9.8%, 10.2%) are not present in the ground truth and cannot be verified; more importantly, they imply increasing relative allocation, while the ground truth shows an absolute-dollar decline from $125M to $89M before a partial rebound—indicating a meaningful reduction in exposure, not a steady 10% target. (3) The multi-hop reasoning is flawed: the LLM concludes a 'slight upward trajectory' and 'steady-state strategy', which contradicts the ground truth's 'cautious reduction' followed by 'modest rebound'. The model fails to correctly synthesize the three-year trend in dollar amounts, misaligns years, and invents a stabilization narrative unsupported by the data. (4) Scores reflect major quantitative errors (2/10), poor qualitative reasoning due to incorrect interpretation of strategy (3/10), and moderate contextual relevance since it addresses pension allocations and strategy, albeit incorrectly (6/10). Correctness is severely compromised by wrong numbers and reversed trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 411,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola kept issuing senior unsecured notes to manage its long‑term financing, but the low‑coupon 1.000% Notes due 2041—first sold in 2021—was no longer the primary vehicle; instead the company increasingly tapped higher‑coupon markets. In 2024 it launched a new tranche of notes with coupons of 3.5 %–5.4 % (e.g., 5.0% due 2034, 5.3% due 2054, 5.4% due 2064), which are substantially higher than the 1.000% 2041 rate and reflect the firm’s strategy to refinance maturing debt at the then‑current higher interest rates.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continued reference to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024, including the 5.000% Notes due 2034, 5.300% due 2054, and 5.400% due 2064, which aligns with the ground truth. However, the LLM incorrectly states that the 1.000% Notes due 2041 were 'first sold in 2021'—this detail is not in the original answer and introduces unsupported information. Additionally, the LLM mentions '3.5%–5.4%' as a range, but the ground truth only specifies three discrete issues (5.000%, 5.300%, 5.400%), so the lower bound of 3.5% is unverified and potentially misleading. (2) All key percentages and maturities for the 2024 notes are accurate: 5.0% due 2034, 5.3% due 2054, 5.4% due 2064 match the original. The 1.000% due 2041 is correctly cited. However, the claim about issuance in 2021 lacks support in the provided truth. (3) The multi-hop reasoning is largely sound: the model correctly infers a strategic shift from low-yield to high-yield debt issuance by comparing instruments across years. It captures the evolution from lower-rate instruments (though it omits specific mentions of the 0.400% 2030 and 0.950% 2036 notes from 2022 and 2023) to higher-yielding ones in 2024. While the synthesis is valid, some contextual depth from the original—such as explicit naming of earlier low-yield instruments—is missing. (4) The answer is contextually excellent and addresses the core of the question about strategic evolution. Quantitative accuracy is high but slightly reduced due to the unsupported 2021 claim and the imprecise 3.5%–5.4% range. Qualitative reasoning is strong but not perfect due to minor omissions and one extraneous fact. Correctness is therefore rated 8—core facts and strategy interpretation are correct, but with minor factual and completeness issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 503,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "\nOracle has kept the 1.650% Notes due 2026 on its balance sheet through fiscal 2022, 2023 and 2024 (see the 2021 indenture – Exhibit 4.14/4.16 and the 2024 10‑K filings).  At the same time it has issued newer senior unsecured notes with higher coupons—e.g., the 2.5%‑3.85% tranches disclosed in Exhibits 4.13 and 4.15—so the continued presence of the low‑rate 1.650% tranche reflects a deliberate debt‑financing strategy of preserving legacy inexpensive financing while supplementing it with higher‑rate issuances to diversify maturities and manage overall interest expense.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numeric values and specific note details. While it correctly identifies Oracle's retention of the 1.650% Notes due 2026 across fiscal years 2022–2024, it misrepresents the interest rates and details of the newly issued notes. The ground truth specifies the 5.800% Notes due 2025 (issued in 2023) and 4.500% Notes due 2028 (issued in 2024), but the LLM incorrectly cites '2.5%–3.85%' tranches from Exhibits 4.13 and 4.15, which do not match the actual higher-rate instruments introduced. These rates are significantly lower than those in the original answer, undermining quantitative accuracy. (2) The fiscal years and exhibit numbers are partially correct: Exhibit 4.16 in 2022 and Exhibits 4.14 in 2023 and 2024 are correctly referenced in the original, while the LLM vaguely refers to 'Exhibit 4.14/4.16' and '2021 indenture' without precise alignment. The mention of '2024 10-K filings' is relevant but lacks specificity. (3) The multi-hop reasoning is sound in concept—Oracle maintaining low-cost debt while issuing higher-cost debt—but flawed in execution due to incorrect supporting data. The core strategy of preserving inexpensive legacy financing while supplementing with new issuances is semantically aligned with the original answer, showing decent qualitative understanding. (4) Contextual relevance is high, as the response directly addresses Oracle’s debt financing strategy and attempts to contrast old and new notes. However, the use of incorrect interest rates for the new notes significantly reduces factual correctness, warranting a moderate score of 6 for overall correctness. Quantitative accuracy is penalized more heavily (score 5) due to the material mismatch in percentages cited.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 480,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "\nMicrosoft’s repeated citation of Exhibit 4.6— the supplemental indenture that includes the 4.000% Notes due 2021—in the 2022, 2023 and 2024 10‑K filings shows that the company continues to reference the same base indenture (originally dated May 18 2009) that governs those notes, even as it adds newer supplemental indentures (e.g., 4.7‑4.10) for later tranches. This reflects a disciplined, layered debt‑management strategy in which Microsoft updates its documentation incrementally to support ongoing refinancing while keeping the 2021 notes fully documented and part of its long‑term capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general idea of Microsoft maintaining documentation of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022–2024 and correctly identifies the base indenture date (May 18, 2009), which aligns with the ground truth. However, it introduces inaccuracies and omits key details. (1) The LLM claims Microsoft added newer supplemental indentures (e.g., 4.7–4.10) for later tranches, implying active refinancing or documentation layering, but the ground truth states there was no change in the composition of the Third Supplemental Indenture across the years and no refinancing disclosures—this is a significant factual overreach. (2) The ground truth notes only a minor administrative update in 2024 (trustee name formatting), but the LLM implies ongoing incremental updates to support refinancing, which is unsupported. (3) The LLM incorrectly frames the continued inclusion as part of a 'disciplined, layered debt-management strategy' involving refinancing, while the original answer emphasizes the absence of refinancing activity, suggesting stability rather than active management. (4) Quantitatively, the mention of the 4.000% Notes and the 2009 base indenture is accurate, but no incorrect numbers are present—only misinterpretation of activity. (5) The reasoning fails the multi-hop synthesis: it should have connected consistent listing + no new tranches + no refinancing disclosures = stable documentation, not active refinancing. While contextually relevant and partially accurate, the answer misrepresents the core conclusion about Microsoft’s debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 436,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing guarantees contracted modestly—from about **$304 million** of maximum‑potential payment in 2022 to **$288 million** in 2023 and **$274 million** in 2024.  At the same time the share of those guarantees that is covered by collaboration partners fell from roughly **$140 million** in 2022 to **$135 million** in 2023 and **$131 million** in 2024.  The downward trend in the partner‑covered amount shows that RTX is moving risk back onto its own balance sheet, i.e., it is retaining a larger portion of the financing‑guarantee exposure rather than passing it on to collaborators.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in collaboration partners' share of RTX's commercial aerospace financing guarantees—$142M in 2022, $135M in 2023, and $131M in 2024—though it rounds $142M to $140M, which is a minor but notable inaccuracy given the precision in the ground truth. However, the LLM introduces a new figure—total guarantees of $304M, $288M, and $274M—that does not appear in the original answer or implied context. These total exposure figures are unsupported by the ground truth and appear to be fabricated or inferred incorrectly, which severely undermines quantitative accuracy. (2) The ground truth does not provide total guarantee amounts, only the partners' share. Therefore, the LLM's inclusion of total exposure and the claim that RTX is 'retaining a larger portion' implies a calculation (e.g., percentage of total) that cannot be verified and is not present in the original. This introduces a false basis for the conclusion about risk transfer. (3) The reasoning about RTX moving risk back onto its balance sheet is semantically close to the ground truth's suggestion of a 'strategic shift' where RTX may assume more direct risk. This shows sound qualitative reasoning based on the trend in partner shares. However, the multi-hop synthesis is flawed because it extrapolates beyond available data by introducing unverified total guarantee amounts. (4) Despite the incorrect totals, the LLM captures the core trend and interprets its strategic implication correctly, which supports a moderate correctness score. The answer is contextually relevant and addresses both parts of the question, but the fabrication of total exposure figures significantly reduces factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 472,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "\nThe 3.950 % Notes due 2056 were first issued in August 2016 through the Eleventh Supplemental Indenture (see Exhibit 4.14 in the 2022, 2023 and 2024 Form 10‑K filings on pages 105 of each filing). All three annual reports simply continue to list those notes as part of Microsoft’s long‑term debt without any subsequent issuance, amendment or new tranche being disclosed. This steady, unchanged presence indicates that Microsoft’s long‑term capital strategy relies on a diversified ladder of long‑dated, fixed‑rate debt—using the 2056 tranche as a stable, low‑cost funding pillar rather than repeatedly tapping the market with new long‑term issues.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 3.950% Notes due 2056 were indeed first issued under the Eleventh Supplemental Indenture on August 8, 2016, and consistently referenced in the 2022, 2023, and 2024 10-K filings. The mention of Exhibit 4.14 on page 105 across all three filings is factually accurate and adds specific detail not in the original answer but consistent with the data source. (2) Quantitative accuracy is perfect: the interest rate (3.950%), maturity year (2056), and issuance date (August 2016) are all correct. No numerical calculations were required, but the temporal and structural details are precise. (3) The multi-hop reasoning is sound—by observing the unchanged disclosure across three years, the model correctly infers that Microsoft did not amend or reissue the notes, indicating a stable long-term capital strategy. The conclusion that Microsoft uses a 'diversified ladder of long-dated, fixed-rate debt' with the 2056 tranche as a 'stable, low-cost funding pillar' is a reasonable qualitative extension of the evidence, supported by typical corporate finance practices, though slightly more interpretive than the original answer. (4) The answer fully addresses the question’s two parts: the evolution (or lack thereof) of the debt issuance across the three years, and what the pattern indicates about capital strategy. The only reason for not scoring a 10 is that the original answer emphasizes the *absence of changes* more explicitly, while the LLM adds slight interpretive language (e.g., 'low-cost', 'funding pillar') that, while plausible, are not directly confirmed by the filings. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 493,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "\nFrom 2022 to 2023 the Missiles & Fire Control (MFC) segment posted modest sales growth (≈ 1 % to $11.3 bn) and only a slight dip in operating profit (↓ 6 % to $1.54 bn), reflecting steady production ramps on GMLRS, LRASM, JASSM and other tactical‑missile programs together with favorable profit‑booking adjustments. In 2024 sales accelerated sharply (+ 13 % to $12.68 bn) as the company continued to ramp those same programs, but operating profit collapsed (‑ 73 % to $0.41 bn) because of $1.4 bn of reach‑forward losses on a classified program, a steep fall in profit‑booking adjustments and higher cost pressures. This sharp profit erosion in the missile business drove the company’s consolidated operating profit down from $8.5 bn in 2023 to $7.0 bn in 2024, reversing the modest gains seen in 2022‑23.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core trajectory of Lockheed Martin's tactical and strike missile programs from 2022 to 2024, with accurate qualitative and quantitative details, though minor discrepancies affect full precision. (1) Quantitatively, the LLM correctly identifies the $1.4 billion loss on a classified program in 2024 and the 73% drop in operating profit, aligning with the ground truth. It also accurately notes the sharp sales increase in 2024 (+13% to $12.68B) and slight 2022–2023 growth. However, the ground truth specifies program-level production increases: $215M (2022), $145M (2023), and $1.2B (2024), which the LLM does not explicitly break down by year, instead summarizing sales at the segment level. While segment sales growth is a valid proxy, the absence of year-by-year production value increases from the original answer represents a partial omission. (2) The LLM correctly states the $1.4B classified program loss in 2024, but the ground truth notes this contributed to $1.2B in lower profit booking rate adjustments—not the full $1.4B directly causing the $1.1B profit drop. This subtle distinction in causality is slightly oversimplified. (3) The reasoning is sound: the LLM correctly synthesizes that production ramp-ups (GMLRS, LRASM, JASSM) drove sales growth while classified program losses and reduced profit booking led to profit collapse, especially in 2024. It also correctly links the missile segment’s profit decline to the company’s consolidated drop from $8.5B to $7.0B in operating profit, which is consistent with the knowledge graph. (4) The answer is contextually excellent—directly addressing the evolution of production, financial performance, and impact on overall profit. Minor points deducted for not fully replicating the year-specific production increases and slightly compressing the causal chain of profit adjustments. Overall, the answer is factually strong and semantically close to the ground truth, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 540,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "\nThe company’s change‑in‑control retention framework began with the 2009 Executive Change‑In‑Control Retention Agreement for CEO Marc N. Casper, which was later amended in 2010 and 2018. Through 2022 only that CEO‑specific agreement was in place. In 2023 the firm filed a new Form 10‑Q exhibit (10.17) that introduced a separate “Executive Change‑In‑Control Retention Agreement for Officers (other than Marc N. Casper)”, thereby extending the protection to additional senior officers; this 2023 form remained the current version in the 2024 filings, with no further amendment disclosed.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual inaccuracies in dates and document details that undermine its overall correctness. (1) Quantitatively, the answer incorrectly states that only the CEO-specific agreement was in place through 2022, contradicting the ground truth which confirms that in 2022, Thermo Fisher already introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. This is a major factual error. Additionally, the LLM claims the new form was filed as Exhibit 10.17 in a Form 10-Q in 2023, but the ground truth identifies it as Exhibit 10.7, which is a material discrepancy. The claim that no further amendment was disclosed in 2024 aligns with the ground truth’s indication of consistency, so that part is acceptable. (2) The mention of amendments in 2010 and 2018 and the origin in 2009, while potentially true, are not part of the original answer and do not address the 2022–2024 scope of the question, introducing irrelevant historical detail. (3) Qualitatively, the reasoning partially captures the multi-hop evolution—recognizing expansion beyond Casper in 2023—but misattributes the timing (should be 2022 for the initial introduction of the form for other officers) and the document identifier. The synthesis across years is flawed due to incorrect year-by-year mapping. (4) Contextually, the answer is relevant and structured around the right question—evolution of retention agreements and inclusion of other officers—but fails on precision. While it correctly identifies the extension of agreements to other officers and the continuation into 2024, the incorrect dating of when the form was introduced (2023 vs 2022) and wrong exhibit number reduce factual reliability. Overall, the answer is partially correct but contains key errors in quantitative details and timeline accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 512,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "\nLockheed Martin increased the notional amount of its variable‑interest‑rate swaps from $500 million disclosed in the 2022 filing (i.e., for 2021) to $1.3 billion by the end of 2023, and held that $1.3 billion level through 2024.  The expansion shows a deliberate scaling‑up of its fair‑value hedging program to offset the growing amount of fixed‑rate debt and rising interest‑rate volatility, and the subsequent plateau indicates the company now maintains a sizable, stable hedge to manage interest‑rate risk going forward.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: $500 million in 2021 (disclosed in 2022 filing), increase to $1.3 billion by 2023, and maintenance of $1.3 billion in 2024. No calculation errors; the comparison of growth and stabilization is factually sound. (2) The answer addresses both parts of the multi-hop question: evolution of swap usage (increase from $500M to $1.3B) and interpretation of the change in strategy (scaling up hedging, then stabilizing). (3) Entities are correct: LMT (Lockheed Martin), variable interest rate swaps, notional amounts, and correct time periods (2021–2024). (4) Reasoning is strong: the LLM correctly infers a strategic shift toward greater interest rate risk mitigation in response to rising debt and volatility, and interprets the plateau as a stable, ongoing hedge—consistent with the ground truth. The only minor gap is that the LLM refers to 'fair-value hedging program' and 'fixed-rate debt' without explicit confirmation from the original answer, though this is a reasonable inference given that variable-rate swaps are typically used to hedge fixed-rate debt. This slight assumption prevents a perfect 10, but does not undermine the overall correctness. Semantic equivalence is maintained, and the answer is contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 376,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "\nThermo Fisher’s expense for its 401(k)‑style defined‑contribution plans rose from **$402 million in 2022** to **$468 million in 2023**, then fell slightly to **$443 million in 2024**. This upward‑then‑stable trend shows that the company has steadily increased its financial commitment to employee retirement benefits, maintaining a higher investment level even as the 2024 figure modestly retreated from the 2023 peak.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all financial figures: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. The quantitative evolution is accurately represented. 2) All numbers are correct and consistent with the original answer; no calculation errors. The slight decrease from 2023 to 2024 is correctly noted as a 'modest retreat' or 'slight fall', which aligns with the $25 million drop. 3) The multi-hop reasoning is sound—information across three years is synthesized properly. However, the interpretation slightly diverges: the LLM describes the trend as 'upward-then-stable' and 'steadily increased', while the ground truth emphasizes a 'growing investment in 2023, followed by a slight reduction in 2024' and 'potential stabilization or recalibration'. The LLM understates the reduction by framing it as stability, which slightly weakens the qualitative accuracy. 4) Despite minor interpretive differences, the answer is contextually relevant, fully addresses both parts of the question (evolution of expense and what it indicates), and maintains semantic equivalence in factual content. Wording differences do not undermine correctness, but the characterization of 2024 as 'stable' rather than 'slightly reduced' introduces a small misinterpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 365,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola continued to value its non‑public equity holdings by applying discounted‑cash‑flow models and, when appropriate, **estimates of future sales proceeds** as a key input, only recording an impairment when a decline was judged “other‑than‑temporary.”  In the 2022 filing the company explicitly concluded that the $87 million excess of carrying value over fair value for its Japan bottling investment was temporary, so no impairment was taken—a stance reiterated in the 2023 and 2024 disclosures.  This consistent treatment shows management’s confidence that the Japanese market will recover and that its sales‑proceeds estimates remain reliable for assessing recoverability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key facts are accurate: the $87 million excess of carrying value over fair value in 2022 for the Japan investment is correctly stated, and the years (2022–2024) are properly referenced. The use of estimates of sales proceeds as a valuation input is accurately described. (2) The answer correctly notes that no impairment was recorded because the decline was deemed temporary, consistent across all three years—this matches the original answer’s claim about management’s confidence. (3) However, the LLM answer omits a key qualitative evolution highlighted in the ground truth: the increasing emphasis in 2023 and 2024 on market participant assumptions and external macroeconomic risks, particularly in emerging markets. While the LLM correctly identifies continuity in methodology and management confidence, it does not fully capture the shift toward greater attunement to external perspectives, which is central to the question’s second part about what the evolution reveals. (4) The reasoning is sound and synthesizes the multi-hop elements (Japan investment, valuation method, impairment judgment), but the analysis of management’s evolving approach is less nuanced than the original. Wording differences are acceptable, and the core message about confidence in recovery is preserved, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 392,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "\nOracle first placed its 2.300% senior unsecured notes due 2028 in March 2021 (Exhibit 4.14), and those notes remained the only 2.300% 2028 tranche through fiscal 2022 and 2023, with no new 2.300% issuance in either year; instead, in fiscal 2023 the company issued a fresh 4.5% senior note maturing in 2028 (Exhibit 4.16). This demonstrates Oracle’s long‑term debt strategy of laddering maturities and re‑entering the market with new tranches at adjusted coupons to match evolving interest‑rate conditions while using the 2028 horizon as a stable funding pillar.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2.300% Notes due 2028 as a consistent instrument across the period and accurately notes no new issuance of this tranche in fiscal 2022 or 2023. It correctly states that Oracle issued a 4.500% Note due 2028 in fiscal 2023, aligning with the ground truth. However, the LLM omits any mention of the 5.800% Notes due 2025 issued in fiscal 2024, which is a key part of the multi-year pattern and Oracle's evolving strategy. This omission reduces completeness and affects the full synthesis required by the question. (2) Quantitatively, all percentages and maturities mentioned are accurate: 2.300% due 2028, 4.5% (correctly interpreted as 4.500%) due 2028. The reference to March 2021 issuance is consistent with known facts (though outside the question’s scope), and no incorrect numbers are presented. (3) The reasoning correctly infers Oracle’s strategy of maturity laddering and adjusting coupons in response to interest rate conditions, which is consistent with the ground truth’s interpretation. However, the conclusion is less complete because it fails to incorporate the 2024 5.800% issuance, missing the upward trend in borrowing costs and the broader refinancing context. (4) The answer is contextually relevant and well-structured, focusing on Oracle’s debt strategy and using the 2028 maturity as a strategic anchor. Despite strong reasoning and accurate numbers, the failure to address all three fiscal years—particularly 2024—limits the correctness score to 7, as the multi-hop synthesis across 2022, 2023, and 2024 is incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 435,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "\nApple’s floating‑rate notes that mature in 2019 are only referenced in the 2014 indenture (Exhibit 4.4) and are captured in the “Term debt” row of the interest‑rate‑risk table (page 30 of the 2023 10‑K).  The related interest expense dropped from $194 million in fiscal 2023 to $139 million in fiscal 2024, indicating that the outstanding balance of those 2019 notes was reduced (or not refilled) during the period.  This pattern shows Apple is deliberately shrinking its short‑term floating‑rate exposure—paying down or replacing the 2019 notes with longer‑dated or fixed‑rate financing—to better manage interest‑rate risk and preserve liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors that deviate from the ground truth. (1) Quantitatively, the claim that interest expense dropped from $194 million in fiscal 2023 to $139 million in fiscal 2024 for the 2019 Floating Rate Notes is unsupported by the ground truth, which does not mention any interest expense figures or changes in outstanding balances. These numbers appear to be fabricated or misattributed. (2) The ground truth states that the Floating Rate Notes due 2019 were originally issued in 2014 and consistently disclosed in each year’s 10-K without modification, indicating no active issuance or repayment activity. The LLM incorrectly infers a deliberate reduction in short-term exposure based on non-existent interest expense trends. (3) Qualitatively, the reasoning is flawed: the model assumes that a decrease in interest expense implies a reduction in principal, but it fails to recognize that these notes matured in 2019—five years before the periods in question (2022–2024). It is highly improbable that Apple would still be carrying or paying interest on notes past their maturity date. The continued disclosure is likely for structural or reporting reasons (e.g., as part of a broader indenture), not ongoing liability. (4) The original answer emphasizes stability and passive disclosure; the LLM instead asserts an active debt management strategy, which contradicts the evidence. While the response attempts to address Apple's short-term debt strategy, its conclusions are based on incorrect data and faulty logic. Contextual relevance is moderate because it discusses the right topic (debt management) and cites relevant documents (10-K, indenture), but the core facts and synthesis are invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 472,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "\nThe repeated appearance of PepsiCo’s 4.000% Senior Note due 2047 in the 2022, 2023 and 2024 10‑K filings shows that the company treats this long‑dated, fixed‑rate instrument as a core element of its capital structure—using it to lock in low‑cost financing for the distant future and to project a stable, long‑term debt profile. In contrast, the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027 are shorter‑dated issues that are handled as more tactical, near‑term funding tools that can be retired or refinanced as market conditions change.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values—4.000% Senior Note due 2047, 2.150% due 2024, and 0.750% due 2027—are correctly stated, with accurate maturities and interest rates. No calculations were required, but the temporal presence across filings is correctly implied through 'repeated appearance' and '2022, 2023, and 2024 10-K filings'. (2) The answer addresses both parts of the multi-hop question: it explains the strategic role of the long-term 2047 note and contrasts it with shorter-dated instruments. The mention of the 2.150% note due 2024 appearing in the 2023 filing and the 0.750% due 2027 introduced in 2024 matches the ground truth's timeline. (3) The reasoning is sound: the LLM correctly infers that the persistent disclosure of the 2047 note reflects a stable, long-term financing strategy, while shorter-dated notes are treated as tactical. It captures the core insight about refinancing risk and financial stability, though it omits the explicit example of the matured 2.500% note due 2022 mentioned in the ground truth, which slightly reduces completeness. (4) Despite this minor omission, the semantic meaning and strategic interpretation are equivalent. The answer is contextually relevant, well-structured, and conveys the intended financial insight accurately. Quantitative accuracy is perfect; qualitative and overall correctness are excellent with only a slight deduction for missing the matured note example that strengthens the contrast.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 416,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "\nApple’s repeated reference to the 0.45 % Notes due 2016—though they matured in 2016 and have been retired—shows that the company continues to disclose the legacy instrument to give a complete picture of its historic debt structure and to satisfy regulatory reporting requirements.  This reflects a strategy of full, transparent disclosure of all debt‑related obligations, even after repayment, to assure investors that no hidden liabilities remain and to preserve legal flexibility for any future related matters.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 0.45% interest rate and 2016 maturity date are correct, and there are no numerical or date inaccuracies. The answer correctly identifies that the notes matured and were retired, and that Apple continues to disclose them post-maturity. The reasoning is sound and aligns with the ground truth in emphasizing transparency and regulatory compliance. However, the LLM omits a key detail present in the original answer: the repeated reference to the Officer's Certificate dated May 3, 2013, across multiple filings, which strengthens the argument for a deliberate, consistent disclosure policy. While the LLM captures the general strategy of transparent disclosure and investor assurance, it does not fully reflect the depth of Apple’s documented continuity in referencing the same historical documentation, which implies a more systematic and possibly conservative record-keeping practice. This omission slightly weakens the qualitative accuracy, though the core reasoning remains logically valid and contextually appropriate. The answer is highly relevant and correctly interprets Apple’s disclosure strategy, earning high marks for contextual relevance and quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 348,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "\nLockheed Martin has continued to shrink its defined‑benefit liability by using plan assets to purchase group‑annuity contracts (GACs) – building on the $4.9 bn annuity purchase completed on August 3 2021 that transferred about $4.9 bn of obligations and generated a $1.7 bn non‑cash settlement charge (see page 19 of the 2021 10‑K).  Subsequent risk‑transfer transactions through 2022‑2024 have further reduced the measured pension obligation (the 2024 discount‑rate increase alone lowered the obligation by roughly $1.8 bn) and cut annual PBGC premiums, while the company repeatedly states it will keep evaluating additional annuity purchases that are expected to produce further non‑cash settlement charges that could materially affect earnings in the period they occur (see pages 46‑47 of the 2024 10‑K).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states the $4.9 billion obligation transfer and $1.7 billion noncash charge from August 2021 (citing the 2021 10-K), which matches the original answer's data. It also notes the continuation of risk-transfer transactions through 2022–2024 and mentions a $1.8 billion reduction in pension obligation due to the 2024 discount-rate change—an additional detail not in the ground truth but consistent with plausible financial dynamics and not contradictory. (2) The answer correctly identifies that future transactions could lead to material noncash charges affecting earnings, citing pages 46–47 of the 2024 10-K, which supports the forward-looking intent described in the original answer. (3) Multi-hop reasoning is sound: it synthesizes past actions (2021 transaction), ongoing strategy (2022–2024), financial impacts (noncash charges, PBGC savings), and future expectations. (4) Minor deduction in quantitative accuracy due to introducing the $1.8 billion discount-related reduction, which was not in the ground truth and slightly shifts focus from transaction-driven reductions to actuarial changes—though not incorrect, it adds a nuance not requested. Otherwise, all entities (Lockheed Martin, GACs, noncash charges), years, and strategic intent are accurately represented. The answer fully addresses pension obligation reductions, expected future actions, and financial impact on earnings, making it contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 419,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "\nBetween 2022 and 2024 Thermo Fisher shifted from a change‑in‑control retention framework that applied only to CEO Marc N. Casper to a program that also covers other senior officers. This expansion is documented by the company’s 2023 filing of a separate “Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.17 in the 2023 Form 10‑K), a form that remained in use in the 2024 filing, thereby formally extending retention terms to the broader officer class.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Thermo Fisher Scientific's Executive Change In Control Retention Agreements from 2022 to 2024. It correctly identifies that in 2023, a new form of agreement was filed for officers other than Marc N. Casper (Exhibit 10.17 in the 2023 10-K), and that this form was reused in 2024, indicating continuation. The date of the 2023 agreement (April 1, 2023) is not mentioned, which is a minor omission from the ground truth, but the core timeline is accurate. The LLM incorrectly implies that in 2022 the framework applied *only* to Casper, whereas the original answer clarifies that a form for other officers (dated March 16, 2018) was already in place and disclosed in 2022—meaning the program was not *only* for Casper even then. This mischaracterization slightly affects the reasoning but not the overall conclusion about formalization and expansion. All entities (Thermo Fisher, Marc N. Casper, officers, 2023/2024 filings) are correct. The reasoning is mostly sound, showing synthesis across years, though the multi-hop logic slightly falters in accurately representing the 2022 state. Wording is semantically close and relevant. Quantitative accuracy is high—dates and document references are mostly correct, with only the 2018 form date missing but not misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 370,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "\nPepsiCo’s 2022‑2024 filings keep the 2.750 % Senior Note due 2051 on the balance sheet as a fixed‑rate tranche with no repayment or early‑retirement disclosed (see the “Form of 2.750 % Senior Note due 2051” entries on pages 115 (2022), 129 (2023) and 134 (2024)).  At the same time the company has issued newer senior notes at higher coupons and entered into cross‑currency interest‑rate swaps to hedge exposure (e.g., the $500 million swaps noted on page 104), indicating a strategy of preserving the low‑cost, long‑dated debt while managing interest‑rate risk rather than refinancing it as rates rise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 2.750% Senior Note due 2051 is consistently referenced across 2022–2024 filings, and the mention of $500 million swaps (though not specifying the exact note) matches disclosed hedging activities. Page numbers cited (115, 129, 134) are plausible and consistent with exhibit index locations. (2) The LLM correctly identifies that the note remains on the balance sheet with no early retirement, which is consistent with the ground truth’s observation that it was repeatedly listed in exhibit indices without change in treatment. (3) The reasoning is sound: the model infers that PepsiCo preserved low-cost, long-dated debt despite rising rates, a conclusion supported by the introduction of higher-coupon notes (e.g., 5.250% due 2054) while retaining the 2.750% note. The mention of cross-currency interest-rate swaps adds contextual depth about risk management, which complements the core strategy. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly reference the 2021 Form 8-K linkage noted in the ground truth (a multi-hop detail), and the $500 million swap is mentioned without full context (e.g., currency or maturity). However, these omissions do not undermine the overall correctness. The answer is semantically equivalent and contextually excellent, capturing the essence of PepsiCo’s stable long-term debt strategy in a rising rate environment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 415,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "\nFrom 2022 through 2024 Apple repeatedly tapped the same 4.45 % Notes‑due‑2044 series, adding new tranches each fiscal year and re‑issuing the securities under the original May 6 2014 officer’s certificate.  This multi‑year pattern shows that Apple’s long‑term capital strategy is built around steady, low‑cost, long‑dated fixed‑rate borrowing—using the 2044 note program to fund growth and shareholder returns while maintaining a strong, diversified balance‑sheet profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies that significantly deviate from the ground truth. (1) Quantitatively, while the 4.45% interest rate and 2044 maturity date are correct, and the May 6, 2014 Officer's Certificate is correctly referenced, the claim that Apple 'added new tranches each fiscal year' and 're-issued the securities' from 2022 to 2024 is factually incorrect. The ground truth states that the notes were consistently referenced in filings, indicating ongoing liability without redemption or restructuring—there is no evidence of re-issuance or new tranches. (2) The answer is incomplete in its reasoning: it misrepresents the nature of the activity (ongoing disclosure vs. active re-issuance), which distorts the strategic interpretation. (3) Entity accuracy is mostly correct—Apple, the note terms, and dates are accurate. (4) Multi-hop reasoning is flawed: the model incorrectly infers repeated issuance from the repeated mention of the same instrument in annual disclosures, failing to distinguish between disclosure of existing debt and new debt activity. This undermines the qualitative accuracy. (5) Despite the factual errors, the answer remains contextually relevant by addressing Apple’s long-term capital strategy and tying it to fixed-rate borrowing, which aligns with the strategic implication in the ground truth. However, the conclusion is based on incorrect premises. Semantic equivalence fails due to the central inaccuracy about re-issuance. Minor wording flexibility is acceptable, but inventing financial activity not present in the source data constitutes a major factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 440,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "\nFrom 2022 to 2023 the pension plan’s allocation to Collective Trust and Other Funds fell from **$498 million (recorded at NAV in the 2022 10‑K)** to **$382 million (recorded at NAV in the 2023 10‑K)** – a drop of roughly 23 % in absolute dollars, while the fund’s share of the total NAV portfolio rose slightly because overall plan assets shrank.  \n\nThe 2024 filing clarifies that these investments are valued daily using the **NAV of their underlying publicly‑traded holdings**, so the plan’s exposure is fully transparent and can be adjusted quickly as market conditions or strategic targets change.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 allocation amount: it reports $498 million instead of the correct $756 million from the ground truth. This significantly undermines the quantitative accuracy. The 2023 figure of $382 million is correct. The claimed 23% drop is inconsistent with the correct figures—(756 - 382)/756 ≈ 50% decrease, not 23%. The LLM’s calculation appears based on an incorrect baseline. (2) The ground truth does not mention any change in the total NAV portfolio size or the relative share of Collective Trust and Other Funds within the total; thus, the claim that the fund’s share rose slightly due to overall asset shrinkage is unsupported and likely incorrect. (3) The qualitative reasoning about the 2024 valuation methodology is partially sound: the LLM correctly identifies NAV as the valuation method and links it to transparency and adjustability. However, it adds unsupported detail—'daily valuation using NAV of underlying publicly-traded holdings'—which goes beyond the original answer’s description (which mentions NAV derived from commingled funds and LLCs with global stock and short-term investments). While NAV typically implies regular valuation, the specific frequency ('daily') and characterization of holdings as 'publicly-traded' are not confirmed in the ground truth. (4) The answer addresses both parts of the question—evolution of allocation and 2024 methodology—so it is contextually relevant. However, due to the major error in the 2022 dollar amount and the resulting incorrect analysis of the change magnitude, the overall correctness is significantly compromised. The multi-hop synthesis fails because the first hop (2022 allocation) is wrong, leading to flawed conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 478,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑Ks each list the same “Officer’s Certificate of the Registrant, dated May 6 2014” that governs the 1.05 % Notes due 2017 (Exhibit 4.4 – see page 55 of the 2022 filing, page 56 of the 2023 filing and page 5 of the 2024 filing). By repeatedly including that historic certificate—originally filed when the notes were issued—Apple preserves an auditable record of the original financing terms even after the notes have matured and been retired. This practice reflects a deliberate retention of legacy debt documentation, ensuring that investors, analysts and regulators can trace and verify Apple’s historical capital‑structure disclosures across reporting periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the Officer's Certificate is dated May 6, 2014, relates to the 1.05% Notes due 2017, and was included in Apple's 10-K filings for fiscal years 2022, 2023, and 2024. The exhibit number (4.4) and page references across filings are accurately cited, demonstrating precise retrieval. (2) Quantitative elements—dates, percentages, and document identifiers—are factually correct with no discrepancies. (3) The reasoning correctly infers that Apple’s inclusion of a matured debt instrument’s documentation reflects a policy of maintaining historical transparency and auditability in capital structure disclosures. The multi-hop synthesis—linking repeated inclusion of a retired debt certificate to broader documentation retention and disclosure practices—is logically sound. (4) The answer captures the core implication: Apple preserves legacy records to ensure traceability for investors, analysts, and regulators. The only minor limitation is that it does not explicitly use the phrase 'documentation retention practices' or directly state that this reflects a 'deliberate approach to preserving full historical context' as in the original, but the meaning is semantically equivalent. Wording differences are acceptable under semantic equivalence. No calculation errors or entity misidentifications. Fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 394,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "\nUnion Pacific trimmed its direct corporate‑stock position in the pension plan from about **$1.1 bn (≈37 % of total plan assets) at year‑end 2022** to roughly **$181 m (≈5 % of assets) at year‑end 2023** (see page 58).  The 2024 disclosure no longer breaks out corporate‑stock separately, but it keeps the overall equity allocation steady at **≈24 % of plan assets** and describes using “registered investment companies” for market exposure rather than individual stocks (see pages 56 and 74).  This shift signals that Union Pacific is moving away from a concentrated, individual‑corporate‑stock stance toward a more diversified, index‑oriented equity strategy and a broader rebalancing of the pension portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Union Pacific's allocation to corporate stock was $1,990 million in 2022, not $1.1 billion as stated in the LLM answer. The 2023 figure of $181 million is correct, but the 2024 figure is reported as $1,116 million in the ground truth, while the LLM claims the data is no longer broken out—this contradicts the verified answer which includes a specific dollar amount for 2024. Additionally, the LLM introduces percentages (37%, 5%, 24%) not present in the original answer and unsupported by the knowledge graph, raising concerns about sourcing. (2) The calculation of a 'drop of over 90%' between 2022 and 2023 in the original answer is accurate: (1,990 - 181)/1,990 ≈ 91%. The LLM’s implied drop from $1.1B to $181M would be ~84%, which is inconsistent. The partial rebound to $1,116M in 2024 is omitted in the LLM response, undermining completeness. (3) The reasoning about a strategic shift away from direct equity exposure is partially sound and aligns with the broader interpretation in the original answer. The mention of using 'registered investment companies' instead of individual stocks suggests awareness of a diversification trend, which is plausible contextually, but the LLM fails to mention the shift toward fixed income instruments like bonds and federal securities, a key element in the ground truth that explains the conservative posture. (4) While the LLM captures the general direction of the strategy shift (from concentrated stock holdings to diversified exposure), it misses the full multi-hop synthesis: the significant drop, partial recovery, and movement into fixed income. The contextual relevance is high because it addresses the evolution and strategic implication, but the factual foundation is flawed, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 514,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "\nMRK’s Prevymis sales have risen each year—$428 million in 2022, $605 million in 2023 and $785 million in 2024—representing roughly a 30‑40 % year‑over‑year increase and an 83 % cumulative gain over the three‑year span.  This upward trajectory signals accelerating market adoption of the CMV‑prophylaxis product within the Hospital Acute Care segment and underscores its growing strategic importance as a high‑growth, high‑margin driver of the segment’s overall revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the sales figures—$428 million in 2022, $605 million in 2023, and $785 million in 2024—are accurate and match the original answer exactly. The year-over-year growth rates are approximately 41% (2022 to 2023) and 30% (2023 to 2024), so the stated '30–40%' range is reasonable. The cumulative growth from 2022 to 2024 is (785 - 428) / 428 ≈ 83.4%, correctly rounded to 83%, demonstrating precise calculation. (2) The answer is complete, addressing both the evolution of sales over time and the implications for market adoption and strategic importance. (3) Entity accuracy is perfect: MRK (Merck), Prevymis, and the Hospital Acute Care segment are correctly identified and contextualized. (4) The reasoning is sound and adds value beyond the ground truth by quantifying growth rates and characterizing Prevymis as a 'high-growth, high-margin driver,' which is a logical inference from the consistent upward trend. This demonstrates strong multi-hop synthesis and qualitative insight. (5) The semantic meaning fully aligns with the original answer, with enhanced detail that improves clarity without introducing error. All scoring categories warrant the maximum score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 353,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "\nPepsiCo continues to disclose the same “Form of 3.000% Senior Note due 2027” in all three annual reports—listed on page 129 of the 2022 filing, page 126 of the 2023 filing, and page 127 of the 2024 filing, each time noting that it is a senior unsecured obligation incorporated by reference to the 2017 8‑K.  This consistent treatment shows that the company still regards the 2027 note as a core component of its laddered, fixed‑rate debt portfolio, using it to lock in long‑term financing and manage interest‑rate risk.  The repeated inclusion signals a deliberate, long‑term debt strategy that emphasizes staggered maturities and stable funding sources.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts: the 3.000% Senior Note due 2027 was consistently disclosed in PepsiCo's 2022, 2023, and 2024 annual filings, and it is accurately described as a senior unsecured obligation incorporated by reference from the 2017 8-K. The page numbers cited (129, 126, 127) align with typical exhibit locations, and the interest rate (3.000%) and maturity (2027) are correct—meeting quantitative accuracy. However, the LLM omits key contextual evolution highlighted in the ground truth: the changing composition of accompanying debt instruments across years (e.g., shift from medium-term notes in 2022 to longer-dated 2046 notes in 2023 and newer short-term instruments in 2024). This evolution is central to the question’s focus on how the *characterization* of the note changed over time to reflect a maturing debt strategy. While the LLM correctly infers a 'laddered, fixed-rate debt portfolio' and 'staggered maturities,' it fails to substantiate this with the multi-hop synthesis of comparative instruments across filings. The conclusion about a stable, long-term strategy is reasonable but less nuanced than the original answer, which ties the strategy directly to refinancing risk management and market-responsive issuance of lower-rate notes. Thus, while factually sound and contextually relevant, the answer lacks completeness in tracing the evolving context, weakening the qualitative accuracy of the reasoning chain.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 401,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "\nAdobe has steadily deepened Frame.io’s integration with its Creative Cloud portfolio: in 2022 it was introduced mainly as a cloud‑based video‑review tool with basic connectivity to Premiere Pro and After Effects; by 2023 the platform added frame‑accurate commenting, Camera‑to‑Cloud upload, and direct integration with Photoshop, Lightroom and Workfront, while also linking to Adobe Express and Firefly AI services; and by 2024 Frame.io was positioned as a core collaboration hub across the entire Creative Cloud suite, supporting still images and PDFs, offering AI‑enhanced workflows through Firefly, and being embedded in Adobe GenStudio for end‑to‑end content creation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in timeline, functional evolution, and integration depth, with accurate dates (2022, 2023, 2024) and correct identification of Adobe and Frame.io. It accurately captures the progression from initial integration to deeper Creative Cloud embedding. However, there are minor factual inaccuracies in the sequence and scope of integrations: (1) The claim that Frame.io had direct integration with Photoshop, Lightroom, and Workfront by 2023 is incorrect—according to the ground truth, these were emphasized in 2024, not 2023. (2) The LLM states that integration with Firefly AI and Adobe Express occurred by 2023, but the original answer only confirms Firefly and Substance 3D integration in the context of Adobe GenStudio in 2024. (3) The original answer notes that still images, design files, and PDFs were introduced in 2023, while the LLM incorrectly attributes support for still images and PDFs to 2024. These sequencing and attribution errors affect the qualitative accuracy of the multi-hop reasoning, particularly in tracking year-by-year capability rollouts. Despite these issues, the overall narrative of deepening integration and strategic positioning is sound and contextually relevant. Quantitative elements (years, product names) are accurate, and no numerical calculations are involved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 369,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 2.40 % Notes due 2023 were disclosed in Exhibit 4.3 as an outstanding senior unsecured tranche, with the indenture details identifying the amount and maturity. By the 2023 filing the same series was still listed but now carried a current‑liability classification, indicating that the notes were approaching maturity and that Apple was preparing to address their repayment. The 2024 filing no longer presents the 2.40 % Notes as a separate outstanding issue—reflecting that they had been retired or refinanced—showing Apple’s proactive debt‑maturity management of retiring near‑term tranches and replacing them with longer‑dated borrowing to keep its maturity profile under control.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the presence of the 2.40% Notes due 2023 in Apple's 2022 and 2023 filings and their absence in the 2024 filing, accurately reflecting the timeline and disclosure evolution. All numeric values—interest rate (2.40%), maturity year (2023), and years of disclosure (2022–2024)—are correct. (2) Quantitative accuracy is perfect: percentages, years, and classification changes (e.g., current liability in 2023) align with expected financial reporting practices and the ground truth. (3) The multi-hop reasoning is mostly sound—synthesizing changes across three years of filings to infer debt management strategy. However, the LLM concludes that Apple 'retired or refinanced' the notes and suggests 'replacing them with longer-dated borrowing,' which goes beyond the evidence. The ground truth only supports retirement at maturity (given no early action and subsequent removal), but there is no indication in the original answer about refinancing or replacement with new debt. This introduces an unsupported inference, slightly weakening the qualitative accuracy. (4) Despite this overinterpretation, the answer remains highly relevant and factually grounded in the disclosure pattern. The core facts are correct, and the reasoning is logical, just slightly overstated in strategic interpretation. Hence, a score of 8 is warranted for correctness—strong but not fully aligned with the more conservative conclusion in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 407,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Multiple‑Purpose Locomotive fleet shrank modestly—total units fell from roughly 7,240 (6,204 owned + 1,038 leased) to about 6,890 (5,973 owned + 920 leased)—while the average age climbed from roughly 22.5 years to 25.2 years.  This pattern shows Union Pacific is deliberately right‑sizing its locomotive base, keeping a smaller, older core of owned units and pulling back on leased capacity, which reflects an asset‑management strategy that prioritizes extending the life of existing equipment and controlling capital outlays while maintaining sufficient capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all quantitative aspects: total locomotives in 2022 (7,242 ≈ 7,240), owned (6,204) and leased (1,038), and 2024 totals (6,893 ≈ 6,890), with owned (5,973) and leased (920) units accurately reflected. The average age progression—22.5 in 2022, 25.2 in 2024—is correctly stated, though the intermediate 2023 value (24.3 years) is omitted but not required for overall trend accuracy. Minor rounding (e.g., 7,242 to 7,240) is acceptable and common in reporting.\n\n2) Quantitative accuracy is perfect: all numbers match or are appropriately rounded versions of the ground truth. Sums are correct: 6,204 + 1,038 = 7,242; 5,973 + 920 = 6,893. Age increase from 22.5 to 25.2 years is accurately captured.\n\n3) The reasoning is sound and captures the multi-hop synthesis: decline in total, owned, and leased units over three years, combined with aging fleet, leads to a logical conclusion about asset management. The interpretation—right-sizing, reliance on older owned units, reduced leasing, capital discipline—is consistent with the ground truth’s implication of a conservative strategy. The LLM adds slightly more interpretive nuance (e.g., 'extending life of existing equipment') but remains factually grounded.\n\n4) The answer is semantically equivalent to the original. It addresses both parts of the question: changes in fleet composition/age profile and the strategic implication. The omission of the 2023 age (24.3) is not material to the overall trend and does not reduce correctness. All entities (Union Pacific, Multiple Purpose Locomotives, years 2022–2024) are correct. Contextual relevance is full and precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 451,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "\nMK‑8591A (doravirine + islatravir) had already entered Phase 3 in February 2020 and stayed in that phase through 2022‑2024. In 2022 the program was placed on a partial FDA clinical hold regarding higher‑dose islatravir, but after submitting additional data the hold was released, allowing the trial to resume and the regimen to advance to an NDA filing and FDA regulatory review by 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly states that MK-8591A entered Phase 3 in February 2020 and remained in that phase through 2022–2024, it incorrectly claims that the FDA lifted the clinical hold and that the program advanced to NDA filing and FDA regulatory review by 2024. According to the ground truth, the FDA only lifted a full hold but maintained a partial hold on higher doses of islatravir in 2024—there was no mention of an NDA filing or regulatory review. Additionally, the LLM omits the key development of MK-8591D (islatravir + lenacapavir) entering Phase 3 in October 2024, which reflects a strategic shift not captured in the response. (2) Quantitatively, the entry date (February 2020) is correct, and the timeline of being in Phase 3 through 2022–2024 aligns with the original answer. However, the claim of NDA filing and regulatory review by 2024 is unsupported and incorrect, introducing a false milestone. (3) The multi-hop reasoning is flawed: the model fails to synthesize the evolution of Merck’s strategy involving the new MK-8591D formulation and misrepresents the regulatory status by implying full progression to review, when the program remained under development with restrictions. It also mischaracterizes the sequence of FDA interactions. (4) Despite these errors, the answer is contextually relevant—it addresses the clinical phase progression and FDA interactions as asked, and focuses on the correct drug and timeframe. However, major factual and reasoning gaps reduce correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 433,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "\nFrom 2022 through 2024 Merck advanced MK‑1308A – the anti‑CTLA‑4 antibody quavonlimab combined with pembrolizumab – from a Phase 3 trial that began in April 2021 (first noted in the 2022 10‑K “Cancer” table of contents, pages 25‑30) to a fully enrolled pivotal study that remained central to its oncology pipeline (still listed in the 2023 10‑K “Cancer” table, page 21).  In the 2024 filing the company explicitly places MK‑1308A in its “Immuno‑oncology” pillar and highlights it as a key investigational therapy for renal‑cell carcinoma (RCC) (see 2024 10‑K, page 49).  This progression shows that Merck is deliberately positioning a CTLA‑4 + PD‑1 combination as a flagship innovation for RCC, underscoring its strategic focus on next‑generation checkpoint‑based, combination immunotherapies in the disease.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1308A is a combination of quavonlimab (anti-CTLA-4) and pembrolizumab; it entered Phase 3 in April 2021; it was listed in Merck’s 2022, 2023, and 2024 10-Ks as part of the RCC pipeline; and by 2024 it was explicitly highlighted in the 'Immuno-oncology' pillar. The dates and progression timeline are accurate. (2) Quantitative accuracy is perfect: the April 2021 start date is correctly cited, and there are no numerical errors. The LLM correctly references document locations (e.g., page numbers), though these are not part of the ground truth but do not detract from factual correctness. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to show evolving strategic emphasis, correctly inferring sustained prioritization and Merck’s focus on combination immunotherapy. The conclusion about 'next-generation checkpoint-based combinations' is a valid interpretation of the trend. (4) The only minor gap is that the LLM mentions the trial was 'fully enrolled' in 2023, which is not present in the ground truth and cannot be verified from the provided answer—this is a slight overreach but does not contradict known facts. Otherwise, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 414,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "\nMicrosoft’s 4.000% Notes due 2021 are disclosed in the same “Third Supplemental Indenture” (Exhibit 4.6) in the 2022, 2023 and 2024 Form 10‑K filings; the description of the indenture, its date ( February 8 2011 ) and the notes’ terms are unchanged across all three filings, with no mention of repayment, amendment or a new issuance to replace the series. This consistent disclosure indicates that the 4.000% 2021 notes remain an outstanding, unchanged tranche of Microsoft’s senior unsecured debt, reflecting a long‑term debt strategy that maintains a diversified ladder of maturities rather than actively refinancing this particular issue.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its core assertion that Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across the 2022, 2023, and 2024 10-K filings, appearing in Exhibit 4.6 (Third Supplemental Indenture), and that there was no indication of refinancing or amendment. However, there is a critical factual error in the date of the supplemental indenture: the LLM states it was dated 'February 8, 2011', while the ground truth correctly identifies that date as the filing date of the 8-K that reported the issuance, not the indenture's execution date. The original Indenture is correctly dated May 18, 2009, in the ground truth, and the Third Supplemental Indenture was executed on February 8, 2011 — but the LLM incorrectly presents the date without clarifying its context, potentially misleading readers about the nature of the date. This affects quantitative accuracy. The reasoning about Microsoft’s long-term debt strategy maintaining a diversified maturity ladder is a reasonable inference, though slightly more interpretive than the ground truth, which sticks to the factual observation that no restructuring occurred. The answer addresses all parts of the question and synthesizes information across years correctly (multi-hop reasoning is sound), and the entity (Microsoft), financial instrument (4.000% Notes due 2021), and exhibit reference (4.6) are accurate. Wording differs but meaning is largely equivalent, except for the date issue. Hence, correctness is reduced due to the date inaccuracy, but not severely, as the overall conclusion about consistency and lack of refinancing remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 444,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm’s automotive‑related revenue in its QCT segment grew sharply—from about **$1.5 billion** in 2022 to **$2.9 billion** in 2024—with the digital‑cockpit portion (the “automotive (2)” line that includes connectivity, digital cockpit and ADAS/AD) showing the strongest increase.  This rise reflects a deliberate strategic shift: Qualcomm is moving from a handset‑centric model toward a broader “digital‑cockpit and automotive‑systems” business, positioning its low‑power, high‑performance compute and connectivity technologies as core supplies for next‑generation vehicle infotainment and ADAS platforms.  The revenue trajectory therefore signals that the company’s automotive business is maturing into a material, high‑margin growth engine that now contributes an expanding share of total sales.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures—$1.5 billion in 2022 and $2.9 billion in 2024—that are not present in the original ground truth and cannot be verified from the provided knowledge graph. These numbers are likely fabricated or inferred incorrectly, severely undermining quantitative accuracy. The ground truth does not provide any actual revenue amounts for digital cockpit or automotive segment revenues in any year, only strategic and reporting developments. (2) The LLM claims that the 'automotive (2)' line includes digital cockpit, connectivity, and ADAS/AD, and attributes strong revenue growth specifically to the digital cockpit portion. However, the original answer does not break down revenue contributions by sub-component nor confirm such categorization in financial reporting beyond stating that digital cockpit became a distinct revenue stream in 2023. This introduces unsupported granularity. (3) While the LLM captures the general strategic shift toward automotive and digital cockpit as a growth area, it misrepresents the evolution: the original answer emphasizes structural and reporting changes (e.g., formal categorization in 2023, operationalization in 2024) rather than revenue growth as evidence. The multi-hop reasoning is partially sound—connecting digital cockpit to broader automotive transformation—but incorrectly substitutes financial data for qualitative strategic milestones. (4) Despite the factual inaccuracies, the LLM answer remains contextually relevant by addressing Qualcomm's strategic positioning and the significance of digital cockpit in its automotive transformation. It correctly identifies the pivot toward software-defined vehicles and the importance of compute/connectivity technologies. However, the inclusion of false quantitative claims significantly reduces overall correctness. The qualitative reasoning would score higher if not for the unsupported numbers. Final scores reflect major penalty on quantitative accuracy (3), moderate qualitative accuracy (5) due to correct direction but flawed support, high contextual relevance (8), and an overall correctness score of 4 due to critical factual errors in financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 590,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "\nLMT’s variable‑interest‑rate swap program was essentially unchanged from 2022 through 2024, holding a notional of roughly **$1.3 billion** at the end of each of those years (up from about $0.5 billion in 2021).  This stable, sizable hedge shows the company deliberately expanded its swap coverage to offset the interest‑rate risk of its fixed‑rate debt and has maintained that level of protection as rates rose, reflecting a disciplined, risk‑focused strategy rather than aggressive or fluctuating hedging.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative timeline. According to the ground truth, LMT had $500 million in notional swaps in 2022, which increased to $1.3 billion in 2023 and remained there in 2024. However, the LLM claims the notional was 'roughly $1.3 billion' at the end of *each* year from 2022 through 2024, which is incorrect—this misrepresents the key trend of a major increase from 2022 to 2023. It also references 2021 ($0.5 billion), which was not part of the original question or ground truth, introducing unverified data. (2) The calculation of a 'fourfold increase' is implied in the ground truth (from $500M to $1.3B is a 2.6x increase, not fourfold), but the LLM fails to note any change between 2022 and 2023, instead asserting stability across all years, which contradicts the documented increase. The numbers themselves ($500M and $1.3B) are factually present in the domain, but their temporal assignment is wrong. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that maintaining a large notional amount reflects a disciplined risk management strategy, and linking swaps to hedging fixed-rate debt is reasonable. However, it misses the strategic *shift* indicated by the 2022–2023 increase, which is central to the question about *evolution*. By claiming the program was 'essentially unchanged,' it fails to capture the key dynamic in the data. (4) Contextual relevance is high—the answer addresses interest rate swaps, notional amounts, risk management, and strategy. But due to the critical error in temporal quantification, the correctness and quantitative accuracy scores are low. The qualitative reasoning is partially accurate but based on flawed premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 477,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Microsoft repeatedly discloses the 3.950 % Notes due 2056 through the same Eleventh Supplemental Indenture (Exhibit 4.14) and classifies them as outstanding long‑term debt, with only a modest decline in interest expense that reflects the maturing of earlier tranches rather than any repayment of the 2056 notes. Instead of refinancing or retiring this ultra‑long‑dated issuance, the company treats it as a permanent, low‑cost funding pillar and manages its overall maturity profile by issuing new debt to roll off nearer‑term maturities while letting the 2056 notes remain on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 are consistently referenced across 2022–2024 10-Ks under the Eleventh Supplemental Indenture (Exhibit 4.14), and they remain outstanding with no indication of early redemption or refinancing. The interest expense decline is correctly attributed to maturing tranches, not the 2056 notes. (2) Quantitative elements—interest rate (3.950%), maturity year (2056), and indenture reference—are factually accurate. No calculations are required, but the comparative observation about interest expense is reasonable and consistent with disclosure patterns. (3) The multi-hop reasoning is sound: the model correctly infers from repeated disclosure that Microsoft maintains a long-term capital strategy by preserving ultra-long-dated debt while managing near-term maturities through new issuances. This reflects a strategic prioritization of long-term stability, as implied in the original answer. (4) The LLM adds value by characterizing the 2056 notes as a 'permanent, low-cost funding pillar'—a slight interpretive extension but logically supported by the data. Only minor deduction from 10 to 9 in correctness and qualitative accuracy due to slightly stronger characterization of permanence, which, while plausible, is not explicitly stated in the ground truth. Otherwise, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 404,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "\nMicrosoft repeatedly cites the Eleventh Supplemental Indenture dated August 8 2016—under which its $3.7 billion 3.700 % Notes due 2046 were issued—to remind investors that this long‑dated debt remains outstanding and on the company’s balance sheet. By continuing to reference the same indenture in its 2022, 2023 and 2024 Form 10‑K filings, Microsoft signals that the terms governing those notes are stable and that its long‑term debt structure is anchored by a sizable, low‑cost obligation that will not mature for another two decades, underscoring a consistent and deliberate approach to its long‑term financial obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the Eleventh Supplemental Indenture dated August 8, 2016, and its relevance to the 3.700% Notes due 2046, which is consistently referenced in Microsoft's 2022, 2023, and 2024 filings. (2) The only minor discrepancy is the introduction of a $3.7 billion figure, which is not present in the original answer or ground truth; while this amount may be factually correct, it was not part of the verified knowledge graph data and thus introduces unverified quantitative information. All other numbers—interest rate (3.700%), maturity year (2046), and dates—are correct. (3) The reasoning is sound: the LLM correctly infers that repeated referencing indicates ongoing obligations, stability in terms, and a deliberate long-term debt strategy. It synthesizes the multi-hop concept that consistent disclosure reflects structural continuity in Microsoft’s debt management. (4) The answer is contextually excellent, addressing the significance of the repeated reference and linking it directly to long-term debt structure and financial consistency. The added interpretation about 'low-cost obligation' and 'two decades' is reasonable extrapolation. Due to the unverified dollar amount, a full 10 is not warranted, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 372,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "\nMicrosoft first listed the 2.125 % Notes due 2021 in the 2022 Form 10‑K (exhibit 4.1) as a long‑term debt issuance. As the 2021 maturity approached, the company re‑classified the remaining balance as a current liability in the 2023 filing, and by the 2024 filing the notes were no longer on the balance sheet—having been retired and refinanced with newer longer‑dated debt. This evolution shows that Microsoft actively manages its debt maturities, using cash and new issuances to roll over maturing notes and extend the average term of its financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in several key aspects. (1) Quantitatively, the LLM claims the notes were 'no longer on the balance sheet' by 2024 and had been 'retired and refinanced,' but the original answer confirms the 2.125% Notes due 2021 were still referenced in Exhibit 4.1 of Microsoft's 2024 10-K, indicating continued disclosure or documentation presence despite their 2021 maturity. The LLM incorrectly states the notes were reclassified as current liabilities in 2023 and then removed—there is no evidence in the ground truth for reclassification or retirement. (2) The LLM fabricates a narrative of refinancing and retirement not supported by the data; the ground truth explicitly states the continued listing raises questions about refinancing or reporting lags, indicating uncertainty, not confirmation. (3) The LLM misrepresents the timeline: it claims the notes were first listed in the 2022 10-K, but the original answer notes they were listed in Exhibit 4.10 of the 2022 filing under a 2013 indenture, meaning they were not newly issued or first disclosed then. (4) The reasoning is flawed: the LLM assumes reclassification and retirement based on maturity, but the ground truth shows persistent disclosure across three years post-maturity, suggesting either rollover, extension, or reporting inertia—none of which support the confident conclusion of refinancing. (5) While the LLM addresses the question's intent (debt management strategy), its factual inaccuracies severely undermine the response. The contextual relevance is moderate because it attempts to interpret strategic implications, but the incorrect facts lead to a misleading conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 462,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "\nThe 2.000% Notes due 2023 were first created in August 2016 through the Eleventh Supplemental Indenture and remained on Microsoft’s balance sheet through the 2022 filing.  Subsequent 2023 and 2024 filings show a decline in interest expense and no new 2.000% 2023 issuances, indicating that the company retired the outstanding 2023‑maturity notes as they matured rather than replacing them with fresh issuances.  This reflects Microsoft’s debt‑management strategy of maintaining a stable, low‑coupon long‑term debt base and proactively retiring and rolling‑over maturing tranches to manage leverage and interest costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the Eleventh Supplemental Indenture dated August 8, 2016, and the existence of the 2.000% Notes due 2023, it incorrectly claims that Microsoft retired the notes upon maturity and that there was a decline in interest expense in 2023 and 2024. The ground truth states that Microsoft continued to reference the same notes in filings through 2024, indicating the debt was still reported—likely because it had not yet been settled or was still part of disclosed debt schedules despite maturity. The claim of declining interest expense and retirement of notes is unsupported by the provided truth. (2) Quantitatively, the interest rate (2.000%) and issuance date (August 8, 2016) are correct, but there are no actual financial figures (e.g., principal amount, interest expense values) provided in either answer to verify calculations. The LLM fabricates a trend in interest expense without data. (3) The multi-hop reasoning is flawed: the model infers retirement and rollover strategy based on absence of new issuances and assumed declining expenses, which contradicts the ground truth that the consistent presence of the note in filings indicates ongoing disclosure and no refinancing. The correct inference is stability and non-refinancing, not proactive retirement and rollover. (4) Contextual relevance is moderate—the response addresses Microsoft’s debt strategy and references the correct indenture and note terms—but the conclusion about strategy is opposite to the truth: the truth emphasizes stability and lack of change, while the LLM describes active management and rollover. This fundamental contradiction severely undermines correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 475,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "\nLockheed Martin has steadily reduced the size of its defined‑benefit obligations by using the master retirement trust to purchase group‑annuity contracts (GACs); by the end of 2022 the company had transferred roughly **$11.6 billion** of pension liabilities (including the $4.9 billion GAC purchase in 2021) and, in 2023, continued to evaluate and execute additional risk‑transfer transactions—though no new multi‑billion‑dollar transfer was disclosed, the firm reiterated its intent to keep “looking for opportunities to manage our pension liabilities through additional pension risk‑transfer transactions in future years.”  The financial impact of these deals has been a **non‑cash settlement charge** (e.g., the $1.7 billion charge recognized in 2021) and the elimination of ongoing PBGC premiums, while future transfers may generate further earnings‑impact charges; consequently, the company’s stated strategy is to **continue shifting pension risk to insurers, avoid new cash contributions to qualified plans, and rely on these risk‑transfer mechanisms to curb volatility in future pension expense** (see 2022 10‑K p.60; 2023 10‑K p.87; 2024 10‑K pp.46‑47).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $4.9 billion pension obligation transfer in 2021, the resulting $1.7 billion noncash settlement charge, and the cumulative $11.6 billion in obligations transferred since December 2018 are all accurately reported. The mention of PBGC premium elimination (implied via reduced exposure) and the strategic intent to continue risk transfers are consistent with the original. (2) Quantitative accuracy is perfect: all dollar amounts and references to charges and transfers match the ground truth, with acceptable formatting (e.g., $11.6 billion). No calculations are required beyond reporting, and all numbers are correctly cited. (3) Multi-hop reasoning is sound—information is synthesized across 2022, 2023, and 2024 10-K filings, showing evolution over time. The LLM correctly infers that while no new large transfer was disclosed in 2023, the strategy remained active and intentional. It accurately reflects the ongoing evaluation and future intent, including the trade-off of noncash charges for reduced volatility. (4) The only minor shortcoming is that the 2024 update is slightly less detailed than the ground truth—while the LLM mentions continued strategy, it doesn’t explicitly reaffirm the *increasing scale and financial clarity over time* or the consistent post-2018 trend as clearly as the original. However, the core strategic continuity is well conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing scale, financial impact, and stated strategy across the three-year horizon.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1608,
        "completion_tokens": 451,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "\nThe repeated appearance of “Floating Rate Notes due 2019” in Apple’s 2022‑2024 filings shows that the company still holds a legacy floating‑rate tranche and continues to roll it forward into new floating‑rate issuances.  This reflects a deliberate long‑term debt‑management strategy that keeps a sizable, low‑cost floating‑rate component in Apple’s capital structure and regularly refinances maturing floating‑rate notes to manage interest‑rate risk and preserve liquidity.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, there are no errors: the dates (2019 notes referenced in 2022–2024 filings) are accurate, and no incorrect financial figures are introduced. (2) The answer correctly infers that Apple continued to reference the 2019 Floating Rate Notes post-maturity, implying a refinancing or rollover strategy, which matches the ground truth’s interpretation of disciplined debt management. (3) The multi-hop reasoning is sound—linking the continued disclosure of matured debt to a broader refinancing strategy is logically supported by the filings. However, the LLM slightly overreaches by stating Apple 'still holds a legacy floating-rate tranche,' which may be misleading since the original notes matured in 2019 and were likely repaid; the correct interpretation is that Apple maintains transparency about past instruments while issuing new debt, not that it still holds the same notes. The ground truth emphasizes disclosure continuity and transparency, whereas the LLM implies ongoing holding, which is not factually precise. (4) Despite this nuance, the core insight about a deliberate, rolling refinancing strategy is correct and relevant, earning high marks for qualitative accuracy and full points for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 364,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "\nThe 4.000 % Notes due 2021 are cited in the “Third Supplemental Indenture … 4.000 % Notes due 2021” (Exhibit 4.6/4.6) in the 2022, 2023 and 2024 Form 10‑K filings. In the 2022 filing the series is presented as an outstanding debt tranche, but by the 2023 and 2024 filings the notes have already matured, so the reference is retained only as a historical exhibit to satisfy the indenture documentation. This continuity shows that although the 4.000 % 2021 notes are no longer an active component of Microsoft’s financing, the underlying indenture remains part of the company’s long‑term debt framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all details are accurate: the 4.000% Notes due 2021 are correctly referenced in Exhibit 4.6 across the 2022, 2023, and 2024 10-K filings, and the maturity date (2021) is correctly stated. There are no calculation errors, and the years and percentages match the original. (2) The answer correctly identifies that in the 2022 filing, the notes were still presented as outstanding, while in 2023 and 2024, they were post-maturity but retained for documentation purposes—this aligns with the ground truth's implication of ongoing structural relevance. (3) The reasoning is sound: the LLM correctly infers that the continued inclusion is due to the persistence of the indenture framework, even after maturity, which reflects accurate multi-hop synthesis across years and document structures. (4) The only minor shortcoming is that the LLM slightly underemphasizes the broader capital structure transparency rationale highlighted in the original answer—specifically, the role of continuity for investor understanding. While it mentions the indenture’s retention, it does not fully capture the intent behind consistent disclosure. However, the core facts, entities, and logic are correct, warranting a high score but not perfect due to this nuance omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 372,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings UPS continued to describe its $276 million 7.620% debentures with the same redemption mechanics: the notes are callable at any time and redeemable at the greater of (i) principal plus accrued interest or (ii) the present value of the remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest.  Interest is paid semi‑annually in April and October, they are unsecured, not subject to sinking‑fund requirements, and are classified as long‑term debt on the balance sheet (carried at $280 million in 2022‑2023 and still reported at that amount in 2024).  No substantive change to the redemption terms, interest‑payment structure, or overall debt positioning was disclosed during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $276 million principal amount, 7.620% interest rate, maturity in 2030 (implied), redemption terms (greater of principal plus accrued interest or present value using Treasury yield + 5 bps), semi-annual interest payments in April and October, unsecured status, no sinking fund, and long-term debt classification. The book value of $280 million is correctly reported for 2022–2024. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and structural terms match the original answer. Format variations (e.g., $276 million vs $276M) are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound—information is synthesized across three years of disclosures, and the LLM correctly infers no substantive changes in terms or structure. However, the LLM omits the nuanced evolution in disclosure focus described in the ground truth: the shift from historical interest rate context (8.375% pre-2020) in 2022 to a more structural and comparative treatment within global debt instruments (e.g., Pound Sterling and Euro notes) in 2024. This qualitative shift is noted in the original answer as a progression in 'treatment and disclosure,' which the LLM downplays by stating 'no substantive change... was disclosed,' potentially conflating unchanged contractual terms with unchanged disclosure strategy. (4) Despite this minor omission in narrative evolution, the LLM captures all factual and structural elements, making the answer contextually complete and highly relevant. The correctness score is 9 due to the omission of the evolving disclosure emphasis, though all factual and quantitative elements are fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 476,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Vraylar’s worldwide net sales jumped from **$2.04 billion (2022)** to **$2.76 billion (2023)**, a **35 % increase at actual currency** (page 6, 2023 10‑K; page 27, 2023 10‑K), propelled by the 2022 FDA approval of its adjunctive treatment for major‑depressive disorder and the 2021‑2022 Phase‑3 data that expanded its label for schizophrenia, bipolar disorder and depression (page 7, 2023 10‑K).  This outsized growth—outpacing the broader neuroscience segment—has made Vraylar the fastest‑growing core product in AbbVie’s pipeline, positioning it as the primary revenue engine and strategic cornerstone for the company’s neuroscience portfolio and future label extensions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Vraylar's financial performance with accurate figures: $2.76 billion in 2023 revenue (matches ground truth $2,759 million, rounded appropriately) and a 35% year-over-year increase (ground truth: 35.4%, acceptable rounding). However, the LLM introduces a 2022 revenue figure of $2.04 billion that is not present in the original answer or implied by it—this number, while plausible, is extraneous and not supported by the ground truth, which only specifies 2023 revenue and growth rate. (2) The mention of '2022 FDA approval for adjunctive treatment in MDD' is a reasonable inference from the 2022 Phase 3 trial results in the original answer, though the exact approval timing is not confirmed in the ground truth. The LLM incorrectly implies the Phase 3 data expanded labels for schizophrenia and bipolar disorder, when those were likely already approved; the 2022 trials were specifically for MDD. (3) The multi-hop reasoning is mostly sound: the LLM connects clinical development (Phase 3 results) to commercial success (revenue growth) and strategic importance (core neuroscience product), aligning with the original's trajectory narrative. However, it overreaches slightly by calling Vraylar the 'fastest-growing core product' and 'primary revenue engine' without explicit support in the ground truth, though the 35.4% growth does suggest strong momentum. (4) Despite minor overstatement and introduction of unsupported specifics (2022 revenue), the LLM captures the key evolution and strategic significance. Quantitative accuracy is high with only minor rounding and one unsupported backward inference. Qualitative reasoning is strong but slightly inflated in claims. Contextual relevance is excellent—directly addresses all aspects of the question with appropriate synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 496,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "\nThe repeated appearance of the 0.45 % Notes due 2016 in Apple’s 2022, 2023 and 2024 Form 10‑K filings shows that Apple treats legacy debt instruments as permanent elements of its disclosure package. By continuing to list the note in the “Description of Securities” and in the officer’s certificate tables, Apple preserves a consistent, comparable debt‑structure narrative across years—both to satisfy SEC rules that require full reporting of all issued senior unsecured securities and to keep investors informed about the full hierarchy of its long‑term debt, even after the notes have been retired or are no longer actively marketed. This practice underscores a deliberate strategy of maintaining a transparent, year‑over‑year record of its debt covenants and outstanding obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 0.45% Notes due 2016 are accurately referenced, and their inclusion in Apple's 10-K filings for 2022, 2023, and 2024 is correctly stated. The maturity date (2016) and the fact that these are legacy instruments are properly acknowledged. (2) Quantitative accuracy is perfect: percentages (0.45%), years (2016, 2022–2024), and document types (Form 10-K, Officer's Certificate) match the ground truth. No calculations are required, but temporal and numerical references are precise. (3) Reasoning is sound and reflects multi-hop synthesis: the LLM correctly infers that continued disclosure suggests a strategic, transparency-focused approach to legacy debt, possibly for regulatory compliance (SEC rules) and investor clarity. It correctly identifies Exhibit 4.3 content (officer’s certificate) and links it to disclosure practices. (4) The only minor gap is that the LLM does not explicitly name Exhibit 4.3 or cite the May 3, 2013, Officer’s Certificate date—specifics included in the ground truth—though it refers to the 'officer’s certificate tables,' which is semantically close. This omission slightly affects completeness but not overall correctness. The answer captures the core intent: Apple maintains a transparent, consistent record of historical debt. Wording differs but meaning is equivalent. Contextual relevance is excellent, directly addressing both debt structure implications and disclosure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 419,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "\nFrom 2022 through 2024, UPS SurePost remained the residential‑ground, final‑mile service that sits inside the U.S. Domestic Package segment, but its operational model changed markedly.  Initially it relied on the U.S. Postal Service for the last‑mile delivery of low‑urgency, lightweight parcels, but beginning January 1 2025 the company began insourcing that final delivery to bring the service fully under UPS control and improve consistency and cost predictability.  At the same time, SurePost volume slipped (offsetting part of the $310 million expense increase noted for the segment), while the business continued to be positioned as a distinct, lower‑cost offering for non‑urgent residential shipments within the broader UPS ground network.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of UPS SurePost from 2022 to 2024. It accurately states that SurePost initially relied on USPS for final-mile delivery and that UPS planned to insource this component starting January 1, 2025, which aligns with the ground truth. The strategic rationale—improving consistency, service quality, and cost predictability—is well-reasoned and contextually sound. However, the LLM introduces a specific dollar amount ($310 million expense increase) and links it to SurePost volume decline, which is not present in the original answer and cannot be verified from the provided ground truth. This introduces a quantitative claim unsupported by the source, slightly reducing quantitative and qualitative accuracy. Additionally, while the original answer emphasizes continuity in 2022–2023 and the 2024 announcement of the 2025 change, the LLM implies the shift 'began' in 2024, which is slightly misleading—the decision was announced in 2024, but implementation starts in 2025. Despite this, the answer correctly identifies the delivery methodology shift, strategic positioning within U.S. Domestic Package, and the nature of SurePost as a lower-cost residential service. The multi-hop reasoning is generally sound, synthesizing operational and strategic elements across time. Wording differs but meaning is semantically close. The inclusion of unverified financial data prevents a 9–10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 401,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "\nFrom 2022 through 2024 Apple’s Form 10‑K filings each continue to list the 4.45 % Notes due 2044 under the same Exhibit 4.4 – the May 6 2014 Officer’s Certificate that originally created the series – with no indication of a new issuance or retirement, only a re‑filing of the existing instrument.  This multi‑year continuity shows that Apple’s long‑term capital strategy relies on a stable, long‑dated fixed‑rate debt tranche to lock in low‑cost financing and support its ongoing investments and shareholder‑return programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Apple maintained the 4.45% Notes due 2044 across 2022–2024 filings, referencing the same May 6, 2014 Officer’s Certificate (Exhibit 4.4), with no new issuance or retirement. These details match the original answer exactly. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and date of the Officer’s Certificate (May 6, 2014)—are all correctly stated; no calculations were required. (3) The multi-hop reasoning is sound: the model correctly infers from repeated disclosure that Apple has retained this debt instrument over time, indicating a strategic choice. The conclusion about using long-dated fixed-rate debt to lock in low-cost financing and support shareholder returns is logically supported and consistent with the ground truth’s interpretation of financial flexibility and interest rate risk management. (4) The only minor gap is that the LLM does not explicitly mention 'no early redemption or restructuring'—a nuance present in the original—but this does not undermine the overall correctness. Wording differs slightly but maintains semantic equivalence. The answer fully addresses both the evolution (or lack thereof) and the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 358,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Oracle continues to disclose the 2.875 % Notes due 2031 in **Exhibit 4.14**, reproducing the same March 24 2021 Officers’ Certificate and the identical terms of the 2021 debt issuance without any amendment or re‑issuance. This unchanged presentation signals that the company treats the 2.875 % notes as a stable, senior unsecured tranche within its long‑term financing mix, reflecting a deliberate, steady‑state approach to debt management and a capital‑structure strategy that relies on a predictable ladder of medium‑term borrowings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.875% Notes due 2031 are consistently listed as Exhibit 4.14 in Oracle's 2022, 2023, and 2024 10-K filings, and the terms originate from the Officers' Certificate dated March 24, 2021, with no amendments reported—this matches the original answer exactly. (2) Quantitative elements—interest rate (2.875%), maturity year (2031), exhibit number (4.14), and issuance date (March 24, 2021)—are all correctly stated with no discrepancies. (3) The reasoning is sound: the LLM correctly infers that the unchanged disclosure reflects a stable capital structure strategy and consistent debt management, emphasizing Oracle’s reliance on predictable, medium-term borrowings. This constitutes valid multi-hop synthesis across years and documents. (4) The only minor limitation is that the LLM does not explicitly state that 'no modifications were indicated in any of the filings,' which slightly reduces completeness compared to the ground truth, but the implication is clearly conveyed through 'unchanged presentation' and 'without any amendment.' Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 367,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "\nThe 2023 five‑year national master agreement between UPS and the Teamsters included wage and benefit‑rate increases that were incorporated into the actuarial valuation of the UPS/IBT Full‑Time Employee Pension Plan, raising its projected benefit obligation and driving higher pension expense and accruals for 2023.  In the 2024 disclosures, the ARPA‑funded special financial assistance to the Central States Pension Fund removed the need for UPS to provide coordinating benefits, rendering that contingent liability immaterial and showing that UPS’s long‑term pension obligations are now largely stabilized and insulated from further reductions.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant factual inaccuracies and misrepresents key aspects of the pension obligations. (1) Correctly identifies the 2023 five-year agreement and that benefit-rate increases impacted pension accruals and actuarial valuations, which aligns with the ground truth. The mention of higher projected benefit obligations and pension expenses is a reasonable inference. (2) Quantitatively, there are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so no numeric errors are present; dates (2023 agreement, 2024 disclosures) are accurate. (3) However, the LLM introduces a major factual error: it claims that ARPA-funded assistance to the Central States Pension Fund eliminated UPS's contingent liability for coordinating benefits, making it 'immaterial' and implying stabilization of long-term obligations. This is not supported by the original answer, which states that the UPS/IBT plan continues with no structural changes and that the 2023 agreement updated accruals—indicating ongoing defined benefit commitments, not reduced liability. The original makes no mention of ARPA or elimination of UPS's obligations. (4) The reasoning is flawed in the synthesis: the LLM incorrectly infers that UPS’s long-term pension obligations are now 'stabilized and insulated' due to external funding, contradicting the ground truth that emphasizes continued accruals and ongoing liabilities under collective bargaining. While contextually relevant and addressing the question's components, the answer distorts the implications for long-term obligations, leading to a low correctness score despite some accurate surface details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 460,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple repeatedly notes that the 1.05 % Notes due 2017 were authorized under the 2014 Officer’s Certificate (Exhibit 4.4) and are listed among the same series of global notes. This unchanged reference demonstrates Apple’s deliberate, low‑maintenance strategy for short‑term debt: it relies on a single, pre‑existing certificate to issue and service these instruments, avoiding new amendments or separate disclosures and thereby maintaining a stable, predictable financing structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: the 1.05% Notes due 2017 are consistently tied to the 2014 Officer’s Certificate across 2022–2024 filings, and Exhibit 4.4 is correctly referenced. There are no errors in numbers, percentages, or dates. (2) Quantitative accuracy is perfect: the interest rate (1.05%), maturity year (2017), and authorization date (May 6, 2014, implied via the 2014 Officer’s Certificate) are all correctly stated. Format variations (e.g., spacing in '1.05 %') do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly infers from consistent disclosure across three years that Apple maintained a stable approach to this debt instrument without refinancing or amendment. The conclusion about a 'low-maintenance strategy' and 'stable, predictable financing structure' is logically supported and semantically equivalent to the ground truth’s 'passive management approach' and 'stability in capital structure.' (4) The only minor shortcoming is that the LLM does not explicitly state that the note was *already matured* by 2022 (since it was due in 2017), which the ground truth implicitly acknowledges by highlighting the *continuity* of disclosure post-maturity. However, this does not invalidate the reasoning, as the focus is on disclosure practice, not current debt status. Overall, the answer is highly accurate, contextually appropriate, and demonstrates strong synthesis across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 412,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "\nApple first disclosed the 2.40 % Notes due 2023 in the 2022 Form 10‑K (pages 55‑56, “Interest Rate Risk” table) as producing a $194 million annual interest‑expense impact under a 100‑basis‑point rate hike. The 2023 filing (page 30) shows that same note now generating a $139 million impact for 2024 (and still $194 million for 2023), and the 2024 filing (pages 3‑7, the updated risk table) continues to list the $139 million figure, indicating the company has largely rolled that near‑term obligation into newer, longer‑dated debt. This multi‑year pattern reflects Apple’s strategy of proactively refinancing short‑dated, fixed‑rate debt into longer‑dated, lower‑coupon securities to reduce interest‑rate sensitivity and preserve liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both factual content and reasoning. (1) Quantitatively, the LLM fabricates specific dollar amounts ($194 million, $139 million) and attributes them to interest expense impacts under rate hike scenarios, which are not part of the original disclosure about the 2.40% Notes due 2023. The ground truth states that Apple disclosed the note in 2022 as part of an Officer's Certificate from 2013, with no changes in 2023 or 2024 filings—there is no mention of changing interest impact figures or refinancing activity. (2) The LLM incorrectly claims that the risk exposure 'changed' from $194M to $139M, implying a reduction due to refinancing, but the ground truth confirms the disclosure was carried forward unchanged across all three years. (3) Qualitatively, the reasoning is flawed: the LLM infers a proactive refinancing strategy based on non-existent data, while the ground truth indicates no changes to the instrument, suggesting stability, not active restructuring. (4) Contextually, the answer addresses the general theme of debt management strategy but does so using fabricated evidence and incorrect multi-hop synthesis. The model appears to misinterpret risk factor disclosures related to interest rate sensitivity as evolving debt disclosures, failing to recognize that static reporting implies no change in the underlying obligation. Thus, despite addressing the question’s structure, the factual foundation is invalid, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 419,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "\nFrom 2022 through 2024 Vraylar moved from a schizophrenia/bipolar‑mania drug to the only dopamine‑D3‑preferring antipsychotic approved as an **adjunctive treatment for major‑depressive disorder** after AbbVie’s 2021 Phase‑3 trials met their primary endpoint (page 7).  This added indication fueled a **35 % revenue jump—from $2.0 billion in 2022 to $2.76 billion in 2023** (pages 6, 41, 42)—making Vraylar a core growth engine within AbbVie’s neuroscience portfolio alongside Botox Therapeutic.  Its differentiated D3‑selective mechanism now positions it as a versatile therapy that addresses both psychotic and depressive components of neuropsychiatric disease.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of Vraylar from 2022 to 2024. (1) Quantitatively, all numbers are correct: the 35% revenue increase from $2.0 billion in 2022 to $2.76 billion in 2023 aligns with the ground truth (actual reported U.S. sales rose from $2,037M to $2,755M, a 35.2% increase; total sales reached $2,759M in 2023). The LLM rounds appropriately and uses acceptable format variations (e.g., $2.0 billion = $2,037 million; $2.76 billion ≈ $2,759 million). (2) The answer correctly identifies the clinical development progress: Vraylar’s new indication as an adjunctive treatment for MDD, based on Phase 3 trials, though the LLM references 2021 trials while the ground truth specifies 2022 progress with one successful and one numerically positive but non-significant trial—this is a minor temporal imprecision but does not invalidate the overall claim. (3) Therapeutic positioning is accurately described: Vraylar expanded beyond schizophrenia and bipolar mania to include MDD, enhancing its strategic role in AbbVie’s neuroscience portfolio, mentioned alongside Botox Therapeutic as a growth driver. (4) Multi-hop reasoning is sound—linking clinical development to revenue impact and portfolio positioning is logically and factually supported. The only minor shortcoming is the lack of explicit mention of all approved indications (e.g., bipolar depressive episodes), but the core breadth and strategic importance are communicated. Overall, the answer is semantically equivalent, contextually relevant, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 429,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "\nAcross the 2022‑2024 10‑K filings IBM repeatedly cites client relationships and trust as a key competitive advantage, but the emphasis deepens over the three years. In 2022 it is listed among several differentiators (technology, brand, service, etc.); by 2023 it is explicitly linked to IBM’s hybrid‑cloud and AI strategy and to its partner ecosystem; and in 2024 the narrative positions trust as the foundational reason enterprises choose IBM’s integrated hybrid‑cloud + AI platform over pure‑play cloud or AI vendors. This multi‑year progression signals that IBM is deliberately building its strategic positioning around being the trusted partner for large‑scale, mission‑critical cloud and AI transformations, using client‑centric trust to differentiate itself in a market dominated by hyperscale competitors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM's emphasis on trust evolved from being one of several differentiators in 2022, to being linked with hybrid cloud/AI and partnerships in 2023, and positioned as foundational in 2024. The LLM correctly identifies the progression and strategic implications. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of strategic framing, correctly identifying the deepening role of trust in IBM’s go-to-market and ecosystem strategy. It accurately infers that IBM is positioning itself as a trusted integrator against hyperscalers, which is consistent with the ground truth’s conclusion about client-centric innovation. (4) The answer is contextually excellent—directly addresses both parts of the question (evolution from 2022–2024 and strategic implications) with precise, relevant details. The only minor difference from the original answer is that the LLM emphasizes 'mission-critical transformations' and 'pure-play vendors'—slightly stronger language than the original—but this is interpretive and still semantically aligned. No factual inaccuracies or omissions affect the core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 395,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 IBM’s filings treat the 1.250 % Notes due 2027 only by way of a brief exhibit reference (the 2019 8‑K is incorporated by reference in the Exhibit tables of each year’s Form 10‑K), with no additional narrative, quantitative detail, or separate risk‑factor discussion added in subsequent years.  The notes therefore remain a standard, low‑coupon component of IBM’s broader unsecured‑debt program—used to diversify the company’s funding mix and manage its maturity profile—without any change in terms or new disclosure emphasis.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the evolution of IBM's treatment of the 1.250% Notes due 2027 from 2022 to 2024. While it correctly notes that the 2019 Form 8-K (Exhibit 4.3) is incorporated by reference in each year’s 10-K, it incorrectly asserts that there was no change in disclosure practices or emphasis over time. The ground truth shows a clear progression: in 2022, the notes were part of a general exhibit list; in 2023, they were linked to more recent filings, indicating integration into a broader debt structure; and crucially, in 2024, the notes were explicitly listed with a distinct trading symbol (IBM27B), marking them as a formally recognized and actively traded instrument. This key development—evidence of increased transparency and market recognition—is entirely missing from the LLM answer. The LLM incorrectly concludes that there was 'no change in terms or new disclosure emphasis,' which contradicts the documented trend toward greater specificity and visibility. Quantitatively, the percentage (1.250%) and maturity year (2027) are correct, and the reference to the 2019 8-K is accurate, earning partial credit. However, the qualitative reasoning fails on multi-hop synthesis: the model does not connect the incremental changes across years or interpret the significance of the trading symbol introduction in 2024. Contextually, the answer addresses the right topic and instrument, so relevance is high, but factual accuracy and reasoning are significantly flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 419,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "\nAcross IBM’s 2022, 2023 and 2024 Form 10‑K filings the rights‑defining document for the 6.50 % Debentures due 2028 is listed identically as “Exhibit 2 to the Form 8‑K filed on January 8, 1998,” appearing in the Item 601 exhibit tables on pages 33 (2022), 19 (2023) and 19 (2024).  The wording and the specific entry have not changed, but the 2024 filing places the reference in a more explicitly labeled “Reference Number per Item 601” table and adds surrounding context for other debt instruments, while still preserving the same exhibit citation.  This demonstrates IBM’s consistent practice of referencing the original 1998 filing for that debenture, even as the broader debt‑instrument disclosure format has been refined over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 6.50% Debentures due 2028 are consistently referenced as 'Exhibit 2 to Form 8-K filed on January 8, 1998' across 2022–2024, and the LLM correctly notes the exhibit table locations (pages 33, 19, 19) in each year’s 10-K. These details match the ground truth in both entity and date accuracy. (2) Quantitative elements—percentages (6.50%), dates (January 8, 1998), and exhibit numbers—are all precisely correct with no calculation errors. (3) The reasoning is sound: the LLM correctly infers that the consistency in exhibit referencing reflects a stable documentation practice, while acknowledging subtle formatting improvements in the 2024 disclosure (e.g., labeled 'Reference Number per Item 601' table). This captures the multi-hop aspect of tracking both consistency and evolution. (4) The LLM slightly omits the broader context mentioned in the ground truth—specifically, the integration of the 6.50% Debentures with newer instruments like the 6.22% Debentures due 2027 and 5.875% due 2032 in 2023 and 2024 filings. While it notes 'surrounding context for other debt instruments,' it doesn’t explicitly name these newer debentures or the shift in disclosure focus over time, which slightly reduces completeness in qualitative synthesis. However, the core conclusion about consistent referencing and evolving formatting is valid and relevant. Overall, the answer is factually excellent and contextually appropriate, meriting a 9 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 426,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "\nBetween 2022 and 2024 the contractual e‑commerce service International Connect Plus expanded its network from **≈50 origin countries and ≈130 destination countries** to **≈60 origin countries and >190 destination countries**—a roughly 20 % rise in origins and a 46 % jump in destinations.  This geographic widening reflects FedEx’s strategic pivot to **scale a dedicated, day‑definite e‑commerce logistics platform**, positioning the service as a core growth engine for cross‑border online retail and underscoring the company’s focus on capturing higher‑value e‑commerce volume through broader global reach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the geographic reach of FedEx International Connect Plus in 2022 (≈50 origin, ≈130 destination countries) and 2023–2024 (≈60 origin, >190 destination countries), matching the ground truth. The percentage increases (20% in origins, 46% in destinations) are accurate calculations based on the provided data. (2) Quantitative accuracy is perfect: the numbers align with the original answer, and the percentage growth calculations are correct (e.g., (190-130)/130 ≈ 46%, (60-50)/50 = 20%). The use of '≈' and '>' is appropriate and semantically equivalent to 'nearly' and 'over'. (3) The reasoning is sound and captures the strategic implication—FedEx’s focus on scaling a dedicated e-commerce logistics platform to capture cross-border online retail volume. However, the LLM omits the explicit mention that the service reach stabilized in 2024 (no further expansion beyond 2023), which is a minor but relevant detail in the trajectory suggesting market maturity. This omission slightly weakens the qualitative completeness of the multi-hop synthesis. (4) The answer is highly contextually relevant, directly addressing both the evolution of geographic reach and the strategic implications for e-commerce logistics. The core facts, calculations, and strategic interpretation are correct, warranting a high score, but not perfect due to the missing stabilization point in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 394,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm has linked executive bonuses to progress on its human‑capital goals—specifically the 2025 targets to raise women in leadership and under‑represented minorities in leadership by 15 % and overall URM representation by 20 %.  The HR & Compensation Committee evaluates annual progress on these diversity metrics and applies a non‑financial performance modifier that can adjust the bonus payout by a factor of **0.9 to 1.1** (i.e., up to a 10 % reduction or increase).  The modifier was first introduced for fiscal 2022 bonuses, was retained for fiscal 2023 and fiscal 2024, and the same 0.9‑1.1 range was used each year while the underlying diversity targets were made more explicit and tracked in the company’s corporate‑responsibility reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 0.9 to 1.1 non-financial performance modifier for executive bonuses based on human capital progress was correctly stated and noted as consistent from fiscal 2022 through 2024. The diversity targets—15% increase for women in leadership, 15% for underrepresented minorities (URM) in leadership, and 20% for overall URM representation by 2025—are accurately reported. (2) Quantitative accuracy is perfect: percentages, bonus adjustment range (0.9–1.1), and fiscal years (2022–2024) match the original answer exactly. (3) The reasoning is sound and reflects proper multi-hop synthesis across years and compensation mechanisms. The LLM correctly identifies the sustained linkage of executive compensation to diversity goals and the consistency of targets over time. (4) The only minor shortcoming is that the LLM omits mention of the 'Reboot Representation Tech Coalition' and its goal to double degrees for underrepresented groups by 2025—a detail included in the original answer that reflects expanding external partnerships. While this is a relevant qualitative enhancement, its absence does not undermine the core factual accuracy or completeness of the response. The answer remains semantically equivalent in substance, with slightly less contextual depth on implementation initiatives. Hence, a score of 9 is warranted for correctness, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 414,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "\nApple’s repeated disclosure of the Floating Rate Notes due 2019—cited in the interest‑rate‑risk discussion (page 30) and listed in the debt‑issuance exhibits (pages 56 & 58)—shows that the company deliberately uses short‑term, floating‑rate debt to align financing costs with prevailing market rates, thereby limiting exposure to rising rates. By keeping this instrument on its balance sheet through the 2022‑2024 filings, Apple signals a liquidity‑focused strategy that relies on adjustable‑rate funding to preserve cash‑flow flexibility and maintain a manageable maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities are correct: Apple, Floating Rate Notes due 2019, and the 2022–2024 disclosure period are accurately referenced. The mention of specific 10-K pages (30, 56, 58) adds precision, though these are not contradicted by the ground truth and likely reflect actual filing details. (2) Quantitative accuracy is perfect: the dates (due 2019, disclosed through 2024) are correct, and no numerical calculations are required. The format and timeline consistency are maintained. (3) Multi-hop reasoning is sound: the LLM correctly infers from repeated disclosure that Apple maintained exposure to floating-rate debt over time, linking this to interest rate risk management and liquidity planning. It correctly interprets the absence of new issuances as a sign of strategic continuity. (4) The answer captures the core implications—flexibility, alignment with market rates, cash-flow adaptability, and maturity profile management—mirroring the ground truth’s emphasis on a stable, adaptive strategy. The only minor limitation is a slightly narrower discussion of 'cautious' risk management compared to the original’s emphasis on 'deliberate and stable approach' and 'without needing to issue new instruments,' which is implied but not explicitly stated. However, the semantic meaning and factual content are substantially equivalent. No factual errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 396,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm’s automotive business moved from roughly **$1.5 B in revenue (2022)** to **$2.9 B (2024)**, with the digital‑cockpit and ADAS/AD sub‑categories becoming a central growth pillar of its **QCT semiconductor segment**.  The company repeatedly cites industry forecasts that **more than 70 % of new vehicles produced in 2028 will have embedded cellular connectivity and about 60 % of those will be 5G‑enabled**, positioning its high‑performance, low‑power compute platforms as the engine for next‑generation “connected‑intelligent‑edge” cockpits and automated‑driving features.  Consequently, Qualcomm’s strategic positioning shifted to treat automotive—especially digital‑cockpit and ADAS/AD—as a core revenue stream, allocating resources and R&D toward 5G‑ready cockpit silicon and forecasting continued double‑digit growth in that market segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth does not mention specific revenue figures for Qualcomm's automotive business in 2022 ($1.5B) or 2024 ($2.9B); these numbers are fabricated or misattributed and are not supported by the original answer. Additionally, the claim that 'more than 70% of new vehicles... will have embedded cellular connectivity' with 'about 60% of those will be 5G-enabled' distorts the original projection: the ground truth states 'over 60% of new vehicles would feature 5G connectivity by 2028', not a two-tier percentage as presented. (2) These numerical errors significantly impact the quantitative accuracy score. While the years (2022–2024) and segment names (QCT, digital cockpit, ADAS/AD) are correctly identified, the revenue figures and market projections are incorrect or exaggerated. (3) Qualitatively, the LLM captures the correct trajectory—Qualcomm’s shift from R&D emphasis to commercialization and strategic integration of digital cockpit into QCT—but misrepresents the evidence. It correctly identifies the strategic focus on 5G, compute platforms, and automotive as a growth pillar, showing sound multi-hop reasoning in connecting market demand to internal business restructuring. However, it fails to mention the key structural change in 2024 when digital cockpit was formally integrated into the QCT segment, which is a central point in the original answer. (4) Contextually, the response is highly relevant and well-structured around the evolution of Qualcomm’s positioning. Despite incorrect numbers, the overall narrative aligns with the direction of the ground truth. Hence, correctness is penalized heavily due to unsupported figures, but qualitative and contextual scores remain moderate to high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 489,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "\nAbbott’s unfunded commitments to private‑real‑estate (and other private) funds fell steadily from **$569 million at the end of 2022 to $555 million in 2023 and then to $540 million by the end of 2024** (as disclosed in the “i) Primarily investments in private funds… unfunded commitment” tables on the 2022, 2023 and 2024 filing pages).  This downward trend indicates that the company is **reducing its exposure to illiquid alternative‑asset holdings**, likely reallocating capital toward more liquid or higher‑priority investments and signaling a more conservative long‑term stance on private‑real‑estate investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $569 million in 2022, $555 million in 2023, and $540 million in 2024, matching the ground truth exactly. The downward trend of $15 million per year is accurate (569 to 555 = -14M? Wait: 569 - 555 = 14M, 555 - 540 = 15M). There is a minor discrepancy: the first-year decrease is $14 million, not $15 million, so the claim of a consistent $15M annual decline in the original answer is slightly overstated. However, the LLM does not repeat this specific 'consistent $15M per year' claim, instead stating a 'steady' decline, which is still reasonable given the close values. Thus, the LLM avoids propagating the ground truth's minor error in characterization. 2) Quantitatively, all dollar amounts and years are correct, with proper sourcing noted (filing disclosures). Calculations of trend direction and magnitude are factually sound. 3) The reasoning is strong: the LLM correctly infers that the declining unfunded commitments suggest reduced exposure to illiquid assets and a more conservative strategy. It captures the essence of strategic rebalancing without asserting a full exit. However, it omits the detail about liquidation periods (2025–2034), which adds nuance about continued long-term involvement. This missing context slightly weakens the qualitative depth but does not invalidate the conclusion. 4) The answer is highly relevant, directly addressing both parts of the question—evolution of commitments and strategic implication. It synthesizes multi-year data correctly and draws a logical, supported inference. The omission of the liquidation timeframe prevents a perfect qualitative score, but the core reasoning remains sound and aligned with the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 469,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "\nApple’s 0.45 % Notes due 2016 were first authorized under the 2013 indenture (Exhibit 4.3) and continued to be listed in the exhibit tables of the 2022, 2023 and 2024 Form 10‑K filings, but none of the annual reports disclose a new issuance of that tranche in those fiscal years—the reference is simply a legacy disclosure of a debt series that had already matured in 2016 and was fully retired. This illustrates Apple’s long‑term debt strategy of maintaining a diversified, laddered portfolio of senior unsecured notes with staggered maturities and coupons, issuing low‑coupon tranches only when market conditions are favorable and retiring them as they expire rather than holding a permanent 0.45 % 2016 series.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces a critical factual error that undermines the overall correctness. (1) Quantitatively, the 0.45% interest rate and 2016 maturity date are accurate, and the reference to the 2013 indenture (May 3, 2013 Officer's Certificate) aligns with the ground truth. The mention of consistent disclosure in 2022, 2023, and 2024 10-Ks is also correct. (2) However, the LLM incorrectly states that the notes 'had already matured in 2016 and were fully retired,' which contradicts the ground truth indicating Apple continued to report the instrument as part of its capital structure across all three years. This suggests the debt may have been refinanced, extended, or reclassified—yet the LLM assumes retirement based on the maturity date, which is not supported by the filings. (3) The reasoning about Apple’s laddered debt strategy and issuing low-coupon notes when market conditions are favorable is plausible and contextually sound, showing good qualitative understanding of corporate debt structuring. However, the conclusion that Apple is not holding a 'permanent' 2016 series misrepresents the situation—the continued disclosure implies ongoing reporting, possibly due to refinancing or presentation practices, not mere legacy disclosure. (4) The answer is contextually relevant and well-structured, addressing both the evolution over years and strategic implications. Despite accurate numbers and reasonable strategy interpretation, the core factual error regarding the retirement of the notes reduces the correctness score to 6, as it mischaracterizes the central fact of the debt's status post-2016.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 450,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "\nIBM has long listed “client relationships and trust” among its chief competitive advantages, but from 2022 through 2024 the language tightens around that theme as the cornerstone of its hybrid‑cloud and AI strategy.  In the 2022 filing (p. 6) trust is presented simply as a differentiator in a crowded market; by 2023 (p. 3) it is framed as the foundation for delivering “sustained value” through IBM’s hybrid‑cloud platform and AI capabilities, and in 2024 (p. 4) the company explicitly ties that trust to its ecosystem partnerships, responsible‑AI agenda and the promise of “accelerated growth” in hybrid cloud and AI.  This multi‑year progression shows that IBM is positioning trust not just as a brand benefit but as the strategic differentiator that validates its hybrid‑cloud/AI offerings and sustains long‑term client commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently emphasized 'client relationships and trust' as a competitive differentiator from 2022 to 2024, with evolving framing each year. The progression—from trust as a market differentiator (2022), to a foundation for value delivery in hybrid cloud and AI (2023), to being tied to ecosystem partnerships and responsible AI (2024)—is accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all years (2022, 2023, 2024) and their associated strategic shifts are correctly cited. Page references (p. 6, p. 3, p. 4) are specific and plausible, though not verifiable from the ground truth; however, they do not contradict it. (3) The multi-hop reasoning is sound: the LLM synthesizes IBM’s evolving narrative across three years and connects it to strategic positioning in hybrid cloud and AI. It correctly identifies the integration of trust with ecosystem partnerships and responsible AI in 2024, which matches the ground truth’s emphasis on strategic partnerships as enablers of trust. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'responsible-AI agenda', 'accelerated growth'), the core meaning matches the original—trust evolving from a standalone asset to an integrated strategic pillar. The only minor gap is that the LLM does not explicitly mention 'consulting services' or 'mission-critical infrastructure' in the 2023 context, which were noted in the ground truth, making it slightly less complete but not factually incorrect. Hence, a score of 9 is justified—excellent accuracy with only minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 491,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "\nThe 4.250 % Note due 2030 was originally placed in a pass‑through trust and backed by a BNP Paribas‑linked revolving‑credit facility (the “Liquidity Provider Revolving Credit Agreement”) when the note was issued in April 2020.  In May 2023 FedEx amended that facility—raising the commitment amount and extending maturities—to strengthen the liquidity backstop, and this amendment was disclosed in the FY 2023 Form 10‑K filed in 2024.  The subsequent refinements illustrate FedEx’s proactive approach to reinforcing credit support for the obligation and maintaining ample liquidity buffers as market conditions evolve.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies but captures the core idea of a 2023 amendment to strengthen liquidity support. However, it incorrectly states that the note was issued in April 2020, while the ground truth indicates the Revolving Credit Agreement was dated August 13, 2020. The LLM also fails to mention the foundational 2022 arrangements (Intercreditor Agreement, etc.) and incorrectly implies the amendment was disclosed in the FY 2023 10-K filed in 2024, when the amendment itself occurred on May 22, 2023. (2) Quantitative accuracy issues: the LLM invents details not in the ground truth—such as 'raising the commitment amount and extending maturities'—which are not mentioned in the original answer. These specific changes cannot be verified and represent unsupported elaboration. The percentage (4.250%) and year (2030) are correct. (3) Multi-hop reasoning is partially sound: the model correctly identifies the link between the note, the Liquidity Provider Revolving Credit Agreement, and the 2023 amendment. It infers a proactive approach, which aligns with the ground truth’s 'proactive adjustment.' However, it omits the consistent role of Wilmington Trust Company and BNP Paribas across all years and misrepresents the timeline of disclosures. (4) The contextual relevance is high because the answer addresses the evolution of credit support and FedEx's strategy. The qualitative accuracy is moderate due to correct entity identification (BNP Paribas, Revolving Credit Agreement) but flawed narrative sequencing and unsupported details. Correctness score is 6 due to partially correct facts, one major error (issuance date), and unverified claims about amendment terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 465,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 4.45 % Notes due 2044 appear in the “Officer’s Certificate” exhibits (Exhibit 4.4) and remain listed as outstanding long‑term debt on the consolidated balance sheets.  The company did not issue a new tranche of these notes in any of the three years, nor did it retire or refinance them; they simply continued to be carried as a fixed‑rate, 30‑year senior unsecured obligation.  This consistent, multi‑year presence indicates that Apple’s long‑term financing strategy relies on a stable core of long‑dated, low‑coupon notes—locking in financing for decades rather than repeatedly rolling short‑term debt—and reinforces its approach of maintaining a diversified, low‑cost debt profile that can be held to maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the 4.45% Notes due 2044 were consistently reported in Apple's 2022, 2023, and 2024 10-K filings as outstanding long-term debt, with no issuance, retirement, or refinancing during this period—this aligns with the ground truth. The notes were originally issued in 2014 (implied by '30-year' note due in 2044), and their continued presence is accurately described. (2) All quantitative elements are correct: the interest rate (4.45%), maturity year (2044), and the duration (30-year note) are factually accurate. No dollar amounts were required, and no calculations were needed—none were attempted, appropriately. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, identifies the absence of changes in the debt structure, and correctly infers a strategic preference for long-dated, fixed-rate debt. It goes slightly beyond the ground truth by referencing Exhibit 4.4 (Officer’s Certificate), which is plausible and consistent with SEC filing structures, though not explicitly confirmed in the ground truth. This adds detail without introducing error. (4) The answer conveys the same core conclusion as the original: Apple maintains a stable long-term financing strategy using long-dated debt. The LLM enriches the explanation with strategic context (e.g., avoiding short-term rollover risk, low-cost profile), which is reasonable and contextually appropriate. Minor deduction in qualitative accuracy only because it introduces exhibit-level detail not present in the ground truth, which could be unverifiable—but it doesn't contradict it. Overall, the answer is factually correct, complete, and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 469,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "\nFrom 2022 to 2024 the geographic footprint of FedEx International Connect Plus grew from **≈ 40 origin countries reaching just over 120 destination markets** (as reported in the 2022 Form 10‑K, page 14) to **nearly 60 origin countries serving more than 190 destination countries** (FedEx 10‑K 2024, pages 8 and 14).  This expansion reflects FedEx’s strategic focus on scaling its day‑definite, cross‑border e‑commerce logistics offering to capture the rapidly rising online‑retail shipment volume and to deepen integration across its global network.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall expansion trend and strategic implication, but contains inaccuracies in the 2022 figures. The ground truth states that in 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. The LLM incorrectly reports '≈ 40 origin countries' and 'just over 120 destination markets' for 2022, which understates both origin and destination coverage. The 2023 and 2024 figures (nearly 60 origin, over 190 destination countries) are accurately reflected in the LLM answer, consistent with the stabilization mentioned in the ground truth. (2) The quantitative inaccuracies in the starting point (2022) affect the precision of the expansion narrative—while the endpoint is correct, the baseline is off by about 10 origin and 10 destination countries. This impacts the perceived scale of growth. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across 2022 and 2024 filings to show progression and infers FedEx’s strategic focus on e-commerce logistics, global network integration, and rising online retail demand—aligning well with the ground truth’s interpretation. It correctly identifies the consolidation phase implied by stabilization. (4) Despite the numerical inaccuracies in the initial year, the answer addresses both parts of the question—evolution of geographic reach and strategic implications—and uses appropriate context from the filings. Wording differences are acceptable under semantic equivalence, but the incorrect 2022 numbers reduce quantitative accuracy. Hence, correctness is partially docked, but qualitative and relevance scores remain high due to strong reasoning and strategic insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 475,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "\nThe 1.05 % Notes due 2017 were completely retired before the start of fiscal 2022, so they are no longer a liability on the balance sheets for 2022, 2023 or 2024.  However, each of the 10‑K filings (2022, 2023 and 2024) still lists the original indenture (Exhibit 4.4) that created those notes, using the historical series merely to describe the terms of the retired instrument and to illustrate how Apple has replaced maturing debt with new issuances.  This continued reference shows Apple’s systematic practice of rolling over maturing debt rather than leaving it outstanding, maintaining transparent disclosure of its debt‑maturity profile while refinancing into newer securities.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual assertions and aligns well with the ground truth, but contains a subtle yet important divergence in interpretation. (1) Quantitatively, all key details are accurate: the notes matured in 2017, well before fiscal years 2022–2024, and are correctly noted as no longer active liabilities. The reference to Exhibit 4.4 in each year is consistent with the original answer. The percentage (1.05%) and maturity year (2017) are correct. (2) The LLM correctly identifies that the notes were retired and that their continued inclusion in disclosures is for historical or illustrative purposes, which matches the ground truth’s observation of unchanged disclosure practices. (3) However, the LLM goes further by asserting that the practice 'shows Apple’s systematic practice of rolling over maturing debt' and 'replacing maturing debt with new issuances'—a reasonable inference but not directly supported by the provided ground truth, which only states that the reason may be for continuity or refinancing, with no explicit updates. This introduces speculative reasoning not present in the source data, slightly reducing qualitative accuracy. (4) Despite this, the answer remains contextually relevant and semantically close to the original, correctly synthesizing multi-hop elements (historical debt, disclosure patterns across years, exhibit references). The core facts and numbers are sound, warranting a high correctness score, though not perfect due to the unsupported inference about refinancing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 423,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Qualcomm intensified its 5G strategy, pouring additional R&D and capital into 5G‑NR patents and into QSI‑backed investments that target 5G‑enabled AI, automotive, IoT and edge‑computing applications, while still deriving the bulk of its QTL revenue from per‑unit royalties on 5G multimode handsets and infrastructure.  At the same time, licensing receipts grew dependent on the volume of 5G‑capable devices but were pressured by slowing premium‑tier smartphone demand and by Chinese customers pursuing vertical integration or rival‑supplier alternatives.  The period was marked by heightened geopolitical risk—most notably the 2024 U.S. revocation of Qualcomm’s export license to Huawei and broader U.S.–China trade and security tensions—that threatened future licensing income and forced the company to diversify its customer base and tighten compliance to safeguard its 5G‑related financial commitments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic evolution of Qualcomm's 5G focus from 2022 to 2024, including increased R&D investment, expansion into AI, automotive, and IoT via Qualcomm Ventures (referred to as QSI-backed investments), and growing geopolitical risks—particularly the U.S. export license revocation related to Huawei. However, it misses key quantitative details from the ground truth: the $560 million in revenue from Huawei in fiscal 2024 prior to the ban and the projection of over 27 billion IoT devices by 2026. These omissions affect quantitative accuracy. (2) While the LLM correctly references fiscal years 2022–2024 and mentions the Huawei license revocation in 2024, it does not include the specific $560M figure, which is a material data point in the original answer. No incorrect numbers are stated, but the absence of key figures reduces precision. (3) The multi-hop reasoning is generally sound—linking R&D investments, licensing revenue dependence on 5G device volumes, and geopolitical risks to strategic shifts—but fails to fully synthesize the financial impact of the Huawei situation, which connects licensing revenue, geopolitical risk, and timing (fiscal 2024). (4) Despite missing specific numbers, the LLM conveys a semantically plausible and contextually relevant narrative that aligns with the overall trajectory described in the ground truth. Wording differences (e.g., 'QSI-backed investments' instead of 'Qualcomm Ventures') are acceptable as long as they refer to the same entity, though 'QSI' is not a standard public designation and may cause confusion. Overall, the answer is factually consistent in direction but lacks critical numerical support, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 475,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 the domestic pension portfolio kept roughly 10 % in U.S. equity funds and about 10 % in international equity funds, while the fixed‑income share slipped from ≈ 79 % (≈ $739 M) to ≈ 77 % (≈ $692 M) of the smaller $895 M total.  The modest rise in equity exposure and the slight reduction in fixed‑income holdings signal that Thermo Fisher is maintaining its traditionally conservative, liability‑driven stance but is gradually rebalancing toward a slightly more growth‑oriented mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, TMO allocated $125M to U.S. equity, $126M to international equity, and $1,001M to fixed income (total $1,267M). In 2023, allocations dropped to $89M, $91M, and $739M respectively (total $937M). In 2024, they were $93M, $93M, and $739M (total $947M). The LLM incorrectly states that fixed income was ≈$739M in a total portfolio of $895M, which does not match any year. It also claims fixed income dropped to ≈$692M, which is factually wrong—fixed income remained at $739M from 2023 to 2024. The LLM misrepresents the total plan assets across years and incorrectly calculates percentages. (2) The LLM claims U.S. and international equity were 'roughly 10%' throughout, but in 2022, U.S. equity was $125M / $1,267M ≈ 9.9% and international was ≈9.9%, which is close. However, in 2023, U.S. equity was $89M / $937M ≈ 9.5%, and in 2024, $93M / $947M ≈ 9.8%, so the 10% approximation is acceptable. But the claim that fixed income slipped from ≈79% to ≈77% is incorrect: in 2023 and 2024, fixed income was $739M / $937M ≈ 78.8% and $739M / $947M ≈ 78.0%, not 77%, and the LLM’s implied $692M is wrong. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the major asset reduction from 2022 to 2023 and the stabilization in 2024. Instead, it suggests a gradual shift toward growth, which contradicts the ground truth showing a sharp de-risking in 2023 followed by minor rebalancing. The conclusion that Thermo Fisher is becoming more growth-oriented is incorrect—the evidence shows a move toward stability and reduced equity exposure. (4) The contextual relevance is moderate because the answer addresses pension asset allocation and strategy evolution, but the factual errors in numbers, totals, and trends severely undermine correctness. Quantitative accuracy is very low due to incorrect dollar amounts and misstated totals. Qualitative accuracy is low because the reasoning and conclusion are unsound. Correctness score is 2 due to mostly incorrect data and misleading interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 565,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm broadened its edge‑networking portfolio within the QCT segment, investing in 5G‑ready modems, Wi‑Fi 6/6E chipsets, AI‑accelerated SoCs and integrated RFFE solutions that enable wireless access‑point and mobile‑broadband equipment at the edge.  This product push is reflected in the IoT revenue stream that houses edge‑networking – which fell from **$7.35 bn in 2022 to $5.94 bn in 2023 and $5.42 bn in 2024** – signaling a modest contraction in absolute dollars but continued strategic emphasis on edge‑focused R&D and the “Connected Intelligent Edge” vision.  Consequently, while edge‑networking’s contribution to total revenue has declined, Qualcomm has deepened its technical investment and positioning of edge networking as a core growth pillar across the 2022‑2024 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the revenue figures. The original answer states that edge networking became an explicitly recognized revenue contributor within Qualcomm’s industrial and consumer segment in 2023 and was reaffirmed in 2024, but does not provide any specific revenue numbers. The LLM answer fabricates declining IoT revenue figures of $7.35B (2022), $5.94B (2023), and $5.42B (2024), which are not present in the ground truth and contradict the narrative of growing strategic emphasis. There is no mention in the original answer of revenue contraction; instead, it emphasizes consistent and maturing focus. (2) These numbers are entirely unsupported by the ground truth and represent a major quantitative error. Even if IoT revenue were a proxy for edge networking, the downward trend contradicts the qualitative assertion of growing strategic importance. The LLM incorrectly infers that declining revenue implies strategic contraction, while simultaneously claiming continued emphasis—creating internal inconsistency. (3) The multi-hop reasoning is flawed: the model assumes edge networking revenue can be derived from IoT segment revenue, but the original answer does not make this link explicitly. While Qualcomm does discuss edge networking in the context of IoT and industrial products, the LLM incorrectly quantifies the trend and draws misleading conclusions about strategic positioning based on false numerical premises. (4) Despite these issues, the LLM captures some contextual elements correctly: it identifies relevant technologies (5G, Wi-Fi 6/6E, mobile broadband, access points) and aligns with Qualcomm’s 'Connected Intelligent Edge' vision. It also correctly frames edge networking as part of broader product development in QCT/IoT. However, the inclusion of fabricated data severely undermines factual correctness, warranting a low correctness score. Quantitative accuracy is very low due to invented figures. Qualitative accuracy is partially met but compromised by incorrect reasoning. Contextual relevance is fair as the topic and themes are aligned with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 578,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "\nApple’s 10‑K filings from 2022 through 2024 repeatedly list the $0.45 % Notes due 2016 among its outstanding fixed‑rate securities (see Exhibit 4.3 in the 2022, 2023 and 2024 filings). By keeping this low‑coupon, long‑dated note on the books year after year, Apple maintains a staggered maturity ladder that anchors its debt profile with a stable, inexpensive source of long‑term financing and preserves flexibility to refinance or issue new debt as market conditions evolve. This consistent inclusion signals a deliberate strategy to manage fixed‑rate maturities prudently and sustain a balanced, resilient capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it claims that Apple's 0.45% Notes due 2016 are still listed as outstanding in its 2022–2024 10-K filings, which is incorrect. The ground truth states that these notes matured in 2016 and are no longer outstanding; their inclusion in recent filings is for historical disclosure and transparency, not because they are active debt instruments. This misrepresents the core fact of the situation. (2) Quantitatively, the percentage (0.45%) and maturity year (2016) are correct, and the reference to filings from 2022–2024 aligns with the original answer. However, the implication that this note is still outstanding or being used to maintain a 'maturity ladder' is false, leading to incorrect financial interpretation. (3) The multi-hop reasoning fails: the model incorrectly infers ongoing financial strategy based on a misunderstanding of the disclosure purpose. The original answer emphasizes transparency and historical tracking, while the LLM interprets it as an active debt management tool, which contradicts the ground truth. (4) Contextual relevance is moderate because the response addresses debt maturity management and capital structure, but the flawed premise undermines the analysis. Correctness and qualitative accuracy are low due to the fundamental error in interpreting the nature of the disclosed debt.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 384,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "\nCaterpillar’s EMD brand distribution network grew its global footprint, covering 187 countries in 2022 and expanding to 191 countries by 2024—a net increase of four additional countries in geographic reach.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude. (1) Quantitatively, the LLM claims EMD covered 187 countries in 2022 and 191 in 2024, which contradicts the ground truth of 130 countries in 2022 and 109 in 2024. The actual change was a decrease of 21 countries (16%), whereas the LLM reports an increase of 4 countries. All key numbers—country counts and the trend—are wrong. (2) Calculations are incorrect: the LLM implies growth, but the truth is contraction. Even basic arithmetic (191 - 187 = +4) supports a false narrative. (3) Qualitatively, the reasoning fails multi-hop synthesis: it should have identified stable coverage in 2022–2023 (130 countries) and a drop to 109 in 2024. Instead, it fabricates expansion. (4) Contextual relevance is low but not zero—the answer addresses geographic reach and time frame, so it stays on topic. However, factual accuracy is severely lacking, warranting a correctness score of 1. Minor credit is given for addressing the right metric (number of countries) and time span, but the answer misrepresents reality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 306,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "\nThe 1.750 % 7‑Year Senior Notes stayed at a $700 million balance at the end of 2022, 2023 and 2024, showing a flat medium‑term debt position.  This consistency reflects Thermo Fisher’s strategy of using a low‑cost, longer‑dated fixed‑rate instrument to fund its healthcare‑focused growth while keeping its capital‑structure profile stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly states that the outstanding value of the 1.750% 7-Year Senior Notes was $700 million in 2022, 2023, and 2024, matching the ground truth exactly. All quantitative figures (amount, percentage, time period) are accurate. 2) The numbers are correct and consistent across years; no calculations were required, but the repetition of $700 million is factually sound. Format variations (e.g., $700 million vs $700 million) are acceptable and do not affect accuracy. 3) The reasoning is sound: the stable balance indicates a consistent medium-term debt strategy, which aligns with the ground truth interpretation. The LLM adds contextual insight—describing the notes as a 'low-cost, longer-dated fixed-rate instrument' and linking it to 'healthcare-focused growth'—which is reasonable and contextually appropriate, though slightly more interpretive than the original. However, this does not contradict the ground truth and enhances the explanation without introducing error. 4) The answer fully addresses both parts of the question: the evolution of the debt (flat over three years) and what it indicates about TMO's strategy (stable capital structure, continued use of fixed-rate debt). The only minor limitation is that the maturity date (October 15, 2028) is omitted, but this is not critical to the core question. Overall, the answer is factually correct, well-reasoned, and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 391,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "\nCaterpillar’s Cat Financial unit moved from LIBOR‑based variable‑rate financing toward SOFR‑linked rates and related hedging instruments, creating a cross‑functional team in 2022 to monitor the LIBOR transition and by 2023‑24 embedding SOFR into loan pricing, derivative hedges and match‑funding strategies. This shift shows the company’s proactive adaptation to global benchmark reforms, using SOFR‑based hedges to manage interest‑rate risk and maintain funding stability as LIBOR is phased out.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Caterpillar's currency hedging and benchmark transition strategy from 2022 to 2024. It correctly identifies Cat Financial as the unit involved, notes the formation of a cross-functional team in 2022 to monitor the LIBOR transition, and accurately reflects the shift to SOFR by 2023–2024 in loan pricing, hedges, and funding strategies. The answer correctly states that Caterpillar proactively adapted to global benchmark reforms, aligning with the ground truth's conclusion about strategic adaptation. Quantitatively, all dates and timelines are consistent: the 2022 planning phase, 2023 transition, and 2024 full adoption (implied by '2023–24') match the ground truth, including the cessation of USD LIBOR in mid-2023. There is no use of incorrect numbers or dates. The qualitative reasoning is sound, demonstrating multi-hop synthesis between LIBOR phase-out timelines, regulatory developments, and Caterpillar’s internal response. The only minor omission is that the original answer specifies Caterpillar stopped referencing LIBOR entirely in 2024, which the LLM answer implies but does not explicitly state. Additionally, the original emphasizes continued use of currency hedging instruments throughout the period, while the LLM focuses more on interest-rate hedges linked to SOFR—slightly narrowing the scope. However, the core strategic adaptation message is preserved with semantic equivalence. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 455,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "\nBetween 2022 and 2024 Thermo Fisher maintained a single, standardized Executive Change‑in‑Control Retention Agreement for all officers except the CEO. The standardized form was first adopted in 2018 (referenced in the 2018 10‑Q as Exhibit 10.2) and was repeatedly filed in the 2022, 2023 and 2024 10‑K exhibits (e.g., 2022 Exhibit 10.18; 2023 Exhibit 10.17; 2024 Exhibit 10.17), showing that no new officer‑specific versions were created—only the CEO’s separate 2009 agreement (with later amendments) remained distinct.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite addressing the right topic. (1) The claim that Thermo Fisher maintained a 'single, standardized agreement for all officers except the CEO' between 2022 and 2024 is incorrect according to the ground truth: in 2022, only CEO Marc N. Casper had an Executive Change in Control Retention Agreement (Exhibit 10.12), and there was no standardized form yet in place for other officers. The standardization for non-CEO officers was introduced in 2023 (Exhibit 10.17), not before. (2) The LLM incorrectly states the standardized form was 'first adopted in 2018' and references a 2018 10-Q Exhibit 10.2, which contradicts the ground truth—no such form existed for other officers in 2018; the 2018 amendment (Exhibit 10.17) referenced in the original answer applies only to the CEO’s agreement. (3) The exhibit numbers cited in the LLM answer are partially accurate (2023 and 2024 use Exhibit 10.17), but the 2022 exhibit is misidentified as 10.18 instead of 10.12 for the CEO-specific agreement. (4) The multi-hop reasoning fails because the LLM misrepresents the evolution: it falsely implies continuity of a pre-existing standardized form, whereas the ground truth shows a clear shift from CEO-only (2022) to standardized non-CEO agreements (2023–2024). While the answer correctly identifies that the CEO had a separate agreement and that Exhibit 10.17 was used in 2023 and 2024, the core narrative of evolution is reversed or misrepresented. Quantitative accuracy is moderate due to correct exhibit numbers in later years but wrong dates and references. Qualitative accuracy suffers from incorrect entity-event mapping. Contextual relevance is high as the response stays on topic and discusses the right agreements and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 490,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved PowerVia from an announced backside‑power concept to a fully engineered node technology that underpins its Intel 18A process. The company validated PowerVia in the Intel 18A roadmap (highlighted in 2023‑2024 disclosures) and positioned it for high‑volume manufacturing with the upcoming Panther Lake client processors slated for 2025, making PowerVia a key differentiator for performance‑per‑watt and density in Intel’s advanced‑node and IFS foundry strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the essential evolution of PowerVia from 2022 to 2024, aligning well with the ground truth. It correctly identifies PowerVia's progression from a conceptual announcement to a core component of Intel 18A, with high-volume manufacturing planned for 2025. The mention of Panther Lake as the first client processor on Intel 18A is consistent with public disclosures and adds relevant detail not in the original answer, but does not contradict it. The strategic importance of PowerVia for performance-per-watt and Intel's IFS foundry ambitions is a reasonable inference. However, the LLM omits key details from 2022 and 2023: specifically, that PowerVia was initially introduced as part of Intel 20A alongside RibbonFET, and that Intel later canceled 20A in favor of 18A—this strategic pivot is a critical multi-hop element in the original answer and is missing. While the LLM correctly notes PowerVia's retention in 18A, it does not acknowledge the roadmap change, which weakens the completeness of the evolution narrative. Quantitatively, all dates (2022–2024 development, 2025 HVM) are accurate, and no numerical errors are present. The reasoning is sound but slightly less comprehensive in tracing the full strategic shift. The answer remains contextually relevant and conveys the central role of PowerVia in Intel's roadmap. Minor omission of the 20A cancellation and initial 2022 positioning prevents a top score, but core facts and implications are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 412,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑K filings each repeat the same debt‑disclosure for the 1.05 % Notes due 2017—citing the identical Exhibit 4.4 indenture language and interest‑rate‑risk table in the “Debt”/Notes‑to‑Financial‑Statements sections. Although the notes matured in 2017 and no longer appear on the balance sheet, the company continues to disclose them in every filing to satisfy SEC reporting requirements and to keep the historical terms of all its financing arrangements visible. This consistent inclusion reflects Apple’s practice of fully transparent debt reporting, retaining legacy debt information in its public filings even after the instruments have been retired.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is quantitatively accurate: it correctly identifies the 1.05% Notes due 2017, references the consistent disclosure across Apple's 2022, 2023, and 2024 10-K filings, and notes the inclusion of Exhibit 4.4 and interest-rate-risk disclosures. There are no errors in dates, percentages, or financial terms. However, the qualitative accuracy is lower because the LLM contradicts the ground truth on a key point: it states the notes 'matured in 2017 and no longer appear on the balance sheet' and are retained 'to satisfy SEC reporting requirements' as 'historical' data. In contrast, the ground truth suggests the repeated inclusion implies the debt may have been rolled over or maintained in the capital structure, indicating continuity in debt management. The LLM interprets the persistence as mere historical transparency for retired debt, while the original answer infers ongoing financial relevance. This represents a significant divergence in reasoning and implication, undermining the multi-hop synthesis. The answer is contextually relevant and well-structured, addressing all parts of the question, but draws a different (and less aligned) conclusion about Apple's debt management practices. Thus, while facts and numbers are correct, the interpretation and underlying reasoning do not fully align with the ground truth, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 381,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "\nFrom 2022 through 2024 Intel’s equity‑incentive program under the 2006 Equity Incentive Plan shifted from a primarily time‑based RSU and option regime to a more performance‑driven framework.  In 2022 the company adopted amendments (first‑amendment to the RSU agreements for Patrick Gelsinger, and first‑amendments to the “Strategic Growth” and “Outperformance” PSU agreements – see 10‑K 2022 p. 121 and 10‑K 2023 p. 120) that introduced performance‑based RSUs and performance‑based stock options, and it restated the plan effective May 11 2023 (Exhibit 10.1 † in the 2023 and 2024 10‑Ks, p. 120).  The restated plan codified four RSU grant forms—retirement‑vesting, non‑retirement, performance‑based for grandfathered and non‑grandfathered executives, and strategic‑growth performance‑based RSUs—while retaining the original time‑vesting and performance‑vesting conditions; no further substantive changes were made in 2024 (see 10‑K 2024 p. 107).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2006 Equity Incentive Plan was amended and restated effective May 11, 2023, which matches the original answer. The types of RSUs referenced—retirement-vesting, non-retirement, performance-based for grandfathered and non-grandfathered executives, and strategic growth performance-based RSUs—are accurately described. (2) Quantitative accuracy is excellent: the date 'May 11, 2023' is correctly cited, and the references to specific 10-K pages (e.g., p. 121 in 2022, p. 120 in 2023, p. 107 in 2024) are consistent with the source documents. No numerical errors or miscalculations are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years (2022–2024), identifies the evolution from time-based to performance-based awards, and notes the structural consolidation in 2024. It correctly references the restatement of the plan and the codification of multiple RSU forms. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'streamlined format for grant agreements' or 'consolidation in documentation structure' in 2024, which is a nuance highlighted in the original answer. However, stating 'no further substantive changes were made in 2024' and citing consistent use of the restated plan implies this stability. Wording differs slightly (e.g., 'strategic growth performance-based RSUs' vs. 'Outperformance PSU'), but these are semantically equivalent. Overall, the answer is factually correct, well-supported, and contextually appropriate, meriting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 449,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "\nMedtronic’s 10‑K filings for fiscal 2022, 2023 and 2024 each state that **no Euro‑Denominated Deferred Shares had been issued or were outstanding at year‑end**, and there is no reference to any issuance against the 40 000‑share authorization in any of those years.  The repeated disclosure shows that the company deliberately left this share reserve untouched, relying instead on conventional debt issuances, credit‑facility borrowings and cash‑flow generation to meet its financing needs.  This consistent absence indicates a financing strategy that preserves the Euro‑Deferred Shares as a “dry‑powder” contingency (e.g., for future employee equity or defensive purposes) rather than using them as an active source of capital.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative claims: it correctly states that no Euro Deferred Shares were issued or outstanding in fiscal years 2022, 2023, and 2024, and accurately notes the authorized amount of 40,000 shares with no issuance against that authorization. The numbers, time frame, and entity (Medtronic) are all correct, satisfying the quantitative accuracy criterion fully. The answer addresses both parts of the multi-hop question—evolution of disclosures (consistent non-issuance) and strategic implication—demonstrating proper synthesis across years. However, while the original answer attributes the non-issuance to a preference for ordinary share repurchases and dividend policies, the LLM instead suggests reliance on debt, credit facilities, and cash flow, and introduces the speculative notion of 'dry powder' for employee equity or defensive purposes. This interpretation, while plausible, goes beyond the documented reasoning in the ground truth and adds strategic hypotheses not supported in the source. Thus, while the core facts and reasoning are sound, the qualitative analysis slightly diverges in emphasis and introduces unsupported speculation, warranting a minor deduction. The answer remains highly relevant and well-aligned with the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 361,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved Advanced Packaging from a strategic pillar of its IDM 2.0 plan to a core growth engine, expanding its roadmap to Intel 18A (RibbonFET/PowerVia) and broader 2.5D/3D capabilities while dramatically increasing R&D spend (≈ $17 B in 2022, $16.5 B in 2024).  This deeper investment raised manufacturing complexity—new fab builds in Ireland and Arizona encountered delays, triggering $3.3 B of impairment charges and a $755 M loss on liquidated‑damage provisions—and pushed cost of sales and operating expenses higher (up $961 M in 2024), yet it also delivered modest packaging‑related revenue and strategic design wins that reinforce Intel’s long‑term positioning.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic evolution of Intel's Advanced Packaging Technologies from 2022 to 2024 and correctly identifies IDM 2.0, increased R&D, manufacturing complexity, and financial impacts. However, key factual inaccuracies undermine correctness. (2) Quantitative inaccuracies include: R&D spending—Intel’s total R&D was $17.2B in 2022 and $16.2B in 2023, but the LLM claims $16.5B in 2024, which is unsupported (actual 2024 R&D was ~$15.1B); impairment charges are stated as $3.3B, but the ground truth specifies $3.1B in non-cash impairments tied to Intel 7 in 2024—close but incorrect; the $755M loss on liquidated damages and $961M increase in operating costs are not present in the ground truth and appear fabricated. (3) Multi-hop reasoning is partially sound—the LLM connects R&D investment to manufacturing delays and financial impact, and references strategic initiatives like chiplet integration and advanced nodes. However, it omits critical elements: no mention of UCIe silicon demonstration in 2023, delays in Intel 4/10nm in 2022, or the specific role of disaggregated designs. It also incorrectly implies revenue from packaging, which is not in the ground truth. (4) Correctness score is 5 due to partial factual alignment but significant numerical and detail-level errors. Quantitative accuracy is low (4) due to incorrect or invented figures. Qualitative accuracy is moderate (6) as the reasoning framework is logical but misses key nuances. Contextual relevance is high (9) because the answer addresses R&D, complexity, and financial impact as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 441,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "\nIntel first unveiled PowerVia in 2022 as a breakthrough backside‑power delivery scheme tied to the then‑upcoming Intel 20A node, positioning it as a key enabler for higher performance‑per‑watt and denser circuitry. By the 2023 roadmap update the company quantified the benefit—projecting up to 15 % performance‑per‑watt gains when PowerVia is combined with RibbonFET—and broadened its scope, stating that the technology would be offered to external foundry customers as part of the Intel 18A platform. In the 2024 disclosures Intel confirmed that PowerVia is now manufacturing‑ready, with high‑volume production slated for Intel 18A (e.g., the Panther Lake client family) in 2025, marking the transition from concept to a production‑ready capability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 15% performance-per-watt improvement, the 2022 introduction, 2023 roadmap update, and 2025 high-volume manufacturing timeline are all consistent with the original answer. The association with Intel 18A and the Panther Lake client family (specific product example) adds contextual detail without introducing error. (2) The answer correctly captures the evolution across years: 2022 introduction as a backside power delivery solution for Intel 20A, 2023 quantification of benefits and expansion to external foundry customers under Intel 18A, and 2024 confirmation of manufacturing readiness with 2025 production plans. (3) The only minor discrepancy is that the original answer notes PowerVia was initially tied to Intel 20A but shifted to Intel 18A as the production node, while the LLM answer states it was introduced with Intel 20A and then offered with Intel 18A—this slightly downplays the roadmap shift but does not misrepresent the final outcome. The multi-hop reasoning across 2022–2024 developments is sound and synthesizes strategic positioning, technical expectations, and manufacturing readiness as required. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (e.g., Panther Lake) enhancing relevance. All entities—PowerVia, RibbonFET, Intel 20A, Intel 18A, performance-per-watt—are correctly identified and contextualized. The conclusion about transition from concept to production-ready is fully supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 434,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "\nMedtronic has not changed the wording of its U.S. employee restricted‑stock‑unit agreement between FY2022 and FY2024 – the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan” is cited verbatim in the 2022, 2023 and 2024 10‑K filings. This continuity indicates that the company is deliberately keeping its U.S. equity‑compensation design stable and predictable, rather than revising the RSU terms on a regular basis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Medtronic did not update its U.S. employee restricted stock unit agreements from FY2022 to FY2024, citing the same form in all three years—the 'Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan.' This matches the original answer exactly in substance. (2) There are no numeric values, dates, or calculations in the question or answer that are incorrect; the LLM correctly avoids introducing any false dates or filing numbers, though it does not mention the specific filing date (August 27, 2013) or File No. 001-07707. This omission is minor and does not affect the core factual accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three fiscal years (2022–2024) and draws a logical conclusion about Medtronic’s equity compensation strategy—namely, stability and predictability. (4) The semantic meaning is equivalent to the original answer, though slightly less detailed in referencing the exact history of the agreement. The conclusion about a stable equity compensation strategy is well-supported and consistent with the evidence. The answer is fully relevant to the question. The score is 9 instead of 10 due to the minor omission of the original filing date and file number, which are part of the full factual record but not critical to the strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 407,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved away from the original 2019 performance‑based RSU grant forms and adopted a revised framework created by a series of November 2022 amendments (Exhibits 10.1.8‑10.1.10) to the 2006 Equity Incentive Plan. These amendments introduced distinct performance‑based RSU categories—Strategic‑Growth PSUs, Outperformance PSUs and Performance Options—each tied to specific company‑performance metrics and incorporated into the executive’s RSU agreement. The amended agreements, cited in the 2023 and 2024 Form 10‑K exhibits, have served as the governing documents for all subsequent executive performance‑based RSU grants, reflecting a shift toward more granular, metric‑driven vesting conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite addressing the right topic. (1) The claim that Intel 'moved away from the original 2019 performance-based RSU grant forms' and adopted a 'revised framework' via November 2022 amendments is not supported by the ground truth. The original answer states consistent use of the 2006 Equity Incentive Plan without mention of a structural shift or new categories like 'Strategic-Growth PSUs', 'Outperformance PSUs', or 'Performance Options'—terms absent from the ground truth. (2) The ground truth confirms continued use of the same plan through 2024, including an S-8 filing on September 26, 2023, for the amended May 11, 2023 version, but does not reference November 2022 amendments or specific exhibit numbers (10.1.8–10.1.10) cited by the LLM. These specific dates and exhibit references are unverified and appear fabricated. (3) The multi-hop reasoning is partially sound in that it attempts to trace plan evolution across years and filings, but it incorrectly infers a substantive overhaul rather than the continuity emphasized in the original answer. (4) While the LLM correctly identifies the use of the 2006 Equity Incentive Plan for performance-based RSUs and references 10-K exhibits, it introduces unsupported details about amendment timing, new grant types, and structural changes. This results in a partially correct narrative with major factual deviations. Quantitative accuracy is low due to incorrect dates (November 2022 vs. May 11, 2023 amendment) and invented document references. Qualitative accuracy suffers from incorrect entity relationships and unsupported claims about plan evolution. Contextual relevance is high as the response stays focused on the question’s scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 481,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "\nFrom 2022 through 2024 Intel poured ever‑greater capital and R&D into advanced‑packaging capabilities—establishing dedicated SCIP entities in Ireland and Arizona, expanding its 2D/2.5D/3D packaging platforms, standardizing the Universal Chiplet Interconnect Express, and securing multiple AI‑focused design wins—yet the packaging unit’s operating loss widened (from $281 M in 2022 to $482 M in 2024) and construction delays persisted. This trajectory shows that while Intel’s disaggregated‑design strategy relies on cutting‑edge packaging to stitch together chiplets for AI workloads, the company’s ability to translate those investments into profitable, market‑leading AI products remains fraught with execution risk amid intense competition.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth states that Intel invested $16.5 billion in R&D in 2024 (including packaging), but the LLM does not mention this figure. Instead, it introduces operating losses for the packaging unit—$281M in 2022 and $482M in 2024—which are not present in the original answer and cannot be verified from the provided ground truth. These specific loss figures and the claim about widening losses are unsupported, making the quantitative foundation of the LLM response unreliable. Additionally, there is no mention in the ground truth about SCIP entities in Ireland and Arizona or construction delays, which appear to be fabricated or misattributed. (2) The only correct quantitative element is the general upward trend in investment, which aligns with the increased R&D focus, but without citing the actual $16.5B figure or the $3.1B impairment charge in 2024, the financial narrative is incomplete and misleading. The absence of the $3.1B non-cash impairment—a key indicator of execution risk in the original answer—significantly weakens the LLM's analysis. (3) Qualitatively, the LLM captures the strategic importance of advanced packaging for Intel’s disaggregated design and AI ambitions, correctly identifying UCIe standardization and AI design wins as strategic moves. It also correctly infers execution risks, which aligns with the ground truth’s emphasis on delays and financial pressures. However, it fails to mention the 2022 acknowledgment of risks in introducing competitive products due to packaging challenges, a key multi-hop link between packaging and product competitiveness. The reasoning is partially sound but built on incorrect or unverified data. (4) Contextually, the answer is relevant and addresses the evolution of investment, the disaggregated design strategy, and competition in the AI market. It synthesizes strategic elements well but lacks fidelity to the actual data. The conclusion about execution risk is consistent with the ground truth, but the supporting evidence is flawed. Thus, while the direction of reasoning is appropriate, the factual inaccuracies—especially in financial figures—reduce overall correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 607,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "\nIntel’s 2006 Equity Incentive Plan was first restated in May 2022 (effective May 11 2022) to expand the share reserve and add retirement‑vesting language, a change that appeared in the 2022 Form 10‑K. In May 2023 the plan was again restated (effective May 11 2023) to incorporate those 2022 changes and to add new performance‑based RSU categories and updated grant‑agreement forms (e.g., the 10.1.6–10.1.7 RSU agreements), which were disclosed in the 2023 filing. No further plan‑wide amendment was made in 2024; the company continued to use the May 2023 restated plan and only issued targeted amendments to executive RSU and option agreements (such as the November 18 2022 First Amendments filed in 2023 and still in effect in 2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding dates and the nature of plan amendments, which undermines its correctness. (1) The claim that the 2006 Equity Incentive Plan was 'first restated in May 2022 (effective May 11, 2022)' is incorrect — the ground truth states the amended and restated version was filed in 2023, effective May 11, 2023, not 2022. This misstatement of a key date severely impacts quantitative accuracy. (2) The LLM incorrectly asserts that changes from a '2022 restatement' were incorporated into the 2023 version, but the original answer does not mention any 2022 amendment — only references to grant agreements. There is no evidence in the ground truth of a formal restatement in 2022. (3) The mention of '10.1.6–10.1.7 RSU agreements' and 'November 18, 2022 First Amendments' lacks support in the original answer and introduces unverified specifics. (4) While the LLM correctly notes continued use of the plan in 2024 and the presence of performance-based RSUs and retirement-vesting terms in agreements, these details are attached to an incorrect timeline and reasoning framework. (5) The multi-hop synthesis is partially sound — the model attempts to trace evolution across years — but fails due to incorrect anchoring on a non-existent 2022 restatement. (6) Contextual relevance is high because the response addresses plan amendments, grant agreements, and year-by-year evolution as required. However, the core factual errors in dates and amendment history reduce correctness significantly. Minor flexibility is allowed for phrasing, but not for invented events. Thus, while some elements align semantically (ongoing use, types of awards), the structural timeline is flawed, warranting a low-to-mid score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 478,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm re‑classified edge‑networking equipment as a distinct sub‑category of its QCT IoT revenue, reporting it explicitly in the segment’s revenue breakdown (e.g., “IoT (internet of things) – edge networking products” in the 2023‑2024 financial tables).  The company’s narrative shifted from a general mention of “edge networking” as a growth area in 2022 to a strategic emphasis on “connected intelligent edge” in 2023‑2024, positioning its 5G‑ and Wi‑Fi 6/6E‑enabled wireless access‑point and edge‑computing chips as a core platform for automotive, industrial and consumer OEMs and as a key growth driver within the broader edge‑networking market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though with slight differences in emphasis and precision. (1) Quantitatively, there are no numeric inaccuracies—no specific revenue figures are cited in either answer, and the years (2022–2024) are correctly referenced. The LLM correctly identifies the evolution across the three years without introducing false data. (2) The LLM accurately reflects that edge networking became a formally reported sub-category within the QCT IoT segment starting in 2023, consistent with the original answer’s claim of explicit categorization in 2023. However, the original answer does not specify that it was labeled as 'IoT – edge networking products' in financial tables, which is a more granular claim; while plausible, this detail is not confirmed in the ground truth and slightly extends beyond it. (3) The reasoning is sound: the LLM captures the multi-hop progression from strategic mention in 2022 to formal classification in 2023–2024 and correctly infers growing strategic importance. It adds value by specifying technologies (5G, Wi-Fi 6/6E) and target markets (automotive, industrial, consumer), which are contextually accurate but not in the original answer—this enriches the response without contradicting facts. (4) The core elements—evolution of financial categorization, strategic emphasis, and positioning within edge networking—are fully addressed, making the response contextually highly relevant. The minor deduction in qualitative accuracy is due to the unverified specificity about financial table labels, and in correctness due to the slight overreach in detail not present in the ground truth, though the overall meaning remains semantically aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 469,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "\nMerck’s Prevymis sales rose steadily — from $428 million in 2022 to $605 million in 2023 and $785 million in 2024 (U.S. + international combined) — showing a clear upward trajectory over the three‑year period.  This consistent growth signals that Prevymis is gaining traction within the Hospital Acute Care segment, positioning it as a leading (and expanding) therapeutic option for CMV prophylaxis and strengthening its competitive standing in that market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the sales figures. According to the ground truth, MRK's Prevymis sales were $370 million in 2022 and $428 million in 2023, but the LLM incorrectly reports $428 million in 2022 and $605 million in 2023. Only the 2024 figure ($785 million) is correct. This misrepresentation leads to an inaccurate growth trajectory. (2) The quantitative inaccuracies are severe: the LLM overstates 2022 sales by $58 million and 2023 sales by $177 million. The compound growth rate cannot be accurately assessed due to incorrect base figures. The ground truth shows ~46% compound growth from 2022 to 2024 ($370M → $785M), but the LLM's numbers imply a much lower growth rate. (3) The qualitative reasoning about market positioning is partially sound — the upward trend and increasing adoption in Hospital Acute Care for CMV prophylaxis align with the ground truth. The LLM correctly identifies the therapeutic use and strategic importance. However, it fails to mention the specific patient population (high-risk transplant recipients), which is a key detail in the original answer. (4) The contextual relevance is high because the answer addresses both parts of the question — sales evolution and market positioning — and uses appropriate terminology. However, the correctness score is low due to major numerical errors that undermine the factual foundation of the response. While the direction of growth (upward) is correct, the magnitude and year-by-year progression are not, leading to a misleading interpretation of the product's performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 439,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "\nBetween 2022 and 2024 Intel broadened its advanced‑packaging capabilities—launching 2D/3D EMIB/Foveros families, supporting the Universal Chiplet Interconnect Express standard, and dedicating new packaging lines for AI‑focused chips—to make packaging a core differentiator of its IDM 2.0 foundry strategy.  This multi‑year investment was funded by large capital commitments (e.g., the Ireland and Arizona SCIP transactions), yet the company incurred impairments, accelerated depreciation of Intel 7 assets and faced construction delays that triggered liquidated‑damage provisions, exposing how manufacturing setbacks and capital constraints are straining the execution of its IDM 2.0 agenda.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Intel's advanced packaging strategy from 2022 to 2024 and correctly identifies key elements of the IDM 2.0 strategy, including EMIB/Foveros, UCIe, and capital investments. However, it omits specific financial figures from the ground truth—namely the $16.5 billion R&D investment in 2024 and the $3.1 billion non-cash impairment in Q3 2024—which are critical quantitative anchors in the original answer. Instead, it vaguely references 'impairments' and 'large capital commitments' without citing exact amounts, reducing quantitative accuracy. (2) The LLM mentions 'liquidated-damage provisions' and 'Arizona and Ireland SCIP transactions'—details not present in the ground truth—which may be contextually plausible but are unsupported by the provided knowledge graph and introduce unverified specifics. These additions do not contradict the original but introduce speculative elements. (3) The multi-hop reasoning is generally sound: the model connects advanced packaging developments to IDM 2.0, acknowledges manufacturing delays and capital constraints, and links impairments and depreciation to execution challenges. It correctly synthesizes the strategic intent with operational headwinds. (4) While the qualitative narrative aligns well—highlighting packaging as a differentiator amid execution strain—the absence of precise figures and the inclusion of unverified program names (e.g., SCIP) reduce factual precision. The answer remains contextually relevant and semantically close, but not fully factually equivalent due to missing key numbers and uncorroborated details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 448,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "\nIBM has repeatedly listed “client relationships and trust” among its principal competitive methods (2022‑2024 10‑Ks), but the language has tightened around the hybrid‑cloud and AI agenda: in 2022 it was presented as one of several differentiators, while 2023‑2024 filings explicitly tie that trust to the adoption of IBM’s hybrid‑cloud platform and AI capabilities that enable clients to “re‑imagine critical workflows” and achieve “business value at scale.” Thus, the evolution shows that IBM is using client trust as the strategic glue that validates and differentiates its hybrid‑cloud and AI strategy, positioning the company not merely as a technology supplier but as a trusted partner for large‑scale digital transformation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: IBM consistently emphasized client relationships and trust from 2022 to 2024 as a competitive differentiator, and this emphasis evolved to be more tightly integrated with hybrid cloud and AI strategy over time. The progression from being one of several differentiators in 2022 to being explicitly tied to hybrid cloud and AI outcomes (e.g., 're-imagine critical workflows', 'business value at scale') in 2023–2024 is correctly captured. (2) There are no numeric values, dates, or calculations in dispute; all timeframes (2022–2024) are accurately referenced. (3) The multi-hop reasoning is sound—synthesizing across three years of 10-K filings to show strategic evolution is done effectively. The LLM correctly infers that trust is becoming a 'strategic glue' for IBM’s broader transformation narrative, which is consistent with the ground truth’s conclusion about trust being foundational. (4) The only minor gap is that the LLM answer does not mention the 2024 strategic partnership with Palo Alto Networks, which is a specific signal of deepening trust-based collaboration noted in the original answer. While the general trend is accurately described, this omission slightly reduces completeness in entity-level detail. However, the core message about trust reinforcing hybrid cloud and AI positioning is semantically equivalent and well-reasoned. Hence, high scores across all dimensions with a 9 on correctness due to this small but relevant omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 428,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "\nFrom 2022 through 2024 IBM continued to disclose the 0.950 % Notes due 2025 by simply referencing the original 8‑K filing (Exhibits 4.1‑4.2 dated May 22 2017) in each year’s 10‑K and by listing the securities (ticker IBM25B) in the “Securities Registered Pursuant to Section 12(b)” table. No new issuance or amendment of the notes was reported; the company merely reaffirmed the existing indenture and provided periodic updates on the same terms. This steady, “hold‑and‑ disclose” approach reflects IBM’s broader debt‑management strategy of maintaining a low‑cost, long‑dated debt profile and managing refinancing through incremental, transparent updates rather than frequent large‑scale issuances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: IBM consistently referenced the May 22, 2017 Form 8-K (Exhibit 4.1) in its disclosures from 2022–2024, and the 0.950% Notes due 2025 were listed under ticker IBM25B on the NYSE. The LLM correctly notes no new issuance or amendment occurred, which matches the original answer’s implication of regulatory continuity. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), filing date (May 22, 2017), exhibit number (4.1), and ticker (IBM25B)—are all factually correct. The LLM mentions Exhibits 4.1–4.2, while the ground truth only specifies Exhibit 4.1; this is a minor overstatement but does not materially misrepresent the facts. (3) The multi-hop reasoning is sound: the model synthesizes disclosure patterns across three years, infers stability in debt management, and connects ongoing registration and lack of amendments to a broader strategy of transparency and low-cost liability management. (4) The answer captures the semantic meaning of the original, adding slight interpretive depth (e.g., 'hold-and-disclose', 'low-cost, long-dated debt profile') that is reasonable and contextually supported. The only reason for not scoring a 10 is the minor reference to Exhibit 4.2 not explicitly confirmed in the ground truth, but this does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 387,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "\nIntel first introduced PowerVia as a “back‑side power‑delivery” breakthrough in its roadmap for the then‑upcoming Intel 20A node (later renamed Intel 18A) and pledged that the technology would be ready for high‑volume production with the Panther‑Lake client family in 2025 【page 14 (2023)】.  By 2024 the company had cancelled the original Intel 20A node, consolidated its effort on the improved Intel 18A process, and began high‑volume manufacturing of Panther‑Lake on that node, explicitly positioning PowerVia as the industry‑first commercial implementation of backside power that will be offered not only to Intel’s internal products but also to external foundry customers under the IDM 2.0/IFS strategy【page 10, 18A description】.  \n\nThis progression shows that Intel’s roadmap for advanced nodes is built around backside power delivery as a core enabler of higher performance‑per‑watt and density scaling, and that PowerVia will underpin Intel’s next‑generation process technologies (18A, 14A) and its broader foundry ambitions beyond 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced as part of Intel 20A (later pivoted to 18A), positioned for high-volume production in 2025 with Panther-Lake, and Intel canceled Intel 20A in favor of 18A. The 2025 timeline and commercial deployment intent are correctly stated. (2) Quantitative accuracy is perfect: no incorrect numbers, dates (2022–2024 evolution, 2025 production), or misstatements. The reference to Panther-Lake in 2025 matches the intended rollout. (3) Multi-hop reasoning is sound: the answer synthesizes Intel's strategic shift from 20A to 18A, integrates PowerVia's role in backside power delivery, and links it to IDM 2.0/IFS foundry ambitions—showing correct understanding across time and strategy layers. (4) The only minor gap is that the LLM does not explicitly mention the 2022 introduction of PowerVia as a roadmap concept (though implied via 'roadmap for upcoming Intel 20A'), slightly reducing completeness compared to the original answer’s clear year-by-year breakdown. However, the core evolution—concept to integration to commercialization—is accurately conveyed. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing the evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 374,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "\nMedtronic’s latest RSU award agreements (2021‑2024 filings) continue to employ the same two‑track vesting structure—either 100 % after the third anniversary or ratable over the first four years—under the Amended and Restated 2013 Stock Award and Incentive Plan, with only minor wording updates from earlier forms. This consistency across the 2022‑2024 Exhibit 10‑K pages shows that the company’s U.S. equity‑compensation framework remains stable, preserving the core RSU design while merely modernizing the documentation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the stability of Medtronic's U.S. equity compensation strategy from 2022 to 2024, aligning with the ground truth's core conclusion. It accurately notes the consistent use of the Amended and Restated 2013 Stock Award and Incentive Plan and mentions minor updates, which supports the idea of structural stability. However, there are key discrepancies in quantitative and factual accuracy: (1) The LLM references a 'two-track vesting structure' (100% after third anniversary or ratable over four years), which is not mentioned or supported in the ground truth; this specific vesting detail is unverified and introduces new, potentially incorrect information. (2) The LLM cites '2021-2024 filings' and 'Exhibit 10-K pages', but the ground truth specifically identifies Exhibit 10.54 and ties it to the August 27, 2013 filing, which the LLM omits. (3) The ground truth emphasizes that the *same document* (Exhibit 10.54) was reused unchanged across all three years, a stronger indicator of stability than the LLM's description of 'minor wording updates', which contradicts the 'unchanged' assertion in the original. This undermines quantitative and qualitative accuracy. While the LLM captures the overall theme of stability (contextually relevant and semantically close), it fails to report the most critical evidence—document reuse without change—and introduces unverified vesting details. Thus, while the conclusion is directionally correct, the supporting facts are partially inaccurate or speculative, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 430,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "\nFrom 2022 through 2024 Intel positioned advanced packaging and disaggregated, chiplet‑based designs as the centerpiece of its IDM 2.0 strategy, promising to monetize packaging through its Intel Foundry Services and to lead in AI‑optimized heterogeneous systems. Execution has been hampered by repeated node delays (10 nm, 7 nm, 4th‑Gen Xeon), steep capital constraints that postponed fab builds in Ohio, Germany, Poland, Malaysia and Israel, and the added complexity and cost of novel 2D/2.5D/3D packaging, which triggered multi‑billion‑dollar impairments and left the company’s packaging ambitions ahead of its realized revenue. Consequently, while packaging revenue modestly rose (e.g., +$483 M in 2023), the company’s advanced‑packaging roadmap remains a high‑risk, capital‑intensive effort with delayed time‑to‑market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Intel's strategic positioning and execution challenges around advanced packaging from 2022 to 2024, correctly identifying delays, capital constraints, and the role of disaggregated design. It accurately reflects the strategic intent behind IDM 2.0 and Intel Foundry Services, as well as the complexity of 2D/2.5D/3D packaging. However, it introduces a $483M revenue increase in 2023 that is not present in the ground truth, which instead cites a $3.1B impairment charge in 2024 — a significant factual discrepancy. The ground truth does not mention any positive revenue figures related to packaging, nor does it quantify packaging revenue growth. Additionally, the LLM references delays in '10 nm, 7 nm, 4th-Gen Xeon' and multiple fab postponements across geographies, which, while contextually plausible, are not explicitly detailed in the original answer. (2) Quantitative accuracy is compromised by the incorrect $483M figure and the absence of the correct $3.1B impairment charge in 2024. The original answer specifically highlights this impairment as a key indicator of execution failure and capital misallocation, which the LLM omits entirely. The LLM’s use of 'multi-billion-dollar impairments' is directionally correct but lacks precision and conflates timing and magnitude. (3) The multi-hop reasoning is generally sound: the model connects advanced packaging to disaggregated design, links capital constraints to delayed fabs, and situates packaging within the foundry strategy. However, it fails to mention UCIe or Intel’s 2023 emphasis on strategic advantage via standards leadership — a key element in the original answer. The 2024 challenges are partially captured but without the specific grounding in the Intel 7 node underutilization. (4) Despite these gaps, the LLM answer remains contextually relevant and conveys a plausible narrative consistent with Intel’s public challenges. The qualitative reasoning is strong, and the structure aligns with the question’s timeline and themes. The correctness score is 7 due to accurate core themes but significant quantitative and detail-level omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 582,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Accenture’s pension glide‑path moved from a modest equity tilt in non‑U.S. plans (≈21‑27 % equity, ≈48‑50 % debt) and near‑zero equity in U.S. plans (≈97‑100 % debt) to a markedly more fixed‑income‑heavy mix: by 2024 the U.S. plan was ~94 % debt with virtually no equity, while non‑U.S. plans cut equity to ~23 % and debt to ~42 % with a larger cash buffer.  This progressive de‑risking—reducing equity exposure and increasing duration‑matched fixed‑income and cash—reflects a strategic shift toward liability‑driven investing and a focus on stable, risk‑adjusted returns rather than growth‑oriented asset allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM provides specific percentages (e.g., 21-27% equity in non-U.S. plans, 97-100% debt in U.S. plans) and claims a shift to 94% debt in 2024 with reduced equity and increased cash. However, the ground truth contains no such numerical data—there are no disclosed percentages for asset allocation across 2022–2024, nor any mention of exact equity/debt splits or cash buffers. These numbers are fabricated or hallucinated. (2) COMPLETENESS: The question asks about the evolution of Accenture’s *target* asset allocation strategy across 2022–2024 and what it suggests about risk-adjusted returns. The LLM attempts to address this but misrepresents the data. The ground truth emphasizes a consistent dual focus on fixed income and equities, with increasing *flexibility* in allocation decisions—not a de-risking trend. (3) ENTITY & REASONING: The LLM incorrectly frames the evolution as a 'progressive de-risking' and 'glide-path' shift toward fixed income, which is not supported by the original answer. The original states that the strategy remained focused on balancing fixed income and equities, with growing flexibility in rebalancing, not a directional shift. The mention of 'liability-driven investing' and 'glide-path' introduces concepts not explicitly stated in the ground truth. (4) SEMANTIC EQUIVALENCE: The LLM answer conveys a different narrative—active de-risking—while the ground truth describes continuity with enhanced adaptability. This is a fundamental divergence in interpretation. While the LLM does address pension plans and risk-adjusted returns, the factual foundation is unsound. Minor credit is given for addressing the general topic and linking allocation to risk-adjusted returns, but core facts and reasoning are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 501,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "\nApple’s repeated citation of the 1.05% Notes due 2017 in its 2023 and 2024 Form 10‑K filings demonstrates that it treats the indenture governing that tranche as a permanent, fully disclosed element of its debt documentation, preserving a complete historical record of all long‑term obligations even after the notes have matured. This reflects a disclosure approach that is deliberately exhaustive and conservative, contrasting with its 2022‑2024 issuance strategy, which focuses on issuing new, low‑coupon, staggered‑maturity debt to fund share buybacks and growth initiatives. Consequently, while Apple’s financing execution is aggressive and diversified, its public debt disclosures remain meticulously comprehensive, retaining legacy series alongside newer tranches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities are correct: Apple, 1.05% Notes due 2017, and the timeframe (2022–2024) are accurately referenced. The LLM correctly notes that the 1.05% Notes matured in 2017 but continue to appear in 2023 and 2024 filings. (2) Quantitative accuracy is perfect: the interest rate (1.05%), maturity year (2017), and context of newer issuances (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, 3.45% Notes due 2024 implied in ground truth) are consistent with Apple’s actual debt strategy, even if specific percentages for 2022–2024 are not repeated verbatim—the LLM captures the pattern of staggered, low-coupon issuances. (3) Reasoning is sound: the multi-hop synthesis between continued disclosure of retired debt and active new issuance is well-executed. The contrast between conservative, transparent disclosure and dynamic financing strategy is logically drawn and supported. (4) Semantic equivalence is strong: while the LLM uses terms like 'indenture' and 'permanent... element' not in the original, these are reasonable interpretations of persistent disclosure. It adds nuance (e.g., 'funding share buybacks') consistent with Apple’s known capital allocation but not explicitly in the ground truth—this is contextually appropriate and not factually overreaching. Only a minor deduction in qualitative accuracy due to slight elaboration beyond the original, but no factual errors. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 426,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Accenture expanded its share‑repurchase authorization—adding $3 billion in September 2022 (raising total authority to $6.13 billion) and a further $4 billion in September 2024 (to $6.69 billion)—and has repurchased roughly $4 billion of stock each year (≈$4.1 billion in FY 22, $4.5 billion in FY 23 and $4.5 billion in FY 24), leaving about $2.7 billion of the current authorization still unused as of August 2024. This steady growth in authorized capacity combined with consistent multi‑billion‑dollar buybacks demonstrates a disciplined, ongoing capital‑return strategy that pairs regular dividends with systematic share repurchases while preserving a sizable reserve for future opportunistic purchases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures and timelines. According to the ground truth, Accenture had $3.13 billion available authorization in fiscal 2022, not $6.13 billion as claimed. The LLM incorrectly states that $3 billion was added in September 2022, but the ground truth does not mention any new authorization in 2022—only that the available authorization was $3.13 billion. The $4 billion addition in September 2024 is correctly identified, but the resulting total of $6.69 billion combines this with prior unused amounts, not from a prior $3 billion increase as implied. (2) The repurchase amounts are severely overstated: the LLM claims ~$4 billion per year in repurchases (e.g., $4.1B in FY22, $4.5B in FY23, $4.5B in FY24), but the ground truth only confirms $605 million in repurchases during fiscal 2024. No repurchase figures for 2022 or 2023 are provided in the original answer, so the LLM’s detailed annual breakdown is fabricated. The remaining authorization of $2.69 billion in 2024 is correctly approximated as $2.7 billion, which is acceptable. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a sustained capital return strategy from repurchase activity and authorization trends—but it builds this conclusion on false quantitative premises. It synthesizes across years but invents missing data rather than acknowledging gaps. (4) Contextual relevance is high because the answer addresses both the evolution of repurchase activity and the strategic implication. However, due to major quantitative errors and invented figures, the correctness score is low. The qualitative reasoning is somewhat accurate in structure but undermined by factual inaccuracies. Final scores reflect partial credit for correct mention of the $4B 2024 authorization and approximate remaining balance, but heavy penalties for incorrect repurchase volumes and phantom authorizations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 528,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "\nThe 4.350 % Senior Notes due 2047 were originally issued in November 2019 as part of the Eleventh Supplemental Indenture to the 1993 indenture.  Subsequent supplemental indentures in March 2022 (the Thirteenth Supplemental) and November 2023 (the Fourteenth Supplemental) added new long‑dated tranches and amended the indenture, keeping the 2047 notes within a broader laddered schedule of multi‑year fixed‑rate debt.  This multi‑year pattern shows Bristol‑Myers Squibb’s strategy of locking in low‑to‑mid‑range coupons for very long maturities and staggering repayments to create a stable, long‑term financing base while managing interest‑rate risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core strategic insight correctly—that BMY maintains a laddered maturity structure with long-term fixed-rate debt, and that the 4.350% Senior Notes due 2047 remain a persistent component of its capital structure. However, there are key factual inaccuracies affecting quantitative accuracy. First, the LLM claims supplemental indentures occurred in March 2022 (Thirteenth) and November 2023 (Fourteenth), but the ground truth does not confirm these specific events or amendments in those years—only that the 2047 notes were referenced as outstanding. The original issuance date (November 2019) and indenture framework (Eleventh Supplemental) are correct. Second, the LLM implies active restructuring or amendment in 2022 and 2023, while the ground truth indicates passive continuity: the 2047 notes were simply listed among outstanding debt, not modified. The mention of new tranches in 2023 and 2024 aligns with ground truth ($1.75B 2.950% Notes due 2032, $2B 3.700% due 2052, $3.75B 4.250% due 2049), though the LLM does not specify these amounts or rates, reducing completeness. The strategic interpretation—staggered maturities, interest rate risk management—is semantically equivalent and well-reasoned. Entity accuracy (BMY, 4.350% Senior Notes due 2047) and years are correct. The answer is contextually relevant and synthesizes across years, but overstates active structuring activity. Quantitative accuracy is reduced due to unverified dates and lack of specific dollar amounts from new issuances mentioned in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 425,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "\nIn the 2022 Form 10‑K Apple placed the 2.40 % Notes due 2023 in the “Description of Securities” exhibit (Exhibit 4.3) and included a full officer’s certificate that spelled out the indenture, redemption provisions and the notes’ position within the 2013 indenture. By the 2023 filing the same exhibit was retained, but Apple added a dedicated “Maturity and Redemption” paragraph that flagged the upcoming 2023 maturity, re‑classified the debt as a current liability and disclosed the exact redemption price—shifting the focus from a generic debt description to explicit maturity‑related disclosure. After the notes matured in 2023, the 2024 filing no longer lists the 2.40 % Notes in the securities description; the only mention is a historical footnote summarizing the redemption and final settlement, showing that Apple’s disclosure evolved from proactive debt detailing to retrospective, post‑maturity reporting.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that Apple's disclosure approach for the 2.40% Notes due 2023 was consistent across 2022, 2023, and 2024, with identical treatment in each filing under Exhibit 4.3 and no changes in format or substance. The LLM claims an evolution: adding a 'Maturity and Redemption' paragraph in 2023, reclassifying the debt as current, disclosing redemption price, and removing it in 2024 with only a historical footnote. These details are not supported by the ground truth and represent a completely different narrative. (2) While the LLM correctly identifies the notes as 2.40% due 2023 and references Exhibit 4.3 and the Officer's Certificate dated May 3, 2013 (which aligns with the ground truth), it fabricates changes in disclosure structure and content that did not occur. There are no numerical values to verify (e.g., dollar amounts), but the dates and percentages mentioned (2.40%, 2023 maturity, May 3, 2013) are accurate. (3) The multi-hop reasoning is flawed: instead of recognizing consistency across filings, the model invents a progression in disclosure strategy—proactive to retrospective—without evidence. The ground truth emphasizes no change despite maturity, but the LLM asserts a shift in focus and classification, indicating a failure in synthesizing the correct pattern. (4) Contextual relevance is moderate because the answer addresses the right company, debt instrument, time frame, and exhibit number, and attempts to analyze disclosure evolution. However, the core factual claim—that the approach evolved—is false. Thus, despite some correct entities and context, the answer is factually wrong on the key point, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 476,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve grew from **127 million Class A ordinary shares** at the end of fiscal 2022 (as noted on page 91 of the 2022 10‑K) to **141 million shares** by the end of fiscal 2024 (page 98 of the 2024 10‑K).  This step‑up in the share‑authorisation ceiling shows that Accenture is deliberately expanding its equity‑award pool to sustain and broaden its long‑term share‑based compensation program, ensuring it can continue granting restricted‑share units and other equity incentives as the workforce and performance‑based reward strategy evolve.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the starting number of authorized shares in fiscal year 2022 (127 million) and the increased amount (141 million), which matches the ground truth. However, it incorrectly states that the increase occurred 'by the end of fiscal 2024' without acknowledging that the increase actually took place by fiscal 2023 and remained unchanged in 2024. This misrepresents the timeline and omits a key detail about the stability in 2024, leading to a partial factual inaccuracy. (2) The numbers themselves are accurate (127M and 141M), and there are no calculation errors. However, the failure to specify that the increase occurred between 2022 and 2023 — not gradually or only by 2024 — undermines the quantitative timeline accuracy. The answer implies a continuous or later change, which is incorrect. (3) The reasoning about Accenture's long-term share-based compensation strategy — expanding the equity pool to support ongoing incentives — is sound and aligns with the ground truth's interpretation. The synthesis of strategic intent from the numerical change is logically valid and contextually appropriate. (4) The answer is highly relevant and well-articulated, addressing both the numerical evolution and strategic implication. However, due to the omission of the 2023 increase and 2024 stability, it falls short on full completeness and temporal precision. A score of 7 is justified because core facts are correct but a significant multi-hop detail (the timing of the change) is misrepresented, affecting overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 429,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved PowerVia from a planned feature of the Intel 20A node—where it would deliver backside power delivery to achieve roughly a 15 % performance‑per‑watt boost (first highlighted in the 2022 roadmap on page 10)—to a core component of the subsequent Intel 18A process, which began high‑volume production in 2025 (the 18A description and its reliance on PowerVia appear on page 16). This progression demonstrates that PowerVia has become a strategic linchpin of Intel’s advanced‑node roadmap, enabling the company to push density and efficiency gains while supporting its IDM 2.0 and foundry ambitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies PowerVia's introduction in 2022 as part of Intel's roadmap, its implementation in Intel 20A, and the transition to Intel 18A as a core feature. The strategic importance in Intel's advanced process roadmap is accurately conveyed. (2) Quantitatively, the 15% performance-per-watt improvement is consistent with known disclosures (though not explicitly mentioned in the original answer, it is a plausible and publicly reported figure, so its inclusion does not detract from accuracy). The timeline is correct: 2022 introduction, 2023–2024 evolution, and 2025 high-volume manufacturing under Intel 18A. The only minor discrepancy is that the original answer specifies Intel canceled Intel 20A in favor of Intel 18A—this nuance is implied but not explicitly stated in the LLM answer. (3) The multi-hop reasoning is sound: the model synthesizes PowerVia’s technical role (backside power delivery), its progression across nodes (20A to 18A), and its strategic significance in performance, efficiency, and foundry ambitions. (4) The answer is contextually excellent, directly addressing the evolution and strategic implications. The mention of IDM 2.0 adds relevant context not in the original but consistent with Intel’s strategy. The answer earns a 9 due to the slight omission of the explicit cancellation of Intel 20A, but all key facts and logic are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 401,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "\nAccenture’s mutual‑fund equity exposure in its defined‑benefit pension assets fell from **$239.3 million in fiscal 2022** to **$196.2 million in fiscal 2023**, then rebounded sharply to **$273.7 million in fiscal 2024** (representing roughly 21 % → 17 % → 23 % of total plan assets, respectively).  The dip in 2023 reflects a temporary de‑risking/rebalancing, while the 2024 rebound shows a deliberate increase in equity‑based holdings, aligning with the company’s target allocation and its broader strategy of boosting long‑term returns from equities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Accenture's allocation to mutual fund equity securities decreased from $239,293 million in FY2022 to $196,226 million in FY2023 and remained flat in FY2024. The LLM incorrectly states that the amount rebounded to $273.7 million in FY2024, which contradicts the stable allocation in the original answer. Additionally, the LLM uses 'million' units (e.g., $239.3 million) instead of the correct 'thousands of millions' (i.e., billions), resulting in a 1,000-fold error in magnitude—$239.3 million vs. $239,293 million (~$239.3 billion). (2) Quantitative accuracy is severely compromised: the values for 2022 and 2023 are off by three orders of magnitude, and the 2024 figure is entirely incorrect—no increase occurred. The percentages cited (21%, 17%, 23%) are unsupported by the ground truth, which provides no such breakdown. (3) The multi-hop reasoning fails: the LLM infers a 'rebound' and 'strategic increase' in equity holdings, while the actual trajectory shows a reduction followed by stability, indicating a de-risking or rebalancing away from equities. The conclusion about strategic positioning is therefore opposite to the correct interpretation. (4) Contextual relevance is moderate—the response addresses the evolution across three years and attempts to interpret strategic intent—but due to fundamental data errors, the analysis is misleading. The entity (Accenture) and metric (mutual fund equity securities) are correctly identified, but fiscal year data is misaligned and misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 440,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "\nFrom 2022 through 2024 Merck kept Dificid on the books as a finite‑lived intangible asset (included in the $7.9 bn “products and product rights” intangible balance disclosed in the 2022 10‑K note 5 and carried forward without any impairment charge in the 2023 10‑K), indicating that the company still values the compound at its original cost less accumulated amortization. Therapeutically the drug’s positioning remained narrow‑spectrum fidaxomicin for C. difficile infection, but Merck treated it as a niche, high‑margin offering within the Hospital‑Acute‑Care portfolio rather than a growth driver, focusing instead on its flagship oncology and vaccine products. Globally, Dificid’s sales have risen modestly—from roughly $263 million in 2022 to $340 million in 2024 (≈ $303 U.S. + $37 International in 2024, page 129)—but it still accounts for less than 1 % of total segment sales, underscoring its limited contribution to Merck’s overall revenue compared with blockbuster lines such as Keytruda or Gardasil.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. While it correctly identifies Dificid's 2024 global sales as $340 million (with $303 million U.S. and $37 million international), matching the ground truth, it incorrectly states that Dificid generated $263 million in 2022, which contradicts the ground truth that does not provide 2022 revenue but only an asset valuation of $145 million. This is a significant factual error. The $145 million in 2022 refers to its balance sheet valuation as an intangible asset, not revenue, and the LLM conflates these two distinct financial metrics. (2) The quantitative accuracy is compromised because the LLM fabricates a $263 million revenue figure for 2022 with no support in the ground truth. Although the 2024 revenue numbers are correct and properly broken down, the incorrect 2022 figure undermines the trend analysis. Additionally, the claim that Dificid accounts for less than 1% of segment sales, while plausible, is not supported in the ground truth and introduces unsupported inference. (3) The reasoning is partially sound: the LLM correctly identifies Dificid as a finite-lived intangible asset and notes its presence in the Hospital Acute Care portfolio. It also correctly observes that Merck highlights it as a niche product. However, it fails to capture the evolution in strategic positioning from 2022 (asset valuation) to 2023 (explicit therapeutic positioning) as described in the ground truth. The LLM skips the 2023 strategic repositioning detail entirely, missing a key multi-hop element. (4) Despite these issues, the answer is contextually relevant and well-structured, addressing all three dimensions of the question (valuation, positioning, revenue). The qualitative reasoning is logical and uses appropriate financial terminology. However, the conflation of asset value with revenue and the introduction of an unsupported 2022 sales figure reduce factual correctness significantly. Hence, the correctness score is 6—partially correct but with major factual inaccuracies in key quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 562,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "\nFrom 2022 through 2024 Intel doubled‑down on Advanced Packaging as a cornerstone of its IDM 2.0 strategy, investing roughly $16‑$17 billion annually in R&D and capital to meet its 2024 performance‑per‑watt parity and 2025 leadership goals, yet it repeatedly missed node roll‑outs (e.g., Intel 7 delays and only limited 18A design wins in 2023) and suffered construction setbacks at its Ireland and Arizona joint‑ventures that triggered a $755 million derivative loss and could incur up to $1.1 billion in liquidated‑damage penalties; these execution delays, combined with the high fixed costs of packaging‑focused fabs and the need to purchase minimum output from new SCIP entities, expose Intel to substantial financial‑risk exposure and underutilization charges if demand does not materialize.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces unsupported quantitative claims not present in the ground truth. While it correctly identifies Intel's strategic focus on Advanced Packaging and IDM 2.0, it fabricates or misrepresents key financial figures and events. The $755 million derivative loss and up to $1.1 billion in liquidated damages are not mentioned in the original answer and lack corroboration in the knowledge base. Similarly, the claim of $16–17 billion annually in R&D and capital spending is not supported; the original answer does not specify R&D investment levels. The mention of 'SCIP entities' and 'minimum output purchases' introduces concepts absent from the ground truth. (2) The only financial figure in the original answer is the $3.1 billion impairment charge in 2024, which the LLM answer omits entirely and replaces with unrelated numbers. The LLM incorrectly attributes construction setbacks and penalties to 2022–2024 without grounding in the source. (3) The multi-hop reasoning is partially sound in linking advanced packaging to strategic goals and execution risks, and it correctly contextualizes delays and financial exposure. However, it fails to accurately trace the evolution from 2022 (complexity and cost) to 2023 (UCIe progress) to 2024 (impairment and execution risks), instead inserting unverified operational setbacks. The absence of UCIe, a key milestone in 2023, is a significant omission. (4) The contextual relevance is high because the answer addresses strategic positioning, execution challenges, and financial risks. However, due to major quantitative inaccuracies and missing core facts from the ground truth, the correctness score is low. The qualitative accuracy is moderate because the general direction of reasoning aligns with the question, but entity and factual errors undermine reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 510,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "\nFrom 2022 through 2024 the MK‑8591A program stayed in Phase 3/under FDA review, but in 2023 the Agency placed a partial clinical hold on the higher‑dose islatravir component, forcing Merck to revise the dosing strategy.  By the 2024 filing the company had moved to a next‑generation combination (MK‑8591D = islatravir + lenacapavir) scheduled for an October 2024 entry, indicating a strategic shift toward a longer‑acting, potentially once‑weekly regimen and a continued, high‑priority investment in HIV‑1 therapeutics.  (Pages 30, 27, 26, 31)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that MK-8591A was under FDA review from 2022–2024, while the ground truth confirms it remained in Phase 3 with no regulatory submission. (2) It claims a partial clinical hold was placed in 2023, but the truth is the FDA lifted a clinical hold in December 4, 2024, with a partial hold continuing on higher doses—this reverses both the timing and direction of the regulatory action. (3) The LLM introduces MK-8591D (islatravir + lenacapavir) entering in October 2024, which is not supported by the ground truth; no such compound or timeline is mentioned, indicating fabrication or confusion. While the answer correctly infers Merck’s continued strategic commitment to HIV therapeutics, this conclusion is based on incorrect premises. The multi-hop reasoning is flawed: it fails to accurately track the actual progression of MK-8591A and introduces non-grounded developments. Quantitative accuracy is low due to wrong dates (2023 hold vs. 2024 lift) and invented timelines (October 2024 entry). Qualitative accuracy is partially preserved in recognizing Merck’s ongoing investment, but entity and timeline errors reduce reliability. Contextual relevance is fair as it addresses the strategic intent question, albeit with incorrect supporting facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 376,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "\nFrom 2022 through 2024 Merck moved MK‑1308A from an early‑phase, broadly‑targeted CTLA‑4 + pembrolizumab exploration across several solid tumours into a late‑stage, pivotal Phase 3 program focused on renal‑cell carcinoma, positioning the fixed‑dose quavonlimab/pembrolizumab combination as a core immuno‑oncology asset.  During this period the programme obtained Breakthrough/Fast‑Track designation and entered the regulatory filing/submission stage, reflecting a clear shift toward advanced‑stage development and regulatory progress for MK‑1308A.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several key inaccuracies that significantly deviate from the ground truth. While it correctly identifies MK-1308A as a combination of quavonlimab and pembrolizumab and notes its focus on renal cell carcinoma (RCC) in a Phase 3 setting, it incorrectly states that the program moved from 'early-phase' in 2022 to 'pivotal Phase 3' by 2024—whereas the original answer confirms it was already in Phase 3 in 2022. This misrepresents the timeline and evolution of development. Additionally, the LLM claims the program received 'Breakthrough/Fast-Track designation' and 'entered the regulatory filing/submission stage' by 2024, which is not supported by the ground truth—there was no indication of regulatory approval or formal designation, only sustained development emphasis. These are major factual errors affecting both clinical focus progression and regulatory progress. The formulation strategy (coformulation) is mentioned in the original answer but only implied in the LLM response via 'fixed-dose combination.' The LLM does capture the increasing strategic importance and combination therapy aspect, showing partial correct synthesis. However, due to significant errors in regulatory status and development phase timeline—despite correct identification of drug components and disease focus—the correctness score is limited to 4. Quantitative accuracy is moderate (5) because no explicit numbers are wrong (no figures cited), but phase progression and regulatory milestones are factually incorrect. Qualitative accuracy is also 5 due to partial correct reasoning but flawed multi-hop synthesis—especially failing to accurately track the unchanged Phase 3 status from 2022 onward. Contextual relevance is high (8) as the response addresses all question dimensions (clinical focus, combination therapies, regulatory progress), even if with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 506,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "\nAccenture repurchased roughly $4.1 bn of Class A shares in fiscal 2022, $4.5 bn in fiscal 2023, and continued an aggressive buy‑back program in fiscal 2024 (e.g., $605 m in the fourth quarter alone), while the Board repeatedly expanded its repurchase authorization—from $6.13 bn after the 2022 increase to $6.69 bn after the 2024 approval—leaving about $2.7 bn of capacity under the existing program at year‑end 2024. This multi‑year trend shows a disciplined, progressive capital‑return strategy that uses excess cash to repurchase stock and regularly augments its authorization, underscoring confidence in cash generation and a commitment to returning surplus to shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures and misrepresents the timeline of share repurchase activity. According to the ground truth, Accenture did not repurchase $4.1 billion in fiscal 2022 or $4.5 billion in fiscal 2023—these numbers are entirely fabricated. The only actual repurchase data provided in the original answer is for fiscal 2024: $605 million in open-market purchases. There is no mention of repurchase amounts for 2022 or 2023 in the ground truth, so asserting specific figures for those years is incorrect. Additionally, the LLM claims a $6.13 billion authorization after a 2022 increase, but the ground truth states $3.13 billion available at the start of the period, with a $4 billion addition in September 2024, bringing total authority to $6.694 billion. The LLM incorrectly implies prior large authorizations that are not supported. (2) The only correct quantitative elements are the $605 million repurchase in fiscal 2024 and the remaining $2.7 billion (rounded from $2,694 million) of available authorization at year-end 2024. The $6.69 billion total outstanding authority after the 2024 approval is approximately correct ($6,694 million). However, all prior-year repurchase amounts and authorizations are wrong. (3) The multi-hop reasoning is partially sound in that the LLM identifies a pattern of replenishing repurchase authority and links it to capital return strategy, which aligns with the ground truth's conclusion about a 'sustained but measured' strategy. However, the reasoning is built on false numerical premises, undermining the validity of the synthesis. The mention of 'fourth quarter alone' is not supported—the $605 million is for the full fiscal 2024. (4) Despite the incorrect numbers, the LLM captures the general strategic intent—consistent repurchases and periodic authorization increases—so the qualitative direction is reasonable, and the answer remains contextually relevant to the question. However, the severe quantitative inaccuracies, especially inventing repurchase volumes for 2022 and 2023, result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 573,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "\nThe $750 million, 2.350 % Notes due 2040—originally issued in November 2020—are repeatedly listed in the Exhibit 4.6 sections of the 2022, 2023 and 2024 Form 10‑K filings, demonstrating that BMS continues to carry this long‑dated, fixed‑rate tranche as a core element of its capital structure. By retaining the note, BMS locks in low‑cost financing for the next two decades, stabilizes its interest‑expense profile and preserves flexibility to fund strategic priorities without resorting to more expensive or variable‑rate borrowings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitative elements are correct: the $750 million (equivalent to $750,000,000), 2.350% interest rate, and 2040 maturity date are all accurately reported. The mention of issuance in November 2020, while not in the original answer, is factually correct and adds context without contradicting the ground truth. (2) The LLM correctly identifies the consistent presence of the notes in the 2022, 2023, and 2024 Form 10-K filings, specifically citing Exhibit 4.6, which demonstrates precise sourcing. (3) The reasoning is sound: the answer correctly infers that retaining this fixed-rate debt reflects a strategic choice to lock in low-cost financing, stabilize interest expenses, and avoid variable-rate risk—directly mirroring the original answer’s conclusion about managing long-term interest rate risk. (4) The only minor gap is that the LLM does not explicitly note the absence of refinancing or retirement of the notes despite market fluctuations, a nuance emphasized in the original answer. However, the core strategic rationale is fully captured. Semantic equivalence is strong, with slightly more concise phrasing but no loss of key meaning. All entities (Bristol-Myers Squibb, the specific notes, years, and filing types) are correct. The answer is fully contextually relevant and addresses the multi-hop nature of the question by synthesizing data across years and interpreting strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 407,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "\nThe 4.350 % Senior Notes due 2047 were first issued in November 2019 (see the 2019 Form 8‑K referenced on pages 133‑134 and the 2020 supplemental indenture on page 136), and subsequent filings—including the 2020 supplemental indenture and the 2023 supplemental indenture (pages 136, 140)—simply add additional tranches under the same indenture without altering the coupon or maturity.  This consistent, unchanged terms across three recent filings reveal that BMS deliberately uses a long‑dated, fixed‑rate debt tranche to lock in financing costs for decades, reflecting a strategy of stable, low‑cost long‑term borrowing rather than frequent refinancing or exposure to interest‑rate volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core factual and strategic elements of the ground truth. (1) It correctly identifies the 4.350% interest rate and the 2047 maturity, and references the initial issuance in November 2019 via Form 8-K, which aligns with the ground truth. It also correctly notes the reaffirmation through supplemental indentures in 2020 and 2023. However, it omits specific exhibit references (e.g., Exhibit 4bbb in 2022, Exhibit 4ff in 2023 and 2024) and does not mention the Fourteenth Supplemental Indenture dated November 13, 2023, which is a minor but notable omission for completeness. (2) Quantitatively, all percentages and dates are accurate: 4.350%, 2019 issuance, 2020 and 2023 supplemental indentures. The LLM does not introduce any incorrect numbers or miscalculations. (3) The reasoning is sound: it correctly infers that unchanged terms across filings reflect a stable, long-term debt strategy aimed at locking in fixed-rate financing and avoiding interest rate volatility. This matches the ground truth's conclusion about transparency and predictability. However, it generalizes 'three recent filings' without explicitly confirming the rate in 2022, 2023, and 2024 as the ground truth does, relying instead on the pattern of supplemental indentures. (4) The answer is contextually relevant and directly addresses both parts of the question—evolution of the interest rate commitment and what it reveals about long-term financing strategy. While slightly less detailed in documentary specifics (exhibits, exact indenture names), the semantic meaning and strategic interpretation are equivalent. Minor deductions in quantitative and qualitative accuracy due to omitted exhibit details and less precise year-by-year confirmation, but overall a strong, factually correct response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 492,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Nike moved from a brief mention of FlyEase as an emerging innovation to a concrete disclosure of its production scale.  The 2024 Form 10‑K quantifies this by stating that FlyEase‑enabled apparel is produced by 68 contract manufacturers across 33 countries, with one supplier alone accounting for >10 % of apparel output and the top five together representing roughly 51 % of total apparel production; factories in Vietnam, China and Cambodia alone supply about 28 %, 16 % and 15 % of that apparel, demonstrating that FlyEase technology is now integrated into Nike’s global manufacturing network.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the data in the original answer. (1) Quantitatively, the LLM claims that FlyEase-enabled apparel is produced by 68 contract manufacturers across 33 countries, with Vietnam, China, and Cambodia producing 28%, 16%, and 15% of 'that apparel'—none of which appears in the original answer. The original answer discusses footwear (not apparel) and provides manufacturing shares for Vietnam (50%), Indonesia (27%), and China (18%)—not Cambodia—and these percentages refer to total Nike Brand footwear, not FlyEase-specific production. The claim about one supplier accounting for >10% and the top five representing 51% of apparel production is unsupported by the original and shifts focus to apparel, which is not mentioned in the context of FlyEase in the ground truth. (2) The original answer does not provide any contract manufacturer counts or country-level supplier distribution, so these numbers are fabricated. (3) Qualitatively, the LLM correctly identifies a progression in reporting—from emerging innovation to scaled production—but incorrectly frames the evolution around apparel rather than footwear, and fails to note the key point that FlyEase was grouped with core technologies like Nike Air by 2023. The multi-hop reasoning is flawed because it invents metrics instead of correctly synthesizing the geographic production data as evidence of integration. (4) Contextually, the answer attempts to address the question’s intent—demonstrating scale and integration—but does so with incorrect data and product categorization, undermining its validity. The mention of global manufacturing is relevant, but the evidence provided is not accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 466,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "\nTarget’s RedCard penetration has been falling steadily: the 2022 10‑K recorded a rate of roughly 20 percent, it slipped to 19.8 percent in fiscal 2023 and to 18.6 percent in fiscal 2024 (as disclosed in the 2023 and 2024 Form 10‑Ks). This downward trend shows that the discount‑driven loyalty‑payment model is losing its ability to generate incremental sales, indicating diminishing effectiveness of the current loyalty‑driven strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a declining trend in RedCard penetration from 2022 to 2024 and attributes it to weakening effectiveness of Target's loyalty-driven strategy, which aligns with the ground truth. However, the quantitative values are partially incorrect: the LLM states 20.0% for 2022 (ground truth: 20.5%), 19.8% for 2023 (correct), and 18.6% for 2024 (ground truth: 17.8%). These discrepancies, especially the 0.8 percentage point overstatement in 2024, affect factual accuracy. (2) The calculation of trend direction (declining) is correct, but the magnitude of decline is misrepresented. The actual drop from 20.5% to 17.8% is 2.7 percentage points, while the LLM implies a 1.4-point drop from 20.0% to 18.6%, underestimating the severity. (3) The multi-hop reasoning is sound—LLM synthesizes data across years and draws a logical conclusion about strategy effectiveness, showing understanding of the link between penetration rates and loyalty program performance. (4) Despite incorrect specific figures, the answer captures the core trend and strategic implication, warranting moderate scores: quantitative accuracy penalized due to significant percentage errors; qualitative accuracy is higher due to correct reasoning and entity identification (Target, RedCard, fiscal years, Form 10-K sourcing); contextual relevance is high as the response directly addresses both parts of the question—trend evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 405,
        "total_tokens": 1635
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 6.58,
    "average_quantitative_accuracy": 6.95,
    "average_qualitative_accuracy": 6.95,
    "average_contextual_relevance": 8.8,
    "score_distribution": {
      "excellent": 279,
      "good": 170,
      "fair": 233,
      "poor": 118
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 1138.45,
    "timestamp": "2026-02-03T01:22:52.738096"
  }
}